<SEC-DOCUMENT>0001493152-24-046303.txt : 20241115
<SEC-HEADER>0001493152-24-046303.hdr.sgml : 20241115
<ACCEPTANCE-DATETIME>20241115163039
ACCESSION NUMBER:		0001493152-24-046303
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		73
CONFORMED PERIOD OF REPORT:	20240630
FILED AS OF DATE:		20241115
DATE AS OF CHANGE:		20241115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fitell Corp
		CENTRAL INDEX KEY:			0001928581
		STANDARD INDUSTRIAL CLASSIFICATION:	 [3949]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41774
		FILM NUMBER:		241468314

	BUSINESS ADDRESS:	
		STREET 1:		23-25 MANGROVE LN
		STREET 2:		TAREN POINT
		CITY:			SYDNEY, NSW
		STATE:			C3
		ZIP:			2229
		BUSINESS PHONE:		61-1300 488 866

	MAIL ADDRESS:	
		STREET 1:		23-25 MANGROVE LN
		STREET 2:		TAREN POINT
		CITY:			SYDNEY, NSW
		STATE:			C3
		ZIP:			2229
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>form20-f.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:FTEL="http://fitellcorp.com/20240630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_FTEL_fitellcorp.com_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230701_20240630 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0001928581 -->
<!-- Field: Set; Name: xdx; ID: xdx_07A_XDX_form20%2Df.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_063_AUD_0_iso4217%2D%2DAUD -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000004" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000005" name="dei:EntityCentralIndexKey">0001928581</ix:nonNumeric>
  <ix:nonFraction name="FTEL:CapitalReceivablesOfConvertibleNotes" contextRef="AsOf2023-06-30" id="xdx2ixbrl0074" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesAndLoansReceivableNetCurrent" contextRef="AsOf2023-06-30" id="xdx2ixbrl0077" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-06-30" id="xdx2ixbrl0139" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-06-30" id="xdx2ixbrl0140" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:ConsultingFees" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0204" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:LicensingFees" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0219" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0291" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-07-012023-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0294" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0297" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0302" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0305" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0306" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0307" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0309" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0310" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0311" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0313" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0316" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0318" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0319" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0324" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0332" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0335" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0343" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0348" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0349" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0358" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0364" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0367" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0375" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0381" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0382" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0388" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0390" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0404" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0407" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0415" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0439" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:IncreaseDecreaseInPrepaidOfferingCosts" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireNotesReceivable" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0484" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0487" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:ProceedsFromIssuanceOfConvertibleNotes" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0499" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0528" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:CapitalReceivableOfConvertibleNotes" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0532" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:OperatingLeaseLiabilityAndRightOfUseAsset" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0535" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:ConversionOfDebtToEquity" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0538" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:ConversionOfWarrantsOfConvertibleNotesToEquity" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0541" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:ConversionOfUnderwritersWarrantToEquity" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0544" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0736" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0738" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0744" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0746" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0752" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0754" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0760" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0762" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember" id="xdx2ixbrl0786" name="us-gaap:WarrantsAndRightsOutstandingTerm">P5Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-06-30_us-gaap_WarrantMember" id="xdx2ixbrl0810" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="FTEL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" contextRef="AsOf2023-06-30_us-gaap_WarrantMember" id="xdx2ixbrl0812" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="FTEL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953" id="xdx2ixbrl0822" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2024-06-30_us-gaap_WarrantMember175940953" id="xdx2ixbrl0824" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="FTEL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" contextRef="AsOf2024-06-30_us-gaap_WarrantMember175940953" id="xdx2ixbrl0826" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0935" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" contextRef="From2023-07-01to2024-06-30" id="xdx2ixbrl0947" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseDebtDiscount" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0951" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0954" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0957" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0960" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" contextRef="From2022-07-012023-06-30" id="xdx2ixbrl0963" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" contextRef="AsOf2024-06-30" id="xdx2ixbrl0976" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" contextRef="AsOf2023-06-30" id="xdx2ixbrl0986" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="FTEL:DeferredTaxAssetsAccumulatedTaxLoss" contextRef="AsOf2023-06-30" id="xdx2ixbrl0989" unitRef="USD" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ftel-20240630.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-07-01to2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_MerchandiseRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:MerchandiseRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_MerchandiseRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:MerchandiseRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_SalesOfConsumableProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:SalesOfConsumableProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_SalesOfConsumableProductsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:SalesOfConsumableProductsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_RevenueFromLicensingCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:RevenueFromLicensingCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_RevenueFromLicensingCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:RevenueFromLicensingCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_FitellCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:FitellCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_FitellCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:FitellCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:KMASCapitalAndInvestmentPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:KMASCapitalAndInvestmentPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:KMASCapitalAndInvestmentPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_GDWellnessPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:GDWellnessPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_GDWellnessPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:GDWellnessPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_GDWellnessPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:GDWellnessPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_OneVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:OneVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:TwoVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_OneVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:OneVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:TwoVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_ThreeVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:ThreeVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_ThreeVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:ThreeVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_FourVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:FourVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_WarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_WarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_WarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_WarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-15_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-152024-01-15_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-15</xbrli:startDate>
        <xbrli:endDate>2024-01-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-15_custom_WarrantTwoMember_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_WarrantMember175940953">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_WarrantMember175940953">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-022023-08-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-02</xbrli:startDate>
        <xbrli:endDate>2023-08-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001928581</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="AUD">
      <xbrli:measure>iso4217:AUD</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">UNITED
STATES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Mark
One)</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">FORM
<span id="xdx_900_edei--DocumentType_c20230701__20240630_zztwFzsc6U9a"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000012" name="dei:DocumentType">20-F</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: center; width: 0.25in"><span id="xdx_90B_edei--DocumentRegistrationStatement_c20230701__20240630_zUwOsc6EtMZ8"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000013" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric></span></td>
  <td style="text-align: justify"><b>REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OFTHE SECURITIES EXCHANGE ACT OF 1934</b></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: center; width: 0.25in"><span id="xdx_907_edei--DocumentAnnualReport_c20230701__20240630_zvHDDkaSiolb"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></td>
  <td style="text-align: left"><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNUALREPORT
PURSUANT TO SECTION 13 OR 15(d) OFTHE SECURITIES EXCHANGE ACT OF 1934</span></p>
                               <p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the fiscal year ended <span style="text-decoration: underline"><span id="xdx_903_edei--DocumentPeriodEndDate_c20230701__20240630_zkDt0HzvVS0d"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:datemonthdayyearen" id="Fact000015" name="dei:DocumentPeriodEndDate"><span id="xdx_90F_edei--CurrentFiscalYearEndDate_c20230701__20240630_zIFtGXHgOGTh"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:datemonthdayen" id="Fact000016" name="dei:CurrentFiscalYearEndDate">June 30</ix:nonNumeric></span>, <span id="xdx_901_edei--DocumentFiscalYearFocus_c20230701__20240630_z0HtuRff1fW4"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000017" name="dei:DocumentFiscalYearFocus">2024</ix:nonNumeric></span></ix:nonNumeric></span></span></b></span></p>

</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: center; width: 0.25in"><span id="xdx_902_edei--DocumentTransitionReport_c20230701__20240630_ziee0YfNVaHb"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000018" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION REPORT PURSUANT
  TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: center; width: 0.25in"><span id="xdx_907_edei--DocumentShellCompanyReport_c20230701__20240630_zntokDmbAGEh"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000019" name="dei:DocumentShellCompanyReport">&#9744;</ix:nonNumeric></span></td>
  <td style="text-align: justify"><b>SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 28.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of event requiring this shell company report</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the transition period from __________________ to ____________________</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
file number: <span id="xdx_90D_edei--EntityFileNumber_c20230701__20240630_zXxVbTF6Kvmd"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000020" name="dei:EntityFileNumber">001-41774</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20230701__20240630_zGX4SgKMDaNk"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000021" name="dei:EntityRegistrantName">FITELL
CORPORATION</ix:nonNumeric></span></b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20230701__20240630_zntjkIsLlo3f"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:edgarprovcountryen" id="Fact000022" name="dei:EntityIncorporationStateCountryCode">Cayman
Islands</ix:nonNumeric></span></b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Jurisdiction
of incorporation or organization)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20230701__20240630_z8cVBl6eGSw1"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000023" name="dei:EntityAddressAddressLine1">23-25
Mangrove Lane</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressAddressLine2_c20230701__20240630_zDyVJXjsDgo7"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000024" name="dei:EntityAddressAddressLine2">Taren
Point</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressCityOrTown_c20230701__20240630_z7Dqbt0XIE2k"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000025" name="dei:EntityAddressCityOrTown">NSW</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20230701__20240630_zZr316Lapx0k"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000026" name="dei:EntityAddressPostalZipCode">2229</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressCountry_c20230701__20240630_z4vflQevPAKg"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:countrynameen" id="Fact000027" name="dei:EntityAddressCountry">Australia</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>+612
95245266</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--ContactPersonnelName_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zYsjJ2EN8wFk"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000028" name="dei:ContactPersonnelName">Cogency
Global Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zy6LSeyzTbqh"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000029" name="dei:EntityAddressAddressLine1">122
East 42nd Street</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z14ckxXJury5"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000030" name="dei:EntityAddressAddressLine2">18th Floor</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zsw4oquRqkCl"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000031" name="dei:EntityAddressCityOrTown">New
York</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z87mgbh0mKB"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000032" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zKbcPwZaVP36"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000033" name="dei:EntityAddressPostalZipCode">10168</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--CityAreaCode_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zQud4WwhaRB9"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000034" name="dei:CityAreaCode">(800)</ix:nonNumeric></span>
<span id="xdx_90A_edei--LocalPhoneNumber_c20230701__20240630__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zbimcA7sd9vc"><ix:nonNumeric contextRef="From2023-07-012024-06-30_dei_BusinessContactMember" id="Fact000035" name="dei:LocalPhoneNumber">221-0102</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities registered or to be registered pursuant to
Section 12(b) of the Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--Security12bTitle_c20230701__20240630_z6IhG6N6IjO3"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000036" name="dei:Security12bTitle">Ordinary
    Shares, par value $0.0001 per share</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--TradingSymbol_c20230701__20240630_zPGAGAxula57"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000037" name="dei:TradingSymbol">FTEL</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    <span id="xdx_906_edei--SecurityExchangeName_c20230701__20240630_z1UG7cGx87Re"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:exchnameen" id="Fact000038" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered or to be registered pursuant to Section 12(g) of the Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title
of Class)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
for which there is a reporting obligation pursuant to Section 15(d) of the Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title
of Class)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered
by the annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityCommonStockSharesOutstanding_iI_c20240630_zAMnxGkP5V7e"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000039" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,123,386</ix:nonFraction></span>
Ordinary Shares were outstanding as of June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&#9744;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes&#160;&#9746;&#160;<span id="xdx_904_edei--EntityWellKnownSeasonedIssuer_c20230701__20240630_z8xgKUaCXkDc"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000040" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&#9744;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Yes&#160;&#9746;&#160;<span id="xdx_906_edei--EntityVoluntaryFilers_c20230701__20240630_zlPRRLivKPl1"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000041" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
&#8211; Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 from their obligations under those Sections.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right">&#9746;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityCurrentReportingStatus_c20230701__20240630_zrJn6f7zPNJ1"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000042" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;&#9744;&#160;No</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&#9746;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityInteractiveDataCurrent_c20230701__20240630_zYrQtqA6Vzmf"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000043" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;&#9744;&#160;No</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth
company. See definition of &#8220;large accelerated filer, &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221;
in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer&#160;&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span>&#160;&#9744;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityFilerCategory_c20230701__20240630_zo90hde5TSF1"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt-sec:entityfilercategoryen" id="Fact000044" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span></span>&#160;&#9744;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</span>&#160;<span id="xdx_905_edei--EntityEmergingGrowthCompany_c20230701__20240630_zyE3OXQawrHc"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleantrue" id="Fact000045" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided
pursuant to Section 13(a) of the Exchange Act. <span id="xdx_905_edei--EntityExTransitionPeriod_c20230701__20240630_zpWCNbHbUpV4"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000046" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;
The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards
Board to its Accounting Standards Codification after April 5, 2012.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the
effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.
7262(b) by the registered public accounting firm that prepared or issued its audit report. <span id="xdx_90F_edei--IcfrAuditorAttestationFlag_c20230701__20240630_zcFmBn1aHTb4"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000047" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. <span id="xdx_90C_edei--DocumentFinStmtErrorCorrectionFlag_c20230701__20240630_zvvENxU0ZfNl"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000048" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>Indicate by check mark whether
any of those error corrections are restatements that required a recovery analysis of incentive- based compensation received by any of
the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-Indicate by check mark which
basis of accounting the registrant has used to prepare the financial statements included in this filing:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--DocumentAccountingStandard_c20230701__20240630_zQHzpBZZJibi"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000049" name="dei:DocumentAccountingStandard">U.S. GAAP</ix:nonNumeric></span></span>&#160;&#9746;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International
    Financial Reporting Standards as issued Other by the International Accounting Standards Board</span>&#160;&#9744;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span>&#160;&#9744;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
&#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the
registrant has elected to follow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&#9744;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
17 &#9744; Item 18</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;&#160;Yes&#160;<span id="xdx_906_edei--EntityShellCompany_dbF_c20230701__20240630_zJ17GRLMsyhc"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" format="ixt:booleanfalse" id="Fact000050" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span>&#160;No</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(APPLICABLE
ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right">&#9744;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes&#160;&#9744;&#160;No</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table
of Contents</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br/> </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PAGE</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#me_001">PART I</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#me_002">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#me_003">OFFER STATISTICS AND EXPECTED TIMETABLE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#me_004">KEY INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#me_005">INFORMATION ON THE COMPANY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">21</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    4A</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#nd_001">UNRESOLVED STAFF COMMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#nd_002">OPERATING AND FINANCIAL REVIEW AND PROSPECTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">32</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#nd_003">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">41</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#nd_004">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#nd_005">FINANCIAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">47</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#nd_006">THE OFFER AND LISTING</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">48</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#nd_007">ADDITIONAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_001">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">62</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_002">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#sw_003">PART II</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_004">DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_005">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">63</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    15 </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_006">CONTROLS AND PROCEDURES.</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_007">[RESERVED]</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_008">AUDIT COMMITTEE FINANCIAL EXPERT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_009">CODE OF ETHICS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_010">PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_011">EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">65</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_012">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16F.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_013">CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16G.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#nd_009">CORPORATE GOVERNANCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM16H.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_014">MINE SAFETY DISCLOSURE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16I.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_015">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16J.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_016">INSIDER TRADING POLICIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16K.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_017">CYBERSECURITY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#sw_018">PART III</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">68</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_019">FINANCIAL STATEMENTS.</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_020">FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">68</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    19 </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sw_021">EXHIBITS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">68</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><a href="#nd_008">SIGNATURES</a></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Certain Defined Terms</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated or the context requires otherwise, references in this annual report to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;AUD&#8221; are to Australian Dollars, the legal currency of Australia;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;Companies Act&#8221; are to the Companies Act (Revised), as consolidated and revised, of the Cayman Islands;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;Exchange Act&#8221; are to the Securities Exchange Act of 1934, as amended;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;FINRA&#8221; are to the Financial Industry Regulatory Authority;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;Fitell,&#8221; &#8220;<span style="background-color: white">the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;
refer to Fitell Corporation,</span> a Cayman Islands exempted company</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporated
under the laws of Cayman Islands on April 11, 2022, <span style="background-color: white">and its consolidated subsidiaries, through
which it conducts its business</span>;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;FY2022&#8221; are to the financial year ended June 30, 2022;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;FY2023&#8221; are to the financial year ended June 30, 2023;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;FY2024&#8221; are to the financial year ended June 30, 2024;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;GD&#8221; are to GD Wellness Ptd Ltd, a wholly-owned operating subsidiary of KMAS, incorporated under the laws of Australia on
July 22, 2005;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;IPO&#8221; are to the Company&#8217;s initial public offering which was consummated on August 10, 2023;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;KMAS&#8221; are to KMAS Capital and Investment Pty Ltd, a company incorporated under the laws of Australia on July 26, 2016, a
wholly-owned subsidiary of Fitell which holds all of the issued and outstanding shares of our operating subsidiary GD;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;$,&#8221; &#8220;U.S. dollars,&#8221; or &#8220;dollars&#8221; are to the legal currency of the United States;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;SEC&#8221; are to the Securities and Exchange Commission;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;Securities Act&#8221; are to the Securities Act of 1933, as amended;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;Shares&#8221;, &#8220;shares,&#8221; or &#8220;Ordinary Shares&#8221; are to the Ordinary Shares of Fitell Corporation, par value
$0.0001 per share; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
&#8220;SKMA&#8221;, are to a company owned by Ms. Jieting Zhao, incorporated under the laws of the British Virgin Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is and has been conducted in Australia through our Australian subsidiary GD Wellness Pty Ltd since our inception, using Australian
dollars, the currency of Australia. Our financial statements are presented in United States dollars. In this annual report, we refer
to assets, obligations, commitments and liabilities in our financial statements in United States dollars. These dollar references are
based on the exchange rate of Australian dollars to United States dollars, determined as of a specific date or for a specific period.
Changes in the exchange rate will affect the amount of our obligations and the value of our assets in terms of United States dollars
which may result in an increase or decrease in the amount of our obligations (expressed in dollars) and the value of our assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report on Form 20-F contains forward-looking statements that involve risks and uncertainties, including statements relating to
our future financial performance and results, financial condition, business strategy, plans, goals and objectives, including certain
projections, milestones, targets, business trends, and other statements that are not historical facts. These forward-looking statements
are made under the &#8220;safe harbor&#8221; provision under Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange
Act, and as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified
by the words &#8220;budget,&#8221; &#8220;target,&#8221; &#8220;aim,&#8221; &#8220;strategy,&#8221; &#8220;guidance,&#8221; &#8220;outlook,&#8221;
&#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;continuing,&#8221; &#8220;ongoing,&#8221;
&#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;could&#8221;
and similar expressions denoting uncertainty or an action that may, will or is expected to occur in the future; although, not all forward-looking
statements contain these identifying words. These statements involve estimates, assumptions, known and unknown risks, uncertainties and
other factors that could cause actual results to differ materially from any future results, performances or achievements expressed or
implied by the forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements include, but are not limited to, statements concerning:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    timing of the development of future services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">projections
    of revenue, earnings, capital structure and other financial items;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">statements
    regarding the capabilities of our business operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">statements
    of expected future economic performance;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">statements
    regarding competition in our market; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumptions
    underlying statements regarding us or our business.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements are subject to a number of risks and uncertainties, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    dependence on macroeconomic conditions and consumer discretionary spending;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    intense competition in the gym and fitness equipment industry;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impacts of the COVID-19 pandemic on our business and results of operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
    in product costs and availability;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">international
    risks and costs associated with our supply chain;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in consumer demand;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    associated with operating our own online platform, including confidential consumer data;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reputational
    harms which could adversely impact our ability to attract and retain customers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potentially negative impact of our strategic plans and initiatives on our financial results;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unauthorized
    disclosure of sensitive or confidential customer, vendor, or our information;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability to attract, train, engage, and retain key personnel;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    loss of one or more of our key executives;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effect of design and manufacturing defects on our products and services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    adverse effects from accidents, safety incidents, or workforce disruptions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability to sustain pricing levels for our products and services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk of warranty claims and product returns;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in marketing of our products and services which could affect our marketing expenses and subscription levels;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    need for additional capital to support business growth and objectives;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">payment
    processing risk;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign
    currency exchange rate fluctuations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    dependence on suppliers and manufactures to provide us with sufficient quantities of quality products in a timely fashion;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    limited control over our suppliers, manufacturers, and logistics partners;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    costs and risks associated with our complex regulatory, compliance, and legal environment;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability or failure to protect our intellectual property rights;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in tax laws and regulations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    to comply with the U.S. Foreign Corrupt Practices Act of 1977 (the &#8220;FCPA&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    status as a &#8220;foreign private issuer&#8221; under U.S. securities laws and the disclosure obligations which are applicable to
    us on the Nasdaq Capital Market;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    use of home country corporate governance practices instead of otherwise applicable Nasdaq corporate governance requirements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    accuracy of our market growth forecasts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    management team&#8217;s limited experience managing a public company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk of earthquakes, fire, power outages, floods, public health crises, including the COVID-19 pandemic, and other catastrophic
    events, and to interruption by man-made problems such as terrorism;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    status as an &#8220;emerging growth company&#8221; and our election to comply with the reduced disclosure requirements as a public
    company that may make our Ordinary Shares less attractive to investors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that Ms. Jieting Zhao may have different interests than that of other shareholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the risk that Flying Height Consulting Services Limited may have different
interests than that of other shareholders;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">the risk that if we fail to establish and maintain an effective system
of internal control over financial reporting, our ability to accurately and timely report our financial results or prevent fraud may be
adversely affected, and investor confidence and the market price of our Ordinary Shares may be adversely impacted;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    intention to not pay dividends for the foreseeable future;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that an active, liquid trading market may not develop or be sustained for our Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that the laws of the Cayman Islands may not provide our shareholders with benefits comparable to those provided to shareholders
    of corporations incorporated in the United States; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that, because we are a Cayman Islands company and all of our business is conducted in Australia, you may be unable to bring
    an action against us or our officers and directors or to enforce any judgment you may obtain, and the U.S. regulatory bodies may
    be limited in their ability to conduct investigations or inspections of our operations in Australia; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we believe these expectations, and the estimates and projections on which they are based, are reasonable and were made in good faith,
the ultimate correctness of these forward-looking statements depends upon a number of known and unknown risks, uncertainties, events,
and other important factors, which include, but are not limited to, the risks disclosed in &#8220;Item 3. Key Information&#8212;3D. Risk
Factors&#8221; of this annual report. Any of these risk factors could cause our actual results, performance or achievements, or industry
results to differ materially from those expressed or implied in our forward-looking statements. Consequently, you should not rely on
any of these forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation
to correct, update, or revise any forward-looking statement to reflect new information, future events or circumstances, or otherwise,
except to the extent required under federal securities laws, after the date on which the statement is made or to reflect the occurrence
of unanticipated events. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or
combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. You are
advised to consult any additional disclosures we make in our other SEC filings. All subsequent written and oral forward-looking statements
attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in
this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="me_001"></span>PART
I</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_002"></span>Item 1.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identity of Directors, Senior Management and Advisers</b></span></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_003"></span>Item 2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offer Statistics and Expected Timetable</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_004"></span>Item 3.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key Information</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved]</span></td></tr>
</table>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
  <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Capitalization and indebtedness.</i></b></span></td></tr>
</table>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
  <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reasons for the offer and use of proceeds.</i></b></span></td></tr>
</table>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable<b>.</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
  <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risk Factors</i></b></span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should carefully consider each of the following risks and all the other information contained in this annual report and in our other
filings with the SEC in evaluating us and our common stock. Although the risks are organized by headings, and each risk is discussed
separately, many are interrelated. Our business, financial condition, results of operations and cash flows could be materially and adversely
affected by these risks, and, as a result, the trading price of our common stock could decline. We have in the past been adversely affected
by certain of, and may in the future be affected by, these risks. You should not interpret the disclosure of any risk factor to imply
that the risk has not already materialized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Risks
Related to Our Industry and Macroeconomic Conditions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business is dependent on macroeconomic conditions and consumer discretionary spending, and reductions in such spending might adversely
affect the Company&#8217;s business, operations, liquidity, and financial results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an online retailer of gym and fitness equipment both under our proprietary brands and other brand names. Fitell&#8217;s mission is
to build an ecosystem with a whole fitness and wellness experience powered by technology to our customers. Our business depends on consumer
discretionary spending, and our results are highly dependent on Australian and Asian consumer confidence and the health of the Australian
and Asian economies. Consumer spending may be affected by many factors outside of the Company&#8217;s control, including general economic
conditions; consumer disposable income; consumer confidence and perception of economic conditions; the threat or outbreak of war, terrorism
or public unrest (including, without limitation, the conflict in Ukraine) which may cause supply chain disruptions, increased fuel costs
and the cost of materials, and create general economic instability; wage and unemployment levels; consumer debt and inflationary pressures;
the costs of basic necessities and other goods; effects of weather and natural disasters caused by climate change or otherwise; and epidemics,
contagious disease outbreaks, and other public health concerns including the ongoing COVID-19 pandemic. Decreases in consumer discretionary
spending may result in a decrease in comparable sales, and average value per transaction, which might cause us to increase promotional
activities, which will have a negative impact on our gross margins, all of which could negatively affect the Company&#8217;s business,
operations, liquidity, and financial results, particularly if consumer spending levels are depressed for a prolonged period of time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Uncertain
global economic conditions could have a material adverse effect on our business, financial condition, results of operations or prospects.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial results are tied to global economic conditions and their impact on levels of consumer confidence and consumer spending. Global
consumer markets can be impacted by significant U.S. and international economic downturns, such as the current levels of inflation and
the global credit crunch experienced in 2008. Continued high levels of inflation or a return to a recession or a weak recovery, due to
factors that include, but are not limited to, disruptions in financial markets in the United States, or elsewhere, federal budget, tax
or trade policy issues in the United States, political upheavals, war or unrest economic sanctions against trading nations, and demonetization,
could cause us to experience revenue declines due to deteriorated consumer confidence and spending, and a decrease in the availability
of credit or on commercially acceptable terms, which could have a material adverse effect on our business prospects or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is also dependent upon certain industries, such as the gym, fitness, and fitness equipment industries, and these are also cyclical
in nature. Therefore, these industries may experience their own significant fluctuations in demand for our products based on such things
as economic conditions and consumer demand. Many of these factors are beyond our control. As a result of the volatility in the industries
we plan to serve, we may ultimately have difficulty increasing or maintaining our level of sales or profitability. If the industries
we serve were to suffer a downturn, then our business may be further adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intense
competition in the gym and fitness equipment industry and in retail could limit our growth and reduce our profitability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for gym and fitness equipment retailers is highly fragmented, intensely competitive, and continually evolving. We compete with
retailers from multiple categories and in multiple channels, including large formats; traditional and specialty formats; mass merchants;
department stores; internet-based and direct-sell retailers; and increasingly from vendors that sell directly to customers. Our competitors
include companies that may have greater market presence (both brick and mortar and online), name recognition and financial, marketing
and other resources than we do. Further, the ability of consumers to compare prices in real-time puts additional pressure on us to maintain
competitive pricing. If we are unsuccessful in marketing and advertising strategies, especially for online and social media platforms,
or less successful than our competitors, we could lose customers and sales could decline, which could have an adverse impact on our revenues,
business, and results of operations. Furthermore, we cannot be sure that we will be able to continue to effectively compete in our markets
due to the disruptions caused by the COVID-19 pandemic or that any of our competitors are not in a better position to either respond
to the disruptions caused by the COVID-19 pandemic or capitalize on potential displaced market share, including vendors with whom we
compete accelerating their existing efforts to sell directly to consumers. An inability to successfully respond to competitive pressures
could have a material adverse effect on our results of operations or reputation. Our responses to competitive pressures could also have
a material effect on our results or reputation, including as it relates to pricing, quality, assortment, advertising, service, locations,
and online shopping experiences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Industry
consolidation may result in increased competition, which could have a material adverse effect on our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our competitors have made, or may make acquisitions or enter into partnerships or other strategic relationships to achieve competitive
advantages. In addition, new entrants not currently considered competitors may enter our market through acquisitions, partnerships or
strategic relationships. We expect industry consolidation to continue and/or increase. Industry consolidation may result in competitors
with more compelling product offerings or greater pricing flexibility than we may have, or business practices that make it more difficult
for us to compete effectively, including on the basis of price, sales, technology or supply. These competitive pressures could have a
material adverse effect on our business.</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 100%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fluctuations
in product costs and availability due to inflationary pressures, fuel price uncertainty, supply chain constraints, increases in commodity
prices, labor shortages and other factors could negatively impact our business and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product costs are affected, in part, by the costs of component materials. A substantial increase in the prices of raw materials or decrease
in the availability of raw materials could dramatically increase the costs associated with manufacturing the equipment that we purchase
from our vendors, which could cause the price of our merchandise to increase and could have a negative impact on our sales and profitability.
In addition, increases in commodity prices could also adversely affect our results of operations. If we increase the price of our products
in order to maintain gross margins for our products, such increase may adversely affect demand for, and sales of, our products, which
could have a material adverse effect on our financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely upon various means of third-party transportation to deliver products from vendors and our manufacturing facilities to our customers.
Consequently, our results may be affected by those factors affecting transportation, including the price of fuel and the availability
of aircraft, ships, trucks, and drivers. The price of fuel and demand for transportation services has fluctuated significantly in recent
years, and has resulted in increased costs for us and our vendors. In addition, changes in regulations may result in higher fuel costs
through taxation, transportation restrictions or other means. Fluctuations in transportation costs and availability could adversely affect
our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labor
shortages in the transportation industry could negatively affect transportation costs and our ability to transport products to our customers
in a timely manner. Our results of operations may be adversely affected if we, or our vendors, are unable to secure adequate transportation
resources at competitive prices to fulfill our delivery schedules. Further, difficulties in moving products manufactured overseas and
through the ports of other jurisdictions, whether due to port congestion, government shutdowns, labor disputes, product regulations and/or
inspections or other factors, including natural disasters or health pandemics, could negatively affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Approximately
85% of the products that the Company purchased in the fiscal year ended June 30, 2024, were manufactured abroad, which subjects us to
various international risks and costs, including foreign trade issues, currency exchange rate fluctuations, shipment delays and supply
chain disruption and political instability, which could cause our sales and profitability to suffer.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
85% of the products that the Company purchased in the fiscal year ended June 30, 2024, were manufactured abroad in China. Foreign imports
subject us to risk relating to changes in import duties quotas, the introduction of taxes on imported goods or the extension of income
taxes on our foreign suppliers&#8217; sales of imported goods through the adoption of destination-based income tax jurisdiction, freight
cost increases and economic and political uncertainties. We may also experience shipment delays caused by shipping port constraints,
labor strikes, work stoppages, acts of war, including the current conflict in Ukraine, and terrorism, or other supply chain disruptions,
including those caused by extreme weather, natural disasters, and pandemics and other public health concerns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of these or other factors, including trade tensions between foreign nations, including China and Russia, were to cause a disruption
of trade from the countries in which our vendors&#8217; supplies are located, our inventory levels may be reduced and/or the cost of
our products may increase. We may need to seek alternative suppliers or vendors, raise prices, or make changes to our operations, any
of which could have a material adverse effect on our sales and profitability, results of operations and financial condition. Additionally,
we could be impacted by negative publicity or, in some cases, face potential liability to the extent that any foreign manufacturers from
whom we directly or indirectly purchase products utilize labor, environmental, workplace safety and other practices that vary from those
commonly accepted in Australia. Also, the prices charged by foreign manufacturers may be affected by the fluctuation of their local currency
against the Australian dollar and the price of raw materials, which could cause the cost of our products to increase and negatively impact
our sales or profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to manage inventory at optimal levels could adversely affect our business, financial condition and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to manage a large volume of inventory effectively for our business. We depend on our forecasts for the anticipated demand
for our products to make procurement plans and manage our inventory. Our forecast for demands, however, may not accurately reflect the
actual market demands, which depends on a number of factors including, without limitation, launches of new products, changes in product
life cycles and pricing, product defects, changes in user spending patterns, supplier back orders and other supplier-related issues,
as well as the volatile economic environment in the markets where we sell our products. We cannot assure you that we will be able to
maintain proper inventory levels for our business at all times, and any such failure may have a material and adverse effect on our business,
financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
levels in excess of demand may result in inventory write-downs or an increase in inventory holding costs and a potential negative effect
on our liquidity. As we plan to continue expanding our product offerings, we expect to include more products in our inventory, which
will make it more challenging for us to manage our inventory effectively and will put more pressure on our warehousing system. If we
fail to manage our inventory effectively, we may be subject to a heightened risk of inventory obsolescence, a decline in inventory values,
and significant inventory write-downs or write-offs. In addition, we may be required to lower sale prices in order to reduce inventory
level, which may lead to lower gross margins. High inventory levels may also require us to commit substantial capital resources, preventing
us from using that capital for other important purposes. Any of the above may materially and adversely affect our results of operations
and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s intangible assets consist of brand names and goodwill. At June 30, 2024 and 2023, the Company had brand names and goodwill
with costs of approximately $337,504 and $1,161,052, respectively, which all have indefinite lives. The Company evaluates intangible
assets with indefinite lives for impairment at least annually or when events or changes in circumstances indicate that an impairment
may exist. The Company determined that none of its intangible assets were impaired in the fiscal year ended June 30, 2024, and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversely,
if we underestimate customer demand, or if our suppliers fail to provide products to us in a timely manner, we may experience inventory
shortages, which may, in turn, require us to purchase our products at higher costs, leading to a negative impact on our financial condition
and our relationships with distributors. Under-stocking can lead to missed sales opportunities, while over-stocking could result in inventory
depreciation and decreased shelf space for stocks that are in higher demands. These results could adversely affect our business, financial
condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Russia&#8217;s
invasion of Ukraine may present risks to our operations and investments.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russia&#8217;s
recent military interventions in Ukraine have led to, and may lead to, additional sanctions being levied by the United States, European
Union and other countries against Russia. Russia&#8217;s military incursion and the resulting sanctions could adversely affect global
financial markets and thus could affect the value of our operations and investments, even though we do not have any direct exposure to
Russia or the adjoining geographic regions. Currently, we do not do any business with parties in Russia, Ukraine or Belarus, nor are
any of the products that we sell or the parts for such products manufactured in Russia, Ukraine or Belarus. In addition, Russia&#8217;s
invasion of Ukraine and the international sanctions against Russia that followed the invasion have not had a direct effect on our business.
The extent and duration of the military action, sanctions, and resulting market disruptions are impossible to predict, but could be substantial.
Any such disruptions caused by Russian military action or resulting sanctions may magnify the impact of other risks described in this
section. We cannot predict the progress or outcome of the situation in Ukraine, as the conflict and governmental reactions are rapidly
developing and beyond their control. Prolonged unrest, intensified military activities, or more extensive sanctions impacting the region
could have a material adverse effect on the global economy, and such effect could in turn have a material adverse effect on our operations,
results of operations, financial condition, liquidity and business outlook.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Risks
Related to Our Business</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to predict or effectively react to changes in consumer demand, we may lose customers and our sales may decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends in part on our ability to anticipate and respond in a timely manner to changing consumer demand, preferences, and shopping
patterns, which cannot be predicted with certainty and are subject to continual change and evolution. We strive to deliver a seamless
shopping experience to our customers through online shopping experiences. For example, we must meet athletes&#8217; expectations with
respect to, among other things, creating appealing and consistent online experiences; delivering elevated customer service; and providing
fast and reliable delivery, and convenient return options. Our customers have expectations about how they shop through eCommerce or more
generally engage with businesses across different channels or media (through online and other digital or mobile channels or particular
forms of social media), which may vary across demographics and may evolve rapidly. If we are unable to provide an online retail experience
across all channels that aligns with our customers&#8217; expectations and preferences, it could have an adverse impact on our revenues,
business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
often make advance commitments to purchase products, which may make it more difficult for us to adapt to rapidly-evolving changes in
consumer preferences. Furthermore, supply chain challenges due to the COVID-19 pandemic and other factors have made it more difficult
to obtain certain in-demand products. Our sales could decline significantly if we misjudge the market for our new merchandise, which
may result in significant merchandise markdowns and lower margins, missed opportunities for other products, or inventory write-downs,
and could have a negative impact on our reputation, profitability and demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be unable to attract and retain subscribers, which could have an adverse effect on our strategy to develop new interactive fitness
equipment and platforms/mobile application with subscription service.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2021, we began development of new interactive fitness equipment and platforms/mobile application with subscription service, which include
smart cardio exercise equipment such as interactive exercise bikes, treadmills, and workout mirrors with built-in touchscreens and training
content platforms and 1FinalRound, our AI-powered interactive platform with our proprietary online training content and capability to
be interactive with personal trainers, follow members, and track workout progress.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of these new products is dependent on our ability to attract and retain subscribers, and we cannot be sure that we will be successful
in these efforts, or that subscriber retention levels will not materially decline in the future. There are a number of factors that could
lead to a decline in subscriber levels or that could prevent us from increasing our subscriber levels, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    failure to introduce new features, products, or services that our potential subscribers find engaging or our introduction of new
    products or services, or changes to existing products and services that are not favorably received;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">harm
    to our brand and reputation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pricing
    and perceived value of our offerings;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to deliver quality products, content, and services; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unsatisfactory
    experiences with the delivery, installation, or servicing of our products, including due to prolonged delivery timelines and limitations
    on or the suspension of the in-home installation, return, and warranty servicing process;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    potential subscribers engaging with competitive products and services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">technical
    or other problems preventing subscribers from accessing our content and services in a rapid and reliable manner or otherwise affecting
    the subscribers&#8217; experience;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decline in the public&#8217;s interest in interactive fitness equipment and platforms;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">deteriorating
    general economic conditions or a change in consumer spending preferences or buying trends, whether as a result of the COVID-19 pandemic
    or otherwise; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruptions
    in our ability to sell or deliver our products or to create content and services for our potential subscribers as a result of the
    COVID-19 pandemic.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
further expansion into international markets such as Southeast Asia will create new challenges in attracting and retaining subscribers
that we may not successfully address. As a result of these factors, we cannot be sure that our potential subscriber levels will be adequate
to maintain or permit the expansion of our operations. A decline in future subscriber levels could have an adverse effect on our business,
financial condition, and/or operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Online
growth in our business is complex and there are risks associated with operating our own online platform, including those relating to
confidential consumer data.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintaining
and continuing to improve our online retail platform involves substantial investment of capital and resources, integrating multiple information
and management systems, increasing supply chain and distribution capabilities, attracting, developing and retaining qualified personnel
with relevant subject matter expertise, and effectively managing and improving the customer experience. This involves substantial risk,
including risk of cost overruns, website downtime and other technology disruptions, supply and distribution delays, and other issues
that can affect the successful operation of our online platform. Technological disruptions can result from delays, or downtime caused
by high volumes of users or transactions, deficiencies in design or implementation, platform enhancements, power outages, computer and
telecommunications failures, computer viruses, worms, ransomware or other malicious computer programs, denial-of-service attacks, security
breaches through cyber-attacks from cyber-attackers or sophisticated organizations, catastrophic events such as fires, tornadoes, earthquakes
and hurricanes, and usage errors. If we are not able to successfully operate and continually improve our online platform to provide a
user-friendly, secure online experience offering merchandise and delivery options expected by our customers, we could be placed at a
competitive disadvantage and our reputation, operations, financial results, and future growth could be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Harm
to our reputation could adversely impact our ability to attract and retain customers.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negative
publicity or perceptions involving us or our brands, products, vendors, or marketing and other partners, or failure to detect, prevent,
mitigate or address issues giving rise to reputational risk could adversely impact our reputation, business, results of operations, and
financial condition, and may adversely impact our ability to attract and retain customers. Issues that might pose a reputational risk
include: an inability to provide an online experience that meets the expectations of consumers; failure of our cyber-security measures
to protect against data breaches; product liability, product recalls, and product boycotts; our handling of issues relating to environmental,
social, and governance (&#8220;ESG&#8221;) matters, including inclusion and diversity; our response to the COVID-19 pandemic; our social
media activity; failure to comply with applicable laws and regulations; public stances on controversial social or political issues; product
sponsorship relationships, including those with celebrity spokespersons, influencers or group affiliations; and any of the other risks
enumerated in this section, &#8220;Item 3 &#8211; 3D. Risk Factors&#8221;. Furthermore, the prevalence of social media and a constant,
on-demand news cycle may accelerate and in the short-term increase the potential scope of any negative publicity we or others might receive
and could increase the negative impact of these issues on our reputation, business, results of operations, and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
strategic plans and initiatives may initially result in a negative impact on our financial results and such plans and initiatives may
not achieve the desired results within the anticipated time frame or at all.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to successfully implement and execute our strategic plans and initiatives depends on many factors, some of which are out of our
control. For example, a strategic determination to increase promotional activities in response to challenging conditions in the retail
market may not achieve the desired results and could negatively impact our gross profit margin. Our focus on long-term strategic investments,
including investments in our digital capabilities, our online platform, improvements to the consumer experience online, our supply chain,
the continued development of our smart cardio exercise equipment and 1FinalRound training platform and other specialty concepts may require
significant capital investment and management attention at the expense of other business initiatives and may take longer than anticipated
to achieve the desired return. Additionally, any new initiative is subject to certain risks, including consumer acceptance, competition,
product differentiation, and the ability to attract and retain qualified personnel to support the initiative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
could be subject to information technology system failures, network disruptions, and breaches in data security which could negatively
affect our business, financial position, results of operations and cash flows.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
dependence on digital technologies is expanding, cyber incidents, including deliberate attacks or unintentional events have been increasing
worldwide. Computers and telecommunication systems are used to conduct our operations and have become an integral part of our business.
We use these systems to analyze and store financial and operating data, as well as to support our internal communications and interactions
with business partners. Cyber-attacks could compromise our computer and telecommunications systems and result in additional costs as
well as disruptions to our business operations or the loss of our data. A cyber-attack involving our information systems and related
infrastructure, or those of our business partners, could disrupt our business and negatively impact our operations in a variety of ways,
such as, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    attack on the computers which control our operations could cause a temporary interruption of our business;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    cyber-attack on our accounting or accounts payable systems could expose us to liability to employees and third parties if their sensitive
    personal information is obtained;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    possible loss of material information, which in turn could delay our operations and selling efforts, causing economic losses; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    cyber-attack on a service provider could result in supply chain disruptions, which could delay or halt our operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: transparent">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Unauthorized
disclosure of sensitive or confidential customer, vendor or Company information could result in substantial costs and reputational damage,
harm our business and standing with our athletes and could subject us to litigation and enforcement actions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
protection of our data as well as customer data is critical. As with most online retailers, we collect, receive, store, manage, transmit
and delete confidential data, including payment card and personally identifiable information, in the normal course of customer transactions,
as well as other confidential and sensitive information, such as personal information about our customers and our vendors, and confidential
Company information. We also work with third-party vendors and service providers that provide technology, systems and services that we
use in connection with the collection, storage and transmission of this information. While we have taken significant steps to protect
confidential information, the intentional or negligent actions of third parties may undermine our existing security measures and allow
unauthorized parties to obtain access to our data systems and misappropriate confidential data. Our information systems, and those of
our third-party service providers, are vulnerable to an increasing threat of continually evolving data protection and cyber-security
risks. There can be no assurance that advances in computer capabilities, new discoveries in the field of cryptography or other developments
will prevent a future compromise of our customer transaction processing capabilities and other personal data. Because the techniques
used to obtain unauthorized access to, disable, degrade, or sabotage systems change frequently and often are not recognized until they
are launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we have no knowledge of any material data security breaches to date, any compromise of our data security could result in a violation
of applicable privacy and other laws or standards, significant legal and financial exposure beyond the scope or limits of our insurance
coverage, interruption of our operations, increased operating costs associated with remediation, equipment acquisitions or disposal,
added personnel, and a loss of confidence in our security measures, which could harm our business, reputation or investor confidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, data governance failures can adversely affect our reputation and business. Our business depends on our customers&#8217; willingness
to entrust us with their personal information. Events that adversely affect that trust, including inadequate disclosure to our customers
of our uses of their information or any security breach involving the misappropriation, loss or other unauthorized disclosure of sensitive
or confidential information could attract a substantial amount of media attention, damage our reputation, expose us to risk of litigation
and material liability, disrupt our operations and harm our business. Further, the data privacy and cyber-security regulatory environment
is constantly changing, with new and increasingly rigorous and complex requirements. Maintaining our compliance with those requirements,
including recently enacted state consumer privacy laws, may require significant effort and cost, require changes to our business practices,
and limit our ability to obtain data used to provide a personalized customer experience. In addition, failure to comply with applicable
requirements could subject us to fines, sanctions, governmental investigations, lawsuits or reputational damage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Problems
with the third-party e-commerce platform for online stores and retail point-of-sale system that we utilize and our information systems
could disrupt our operations and negatively impact our financial results and materially adversely affect our business operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
utilize a third-party e-commerce platform for online stores and retail point-of-sale system for the needs of our business, including
as a provider for electronic payment processing. If any of these systems fail to function properly, it could disrupt our operations,
including our ability to track, record and analyze the merchandise that we sell, process shipments of goods, process financial information
or credit card or electronic payment transactions, deliver products or engage in similar normal business activities. If our independent
service provider becomes unwilling or unable to provide these services to us or if the cost of using our provider increases, our business
could be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
information systems, including our back-up systems, are subject to damage or interruption from power outages; computer and telecommunications
failures; computer viruses, worms, ransomware, and other malicious computer programs; denial-of-service attacks; security breaches (through
cyber-attacks from cyber-attackers or sophisticated organizations); catastrophic events such as fires, tornadoes, earthquakes and hurricanes;
and usage errors. If our information systems and our back-up systems are damaged, breached or cease to function properly, we may have
to make a significant investment to repair or replace them, and we may suffer loss of critical data and interruptions or delays in our
business operations. Any material disruption, malfunction or other similar problems in or with our core information systems could negatively
impact our financial results and materially adversely affect our business operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be unable to attract, train, engage and retain key personnel.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
long-term success and ability to implement our strategic and business planning processes depends in large part on our ability to continue
to attract, retain, train and develop key personnel and qualified employees in all areas of the Company. Our ability to meet our labor
needs while controlling labor costs is subject to numerous external factors, including market pressures with respect to prevailing wage
rates, unemployment levels, and health and other insurance costs; the impact of legislation or regulations governing labor relations,
immigration, minimum wage, and healthcare benefits; changing demographics; and our reputation within the labor market. Should we fail
to increase our wages competitively in response to any increasing wage rates, the quality of our workforce could decline, causing our
customer service to suffer. Any increase in the cost of our labor could have an adverse effect on our operating costs, financial condition
and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in order to continue to build and enhance our online platforms, we must attract and retain a large number of skilled professionals,
including technology professionals to implement our ongoing technology and other strategic offerings. The market for these professionals
is increasingly competitive. An inability to provide wages and/or benefits that are competitive within the markets in which we operate
could adversely affect our ability to retain and attract these employees. Further, changes in market compensation rates may adversely
affect our labor costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
loss of one or more of our key executives or the inability to successfully attract and retain executive officers or implement effective
succession planning strategies could have a material adverse effect on our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
long-term success and ability to implement our strategic and business planning processes depends in large part on our ability to continue
to attract and retain executive management. All employees, including members of our executive management and key personnel, are at-will
employees. The loss of any one or more of our executive management, including our chief executive officer and director, Yinying Lu, or
other key personnel could seriously harm our business. Additionally, effective succession planning for executive management and key personnel
is vital to our long-term continued success. Failure to ensure effective transfer of knowledge, setting of strategic direction, and smooth
transitions involving executive management and key personnel could hinder our long-term strategies and success.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are dependent upon key management employees and third parties.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
responsibility of overseeing the day-to-day operations and the strategic management of our business depends substantially on our senior
officers and our key personnel. Loss of such personnel may have an adverse effect on our performance. The success of our operations will
depend upon numerous factors, many of which are beyond our control, including our ability to attract and retain additional key personnel
in sales, marketing, technical support and finance. We currently depend upon a relatively small number of key persons to seek out and
form strategic alliances and find and retain additional employees. Certain areas in which we operate are highly competitive regions and
competition for qualified personnel is intense. We may be unable to hire suitable personnel or there may be periods of time where a particular
position remains vacant while a suitable replacement is identified and appointed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
inability to hire and maintain suitable personnel could have a material adverse effect on us and could prevent us from effectively pursuing
our business plan, including developing, growing, and operating our business profitably.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also depend upon third parties, including consultants, suppliers and others, for their expertise and expect to continue to do so for
the foreseeable future. Our ability to continue conducting our activities is in large part dependent upon the efforts of third parties.
We may need to engage additional third parties for new business operations. If such parties&#8217; work is deficient or negligent or
is not completed in a timely manner, it could have a material adverse effect on the Company. As a result, our use of the services of
consultants could have a material adverse effect on us and could prevent us from effectively pursuing our business plan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
independent directors do not devote their full-time attention to the affairs of the Company and could allocate their time and attention
to other business ventures which may not benefit the Company.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
independent directors do not devote their time exclusively to the Company and engage in other business activities. Although there are
none known to us, the potential for conflicts of interest exists among us and affiliated persons for future business opportunities that
may not be presented to us. Our directors may have conflicts of interests in allocating time, services, and functions between the other
business ventures in which those persons may be or become involved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
directors and officers may in the future be in a position of conflict of interest.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our directors and officers currently also serve as directors and officers of other companies involved in the fitness industry, and
any of our directors may in the future serve in such positions. As at the date of this annual report, none of our directors or officers
serves as an officer or director of a gym and fitness equipment company nor possesses a conflict of interests with our business. However,
there exists the possibility that they may in the future be in a position of conflict of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may acquire additional businesses or assets, form joint ventures or make investments in other companies in the future that may be unsuccessful
and may harm our operating results and prospects.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of our business strategy, we may pursue additional acquisitions of complementary businesses or assets. The type of financing for
any such acquisition will depend on circumstances existing at that time, including market conditions and our share price. If we are successful
at identifying and making such acquisitions, integration of any acquired businesses or assets nevertheless involves many challenges,
including a potential strain on our administrative and operational resources, unanticipated issues, expenses or liabilities, and difficulties
in the assimilation of different corporate cultures and business practices. We may also seek to enter into joint ventures, pursue strategic
alliances in an effort to leverage our existing operations and industry experience, increase our product offerings, expand our distribution
and make investments in other companies. We do not have specific timetables for these potential activities and we cannot guarantee that
we will be able to identify and complete suitable acquisitions or investments at reasonable prices, or that we will be successful in
realizing any anticipated benefits from any future acquisitions or investments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of any acquisitions, joint ventures, strategic alliances or investments will depend on our ability to identify, negotiate, complete
and, in the case of acquisitions, integrate those transactions and, if necessary, obtain satisfactory debt or equity financing to fund
those transactions. We may not realize the anticipated benefits of any acquisition, joint venture, strategic alliance or investment.
We may not be able to integrate acquisitions successfully into our existing business, maintain the key business relationships of businesses
we acquire, or retain key personnel of an acquired business, and we could assume unknown or contingent liabilities or incur unanticipated
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integration
of acquired companies or businesses also may require management resources that otherwise would be available for ongoing development of
our existing business. Any acquisitions or investments made by us also could result in significant write-offs or the incurrence of debt
and contingent liabilities, any of which could harm our operating results. In addition, if we choose to issue equity as consideration
for any acquisition, our shareholders may experience dilution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
products and services may be affected from time to time by design and manufacturing defects that could adversely affect our business
and result in harm to our reputation.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer products and services that can be affected by design and manufacturing defects. Defects may also exist in components and products
that we source from third parties. Any such defects could make our products and services unsafe, create a risk of environmental or property
damage and personal injury, and subject us to the hazards and uncertainties of product liability claims and related litigation. There
can be no assurance that we will be able to detect and fix all issues and defects in the products and services we offer. Failure to do
so could result in widespread technical and performance issues affecting our products and services and could lead to claims against us.
We maintain general liability insurance; however, design and manufacturing defects, and claims related thereto, may subject us to judgments
or settlements that result in damages materially in excess of the limits of our insurance coverage. In addition, we may be exposed to
recalls, product replacements or modifications, write-offs of inventory, property and equipment, or intangible assets, and significant
warranty and other expenses such as litigation costs and regulatory fines. If we cannot successfully defend any large claim, maintain
our general liability insurance on acceptable terms, or maintain adequate coverage against potential claims, our financial results could
be adversely impacted. Further, quality problems could adversely affect the experience for users of our products and services, and result
in harm to our reputation, loss of competitive advantage, poor market acceptance, reduced demand for our products and services, delays
in new product and service introductions, and lost revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business could be adversely affected by an accident, safety incident, or workforce disruption.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
manufacturing processes and related activities, as well as our warehousing and logistics activities, could expose us to significant personal
injury claims that could subject us to substantial liability. While we maintain liability insurance in amounts and of the type generally
consistent with industry practice, the amount of such coverage may not be adequate to cover fully all claims, and we may be forced to
bear substantial losses from an accident or safety incident resulting from our manufacturing, warehousing, or delivery activities. Additionally,
if our employees decide to join or form a labor union, we may become party to a collective bargaining agreement, which could result in
higher employee costs and increased risk of work stoppages. It is also possible that a union seeking to organize one subset of our employee
population, such as the employees in our manufacturing facility, could also mount a corporate campaign, resulting in negative publicity
or other actions that require attention by our management team and our employees. Negative publicity, work stoppages, or strikes by unions
could have an adverse effect on our business, prospects, financial condition, and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
quarterly operating results and other operating metrics may fluctuate from quarter to quarter, which makes these metrics difficult to
predict.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
quarterly operating results and other operating metrics have fluctuated in the past and may continue to fluctuate from quarter to quarter
and make it difficult to forecast our future results. Consequently, you should not rely on our past quarterly operating results as indicators
of future performance. Our financial condition and operating results in any given quarter can be influenced by numerous factors, many
of which we are unable to predict or are outside of our control, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    continued market acceptance of, and the growth of the fitness and wellness market;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain and attract new customers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    timing and success of new product, service, feature, and content introductions by us or our competitors or any other change in the
    competitive landscape of our market;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pricing
    pressure as a result of competition or otherwise;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    or disruptions in our supply chain;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">errors
    in our forecasting of the demand for our products and services, which could lead to lower revenue or increased costs, or both;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increases
    in marketing, sales, and other operating expenses that we may incur to grow and expand our operations and to remain competitive;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to maintain our showroom;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">successful
    expansion into international markets, including Asia;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain gross margins and operating margins;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">system
    failures or breaches of security or privacy;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    litigation judgments, settlements, or other litigation-related costs, including content costs for past use;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the legislative or regulatory environment, including with respect to privacy, consumer product safety, and advertising, or enforcement
    by government regulators, including fines, orders, or consent decrees;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
    in currency exchange rates and changes in the proportion of our revenue and expenses denominated in foreign currencies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our effective tax rate;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in accounting standards, policies, guidance, interpretations, or principles; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in business or macroeconomic conditions, including the impact of the current COVID-19 outbreak, lower consumer confidence, recessionary
    conditions, increased unemployment rates, or stagnant or declining wages.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
one of the factors above or the cumulative effect of some of the factors above may result in significant fluctuations in our operating
results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
variability and unpredictability of our quarterly operating results or other operating metrics could result in our failure to meet our
expectations or those of analysts that cover us or investors with respect to revenue or other operating results for a particular period.
If we fail to meet or exceed such expectations, the market price of our shares could fall substantially, and we could face costly lawsuits,
including securities class action suits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to sustain pricing levels for our products and services, our business could be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to sustain pricing levels for our products and services, whether due to competitive pressure or otherwise, our gross margins
could be significantly reduced. Further, our decisions around the development of new products and services are grounded in assumptions
about eventual pricing levels. If there is price compression in the market after these decisions are made, it could have a negative effect
on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to warranty claims that could result in significant direct or indirect costs, or we could experience greater product returns
than expected, either of which could have an adverse effect on our business, financial condition, and/or operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generally provide a 30-day return policy to customers for all of our non-electronic products. Our suppliers generally provide a warranty
for all of our electronic products. The occurrence of any material defects in our products could result in an increase in returns or
make us liable for damages and warranty claims in excess of our current reserves, which could result in an adverse effect on our business
prospects, liquidity, financial condition, and cash flows if returns or warranty claims were to materially exceed anticipated levels.
In addition, we could incur significant costs to correct any defects, warranty claims, or other problems, including costs related to
product recalls. Any negative publicity related to the perceived quality or safety of our products could affect our brand image, decrease
consumer confidence and demand, and adversely affect our financial condition and operating results. Also, warranty claims may result
in litigation, the occurrence of which could have an adverse effect on our business, financial condition, and/or operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in how we market our products and services could adversely affect our marketing expenses and subscription levels.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
marketing strategy focuses on delivering high quality fitness equipment to our customers and, in the future, to our licensees and their
members and raising awareness of our brand through a broad range of channels. These channels include Google Search (organic and paid),
Google Shopping Campaign, Google Ads word, affiliate partners programs, social media such as Facebook and Instagram, e-mail marketing,
SMS marketing, E catalogue, and First Australia Fitness Mobile App.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
online and social media platforms continue to rapidly evolve or grow more competitive, we must continue to maintain a presence on these
platforms and establish a presence on new or emerging popular social media and advertising and marketing platforms. If we cannot cost
effectively use these marketing tools, if we fail to promote our products and services efficiently and effectively, or if our marketing
campaigns attract negative media attention, our ability to acquire new customers and our financial condition may suffer and the price
of our shares could decline. In addition, an increase in the use of online and social media for product promotion and marketing may increase
the burden on us to monitor compliance of such materials and increase the risk that such materials could contain problematic product
or marketing claims in violation of applicable regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may require additional capital to support business growth and objectives, and this capital might not be available to us on reasonable
terms, if at all, and may result in stockholder dilution.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that our existing cash and cash equivalents will be sufficient to meet our anticipated cash needs for the foreseeable future.
However, we intend to continue to make investments to support our business growth and may require additional capital to fund our business
and to respond to competitive challenges, including the need to promote our products and services, develop new products and services,
enhance our existing products, services, and operating infrastructure, and potentially to acquire complementary businesses and technologies.
Accordingly, we may need to engage in equity or debt financings to secure additional funds. There can be no assurance that such additional
funding will be available on terms attractive to us, or at all. Our inability to obtain additional funding when needed could have an
adverse effect on our business, financial condition, and/or operating results. If additional funds are raised through the issuance of
equity or convertible debt securities, holders of our shares could suffer significant dilution, and any new shares we issue could have
rights, preferences, and privileges superior to those of our shares. Any debt financing secured by us in the future could involve restrictive
covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for
us to obtain additional capital and to pursue business opportunities, including potential acquisitions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to payment processing risk</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customers pay for our products and services using a variety of different payment methods, including credit and debit cards, gift cards,
and online wallets. We rely on internal systems as well as those of third parties to process payment. Acceptance and processing of these
payment methods are subject to certain rules and regulations and require payment of interchange and other fees. To the extent there are
disruptions in our payment processing systems, increases in payment processing fees, material changes in the payment ecosystem, such
as large re-issuances of payment cards, delays in receiving payments from payment processors, or changes to rules or regulations concerning
payment processing, our revenue, operating expenses and results of operations could be adversely impacted. We leverage our third-party
payment processors to bill customers on our behalf. If these third parties become unwilling or unable to continue processing payments
on our behalf, we would have to find alternative methods of collecting payments, which could adversely impact customer acquisition and
retention. In addition, from time to time, we encounter fraudulent use of payment methods, which could impact our results of operations
and if not adequately controlled and managed could create negative consumer perceptions of our services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may face exposure to foreign currency exchange rate fluctuations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have transacted in Australian dollars, U.S. dollars, and Renminbi with the majority of our customers and suppliers, and we may transact
in additional foreign currencies in the future. Accordingly, changes in the value of foreign currencies relative to the U.S. dollar can
affect our revenue and operating results. As a result of such foreign currency exchange rate fluctuations, it could be more difficult
to detect underlying trends in our business and operating results. In addition, to the extent that fluctuations in currency exchange
rates cause our operating results to differ from our expectations or the expectations of our investors, the trading price of our Ordinary
Shares could be lowered. We use derivative instruments, such as foreign currency forward and option contracts, to hedge certain exposures
to fluctuations in foreign currency exchange rates. The use of such hedging activities may not offset any or more than a portion of the
adverse financial effects of unfavorable movements in foreign exchange rates over the limited time the hedges are in place and may introduce
additional risks if we are unable to structure effective hedges with such instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
depend on our suppliers and manufacturers to provide us with sufficient quantities of quality products in a timely fashion.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
dependence on suppliers involves risk. We might be unable to obtain merchandise that consumers demand in a timely manner if there are
disruptions in our relationships with key suppliers, which could cause our revenue to materially decline. The terms of our written contracts
with Australian suppliers are one year. We generally do not have long-term written contracts with our suppliers in China that would require
them to continue supplying us with merchandise. Key suppliers may also fail to deliver on their commitments or fail to supply us with
sufficient products that comply with our safety and quality standards, whether as a result of supply chain disruptions (for example,
in connection with the COVID-19 pandemic) or other causes, or fail to continue to develop new products that create consumer demand. Furthermore,
vendors increasingly sell their products directly to customers or through broadened or alternative distribution channels, such as department
stores or other eCommerce companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have limited control over our suppliers, manufacturers, and logistics partners, which may subject us to significant risks, including
the potential inability to produce or obtain quality products and services on a timely basis or in sufficient quantity.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have limited control over our suppliers, contract manufacturers, and logistics partners, which subjects us to the following risks:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    to satisfy demand for our products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    control over delivery timing and product reliability;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    ability to monitor the manufacturing processes and components used in our products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited
    ability to develop comprehensive manufacturing specifications that take into account any materials shortages or substitutions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variance
    in the manufacturing capability of our third-party manufacturers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
    increases;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    of a significant supplier, manufacturer, or logistics partner to perform its obligations to us for technical, market, or other reasons;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variance
    in the quality of services provided by our third-party logistics partners;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in establishing additional supplier, manufacturer, or logistics partner relationships if we experience difficulties with our existing
    suppliers, manufacturers, or logistics partners;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shortages
    of materials or components;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">misappropriation
    of our intellectual property;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exposure
    to natural catastrophes, political unrest, terrorism, labor disputes, and economic instability resulting in the disruption of trade
    from foreign countries in which our products are manufactured or the components thereof are sourced;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in local economic conditions in the jurisdictions where our suppliers, manufacturers, and logistics partners are located;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    imposition of new laws and regulations, including those relating to labor conditions, quality and safety standards, imports, duties,
    tariffs, taxes, and other charges on imports, as well as trade restrictions and restrictions on currency exchange or the transfer
    of funds; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insufficient
    warranties and indemnities on components supplied to our manufacturers or performance by our partners.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also rely on our logistics partners, including warehouse and delivery partners, to complete our deliveries to customers. If any of these
partners do not perform their obligations or meet the expectations of us or our customers, our reputation and business could suffer.
The occurrence of any of these risks could cause us to experience a significant disruption in our ability to produce and deliver our
products to our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Less
than 10% of our revenue is derived from China and approximately 85% of the products that we purchase are</i></b> <b><i>manufactured
in China. The ability of our licensee and suppliers to operate in China may be impaired by changes in Chinese laws and regulations, including
those relating to taxation, environmental regulation, restrictions on foreign investment, and other matters.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we are a Cayman Islands exempted company headquartered in Australia, as of the date of this annual report, less than <i>10</i>% of our
revenue is derived from China and approximately <i>85</i>% of the products that we purchase are manufactured abroad in China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chinese government has exercised and continues to exercise substantial control over virtually every sector of the Chinese economy through
regulation and state ownership. The central Chinese government or local governments having jurisdiction within China may impose new,
stricter regulations, or interpretations of existing regulations, that would require additional expenditures and efforts on the part
of our suppliers and licensee to ensure compliance with such regulations or interpretations. As such, our third-party suppliers in China
or our licensee&#8217;s operations in China may be subject to governmental and regulatory interference in the provinces in which they
operate. Our third-party suppliers in China or our licensee&#8217;s operations in China could also be subject to regulation by various
political and regulatory entities, including local and municipal agencies and other governmental subdivisions in China. The ability of
our suppliers and licensee to operate in China may be impaired by any such laws or regulations, or any changes in laws and regulations
in the PRC. Our third-party suppliers or licensee may incur increased costs necessary to comply with existing and future laws and regulations
or penalties for any failure to comply. If our suppliers or licensees incur increased costs, they may attempt to pass such costs on to
us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the PRC legal system is based in part on government policies and internal rules, some of which are not published on a timely basis or
at all and may have a retroactive effect. As a result, our licensee or our suppliers may not be aware of violations of any of these policies
and rules until some time after the alleged violation. In addition, any administrative and court proceedings in China may be protracted,
resulting in substantial costs and diversion of resources and management attention to our licensee and/or our suppliers. Further, such
evolving laws and regulations and the inconsistent enforcement thereof could also lead to failure to obtain or maintain licenses and
permits to do business in China, which would adversely affect our licensee&#8217;s operations in China and/or our suppliers in China.
Any such increased costs or disruptions could materially and adversely impact our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to costs and risks associated with a complex regulatory, compliance and legal environment, including increased or changing
laws and regulations affecting our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate in a complex regulatory and legal environment that exposes us to compliance and litigation risks that could materially affect
our operations and financial results. Establishing the necessary internal infrastructure to allow for the monitoring and other compliance
requirements required by laws and regulations and enforcement efforts requires expenditure of considerable Company resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, laws at the federal, state or local level may change, sometimes significantly and unexpectedly, as a result of political, economic
or social events. Some of the federal, state or local laws and regulations that affect us include those relating to consumer products,
product liability and consumer protection; reducing the spread of COVID-19; eCommerce, data protection and privacy; advertisement and
marketing; labor and employment; taxes; accounting, corporate governance and securities; customs or imports; and intellectual property.
Continued monitoring and efforts to ensure compliance with these regulations require considerable expenditure of Company time and money,
which could detract from other operational initiatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lawsuits
may be filed against us or arbitration proceedings may be commenced and an adverse ruling in any such lawsuit or arbitration may adversely
affect our business or financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of our business, we may become involved in, named as a party to, or be the subject of, various legal proceedings,
including regulatory proceedings, tax proceedings and legal actions, including arbitration proceedings, relating to personal injuries,
workers&#8217; compensation, employment discrimination, damages related to breaches of privacy or data security, and contract disputes.
Such proceedings and actions may involve liquidated damages, consequential damages, punitive damages and civil penalties or other losses,
or injunctive or declaratory relief. In addition, we may also be subject to class action lawsuits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the inherent uncertainties of litigation and other dispute resolution proceedings, the outcome of outstanding, pending or future actions
or proceedings may be difficult to assess or quantify, cannot be predicted with certainty and may be determined adversely to us and as
a result, could have a material adverse effect on our assets, liabilities, business, financial condition or results of operations. Even
if we prevail in any such action or proceeding, they could be costly and time-consuming and may divert the attention of management and
key personnel from our business operations, which could adversely affect our financial condition. The ultimate resolution of any litigation
or proceeding through settlement, mediation, or a judgment could have a material impact on our reputation and adversely affect our financial
performance and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
sales and operating results could be adversely affected by product safety concerns.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the products that we offer do not meet applicable safety standards or our customers&#8217; expectations regarding safety, we could experience
decreased sales, increased costs, and/or be exposed to legal and reputational risk. All of our vendors must comply with applicable product
safety laws, and we are dependent on them to ensure that the products we buy comply with all safety standards. Negative customer perceptions
regarding the safety and sourcing of the products we sell, and events that give rise to actual, potential, or perceived product safety
concerns could expose us to government enforcement action and/or private litigation. Furthermore, reputational damage caused by real
or perceived product safety concerns could have a negative impact on our sales and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
inability or failure to protect our intellectual property rights or any third parties claiming that we have infringed on their intellectual
property rights could negatively impact our brand or have a negative impact on our operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
trademarks, trade secrets, domain names and other intellectual property are valuable assets that are critical to our success. Effective
trademark and other intellectual property protection may not be available in every country in which our products are manufactured or
may be made available. The unauthorized reproduction or other misappropriation of our intellectual property could diminish the value
of our brands or goodwill and cause a decline in our revenue. In addition, any infringement or other intellectual property claim made
against us could be time-consuming to address, result in costly litigation, cause product delays, require us to enter into royalty or
licensing agreements or result in our loss of ownership or use of the intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
to tax laws and regulations could adversely affect our financial results or condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
effective income tax rates could be unfavorably impacted by a number of factors, including changes in the valuation of deferred tax assets
and liabilities; other changes in applicable tax laws, regulations, treaties, interpretations, and other guidance; changes in transfer
pricing rules; and the outcome of income tax audits. Changes in applicable tax laws and regulations, or their interpretation and application,
including the possibility of retroactive effect, could affect our income tax expense and profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to anti-bribery, anti-corruption, and anti-money laundering laws, including the U.S. Foreign Corrupt Practices Act, as well
as export control laws, customs laws, sanctions laws and other laws governing our operations. If we fail to comply with these laws, we
could be subject to civil or criminal penalties, other remedial measures and legal expenses, which could adversely affect our business,
results of operations and financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. Departments of Justice, Commerce, State and Treasury and other federal agencies and authorities have a broad range of civil and
criminal penalties they may seek to impose against corporations and individuals for violations of economic sanctions laws, export control
laws, the FCPA, and other federal statutes and regulations, including those established by the Office of Foreign Assets Control (&#8220;OFAC&#8221;).
Under these laws and regulations, as well as other anti-corruption laws, anti-money laundering laws, export control laws, customs laws,
sanctions laws and other laws governing our operations, various government agencies may require export licenses, may seek to impose modifications
to business practices, including cessation of business activities in sanctioned countries or with sanctioned persons or entities and
modifications to compliance programs, which may increase compliance costs, and may subject us to fines, penalties and/or other sanctions.
A violation of these laws or regulations would negatively affect our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have implemented policies and procedures designed to ensure compliance by us and our directors, officers, employees, representatives,
consultants and agents with the FCPA, OFAC restrictions and other export control, anti-corruption, anti-money-laundering and anti-terrorism
laws and regulations. We cannot assure you, however, that our policies and procedures are or will be sufficient or that directors, officers,
employees, representatives, consultants and agents have not engaged and will not engage in conduct for which we may be held responsible,
nor can we assure you that our business partners have not engaged and will not engage in conduct that could materially affect their ability
to perform their contractual obligations to us or even result in our being held liable for such conduct. Violations of the FCPA, OFAC
restrictions or other export control, anticorruption, anti-money laundering and anti-terrorism laws or regulations may result in severe
criminal or civil sanctions, and we may be subject to other liabilities, which could have a material adverse effect on our business,
financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to comply with the U.S. Foreign Corrupt Practices Act of 1977, or the FCPA, could result in fines, criminal penalties, and an adverse
effect on our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may operate in a number of countries throughout the world, including countries known to have a reputation for corruption. We are committed
to doing business in accordance with applicable anti-corruption laws and have adopted a code of business conduct and ethics that is consistent
and in full compliance with the FCPA. We are subject, however, to the risk that we, our affiliated entities or our or their respective
officers, directors, employees, and agents may take actions determined to be in violation of such anti-corruption laws, including the
FCPA. In addition, actual or alleged violations could damage our reputation and ability to do business. Furthermore, detecting, investigating,
and resolving actual or alleged violations is expensive and can consume significant time and attention of our senior management. Any
such violation could result in substantial fines, sanctions, civil and/or criminal penalties, curtailment of operations in certain jurisdictions,
and might adversely affect our business, earnings or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are a &#8220;foreign private issuer&#8221; under U.S. securities laws and, as a result, are subject to disclosure obligations that are
different from those applicable to U.S. domestic issuers listed on the Nasdaq Capital Market.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated under the laws of the Cayman Islands and are considered a &#8220;foreign private issuer&#8221; under U.S. securities
laws. Although we will be subject to the periodic reporting requirements of the Exchange Act, the periodic disclosure required of foreign
private issuers under the Exchange Act is different from the periodic disclosure required of U.S. domestic issuers. Therefore, there
may be less publicly available information about us than is regularly published by or about other public companies in the United States.
We are also exempt from certain other sections of the Exchange Act that U.S. domestic issuers are otherwise subject to, including the
requirement to provide our shareholders with information statements or proxy statements that comply with the Exchange Act. Moreover,
we are not required to comply with Regulation FD, which restricts the selective disclosure of material information. These exemptions
and leniencies may reduce the frequency and scope of information and protections to which you may otherwise have been eligible if you
held ordinary shares or common stock of a domestic U.S. issuer. In addition, insiders and large shareholders of ours will be exempt from
the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act and will not be obligated to file
the reports required by Section 16 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
would lose our foreign private issuer status if a majority of our shares became held by U.S. persons and a majority of our directors
or executive officers are U.S. citizens or residents and we fail to meet additional requirements necessary to avoid loss of foreign private
issuer status. Our loss of foreign private issuer status would make compliance with Nasdaq corporate governance rules applicable to U.S.
domestic listed companies mandatory. The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may
be significantly higher. If we are not a foreign private issuer, we will be required to file periodic reports and registration statements
on U.S. domestic issuer forms with the SEC, which are more detailed and extensive than the forms available to a foreign private issuer,
and prepare our financial statements under U.S. Generally Accepted Accounting Principles. To the extent we had not already done so, we
may also be required to modify certain of our policies to comply with accepted governance practices associated with U.S. domestic issuers
and may lose our ability to rely upon exemptions from certain corporate governance requirements on the Nasdaq that are available to foreign
private issuers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a foreign private issuer, we may follow certain home country corporate governance practices instead of otherwise applicable Nasdaq corporate
governance requirements, and this may result in less investor protection than that accorded to investors under rules applicable to U.S.
domestic issuers.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a foreign private issuer, we are permitted to follow certain home country corporate governance practices instead of those otherwise required
under Nasdaq&#8217;s rules for domestic U.S. issuers, provided that we disclose which requirements we are not following and describe
the equivalent home country requirement. Availing ourselves of any of the other corporate governance exemptions, as opposed to complying
with the requirements that are applicable to a U.S. domestic issuer, may provide less protection to you than is accorded to investors
under Nasdaq&#8217;s corporate governance rules. Therefore, any foreign private issuer exemptions we have availed ourselves of, or may
avail ourselves of in the future, may reduce the scope of information and protection to you as an investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>New
climate-related disclosure obligations in proposed SEC rule amendments could have uncertain impacts on our business, impose additional
reporting obligations on us, and increase our costs.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the SEC proposed rule amendments that would implement a framework for the reporting of climate-related risks and create a
wide range of new climate-related disclosure obligations for all registrants, including us. The proposed rules would require us to include
certain climate-related information in registration statements and annual reports, including (i) climate-related risks and their actual
or likely material impacts on our business, strategy, and outlook; (ii) our governance of climate-related risks and relevant risk management
processes; (iii) information on our greenhouse gas emissions; (iv) certain climate-related financial statement metrics and related disclosures
in a note to our audited financial statements; and (v) information about our climate-related targets, goals, and transition plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proposed rules remain open to public comment and may be subject to challenges and litigation. Thus, the ultimate scope and impact of
the proposed rules on our business remain uncertain. To the extent new rules, if finalized, impose additional reporting obligations on
us, we could face substantial increased costs. Separately, the SEC has also announced that it is scrutinizing climate-change related
disclosures in public filings, increasing the potential for enforcement if the SEC were to allege that our existing climate disclosures
are misleading or deficient.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, we
cannot assure you that our business will grow at a similar rate, if at all.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Growth
forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. The forecasts
relating to the expected growth in the connected fitness and wellness market, including estimates based on our own internal survey data,
may prove to be inaccurate. Even if the market experiences the growth we forecast, we may not grow our business at a similar rate, or
at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many
risks and uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
management team has limited experience managing a public company.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
members of our management team have limited experience managing a publicly traded company, interacting with public company investors,
and complying with the increasingly complex laws pertaining to public companies. We are subject to significant regulatory oversight and
reporting obligations under the federal securities laws and the continuous scrutiny of securities analysts and investors. These obligations
and constituents require significant attention from our senior management and could divert their attention away from the day-to-day management
of our business, which could adversely affect our business, financial condition, and/or operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business is subject to the risk of earthquakes, fire, power outages, floods, public health crises, including the current COVID-19 pandemic,
and other catastrophic events, and to interruption by man-made problems such as terrorism.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is vulnerable to damage or interruption from earthquakes, fires, floods, power losses, telecommunications failures, terrorist
attacks, acts of war, human errors, break-ins, public health crises, including the COVID-19 pandemic, and similar events. The third-party
systems and operations and contract manufacturers we rely on are subject to similar risks. Our insurance policies may not cover losses
from these events or may provide insufficient compensation that does not cover our total losses. For example, a significant natural disaster,
such as an earthquake, fire, or flood, could have an adverse effect on our business, financial condition and operating results, and our
insurance coverage may be insufficient to compensate us for losses that may occur. Acts of terrorism, which may be targeted at metropolitan
areas that have higher population density than rural areas, could also cause disruptions in our or our suppliers&#8217; and contract
manufacturers&#8217; businesses or the economy as a whole. We may not have sufficient protection or recovery plans in some circumstances,
such as natural disasters affecting locations that store significant inventory of our products, that house our servers, or from which
we generate content. As we rely heavily on our computer and communications systems, and the internet to conduct our business and provide
high-quality customer service, these disruptions could negatively impact our ability to run our business and either directly or indirectly
disrupt suppliers&#8217; and/or our contract manufacturers&#8217; businesses, which could have an adverse effect on our business, financial
condition, and/or operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are an &#8220;emerging growth company,&#8221; and our election to comply with the reduced disclosure requirements as a public company
may make our Ordinary Shares less attractive to investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and we may take advantage of certain exemptions and relief
from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies.&#8221;
In particular, while we are an &#8220;emerging growth company&#8221; (1) we will not be required to comply with the auditor attestation
requirements of Section 404(b) of the Sarbanes-Oxley Act, (2) we will be exempt from any rules that may be adopted by the PCAOB requiring
mandatory audit firm rotations or a supplement to the auditor&#8217;s report on financial statements, (3) we will be subject to reduced
disclosure obligations regarding executive compensation in our periodic reports and proxy statements and (4) we will not be required
to hold nonbinding advisory votes on executive compensation or shareholder approval of any golden parachute payments not previously approved.
We currently intend to take advantage of the reduced disclosure requirements regarding executive compensation. If we remain an &#8220;emerging
growth company&#8221; after FY2024, we may take advantage of other exemptions, including the exemptions from the advisory
vote requirements and executive compensation disclosures under the Dodd-Frank Wall Street Reform and Customer Protection Act, or the
Dodd-Frank Act, and the exemption from the provisions of Section 404(b) of the Sarbanes-Oxley Act. In addition, Section 107 of the JOBS
Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the
Securities Act for complying with new or revised accounting standards, meaning that the company can delay the adoption of certain accounting
standards until those standards would otherwise apply to private companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may remain an &#8220;emerging growth company&#8221; until the fiscal year-end following August 10, 2028, though we may cease to be an
&#8220;emerging growth company&#8221; earlier under certain circumstances, including (1) if we become a large accelerated filer, (2)
if our gross revenue exceeds US$1.235 billion in any fiscal year or (3) if we issue more than US$1.0 billion in non-convertible notes
in any three year period. The exact implications of the JOBS Act are still subject to interpretations and guidance by the SEC and other
regulatory agencies, and we cannot assure you that we will be able to take advantage of all of the benefits of the JOBS Act. In addition,
investors may find our Ordinary Shares less attractive if we rely on the exemptions and relief granted by the JOBS Act. If some investors
find our Ordinary Shares less attractive as a result, a less active trading market for our Ordinary Shares may develop or be sustained
and our stock price may decline and/or become more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Risks
Related to Our Ordinary Shares</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ms.
Jieting Zhao, our director, beneficially owns approximately 32.0% of our outstanding shares, and her interests may differ from the interests
of other shareholders, which could cause a material decline in the value of our Ordinary Shares.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Jieting Zhao, our director, is the 100% owner of SKMA and thus, she is deemed as the beneficial owner of our shares owned by SKMA. She
thus has significant influence over a decision to enter into any corporate transaction and has the ability to prevent any transaction
that requires the approval of shareholders. Such concentration of voting power could have the effect of delaying, deterring, or preventing
a change of control or other business combination, which could, in turn, have an adverse effect on the market price of our Ordinary Shares
or prevent our shareholders from realizing a premium over the then-prevailing market price for their Ordinary Shares. She will have significant
influence on determining the outcome of any matters submitted to the shareholders for approval, including mergers, consolidations, the
election of directors and other significant corporate actions. Without her consent, we may be prevented from entering into transactions
that could be beneficial to us or our minority shareholders. Her interest may differ from the interests of our other shareholders. The
concentration in the ownership of our Ordinary Shares may cause a material decline in the value of our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Flying
Height Consulting Services Limited, our shareholder, beneficially owns approximately 44.7% of our outstanding shares, and its interests
may differ from the interests of other shareholders, which could cause a material decline in the value of our Ordinary Shares.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2024, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with Flying Height
Consulting Services Limited (&#8220;Flying Height&#8221;). Pursuant to the Purchase Agreement, the Company issued to Flying Height a
three-year 8% senior unsecured convertible promissory note in the principal amount of $3,600,000, with an 8% original issue discount
(the &#8220;Note&#8221;) and, as additional consideration for the purchase of the Note, a stock purchase warrant to purchase 5,645,455
Ordinary Shares (the &#8220;Warrant&#8221;), for the funding amount of $3,312,000. The proceeds from the sale of the Note and Warrant
shall be used by the Company for general working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, Flying Height converted the Note in full and, on March 19, 2024, Flying Height exercised the Warrant via cashless exercise
in full, for the aggregate of 8,983,636 Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Flying
Height thus has significant influence over a decision to enter into any corporate transaction and has the ability to prevent any transaction
that requires the approval of shareholders. Such concentration of voting power could have the effect of delaying, deterring, or preventing
a change of control or other business combination, which could, in turn, have an adverse effect on the market price of our Ordinary Shares
or prevent our shareholders from realizing a premium over the then-prevailing market price for their Ordinary Shares. Flying Height will
have significant influence on determining the outcome of any matters submitted to the shareholders for approval, including mergers, consolidations,
the election of directors and other significant corporate actions. Without its consent, we may be prevented from entering into transactions
that could be beneficial to us or our minority shareholders. Its interest may differ from the interests of our other shareholders. The
concentration in the ownership of our Ordinary Shares may cause a material decline in the value of our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><b><i>If we fail to establish and maintain an effective system of internal
control over financial reporting, our ability to accurately and timely report our financial results or prevent fraud may be adversely
affected, and investor confidence and the market price of our Ordinary Shares may be adversely impacted.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are subject to reporting obligations under U.S.
securities laws. The SEC adopted rules pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 requiring every public company to include
a management report on such company&#8217;s internal control over financial reporting in its annual report, which contains management&#8217;s
assessment of the effectiveness of its internal control over financial reporting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our independent registered public accounting firm
has not conducted an audit of our internal control over financial reporting. However, in preparing our consolidated financial statements
as of and for the years ended June 30, 2024 and 2023, we have identified a material weakness in our internal control over financial reporting,
as defined in the standards established by the PCAOB, and other control deficiencies. The material weakness identified was as a result
of the accounting and disclosure requirements surrounding the warrants issued during the fiscal year ended June 30, 2024. In an effort
to remediate the identified material weaknesses in our internal control over financial reporting and enhance our internal controls,&#160;our
management is currently in the process of&#160;implementing additional training programs on financial derivatives accounting and disclosure
matters for our finance staff. See &#8220;Item 15. Controls and Procedures.&#8221; Measures that we implement may not fully address the
material weakness in our internal control over financial reporting and we may not be able to conclude that the material weakness has been
fully remedied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Failure to correct the material weakness and other control deficiencies
or failure to discover and address any other control deficiencies could result in inaccuracies in our consolidated financial statements
and could also impair our ability to comply with applicable financial reporting requirements and make related regulatory filings on a
timely basis. As a result, our business, financial condition, results of operations, and prospects, as well as the trading price of our
Ordinary Shares, may be materially and adversely affected. Due to the material weakness in our internal control over financial reporting
as described above, our management concluded that our internal control over financial reporting was not effective as of June 30, 2024.
This could adversely affect the market price of our Ordinary Shares due to a loss of investor confidence in the reliability of our reporting
processes.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not intend to pay dividends for the foreseeable future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare
or pay any dividends in the foreseeable future. As a result, you may only receive a return on your investment in our Ordinary Shares
if the market price of our Ordinary Shares increases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market price and trading volume of our Ordinary Shares may be volatile and may be affected by economic conditions beyond our control.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our Ordinary Shares may be highly volatile and subject to wide fluctuations. In addition, the trading volume of our Ordinary
Shares may fluctuate and cause significant price variations to occur. If the market price of our Ordinary Shares declines, you may be
unable to resell your Ordinary Shares at a competitive price. We cannot assure you that the market price of our Ordinary Shares will
not fluctuate or significantly decline in the future. In addition, we cannot assure you that a trading market for our Ordinary Shares
will be maintained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
specific factors that could negatively affect the price of our Ordinary Shares or result in fluctuations in their price and trading volume
include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or expected fluctuations in our prospects or operating results;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the demand for, or market prices for, gym and fitness equipment;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
    or departures of our key personnel;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    or proposed changes in laws, regulations or tax policy;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    or perceived potential sales of our Ordinary Shares by us or our directors, senior management or shareholders in the future;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    or expectations concerning additional financing efforts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conditions
    in the U.S. and global financial markets, or in our industry in particular, or changes in general economic conditions; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    other factors described in this &#8220;Item 3. Key Information&#8212;3D. Risk Factors&#8221; section and elsewhere in this annual
    report.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years, the stock markets generally have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of constituent companies. Broad market and industry factors may significantly affect the market price of
our Ordinary Shares, regardless of our actual operating performance. These fluctuations may be even more pronounced in the trading market
in the immediate future. If the market price for our Ordinary Shares drops below the IPO price of $5 per Ordinary Share, you may not
realize any return on your investment in us and may lose some or all of your investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
recent IPOs of companies with relatively small public floats comparable to our public float have experienced extreme volatility that
was seemingly unrelated to the actual or expected operating performance and financial condition or prospects of the respective company.
Our Ordinary Shares may potentially experience rapid and substantial price volatility, which may make it difficult for prospective investors
to assess the rapidly changing value of our Ordinary Shares.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the risks addressed above, the market price and trading volume of our Ordinary Shares may be affected by economic conditions
beyond our control and thus may be subject to rapid and substantial price volatility. Recently, companies with comparably small public
floats and IPO sizes have experienced instances of extreme stock price run-ups followed by rapid price declines, and such stock price
volatility was seemingly unrelated to the respective companies&#8217; actual or expected operating performance and financial condition
or prospects. Although the specific cause of such volatility is unclear, our public float may amplify the impact the actions taken by
a few shareholders have on the price of our shares, which may cause our share price to deviate, potentially significantly, from a price
that better reflects the underlying performance of our business. Our Ordinary Shares may experience run-ups and declines that are seemingly
unrelated to our actual or expected operating performance and financial condition or prospects, making it difficult for prospective investors
to assess the rapidly changing value of our Ordinary Shares. In addition, investors in our Ordinary Shares may experience losses, which
may be material, if the price of our Ordinary Shares declines or if such investors purchase our Ordinary Shares prior to any price decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be classified as a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S.
Holders of our Ordinary Shares.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
would be classified as a passive foreign investment company, or PFIC, for any taxable year if, after the application of certain look-through
rules, either: (i) 75% or more of our gross income for such year is &#8220;passive income&#8221; (as defined in the relevant provisions
of the Internal Revenue Code of 1986, as amended) (the income test), or (ii) 50% or more of the value of our assets (generally determined
on the basis of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive
income (the asset test). Based on the market price of our Ordinary Shares and the composition of our income and assets, including goodwill,
although not clear, we do not expect to be treated as a PFIC for U.S. federal income tax purposes for the current taxable year or in
the foreseeable future. However, this is a factual determination that must be made annually after the close of each taxable year, and
the application of the PFIC rules is subject to uncertainty in several respects. Moreover, the value of our assets for purposes of the
PFIC determination will generally be determined by reference to the market price of our Ordinary Shares, which could fluctuate significantly.
Therefore, there can be no assurance that we are not a PFIC for the current taxable year or will not be classified as a PFIC in the future.
Certain adverse U.S. federal income tax consequences could apply to a U.S. Holder if we are treated as a PFIC for any taxable year during
which such U.S. Holder holds our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
laws of the Cayman Islands may not provide our shareholders with benefits comparable to those provided to shareholders of corporations
incorporated in the United States.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an exempted company incorporated with limited liability under the laws of the Cayman Islands. Our corporate affairs are governed
by our amended and restated memorandum and articles of association, by the Companies Act (Revised) of the Cayman Islands and by the common
law of the Cayman Islands. The rights of shareholders to take action against our directors, actions by minority shareholders and the
fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman
Islands. The common law in the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands
and from the common law of England, the decisions of whose courts are of persuasive authority but are not binding, on a court in the
Cayman Islands. The rights of our shareholders and the fiduciary duties of our directors under Cayman Islands law may not as clearly
established as they would be under statutes or judicial precedents in some jurisdictions in the United States. In particular, the Cayman
Islands has a less developed body of securities laws relative to the United States. Some U.S. states, such as Delaware, have more fully
developed and judicially interpreted bodies of corporate law than the Cayman Islands. In addition, Cayman Islands companies may not have
the standing to initiate a shareholder derivative action in a federal court of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Because
we are a Cayman Islands company and all of our business is conducted in Australia, you may be unable to bring an action against us or
our officers and directors or to enforce any judgment you may obtain, and the U.S. regulatory bodies may be limited in their ability
to conduct investigations or inspections of our operations in Australia.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated in the Cayman Islands and conduct our operations primarily in Australia. Substantially all of our assets are located
outside of the United States and the proceeds which we raised from the capital markets will primarily be held in banks outside of the
United States. In addition, the majority of our directors and officers reside outside of the United States. As a result, it may be difficult
or impossible for you to bring an action against us or against these individuals in the United States in the event that you believe we
have violated your rights, either under United States federal or state securities laws or otherwise, or if you have a claim against us.
Even if you are successful in bringing an action of this kind, the laws of the Cayman Islands and of Australia may not permit you to
enforce a judgment against our assets or the assets of our directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will incur increased costs as a result of operating as a U.S. listed public company, and our management will be required to devote substantial
time to new compliance initiatives and corporate governance practices.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a U.S. listed public company we will incur, particularly after we are no longer an &#8220;emerging growth company,&#8221; significant
additional legal, accounting, and other expenses. The Dodd-Frank Wall Street Reform and Consumer Protection Act, the Sarbanes-Oxley Act,
the listing requirements of Nasdaq, and other applicable securities rules and regulations impose various requirements on public companies,
including establishment and maintenance of effective disclosure and financial controls and corporate governance practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that we will need to hire additional accounting, finance, legal, and other personnel in connection with our becoming, and our
efforts to comply with the requirements of being, a public company, and our management and other personnel will need to devote a substantial
amount of time towards maintaining compliance with these requirements. These requirements increase our legal and financial compliance
costs and make some activities more time-consuming and costly. In addition, we expect that the rules and regulations applicable to us
as a public company may make it more difficult and more expensive for us to obtain directors&#8217; and officers&#8217; liability insurance,
which could make it more difficult for us to attract and retain qualified members of our board of directors or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish research or reports about our business, or if they issue an adverse or misleading opinion
regarding our stock, the market price and trading volume of our Ordinary Shares could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for the Company&#8217;s Ordinary Shares will be influenced by the research and reports that U.S. securities or industry
analysts publish about us or our business. Securities and industry analysts may discontinue research on us, to the extent such coverage
currently exists, or in other cases, may never publish research on us. If no or few U.S. securities or industry analysts commence coverage
of the Company, the trading price for our Ordinary Shares would be negatively affected. In the event securities or industry analysts
initiate coverage, if one or more of the analysts who cover us downgrade our Ordinary Shares or publish adverse or misleading research
about our business, the market price of our Ordinary Shares would likely decline. If one or more of these analysts cease coverage of
us or fail to publish reports on us regularly, we could lose visibility in the financial markets, demand for our Ordinary Shares could
decrease, which might cause our price and trading volume to decline. In addition, research and reports that Australian securities or
industry analysts may, initiate or may continue to, publish about us, our business or our Common Stock may impact the market price of
our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nasdaq
may de-list the Company&#8217;s securities from its exchange, which could limit investors&#8217; ability to make transactions in the
Company&#8217;s securities and subject the Company to additional trading restrictions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Ordinary Shares are currently on Nasdaq. In the future, the Company&#8217;s Ordinary Shares may fail to meet the continued
listing requirements to be listed on the Nasdaq. If Nasdaq delists our Ordinary Shares from trading on its exchange, the Company could
face significant material adverse consequences, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    limited availability of market quotations for our Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    determination that our Ordinary Shares is a &#8220;penny stock&#8221; which will require brokers trading in our Ordinary Shares to
    adhere to more stringent rules, which could result in a reduced level of trading activity in the secondary trading market for our
    Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">more
    limited news and analyst coverage of the Company; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decreased ability to issue additional securities or obtain additional financing in the future.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="me_005"></span>Item 4.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information on the Company</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4A.
<span style="text-decoration: underline">History and Development of the Company</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a holding company incorporated in the Cayman Islands under Cayman Islands Law on April 11, 2022 under the name &#8220;Fitell Corporation&#8221;.
We have no substantive operations other than holding all of the issued and outstanding shares of KMAS, which holds all of the issued
and outstanding shares of our operating subsidiary, GD. The address and telephone number of our registered office is 23-25 Mangrove Lane,
Taren Point, NSW 2229, Australia, +612 95245266 and the name, address and telephone number of our US agent is Cogency Global Inc., 122
East 42nd Street, 18th Floor, New York, NY 10168, (800) 221-0102. Our website address is https://www.fitellcorp.com/. Information contained
on, or that can be accessed through, our website does not constitute a part of this annual report and is not incorporated by reference
herein. We have included our website address in this annual report solely for informational purposes. The SEC maintains an Internet site
that contains reports, proxy and information statements, and other information regarding issuers, such as we, that file electronically,
with the SEC at <span style="text-decoration: underline">www.sec.gov</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
wholly owned operating subsidiary, GD, was founded in 2005. Upon our reorganization, on May 4, 2022, the Company issued 280,000 Ordinary
Shares each to L&amp;H Investment Management Limited, a company incorporated under the laws of the British Virgin Islands, and PRMD Investment
Consultation Company Limited, a company incorporated under the laws of the British Virgin Islands, representing issuances to our co-founders.
In addition, one (1) Ordinary Share was transferred back to SKMA from the registered office service provider in the setup of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 5, 2022, we entered into a Share Exchange Agreement (&#8220;Share Exchange Agreement&#8221;) with KMAS, which holds all of the issued
and outstanding shares of GD, and SKMA, which holds all of the issued and outstanding shares of KMAS, pursuant to which the Company shall
acquire all of the shares in KMAS from SKMA in exchange for the Company issuing 6,439,999 Ordinary Shares to SKMA in accordance with
the terms of the Share Exchange Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4B. <span style="text-decoration: underline">Business Overview</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founded
in 2005 and headquartered in New South Wales, Australia, GD is a wholly owned subsidiary of Fitell. We operate in Australia and are an
online retailer of gym and fitness equipment both under our proprietary brands and other brand names. Our mission is to build an ecosystem
with a whole fitness and wellness experience powered by technology to our customers. GD has served over 100,000 customers with large
portions of sales from repeat customers over the years, which we believe to be a testament of our product quality and brand loyalty.
Our brand portfolio can be categorized into three proprietary brands under our Gym Direct brand: Muscle Motion, Rapid Motion, and FleetX,
in approximately 2,000 stock-keeping units (SKUs).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to our all-around fitness equipment portfolio to individual and commercial customers, we launched three new business verticals
with integration of technology in 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Smart
Connected Equipment: </span>Still in development and initiated in May 2021, our smart fitness equipment is a natural extension of our core
business and includes interactive exercise bikes and workout mirrors. We expect commercial launch in December 2024, with retail products
being available in November 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1FinalRound:
    Our <span style="text-decoration: underline">AI-powered interactive platform</span> with our proprietary online training content and capability to be interactive with personal
    trainers, follow members and track workout progress.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Boutique
    Fitness Clubs Licensing</span>: Leveraging our years of experience in the fitness and wellness industry servicing both businesses and
    individual customers, we launched our licensing business in late 2021. mYSTEPS Training Clinic, a new concept fitness club chain,
    is our first licensee and dedicated to helping fitness-savvy and health-conscious consumers with higher disposable incomes achieve
    a motivating and healthy lifestyle with an engaging and dynamic fitness community in both online and offline settings. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="form20-f_001.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Products
and Services</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fitness
Equipment</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
market and sell fitness equipment and related products as well as serving as a one-stop shop for business setup from personal training
studios to commercial gyms. Our full spectrum of product coverage is exemplified by the following three proprietary brand names, which
represent over 70% of our revenues in the fiscal year ended June 30, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    <i>Muscle Motion</i> brand is a supplier of home gym and commercial strength-training equipment. Products have an emphasis on weights,
    bars, power racks, benches, and gym machines.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    <i>Rapid Motion</i> brand features similar products as Muscle Motion but with a stronger focus on commercial items.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    <i>FleetX</i> brand focuses on cardio equipment, including products such as rowing machines, exercise bikes, treadmills and more.
    All of these items are available in both home and commercial-grade quality.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our fitness equipment business segment, we sell our products directly to customers through online or offline platforms. Revenue from
our own e-commerce website accounted for approximately 58.72% of our total sales for the fiscal year ended June 30, 2024, with the remaining
sales derived from commercial sale orders, our showroom and phone orders as well as third party channels, such as Bunnings Marketplace
and eBay.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Licensing
Business</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer a turnkey solution for personal training studios and commercial gym chains. The primary focus of our licensing business is the
new concept fitness studios established to meet the increasing demand of affluent, educated, middle class individuals with higher brand
awareness and loyalty, usually from ages 28 to 55. Our typical licensees are either entrepreneurs or fitness professionals and teams
with established track records who share the same vision of building the next-generation of multi-dimensional fitness centers. We work
closely with our licensees and offer the following services:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    selection and preparation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designing
    and build-out;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outfitting
    their facilities with our proprietary state-of-the-art equipment and related products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
    pre-opening support;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Installation
    of intuitive members management systems and in-depth training;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integrating
    social communication apps; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Training
    services for personal trainers and coaches; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In-person
    training and virtual training which gives greater flexibility and convenience to time poor users</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
assisted our first licensee, Js &amp; Je Company Limited, in opening 6 mYSTEPS fitness centers in Eastern China as of April 25, 2022.
Pursuant to our license agreement with our first licensee, the territories in which our licensee will seek opportunities to open fitness
centers are Indonesia, Singapore, Malaysia, mainland China, Hong Kong, and Macau. Fees payable by our licensee to us are a base fee per
annum of US$125,000 plus US$40,000 for each opened fitness center per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
approximately two decades of experience in the fitness market and constant innovative product development based on feedback collected
over the years from our customers, we are developing a model that allows fitness users to access the flexibility of virtual training
platforms with connected machines or in-person offline training modules in the licensed studios. We believe this offering not only promotes
broader awareness and acceptance of the online and offline model in the fitness industry, but also delivers unique fitness experiences
to broader gym goers to increase exercise frequency virtually while encouraging the development of experiences at offline studios with
interactive programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interactive
Fitness Equipment and Platform/Mobile Application</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic has dramatically changed how we live, work, play and stay healthy. The fitness industry, without exception, has undergone
profound transformation in the past years, starting with the closure of gyms and fitness studios followed by growth in smart fitness
equipment. We are currently developing our smart fitness equipment through a Shenzhen, China-based service provider specializing in AI-powered
products like interactive-monitors/screens, handheld devices, as well as platform development, in building innovative integrated fitness
equipment and interactive platforms designed to provide a seamless connection between users and our user-friendly platform, proprietary
content, and interactive equipment. Fitness Mirror, an e-training platform, and Yoga-Mirror are in final testing stages, and we expect
to commercially launch these platforms in November 2024. The beta versions of these platforms have been in trial stages since March 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
joint development of interactive fitness equipment and platforms with subscription service comprises the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smart
    connected equipment: interactive exercise bikes, treadmills, and workout mirrors with built-in touchscreens and training content
    platforms.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1FinalRound:
our proprietary artificial intelligence training platform under development, currently in its internal testing stage prior to public
launch. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1FinalRound
    will come pre-installed with our interactive fitness equipment. Its key features include visual and trackable workout progress and
    results available to mobile users.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customized
    solutions will be available as a premium for one-on-one remote coaching. Users pay a premium and will receive customized programs
    to fit individual schedules and personalized needs.</span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    will allow both online and offline users to participate in the training either on their own schedule or via livestreaming to interact
    with other subscribed members to encourage a more interactive, engaging and motivating lifestyle.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="form20-f_002.jpg" alt=""/></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales
and Marketing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our fitness equipment business segment, we sell our products directly to customers through online or offline platforms. Revenue from
our own e-commerce website accounted for approximately 58.72% of our total sales for the fiscal year ended June 30, 2024 with the remaining
sales derived from commercial sale orders, our showroom and phone orders as well as third party channels, such as Bunnings Marketplace
and eBay. Our marketing strategy focuses on delivering fitness equipment to our customers and, in the future, to our licensees and their
members and raising awareness of our brand through a broad range of channels. These channels include Google Search (organic and paid),
Google Shopping Campaign, Google Ads word, affiliate partners programs, social media such as Facebook and Instagram, e-mail marketing,
SMS marketing, E catalogue, and First Australia Fitness Mobile App. We utilize a multi-prong marketing strategy focused on attracting
and educating prospective customers and licensees, driving demand with new and existing customers and increasing general awareness and
affinity for our brand. Our loyalty program Gym Direct Lion Rewards Club is used to encourage both repeat purchases and order sizes and
enhance brand loyalty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Online</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our online business, we predominately sell our fitness products directly to consumers through our website GymDirect.com.au, which was
first launched in 2007. Customers can find the three proprietary brands of Gym Direct along with other fitness equipment retail brands
on our e-commerce website. All of our products are listed on our website, which is also a key channel for our customer acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Offline</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
offline business is conducted through phone, e-mail, and showroom sales for large and repeat customers. We generally provide opportunities
for our commercial or repeat customers (including fitness studios, gyms, and government institutions) to view our products prior to ordering
to help secure large customer orders. Alternatively, we often customize the combination of products to our commercial customers based
on their budgets and actual floor plans. Our showroom carries a large variety of strength and cardio equipment and other fitness equipment/machines
as well as accessories. In addition, we offer programs that provide price promotion to incentivize sales, such as our Lion Loyalty Reward
Program and Special EDM campaign that target different groups of customers on a regular basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Licensing
Business Marketing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propelled
by the momentum of our first licensee, our primary focus for marketing to prospective licensees includes a mix of social, digital, search,
referral, and experiential marketing. We offer prospective licensees a turnkey solution with our high-quality products and license our
trademarks, including Gym Direct, Muscle Motion, FleetX, and Rapid Motion, which cover the functional needs of the studios as well as
enable users to access the one-stop shop of Gym Direct via website or application.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, with the introduction of 1FinalRound and smart connected fitness equipment via our corporate website and application, which
are accessible to our licensees, we are able to broaden our marketing coverage virtually as well as with our physical branded products.
We believe the coverage of the brand awareness extends beyond the physical locations of our licensees and penetrates into wider markets
and segments of fitness consumers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Product
Design and Innovation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
provide our customers with high quality user experience, we constantly search for creativity and innovation to expand and diversify our
product portfolio by leveraging different resources and channels. Our procurement team identifies trends and popular fitness equipment
development locally and globally to create on-trend fitness equipment and content for our customers and users. Our customer team also
conducts surveys periodically to obtain feedback for product modification and improvement. After identifying new trends or product types,
we will consult with our in-house product development advisors and engineer designers from suppliers to co-develop such fitness equipment.
Our suppliers will then complete the manufacturing and provide sample products for inspection and testing. After this process, we will
confirm the purchase order with our suppliers for the newly developed product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Suppliers
and Customers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
enjoy a broad network of our product suppliers and customers. In addition, searching for qualified alternative suppliers and manufacturers
has been our priority, which we believe will limit the risks of single source of supply, and we have developed contingency plans for
supply disruptions. We currently have 27 suppliers, 12 of which are Australian suppliers and 15 are overseas suppliers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
85% of our products come from overseas suppliers and they predominantly manufacture made-to-order products, such as commercial machine
equipment XRFM series and FT1009 under our proprietary brands Muscle Motion and Rapid Motion and FX AB03 bike and FleetX Rower are under
our proprietary brand FleetX. Payment terms with our suppliers vary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is a tabular summary of our relationships with suppliers that represent over 5% of our supplies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplier
    Name</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
    Name</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terms</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kynson
    Limited (23.68%)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motion
    Bikes and Spin Bikes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    within 7 days from invoice date</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nantong
    Tengtai Sporting Fitness (16.83%)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rubber
    Hex Dumbbells</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
                                            paid against copy of B/L. Seller releases the B/L to buyer after receiving payment.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nantong
                                            Duro Fitness Co., Ltd. (7.09%)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weight
    Plates</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    within 14 days from receiving goods.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qingdao
    Imbell Sporting Goods Co., Ltd (8.58%)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strength
    Products </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
                                            paid against copy of B/L. Seller releases the B/L to buyer after receiving payment.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Morgan
    Imports Pty Ltd (5.23%)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boxing
    &amp; MMA products</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1<sup>st
    </sup>of the following month.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
top four suppliers representing over 5% of the Company&#8217;s supplies are based in China. The Company has not entered into any written
agreements with these four suppliers, but places purchase orders with these three suppliers as needed. The remaining supplier is based
in Australia. The company has not entered into any written agreements with this supplier, but places purchase orders with it. The Company
has no material affiliations or relationships with any of the above five suppliers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the twelve-month period ended June 30, 2024, we received 17,926 orders and 26,266 customers, an increase of 18.0% and an increase of
13.1%, respectively, compared to the same period in 2023. In the twelve-month period ended June 30, 2023, we received 15,189 orders and
23,231 customers, a decrease of 42.6% and a decrease of 41% respectively, compared to the same period in 2022. This was primarily due
to the management has strategically lower the selling prices or our products in order to cope with the recent economic conditions in
Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
e-commerce conversion rates have decreased by 1.37% from 0.73% in fiscal year 2023 to 0.72% in fiscal year 2024. Approximately 34.4%
of orders were from existing customers and the average purchase frequency was 2.2 across all customers in fiscal year 2024. The number
of our repeat customers increased from 3,793 in fiscal year 2023 to 3,937 in fiscal year 2024. Based on our database, customers stood
at 198,163 members by end of fiscal year 2024, compared to 171,897 members at the end of fiscal year 2023, which we believe reflects
the ability of the business to respond in economic downturn with challenging obstacles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is a tabular summary of our online customer purchase data:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">Status</span></td><td style="text-align: left; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">#
    of<br/>
    Customers</span></td><td style="text-align: left; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">Average
    <br/>
    Size of Order</span></td><td style="text-align: left; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">Average
    <br/>
    Total Spending</span></td><td style="text-align: left; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">First time Customers FY2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,261</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
                                            Units</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">254.13</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Return Customers FY2024</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,937</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
                                            Units</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">304.77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
received 17,926 orders and acquired 26,266 customers in fiscal year 2024, an increase of 18.0% and 13.1%, respectively, compared to the
same period of fiscal year 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to our retail customers, our commercial customers include chains of fitness gyms and studios, government agencies, schools,
healthcare providers and educational institutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is the graph summary of revenue by customer type:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="form20-f_003.jpg" alt=""/></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
fiscal year 2024, retail customers accounted for 70.35% of the Company&#8217;s total revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Growth
Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
goal is to grow our fitness equipment business segment while continuing to engage and retain our loyal community of customers and fitness
platform members. Our business development and expansion strategies over the next two to three years are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Increase
Fitness Equipment Product Marketing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    currently rely primarily on organic traffic through search engine optimization to achieve customer acquisition. Leveraging our high-ranking
    position in search engine result pages, we intend to expand our strategic investment on marketing campaigns in Key Opinion Leaders
    (KOLs), sponsoring sports events and outdoor advertisement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Development
of Private-Label Cardio Equipment</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    profit margin for cardio fitness equipment is higher than that of strength and weight equipment. We intend to develop our proprietary
    branded cardio equipment to increase our profitability in the market.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Development
of Gym Direct Mobile Application</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Traditionally,
    we only use our e-commerce website as a platform to sell our products and communicate with our retail customers. We are now developing
    a native mobile application to further expand the marketing platform and provide easy, repeatable and convenient shopping experiences
    for customers, which will also be beneficial in tracking consumer trends and purchasing data. The beta versions of these platforms
    have been in trial stages since March 2022 and the official version has been launched since November 2023.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="form20-f_004.jpg" alt=""/></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expansion
of Licensing Business</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
    our years of experience in the fitness and wellness industry servicing both business and individual customers, we launched our licensing
    business with mYSTEPS Training Clinic in late 2021. As of the fiscal year ended June 30, 2024, mYSTEPS has opened 6 fitness and gym
    studios. Currently, our licensee has no plans to open additional fitness centers in China (including Hong Kong and Macau) due to
    COVID-19 policies and market conditions and will continue to explore opportunities in Indonesia, Singapore, and Malaysia. Based on
    the current license sold, we believe there will be long-term potential and opportunities for us outside of the Australian market.
    Going forward, we intend to seek opportunities to expand our licensing partnership footprint in the Asia-Pacific regions with other
    selective partners.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Development
of Smart Connected Equipment and Digital Fitness Program</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Digital
    subscription-based machines have led the trend in the U.S. market, such as Mirror, Peloton, Tonal, where the demand for interactive
    fitness applications has risen. We plan to expand into this market in Australia and Southeast Asia where the concept of the home
    gym has not been fully deployed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Growing
    brand awareness.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improving
    member experience.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
    our database of customers which we have accumulated from the sales of fitness equipment to increase interactive cardio equipment
    sales and subscription revenues.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
    to launch new and innovative content and products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Opportunities
to Explore Other Revenue Streams</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
    our expertise in targeting health-conscious consumer audiences, we plan to develop a host of solutions for white-label functional
    health supplement products, including muscle building beverages, vitamins and other sports nutrition products in Australia and Asia-Pacific
    regions. We have engaged an Australian pharmaceutical company to develop formulas for muscle protein powder, multi-vitamins and post-exercise
    drinks. These products are developed based on the existing data and feedback we received from our customers and intend to target
    these health-conscious consumers.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
    our expertise in developing and marketing fitness equipment, there is the opportunity for us to expand our businesses into used fitness
    equipment sales (e-commerce), including used home cardio machines and other domestic used fitness equipment. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    addition, we also intend to expand our business segments to target the health and fitness needs of our target consumers in the following
    cross selling opportunities: apparel, niche sports and health equipment, and sporting footwear, among others, which widen the shopping
    choices to fitness-conscious or generic consumers. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supply
Chain Challenges and Strategies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Buying
    cost remain stable:</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
    to the COVID-19 pandemic, the cost of raw materials has remain relatively stable in the last one to two years. Our buying cost in
    the fiscal year ended June 30, 2024 has remain relatively constant, as compare to the fiscal year ended June 30, 2023.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leading
    time remain stable: </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
    to the COVID-19 pandemic, the leading time of manufacturing and logistics has been stabilized and back to normal. The Sea freight
    in the fiscal year ended 2024 and 2023, usually took approximately 3 to 4 weeks, as compare to up 6 to 8 weeks during the COVID-19
    pandemic.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Logistics
    cost increase:</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                            the fiscal year 2024, sea freight costs increased dramatically by approximately 190.5%, the
                                            significant increase in logistic cost was due to the drop in supply of available shipping
                                            vessels on a global basis, due to recent geopolitical tensions.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.25in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">Sea freight cost</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">Mid of <br/>
    2023 (AUD)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">Early <br/>
    2024 (AUD)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">Increase</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">20GP from Shanghai</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">878.22</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,551.02</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">190.5</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delivery
    time remain stable:</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
    to the COVID-19 pandemic, delivery time was back to normal and was approximately 1 to 2 business days to metro and NSW areas in Sydney,
    Australia, 2 to 3 business days in transit for interstate or other metro cities, and approximately 5 business days to remote areas
    in the fiscal year ended June 30, 2024 and 2023. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Strategies
    for Possible Out-of-Stock Products</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to the increased sea freight cost and the delays in shipment, we increased our minimum order quantity (MOQ) to ensure sufficient
    stock. In the meantime, we also intend to engage with a third party logistic (3PL) service provider overseas as a satellite warehouse
    to improve stock availability to meet in-time delivery. As the peak of the pandemic eased, stock returned to usual levels by April
    2022 when the pandemic effects around the world became more stable.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actions
    and Initiatives to Mitigate Challenge</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    believe the establishment of 3PLs in both overseas locations and interstate locations will significantly reduce our logistic costs
    while maintaining higher efficiency rates with sound procurement procedures;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Catch
    me if you can&#8221; strategy: Constant launch of innovative and unique products to ensure healthy and above-average gross profit
    margins; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natural
    hedging strategy with expansion of licensing business in South-East Asia;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frequent
    pricing review procedures to ensure our competitiveness while avoiding any pricing wars by strategically bringing new offers of services
    and products; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    position of GD, with both virtual training modules and physical products offerings, gives competitive advantages to our business
    while mitigating the objective challenges.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for all fitness related products is highly competitive. However, we believe our quality, innovation, pricing and loyal customers
position us competitively in the marketplace. We are not only involved in at-home fitness equipment but also in commercial equipment
solutions by both offline selling and e-commerce platforms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal competitors include Nautilus, Peloton, ICON Health &amp; Fitness (NordicTrack), Johnson Health Tech, Technogym, Echelon, Mirror,
Hydrow, Tonal, JaxJox and Tempo. We also compete with marketers of smart device applications focused on fitness training and coaching,
such as Peloton, Zwift, Strava, Mirror, BeachBody, Apple Fitness+, NeoU, Equinox+, FitScope, FitOn, Fulgaz Video Cycling, Sufferfest
Training Systems, At Home Workouts by Daily Burn, and NIKE&#174; Training Club. Additional marketers of competitive products include the
following: activity trackers and content-driven physical activity products, such as Fitbit&#174;, Garmin vivofit&#174;, Whoop, and Oura;
group fitness, such as cross-fit classes; and gym memberships, each of which offers alternative solutions for a fit and healthy lifestyle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competitive
Strengths</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that there are several competitive strengths that differentiate us from our competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Proprietary
Brands and Diversified Product Portfolio</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    three proprietary brands &#8211; Muscle Motion, Rapid Motion, and FleetX &#8211; provide both in-home options and commercial solutions.
    Our product portfolio of these three diversified brands spans a variety of popular fitness and workout verticals, including weightlifting,
    stretch, yoga, boxing, running and cycling. We believe that our diversification represents competitive advantages compared to other
    competitors in the market. With the development of the integrated fitness equipment and virtual platform, we believe we will be able
    to create more valuable opportunities for business expansion.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Innovative
Smart Connected Equipment</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
connected equipment, which has been the global trend for the fitness and gym industry, is also under development. Initiated in May 2021,
our development concept includes interactive exercise bikes and workout mirrors. We expect that the interactive gym equipment will be
commercially launched in December 2024 and believe that our new product will better serve both retail and commercial customers and accelerate
our business growth.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Virtual
Training Platform with Cutting Edge Content</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraging
    our years of experience in the fitness and wellness industry, we have developed an online proprietary training platform &#8211; 1FinalRound
    &#8211; which will be pre-built into our connected equipment that allows our customers to maintain engagement with us during any
    potential temporary closures of gyms and studios. This model allows flexibility for both online and offline users to participate
    in training either on their own schedules or via livestreaming to interact with other subscribed members to encourage more interactive,
    engaging and motivating lifestyles. The platform will provide an extensive offline library with high production value or various
    online live stream experiences. Moreover, based on the large, consolidated dataset we received from our fitness equipment customers,
    we believe we will be able to create and develop on-trend fitness content for our users.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consolidated
Database with Loyal Customer Base</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GD
    has served over 190,000 customers with large portions of sales coming from repeat customers over the years. We believe that our
    sales strategies also create inventive solutions for existing customers and drive loyalty. As of June 30, 2024, 34.41% of our orders
    are from existing customers, the average purchase frequency is 2.2 across all customers. We believe that we will be able to deepen
    our customer loyalty through our newly developed Gym Direct mobile application and 1FinalRound.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compelling
and Scalable Licensing Model</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademarks,
patents and other forms of intellectual property are vital to the success of our business and are an essential factor in maintaining
our competitive position in the health and fitness industry. We own the following trademarks: Gym Direct, Muscle Motion, Rapid Motion
and FleetX. We regularly monitor commercial activity in our industry to identify potential infringement of our intellectual property.
We protect our proprietary rights and attempt to take prompt, reasonable actions to prevent counterfeit products and other infringement
on our intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="form20-f_005.jpg" alt="" style="width: 600px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business. As
of the date of this annual report, neither we nor any of our subsidiaries is a party to any pending legal proceedings, nor are we aware
of any such proceedings threatened against us or our subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
must comply with various federal, state and local regulations in Australia, including regulations relating to consumer products and consumer
protection, advertising and marketing, labor and employment, data protection and privacy, intellectual property, the environment and
tax. Ensuring our compliance with these various laws and regulations, and keeping abreast of changes to the legal and regulatory landscape
present in our industry, may cause us to expend considerable resources. Summarized below are a number of Australian regulation aspects
to which our business is subject.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consumer
controls</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
sell products to Australian consumers online and therefore are subject to the requirements of the <i>Competition and Consumer Act 2010
(Cth)</i> (CCA) and the Australian Competition &amp; Consumer Commission&#8217;s oversight. The CCA regulates anti-competitive behavior,
misleading and deceptive conduct and price-fixing. In addition, the Australian Consumer Law, which is set out in Schedule 2 of the CCA
regulates unfair contract terms, guarantees consumer rights when buying goods and services and applies product safety standards. Breaches
of the CCA, including the Australian Consumer Law may result in criminal or civil pecuniary penalties, infringement notices, or more
formal legal action in the courts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Privacy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate in the Australian online market and therefore are required to comply with the privacy regime as outlined in the <i>Privacy Act
1988 (Cth)</i>, which includes the Australian Privacy Principles (APPs) and the Office of the Australian Information Commissioner&#8217;s
oversight. The 13 APPs prescribe responsibilities for maintaining personal information privacy, including around collection, use, disclosure
and access to data, as well as the publication of a clearly expressed and up-to-date privacy policy. A breach of those requirements may
result in investigations, enforceable undertakings, injunctions, or civil penalty orders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Regulation
of electronic communications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate in the Australian online market and use telecommunication services to publish and distribute electronic marketing material. Such
operations of ours are subject to the <i>Spam Act 2003 (Cth) </i>(Spam Act) and the <i>Spam Regulations 2021</i> (Cth)(Spam Regulations),
which the Australian Communications and Media Authority (ACMA) can enforce through court action. Breaches of the Spam Act or Spam Regulations
may result in the ACMA issuing a formal warning, giving an infringement notice, requiring the party in breach to accept enforceable undertaking
or taking the matter to the Federal Court, which can impose significant penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4C.
<span style="text-decoration: underline">Organizational Structure</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following diagram illustrates our corporate structure as of the date of this annual report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="form20-f_006.jpg" alt=""/></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4D.
<span style="text-decoration: underline">Property, plants and equipment</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not own any real property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Facilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
corporate headquarters is located at 23-25 Mangrove Lane, Taren Point, New South Wales 2229, Australia, where we occupy facilities
totaling over 30,000 square feet. Our showroom and storage facility are located at the same address as our corporate office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease the facilities in Taren Point, New South Wales, Australia. The current lease commenced on July 15, 2023. The monthly lease payment
is AUD40,334, with goods and services tax, and is subject to an annual escalation rate of 3%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="form20-f_007.jpg" alt=""/></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="form20-f_008.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we have a total of 15 employees and all of them are full-time employees&#8212;5 employees serve as management, 5 employees
serve as sales and marketing, 4 employees serve as warehouse management, and 1 employees serve as procurement and logistics. All of our
employees and contractors are located in Sydney, Australia. Our employees are not represented by a labor organization or covered by a
collective bargaining agreement. We have not experienced any work stoppages. We believe that we maintain a good working relationship
with our employees, and we have not experienced any major labor disputes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="nd_001"></span>Item
4A. Unresolved Staff Comments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="nd_002"></span>Item
5. Operating and Financial Review and Prospects</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">You
should read the following discussion and analysis of the Company&#8217;s financial condition and results of operations in conjunction
with the Company&#8217;s consolidated financial statements and the related notes included elsewhere in this annual report. This discussion
may contain forward-looking statements based upon current expectations that involve risks and uncertainties. The Company&#8217;s actual
results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those
set forth under &#8220;Item 3. Key Information &#8212; 3.D. Risk Factors&#8221; or in other parts of this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<span style="text-decoration: underline">Operating Results</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company runs its business through its wholly-owned subsidiary GD. GD was founded in 2005 and is headquartered in New South Wales,
Australia. GD is a gym and fitness equipment retailer both under its proprietary brands and other reputable and industry recognized
names. GD carries over 2,000 SKUs and has served over 190,000 customers with a large portion of sales from repeat customers over the
years &#8211; a testament of our product quality and brand loyalty. The Company has launched its global expansion strategy with
initial geographic focus in South-East Asia markets in late 2021 as described in detailed in the &#8220;Recent Developments&#8221;
section immediately below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2024, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with Flying Height
Consulting Services Limited (&#8220;Flying Height&#8221;). Pursuant to the Purchase Agreement, the Company issued to Flying Height a
three-year 8% senior unsecured convertible promissory note in the principal amount of $3,600,000, with an 8% original issue discount
(the &#8220;Note&#8221;) and, as additional consideration for the purchase of the Note, a stock purchase warrant to purchase 5,645,455
Ordinary Shares (the &#8220;Warrant&#8221;), for the funding amount of $3,312,000. The proceeds from the sale of the Note and Warrant
shall be used by the Company for general working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Note, Flying Height may convert all or any part of the remaining outstanding principal amount of the Note and unpaid interest
on the date of conversion into fully paid and non-assessable Ordinary Shares, at any time after the issuance of the Note until the later
of (i) January 15, 2027, the maturity date of the Note and (ii) the date of payment upon any event of default. The conversion price of
the Note is equal to the lowest closing price for the Company&#8217;s Ordinary Shares as reported on The Nasdaq Capital Market during
the five (5) trading days immediately preceding the date of conversion, provided, however, that the Conversion Price shall not be lower
than $0.80 per share (the &#8220;Floor Price&#8221;). The Conversion Price and the Floor Price are subject to equitable adjustments for
stock splits, stock dividends, combinations, recapitalization, reclassifications, extraordinary distributions and similar events. In
addition to voluntary conversion rights of Flying Height, the Company will have the right, but not the obligation, at any time after
six months following the date of the issuance of the Note, to require Flying Height to convert the outstanding principal amount of the
Note and unpaid interest into Ordinary Shares if the closing price per share of Ordinary Shares exceeds $10.00 per share as reported
on The Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant entitles Flying Height to purchase up to 5,645,455 Ordinary Shares of the Company, commencing on January 15, 2024, the date of
the issuance of the Warrant, and ending on the date that is sixty (60) months from the date of the issuance of the Warrant at an exercise
price of $1.056 per share, subject to customary adjustments. The Warrant includes a cashless exercise option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuances of the Note and Warrant were, and, upon conversion of the Note and exercise of the Warrant to Ordinary Shares, will be, exempt
from registration requirements in reliance upon Section 4(a)(2) the Securities Act, and/or Rule 506(b) of Regulation D and/or Regulation
S, as promulgated by the SEC thereunder. At the time of their issuance, the Note and the Warrant were deemed to be restricted securities
for purposes of the Act and will bear restrictive legends to that effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, Flying Height converted the Note in full and, on March 19, 2024, Flying Height exercised the Warrant via cashless exercise
in full, for the aggregate of 8,983,636 Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Financial Performance Indicators</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing our financial performance, we consider a variety of financial performance measures, including principal growth in revenue and
gross profit, our ability to control costs and operating expenses to improve our operations and profitability. Our review of these indicators
facilitates timely evaluation of the performance of our business and effective communication of results and key decisions, allowing our
business to respond promptly to the dynamic market conditions and the different demands and preferences from our customers. The key measures
that we use to evaluate the performance of our business are set forth below and are discussed in greater details under &#8220;Results
of Operations&#8221;:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue consists of merchandise revenues, sales of consumable products, and revenue from licensing customers accounted for 88.6%, 8.0%,
and 3.4% of our total revenue for the fiscal year ended June 30, 2024, and accounted for 84.1%, 4.7%, and 11.2% of our total revenue
for the fiscal year ended June 30, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
merchandise revenue is driven by changes in the number of sales orders, and the average order value. Almost all our sales were sold to
end users, and in most cases, we do not provide credits to them. Therefore, we receive payments from customers upfront for most of our
sales. The sales volume of our merchandise revenues by sales orders has increased by 18.0% in the fiscal year ended June 30, 2024, as
compared to fiscal year ended June 30, 2023. This was because management has made its best efforts to boost sales, including but not
limited to promotions and providing discounts to our customers. Our average order value per sales order has dropped slightly by 16.9%
in fiscal year ended June 30, 2024, as compared to fiscal year ended June 30, 2023. This was primarily due to inflation and interest
rates in Australia, which has significantly reduced the disposal income of Australia households and affected the consumers&#8217; sentiment.
In the fiscal year June 30, 2024, the inflation was more than 4% on average throughout the year, and the Australis cash rate target,
which was set by the Reserve Bank of Australia, has also increased from 0.25% to 4.35%. However, management believes that the impact
is short-term because the salaries of Australian individuals are also increasing gradually, and the interest may start falling again
in the near future.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sales of consumable products consist of selling fitness and wellness related products to overseas market. The revenue generated from
this activity has increased 60.5% from $223,343 for the fiscal year ended June 30, 2023 to $358,536 for the fiscal year ended June 30,
2024. Management is aiming to find more business opportunities in the overseas market in order to boost sales in the foreseeable
future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
revenue from licensing customers has decreased 72.0%, from $539,832 for the fiscal year ended June 30, 2023, to $151,277 for the fiscal
year ended June 30, 2024. The decrease was due to the management having to strategically postpone the overseas expansions
in this area, as the market sentiments are negatively affected by the inflations and the high interest rate in the global market. Nevertheless,
we will expand these services again, especially to the Asia market, when the time is right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross
Profit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit is equal to revenue minus cost of goods sold. Cost of goods sold primarily includes inventory costs (third-party products purchase
price, freight costs, custom duties, and other miscellaneous costs related to purchase). Our cost of goods sold account for 64.5% and
54.7% of our total revenue for the fiscal year ended June 30, 2024 and fiscal year ended June 30, 2023, respectively. Our gross profit
margin has decreased 9.8% for the fiscal year ended June 30, 2024, as compared to the fiscal year ended June 30, 2023. The drop in gross
profit margin was because management has lowered the selling prices strategically in general to cope with the economic conditions in
Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operating expenses consist of personnel expenses, consulting fees, licensing fees, general and administrative expenses, sales and marketing
expenses, operating lease expenses, and depreciation expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
personnel expenses consist primarily of employee salaries, superannuation, external consulting expenses and other employment-related
expenses. Personnel expenses were 21.3% and 20.1% of our revenues for the fiscal years ended June 30, 2024 and 2023, respectively. Going
forward, we expect our personnel expenses will increase gradually in the foreseeable future, as we plan to hire additional personnel
in connection with the expansion of our business operations and the additional corporate functions after we have become a public company
since August 8, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expenses consist primarily of insurance, warehouse costs and other corporate expenses. General and administrative
expenses account for 54.9% and 18.5% of our revenue for the fiscal years ended June 30, 2024 and 2023, respectively. The increase in
general and administrative expenses is mainly due to several one-off in nature expenses which were incurred during the fiscal year ended
June 30, 2024, which includes but not limited to, research and development costs of $798,684 for the mobile application development,
the doubtful debt provision of $579,265, and legal and professional fees of $218,755 which was related to the IPO. These expenses were
mainly one-off in nature, and if they are excluded the overall general and administrative expenses have remained stable as compared to
the previous fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sales and marketing expenses consist primarily of advertising and marketing expenses on various online platforms. Sales and marketing
expenses account for 7.9% and 9.5% of our revenues for the fiscal year ended June 30, 2024 and 2023, respectively. The decrease is mainly
due to the consumer confidence in Australia was weak during the fiscal year ended June 30, 2024, and the ability for sales and marketing
activities to generate sales has decreased. Therefore, management has reduced its spendings on sales and marketing accordingly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease expense refers to the amortization of the finance lease for our office and warehouse. It accounts for 6.4% and 4.1% of revenue
for the fiscal year ended June 30, 2024 and 2023 respectively. The absolute amounts were $284,169 and $198,914 for the fiscal years ended
June 30, 2024 and 2023, respectively. The increase is mainly due to the expiration of the previous rental agreement, and the rental cost
pursuant to the new lease agreement is relatively higher.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comparisons
of the Fiscal Years Ended June 30, 2024 and 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the results of our operations during the fiscal years ended June 30, 2024 and 2023, respectively, and provides
information regarding the dollar and percentage increase or (decrease) during such years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="22" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Variance</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%&#160;of&#160;revenue</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%&#160;of&#160;revenue</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">REVENUE</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,466,775</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,799,222</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(332,447</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-6.9</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">COST
    OF GOODS SOLD</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,881,060</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-64.5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,625,821</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-54.7</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">255,239</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.7</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">GROSS
    PROFIT</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,585,715</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35.5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,173,401</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">45.3</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(587,686</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-27.0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">OPERATING EXPENSES</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Personnel expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">951,451</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">965,395</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13,944</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Consulting fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,468,126</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,468,126</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Licensing fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">65,839</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">65,839</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,452,954</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">54.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">888,141</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,564,813</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">176.2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">351,298</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">454,995</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(103,697</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-22.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">284,169</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">198,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,255</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">42.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,385</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.2</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,268</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.3</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,883</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-15.3</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total operating expenses</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,584,222</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">214.6</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,519,713</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52.5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,064,509</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">280.4</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LOSS FROM OPERATIONS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,998,507</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-179.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(346,312</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-7.2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,652,195</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2209.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">OTHER INCOME (EXPENSE)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">IPO related expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(50,523</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(662,418</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-13.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(611,895</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-92.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized loss on investment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(354,781</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-7.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(529,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-11.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(174,707</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-33.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other income (expenses)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">121,889</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,885</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">112,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1133.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest income</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,574</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,978</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">596</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">30.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,242,140</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-27.8</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(92,800</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.9</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,149,340</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1238.5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    other income (expenses)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,522,981</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-34.1</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,272,843</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-26.5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(250,138</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-19.7</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LOSS BEFORE TAX</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,521,488</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-213.2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,619,155</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-33.7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,902,333</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">488.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">INCOME
    TAX CREDIT</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(209,343</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-4.7</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,761</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.5</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(183,582</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">712.6</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">NET
    LOSS</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,312,145</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-208.5</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,593,394</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-33.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,718,751</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">484.4</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">EXTRAORDINARY ITEMS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Consulting fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,468,126</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,468,126</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">IPO related expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,523</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">662,418</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(611,895</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-92.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized loss on investment, net of tax</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">266,086</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">397,116</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(131,030</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-33.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Debt discount</span> <p style="margin: 0">(in interest expense)</p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,108,088</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24.8</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,108,088</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">NORMALIZED
    NET LOSS</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,419,322</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-54.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(533,860</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-11.1</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,885,462</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">353.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenues</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently generate our revenue from three business activities: merchandise revenue, sales of consumable products, and revenue from licensing
customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
were $4,466,775 for the fiscal year ended June 30, 2024 and $4,799,222 for the fiscal year ended June 30, 2023, a decrease of $332,447,
or 6.9%. Revenues consist primarily of (i) merchandise revenues of $3,956,962 and $4,036,047 for the fiscal years ended June 30, 2024
and 2023 respectively; plus (ii) sales of consumable products of $358,536 and $223,343 for the fiscal years ended June 30, 2024 and 2023
respectively; and (iii) revenue from licensing customers of $151,277 and $539,832 for the fiscal years ended June 30, 2024 and 2023 respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the breakdown of revenues by categories for the periods indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Merchandise revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,956,962</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">88.6</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,036,047</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">84.1</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(79,085</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-2.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales of consumable products</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">358,536</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">223,343</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">135,193</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">60.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Revenue from licensing
    customers</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">151,277</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.4</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">539,832</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11.2</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(388,555</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-72.0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,466,775</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100.0</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,799,222</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100.0</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(332,447</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-6.9</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merchandise
revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
merchandise revenue represents the sales of our various gym &amp; fitness equipment and products. Merchandise revenue decreased slightly
by 2.0% or $79,085 to $3,956,962 in fiscal year June 30, 2024 from $4,036,047 in the fiscal year June 30, 2023. The decrease in merchandise
revenue was primarily attributable to the following: (i) a 18.0% increase in sales order from 15,189 in fiscal year June 30, 2023 to
17,926 in the fiscal year June 30, 2024, thanks to the continuous efforts devoted by our sales and marketing team. They have successfully
retained many loyal customers and attract new buyers, but offset by (ii) a decrease of 16.9% in the average revenue per order from $265.72
in fiscal year June 30, 2023 to $220.74 in the fiscal year June 30, 2024, which primarily due to inflation and raising of interest rates
in Australia, has significantly reduced the disposal income of Australia households and affected the consumers&#8217; sentiment. In the
fiscal year June 30, 2024, the inflation was more than 4% on average throughout the year, and the Australis cash rate target, which was
set by the Reserve Bank of Australia, has also increased from 0.25% to 4.35%. However, the management believes that the impact is short-term
because the salaries of Australian individuals are also increasing gradually, and the interest may start falling again in the near future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
of consumable products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sales of consumable products represent the sales of fitness and wellness related products to overseas market. The revenue of this business
operation has increased 60.5% from $223,343 in fiscal year ended June 30, 2023, to $358,536 in fiscal year ended June 30, 2024. The management
is aiming to find more business opportunities in the overseas market in order to boost sales in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
from licensing customers</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
revenue from licensing customers represents the income we have received from our corporate clients in the fitness and wellness
industry. Revenue from licensing customers has decreased by 72.0% or $388,555 to $151,277 in fiscal year ended June 30, 2024, from
$539,832 in fiscal year ended June 30, 2023. The decrease was due to the fact management has strategically postponed the overseas
expansions in this area, as the market sentiments are negatively affected by the inflations and the high interest rate in the global
market. Nevertheless, we will expand these services again, especially to the Asia market, when the time is right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost
of goods sold</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of goods sold were $2,881,060 for the fiscal year ended June 30, 2024, and $2,625,821 for the fiscal year ended June 30, 2023, an increase
of $255,239, or 9.7%. Cost of goods sold consist primarily of the merchandise costs, the freight costs, and also other related purchase
costs like the custom duties. The increase was in line with the increase in our sales orders of merchandise revenues. Our cost of goods
sold account for 64.5% and 54.7% of our total revenue for the fiscal year ended June 30, 2024 and fiscal year ended June 30, 2023, respectively.
The ratio for cost of goods sold to revenue has increased mainly because the management has lowered the selling prices strategically
in general to cope with the economic conditions in Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross
Profit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross Profit</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,585,715</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,173,401</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(587,686</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-27.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross Profit Margin</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">45.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-9.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit was $1,585,715 for the fiscal year ended June 30, 2024, and $2,173,401 for the fiscal year ended June 30, 2023, a decrease of
$587,686, or 27.0%. The decrease was a combined result of the decrease in merchandise revenues and service revenue. The Gross Profit
margin decreased 9.8% from 45.3% in the fiscal year June 30, 2023, to 35.5% in the fiscal year ended June 30, 2024. The drop in gross
profit margin was because management has lowered the selling prices strategically in general to cope with the economic conditions
in Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Personnel
Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Personnel expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">951,451</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">965,395</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13,944</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.4</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">as percentage of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Personnel
expenses were $951,451 for the fiscal year ended June 30, 2024, and $965,395 for the fiscal year ended June 30, 2023, a slight decrease
of $13,944, or 1.4%. Personnel expenses consist primarily of employee salaries, superannuation, external consulting expenses and other
employment expenses. The Personnel Expenses for the fiscal year ended June 30, 2024 is similar to the fiscal year ended June 30, 2023.
Management always aims to hire the right people for each different tasks, and to maintain an effective and efficient operational
team in the right size.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consulting
fees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Consulting fees</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,468,126</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right">0</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,468,126</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">as percentage of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Management of the Company was planning
to do a second round of fund raising after the IPO and has engaged several external consultants to assist the process. As a result, the
Company has incurred $5,468,126 of consulting fess in the fiscal year ended June 30, 2024. These consulting fees are considered as one-off
in nature and may not be recurring in future years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
and Administrative Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,452,954</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">888,141</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,564,813</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">176.2</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">as percentage of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">54.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses were $2,452,954 for the fiscal year ended June 30, 2024 and $888,141 for the fiscal year ended June 30, 2023,
an increase of $1,564,813, or 176,2%. General and administrative expenses consist primarily of insurance, warehouse costs and other corporate
expenses. The increase in general and administrative expenses mainly due to several one-off in nature expenses which were incurred during
the fiscal year ended June 30, 2024, which includes but not limited to, research and development costs of $798,684 for the mobile application
development, the doubtful debt provision of $579,265, legal and professional fees of $218,755 which was related to the IPO. These expenses
were mainly one-off in nature, and if they are excluded the overall general and administrative expenses have remained stable as compared
to the previous fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales
and Marketing Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">351,298</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">454,995</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(103,697</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-22.8</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">as percentage of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and marketing expenses were $351,298 for the fiscal year ended June 30, 2024, and $454,955 for the fiscal year ended June 30, 2023,
a decrease of $103,697, or 22.8%. Sales and marketing expenses consisted primarily of advertising and marketing expenses on various
online platforms. The decrease was due to the fact the company has cut costs in the view of the economic conditions in Australia.
The sales and marketing expenses, as a percentage of total revenue, have decreased to 7.9% for the fiscal year ended June 30, 2024,
from 9.5% for the fiscal year ended June 30, 2023. The decrease is mainly due to the consumer confidence in Australia was weak
during the fiscal year ended June 30, 2024, and the ability for sales and marketing activities to generate sales has decreased.
Therefore, the management has reduced its spendings on sales and marketing accordingly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
lease expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease expense</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">284,169</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">198,914</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,255</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42.9</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">as percentage of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
of right of use asset refers to the amortization of the finance lease for our office and warehouse. It accounts for 6.4% and 4.1% of
revenue for the fiscal year ended June 30, 2024 and 2023, respectively. The absolute amount is $284,169 and $198,914 for the fiscal year
ended June 30, 2024 and 2023, respectively. The increase is mainly due to the expiration of the previous rental agreement, and the rental
cost pursuant to the new lease agreement is relatively higher.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Depreciation
expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation expense</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,385</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,268</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,883</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-15.3</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">as percentage of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $10,385 and $12,268 for the fiscal year ended June 30, 2024 and 2023, respectively. It was derived from the depreciation
of a motor vehicle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income
from Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had loss from operations of $7,998,507 for the fiscal year ended June 30, 2024, and $346,312 for the fiscal year ended June 30,
2023, an increase of $7,652,195. The increase in loss was a result of the drop in total revenues while the operating expenses were increasing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IPO
related expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">IPO related expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,523</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">662,418</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(611,895</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-92.4</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">as percentage of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-12.7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IPO related expenses include the accounting fee, auditing fee, legal fee, and consulting fee which are incurred due to the Initial Public
Offering project and are not related to the daily operations of the Company. The IPO related expenses have decreased significantly by
92.4% from $662,418 for the fiscal year ended June 30, 2023, to $50,523 for the fiscal year ended June 30, 2024. The decrease was mainly
due to the IPO was completed in August 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized
loss on investment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized loss on investment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(354,781</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(529,488</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">174,707</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-33.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">as percentage of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-7.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-11.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had purchased some securities on the Hong Kong stock exchange for investment purpose in the fiscal year June 30, 2022. The unrealized
loss on investment was attributable to the investment valued below the historical purchase cost in the fiscal year June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Income and other expense, net</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income was $121,889 for the fiscal year ended June 30, 2024 which was mainly referring to the profit of the disposal of lease asset of
$77,499 and an exchange difference of $44,390. For the fiscal year ended June 30, 2023, there was a net other income of $9,885, which
was mainly referring to the governmental subsidy provided for staff parental leaves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interest
Income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income was $2,574 for the fiscal year ended June 30, 2024 and $1,978 for the fiscal year ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interest
Expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Interest expense was $1,242,140 for the fiscal year ended June 30, 2024
and $92,800 for the fiscal year ended June 30, 2023, an increase of $1,149,340, or 1238.5%. The increase was mainly due to the interest
expense in fiscal year ended June 30, 2024 included a debt discount of $1,108,088. On January 15, 2024, the Company issued the Convertible
Notes with a principal amount of $3,600,000 for the funding amount of US$3,312,000. In addition, the note holder received an aggregate
5,645,455 warrants, and based on the Black Scholes model, the fair value of these warrants are valuated at $820,088 in total. Hence, there
is a debt discount of $1,108,088 incurred in the fiscal year ended June 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income
tax credit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">(in US dollars, except percentage)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax credit</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(209,343</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,761</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(183,582</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">712.6</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">effective tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-0.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-1.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax credit was $209,343 for the fiscal year ended June 30, 2024 and income tax credit was $25,761 for the fiscal year ended June 30,
2023, an increase of $183,582, or 712.6%. The effective tax rate has decreased from (1.6)% for the fiscal year ended June 30, 2023 to
(0.4)% for the fiscal year ended June 30, 2024. The applicable corporate tax rate in Australia was 25% for the fiscal year ended June
30, 2024 and 2023. However, there are several material items which are either tax exempted or non-tax deductible. These items include,
but are not limited to, government subsidy tech boost, stock issued for services expense, IPO related expenses, provision for bad debt,
unrealized loss on investments, fair value adjustment on financial instruments etc. The combined effect of the aforesaid items would
make the effective tax rates move away from the applicable corporate tax rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
loss and comprehensive loss</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss was $9,312,145 and $1,593,394 for the fiscal year ended June 30, 2024 and 2023 respectively, an increase of $7,718,751, or 4.8 times.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
loss was $9,325,818 for the fiscal year ended June 30, 2024 and $1,620,457 for the fiscal year ended June 30, 2023, a difference of $7,705,361.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net loss and comprehensive loss were a result of the drop in revenue, and the negative effect caused by various other items, such as
the provision for bad debt, IPO related expenses, the unrealized loss on investment, and additional interest related to the debt discount, in the fiscal year of June 30,
2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Normalized
Loss</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net loss includes some extraordinary items which may not reflect the true picture of the operations of the Company. For the fiscal
year ended June 30, 2024, the extraordinary items include the consulting fees related to the 2nd round of fund raising of
$5,468,126, a debt discount of $1,108,088 the unrealized loss on investment of $266,086, and IPO related expenses of $50,523. If we take out the effect of these extraordinary
items, the normalized net loss would be $2,419,322 for the fiscal year ended June 30, 2024, an increase of $1,885,462 or 353.2% as
compared to the fiscal year ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended June 30, 2023, the extraordinary items include the IPO related expenses
of $662,418, and the unrealized loss on investment of $397,116, net of tax. All of these items are not related to our normal operations.
If we take out the effect of these extraordinary items, the normalized net loss would be $533,860 for the fiscal year ended June 30,
2003.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Current
Liquidity and Capital Resources for the fiscal year ended June 30, 2024 compared to fiscal year ended June 30, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Summary of Cash Flows:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash used in operating activities</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(12,253,539</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(373,104</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash used in investing activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,500,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash provided by (used in) financing activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,469,405</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(79,064</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13,673</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(27,063</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net change in cash and cash equivalents</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">702,193</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(479,231</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Beginning cash and cash
    equivalents</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">236,821</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">716,052</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending cash and cash
    equivalents</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">939,014</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">236,821</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
used in operating activities of $12,253,539 during the year ended June 30, 2024 was primarily a result of our net loss of $9,312,145
reconciled with our changes in operating assets and liabilities, which include primarily (i) increase in prepaid offering costs of $1,999,475
as the company is aiming for raising additional capital from the equity market after the IPO; (ii) an increase in inventories of $1,914,007
as the management is expanding the inventories to cope with the growth in sales of consumable products in overseas markets; (iii) increase
in accounts receivable of $449,210 which mainly due to the sales of consumable products have relatively longer credit period; (iv) increase
in deposits and prepaid of $303,457 due to the prepayment of costs related to new fund raising; (v) increase in deferred tax assets of
$209,768 which mainly due to the timing effect of the accumulated tax losses; and partially offset by (vi) the amortization of the debt discount of $1,108,088
attributed to the issuance of convertible promissory notes; (vii) a bad debt provision of $579,265 attributable to long outstanding debtors;
and (viii) an unrealized loss in investments of $354,781 due to the fall in share prices of the investments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
used in operating activities of $373,104 during the year ended June 30, 2023 was primarily a result of our net loss of
$1,593,394reconciled with our changes in operating assets and liabilities, which include primarily (i) an unrealized loss in
investments of $529,488 due to the fall in share prices of the investments; (ii) Stock issued for services of $560,000 due to fund
raising activities; (iii) bad debt provision of $426,971 due to recoverability problems, (iv) a decrease in inventory of $393,636
which is in-line with the decrease in revenue; and (v) an increase in trade and other payables of $363,694 because the management
has obtained better credit terms from the supplier in the fiscal year ended June 30, 2023; partially offset by (vi) net increase in
net account receivables of $560,215 due to increase in corporate client sales; (vii) a decrease in deferred revenue of $263,625
which is inline with the drop in sales and; (viii) a decrease in income tax payable of $169,615 due to the net loss in the fiscal
year ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cash used in investing activating for the fiscal year ended June 30, 2024 represents an investment in note receivables of $2,500,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no investing activity for the year ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash from financing activities was $15,469,405 for the fiscal year ended June 30, 2024, versus net cash used in financing activities
of $79,064 for the fiscal year ended June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net cash from financing activities was for the fiscal year ended June 30, 2024 includes the net proceeds raised in the IPO of $13,614,983, $1,840,000 raised in the issuance of the convertible promissory note, and a minor addition working capital provided by a
related party of $14,422.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net cash used in financing activities for the fiscal year ended June 30, 2023 was due to the repayment of intercompany balance to a related
company.<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
Capital Requirements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
capital requirements for the fiscal year ending June 30, 2025 and beyond, will depend on numerous factors, including management&#8217;s
evaluation of the timing of projects to pursue. Subject to our ability to generate revenues and cash flow from operations and our ability
to raise additional capital (including through possible joint ventures, acquisitions, and/or partnerships), we expect to incur substantial
expenditures to carry out our business plan, as well as costs associated with our capital raising efforts and being a public company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inflation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts presented in our consolidated financial statements do not provide for the effect of inflation on our operations or financial
position. The net operating profit shown would be smaller than reported if the effects of inflation was reflected either by charging
operations with amounts that represent replacement costs or by using other inflation adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Off-Balance
Sheet Arrangements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial
condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_003"></span>Item
6. Directors, Senior Management and Employees</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6A.
<span style="text-decoration: underline">Directors and senior management</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is information concerning our directors, executive officers and other key employees as of the date of this annual report.
The following individuals are members of the board of directors and executive management of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position(s)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yinying
    Lu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jamarson
    Kong</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jieting
    Zhao</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jun
    Wu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence
    W. Leighton</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel
    J. Ross</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief biography of each of our executive officers and directors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Yinying
Lu</i></b> has served as our Chief Executive Officer since October 23, 2023 and as our director since April 2022. She has served as the
General Manager of GD since April 2017, overseeing procurement, operations, marketing, and financing, growing GD&#8217;s customer database
from 60,000 members in 2019 to over 100,000 members in 2023, and introducing Lion Loyalty, GD&#8217;s VIP membership program. Ms. Lu
holds a Bachelor of Business degree in Marketing and Event Management from Griffith University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Jamarson
Kong</i></b> has served as our Chief Financial Officer since April 2022 and has served as the Chief Financial Officer of GD since February
2022. From June 2017 to December 2020, Mr. Kong served as the Chief Financial Officer of Leyou Technologies Holdings Limited. In addition,
Mr. Kong served as the Chief Financial Officer of Idea Charm Investment from August 2015 to May 2017 and of Wonderful Sky Financial Group
Holding Limited (HKEx: 1260) from September 2014 to August 2015. Mr. Kong holds an MBA from Hong Kong University of Science and Technology
and a Bachelor of Commerce in Accounting and Finance from the University of Melbourne. He is a CPA (Australia), a member of the Hong
Kong Institute of Certified Public Accountants, and a CFA chartered holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Jieting
Zhao</i></b> has served as our director since April 2022 and has served as an executive director of GD since April 2017, overseeing our
website development, e-commerce operation, procurement, financing, e-marketing and strategy. From 2017 to 2022, Ms. Zhao led the team
at GD in growing GD&#8217;s revenue and in building the customer database to over 100,000 members. From 2006 to 2017, Ms. Zhao served
as Managing Director of Ansa Group Limited, overseeing the Fast Moving Consumer Goods or FMCG segment of the business, including launching
an online vitamin platform in Australia and China, launching and implementing cross-border marketing campaigns both online and offline
across Australia, Malaysia, Hong Kong and mainland China, completing two acquisitions of Malaysian targets companies, and building an
extensive distribution network in the FMCG sector across south-east Asia with a prime focus on fitness and wellness. Ms. Zhao holds a
Master of Information System and a Master of Information and Communication Technology from the University of Wollongong and a Bachelor
of Computer Science degree from Guangdong Polytechnic Normal University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Jun
Wu</i></b> has served as an independent director since August 2023. Since November 2020, Mr. Wu has served as Company Secretary of Victor
Group Holdings Limited (VIG.ASX), providing guidance to its board of directors on corporate governance policies and implementing procedures
to ensure compliance, advising directors and officers in relation to ASX listing rules and other regulations, and managing corporate
compliance and regular disclosure obligations. From December 2015 to March 2020, Mr. Wu served as the founding director of The President
Group in Sydney, Australia, during which time he advised on ASX/NSX Australian stock exchange listings, provided post-listing services
to clients, and provided investor relations services. Mr. Wu has previous experience from March 2007 to December 2013 as a senior analyst,
account manager, and investment banking associate with JP Morgan Australia, FNZ Australia, and UBS AG, respectively. Mr. Wu holds a Bachelor
of Commerce degree in Marketing from Macquarie University and is RG146 compliant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Lawrence
W. Leighton</i></b> has served as an independent director since August 2023. Mr. Leighton is an experienced investment banker with a
strong background in international finance and mergers and acquisitions. He has represented many major international companies throughout
his career, including Pernod Ricard SA (ENXTPA:RI), and Verizon Communications Inc. (NYSE: VZ). He joined Bentley in 1997 as a Managing
Director. Starting in 1989 he was President and Chief Executive Officer of UI USA, the US subsidiary of Union d&#8217;&#200;tudes et
d&#8217;Investissements, the merchant banking arm of Cr&#233;dit Agricole SA (ENXTPA:ACA), the largest bank in France. Mr. Leighton
joined Chase Investment Bank in 1982 as a Managing Director, where he focused on cross-border mergers. Previously, he was a Limited Partner
at Bear, Sterns &amp; Co., also focusing on international mergers and acquisitions. Starting in 1974, he was with Norton Simon as the
Director of Strategic Planning/Mergers &amp; Acquisitions, where he was responsible for several significant acquisitions for that company,
including Avis Rent-A-Car. Before Norton Simon, Mr. Leighton was with Clark, Dodge &amp; Co. where he became Co-Head of the Corporate
Finance Department. He began his extensive investment banking career at Kuhn, Loeb &amp; Co. Mr. Leighton is on the Board of Trustees
of the Gillen Brewer School and is a Director Emeritus of the Waterford Institute and the Princeton Club of New York. He received his
B.S.E. degree from Princeton University and an M.B.A. from Harvard Business School. Due to his strong experience in investment banking,
mergers and acquisitions, and international finance, we believe Mr. Leighton is well-qualified to serve as a director</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Daniel
J. Ross</i></b> has served as an independent director since August 2023. Mr. Ross brings nearly 30 years of experience in legal transactions
and legal compliance. Since December 2018, he has served as General Counsel to Tandy Leather Factory, Inc., overseeing all legal and
legal compliance matters for the specialty retailer. Since September 2015, he has also provided freelance legal services to companies
in a variety of industries. From March 2001 to August 2015, Mr. Ross served as in-house counsel to Coach, Inc., most recently as Senior
VP and Deputy General Counsel. Mr. Ross holds a JD degree from the University of Chicago Law School and a B.A. from Yale University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family
Relationships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
family relationship exists between any of our directors and executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6B.
<span style="text-decoration: underline">Compensation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information with respect to compensation for the year ended June 30, 2024 earned by or paid to our
principal executive officer, our principal financial officer, and our other most highly compensated executive officers (the &#8220;named
executive officers&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name and Principal
    Position</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Salary&#160;($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Bonus&#160;($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Share<br/>
    Awards&#160;($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Option<br/>
    Awards&#160;($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Deferred<br/>
    Compensation<br/>
    Earnings</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total&#160;($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 29%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Yinying Lu, CEO</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,012</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,012</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Jamarson Kong, CFO</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">101,642</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">101,642</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended June 30, 2022, Yinying Lu was compensated $95,411 in salary and $10,972 in annuities, pensions and retirement benefits
for services as a director of GD. For the fiscal year ended June 30, 2023, Ms. Lu was compensated $92,969 in salary and $9,762 in annuities,
pensions and retirement benefits for services as a director of GD. For the fiscal year ended June 30, 2024, Ms. Lu was compensated $110,012
in salary and $13,751 in annuities, pensions and retirement benefits for services as a director of GD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2022, we entered into an employment agreement with Jamarson Kong, who joined GD as Chief Financial Officer. Pursuant to the
employment agreement, he shall receive an annual salary of AUD150,000, exclusive of superannuation. Mr. Kong may terminate the employment
agreement by giving a two week prior written notice and GD may terminate the employment agreement by giving written notice in accordance
with a schedule based on the length of time of the employment. Mr. Kong&#8217;s main responsibilities include but are not limited to
general duties of the Chief Financial Officer, ensuring effective internal controls, and compliance with all relevant accounting and
financial regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended June 30, 2023, we did not compensate any other executive directors for their services other than to reimburse them
for out-of-pocket expenses incurred in connection with their attendance at meetings of the board of directors. For the fiscal year ended
June 30, 2024, we have also compensated our executive director Ms. Jieting Zhao a director fee of $26,667.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not adopted any equity compensation plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we had no outstanding equity awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6C.
<span style="text-decoration: underline">Board Practices</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors consists of five (5) directors, comprising two (2) directors and three (3) independent directors. Subject to making
appropriate disclosures to the board of directors in accordance with our amended and restated memorandum and articles of association,
a director may vote with respect to any contract, proposed contract, or arrangement in which he or she is interested, in voting in respect
of any such matter, such director should take into account his or her director&#8217;s duties. A director may exercise all the powers
of the Company to borrow money, mortgage its business, property and uncalled capital, and issue debentures or other securities whenever
money is borrowed or as security for any obligation of the company or of any third party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms
of Directors and Executive Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors may be elected by ordinary resolution of the shareholders or by our board of directors. Our directors are not subject to a
term of office and hold office until such time as they are removed from office by ordinary resolution of the shareholders. A director
will cease to be a director if, among other things, (a) he is prohibited by the laws of the Cayman Islands from acting as a director,
(b) he is made bankrupt or makes an arrangement or composition with his creditors generally, (c) in the opinion of a registered medical
practitioner by whom he is being treated he becomes physically or mentally incapable of acting as a director, (d) he is made subject
to any law relating to mental health or incompetence, whether by court order or otherwise, or (e) without the consent of the other directors,
he is absent from meetings of directors for continuous period of six months. All of our executive officers are appointed by and serve
at the discretion of our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Qualification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no membership qualifications for directors. Further, there are no share ownership qualifications for directors unless so fixed by
us in a general meeting by ordinary resolution of our shareholders. There are no other arrangements or understandings pursuant to which
our directors are selected or nominated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Diversity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
seek to achieve board diversity through the consideration of a number of factors when selecting the candidates to our board of directors,
including but not limited to gender, skills, age, professional experience, knowledge, cultural, education background, ethnicity and length
of service. The ultimate decision of the appointment will be based on merit and the contribution which the selected candidates will bring
to our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors have a balanced mix of knowledge and skills. We have three independent directors with different industry backgrounds, representing
a majority of the members of our board of directors. We also achieved gender and demographic background diversity by having 2 female
directors and 3 directors who are underrepresented individuals in our home country jurisdiction. Our board of directors is well balanced
and diversified in alignment with our business development and strategy objectives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
    Diversity Matrix (As of the date of this annual report)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Country
    of Principal Executive Offices:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    Private Issuer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
    Prohibited Under Home Country Law</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Number of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 52%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Female</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Male</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Binary</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Did
    Not<br/>
    Disclose<br/>
    Gender</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part
    I: Gender Identity</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part
    II: Demographic Background</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underrepresented
    Individual in Home Country Jurisdiction</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LGBTQ+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Did
    not Disclose Demographic Background</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of our Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
established an audit committee, a compensation committee and a nominating and corporate governance committee under our board of directors
after our IPO. We have adopted a charter for each of the three committees. Each committee&#8217;s members and functions are described
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence
W. Leighton, Jun Wu, and Daniel J. Ross are the members of our Audit Committee, with Jun Wu serving as the chairperson. All members of
our Audit Committee satisfy the independence standards promulgated by the SEC and by Nasdaq as such standards apply specifically to members
of audit committees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
adopted an Audit Committee Charter on November 23, 2022, and it became effective on August 7, 2023. Our Audit Committee shall perform
several functions, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluates
    the independence and performance of, and assesses the qualifications of, our independent auditor, and engages such independent auditor;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approves
    the plan and fees for the annual audit, quarterly reviews, tax and other audit-related services, and approves in advance any non-audit
    service to be provided by the independent auditor;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitors
    the independence of the independent auditor and the rotation of partners of the independent auditor on our engagement team as required
    by law;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviews
    the financial statements to be included in our Annual Report on Form 20-F and Quarterly Reports on Form 6-K and reviews with management
    and the independent auditors the results of the annual audit and reviews of our quarterly financial statements;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">oversees
    all aspects our systems of internal accounting control and corporate governance functions on behalf of the board;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviews
    and approves in advance any proposed related-party transactions and report to the full Board on any approved transactions; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provides
    oversight assistance in connection with legal, ethical and risk management compliance programs established by management and the
    Board, including Sarbanes-Oxley Act implementation, and makes recommendations to the Board regarding corporate governance issues
    and policy decisions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is determined that Jun Wu possesses accounting or related financial management experience that qualifies him as an &#8220;audit committee
financial expert&#8221; as defined by the rules and regulations of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
Committee</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence
W. Leighton, Jun Wu, and Daniel J. Ross are the members of our Compensation Committee with Lawrence W. Leighton serving as the chairperson.
We adopted the Compensation Committee Charter on November 23, 2022, and it became effective on August 7, 2023. In accordance with the
Compensation Committee&#8217;s Charter, the Compensation Committee shall be responsible for overseeing and making recommendations to
the Board regarding the salaries and other compensation of our executive officers and general employees and providing assistance and
recommendations with respect to our compensation policies and practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nominating
and Governance Committee</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence
W. Leighton, Jun Wu, and Daniel J. Ross are the members of our Nominating and Governance Committee with Daniel J. Ross serving as the
chairperson. We have adopted Nominating and Governance on November 23, 2022, and it became effective on August 7, 2023. In accordance
with the Nominating and Governance Committee&#8217;s Charter, the Nominating and Corporate Governance Committee shall be responsible
to identity and propose new potential director nominees to the Board of Directors for consideration and review our corporate governance
policies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign
Private Issuer Exemption</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &#8220;foreign private issuer,&#8221; as defined by the SEC. As a result, in accordance with the rules and regulations of Nasdaq,
we may choose to comply with home country governance requirements and certain exemptions thereunder rather than complying with Nasdaq
corporate governance standards. We may choose to take advantage of the following exemptions afforded to foreign private issuers:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemption
    from filing quarterly reports on Form 10-Q, from filing proxy solicitation materials on Schedule 14A or 14C in connection with annual
    or special meetings of shareholders, or from providing current reports on Form 8-K disclosing significant events within four (4)
    days of their occurrence, and from the disclosure requirements of Regulation FD.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemption
    from Section 16 rules regarding sales of Ordinary Shares by insiders, which will provide less data in this regard than shareholders
    of U.S. companies that are subject to the Exchange Act.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemption
    from the Nasdaq rules applicable to domestic issuers requiring disclosure within four (4) business days of any determination to grant
    a waiver of the code of business conduct and ethics to directors and officers. Although we will require board approval of any such
    waiver, we may choose not to disclose the waiver in the manner set forth in the Nasdaq rules, as permitted by the foreign private
    issuer exemption.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
Nasdaq Rule 5615(a)(3) provides that a foreign private issuer, such as us, may rely on our home country corporate governance practices
in lieu of certain of the rules in the Nasdaq Rule 5600 Series and Rule 5250(d), provided that we nevertheless comply with Nasdaq&#8217;s
Notification of Non-compliance requirement (Rule 5625), the Voting Rights requirement (Rule 5640) and that we have an audit committee
that satisfies Rule 5605(c)(3), consisting of committee members that meet the independence requirements of Rule 5605(c)(2)(A)(ii). If
we rely on our home country corporate governance practices in lieu of certain of the rules of Nasdaq, our shareholders may not have the
same protections afforded to shareholders of companies that are subject to all of the corporate governance requirements of Nasdaq. If
we choose to do so, we may utilize these exemptions for as long as we continue to qualify as a foreign private issuer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we are permitted to follow certain corporate governance rules that conform to Cayman Islands requirements in lieu of many of the Nasdaq
corporate governance rules, we intend to comply with the Nasdaq corporate governance rules applicable to foreign private issuers, including
the requirement to hold annual meetings of shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Duties
of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Cayman Islands law, directors owe the following fiduciary duties: (i) duty to act in good faith in what the director believes to be in
the best interests of the company as a whole; (ii) duty to exercise powers for the purposes for which those powers were conferred and
not for a collateral purpose; (iii) directors should not improperly fetter the exercise of future discretion; (iv) duty not to put themselves
in a position in which there is a conflict between their duty to the company and their personal interests; and (v) duty to exercise independent
judgment. In addition to the above, directors also owe a duty to act with skill, care and diligence. This duty has been defined as a
requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected
of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge
skill and experience which that director has. In fulfilling their duty of care to us, our directors must ensure compliance with our memorandum
and articles of association, as amended and restated from time to time. As set out above, directors have a duty not to put themselves
in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position.
However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders
provided that there is full disclosure by the directors. This can be done by way of permission granted in the amended and restated memorandum
and articles of association or alternatively by shareholder approval at general meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association provide that a director must disclose the nature and extent of any material
interests or duty in any contract or arrangement, provided that the required notice has been given to the other directors, a director
may vote at a meeting of directors on any resolution concerning a matter in which that director has an interest or duty, whether directly
or indirectly and may be counted in the quorum at such meeting. However, even if a director discloses his interest and is therefore permitted
to vote, he must still comply with his duty to act bona fide in the best interest of our company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6D.
<span style="text-decoration: underline">Employees</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024, we have a total of 15 employees and all of them are full-time employees&#8212;5 employees serve as management, 5 employees
serve as sales and marketing, 4 employees serve as warehouse management, and 1 employees serve as procurement and logistics. All of our
employees and contractors are located in Sydney, Australia. Our employees are not represented by a labor organization or covered by a
collective bargaining agreement. We have not experienced any work stoppages. We believe that we maintain a good working relationship
with our employees, and we have not experienced any major labor disputes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6E.
<span style="text-decoration: underline">Share ownership</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth
information with respect to beneficial ownership of our Ordinary Shares as of November 15, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    person who is known by us to beneficially own more than 5% of our outstanding Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of our director, director nominees and named executive officers; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    directors and named executive officers as a group.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this annual report, the Company is authorized to issue 500,000,000 Ordinary Shares with a par value $0.0001 each. The
number and percentage of Ordinary Shares beneficially owned are 20,123,386 Ordinary Shares issued and outstanding as of the date of this
annual report. Information with respect to beneficial ownership has been furnished by each director, officer or beneficial owner of more
than 5% of our Ordinary Shares. Beneficial ownership is determined in accordance with the rules of the SEC and generally requires that
such person have voting or investment power with respect to securities. In computing the number of Ordinary Shares beneficially owned
by a person listed below and the percentage ownership of such person, Ordinary Shares underlying options, warrants or convertible securities
held by each such person that are exercisable or convertible within 60 days are deemed outstanding, but are not deemed outstanding for
computing the percentage ownership of any other person. Except as otherwise indicated in the footnotes to this table, or as required
by applicable community property laws, all persons listed have sole voting and investment power for all Ordinary Shares shown as beneficially
owned by them. Unless otherwise indicated in the footnotes, the address for each beneficial owner is in the care of the Company at 23-25
Mangrove Lane, Taren Point, NSW 2229 Australia. As of the date of this annual report, we have three shareholders of record.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Ordinary
    Shares <br/> Beneficially Owned</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Percentage
    <br/> of Votes <br/> Held</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Percent</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Percent</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Directors and Executive
    Officers:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">YinYing Lu</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Jamarson Kong</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jieting Zhao<sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,440,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lawrence W. Leighton</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Jun Wu</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Daniel J. Ross</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">5% Shareholders:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SKMA Capital and<br/> Investment
    Ltd.<sup>(1)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,440,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Flying Height Consulting Services
    Limited <sup>(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,983,636</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">44.7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">44.7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    Ordinary Shares are held by SKMA Capital and Investment Ltd, a company incorporated under the laws of the British Virgin Islands
    (&#8220;SKMA&#8221;). Since Jieting Zhao is the 100% owner of SKMA, she is deemed as the beneficial owner of these securities.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 15, 2024, the Company entered into the Private Placement Purchase Agreement with Flying Height Consulting Services Limited
    (&#8220;Flying Height&#8221;), pursuant to which the Company issued to Flying Height a three-year 8% senior secured convertible promissory
    note in the principal amount of $3,600,000, with an 8% original discount and a stock purchase warrant to purchase 5,645,455 Ordinary
    Shares. On January 19, 2024, Flying Height converted the full amount of the promissory note, and, on March 19, 2024, Flying Height
    exercised the stock purchase warrant in full via cashless exercise, for an aggregate of 8,983,636 ordinary shares. The address of
    Flying Height is Flat/Rm 7022, Block D, 7/F, Tak Wing Ind Building 3, Tsun Wen Road, Tuen Mun NT, Hong Kong.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6F.
<span style="text-decoration: underline">Disclosure of a registrant&#8217;s action to recover erroneously awarded compensation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="nd_004"></span>Item
7. Major Shareholders and Related Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7A.
<span style="text-decoration: underline">Major shareholders</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 6. Directors, Senior Management and Employees&#8212;E. Share Ownership.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7B.
<span style="text-decoration: underline">Related party transactions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth below, there have been no transactions or loans between the company and (a) enterprises that directly or indirectly through
one or more intermediaries, control or are controlled by, or are under common control with, the company; (b) associates; (c) individuals
owning, directly or indirectly, an interest in the voting power of the company that gives them significant influence over the company,
and close members of any such individual&#8217;s family; (d) key management personnel, that is, those persons having authority and responsibility
for planning, directing and controlling the activities of the company, including directors and senior management of companies and close
members of such individuals&#8217; families; and (e) enterprises in which a substantial interest in the voting power is owned, directly
or indirectly, by any person described in (c) or (d) or over which such a person is able to exercise significant influence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ansa
Group Limited (&#8220;Ansa&#8221;) has provided short term financings to our operating subsidiary GD occasionally. The outstanding balances
were $38,808 and $24,386, respectively, as at June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
our reorganization, on May 4, 2022, the Company issued 280,000 Ordinary Shares each to L&amp;H Investment Management Limited, a company
incorporated under the laws of the British Virgin Islands, and PRMD Investment Consultation Company Limited, a company incorporated under
the laws of the British Virgin Islands, representing issuances to our co-founders. In addition, one (1) Ordinary Share was transferred
back to SKMA from the registered office service provider in the setup of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 5, 2022, we entered into a Share Exchange Agreement (&#8220;Share Exchange Agreement&#8221;) with KMAS, which holds all of the
issued and outstanding shares of GD, and SKMA Capital and Investment Ltd, a company incorporated under the laws of the British Virgin
Islands (&#8220;SKMA&#8221;), which holds all of the issued and outstanding shares of KMAS, pursuant to which the Company shall acquire
all of the shares in the KMAS from SKMA in exchange for the Company issuing 6,439,999 Ordinary Shares to SKMA in accordance with the
terms of the Share Exchange Agreement. Jieting Zhao, our director, holds all of the issued and outstanding shares of SKMA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7C.
<span style="text-decoration: underline">Interests of experts and counsels</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_005"></span>Item
8. Financial Information</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8A.
<span style="text-decoration: underline">Consolidated statements and other financial information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have appended consolidated financial statements filed as part of this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8B.
<span style="text-decoration: underline">Significant changes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
significant change has occurred since the date of our consolidated financial statements filed as part of this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_006"></span>Item
9. The Offer and Listing</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9A.
<span style="text-decoration: underline">Offer and Listing Details</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
Ordinary Shares are listed on the Nasdaq Capital Market under the symbol &#8220;FTEL,&#8221; and began trading on August 8, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9B.
<span style="text-decoration: underline">Plan of Distribution</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9C.
<span style="text-decoration: underline">Markets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
our disclosures above under &#8220;9.A. Offer and Listing Details.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9D.
<span style="text-decoration: underline">Selling Shareholders</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.E.
<span style="text-decoration: underline">Dilution</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9F.
<span style="text-decoration: underline">Expenses of the Issue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_007"></span>Item
10. Additional Information.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10A.
<span style="text-decoration: underline">Share Capital</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10B.
<span style="text-decoration: underline">Memorandum and Articles of Association</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of our share capital and provisions of our Amended and Restated Articles and Memorandum of Association are summaries
and do not purport to be complete. Reference is made to our Amended and Restated Articles and Memorandum of Associations filed as an
exhibit to this annual report (and which is referred to in this section as, respectively, the &#8220;Articles&#8221; and the &#8220;Memorandum&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated as an exempted company with limited liability under the Companies Act (Revised) of the Cayman Islands (which is referred
to in this section as the &#8220;Cayman Companies Act&#8221;). A Cayman Islands exempted company is a company that conducts its business
mainly outside the Cayman Islands and:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
may issue shares with no par value;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
is prohibited from making any invitation to the public in the Cayman Islands to subscribe for any of its securities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
is prohibited from trading in the Cayman Islands with any person, firm or corporation except in furtherance of the business of the exempted
company carried on outside the Cayman Islands (and for this purpose can affect and conclude contracts in the Cayman Islands and exercise
in the Cayman Islands all of its powers necessary for the carrying on of its business outside the Cayman Islands);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
does not have to hold an annual general meeting;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
does not have to make its register of members open to inspection by shareholders of that company;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
may obtain an undertaking against the imposition of any future taxation;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
may register as a limited duration company; and</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
may register as a segregated portfolio company.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Ordinary Shares are issued in book entry form and are issued when registered in our register of members. Our shareholders who are non-residents
of the Cayman Islands may freely hold and vote their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this annual report, the authorized share capital of the Company is $50,000 divided into 500,000,000 Ordinary Shares of
$0.0001 par value each. Subject to the provisions of the Cayman Companies Act and the provisions, if any, of the Articles, and any directions
given by any ordinary resolution and the rights attaching to any class of existing shares, the directors may issue, allot, grant options
over or otherwise dispose of shares (including any fractions of Shares) and other securities of our company at such times, to such persons,
for such consideration and on such terms as the directors may determine. Such authority could be exercised by the directors to allot
shares which carry rights and privileges. No share may be issued at a discount except in accordance with the provisions of the Cayman
Companies Act. The directors may refuse to accept any application for shares, and may accept any application in whole or in part, for
any reason or for no reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Ordinary Shares are listed on the Nasdaq Capital Market under the symbol &#8220;FTEL.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for the Ordinary Shares is Vstock Transfer, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the provisions of the Cayman Companies Act and any rights attaching to any class or classes of shares under and in accordance with
the Articles, the holders of our Ordinary Shares are entitled to such dividends as may be declared by our board of directors. In addition,
our shareholders may by ordinary resolution declare a final dividend, but no dividend may exceed the amount recommended by our directors.
Subject to the Cayman Companies Act requirements regarding the application of a company&#8217;s share premium account and with the sanction
of an ordinary resolution, dividends may also be declared and paid out of any share premium account. The directors when paying dividends
to shareholders may make such payment either in cash or in specie, and unless provided for by the rights attached to a share, no dividend
or other monies payable by the Company in respect of a Share shall bear interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
action required or permitted to be taken by the shareholders must be taken at a duly called and quorate general meeting of the shareholders
entitled to vote on such action, or in lieu of a general meeting, be effected by a resolution in writing. On a show of hands each shareholder
is entitled to one vote or, on a poll, each shareholder is entitled to one vote for each ordinary share, voting together as a single
class, on all matters that require a shareholder&#8217;s vote. Voting at any shareholders&#8217; meeting is by show of hands unless a
poll is demanded. A poll may be demanded by the chairman of such meeting or one or more shareholders present in person or by proxy entitled
to vote and who, individually or collectively, hold at least 10 percent of the voting rights of all those who have a right to vote on
the resolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum required for a meeting of shareholders consists of one shareholder present if the Company only has one shareholder and two shareholders
present if the Company has more than one shareholder. Shareholders may be present in person or by proxy or, if the shareholder is a legal
entity, by its duly authorized representative. Shareholders&#8217; meetings may be convened by our board of directors on its own initiative
or upon a request to the directors by shareholders holding at least 10 percent of the rights to vote at such general meeting. Advance
notice of at least five clear days is required for the convening of our annual general shareholders&#8217; meeting and any other general
shareholders&#8217; meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Election
of directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
may be appointed by an ordinary resolution of our shareholders or by the directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meetings
of directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any meeting of directors, a quorum will be present if two directors are present, unless otherwise fixed by the directors. If there is
a sole director, that director shall be a quorum. A person who holds office as an alternate director shall be counted in the quorum.
A director who also acts as an alternate director shall be counted twice towards the quorum. An action that may be taken by the directors
at a meeting may also be taken by a resolution of directors consented to in writing by all of the directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
of Ordinary Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of our shareholders may transfer all or any of his or her Ordinary Shares by an instrument of transfer in the usual or common form or
any other form approved by our board of directors. Where the Shares in question are not listed on or subject to the rules of any Designated
Stock Exchange (as defined in our Amended and Restated Memorandum and Articles of Association), the directors may in their absolute discretion
decline to register any transfer of such Shares which are not fully paid up or on which the Company has a lien. The directors may also,
but are not required to, decline to register any transfer of any such Ordinary Share unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    instrument of transfer is lodged with the Company, accompanied by the certificate (if any) for the Shares to which it relates and
    such other evidence as the Board may reasonably require to show the right of the transferor to make the transfer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    instrument of transfer is in respect of only one class of Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    instrument of transfer is properly stamped, if required;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the case of a transfer to joint holders, the number of joint holders to whom the Share is to be transferred does not exceed four;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Shares transferred are Fully Paid Up and free of any lien in favour of the Company; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    applicable fee of such maximum sum as the Designated Stock Exchanges may determine to be payable, or such lesser sum as the Board
    may from time to time require, related to the transfer is paid to the Company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our directors refuse to register a transfer they shall, within one month after the date on which the instrument of transfer
was lodged, send to each of the transferor and the transferee notice of such refusal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration of transfers may, on 14 days&#8217; notice being given by advertisement in such one or more newspapers or by Electronic
means, be suspended and the register of Members closed at such times and for such periods as the directors may, in their absolute discretion,
from time to time determine, provided always that such registration of transfer shall not be suspended nor the register of Members closed
for more than 30 days in any year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
a return of capital on winding up, the shareholders may, subject to the Articles and any other sanction required by the Companies Act,
pass a special resolution allowing the liquidator to do either or both of the following: (a) to divide in specie among the shareholders
the whole or any part of the assets of the Company and, for that purpose, to value any assets and to determine how the division shall
be carried out as between the shareholders or different classes of shareholders; and (b) to vest the whole or any part of the assets
in trustees for the benefit of shareholders and those liable to contribute to the winding up.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Calls
on Shares and Forfeiture of Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may from time to time make calls upon shareholders for any amounts unpaid on their shares in a notice served to such
shareholders at least 14 days prior to the specified time and place of payment. The shares that have been called upon and remain unpaid
are subject to forfeiture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
Premium Account</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
directors shall establish a share premium account and shall carry the credit of such account from time to time to a sum equal to the
amount or value of the premium paid on the issue of any shares as required by the Cayman Companies Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption
of Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Cayman Companies Act, we may by our directors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issue shares that are to
  be redeemed or liable to be redeemed, at our option on the terms and in the manner its directors determine before the issue of those
  shares; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchase all or any of our
  own shares of any class including any redeemable shares on the terms and in the manner which the directors determine at the time of
  such purchase and agree with the shareholder.</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Cayman Companies Act, the repurchase of any share may be paid out of our company&#8217;s profits, out of our share capital account
or out of the proceeds of a fresh issue of shares made for the purpose of such repurchase, or, subject to certain conditions, out of
capital. If the repurchase proceeds are paid out of the Company&#8217;s capital, the Company must, immediately following such payment,
be able to pay its debts as they fall due in the ordinary course of business. In addition, under the Cayman Companies Act, no such share
may be repurchased (1) unless it is fully paid up, (2) if such repurchase would result in there being no shares outstanding, and (3)
unless the manner of purchase (if not so authorized under the memorandum and articles of association) has first been authorized by a
resolution of our shareholders. In addition, under the Cayman Companies Act, the Company may accept the surrender of any fully paid share
for no consideration unless, as a result of the surrender, the surrender would result in there being no shares outstanding (other than
shares held as treasury shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Variations
of Rights of Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whenever
our capital is divided into different classes of shares, the rights attached to any class of shares (unless otherwise provided by the
terms of issue of the shares of that class or series), may be varied either with the consent in writing of the holders of two-thirds
of the issued shares of that class or with the sanction of a special resolution passed at a separate meeting of the holders of the shares
of the class. The rights conferred upon the holders of the shares of any class issued shall not, unless otherwise expressly provided
by the terms of issue of the shares of that class, be deemed to be varied by the creation or issue of further shares ranking <i>pari
passu</i> with such existing class of shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in the number of shares we are authorized to issue and those in issue.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Cayman Companies Act, our shareholders may, by ordinary resolution:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
increase or decrease the authorized share capital of the Company;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
consolidate and divide all or any of its share capital into shares of larger amount than its existing shares;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
subdivide our authorized shares or any of them into shares of an amount smaller than that fixed by the Memorandum, so, however, that
in the sub-division, the proportion between the amount paid and the amount, if any, unpaid on each reduced Share shall be the same as
it was in case of the share from which the reduced share is derived;.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
convert all or any of our paid up shares into stock, and reconvert that stock into paid up shares of any denomination; and</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
cancel shares which, at the date of the passing of that ordinary resolution, have not been taken or agreed to be taken by any person
and diminish the amount of our share capital by the amount of the shares so cancelled.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the Cayman Companies Act, our shareholders may, by special resolution, reduce its share capital in any manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance
of Additional Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Amended and Restated Memorandum and Articles of Association authorizes our board of directors to issue additional Ordinary Shares from
time to time as our board of directors shall determine, to the extent of available authorized but unissued shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inspection
of Books and Records</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our Ordinary Shares will have no general right under Cayman Islands law to inspect or obtain copies of our list of shareholders or
our corporate records. However, we will provide our shareholders with annual audited financial statements. See &#8220;Where You Can Find
Additional Information.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Differences
in Corporate Law</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Companies Act is derived, to a large extent, from the older Companies Acts of England and Wales but does not follow recent United
Kingdom statutory enactments, and accordingly there are significant differences between the Cayman Companies Act and the current Companies
Act of England. In addition, the Cayman Companies Act differs from laws applicable to United States corporations and their shareholders.
Set forth below is a summary of certain significant differences between the provisions of the Cayman Companies Act applicable to us and
the comparable laws applicable to companies incorporated in the State of Delaware in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mergers
and Similar Arrangements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Companies Act permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman
Islands companies provided that the laws of the foreign jurisdiction permit such merger or consolidation. For these purposes, (a) &#8220;merger&#8221;
means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such
companies as the surviving company, and (b) a &#8220;consolidation&#8221; means the combination of two or more constituent companies
into a new consolidated company and the vesting of the undertaking, property and liabilities of such companies to the consolidated company.
In order to effect such a merger or consolidation, the directors of each constituent company must approve a written plan of merger or
consolidation, which must then be authorized by (a) a special resolution of the shareholders of each constituent company, and (b) such
other authorization, if any, as may be specified in such constituent company&#8217;s articles of association. The plan must be filed
with the Registrar of Companies together with a declaration as to the solvency of the consolidated or surviving company, a list of the
assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will
be given to the shareholders and creditors of each constituent company and that notification of the merger or consolidation will be published
in the Cayman Islands Gazette. Court approval is not required for a merger or consolidation which is affected in compliance with these
statutory procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
merger between a Cayman parent company and its Cayman subsidiary or subsidiaries does not require authorization by a resolution of shareholders.
For this purpose, a subsidiary is a company of which at least 90% of the issued shares entitled to vote are owned by the parent company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consent of each holder of a fixed or floating security interest of a constituent company is required unless this requirement is waived
by a court in the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
in certain limited circumstances, a dissenting shareholder of a Cayman Islands constituent company is entitled to payment of the fair
value of his or her shares upon dissenting from a merger or consolidation. The exercise of such dissenter rights will preclude the exercise
by the dissenting shareholder of any other rights to which he or she might otherwise be entitled by virtue of holding shares, except
for the right to seek relief on the grounds that the merger or consolidation is void or unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, there are statutory provisions that facilitate the reconstruction and amalgamation of companies, provided that the arrangement
is approved by seventy-five percent (75%) in value of the shareholders or class of shareholders or creditors, as the case may be, that
are present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings
and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the
right to express to the court the view that the transaction ought not to be approved, the court can be expected to approve the arrangement
if it determines that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the statutory provisions as to the required majority vote have been met;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion
of the minority to promote interests adverse to those of the class;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest;
and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
the arrangement is not one that would more properly be sanctioned under some other provision of the Cayman Companies Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
a takeover offer is made and accepted by holders of 90% of the shares affected within four months the offeror may, within a two-month
period commencing on the expiration of such four-month period, require the holders of the remaining shares to transfer such shares on
the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed in the case
of an offer which has been so approved unless there is evidence of fraud, bad faith or collusion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an arrangement and reconstruction is thus approved, or if a takeover offer is made and accepted, a dissenting shareholder would have
no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of Delaware corporations,
providing rights to receive payment in cash for the judicially determined value of the shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholders&#8217;
Suits</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company and as a general rule, a derivative action
may not be brought by a minority shareholder. However, based on English law authorities, which would in all likelihood be of persuasive
authority in the Cayman Islands, the Cayman Islands courts can be expected to follow and apply the common law principles (namely the
rule in <i>Foss v. Harbottle</i> and the exceptions thereto) so that a non-controlling shareholder may be permitted to commence a class
action against or derivative actions in the name of the company to challenge:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
an act which is illegal or ultra vires with respect to the company and is therefore incapable of ratification by the shareholders;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
an act which, although not ultra vires, requires authorization by a qualified (or special) majority (that is, more than a simple majority)
which has not been obtained; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
an act which constitutes a &#8220;fraud on the minority&#8221; where the wrongdoers are themselves in control of the company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Indemnification
of Directors and Executive Officers and Limitation of Liability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Islands law does not limit the extent to which a company&#8217;s articles of association may provide for indemnification of officers
and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such
as to provide indemnification against civil fraud or the consequences of committing a crime, or against the indemnified person&#8217;s
own fraud or dishonesty. Our Articles provide to the extent permitted by law, we shall indemnify each existing or former secretary, director
(including alternate director), and any of our other officers (including an investment adviser or an administrator or liquidator) and
their personal representatives against:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by the existing or former director
    (including alternate director), secretary or officer in or about the conduct of our business or affairs or in the execution or discharge
    of the existing or former director (including alternate director), secretary&#8217;s or officer&#8217;s duties, powers, authorities
    or discretions; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">without
    limitation to paragraph (a) above, all costs, expenses, losses or liabilities incurred by the existing or former director (including
    alternate director), secretary or officer in defending (whether successfully or otherwise) any civil, criminal, administrative or
    investigative proceedings (whether threatened, pending or completed) concerning us or our affairs in any court or tribunal, whether
    in the Cayman Islands or elsewhere.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
such existing or former director (including alternate director), secretary or officer, however, shall be indemnified in respect of any
matter arising out of his own dishonesty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent permitted by law, we may make a payment, or agree to make a payment, whether by way of advance, loan or otherwise, for any
legal costs incurred by an existing or former director (including alternate director), secretary or any of our officers in respect of
any matter identified in above on condition that the director (including alternate director), secretary or officer must repay the amount
paid by us to the extent that it is ultimately found not liable to indemnify the director (including alternate director), the secretary
or that officer for those legal costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation. In addition,
we intend to enter into indemnification agreements with our directors and executive officers that will provide such persons with additional
indemnification beyond that provided in our articles of association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Anti-Takeover
Provisions in Our Articles</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
provisions of our Articles may discourage, delay or prevent a change in control of our company or management that shareholders may consider
favorable, including provisions that authorize our board of directors to issue shares at such times and on such terms and conditions
as the board of directors may decide without any further vote or action by our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Cayman Companies Act, our directors may only exercise the rights and powers granted to them under our articles for what they believe
in good faith to be in the best interests of our company and for a proper purpose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Directors&#8217;
Fiduciary Duties</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty
has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care
that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of, and
disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires
that a director act in a manner he or she reasonably believes to be in the best interests of the corporation. He or she must not use
his or her corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best
interests of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder
and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis,
in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption
may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by
a director, a director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a matter of Cayman Islands law, a director of a Cayman Islands company owes fiduciary duties to their respective companies to, amongst
other things, act in good faith in their dealings with or on behalf of the company and exercise their powers and fulfill the duties of
their office honestly. Core duties are: (a) a duty to act in good faith in what the director bona fide considers to be in the best interests
of the company (and in this regard, it should be noted that the duty is owed to the company and not to associate companies, subsidiaries
or holding companies), (b) a duty not to personally profit from opportunities that arise from the office of director, (c) a duty of trusteeship
of the company&#8217;s assets (d) a duty not to put himself in a position where the structures of a company conflict of his or her personal
interest on his or her duty to a third party to avoid conflicts of interest; and (e) a duty to exercise powers for the purpose for which
such powers were conferred. A director of a Cayman Islands company also owes the company a duty to act with skill, care and diligence.
A director need not exhibit in the performance of his or her duties a greater degree of skill than may be reasonably expected from a
person of his or her knowledge and experience. In fulfilling their duty of care to us, our directors must ensure compliance with our
articles of association, as amended and restated from time to time. We have the right to seek damages if a duty owed by any of our directors
is breached.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
independent director nominees will also serve as members of the audit committee, the compensation committee, and the nomination and corporate
governance committee of the board upon the effectiveness of the registration statement and have additional duties under the charters
of the committees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
Proposals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders, provided
it complies with the notice provisions in the governing documents. The Delaware General Corporation Law does not provide shareholders
an express right to put any proposal before the annual meeting of shareholders, but in keeping with common law, Delaware corporations
generally afford shareholders an opportunity to make proposals and nominations provided that they comply with the notice provisions in
the certificate of incorporation or bylaws. A special meeting may be called by the board of directors or any other person authorized
to do so in the governing documents, but shareholders may be precluded from calling special meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders
with any right to put any proposal before a general meeting. However, these rights may be provided in a company&#8217;s articles of association.
Our Articles provide that general meetings shall be convened on the written requisition of one or more of the shareholders entitled to
attend and vote at our general meetings who (together) hold not less than ten per cent of our paid up voting share capital deposited
in accordance with the notice provisions in the Articles, specifying the purpose of the meeting and signed by each of the shareholders
making the requisition. If the directors do not convene such meeting for a date not later than twenty-one clear days&#8217; after the
date of receipt of the written requisition, those shareholders who requested the meeting may convene the general meeting themselves within
three months after the end of such period of twenty-one clear days in which case reasonable expenses incurred by them as a result of
the directors failing to convene a meeting shall be reimbursed by us. Our Articles provide no other right to put any proposals before
annual general meetings or extraordinary general meetings. As a Cayman Islands exempted company, we are not obligated by law to call
shareholders&#8217; annual general meetings. However, our corporate governance guidelines require us to call such meetings every year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cumulative
Voting</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation&#8217;s certificate
of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders
on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single
director, which increases the shareholder&#8217;s voting power with respect to electing such director. As permitted under the Cayman
Companies Act, our Articles do not provide for cumulative voting. As a result, our shareholders are not afforded any less protections
or rights on this issue than shareholders of a Delaware corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Removal
of Directors</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Delaware General Corporation Law, a director of a corporation with a classified board may be removed only for cause with the approval
of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Subject to the
provisions of our Articles of Association (which include the removal of a director by ordinary resolution), the office of a director
may be terminated forthwith if (a) he is prohibited by the laws of the Cayman Islands from acting as a director, (b) he is made bankrupt
or makes an arrangement or composition with his creditors generally, (c) in the opinion of a registered medical practitioner by whom
he is being treated he becomes physically or mentally incapable of acting as a director, (d) he is made subject to any law relating to
mental health or incompetence, whether by court order or otherwise, or (e) without the consent of the other directors, he is absent from
meetings of directors for continuous period of six months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
with Interested Shareholders</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Delaware General Corporation Law contains a business combination statute applicable to Delaware public corporations whereby, unless the
corporation has specifically elected not to be governed by such statute by amendment to its certificate of incorporation or bylaws that
is approved by its shareholders, it is prohibited from engaging in certain business combinations with an &#8220;interested shareholder&#8221;
for three years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person
or a group who or which owns or owned 15% or more of the target&#8217;s outstanding voting stock or who or which is an affiliate or associate
of the corporation and owned 15% or more of the corporation&#8217;s outstanding voting stock within the past three years. This has the
effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be
treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an interested
shareholder, the board of directors approves either the business combination or the transaction which resulted in the person becoming
an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate the terms of any acquisition
transaction with the target&#8217;s board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Companies Act has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware
business combination statute. However, although the Cayman Companies Act does not regulate transactions between a company and its significant
shareholders, under Cayman Islands law such transactions must be entered into bona fide in the best interests of the company and for
a proper corporate purpose and not with the effect of constituting a fraud on the minority shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dissolution;
Winding Up</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by
shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors
may it be approved by a simple majority of the corporation&#8217;s outstanding shares. Delaware law allows a Delaware corporation to
include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board
of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Cayman Companies Act and our Articles, the Company may be wound up by a special resolution of our shareholders, or if the winding
up is initiated by our board of directors, by either a special resolution of our members or, if the Company is unable to pay its debts
as they fall due, by an ordinary resolution of our members. In addition, a company may be wound up by an order of the courts of the Cayman
Islands. The court has authority to order winding up in a number of specified circumstances including where it is, in the opinion of
the court, just and equitable to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Variation
of Rights of Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding
shares of such class, unless the certificate of incorporation provides otherwise. Under the Cayman Companies Act and our Articles, if
our share capital is divided into more than one class of shares, the rights attaching to any class of share (unless otherwise provided
by the terms of issue of the shares of that class) may be varied if one of the following applies: &#8232;(a) the shareholders holding
not less than two thirds of the issued shares of that class consent in writing to the variation; or (b) the variation is made with the
sanction of a special resolution of the holders of shares of the class present in person or by proxy at a separate general meeting of
the holders of shares of that class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment
of Governing Documents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Delaware General Corporation Law, a corporation&#8217;s certificate of incorporation may be amended only if adopted and declared
advisable by the board of directors and approved by a majority of the outstanding shares entitled to vote, and the bylaws may be amended
with the approval of a majority of the outstanding shares entitled to vote and may, if so provided in the certificate of incorporation,
also be amended by the board of directors. Under the Cayman Companies Act, our Articles may only be amended by special resolution of
our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Anti-money
Laundering&#8212;Cayman Islands</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to comply with legislation or regulations aimed at the prevention of money laundering, we may be required to adopt and maintain
anti-money laundering procedures and may require subscribers to provide evidence to verify their identity. Where permitted and subject
to certain conditions, we may also delegate the maintenance of our anti-money laundering procedures (including the acquisition of due
diligence information) to a suitable person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reserve the right to request such information as is necessary to verify the identity of a subscriber. In the event of delay or failure
on the part of the subscriber in producing any information required for verification purposes, we may refuse to accept the application,
in which case any funds received will be returned without interest to the account from which they were originally debited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also reserve the right to refuse to make any redemption payment to a shareholder if our directors or officers suspect or are advised
that the payment of redemption proceeds to such shareholder might result in a breach of applicable anti-money laundering or other laws
or regulations by any person in any relevant jurisdiction, or if such refusal is considered necessary or appropriate to ensure our compliance
with any such laws or regulations in any applicable jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any person resident in the Cayman Islands knows or suspects or has reason for knowing or suspecting that another person is engaged in
criminal conduct or is involved with terrorism or terrorist property and the information for that knowledge or suspicion came to their
attention in the course of their business in the regulated sector, or other trade, profession, business or employment, the person will
be required to report such knowledge or suspicion to (i) a nominated officer (appointed in accordance with the Proceeds of Crime Act
(Revised) of the Cayman Islands) or the Financial Reporting Authority of the Cayman Islands, pursuant to the Proceeds of Crime Act (Revised),
if the disclosure relates to criminal conduct or money laundering or (ii) to a police constable or a nominated officer (pursuant to the
Terrorism Act(Revised) of the Cayman Islands) or the Financial Reporting Authority, pursuant to the Terrorism Act(Revised), if the disclosure
relates to involvement with terrorism or terrorist financing and terrorist property. Such a report shall not be treated as a breach of
confidence or of any restriction upon the disclosure of information imposed by any enactment or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Data
Protection in the Cayman Islands &#8212; Privacy Notice</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
privacy notice explains the manner in which the Company collects, processes and maintains personal data about investors of the Company
pursuant to the Data Protection Act, 2017 of the Cayman Islands, as amended from time to time and any regulations, codes of practice
or orders promulgated pursuant thereto (&#8220;<b>DPA</b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is committed to processing personal data in accordance with the DPA. In its use of personal data, the Company will be characterized
under the DPA as a &#8216;data controller&#8217;, whilst certain of the Company&#8217;s service providers, affiliates and delegates may
act as &#8216;data processors&#8217; under the DPA. These service providers may process personal information for their own lawful purposes
in connection with services provided to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
privacy notice puts our shareholders on notice that, by virtue of making an investment in the Company, the Company and certain of the
Company&#8217;s service providers may collect, record, store, transfer and otherwise process personal data by which individuals may be
directly or indirectly identified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
personal data will be processed fairly and for lawful purposes, including (a) where the processing is necessary for the Company to perform
a contract to which you are a party or for taking pre-contractual steps at your request (b) where the processing is necessary for compliance
with any legal, tax or regulatory obligation to which the Company is subject or (c) where the processing is for the purposes of legitimate
interests pursued by the Company or by a service provider to whom the data are disclosed. As a data controller, we will only use your
personal data for the purposes for which we collected it. If we need to use your personal data for an unrelated purpose, we will contact
you.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that we will share your personal data with the Company&#8217;s service providers for the purposes set out in this privacy
notice. We may also share relevant personal data where it is lawful to do so and necessary to comply with our contractual obligations
or your instructions or where it is necessary or desirable to do so in connection with any regulatory reporting obligations. In exceptional
circumstances, we will share your personal data with regulatory, prosecuting and other governmental agencies or departments, and parties
to litigation (whether pending or threatened), in any country or territory including to any other person where we have a public or legal
duty to do so (e.g. to assist with detecting and preventing fraud, tax evasion and financial crime or compliance with a court order).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
personal data shall not be held by the Company for longer than necessary with regard to the purposes of the data processing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not sell your personal data. Any transfer of personal data outside of the Cayman Islands shall be in accordance with the requirements
of the DPA. Where necessary, we will ensure that separate and appropriate legal agreements are put in place with the recipient of that
data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will only transfer personal data in accordance with the requirements of the DPA, and will apply appropriate technical and organizational
information security measures designed to protect against unauthorized or unlawful processing of the personal data and against the accidental
loss, destruction or damage to the personal data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a natural person, this will affect you directly. If you are a corporate investor (including, for these purposes, legal arrangements
such as trusts or exempted limited partnerships) that provides us with personal data on individuals connected to you for any reason in
relation to your investment into the Company, this will be relevant for those individuals and you should inform such individuals of the
content.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
have certain rights under the DPA, including (a) the right to be informed as to how we collect and use your personal data (and this privacy
notice fulfils the Company&#8217;s obligation in this respect) (b) the right to obtain a copy of your personal data (c) the right to
require us to stop direct marketing (d) the right to have inaccurate or incomplete personal data corrected (e) the right to withdraw
your consent and require us to stop processing or restrict the processing, or not begin the processing of your personal data (f) the
right to be notified of a data breach (unless the breach is unlikely to be prejudicial) (g) the right to obtain information as to any
countries or territories outside the Cayman Islands to which we, whether directly or indirectly, transfer, intend to transfer or wish
to transfer your personal data, general measures we take to ensure the security of personal data and any information available to us
as to the source of your personal data (h) the right to complain to the Office of the Ombudsman of the Cayman Islands and (i) the right
to require us to delete your personal data in some limited circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you consider that your personal data has not been handled correctly, or you are not satisfied with the Company&#8217;s responses to any
requests you have made regarding the use of your personal data, you have the right to complain to the Cayman Islands&#8217; Ombudsman.
The Ombudsman can be contacted by calling +1 (345) 946-6283 or by email at info@ombudsman.ky.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10C.
<span style="text-decoration: underline">Material Contracts</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the two years immediately preceding the date of this annual report, we have not entered into any material contracts other than in the
ordinary course of business and other than those described below and in Item 6 &#8220;Directors, Senior Management and Employees,&#8221;
Item 7 &#8220;Major Shareholders and Related Party Transactions,&#8221; or filed (or incorporated by reference) as exhibits to this annual
report or otherwise described or referenced in this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the IPO, on August 7, 2023, the Company entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;)
with Revere Securities LLC and R.F. Lafferty &amp; Co., Inc., as representatives of the several underwriters listed on Schedule 1 of
the agreement (the &#8220;Representatives&#8221;) relating to the Company&#8217;s IPO of 3,000,000 Ordinary Shares, attached as Exhibit
1.1 to the Company&#8217;s Form 6-K filed on August 10, 2023 and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2024, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with Flying Height
Consulting Services Limited (&#8220;Flying Height&#8221;). Pursuant to the Purchase Agreement, the Company issued to Flying Height a
three-year 8% senior unsecured convertible promissory note in the principal amount of $3,600,000, with an 8% original issue discount
(the &#8220;Note&#8221;) and, as additional consideration for the purchase of the Note, a stock purchase warrant to purchase 5,645,455
Ordinary Shares (the &#8220;Warrant&#8221;), for the funding amount of $3,312,000. The proceeds from the sale of the Note and Warrant
shall be used by the Company for general working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Note, Flying Height may convert all or any part of the remaining outstanding principal amount of the Note and unpaid interest
on the date of conversion into fully paid and non-assessable Ordinary Shares, at any time after the issuance of the Note until the later
of (i) January 15, 2027, the maturity date of the Note and (ii) the date of payment upon any event of default. The conversion price of
the Note is equal to the lowest closing price for the Company&#8217;s Ordinary Shares as reported on The Nasdaq Capital Market during
the five (5) trading days immediately preceding the date of conversion, provided, however, that the Conversion Price shall not be lower
than $0.80 per share (the &#8220;Floor Price&#8221;). The Conversion Price and the Floor Price are subject to equitable adjustments for
stock splits, stock dividends, combinations, recapitalization, reclassifications, extraordinary distributions and similar events. In
addition to voluntary conversion rights of Flying Height, the Company will have the right, but not the obligation, at any time after
six months following the date of the issuance of the Note, to require Flying Height to convert the outstanding principal amount of the
Note and unpaid interest into Ordinary Shares if the closing price per share of Ordinary Shares exceeds $10.00 per share as reported
on The Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant entitles Flying Height to purchase up to 5,645,455 Ordinary Shares of the Company, commencing on January 15, 2024, the date of
the issuance of the Warrant, and ending on the date that is sixty (60) months from the date of the issuance of the Warrant at an exercise
price of $1.056 per share, subject to customary adjustments. The Warrant includes a cashless exercise option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuances of the Note and Warrant were, and, upon conversion of the Note and exercise of the Warrant to Ordinary Shares, will be, exempt
from registration requirements in reliance upon Section 4(a)(2) the Securities Act, and/or Rule 506(b) of Regulation D and/or Regulation
S, as promulgated by the SEC thereunder. At the time of their issuance, the Note and the Warrant were deemed to be restricted securities
for purposes of the Act and will bear restrictive legends to that effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, Flying Height converted the Note in full and, on March 19, 2024, Flying Height exercised the Warrant via cashless exercise
in full, for the aggregate of 8,983,636 Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement, Note, and Warrant are attached as Exhibits 10.1, 4.1, and 10.2, respectively, to the Company&#8217;s Form 6-K filed
on January 18, 2024 and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10D.
<span style="text-decoration: underline">Exchange Controls</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cayman
Islands Exchange Controls</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no material exchange controls restrictions on payment of dividends, interest or other payments to the holders of our common stock
or on the conduct of our operations in the Cayman Islands, where we were incorporated. There are no material Cayman Islands laws that
impose any material exchange controls on us or that affect the payment of dividends, interest or other payments to nonresident holders
of our common stock. Cayman Islands law and our memorandum and articles of association do not impose any material limitations on the
right of non-residents or foreign owners to hold or vote our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10D.
<span style="text-decoration: underline">Taxation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a general summary of certain material U.S. federal income tax and Cayman Islands tax considerations. The discussion is not
intended to be, nor should it be construed as, legal or tax advice to any particular shareholder or prospective shareholder. The discussion
is based on laws and relevant interpretations thereof in effect as of the date hereof, all of which are subject to change or different
interpretations, possibly with retroactive effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
U.S. Federal Income Tax Consequences Applicable to U.S. Holders of Our Ordinary Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
brief description below of the U.S. federal income tax consequences to &#8220;U.S. Holders&#8221; will apply to you if you are a beneficial
owner of Ordinary Shares and you are, for U.S. federal income tax purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who is a citizen or resident of the United States;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized under the laws of the United
    States, any state thereof or the District of Columbia;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate whose income is subject to U.S. federal income taxation regardless of its source; or</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust that (1) is subject to the primary supervision of a court within the United States and the control of one or more U.S. persons
    for all substantial decisions or (2) has a valid election in effect under applicable U.S. Treasury regulations to be treated as a
    U.S. person.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a partnership (or other entity treated as a partnership for United States federal income tax purposes) is a beneficial owner of our Ordinary
Shares, the tax treatment of a partner in the partnership will depend upon the status of the partner and the activities of the partnership.
Partnerships and partners of a partnership holding our Ordinary Shares are urged to consult their tax advisors regarding an investment
in our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WE
URGE POTENTIAL PURCHASERS OF OUR ORDINARY SHARES TO CONSULT THEIR OWN TAX ADVISORS CONCERNING THE U.S. FEDERAL, STATE, LOCAL AND NON-U.S.
TAX CONSEQUENCES OF PURCHASING, OWNING AND DISPOSING OF OUR ORDINARY SHARES.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following does not address the tax consequences to any particular investor or to persons in special tax situations such as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
    institutions;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
    companies;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
    investment companies;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">real
    estate investment trusts;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">traders
    that elect to mark-to-market;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    expatriates;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
    entities;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    liable for alternative minimum tax;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    holding our Ordinary Shares as part of a straddle, hedging, conversion or integrated transaction;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that actually or constructively own 10% or more of our voting shares (including by reason of owning our Ordinary Shares);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who acquired our Ordinary Shares pursuant to the exercise of any employee share option or otherwise as compensation;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    holding our Ordinary Shares through partnerships or other pass-through entities;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">governments
    or agencies or instrumentalities thereof;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">beneficiaries
    of a trust holding our Ordinary Shares; or</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    holding our Ordinary Shares through a trust.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion set forth below is addressed only to U.S. Holders of Ordinary Shares who hold such Ordinary Shares as capital assets (generally,
property held for investment) and that have the U.S. dollar as their functional currency. The summary below does not discuss certain
U.S. federal tax consequences that may be relevant to a particular U.S. Holder&#8217;s particular circumstances, such as consequences
relating to the Medicare contribution tax on net investment income. Shareholders and prospective shareholders are urged to consult their
own tax advisors about the application of the U.S. federal tax rules to their particular circumstances as well as the state, local, foreign
and other tax consequences to them of the purchase, ownership and disposition of our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Taxation
of Dividends and Other Distributions on our Ordinary Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the passive foreign investment company rules discussed below, the gross amount of distributions made by us with respect to the Ordinary
Shares (including the amount of any taxes withheld therefrom) will generally be includable in your gross income as dividend income on
the date of receipt by you, but only to the extent that the distribution is paid out of our current or accumulated earnings and profits
(as determined under U.S. federal income tax principles). With respect to corporate U.S. Holders, the dividends will not be eligible
for the dividends-received deduction allowed to corporations in respect of dividends received from other U.S. corporations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to non-corporate U.S. Holders, including individual U.S. Holders, dividends may be taxed at the lower capital gains rate applicable
to qualified dividend income, provided that (1) the Ordinary Shares are readily tradable on an established securities market in the United
States, or we are eligible for the benefits of an approved qualifying income tax treaty with the United States that includes an exchange
of information program, (2) we are not a PFIC for either our taxable year in which the dividend is paid or the preceding taxable year,
and (3) certain holding period requirements are met. Because there is no income tax treaty between the United States and the Cayman Islands,
clause (1) above can be satisfied only if the Ordinary Shares are readily tradable on an established securities market in the United
States. Under U.S. Internal Revenue Service authority, Ordinary Shares are considered for purpose of clause (1) above to be readily tradable
on an established securities market in the United States if they are listed on Nasdaq, as our Ordinary Shares are. Shareholders and prospective
shareholders are urged to consult their tax advisors regarding the availability of the lower rate for dividends paid with respect to
our Ordinary Shares, including the effects of any change in law after the date of this annual statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
will constitute foreign source income for foreign tax credit limitation purposes. If the dividends are taxed as qualified dividend income
(as discussed above), the amount of the dividend considered for purposes of calculating the foreign tax credit limitation will be limited
to the gross amount of the dividend, multiplied by the reduced rate and divided by the highest rate of tax normally applicable to dividends.
The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes of income. For this purpose,
dividends distributed by us with respect to our Ordinary Shares will constitute &#8220;passive category income&#8221; but could, in the
case of certain U.S. Holders, constitute &#8220;general category income.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that the amount of the distribution exceeds our current and accumulated earnings and profits (as determined under U.S. federal
income tax principles), it will be treated first as a tax-free return of a shareholder&#8217;s tax basis in their Ordinary Shares, and
to the extent the amount of the distribution exceeds their tax basis, the excess will be taxed as capital gain. We do not intend to calculate
our earnings and profits under U.S. federal income tax principles. Therefore, a U.S. Holder should expect that a distribution will be
treated as a dividend even if that distribution would otherwise be treated as a non-taxable return of capital or as capital gain under
the rules described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Taxation
of Dispositions of Ordinary Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the passive foreign investment company rules discussed below, shareholders will recognize taxable gain or loss on any sale, exchange
or other taxable disposition of a share equal to the difference between the amount realized (in U.S. dollars) for the share and their
tax basis (in U.S. dollars) in the Ordinary Shares. The gain or loss will be capital gain or loss. If a shareholder is a non-corporate
U.S. Holder, including an individual U.S. Holder, who has held the Ordinary Shares for more than one year, they will be eligible for
reduced tax rates. The deductibility of capital losses is subject to limitations. Any such gain or loss that they recognize will generally
be treated as United States source income or loss for foreign tax credit limitation purposes which will generally limit the availability
of foreign tax credits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
Reporting Requirements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S. Holders are required to file information returns with the IRS, including IRS Form 926, Return by a U.S. Transferor of Property to
a Foreign Corporation, reporting transfers of cash (in excess of $100,000) or other property to our company and information relating
to the U.S. Holder and our company. Substantial penalties may be imposed upon a U.S. Holder that fails to comply.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
individual U.S. Holders (and, under applicable Treasury Regulations, certain entities) may be required to report to the IRS (on Form
8938) information with respect to their investments in our Ordinary Shares not held through an account with a U.S. financial institution.
U.S. Holders who fail to report required information could become subject to substantial penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Holders are encouraged to consult with their own tax advisors regarding foreign financial asset reporting requirements with respect to
their investment in our Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Backup
Withholding Tax and Information Reporting Requirements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
certain circumstances, U.S. backup withholding tax and/or information reporting may apply to U.S. Holders with respect to dividend payments
made on or the payment of proceeds from the sale, exchange or other disposition of the Ordinary Shares, unless an applicable exemption
is satisfied. U.S. Holders that are corporations generally are excluded from these information reporting and backup withholding tax rules.
Backup withholding is not an additional tax. Any amounts withheld under the backup withholding tax rules will be allowed as a credit
against a U.S. Holder&#8217;s U.S. federal income tax liability, if any, or will be refunded, if such U.S. Holder timely furnishes required
information to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Passive
Foreign Investment Company</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special
U.S. federal income tax rules apply to a U.S. Holder that holds stock in a foreign corporation classified as a PFIC for U.S. federal
income tax purposes. In general, we would be treated as a PFIC with respect to a U.S. Holder if, for any taxable year in which such U.S.
Holder held our Ordinary Shares, either:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
at least 75% of our gross income for such taxable year consisted of passive income (e.g., dividends, interest, capital gains and rents
derived other than in the active conduct of a rental business), (the &#8220;income test&#8221;); or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
at least 50% of the average value of our assets during such taxable year produced, or were held for the production of, passive income
(the &#8220;assets&#8221; test&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
this purpose, we will be treated as owning our proportionate share of the assets and earning our proportionate share of the income of
any other corporation in which we own, directly or indirectly, 25% (by value) of the stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the market price of our ordinary shares and the composition of our income and assets, including goodwill, although not clear, we do
not expect to be treated as a PFIC for U.S. federal income tax purposes for the current taxable year or in the foreseeable future. This
is, however, a factual determination made on an annual basis and is subject to change. If we were to be classified as a PFIC in any taxable
year, (i) U.S. Holders would generally be required to treat any gain on sales of our shares held by them as ordinary income and to pay
an interest charge on the value of the deferral of their United States federal income tax attributable to such gain; and (ii) distributions
paid by us to our U.S. Holders could also be subject to an interest charge. In addition, we would not provide information to our U.S.
Holders that would enable them to make a &#8220;qualified electing fund&#8221; election under which, generally, in lieu of the foregoing
treatment, our earnings would be currently included in their United States federal taxable income.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
and prospective shareholders are urged to consult their tax advisors regarding the application of the PFIC rules to their investment
in our Ordinary Shares and the elections discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cayman
Islands Taxation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a discussion of certain Cayman Islands income tax consequences related to an investment in the Ordinary Shares. The discussion
is a general summary of the present law, which is subject to prospective and retroactive change. It is not intended as tax advice, does
not consider any shareholder or prospective shareholder&#8217;s particular circumstances, and does not consider tax consequences other
than those arising under Cayman Islands law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation and there is
no taxation in the nature of inheritance tax or estate duty. There are no other taxes likely to be material to our company levied by
the Government of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or after execution brought
within the jurisdiction of the Cayman Islands. The Cayman Islands is a party to a double tax treaty entered with the United Kingdom in
2010 but is otherwise not a party to any double tax treaties that are applicable to any payments made to us or by the Company. There
are no exchange control regulations or currency restrictions in the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
of dividends and capital in respect of our Ordinary Shares will not be subject to taxation in the Cayman Islands and no withholding will
be required on the payment of a dividend or capital to any holder of our Ordinary Shares, as the case may be, nor will gains derived
from the disposal of our Ordinary Shares be subject to Cayman Islands income or corporation tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Islands enacted the International Tax Co-operation (Economic Substance) Act (as revised) together with the Guidance Notes published
by the Cayman Islands Tax Information Authority from time to time. The Company is required to comply with the economic substance requirements
from July 1, 2019 and make an annual report in the Cayman Islands as to whether or not it is carrying on any relevant activities and
if it is, it must satisfy an economic substance test.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
ABOVE SUMMARY IS NOT INTENDED TO CONSTITUTE A COMPLETE ANALYSIS OF ALL TAX CONSIDERATIONS APPLICABLE TO PROSPECTIVE PURCHASERS WITH RESPECT
TO THE ACQUISITION, OWNERSHIP, AND DISPOSITION OF ORDINARY SHARES. PROSPECTIVE PURCHASERS SHOULD CONSULT THEIR OWN TAX ADVISORS AS TO
THE TAX CONSIDERATIONS APPLICABLE TO THEM IN THEIR OWN PARTICULAR CIRCUMSTANCES.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10F.
<span style="text-decoration: underline">Dividends and Paying Agents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10G.
<span style="text-decoration: underline">Statement by Experts</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10H.
<span style="text-decoration: underline">Documents on Display</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed this annual report on Form 20-F with the SEC under the Exchange Act. Statements made in this report as to the contents of
any document referred to are not necessarily complete. With respect to each such document filed as an exhibit to this report, reference
is made to the exhibit for a more complete description of the matter involved, and each such statement shall be deemed qualified in its
entirety by such reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the informational requirements of the Exchange Act as a foreign private issuer and file reports and other information
with the SEC. Reports and other information filed by us with the SEC including this report, may be inspected and copied at the public
reference room of the SEC at 100 F Street, N.E., Washington D.C. 20549. You can also obtain copies of this report by mail from the Public
Reference Section of the SEC, 100 F. Street, N.E., Washington D.C. 20549, at prescribed rates. Additionally, copies of this material
may be obtained from the SEC&#8217;s Internet site at http://www.sec.gov. The SEC&#8217;s telephone number is 1-800-SEC-0330. In accordance
with NASDAQ Stock Market Rule 5250(d), we will also post this annual report on Form 20-F on our website at <span style="text-decoration: underline">https://www.fitellcorp.com/</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10I.
<span style="text-decoration: underline">Subsidiary Information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see Item 4.A &#8220;Information on the Company &#8211; History and Development of the Company&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10J.
<span style="text-decoration: underline">Annual Report to Security Holders</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_001"></span>Item 11.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantitative and Qualitative Disclosures About Market Risk.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables
arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions.
The Company controls credit risk related to accounts receivable through credit approvals, credit limits and monitoring procedures. The
Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an
allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure
beyond such allowance is limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
Exchange Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inventories purchased by the Company are mainly denominated in US dollars, whereas the revenue and other operating costs are mainly denominated
in Australian dollars. The fluctuation in Foreign Exchange rate could have a significant effect on the operating performances of the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Interest
Rate Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
the interest rate increase, it might have negative impacts on the operations of the Company in two ways. Firstly, it might increase the
interest expenses attributed to our interest-bearing liabilities. Secondly, it might reduce the disposable income of our target customers,
and it would indirectly affect our sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Inflation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similar
to the impact of interest rate, inflation might reduce the disposable income of our target customers, and it might indirectly affect
our sales and profits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 12.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_002"></span>Description of Securities Other than Equity Securities.</b></span></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12A.
<span style="text-decoration: underline">Debt Securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12B.
<span style="text-decoration: underline">Warrants and Rights</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12C.
<span style="text-decoration: underline">Other Securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12D.
<span style="text-decoration: underline">American Depositary Shares</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sw_003"></span>PART
II</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 13.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_004"></span>Defaults, Dividend Arrearages and Delinquencies.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 14.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_005"></span>Material Modifications to the Rights of Security Holders and Use of Proceeds.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the Extraordinary General Meeting on January 8, 2024, the Memorandum and Articles of Association was amended and restated to reflect,
among others: (i) the ability for the Company to hold general meetings virtually; (ii) the different requirements as to the transfer
of listed shares and non-listed shares; (iii) the ability to pass an ordinary resolution in writing signed by the required majority of
members subject to satisfying certain conditions and (iv) other clarification changes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2023, the Company entered into the Underwriting Agreement with Revere Securities LLC and R.F. Lafferty &amp; Co., Inc., as
representatives of the several underwriters listed on Schedule 1 to the Underwriting Agreement (the &#8220;Representatives&#8221;), relating
to the Company&#8217;s initial public offering (the &#8220;IPO&#8221;) of 3,000,000 Ordinary Shares. On August 10, 2023, the Company
closed its IPO. The Company completed the IPO pursuant to its registration statement on Form F-1 (File No. 333-267778), which was initially
filed with the SEC on October 7, 2022, as amended, and declared effective by the SEC on August 7, 2023 (the &#8220;Registration Statement&#8221;).
The Ordinary Shares were priced at $5.00 per share, and the offering was conducted on a firm commitment basis. The underwriters were
granted a 45-day option to purchase up to additional 450,000 Ordinary Shares to cover over-allotments, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 10, 2023, pursuant to the Underwriting Agreement, the Company issued warrants (the &#8220;Representatives&#8217; Warrants&#8221;)
to the Representatives, which enable the Representatives to purchase up to an aggregate of 60,000 Ordinary Shares, at an exercise price
equal to $5.75 per share. The Representatives&#8217; Warrants may be exercised beginning on August 10, 2023 until August 10, 2028.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IPO (including the sale of the Ordinary Shares to cover over-allotment) generated gross proceeds to the Company of $15,000,000. The net
proceeds after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us were approximately
$13,615,000. The Company intends to use the proceeds for the expansion of our online retail gym and fitness equipment business; the
development of our smart connected equipment, interactive platform, and mobile application; the expansion of our licensing business;
potential mergers and acquisitions; and working capital and other general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
15. <span id="sw_006"></span>Controls and Procedures.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Disclosure controls and procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted
an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and 15d-15(e) promulgated under
the Exchange Act. Controls and other procedures that are designed to provide reasonable assurance that the information that we are required
to disclose in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including
our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures
were not effective as of June 30, 2024 and as of the date that the evaluation of the effectiveness of our disclosure controls and
procedures was completed, because of the material weakness in our internal control over financial reporting described
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Management&#8217;s annual report on internal control over financial reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
management of the Company is responsible for establishing, maintaining, and assessing the effectiveness of internal control over financial
reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Our management, under the supervision of our chief executive officer
and chief financial officer, is responsible for establishing and maintaining adequate internal control over financial reporting. Internal
control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with US GAAP. Internal control over financial reporting
includes policies and procedures that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pertain
                                                         to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the
                                                         assets of the Company;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
                                                         reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with US
                                                         GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and
                                                         directors of the Company; and</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
                                                         reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the
                                                         Company&#8217;s assets that could have a material effect on the financial statements.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with existing policies or procedures may deteriorate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision of our chief executive officer and chief financial officer, our management conducted an assessment of our internal control
over financial reporting as of June 30, 2024, based on the framework and criteria established in <i>Internal Control &#8212;
Integrated Framework (2013),</i> issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there
is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or
detected on a timely basis. In connection with management&#8217;s assessment of our internal control over financial reporting
described above, management has identified a material weakness in our internal control over financial reporting as of June 30, 2024
as a result of the accounting and disclosure requirements surrounding the warrants issued during the fiscal year. As a result of the above material weakness, we concluded that
our internal control over financial reporting was ineffective as of June 30, 2024 .</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">In an effort to remediate the
identified material weaknesses in our internal control over financial reporting and enhance our internal controls, our management
is currently in the process of&#160;implementing additional training programs on financial derivatives accounting and disclosure matters
for our finance staff.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">However, we cannot assure you
that we will remediate our material weakness in a timely manner, or at all. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks
Relating to Our Ordinary Shares&#8212;If we fail to establish and maintain an effective system of internal control over financial reporting,
our ability to accurately and timely report our financial results or prevent fraud may be adversely affected, and investor confidence
and the market price of our Ordinary Shares may be adversely impacted.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
believes that our consolidated financial statements included in this annual report on Form 20-F have been prepared in accordance with
generally accepted accounting principles. Notwithstanding management&#8217;s assessment that our internal control
over financial reporting was ineffective as of June 30, 2024 due to the material weakness described above, our chief executive officer and chief financial officer have concluded that, based on such
officer&#8217;s knowledge, the financial statements and other financial information included in this annual report on Form 20-F fairly
present in all material respects the financial position, results of operations and cash flows of the Company as of, and for, the periods
presented in this report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Attestation report of the registered public accounting firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report does not include an attestation report of the Company&#8217;s independent registered public accounting firm regarding internal
control over financial reporting. As an emerging growth company, management&#8217;s report is not subject to attestation by our independent
registered public accounting firm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Changes in Internal Controls over Financial Reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during
the year ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal controls over
financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_007"></span>Item 16.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[Reserved]</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 16A.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_008"></span>Audit committee financial expert.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has determined that Mr. Jun Wu, an independent director (under the standards set forth in set forth in Nasdaq Stock
Market Rule 5605(a)(2) and Rule 10A-3 under the Exchange Act) and the chairperson of our audit committee, is our audit committee financial
expert.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_009"></span>Item 16B.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code of Ethics.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a code of business conduct and ethics that applies to all of our employees, officers and directors, including those officers
responsible for financial reporting. The most recent version is available in the Governance sub-section of the Investors section of our
website at https://www.fitellcorp.com/. The information contained on our website is not incorporated by reference into this annual report.
If we make any substantive amendments to the code or grant any waiver from a provision of the code to any executive officer or director,
we will promptly disclose the nature of the amendment or waiver on our website, as well as via any other means required by applicable
law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 16C.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_010"></span>Principal Accountant Fees and Services.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the aggregate fees by categories specified below in connection with certain professional services rendered
by our independent registered public accounting firms for the periods indicated. We did not pay any other fees to during the periods
indicated below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    Ended<br/> June 30,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Fees</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,664</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,640</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related
    Fees</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,300</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,700</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Fees</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Other Fees</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115,964</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,340</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audit
Fees&#8221; consisted of the aggregate fees billed for professional services paid for the audit of our annual financial statements and
the reviews of the financial statements included in our SEC Forms as previously filed and for any other services that were normally provided
in connection with our statutory and regulatory filings or engagements, which were incremental costs directly associated with our IPO
and capitalized as deferred offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audit
Related Fees&#8221; consisted of the aggregate fees billed for professional services rendered for assurance and related services that
were reasonably related to the performance of the audit or review of our financial statements and were not otherwise included in Audit
Fees, which were incremental costs directly associated with our IPO and capitalized as deferred offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Tax
Fees&#8221; consisted of the aggregate fees billed for professional services rendered for tax compliance, tax advice and tax planning.
Included in such Tax Fees were fees for preparation of our tax returns and consultancy and advice on other tax planning matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;All
Other Fees&#8221; consisted of the aggregate fees billed for products and services provided and not otherwise included in Audit Fees,
Audit Related Fees or Tax Fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sw_011"></span>Item
16D. Exemptions from the Listing Standards for Audit Committees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sw_012"></span>Item
16E Purchases of Equity Securities by the Issuer and Affiliated Purchasers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify; text-indent: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sw_013"></span>Item
16F. Change in Registrant&#8217;s Certifying Accountant.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 13, 2024, the Company was advised that the Company&#8217;s independent registered public accounting firm, Accell Audit and
Compliance, P.A. (&#8220;Accell&#8221;), was ceasing to provide PCAOB audit services and that all of the existing PCAOB clients of Accell
are required to engage new audit firms to fulfill their annual PCAOB audit requirements. On September 13, 2024, the Audit Committee (the
&#8220;Audit Committee&#8221;) of the Board of Directors (the &#8220;Board&#8221;) of the Company dismissed Accell. The Company has retained
Astra Audit &amp; Advisory LLC (&#8220;Astra&#8221;) as Accell&#8217;s successor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit reports of Accell on the Company&#8217;s consolidated financial statements as of and for the years ended June 30, 2023 and 2022
did not contain any adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or
accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the last two fiscal years ended June 30, 2023 and 2022 and through September 13, 2024, (i) there were no disagreements (as defined in
Item 16F(a)(1)(iv) of Form 20-F and the related instructions thereto) with Accell on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedures that, if not resolved to Accell&#8217;s satisfaction, would have caused
Accell to make reference in connection with their opinion to the subject matter of the disagreement, and (ii) there were no reportable
events (as defined in Item 16F(a)(1)(v) of Form 20-F).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 13, 2024, the Audit Committee approved the appointment of Astra, effective September 13, 2024, as the Company&#8217;s new independent
registered public accounting firm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the two fiscal years ended June 30, 2023 and 2022 and through September 13, 2024, the Company has not consulted with Astra regarding
either (i) the application of accounting principles to a specific transaction, either completed or proposed; or the type of audit opinion
that might be rendered on the Company&#8217;s financial statements, and neither a written report or oral advice was provided to the Company
that Astra concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial
reporting issue, (ii) any matter that was the subject of a disagreement pursuant to Item 16F(a)(1)(iv) of Form 20-F and the related instructions
thereto, or (iii) any reportable event pursuant to Item 16F(a)(1)(v) of Form 20-F.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Accell
addressed a letter to the SEC stating that it concurs with the statements made by the Company with respect to Accell. A copy of such
letter was included in the Company&#8217;s report on Form 6-K furnished with the SEC on September 13, 2024, which is hereby incorporated
by reference as Exhibit 15.1 to this annual report on Form 20-F.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="nd_009"></span>Item
16G. Corporate Governance</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a Cayman Islands company listed on the Nasdaq Capital Market, we are subject to Nasdaq Stock Market corporate governance listing standards.
However, the Nasdaq Stock Market rules permit a foreign private issuer like us to follow the corporate governance practices of its home
country. Certain corporate governance practices in the Cayman Islands, which is our home country, may differ significantly from Nasdaq
Stock Market corporate governance listing standards. Shareholders of Cayman Islands exempted companies like us have no general rights
under Cayman Islands law to inspect corporate records or to obtain copies of register of members of these companies (other than the memorandum
and articles of association, special resolutions, and the register of mortgages and charges). Our directors have discretion under our
articles of association to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders,
but are not obliged to make them available to our shareholders. This may make it more difficult for a shareholder to obtain the information
needed to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy
contest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
corporate governance practices in the Cayman Islands, which is our home country, differ significantly from requirements for companies
incorporated in other jurisdictions such as the United States. To the extent we choose to follow home country practice with respect to
corporate governance matters, our shareholders may be afforded less protection than they otherwise would under rules and regulations
applicable to U.S. domestic issuers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted a code of business conduct and ethics, which is applicable to all of our directors, officers and employees.
This code is available in the Governance sub-section of the Investors section of our website at https://www.fitellcorp.com/.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sw_014"></span>Item
16H. Mine Safety Disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sw_015"></span>Item
16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sw_016"></span>Item
16J. Insider Trading Policies</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted insider trading policies and procedures governing the purchase, sale, and other dispositions of our securities
by directors, senior management, and employees that are reasonably designed to promote compliance with applicable insider trading laws,
rules, and regulations, and any listing standards applicable to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has also adopted a compensation recovery policy required by the Nasdaq Listing Rule 5608, the form of which is attached
as Exhibit 97.1 to this annual report.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sw_017"></span>Item
16K. Cybersecurity</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Management and Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have implemented processes for assessing, identifying and managing material risks from cybersecurity threats and monitoring the prevention,
detection, mitigation and remediation of material cybersecurity incident. We have also integrated cybersecurity risk management into
our overall risk management system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed a cybersecurity threat defense system to address both internal and external threats. This system encompasses various levels,
including network, host and application security and incorporates systematic security capabilities for threat defense, monitoring, analysis,
response, deception and countermeasures. We strive to manage cybersecurity risks and protect sensitive information through various means,
such as technical safeguards, procedural requirements, a program of monitoring our network, testing of aspects of our security posture,
an incident response program, and cybersecurity awareness training for employees. We regularly monitors the performance of our apps,
platform, and infrastructure to enable us to respond quickly to potential problems, including potential cybersecurity threats.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not engage any third parties in connection with the processes for assessing, identifying, and managing material risks from cybersecurity
threats. As of the date of this annual report, we have not experienced any material cybersecurity incidents or identified any material
cybersecurity threats that have affected or are reasonably likely to materially affect us, our business strategy, results of operations
or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is responsible for overseeing our cybersecurity risk management. Our board of directors shall review, approve and
maintain oversight of the disclosure (i) on Form 6-K for material cybersecurity incidents (if any) and (ii) related to cybersecurity
matters in the periodic reports (including annual report on Form 20-F) of our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
management level, our Chief Executive Officer and Chief Financial Officer are responsible for assessing, identifying and managing material
risks from cybersecurity threats to our Company and monitoring the prevention, detection, mitigation and remediation of material cybersecurity
incident. Our executive officers shall meet with the board of directors (i) in connection with each current report to furnish information
concerning any material cybersecurity incident, report the status of any material cybersecurity incidents or material risks from cybersecurity
threats to our Company, if any, and the relevant disclosure issue, and (ii) in connection with each annual report, present the disclosure
concerning cybersecurity matters in Form 20-F.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a cybersecurity incident occurs, our executive officers will promptly organize relevant personnel for internal assessment and if it is
determined that the incident could potentially be a material cybersecurity event, our executive officers will promptly report the incident
and assessment results to our board of directors and external legal counsel, to the extent appropriate. Our executive officers shall
prepare disclosure material on the cybersecurity incident for review and approval by the board of directors, and external legal counsel
(if necessary), before it is disseminated to the public.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sw_018"></span>PART
III</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_019"></span>Item
17. Financial Statements.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have elected to provide financial statements pursuant to Item 18.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_020"></span>Item
18. Financial Statements.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial statements are included at the end of this annual report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sw_021"></span>Item
19. Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exhibit
    No.</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Description</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315224001855/ex99-1.htm" style="-sec-extract: exhibit">Amended and Restated Memorandum &amp; Articles of Association (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Report on Form 6-K filed with the SEC on January 9, 2024).</a></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex3-2.htm" style="-sec-extract: exhibit">Certificate of Registration of See Trading Co. Pty Ltd (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Registration Statement on Form F-1 filed with the SEC on July 26, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex3-3.htm" style="-sec-extract: exhibit">Certificate of Registration of See Trading Co. Pty Ltd (name change to GD Wellness Pty Ltd) (incorporated by reference to Exhibit 3.3 to the Company&#8217;s Registration Statement on Form F-1 filed with the SEC on July 26, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex3-3.htm" style="-sec-extract: exhibit">Certificate of Registration of See Trading Co. Pty Ltd (name change to GD Wellness Pty Ltd) (incorporated by reference to Exhibit 3.3 to the Company&#8217;s Registration Statement on Form F-1 filed with the SEC on July 26, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex3-4.htm" style="-sec-extract: exhibit">Certificate of Registration of KMAS Capital and Investment Pty Ltd (incorporated by reference to Exhibit 3.4 to the Company&#8217;s Registration Statement on Form F-1 filed with the SEC on July 26, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex2-1.htm" style="-sec-extract: exhibit">Share Exchange Agreement, dated as of May 5, 2022, by and among Fitell Corporation, KMAS Capital and Investment Pty Ltd, and SKMA Capital and Investment Ltd. (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Registration Statement on Form F-1 filed with the SEC on July 26, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222033910/ex4-1.htm" style="-sec-extract: exhibit">Specimen Certificate for Ordinary Shares (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1928581/000149315223027614/ex1-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representatives&#8217; Warrants (included in Exhibit 4.1).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315223038742/ex2-2.htm" style="-sec-extract: exhibit">Description of Securities (incorporated by reference to Exhibit 2.2 to the Company&#8217;s Annual Report on Form 20-F filed with the Securities and Exchange Commission on October 30, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315223027614/ex1-1.htm" style="-sec-extract: exhibit">Underwriting Agreement dated August 7, 2023 by and between the Company and the Representatives (incorporated by reference to Exhibit 1.1 to the Company&#8217;s Current Report on Form 6-K filed with the Securities and Exchange Commission on August 10, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured Loan Agreement, dated as of March 10, 2020, by and between GD Wellness Pty Ltd and Ansa Group Limited (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222033910/ex10-2.htm" style="-sec-extract: exhibit">Form of Indemnification Agreement between the registrant and its officers and directors (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</a></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222033910/ex10-3.htm" style="-sec-extract: exhibit">Form of Director Agreement between the registrant and its directors (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</a></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222033910/ex10-4.htm" style="-sec-extract: exhibit">Form of Independent Director Agreement between the registrant and its independent directors (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</a></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222033910/ex10-5.htm" style="-sec-extract: exhibit">Form of Employment Agreement between the registrant and its officers (incorporated by reference to Exhibit 10.5 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</a></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex10-6.htm" style="-sec-extract: exhibit">Lease Agreement (incorporated by reference to Exhibit 10.6 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</a></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex10-8.htm" style="-sec-extract: exhibit">License Agreement, dated as of November 9, 2021, by and between GD Wellness Pty Ltd and Js &amp; Je Company Limited (incorporated by reference to Exhibit 10.8 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</a></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315224002829/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement dated January 15, 2024, by and between the Company and Flying Height Consulting Services Limited (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Report on Form 6-K filed with the SEC on January 18, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315224002829/ex4-1.htm" style="-sec-extract: exhibit">Senior Unsecured Convertible Promissory Note dated January 15, 2024, in the principal amount of $3,600,000 issued by the Company to Flying Height Consulting Services Limited (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Report on Form 6-K filed with the SEC on January 18, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315224002829/ex10-2.htm" style="-sec-extract: exhibit">Warrant dated January 15, 2024, issued by the Company to Flying Height Consulting Services Limited (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Report on Form 6-K filed with the SEC on January 18, 2024).</a></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex21-1.htm" style="-sec-extract: exhibit">List of subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</a></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315222027930/ex99-1.htm" style="-sec-extract: exhibit">Code of Business Conduct and Ethics of the Registrant (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Registration Statement on Form F-1 (Registration No. 333-267778) filed with the Securities and Exchange Commission on July 26, 2023).</a></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex11-2.htm">Insider Trading Policy of the Registrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex12-1.htm">CEO
                                            Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex12-2.htm">CFO
                                            Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex13-1.htm">CEO
    Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex13-2.htm">CFO
    Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1928581/000149315224036209/ex99-1.htm" style="-sec-extract: exhibit">Letter to the Securities and Exchange Commission dated September 13, 2024, from Accell Audit and Compliance, P.A. (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Report on Form 6-K filed with the SEC on September 13, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex97-1.htm">Compensation
    Recovery Policy of the Registrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Taxonomy Extension Calculation Linkbase Document</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Taxonomy Extension Definition Linkbase Document</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Taxonomy Extension Label Linkbase Document</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Taxonomy Extension Presentation Linkbase Document</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">* Filed with this annual report on Form
20-F.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="nd_008"></span>SIGNATURES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized
the undersigned to sign this annual report on its behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FITELL
    CORPORATION<br/>
    (Registrant)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    November 15, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Yinying Lu</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yinying
    Lu</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer<br/>
                                            (Principal Executive Officer)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fitell
Corporation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
FINANCIAL STATEMENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Years Ended</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30, 2024 and 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED JUNE 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated
    Financial Statements</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report
    of Independent Registered Public Accounting Firm </span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets at June 30, 2024 and 2023</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Operations and Comprehensive Loss for the years ended June 30, 2024 and 2023</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Stockholders&#8217; Equity for the years ended June 30, 2024 and 2023</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Cash Flows for the years ended June 30, 2024 and 2023</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-9</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="aud_001.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and<br/>
Stockholders of Fitell Corporation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of Fitell Corporation and subsidiaries (the Company) as of June 30, 2024,
and the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity, and cash flows for the
year then ended, and the related notes [and schedules] (collectively referred to as the financial statements). In our opinion, the
financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2024, and the
results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in
the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Substantial
Doubt about the Company&#8217;s Ability to Continue as a Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
2, the Company has incurred net losses and negative cash flow from operations. These factors raise substantial doubt about the Company&#8217;s
ability to continue as a going concern. Our opinion is not modified with respect to that matter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="aud_002.jpg" alt=""/></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have served as the Company&#8217;s auditor since 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--AuditorName_c20230701__20240630_zunITQNFac9e" style="display: none"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000051" name="dei:AuditorName">Astra
Audit &amp; Advisory LLC</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
Firm ID #<span id="xdx_905_edei--AuditorFirmId_c20230701__20240630_z8PnH3SCREG3"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000052" name="dei:AuditorFirmId">6920</ix:nonNumeric></span> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--AuditorLocation_c20230701__20240630_zfqtQUcbe8ee"><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" id="Fact000053" name="dei:AuditorLocation">Tampa, Florida</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 15, 2024</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3702
W Spruce St #1430 &#9679;  Tampa, Florida 33607 &#9679; +1.813.441.9707</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="aud_003.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and Stockholders of Fitell Corporation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
on the Financial Statements</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of Fitell Corporation and subsidiaries (the &#8220;Company&#8221;) as of June
30, 2023, and the related consolidated statements of operations and comprehensive income, changes in stockholders&#8217; equity and cash
flows for the year then ended, and the related notes (collectively referred to as the financial statements). In our opinion, the financial
statements present fairly, in all material respects, the consolidated financial position of the Company as of June 30, 2023, and the
results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in
the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
for Opinion</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="aud_004.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tampa,
Florida</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
24, 2023</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3001
N. Rocky Point Dr. East, Suite 200  &#9679; Tampa, Florida 33607 &#9679; +1.813.367.3527</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_111_zfJic7PPsabi" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20240630_zQ4J8N0gCg49" style="text-align: center">June 30,</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_492_20230630_zoGc7PwbbyG5" style="text-align: center">June 30,</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsAbstract_iB_zEq49TBjUk1d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_z0IMuAqa1c58" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzCsi_zVS5cAh0rWm4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-06-30" id="Fact000061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,014</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-06-30" id="Fact000062" format="ixt:numdotdecimal" decimals="0" unitRef="USD">236,821</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--MarketableSecuritiesCurrent_i02I_maACzCsi_zMMwFDi2xNde" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Investment in marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30" id="Fact000064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,963</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,275</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_i02I_maACzCsi_zggS1mTbQtzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-06-30" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,042</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-06-30" id="Fact000068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,341</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryNet_i02I_maACzCsi_zsFG0wIahgqa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Inventory, at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-06-30" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,439,793</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-06-30" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">525,786</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--CapitalReceivablesOfConvertibleNotes_i02I_maACzCsi_zWnCRKcei0ud" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Capital receivables of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:CapitalReceivablesOfConvertibleNotes" contextRef="AsOf2024-06-30" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,472,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0074">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NotesAndLoansReceivableNetCurrent_i02I_maACzCsi_zJnBKK7Nv3b9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Note receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesAndLoansReceivableNetCurrent" contextRef="AsOf2024-06-30" id="Fact000076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0077">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--DepositsAndPrepaids_i02I_maACzCsi_zf4Wl1HZv9Jg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deposits and prepaids</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:DepositsAndPrepaids" contextRef="AsOf2024-06-30" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">316,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:DepositsAndPrepaids" contextRef="AsOf2023-06-30" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,412</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PrepaidExpenseCurrent_i02I_maACzCsi_zAw0nJJtUqra" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid offering costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2024-06-30" id="Fact000082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,200,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2023-06-30" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,317,866</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetsCurrent_i02TI_mtACzCsi_maAz7S0_zPUfkbqAUX5j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000085" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,052,681</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-06-30" id="Fact000086" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,762,501</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_i02I_maAz7S0_zI5aZFCL4boj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30" id="Fact000088" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,133</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30" id="Fact000089" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,743</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_maAz7S0_zzyk5yJr2VQk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Operating right of use asset, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">557,798</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" id="Fact000092" format="ixt:numdotdecimal" decimals="0" unitRef="USD">605,794</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredIncomeTaxAssetsNet_i02I_maAz7S0_zkOE9WknwJTi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred tax asset, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2024-06-30" id="Fact000094" format="ixt:numdotdecimal" decimals="0" unitRef="USD">342,122</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2023-06-30" id="Fact000095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,354</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_i02I_maAz7S0_zDtvVjSdaDxi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Brand names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="AsOf2024-06-30" id="Fact000097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">337,504</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="AsOf2023-06-30" id="Fact000098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">337,504</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--Goodwill_i02I_maAz7S0_zqKVFiZzFFCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-06-30" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,161,052</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-06-30" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,161,052</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Assets_i01TI_mtAz7S0_zedktvLxMnQl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-06-30" id="Fact000103" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,478,290</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-06-30" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,037,948</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_ztk5Hl77OEYk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zQGeMNf6Dxn2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzlDu_zGB0HmtTLjxj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000112" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,210,956</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,168,723</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredRevenueCurrent_i02I_maLCzlDu_zMl4ICsB1Fw9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-06-30" id="Fact000115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-06-30" id="Fact000116" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,351</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--TaxesPayableCurrent_i02I_maLCzlDu_zgSXhXQM5cu9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2024-06-30" id="Fact000118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">408,681</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2023-06-30" id="Fact000119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">486,058</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzlDu_z9Gj4xRacCHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember" id="Fact000121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,808</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-06-30_us-gaap_RelatedPartyMember" id="Fact000122" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,386</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maLCzlDu_zwP81zDZPkN9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Current portion of operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000124" format="ixt:numdotdecimal" decimals="0" unitRef="USD">278,432</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" id="Fact000125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">212,062</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzlDu_maLzZXB_z2bqNSdI1W0d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000127" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,145,977</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-06-30" id="Fact000128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,129,580</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--WorkersCompensationLiabilityNoncurrent_i02I_maLzZXB_zgXnb5Uxtxmg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accrued employee benefits, non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WorkersCompensationLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000130" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,520</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WorkersCompensationLiabilityNoncurrent" contextRef="AsOf2023-06-30" id="Fact000131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,430</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maLzZXB_zxsNYfM4EgE3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Operating lease liability, less current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000133" format="ixt:numdotdecimal" decimals="0" unitRef="USD">301,921</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" id="Fact000134" format="ixt:numdotdecimal" decimals="0" unitRef="USD">473,015</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Liabilities_i01TI_mtLzZXB_maLASEzORP_z089kR1A684j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-06-30" id="Fact000136" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,469,418</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-06-30" id="Fact000137" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,621,025</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzORP_zQhZJ9N4LY5j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Commitments and contingencies (Note 9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0139">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0140">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zTj8nEDYOZ15" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stockholders&#8217; equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CommonStockValue_i02I_maSEzADc_zsJihPbhOoqb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock, $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240630_zMJmevzvtGUg" title="Common stock, par value"><span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230630_zZGHdx0Ergij" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30" id="Fact000148" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30" id="Fact000150" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240630_znJ1Gsv4hVp6" title="Common stock, shares authorized"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230630_zw1Azxb0sB74" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30" id="Fact000152" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-06-30" id="Fact000154" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_pid_c20240630_zJPAJao5f8bj" title="Common stock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240630_zBq5k26P4f39" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30" id="Fact000156" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000158" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,123,386</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pid_c20230630_z5e6HuGIl4li" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20230630_zjAA0gRzx1Ph" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30" id="Fact000160" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30" id="Fact000162" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,120,000</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding at June 30, 2024 and 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30" id="Fact000145" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30" id="Fact000146" format="ixt:numdotdecimal" decimals="0" unitRef="USD">812</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_i02I_maSEzADc_zL87SZKbck69" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-06-30" id="Fact000164" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,014,389</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-06-30" id="Fact000165" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,097,822</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maSEzADc_zeiVeAzqzrPa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated other comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-06-30" id="Fact000167" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,737</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-06-30" id="Fact000168" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">64</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzADc_z7uPHCyFrmrb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-06-30" id="Fact000170" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,993,792</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-06-30" id="Fact000171" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">681,647</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_mtSEzADc_maLASEzORP_zTSIdG3BIpR7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 50pt; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000173" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,008,872</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000174" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,416,923</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtLASEzORP_zP5Gbxf4Ycv1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&#8217; equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000176" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,478,290</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,037,948</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_113_zUl5GsgOdMA5" summary="xdx: Statement - Consolidated Statements of Operations and Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230701__20240630_zEWiCFm887w4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220701__20230630_zqcvVZucOh3i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenuesAbstract_iB_zkK8fZPSOQkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenues:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01_hsrt--ProductOrServiceAxis__custom--MerchandiseRevenueMember_zK7AiUz0Jape" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Merchandise revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-07-012024-06-30_custom_MerchandiseRevenueMember" id="Fact000182" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,956,962</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-07-012023-06-30_custom_MerchandiseRevenueMember" id="Fact000183" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,036,047</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01_hsrt--ProductOrServiceAxis__custom--SalesOfConsumableProductsMember_zr0Im5WHbCCd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales of consumable products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-07-012024-06-30_custom_SalesOfConsumableProductsMember" id="Fact000185" format="ixt:numdotdecimal" decimals="0" unitRef="USD">358,536</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-07-012023-06-30_custom_SalesOfConsumableProductsMember" id="Fact000186" format="ixt:numdotdecimal" decimals="0" unitRef="USD">223,343</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01_hsrt--ProductOrServiceAxis__custom--RevenueFromLicensingCustomersMember_zJzFELC7K1if" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Revenue from licensing customers</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-07-012024-06-30_custom_RevenueFromLicensingCustomersMember" id="Fact000188" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,277</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-07-012023-06-30_custom_RevenueFromLicensingCustomersMember" id="Fact000189" format="ixt:numdotdecimal" decimals="0" unitRef="USD">539,832</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01_maGPzmBv_zRoV6J0Tu5m8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-07-01to2024-06-30" id="Fact000191" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,466,775</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-07-012023-06-30" id="Fact000192" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,799,222</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CostOfRevenue_i01N_di_msGPzmBv_z5jazuM86lal" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Cost of goods sold</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-07-01to2024-06-30" id="Fact000194" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,881,060</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-07-012023-06-30" id="Fact000195" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,625,821</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GrossProfit_i01T_mtGPzmBv_maOILz0qD_zaIOIBd5DcIh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-07-01to2024-06-30" id="Fact000197" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,585,715</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-07-012023-06-30" id="Fact000198" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,173,401</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zTAObBbe0qfe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ConsultingFees_i01_maOEzp9Z_zZ3C8ubMNTNh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Consulting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:ConsultingFees" contextRef="From2023-07-01to2024-06-30" id="Fact000203" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,468,126</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0204">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzp9Z_zNx0trto9Zlh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000206" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,452,954</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-07-012023-06-30" id="Fact000207" format="ixt:numdotdecimal" decimals="0" unitRef="USD">888,141</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--PersonnelExpenses_i01_maOEzp9Z_zaXY7cWtMhqc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Personnel expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:PersonnelExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000209" format="ixt:numdotdecimal" decimals="0" unitRef="USD">951,451</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:PersonnelExpenses" contextRef="From2022-07-012023-06-30" id="Fact000210" format="ixt:numdotdecimal" decimals="0" unitRef="USD">965,395</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--SellingAndMarketingExpense_i01_maOEzp9Z_zqjCNk5k5Ux9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000212" format="ixt:numdotdecimal" decimals="0" unitRef="USD">351,298</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-07-012023-06-30" id="Fact000213" format="ixt:numdotdecimal" decimals="0" unitRef="USD">454,995</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseExpense_i01_maOEzp9Z_zYsLWpEN5O39" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000215" format="ixt:numdotdecimal" decimals="0" unitRef="USD">284,169</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2022-07-012023-06-30" id="Fact000216" format="ixt:numdotdecimal" decimals="0" unitRef="USD">198,914</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--LicensingFees_i01_maOEzp9Z_znx7CJ4tktu7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licensing fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:LicensingFees" contextRef="From2023-07-01to2024-06-30" id="Fact000218" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,839</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0219">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Depreciation_i01_maOEzp9Z_zp84iGRyrake" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Depreciation expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-07-01to2024-06-30" id="Fact000221" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,385</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-07-012023-06-30" id="Fact000222" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,268</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingExpenses_i01T_mtOEzp9Z_msOILz0qD_zPGWLErTSsOf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000224" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,584,222</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-07-012023-06-30" id="Fact000225" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,519,713</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_iT_mtOILz0qD_zsmIeXX9P6Ga" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Loss from operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000227" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,998,507</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-07-012023-06-30" id="Fact000228" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">346,312</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zn1QDBIg6Fub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other income (expenses):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PublicOfferingRelatedExpenses_i01N_di_msNIEzRmQ_zQfKKNnzCrw7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">IPO related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:PublicOfferingRelatedExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000233" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,523</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:PublicOfferingRelatedExpenses" contextRef="From2022-07-012023-06-30" id="Fact000234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">662,418</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--UnrealizedGainLossOnInvestments_i01_maNIEzRmQ_znfKS4Ib2huj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized loss on investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2023-07-01to2024-06-30" id="Fact000236" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">354,781</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2022-07-012023-06-30" id="Fact000237" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">529,488</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--OtherNonoperatingIncome_i01_maNIEzRmQ_zWyo5azctu5g" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2023-07-01to2024-06-30" id="Fact000239" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,889</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2022-07-012023-06-30" id="Fact000240" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,885</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InvestmentIncomeInterest_i01_maNIEzRmQ_zDch1abbpOZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000242" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,574</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2022-07-012023-06-30" id="Fact000243" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,978</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--InterestExpenseNonoperating_i01N_di_msNIEzRmQ_zAVRF0PmxKh1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Interest expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-07-01to2024-06-30" id="Fact000245" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,242,140</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2022-07-012023-06-30" id="Fact000246" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,800</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpense_i01T_mtNIEzRmQ_zxrbza7XtMI1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total other expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000248" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,522,981</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-07-012023-06-30" id="Fact000249" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,272,843</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzpED_znZjVVUi040c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000251" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,521,488</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="Fact000252" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,619,155</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_msNILzpED_zEgcvDCCTiV5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Income tax benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact000254" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">209,343</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact000255" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,761</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_iT_mtNILzpED_maCINOTzyDX_zotBXuYG2ly" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000257" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,312,145</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30" id="Fact000258" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,593,394</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_maCINOTzyDX_zTWMfBstyYR7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation adjustment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-07-01to2024-06-30" id="Fact000260" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,673</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30" id="Fact000261" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,063</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--ComprehensiveIncomeNetOfTax_iT_mtCINOTzyDX_zg44ps151Ok5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-07-01to2024-06-30" id="Fact000263" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,325,818</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-07-012023-06-30" id="Fact000264" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,620,457</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted loss per share on net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareBasic_pid_c20230701__20240630_zAT1o649Xx57" title="Basic loss per share on net loss" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230701__20240630_zJ0TD11zbe4a" title="Diluted loss per share on net loss" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-01to2024-06-30" id="Fact000266" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-01to2024-06-30" id="Fact000268" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.66</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20220701__20230630_z56A8lcb0z58" title="Basic loss per share on net loss" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20220701__20230630_zlbz7oOEjrC2" title="Diluted loss per share on net loss" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012023-06-30" id="Fact000270" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-06-30" id="Fact000272" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.21</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Weighted average shares outstanding - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230701__20240630_zCiDabEN5gGb" title="Weighted average shares outstanding - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230701__20240630_zxwaW7Hjzkyd" title="Weighted average shares outstanding - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-01to2024-06-30" id="Fact000274" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-01to2024-06-30" id="Fact000276" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,020,251</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220701__20230630_z5a5D1LmqpPe" title="Weighted average shares outstanding - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220701__20230630_zsGPKmeU2ev5" title="Weighted average shares outstanding - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyBhbmQgQ29tcHJlaGVuc2l2ZSBMb3NzAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012023-06-30" id="Fact000278" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012023-06-30" id="Fact000280" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,714,959</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED JUNE 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_114_zyrLRBTS7n44" summary="xdx: Statement - Consolidated Statements of Stockholders' Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z3MR1OKifXi7" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_custom--SubscriptionReceivableMember_zxqnDHRza9Qj" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zKFp6sjlgxke" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zN2YL6PYc8zg" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zUZs3lnFRxTe" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_zazq2hLczByf" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Common</p>
                                                                    <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Subscription</p>
                                                                    <p style="margin-top: 0; margin-bottom: 0">Receivable</p></td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Additional</p>
                                                                    <p style="margin-top: 0; margin-bottom: 0">Paid-in</p></td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                    <p style="margin-top: 0; margin-bottom: 0">Other</p>
                                                                    <p style="margin-top: 0; margin-bottom: 0">Comprehensive</p></td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Retained</p>
                                                                    <p style="margin-top: 0; margin-bottom: 0">Earnings</p>
                                                                    <p style="margin-top: 0; margin-bottom: 0">(Accumulated</p></td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center"/><td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"> Capital</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Income (Loss)</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Deficit)</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_434_c20220701__20230630_eus-gaap--StockholdersEquity_iS_zyW9C6F20DZb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: justify">Balance July 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIcKrMu4qP03" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" id="Fact000289" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" id="Fact000282" format="ixt:numdotdecimal" decimals="0" unitRef="USD">700</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__custom--SubscriptionReceivableMember_zd4cC2ddZeG1" title="Beginning balance, shares" style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0291">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_custom_SubscriptionReceivableMember" id="Fact000283" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">56</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000284" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,497,990</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000285" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,999</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" id="Fact000286" format="ixt:numdotdecimal" decimals="0" unitRef="USD">911,747</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" id="Fact000287" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,437,380</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zmGqzgFZvbY2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zAoStHrgGjZe" title="Stock issued for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000300" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,120,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="Fact000293" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0294">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000295" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,599,888</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0296">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0297">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-07-012023-06-30" id="Fact000298" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--StockIssuedDuringPeriodValueSettlementOfStockSubscription_zHGD6JEmXKg7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Settlement of stock subscription</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0302">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription" contextRef="From2022-07-012023-06-30_custom_SubscriptionReceivableMember" id="Fact000303" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000304" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">56</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0305">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0306">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0307">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zVYpVddU5S36" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign currency translation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0310">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0311">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000312" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,063</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0313">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-07-012023-06-30" id="Fact000314" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,063</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zdSh2aP0pjb4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0316">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0317">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0318">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0319">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="Fact000320" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,593,394</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30" id="Fact000321" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,593,394</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20230701__20240630_eus-gaap--StockholdersEquity_iS_zAotiK9fOu3d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Balance June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDggalIvxpa8" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000330" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,120,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000323" format="ixt:numdotdecimal" decimals="0" unitRef="USD">812</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--SubscriptionReceivableMember_zzqnaEnixQJe" title="Beginning balance, shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0332">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0324">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000325" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,097,822</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000326" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">64</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000327" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">681,647</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000328" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,416,923</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_439_c20230701__20240630_eus-gaap--StockholdersEquity_iS_zyY3ZBYIKa8k" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Balance <br/></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbYWwcBr28Vf" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000341" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,120,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000334" format="ixt:numdotdecimal" decimals="0" unitRef="USD">812</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--SubscriptionReceivableMember_zdhoPpitvqm2" title="Beginning balance, shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0343">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0335">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000336" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,097,822</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000337" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">64</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000338" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">681,647</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000339" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,416,923</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z55EC7xUlh56" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Funds raised in IPO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1I9OckdppF4" title="Funds raised in IPO, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000352" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000345" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0346">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,497,342</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0348">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0349">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-01to2024-06-30" id="Fact000350" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,497,642</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_zirBRe2ezEFh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share issued for conversion of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zW9U5l4vtQp7" title="Share issued for conversion of debt, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000361" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,090,909</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000354" format="ixt:numdotdecimal" decimals="0" unitRef="USD">409</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000356" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,599,591</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0357">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0358">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2023-07-01to2024-06-30" id="Fact000359" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zaPRjts5upc3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share issued pursuant to warrants of the convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDhsxn60YKU2" title="Share issued pursuant to warrants of the convertible notes, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000370" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,892,727</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000363" format="ixt:numdotdecimal" decimals="0" unitRef="USD">489</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0364">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000365" format="ixt:numdotdecimal" decimals="0" unitRef="USD">819,599</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0366">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-07-01to2024-06-30" id="Fact000368" format="ixt:numdotdecimal" decimals="0" unitRef="USD">820,088</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueOther_zTRTwfJNRlRj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share issued pursuant to underwriter&#8217;s warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesOther_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIfFKhmdg9g9" title="Share issued pursuant to underwriter's warrants, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000379" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000372" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0373">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000374" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0376">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-07-01to2024-06-30" id="Fact000377" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zbfcIrEvEHKe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign currency translation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0381">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0383">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000384" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,673</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-07-01to2024-06-30" id="Fact000386" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,673</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zl3Tp0JBpnA8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0388">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0389">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000392" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,312,145</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000393" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,312,145</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20230701__20240630_eus-gaap--StockholdersEquity_iE_zWchMM5Fp4E8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Balance June 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zc0j1GD2dsfe" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000402" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,123,386</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000395" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,012</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--SubscriptionReceivableMember_zC2wYjrhmPB6" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0404">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0396">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000397" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,014,389</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000398" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,737</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000399" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,993,792</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,008,872</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20230701__20240630_eus-gaap--StockholdersEquity_iE_zPyt5etqF7Ab" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Balance <br/></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaq6hO5caY37" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000413" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,123,386</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000406" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,012</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--SubscriptionReceivableMember_zwawD3kr8Gg4" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0415">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0407">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000408" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,014,389</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000409" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,737</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000410" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,993,792</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000411" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,008,872</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_112_zVVo1xcY2FU2" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230701__20240630_zz4BnGq5mwnl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220701__20230630_zpUgpt3V4jTk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_z6PJp7n623Jb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Operating Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_i01_maNCPBUzUTS_zBkX89BaZ9Nb" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000420" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,312,145</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30" id="Fact000421" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,593,394</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zCbf1FteAwo8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Depreciation_i02_maNCPBUzUTS_zJzz2Hnfgxa6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-07-01to2024-06-30" id="Fact000426" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,385</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-07-012023-06-30" id="Fact000427" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,268</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_maNCPBUzUTS_zZgrE2ND5fOk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amortization of right of use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000429" format="ixt:numdotdecimal" decimals="0" unitRef="USD">284,169</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2022-07-012023-06-30" id="Fact000430" format="ixt:numdotdecimal" decimals="0" unitRef="USD">198,914</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProvisionForDoubtfulAccounts_i02_maNCPBUzUTS_zhwDCOGx3Hjg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Bad debt provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2023-07-01to2024-06-30" id="Fact000432" format="ixt:numdotdecimal" decimals="0" unitRef="USD">579,265</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2022-07-012023-06-30" id="Fact000433" format="ixt:numdotdecimal" decimals="0" unitRef="USD">426,971</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--UnrealizedGainLossOnInvestments_i02N_di_msNCPBUzUTS_zyJbDgWYd7Ec" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Unrealized loss on investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2023-07-01to2024-06-30" id="Fact000435" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">354,781</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2022-07-012023-06-30" id="Fact000436" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">529,488</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AmortizationOfDebtDiscountPremium_i02_maNCPBUzUTS_zYVJt0wlEcU8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amortization of debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-07-01to2024-06-30" id="Fact000438" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,108,088</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i02_maNCPBUzUTS_zYrSlDe8mAX6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2023-07-01to2024-06-30" id="Fact000441" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2022-07-012023-06-30" id="Fact000442" format="ixt:numdotdecimal" decimals="0" unitRef="USD">560,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zJjaw6ojQkog" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in operating assets and liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUzUTS_zpq2DO4LpiEk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-07-01to2024-06-30" id="Fact000447" format="ixt:numdotdecimal" decimals="0" unitRef="USD">449,210</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-07-012023-06-30" id="Fact000448" format="ixt:numdotdecimal" decimals="0" unitRef="USD">560,215</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msNCPBUzUTS_zrxUQ7QLqjcj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Inventory, at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-07-01to2024-06-30" id="Fact000450" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,914,007</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-07-012023-06-30" id="Fact000451" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">393,636</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_msNCPBUzUTS_zxBmvApsdND" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deposits and prepaids</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2023-07-01to2024-06-30" id="Fact000453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">303,457</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-07-012023-06-30" id="Fact000454" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,177</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseInPrepaidOfferingCosts_i03N_di_msNCPBUzUTS_zbsDoqenbA7g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepaid offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:IncreaseDecreaseInPrepaidOfferingCosts" contextRef="From2023-07-01to2024-06-30" id="Fact000456" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,999,475</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_maNCPBUzUTS_zRz4GbaJ1bOd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2023-07-01to2024-06-30" id="Fact000459" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">340,897</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2022-07-012023-06-30" id="Fact000460" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">202,437</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--IncreaseDecreaseInDeferredTaxAsset_i03N_di_msNCPBUzUTS_zhPhsrFNw6pl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:IncreaseDecreaseInDeferredTaxAsset" contextRef="From2023-07-01to2024-06-30" id="Fact000462" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,768</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:IncreaseDecreaseInDeferredTaxAsset" contextRef="From2022-07-012023-06-30" id="Fact000463" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,759</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUzUTS_zrqA68NlN7m2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-07-01to2024-06-30" id="Fact000465" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,233</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-07-012023-06-30" id="Fact000466" format="ixt:numdotdecimal" decimals="0" unitRef="USD">363,694</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUzUTS_z43BkNrNgfZi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-07-01to2024-06-30" id="Fact000468" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,251</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-07-012023-06-30" id="Fact000469" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">263,625</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzUTS_zg70Ua9cd8gh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2023-07-01to2024-06-30" id="Fact000471" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">77,377</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2022-07-012023-06-30" id="Fact000472" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">169,615</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent_i03_maNCPBUzUTS_zt20JuI7q8Xe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accrued employee benefits, non-current</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FTEL:IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" contextRef="From2023-07-01to2024-06-30" id="Fact000474" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,090</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FTEL:IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" contextRef="From2022-07-012023-06-30" id="Fact000475" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,147</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzUTS_maCCERCz4hF_zw93I5cmcYk5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash from activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000477" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,253,539</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-012023-06-30" id="Fact000478" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">373,104</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zTgMpt0L2csj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash Flows from Investing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PaymentsToAcquireNotesReceivable_i01N_di_msNCPBUzdcC_zFwDoKca3tJ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Investment in note receivable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireNotesReceivable" contextRef="From2023-07-01to2024-06-30" id="Fact000483" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,500,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0484">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzdcC_maCCERCz4hF_zyTNOZUmdp3d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash from investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000486" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,500,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zWY14kJWAXE3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash Flows from Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_i01_maNCPBUzfer_zd8d4Go7d1Kh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net activity on due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2023-07-01to2024-06-30" id="Fact000492" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,422</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2022-07-012023-06-30" id="Fact000493" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">79,064</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i01_maNCPBUzfer_zBSrGlGbUL17" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Funds raised in IPO, gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-07-01to2024-06-30" id="Fact000495" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,614,983</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0496">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ProceedsFromIssuanceOfConvertibleNotes_i01_maNCPBUzfer_z5fEU2QSoZQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Funds raised in convertible notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FTEL:ProceedsFromIssuanceOfConvertibleNotes" contextRef="From2023-07-01to2024-06-30" id="Fact000498" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,840,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0499">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzfer_maCCERCz4hF_zs6FFPaKzF22" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash from financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000501" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,469,405</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-07-012023-06-30" id="Fact000502" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">79,064</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_iN_di_msCCERCz4hF_zNHQxbAjv9Jb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation adjustment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2023-07-01to2024-06-30" id="Fact000504" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,673</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2022-07-012023-06-30" id="Fact000505" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,063</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCz4hF_zZv3acqIAYDl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-07-01to2024-06-30" id="Fact000507" format="ixt:numdotdecimal" decimals="0" unitRef="USD">702,193</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-07-012023-06-30" id="Fact000508" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">479,231</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zyUj9DKii997" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Cash and cash equivalents at beginning of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-06-30" id="Fact000510" format="ixt:numdotdecimal" decimals="0" unitRef="USD">236,821</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-06-30" id="Fact000511" format="ixt:numdotdecimal" decimals="0" unitRef="USD">716,052</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_z96PupIiVJti" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-06-30" id="Fact000513" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,014</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-06-30" id="Fact000514" format="ixt:numdotdecimal" decimals="0" unitRef="USD">236,821</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--SupplementalCashFlowInformationAbstract_iB_z2QMV3iY157h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Supplemental Cash Flow Information</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestPaidNet_i01_zUgfxXB9vm7l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for interest</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxesPaidNet_i01_zJFCSkxy0f7b" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-07-01to2024-06-30" id="Fact000522" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,313</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-07-012023-06-30" id="Fact000523" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,375</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zd8JHvFkbXjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssued1_i01_zCkfBz4GqqM2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Stock issued for prepaid IPO services</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0528">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2022-07-012023-06-30" id="Fact000529" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,040,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--CapitalReceivableOfConvertibleNotes_i01_ze7m8PbxMy8c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capital receivable of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FTEL:CapitalReceivableOfConvertibleNotes" contextRef="From2023-07-01to2024-06-30" id="Fact000531" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,472,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0532">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--OperatingLeaseLiabilityAndRightOfUseAsset_i01_zDtW845cP4tf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease liability and right of use asset</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FTEL:OperatingLeaseLiabilityAndRightOfUseAsset" contextRef="From2023-07-01to2024-06-30" id="Fact000534" format="ixt:numdotdecimal" decimals="0" unitRef="USD">836,697</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ConversionOfDebtToEquity_i01_zJ7xVQ2aeA5g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of debt to equity</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FTEL:ConversionOfDebtToEquity" contextRef="From2023-07-01to2024-06-30" id="Fact000537" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0538">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ConversionOfWarrantsOfConvertibleNotesToEquity_i01_zsw4HcwML0mk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of warrants of convertible notes to equity</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FTEL:ConversionOfWarrantsOfConvertibleNotesToEquity" contextRef="From2023-07-01to2024-06-30" id="Fact000540" format="ixt:numdotdecimal" decimals="0" unitRef="USD">820,088</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0541">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ConversionOfUnderwritersWarrantToEquity_i01_zsIsVSqT5tih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of underwriter&#8217;s warrant to equity</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="FTEL:ConversionOfUnderwritersWarrantToEquity" contextRef="From2023-07-01to2024-06-30" id="Fact000543" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0544">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000546" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80A_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zlMOP2hcn6O2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zrn7j9Jj8Bm2">Organization and principal activities</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fitell
Corporation (the &#8220;Company&#8221;) was incorporated in the Cayman Islands on April 11, 2022 under the Companies Act as an exempted
company with limited liability. The Company conducts its primary operations of selling gym and fitness equipment in Australia through
its indirectly held wholly owned subsidiary that are incorporated and domiciled in Australia, namely GD Wellness Pty Ltd (&#8220;GD&#8221;).
The Company holds GD via a wholly owned subsidiary, namely KMAS Capital and Investment Pty Ltd (&#8220;KMAS&#8221;) which is incorporated
and domiciled in Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000548" name="FTEL:ScheduleOfSubsidiariesOfCompanyTableTextBlock"><p id="xdx_898_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zAZhsVtOGGlk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the Company and its subsidiaries are set out in the table as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_ziwBcBbKXaa1" style="display: none">Schedule of the Company and its Subsidiaries</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Percentage of effective ownership</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Name</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Date of incorporation</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2023</td><td>&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Place of incorporation</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Principal activities</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Fitell Corporation</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span id="xdx_901_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_za9zREEZQKv8" title="Date of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_FitellCorporationMember" format="ixt:datemonthdayyearen" id="Fact000550" name="dei:EntityIncorporationDateOfIncorporation">April 11, 2022</ix:nonNumeric></span></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_908_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zyCOFRLqjQH3" title="Percentage of effective ownership description"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_FitellCorporationMember" id="Fact000552" name="us-gaap:EquityMethodInvestmentAdditionalInformation">Parent</ix:nonNumeric></span></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_903_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20220701__20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zrVcGpcODDYk" title="Percentage of effective ownership description"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_FitellCorporationMember" id="Fact000554" name="us-gaap:EquityMethodInvestmentAdditionalInformation">Parent</ix:nonNumeric></span></td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_902_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zQdlS8nwqKNf" title="Place of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_FitellCorporationMember" id="Fact000556" name="FTEL:EquityMethodInvestmentPlaceOfIncorporation">Cayman Islands</ix:nonNumeric></span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zjXjIOxhY61f" title="Principal activities"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_FitellCorporationMember" id="Fact000558" name="us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities">Investment holdings</ix:nonNumeric></span></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">KMAS Capital and Investment Pty Ltd</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_z3hRSq96jH93" title="Date of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember" format="ixt:datemonthdayyearen" id="Fact000560" name="dei:EntityIncorporationDateOfIncorporation">July 26, 2016</ix:nonNumeric></span></span></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zVibSR1cOR5e" title="Percentage of effective ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember" id="Fact000562" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></td><td>%</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zyXDegyk8Wwb" title="Percentage of effective ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2023-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember" id="Fact000564" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></td><td>%</td><td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_903_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zcckMFrif5q7" title="Place of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember" id="Fact000566" name="FTEL:EquityMethodInvestmentPlaceOfIncorporation">Australia</ix:nonNumeric></span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span id="xdx_90A_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zqUL7glRaf1e" title="Principal activities"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember" id="Fact000568" name="us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities">Investment holdings</ix:nonNumeric></span></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 15%">GD Wellness Pty Ltd</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zPbUYFnBwdoe" title="Date of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_GDWellnessPtyLtdMember" format="ixt:datemonthdayyearen" id="Fact000570" name="dei:EntityIncorporationDateOfIncorporation">July 22, 2005</ix:nonNumeric></span></span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 13%"><span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zSbrjc1a7YAd" title="Percentage of effective ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-06-30_custom_GDWellnessPtyLtdMember" id="Fact000572" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></td><td style="text-align: left; width: 1%">%</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 13%"><span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zCBPwKZfwkdc" title="Percentage of effective ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2023-06-30_custom_GDWellnessPtyLtdMember" id="Fact000574" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></td><td style="text-align: left; width: 1%">%</td><td style="width: 2%">&#160;</td>
    <td style="text-align: justify; width: 15%"><span id="xdx_90D_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zZaMwOMd1JMa" title="Place of incorporation"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_GDWellnessPtyLtdMember" id="Fact000576" name="FTEL:EquityMethodInvestmentPlaceOfIncorporation">Australia</ix:nonNumeric></span></td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zFNDkEOL8maf" title="Principal activities"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_GDWellnessPtyLtdMember" id="Fact000578" name="us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities">Sales of gym and fitness equipment</ix:nonNumeric></span></span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zbdNEkVpTIei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000580" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_ztJK3fGnOud3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_zaWeaWL8XvC9">Summary of significant accounting policies</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000582" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"><p id="xdx_847_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zdLEDuzG8uVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities
and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements have been prepared using the accrual basis of accounting
in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and presented in
US dollars. The year end is June 30.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000584" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_zRZ6MgKLFQa3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basic
of Consolidation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements of the Company and its subsidiaries. All inter-company transactions
and balances between the Company and its subsidiaries have been eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000586" name="FTEL:ConcentrationsofVendorsPolicyTextBlock"><p id="xdx_845_ecustom--ConcentrationsofVendorsPolicyTextBlock_zNZvAji6B1el" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentrations
of vendors</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended June 30, 2024, there are two vendors which accounts for more than 10% of the Company total purchases
individually, and they account for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_z1AzUGQtk8Ib" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_OneVendorsMember" id="Fact000588" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">23.68</ix:nonFraction></span>%
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zuQ7Jo75IwHk" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember" id="Fact000590" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16.83</ix:nonFraction></span>%
of the total purchases respectively. During the fiscal year ended June 30, 2023, there are three vendors which accounts for more
than 10% of the Company total purchase individually, and they account for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_zRUtLTivHyC" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_OneVendorsMember" id="Fact000592" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">28.63</ix:nonFraction></span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zXnrg1OFlgHf" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember" id="Fact000594" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16.55</ix:nonFraction></span>%, and<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zroiiC2ik71h" title="Concentration risk percentage"> <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_ThreeVendorsMember" id="Fact000596" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.66</ix:nonFraction></span>% of the total purchases
respectively. As of June 30, 2024 and 2023, three and four vendors, respectively, account for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zchNOoVAMM19" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_ThreeVendorsMember" id="Fact000598" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span>%
and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourVendorsMember_zD7wHxr38YG5" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_FourVendorsMember" id="Fact000600" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">58</ix:nonFraction></span>%
of total accounts payable, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000602" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zxohUoZmgnie" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables
arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions.
The Company controls credit risk related to accounts receivable through credit approvals, credit limits and monitoring procedures. The
Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an
allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure
beyond such allowance is limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000604" name="us-gaap:UseOfEstimates"><p id="xdx_848_eus-gaap--UseOfEstimates_z4fZuz8a4Sr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use
of Estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000606" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zmUYDeKS1ZJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue
Recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates it main income source from the sales of merchandise, which includes the sales of various gym equipment and fitness
products. It recognizes this merchandise revenue in accordance with Accounting Standards Update&#160;&#160; (&#8220;ASU&#8221;) 2014-09,
&#8220;<i>Revenue from contracts with customers,&#8221;</i> (Topic 606). Revenue is recognized when a customer obtains control of promised
goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows
arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to
receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification
of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether
they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration;
(iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies
each performance obligation. The Company&#8217;s main revenue stream is from sales of products. The Company recognizes as revenues the
amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied
or as it is satisfied. Generally, the Company&#8217;s performance obligations are transferred to customers at a point in time, typically
upon shipment. The Company offers <span style="background-color: white">refunds, repairs and replacements in accordance with the Australian
Consumer Law. The Company recognized the sales discount and returns against its revenues in the same period as the original sales transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also occasionally sells various consumable products. These products include, but are not limited to, coffee and nutritional supplement
products. Similar to the aforesaid merchandise revenue, it also recognizes the revenue in accordance with Topic 606 upon shipment. If
the Company <span style="background-color: white">provided a sales discount or allowed sales returns, it is recognized against its revenues
in the same period as the original sales transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also provides licensing services and gym equipment to gym studios in overseas. These services include, but are not limited to,
providing the brand name, and offer initial design services to these gym studios. Similar to the aforesaid merchandise revenue, it also
recognizes the revenue in accordance with Topic 606 based on the straight-line basis over the contractual service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000608" name="us-gaap:RevenueRecognitionDeferredRevenue"><p id="xdx_840_eus-gaap--RevenueRecognitionDeferredRevenue_zrq3A5crubDj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred
Revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized the deposits received from its customers as deferred revenue if the goods or service is not delivered. It would be
recognized as revenue after the goods or service is delivered. During the fiscal years ended June 30, 2024 and 2023, a total of $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230701__20240630_zEaFFrY3lIq4" title="Deferred revenue, revenue recognized"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2023-07-01to2024-06-30" id="Fact000610" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,351</ix:nonFraction></span>
and $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220701__20230630_zZrOo4GFcNQ8" title="Deferred revenue, revenue recognized"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2022-07-012023-06-30" id="Fact000612" format="ixt:numdotdecimal" decimals="0" unitRef="USD">501,976</ix:nonFraction></span>, respectively, of deferred revenue was recognized into merchandise revenue. At June 30, 2024 and 2023, a total of $<span id="xdx_902_eus-gaap--DeferredRevenueCurrent_iI_c20240630_zjB8NmzyPGtf" title="Deferred revenue"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-06-30" id="Fact000614" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,100</ix:nonFraction></span>
and $<span id="xdx_903_eus-gaap--DeferredRevenueCurrent_iI_c20230630_zmmlyyWhXq87" title="Deferred revenue"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-06-30" id="Fact000616" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,351</ix:nonFraction></span>, respectively, of revenue has been deferred to be recognized in future periods as merchandise revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000618" name="us-gaap:CompensationRelatedCostsPolicyTextBlock"><p id="xdx_84C_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zR90CHWqDoy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Stock-based
Compensation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records stock-based compensation in accordance with the provisions of the Accounting Standards Codification (&#8220;ASC&#8221;)
718, &#8220;<i>Accounting for Stock Compensation</i>,&#8221; which establishes accounting standards for the transaction in
which an entity exchanges its equity instruments for goods or services. In accordance with guidance provided under ASC 718, the Company
recognizes an expense for the fair value of its stock awards at the time of the grant and the fair value of its outstanding stock options
as they vest, whether held by employees or others. During the fiscal year ended June 30, 2024, there was no stock-based compensation.
During the fiscal year ended June 30, 2023, the Company has issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220701__20230630_zmQQdpfzXE7k" title="Stock issued for services, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-07-012023-06-30" id="Fact000620" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,120,000</ix:nonFraction></span> shares for services, and the value of those shares were
determined at $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_c20230630_z1BJB6aCTqh7" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-06-30" id="Fact000622" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></span> which was same as the IPO price on August 8, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000624" name="FTEL:PrepaidOfferingCostsPolicyTextBlock"><p id="xdx_84D_ecustom--PrepaidOfferingCostsPolicyTextBlock_zN0x9mqLI4w1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="text-decoration: underline"><span id="xdx_86C_zk4T2Weg48Hc">Prepaid Offering Costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">Prepaid offering costs are accounted for under ASC 340-10 and consist of
legal, accounting and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are
directly related to IPO or other fundraising and that will be charged upon the completion of the IPO or fundraising.&#160; As of June
30, 2024 and 2023, the Company had prepaid offering costs of $<span id="xdx_90C_eus-gaap--PrepaidExpenseCurrent_iI_c20240630_zBk8pt9CcPIc" title="Prepaid offering cost"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2024-06-30" id="Fact000626" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,200,000</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--PrepaidExpenseCurrent_iI_c20230630_zeqGwuOsk69h" title="Prepaid offering cost"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2023-06-30" id="Fact000628" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,317,866</ix:nonFraction></span>, respectively.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000630" name="us-gaap:RevenueRecognitionLoyaltyPrograms"><p id="xdx_84A_eus-gaap--RevenueRecognitionLoyaltyPrograms_zqLYer8wBuo7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Customers
Loyalty Program</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
certain sales transactions, the Company offers loyalty points to its customer based on the dollar value of the transaction which gives
the customer the option to acquire additional goods or services at a price that is lower than its stand-alone selling price. In accordance
with Topic 606, the Company evaluates whether these loyalty points constitute separate performance obligations and the need to allocate
the transaction price between revenue and performance obligation. As of June 30, 2024 and 2023, the Company does not believe that any
separate performance obligation under the loyalty program is material<span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000632" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z5qvaaAFU671" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
Value Measurements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 820, <i>Fair Value Measurements</i>, clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes
a fair value hierarchy to classify the inputs used in measuring fair value as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets
and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated
by observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Inputs are unobservable inputs which reflect the reporting entity&#8217;s own assumptions on what assumptions the market participants
would use in pricing the asset or liability based on the best available information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair value of certain financial instruments, including all current liabilities are carried at historical cost basis, which
approximates their fair values because of the short-term nature of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000634" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zhE6Wm3veNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
Value of Financial Instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Subtopic 825-10, <i>Financial Instruments</i> requires disclosure of the fair value of certain financial instruments. The carrying value
of cash and cash equivalents, accounts payable and accrued liabilities as reflected in the consolidated balance sheets, are approximately
fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and
equity instruments of the Company are either recognized or disclosed in the consolidated financial statements together with other information
relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values
of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair
value has been disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000636" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zrXimYK3vRqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
and Cash Equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000638" name="us-gaap:MarketableSecuritiesPolicy"><p id="xdx_84B_eus-gaap--MarketableSecuritiesPolicy_zeF4adZfEXTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Marketable
Securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for investments in marketable securities in accordance with ASC Topic 825, <i>Financial Instruments. </i>All of the
Company&#8217;s investments at June 30, 2024 and 2023 are treated as trading securities with the unrealized gains and losses reflected
in Other income/(expense) on the consolidated statements of operations and comprehensive loss. During the years ended June 30, 2024 and
2023, the Company recorded an unrealized loss on investments in marketable securities of $<span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20230701__20240630_zQTgrsKh9Ewk" title="Unrealized loss on investments"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000640" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,781</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220701__20230630_zY4dlGzvQBO5" title="Unrealized loss on investments"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-07-012023-06-30" id="Fact000642" format="ixt:numdotdecimal" decimals="0" unitRef="USD">529,488</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000644" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zTCNjzmSEOp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Advertising
and Promotion</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the policy of charging the costs of advertising, marketing, and public relations to expense as incurred. The Company
has $<span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20230701__20240630_z9rzveonpwId" title="Sales and marketing expenses"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000646" format="ixt:numdotdecimal" decimals="0" unitRef="USD">351,298</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20220701__20230630_z0jX5FMWia67" title="Sales and marketing expenses"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-07-012023-06-30" id="Fact000648" format="ixt:numdotdecimal" decimals="0" unitRef="USD">454,995</ix:nonFraction></span> in sales and marketing expenses for the years ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000650" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zIQSJwWrJf2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income
Taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their
respective tax basis and operating loss, capital loss and tax credit carryforwards. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes
the enactment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized
income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or
measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to
unrecognized tax benefits as a component of general and administrative expenses. Our federal tax return and any state tax returns are
not currently under examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted ASC 740-10, <i>Accounting for Income Taxes</i>, which requires an asset and liability approach to financial accounting
and reporting for income taxes. Deferred income tax assets and liabilities are computed annually from differences between the consolidated
financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on
enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances
are established when necessary to reduce deferred tax assets to the amount expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000652" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z96cGrTCLI9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Inventory</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consists of only finished goods and are stated at the lower of cost and net realizable value on a &#8216;first in first out&#8217; basis.
Cost comprises of direct materials and delivery costs, direct labor, import duties and other taxes, and an appropriate proportion of
variable and fixed overhead expenditure based on normal operating capacity. Costs of purchased inventory are determined after deducting
rebates and discounts received or receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
in transit is stated at the lower of cost and net realizable value. Cost comprises purchase and delivery costs, net of rebates and discounts
received or receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated
costs necessary to make the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company records an allowance for potentially excess and obsolete inventory based upon recent sales history, the quantity of inventory
on-hand, and a forecast of potential use of the inventory. The Company periodically reviews inventory to identify excess quantities and
part numbers that are experiencing a reduction in demand. Any part numbers with quantities identified during this process are reserved
for at rates based upon management&#8217;s judgment, historical rates, and consideration of possible scrap and liquidation values which
may be as high as 100% of cost if no liquidation market exists for the part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000654" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zUdhu2Begd8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Receivable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Account balances deemed to be uncollectible are
charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. At June 30, 2024 and 2023, the Company has considered an allowance of $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240630_z9RoaSTTwa9f" title="Allowance for doubtful accounts receivable"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2024-06-30" id="Fact000656" format="ixt:numdotdecimal" decimals="0" unitRef="USD">585,672</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20230630_zi3SvUbDEE6d" title="Allowance for doubtful receivable accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-06-30" id="Fact000658" format="ixt:numdotdecimal" decimals="0" unitRef="USD">426,971</ix:nonFraction></span>, respectively, for
doubtful receivable accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000660" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zHyXa7tPTC3b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property
and Equipment</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment is stated at cost, net of depreciation. Depreciation is provided over the estimated useful lives of the related assets
using the straight-line method. Depreciation expense totaled $<span id="xdx_90B_eus-gaap--Depreciation_c20230701__20240630_z94WZe1bFtN1" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-07-01to2024-06-30" id="Fact000662" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,385</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--Depreciation_c20220701__20230630_zCOmyPPoeVX3" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-07-012023-06-30" id="Fact000664" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,268</ix:nonFraction></span> for the years ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000666" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z7eUSUczlSPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment
of Long-Lived Assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
impairments of long lived assets are reviewed when events or changes in circumstances indicate a potential impairment may exist. In accordance
with ASC Subtopic 360-10, <i>&#8220;Property, Plant and Equipment &#8211; Overall&#8221;</i>, impairment is determined when estimated
future undiscounted cash flows associated with an asset are less than asset&#8217;s carrying value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000668" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zXuSjj2WQo4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intangible
Assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s intangible assets consist of brand names and goodwill. At June 30, 2024 and 2023, the Company had brand names and goodwill
with costs of approximately $<span id="xdx_906_ecustom--BrandNames_iI_c20240630_zQDuWHJcvyq8" title="Brand names cost"><span id="xdx_907_ecustom--BrandNames_iI_c20230630_zsW6SEMq3DCj" title="Brand names cost"><ix:nonFraction name="FTEL:BrandNames" contextRef="AsOf2024-06-30" id="Fact000670" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="FTEL:BrandNames" contextRef="AsOf2023-06-30" id="Fact000672" format="ixt:numdotdecimal" decimals="0" unitRef="USD">337,504</ix:nonFraction></ix:nonFraction></span></span> and $<span id="xdx_900_eus-gaap--Goodwill_iI_c20240630_zvu9LfTRBLgb" title="Goodwill"><span id="xdx_909_eus-gaap--Goodwill_iI_c20230630_zTZLYCKQT3A3" title="Goodwill"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-06-30" id="Fact000674" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-06-30" id="Fact000676" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,161,052</ix:nonFraction></ix:nonFraction></span></span> respectively, which all have indefinite lives. The Company evaluates intangible assets
with indefinite lives for impairment at least annually or when events or changes in circumstances indicate that an impairment may exist.
The Company determined that <span id="xdx_909_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20230701__20240630_zx5XQfHmgU0d" title="Impairment of intangible assets"><span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20220701__20230630_zNR1ESCIpFCh" title="Impairment of intangible assets"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2023-07-01to2024-06-30" id="Fact000678" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2022-07-012023-06-30" id="Fact000680" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">none</ix:nonFraction></ix:nonFraction></span></span> of its intangible assets were impaired in the fiscal years ended June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000682" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zgdajUijfRM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Net
Income (Loss) Per Common Share</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes income (loss) per common share in accordance with ASC Topic 260, <i>Earnings Per Share, </i>which requires dual presentation
of basic and diluted earnings per share. Basic income or loss per common share is computed by dividing net income or loss by the weighted
average number of common shares outstanding during the period. Diluted income or loss per common share is computed by dividing net income
or loss by the weighted average number of common shares outstanding, plus the issuance of common shares, if dilutive, that could result
from the exercise of outstanding stock options and warrants. <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230701__20240630_zXOaFnm78TS" title="Potential dilutive common shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-07-01to2024-06-30" id="Fact000684" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">No</ix:nonFraction></span> potential dilutive common shares are included in the computation of any
diluted per share amount when a loss is reported.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000686" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z48yciGiVuoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comprehensive
Income (loss)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 220, <i>Comprehensive Income</i>, establishes standards for reporting comprehensive income (loss) and its components.
Comprehensive income or loss is defined as the change in equity during a period from transactions and other events from non-owner
sources. The component of comprehensive loss totaling $<span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20230701__20240630_zpfmdYobXYii" title="Foreign currency translation adjustment"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-07-01to2024-06-30" id="Fact000688" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,673</ix:nonFraction></span>
and $<span id="xdx_900_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20220701__20230630_zPWTqaR0gQb9" title="Foreign currency translation adjustment"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-07-012023-06-30" id="Fact000690" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,063</ix:nonFraction></span>
for the years ended June 30, 2024 and 2023, respectively, related to foreign currency translation adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000692" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zbFHXOWfguFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
Currencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determined that its functional currency is the Australian dollar since the Australian dollar is the currency of the environment
in which the Company primarily generates and expends cash; however, the Company&#8217;s reporting currency is the U.S. dollar. Foreign
currency transaction gains and losses represent gains and losses resulting from transactions entered into in a currency other than the
functional currency of the Company. These transaction gains and losses, if any, are included in results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000694" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_z1M4V5P1r2lh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for leases in accordance with ASC Topic 842, <i>Lease</i>. Operating lease right-of-use assets represents the right
to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum
lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental
borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense
for minimum lease payments is amortized on a straight-line basis over the lease term and is presented on the consolidated statements
of operations and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
permitted under ASC Topic 842, the Company has made an accounting policy election not to apply the lease recognition provision to short
term leases (leases with a lease term of 12 months or less that do not include an option to purchase the underlying asset that the lessee
is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis
over the lease term. The Company did <span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20230701__20240630_z2aGYYDPEWQj" title="Short-term leases"><span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20220701__20230630_znwvMIWi5Udb" title="Short-term leases"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2023-07-01to2024-06-30" id="Fact000696" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2022-07-012023-06-30" id="Fact000698" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span>t have any short-term leases at June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000700" name="us-gaap:DebtPolicyTextBlock"><p id="xdx_841_eus-gaap--DebtPolicyTextBlock_zY9ye2PWHI03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Convertible
notes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for convertible notes deemed conventional and conversion options embedded in non-conventional convertible notes which
qualify as equity under Accounting Standards Update No. 2020-06, <i>Debt-Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts
in an Entity&#8217;s Own Equity </i>(&#8220;ASU 2020-06&#8221;), which simplifies the accounting for certain financial instruments with
characteristics of liabilities and equity, including certain convertible instruments and contracts on an entity&#8217;s own equity. ASU
2020-06 removes the separation models required for convertible debt with cash conversion features and convertible instruments with beneficial
conversion features. It also removes certain settlement conditions that were required for equity for equity contracts to qualify for
the derivative scope exception and simplifies the diluted earnings per share calculation for convertible instruments. Accordingly, the
underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt
discounts under these arrangements are amortized over the term of the related debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000702" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zJvY2BiWmNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Warrants</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the warrants under ASC 815, <i>Derivatives and Hedging </i>(&#8220;ASC 815&#8221;), and determined that they did not
require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair values,
by using the Black-Scholes model when the warrants are granted. During the fiscal year June 30, 2024, the Company has issued <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zsX6QLjzmDP7" title="Issued warrants, net basis"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_WarrantOneMember" id="Fact000704" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,000</ix:nonFraction></span>
warrants on a net basis, and <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zYjkHZxiOdla" title="Number of warrant issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_WarrantTwoMember" id="Fact000706" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,645,455</ix:nonFraction></span> warrants, respectively, to the IPO underwriter and the Convertible Notes noteholder. All of the
warrants were fully converted into shares during the fiscal year June 30, 2024. They were all converted based on cashless basis and have
been converted into <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zoW9zluA01dd" title="Converted warrant"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-07-012024-06-30_custom_WarrantOneMember" id="Fact000708" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,750</ix:nonFraction></span> shares and <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zvlj1x6bVhI9" title=" Warrant converted into share"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-07-012024-06-30_custom_WarrantTwoMember" id="Fact000710" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,892,727</ix:nonFraction></span> shares respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000712" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zR89hiLUuXQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent
Accounting Pronouncements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on
the consolidated financial statements, and the Company does not believe that there are any other new accounting pronouncements that have
been issued that might have a material impact on its financial position or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000714" name="FTEL:GoingConcernPolicyTextBlock"><p id="xdx_849_ecustom--GoingConcernPolicyTextBlock_zhhzDz1h17we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Going
Concern</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will be able to continue
trading, realise its assets and discharge its liabilities in the ordinary course of business for a period of at least 12 months from
the date that these consolidated financial statements are approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Directors note that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group made a loss of $<span id="xdx_90D_eus-gaap--NetIncomeLoss_iN_di_c20230701__20240630_z7PwMAYZxsXc" title="Net income loss"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2024-06-30" id="Fact000716" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,312,145</ix:nonFraction></span> from its continuing operations for the year ended June 30,
                                            2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group held cash and cash equivalents of $<span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240630_zkfAI461Ib04" title="Cash and cash equivalents"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-06-30" id="Fact000718" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,014</ix:nonFraction></span> as at June 30, 2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group incurred a net cash outflow from operating activities of $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230701__20240630_zLb6uYGVooMi" title="Net cash outflow from operating activities"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-01to2024-06-30" id="Fact000720" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,253,539</ix:nonFraction></span> for the year ended
                                            June 30, 2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            successful capital raising (IPO) in August 2023 arose for $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230701__20240630_zlZzxonGwjXl" title="Issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-07-01to2024-06-30" id="Fact000722" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,614,983</ix:nonFraction></span> before cost of capital.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the appropriateness of using the going concern assumption, the Directors have noted:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                            are reasonable grounds to believe that the Company will be able to continue as a going concern
                                            as the Directors are satisfied that the Company will be able to either secure additional
                                            working capital as required through raising additional capital or reducing the Company&#8217;s
                                            discretionary spending;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
                                            the directors consider it appropriate to prepare the consolidated financial statements on
                                            a going concern basis.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whilst
the Directors remain confident in the Company&#8217;s ability to access further working capital through debt, equity or asset sales if
required, there remains material uncertainty as to whether the Company will continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Had
the going concern basis not been used, adjustments would need to be made relating to the recoverability and classification of certain
assets, and the classification and measurement of certain liabilities to reflect the fact that the Company may be required to realize
its assets and settle its liabilities other than in the ordinary course of business, and at amounts different from those stated in the
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000724" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zbrWAtnQg7G6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Subsequent
Events</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC Topic 855, <i>Subsequent Events</i>, the Companies evaluated subsequent events through November 15, 2024; the date
the consolidated financial statements were available for issue.</span></p>

</ix:nonNumeric><p id="xdx_856_z3baOFxSydR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000726" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"><p id="xdx_804_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zCBTKM8mtRO8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zjvSkQHccGqd">Investment in marketable securities</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000728" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zqY8JaNkrKC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and 2023, the Company held some equity securities which are publicly traded on registered Stock Exchanges. The equity
securities being held as of June 30, 2024 and 2023 were valued at $<span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zezLm7sdIfYg" title="Investment in marketable securities" class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember" id="Fact000730" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,963</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zKVFPp2jUcUb" title="Investment in marketable securities" class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember" id="Fact000732" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,275</ix:nonFraction></span> respectively. The following tables classify the
Company&#8217;s assets measured at fair value on a recurring basis into the fair value hierarchy: &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zMdqkMGft4kb" style="display: none">Schedule of Assets Measured at Fair Value on Recurring Basis</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at June 30, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Description</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-bottom: 1pt">Equity securities</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvEZtKuJ1H27" title="Total" style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000734" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,963</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmI1RvqnzPB1" title="Total" style="border-bottom: Black 1pt solid; width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0736">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zznqeo8Bp622" title="Total" style="border-bottom: Black 1pt solid; width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0738">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zl2egzj8G3o6" title="Total" style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000740" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,963</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zX4kmtQFuCll" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000742" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,963</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z42YydfQ2lWj" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zULrCbRv5hmf" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zx8xID1OKiW8" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2024-06-30_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000748" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,963</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at June 30, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Description</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-bottom: 1pt">Equity securities</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCJCRnZ51lJ7" title="Total" style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000750" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,275</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z6aMo0MjMy11" title="Total" style="border-bottom: Black 1pt solid; width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpKBE11yQZ13" title="Total" style="border-bottom: Black 1pt solid; width: 11%; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUQNdFTbPEu9" title="Total" style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000756" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,275</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxo1oTN8VFhc" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000758" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,275</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmWgqANFnVDb" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOCB5xLwsLk" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0762">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGrwJk02w4Sk" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-06-30_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000764" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,275</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zneESdwv62Ek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000766" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zm9ee2n0XjT1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_zkdW9q8AuNz2">Convertible Notes</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2024, the Company issued Convertible Notes with a principal amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_znKMHBt1Xpyb" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember" id="Fact000768" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,600,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
with an <span id="xdx_90A_ecustom--OriginalIssueDiscountPercentage_iI_dp_uPure_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zQRUZduzdTnb" title="Original issue discount"><ix:nonFraction name="FTEL:OriginalIssueDiscountPercentage" contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember" id="Fact000770" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
original issue discount (&#8220;OID&#8221;) for a total funding amount of $<span id="xdx_901_eus-gaap--ConvertibleDebt_iI_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zXEkdbkrkDWh" title="Convertible debt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember" id="Fact000772" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,312,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
notes bear interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zFzM9x8DUYB" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember" id="Fact000774" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per annum and a maturity date of <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20240115__20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zOLIETcCFTHa" title="Maturity date description"><ix:nonNumeric contextRef="From2024-01-152024-01-15_custom_ConvertibleNotesMember" id="Fact000776" name="us-gaap:DebtInstrumentMaturityDateDescription">36
months</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The noteholder was given the right to
convert all or any amount of the principal face amount into the ordinary shares of the Company at a conversion price based on the lowest
closing price of the Company&#8217;s ordinary shares as reported on the Nasdaq Capital Market during the five (5) trading days immediately
preceding the date of conversion, provided, however that conversion price shall not be lower than $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240115_zdDMn6p2lj28" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-01-15" id="Fact000778" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.80</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. In addition to the Convertible Notes,
the note holder received an aggregate <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240115__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zIAwVzt5BTGf" title="Warrant outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-01-15_custom_WarrantTwoMember_custom_ConvertibleNotesMember" id="Fact000780" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,645,455</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants. The warrants have an exercise price
of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240115__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zLEfbJG5WBri" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-01-15_custom_WarrantTwoMember_custom_ConvertibleNotesMember" id="Fact000782" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.056</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share which represents <span id="xdx_900_ecustom--WarrantSharePricePercentage_iI_pid_dp_c20240115__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z6AWQIzHVd21" title="Warrant share price percentage"><ix:nonFraction name="FTEL:WarrantSharePricePercentage" contextRef="AsOf2024-01-15_custom_WarrantTwoMember_custom_ConvertibleNotesMember" id="Fact000784" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">120</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the share price on the Nasdaq Capital Market as of the issue date, and have a <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zVHahspFGcEi" title="Warrants exercise term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0786">five</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-year
exercise term. The noteholder has paid the Company $<span id="xdx_901_ecustom--ProceedsFromIssuanceOfConvertibleNotes_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zLMqq3Bgjqbk" title="Proceeds from issuance of convertible notes"><ix:nonFraction name="FTEL:ProceedsFromIssuanceOfConvertibleNotes" contextRef="From2023-07-012024-06-30_custom_ConvertibleNotesMember" id="Fact000788" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,840,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of June 30, 2024, thus there was a capital
receivable of $<span id="xdx_90C_ecustom--CapitalReceivablesOfConvertibleNotes_iI_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z9LxUNPe6Io6" title="Capital receivables of convertible notes"><ix:nonFraction name="FTEL:CapitalReceivablesOfConvertibleNotes" contextRef="AsOf2024-06-30_custom_ConvertibleNotesMember" id="Fact000790" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,472,000</ix:nonFraction></span> as of June 30, 2024.</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This capital receivable has been fully settled subsequent to
June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has used the Black Scholes model to evaluate the fair value of the aforesaid warrants attached to the Convertible Notes at $<span id="xdx_909_ecustom--ConvertibleNotes_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z2qcEdn5Ya96" title="Convertible note"><ix:nonFraction name="FTEL:ConvertibleNotes" contextRef="From2023-07-012024-06-30_custom_ConvertibleNotesMember" id="Fact000792" format="ixt:numdotdecimal" decimals="0" unitRef="USD">820,088</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in total. These Convertible Notes were fully
converted into shares during the fiscal year ended June 30, 2024, on cashless basis and converted into <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z2TpbdcLcz06" title="Shares issued upon note conversion"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2023-07-012024-06-30_custom_ConvertibleNotesMember" id="Fact000794" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,090,909</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares, at which time the discount was fully amortized, which totaled $<span id="xdx_903_eus-gaap--AmortizationOfDebtDiscountPremium_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_ze0Q8wOzMNta" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-07-012024-06-30_custom_ConvertibleNotesMember" id="Fact000796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,108,088</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000798" name="FTEL:WarrantsDisclosureTextBlock"><p id="xdx_805_ecustom--WarrantsDisclosureTextBlock_zmVxCWWCRghf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_822_z3tRHah10IQ5">Warrants</span></span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year June 30, 2024, the Company has issued <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zFzMRREJ7DL4" title="Warrants issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_WarrantOneMember" id="Fact000800" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,000</ix:nonFraction></span> warrants on a net basis, and <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zS8Wyyhl13Hb" title="Warrants issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30_custom_WarrantTwoMember" id="Fact000802" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,645,455</ix:nonFraction></span> warrants, respectively, to the IPO
underwriter and the Convertible Notes noteholder. All of the warrants were fully converted into shares during the fiscal year June 30,
2024. They were all converted based on cashless basis, and converted into <span id="xdx_90E_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zPWc1yCK3acc" title="Warrants converted into shares"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-07-012024-06-30_custom_WarrantOneMember" id="Fact000804" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,750</ix:nonFraction></span> shares and <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zGmDUZXbawL8" title="Warrants converted into shares"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-07-012024-06-30_custom_WarrantTwoMember" id="Fact000806" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,892,727</ix:nonFraction></span> shares respectively. The warrants
are detailed as follows:</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000808" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z27Osr7LE71i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zVeEWUeTc6l9" style="display: none">Schedule
of Warrants</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Contractual Term (in years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Outstanding as June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl7LbqMSYDBl" title="Number of warrants, Outstanding, Beginning Balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7iYr2Sl25F5" title="Weighted-Average Exercise Price, Outstanding, Beginning Balance" style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%">Granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMFmN1Ae01D7" title="Number of warrants, Granted" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953" id="Fact000814" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,675,455</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrGzWlSoHkLj" title="Weighted-Average Exercise Price, Granted" style="width: 12%; text-align: right"><ix:nonFraction name="FTEL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953" id="Fact000816" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1.08</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zy8FrtL4KYZ9" title="Weighted Average Contractual Term (in years), Granted"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953" format="ixt-sec:duryear" id="Fact000818" name="FTEL:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm">5.0</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuzWMVOUjIBa" title="Number of warrants, Exercised" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953" id="Fact000820" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">5,675,455</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zx317BbuXLOa" title="Weighted-Average Exercise Price, Exercised" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0822">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Outstanding as June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zY0JujF3k1D5" title="Number of warrants, Ouststanding, Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0824">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6tdc1iFjq66" title="Weighted-Average Exercise Price, Outstanding, Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0826">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left"/><td style="text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zPWifVD66gG6" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each warrant on the date of grant is estimated using the Black-Scholes option valuation model. The following weighted-average
assumptions were used for warrants granted during the year ended June 30, 2024: exercise price of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zFNJOtl4CUZ1" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2024-06-30_us-gaap_WarrantMember" id="Fact000828" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.0560</ix:nonFraction></span>, expected term of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUSa7VKLlzz" title="Expected term"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" format="ixt-sec:durwordsen" id="Fact000830" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">five years</ix:nonNumeric></span>,
expected average volatility of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zJrEWFFzH767" title="Expected average volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="Fact000832" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27.76</ix:nonFraction></span>%, <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dpo_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zbjdeboQpQd8" title="Expected dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="Fact000834" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Pure">no</ix:nonFraction></span> expected dividend yield, and risk-free interest rate of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPgigwPqsDHi" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember" id="Fact000836" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.84</ix:nonFraction></span>%.</span></p>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000838" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_807_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zHS2Hmq9Y6Fi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zIE8ajkraa5">Note Receivables</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 2, 2023, the Company has entered into a loan agreement with an independent third party (&#8220;Borrower&#8221;), in which,
the Company has lent $<span id="xdx_905_eus-gaap--OtherReceivablesNetCurrent_iI_c20230802_z2XCsHGQC3vd" title="Loan lended amount"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2023-08-02" id="Fact000840" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,500,000</ix:nonFraction></span>
to the Borrower, with a loan period of <span id="xdx_90F_eus-gaap--DebtInstrumentTerm_dtM_c20230802__20230802_zB6ESpLjNT27" title="Loan period"><ix:nonNumeric contextRef="From2023-08-022023-08-02" format="ixt-sec:durmonth" id="Fact000842" name="us-gaap:DebtInstrumentTerm">36</ix:nonNumeric></span>
months, and at an annualized interest of <span id="xdx_909_ecustom--DebtInstrumentIncreaseAccruedInterestPercentage_dp_uPure_c20230802__20230802_zedRkryPdsr4" title="Annualized interest"><ix:nonFraction name="FTEL:DebtInstrumentIncreaseAccruedInterestPercentage" contextRef="From2023-08-022023-08-02" id="Fact000844" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.8</ix:nonFraction></span>%,
with the first eight months being interest-free. The Company has the option to convert this loan into equity of the Borrower. As of
June 30, 2024, the total balance outstanding was $<span id="xdx_905_eus-gaap--NotesAndLoansReceivableNetCurrent_iI_c20240630_zepvfZRjmC43" title="Note receivable outstanding"><ix:nonFraction name="us-gaap:NotesAndLoansReceivableNetCurrent" contextRef="AsOf2024-06-30" id="Fact000846" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,500,000</ix:nonFraction></span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000848" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zk27CUEGmah7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zjEgIF49u6Y6">Property and Equipment</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000850" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zkHrHygNCJSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s property and equipment at June 30, 2024 and 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zX0BPzo7oCg7" style="display: none">Schedule
of Property and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240630_zqPzPufjjqea" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20230630_zz8st7gQp3n" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zyKeB7OeBCee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; text-align: left; padding-bottom: 1pt">Motor Vehicle</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 14%; text-align: center; padding-bottom: 1pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zIl6FYmYshe5" title="Estimated Useful Life"><ix:nonNumeric contextRef="AsOf2024-06-30_us-gaap_VehiclesMember" format="ixt-sec:duryear" id="Fact000855" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_us-gaap_VehiclesMember" id="Fact000852" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,741</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_VehiclesMember" id="Fact000853" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,741</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzbdW_zdSzExPJk0yl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property and equipment, gross</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30" id="Fact000857" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,741</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30" id="Fact000858" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,741</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzbdW_zyTLiZfNDHbd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-06-30" id="Fact000860" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,608</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-06-30" id="Fact000861" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,998</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzbdW_zI877cMqrynh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30" id="Fact000863" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,133</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30" id="Fact000864" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,743</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A1_zyCQ6dy5ARHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended June 30, 2024 and 2023, the Company recorded $<span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20230701__20240630_z5zGcv8hzGb4" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-07-01to2024-06-30" id="Fact000866" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,385</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20220701__20230630_zuI1tqfzbwOd" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-07-012023-06-30" id="Fact000868" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,268</ix:nonFraction></span>, respectively, of depreciation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000870" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_zOkYJXgVjthf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_zoQ0pznev3M3">Lease right-of-use assets and lease liabilities</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
leases</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases office space in Taren Point, NSW, Australia. The lease commenced July 15, 2018 and ended on July 14, 2023, at which time
the Company extended the lease, which commenced on July 15, 2023 and ends on July 14, 2026. The initial monthly lease
payments are $<span id="xdx_900_eus-gaap--OperatingLeasePayments_uAUD_c20230701__20240630_zn94Q1PViOBa" title="Operating lease payments"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2023-07-01to2024-06-30" id="Fact000872" format="ixt:numdotdecimal" decimals="0" unitRef="AUD">25,000</ix:nonFraction></span> AUD and the monthly payments of the lease extension are $<span id="xdx_90E_eus-gaap--OperatingLeasePaymentsUse_uAUD_c20230701__20240630_z2Us7J2ANlQ2" title="Operating lease payments"><ix:nonFraction name="us-gaap:OperatingLeasePaymentsUse" contextRef="From2023-07-01to2024-06-30" id="Fact000874" format="ixt:numdotdecimal" decimals="0" unitRef="AUD">36,667</ix:nonFraction></span> AUD and are subject to annual escalation
rate of <span id="xdx_907_ecustom--AnnualEscalationRate_pid_dp_uPure_c20230701__20240630_zygwthcABA0f" title="Annual escalation rate"><ix:nonFraction name="FTEL:AnnualEscalationRate" contextRef="From2023-07-01to2024-06-30" id="Fact000876" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease right-of-use assets and liabilities are recognized at the present value of the future lease payments at the lease commencement
date. The interest rate used to determine the present value is the Company&#8217;s incremental borrowing rate, estimated to be <span id="xdx_90A_ecustom--IncrementalBorrowingRate_pid_dp_uPure_c20230701__20240630_zHqQq9xmdfLd" title="Incremental borrowing rate"><ix:nonFraction name="FTEL:IncrementalBorrowingRate" contextRef="From2023-07-01to2024-06-30" id="Fact000878" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.70</ix:nonFraction></span>%,
as the interest rate implicit in most of the Company leases is not readily determinable. Operating lease expense is recognized on a straight-line
basis over the lease term. During the years ended June 30, 2024 and 2023, the Company recorded $<span id="xdx_908_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zZTygI2sILZ3" title="Operating lease expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-07-01to2024-06-30" id="Fact000880" format="ixt:numdotdecimal" decimals="0" unitRef="USD">284,169</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--OperatingLeaseExpense_c20220701__20230630_zIS3dwhNf36" title="Operating lease expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2022-07-012023-06-30" id="Fact000882" format="ixt:numdotdecimal" decimals="0" unitRef="USD">198,914</ix:nonFraction></span>, respectively, as
operating lease expense on the consolidated statements of operations and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000884" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_899_eus-gaap--LeaseCostTableTextBlock_z7diGR7hWIqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
right-of- use assets are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zbSyHoMEwi66" style="display: none">Schedule
of Operating Right of use Assets and Operating Lease Liabilities</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240630_z8WknsJvSLz8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230630_zfuq8aTlSJce" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RightOfUseAssetsForOfficeLease_iI_zhiqXCzHStIc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Office lease</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="FTEL:RightOfUseAssetsForOfficeLease" contextRef="AsOf2024-06-30" id="Fact000886" format="ixt:numdotdecimal" decimals="0" unitRef="USD">836,697</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="FTEL:RightOfUseAssetsForOfficeLease" contextRef="AsOf2023-06-30" id="Fact000887" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,541,390</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AdjustmentForAmortizations_iI_zsJX6Wbr891f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FTEL:AdjustmentForAmortizations" contextRef="AsOf2024-06-30" id="Fact000889" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">278,899</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FTEL:AdjustmentForAmortizations" contextRef="AsOf2023-06-30" id="Fact000890" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">935,596</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zESJ0dHRni16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Right-of-use, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000892" format="ixt:numdotdecimal" decimals="0" unitRef="USD">557,798</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" id="Fact000893" format="ixt:numdotdecimal" decimals="0" unitRef="USD">605,794</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    lease liabilities are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zacSsWYNQJv9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230630_zNZO6lj9hDr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zC0qo7YHYdE6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--OperatingLeaseLiabilityForOfficeLease_i01I_zCsMAC5wtQCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Office lease</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="FTEL:OperatingLeaseLiabilityForOfficeLease" contextRef="AsOf2024-06-30" id="Fact000898" format="ixt:numdotdecimal" decimals="0" unitRef="USD">580,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="FTEL:OperatingLeaseLiabilityForOfficeLease" contextRef="AsOf2023-06-30" id="Fact000899" format="ixt:numdotdecimal" decimals="0" unitRef="USD">685,077</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_z5sJvuQBVZEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000901" format="ixt:numdotdecimal" decimals="0" unitRef="USD">278,432</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" id="Fact000902" format="ixt:numdotdecimal" decimals="0" unitRef="USD">212,062</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_z973UiSt0dl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000904" format="ixt:numdotdecimal" decimals="0" unitRef="USD">301,921</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" id="Fact000905" format="ixt:numdotdecimal" decimals="0" unitRef="USD">473,015</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zec8Dg8mIGBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000907" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zO1BmhNRgKLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zcaODomHCCHh">Schedule of Maturity of Operating Lease Liabilities</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zoRlLsgTAAH4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzYvG_zlDHNGCMXp5k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Year ending June 30, 2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2024-06-30" id="Fact000909" format="ixt:numdotdecimal" decimals="0" unitRef="USD">301,127</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzYvG_z5SoOw7qQHQd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Year ending June 30, 2026</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2024-06-30" id="Fact000911" format="ixt:numdotdecimal" decimals="0" unitRef="USD">310,160</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzYvG_z044FjJ7QmHd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-06-30" id="Fact000913" format="ixt:numdotdecimal" decimals="0" unitRef="USD">611,287</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zV7QKS0QdEFb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2024-06-30" id="Fact000915" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,934</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseLiability_iTI_zwPZuivlSuua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">PV of Payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-06-30" id="Fact000917" format="ixt:numdotdecimal" decimals="0" unitRef="USD">580,353</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zKEgMofct5Pl" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000919" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z0RBL5Jms2u6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_825_zRpEOWSw6TSi">Commitments and contingencies</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates
the merits of the case in accordance with ASC 450-20-50, <i>Contingencies</i>. The Company evaluates its exposure to the matter, possible
legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is
probable and can be reasonably estimated, it establishes the necessary accruals. As of June 30, 2024 and 2023, the Company is not aware
of any contingent liabilities that should be reflected in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000921" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_805_eus-gaap--IncomeTaxDisclosureTextBlock_zwZTE5NCS7La" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_820_zDSmsY44uTFj">Income taxes</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000923" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zY8kUMKyxBC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the effective tax rate to the statutory rate is shown below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B9_zey4Pai7f8cb" style="display: none">Schedule of Reconciliation of Provision of Income Tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230701__20240630_zs18L6nifvxg" style="border-bottom: Black 1pt solid; text-align: right">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220701__20230630_z9A0mcQEcnh1" style="border-bottom: Black 1pt solid; text-align: right">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z8aJc3TVMtM5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 1pt">Loss before taxes</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-01to2024-06-30" id="Fact000925" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,521,488</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-012023-06-30" id="Fact000926" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,619,155</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsTax_znaiwqsugeAa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Expected income tax credit at statutory rate of <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230701__20240630_zCHlPT3bxFlc" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" title="Expected income tax credit at statutory rate, percent"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-07-01to2024-06-30" id="Fact000931" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>% <br/>(2023: <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20220701__20230630_zhpj2PjROZSe" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" title="Expected income tax credit at statutory rate, percent"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-07-012023-06-30" id="Fact000933" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>%)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" contextRef="From2023-07-01to2024-06-30" id="Fact000928" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,380,372</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" contextRef="From2022-07-012023-06-30" id="Fact000929" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">404,789</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Increase (decrease) in income taxes resulting from:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_zEwqseE5qKti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" contextRef="From2022-07-012023-06-30" id="Fact000936" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses_zFiKXX8cI9Mj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">IPO related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000938" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,622</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" contextRef="From2022-07-012023-06-30" id="Fact000939" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,601</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt_z2b5pX2Pwvpc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Provision for bad debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" contextRef="From2023-07-01to2024-06-30" id="Fact000941" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,816</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" contextRef="From2022-07-012023-06-30" id="Fact000942" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,742</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_zkN7g8795bXi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Unrealized loss on investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" contextRef="From2023-07-01to2024-06-30" id="Fact000944" format="ixt:numdotdecimal" decimals="0" unitRef="USD">88,695</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" contextRef="From2022-07-012023-06-30" id="Fact000945" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,613</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost_zqGc2MhZLRkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Government Subsidy Tech Boost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" contextRef="From2022-07-012023-06-30" id="Fact000948" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,721</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxReconciliationNondeductibleExpenseDebtDiscount_zoabnxNW9Vf7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseDebtDiscount" contextRef="From2023-07-01to2024-06-30" id="Fact000950" format="ixt:numdotdecimal" decimals="0" unitRef="USD">277,022</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0951">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome_zUN0f0fzz93g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-taxable other income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" contextRef="From2023-07-01to2024-06-30" id="Fact000953" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,472</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses_zAUheZ3dBiwl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">-Non-tax deductible personnel expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000956" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,544</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0957">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees_zdlrPyauni4l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-tax deductible consulting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" contextRef="From2023-07-01to2024-06-30" id="Fact000959" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,367,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses_zeko93dyfLca" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Non-tax deductible general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" contextRef="From2023-07-01to2024-06-30" id="Fact000962" format="ixt:numdotdecimal" decimals="0" unitRef="USD">308,512</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0963">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxContingenciesOther_z1RkZtK6PVX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other items, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxContingenciesOther" contextRef="From2023-07-01to2024-06-30" id="Fact000965" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">26,742</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxContingenciesOther" contextRef="From2022-07-012023-06-30" id="Fact000966" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,207</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_zr01HQ1Q6xod" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-01to2024-06-30" id="Fact000968" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">209,343</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-012023-06-30" id="Fact000969" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,761</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zUbbi7ykRf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000971" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zWQcrDJeQtec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax effects temporary differences that gave rise to the deferred tax assets and liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_zXR1LzmgNvx9" style="display: none">Schedule of Components of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20240630_zKpglvizraSe" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230630_z0HpqOiPyBca" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_zCC5nGc12gLj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Accrued employee benefits</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" contextRef="AsOf2024-06-30" id="Fact000973" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,199</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" contextRef="AsOf2023-06-30" id="Fact000974" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,877</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_iI_zxktZAdYfdY9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized loss on investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0976">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" contextRef="AsOf2023-06-30" id="Fact000977" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,082</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--DeferredTaxAssetsUnrealizedCurrencyGain_iNI_di_zNMV84rbgKPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Unrealized foreign exchange gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:DeferredTaxAssetsUnrealizedCurrencyGain" contextRef="AsOf2024-06-30" id="Fact000979" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,294</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:DeferredTaxAssetsUnrealizedCurrencyGain" contextRef="AsOf2023-06-30" id="Fact000980" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,394</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--DeferredTaxAssetsDepreciation_zO7prOH2xZ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="FTEL:DeferredTaxAssetsDepreciation" contextRef="AsOf2024-06-30" id="Fact000982" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,783</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:DeferredTaxAssetsDepreciation" contextRef="AsOf2023-06-30" id="Fact000983" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,049</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities_iI_zryj0QXs4Yve" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating right of use assets and lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" contextRef="AsOf2024-06-30" id="Fact000985" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,639</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0986">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsAccumulatedTaxLoss_iI_zTPtHKunWhQ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated tax loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="FTEL:DeferredTaxAssetsAccumulatedTaxLoss" contextRef="AsOf2024-06-30" id="Fact000988" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,989</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0989">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zUsJv7Ux7es6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Provision for bad debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2024-06-30" id="Fact000991" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,784</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2023-06-30" id="Fact000992" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,740</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iI_zwnXuUX1CPyj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-06-30" id="Fact000994" format="ixt:numdotdecimal" decimals="0" unitRef="USD">342,122</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-06-30" id="Fact000995" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,354</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zEHt4BY2O99a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and 2023, the Company had no material net operating loss or tax credit carryforwards. As of June 30, 2024 and 2023,
the Company had no provision for uncertain tax positions and no provisions for penalties or interest. In addition, the Company does not
believe that there are any uncertain tax benefits that could be recognized in the near future that would impact the Company&#8217;s effective
tax rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2024-06-30" escape="true" id="Fact000997" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zCgMXinV4fo5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zlEzodukS974">Due to Related Party Transactions</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount due to a related party called Ansa Group Limited (&#8220;Ansa&#8221;), an entity under common control of the majority shareholder
of the Company was $<span id="xdx_90D_eus-gaap--OtherLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zclZIcclJq73"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember" id="Fact000998" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,808</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--OtherLiabilitiesCurrent_iI_c20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zJBYRoZ8bM87" title="Amount due to related party"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-06-30_us-gaap_RelatedPartyMember" id="Fact001000" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,386</ix:nonFraction></span> as at June 30, 2024 and 2023 respectively. The balance is interest-free and does not have a fixed
maturity. The terms are not necessarily indicative of what a third party would agree to.</span></p>

</ix:nonNumeric><p id="xdx_816_zjZLJuZKV54j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 91; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.2
<SEQUENCE>2
<FILENAME>ex11-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
11.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Insider
Trading Compliance Manual</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fitell
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adopted
[&#9679;], 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to take on an active role in the prevention of insider trading violations by its officers, directors, employees, consultants, advisors,
and other related individuals, the Board of Directors (the &ldquo;<B>Board</B>&rdquo;) of Fitell Corporation, an exempted company organized
under the laws of the Cayman Islands (the &ldquo;<B>Company</B>&rdquo;), has adopted the policies and procedures described in this Insider
Trading Compliance Manual.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.
<U>Adoption of Insider Trading Policy</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of the date written above, the Company has adopted the Insider Trading Policy (the &ldquo;<B>Policy</B>&rdquo;), which prohibits trading
based on material, non-public information regarding the Company and its subsidiaries (&ldquo;<B>Inside Information</B>&rdquo;). The Policy
covers all officers and directors of the Company and its subsidiaries, all other employees of the Company and its subsidiaries, all secretaries
and assistants supporting such officers, directors, or employees and consultants or advisors to the Company or its subsidiaries who have
or may have access to Inside Information and members of the immediate family or household of any such person. The Policy (and/or a summary
thereof) is to be delivered to all new officers, directors, employees, consultants, advisors and related individuals who are within the
categories of covered persons upon the commencement of their relationships with the Company, and is to be circulated to all covered personnel
at least annually.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II.
<U>Designation of Certain Persons</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.
<U>Insiders</U></B> Section 16 of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), prohibits
&ldquo;short-swing&rdquo; profits by all directors and executive officers of the Company, and any direct or indirect beneficial owner
of 10% or more of any of the Company&rsquo;s equity security of any class (collectively, the &ldquo;<B>Insiders</B>&rdquo;) and such
Insiders, in addition to any beneficial owners of 5% or more of the Company&rsquo;s registered securities of any class, are subject to
the reporting and liability provisions of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder (collectively,
the &ldquo;<B>Section 13(d) Individuals</B>&rdquo;). Rule 3a12-3 under the Exchange Act exempts securities registered by a Foreign Private
Issuer, or FPI from Section 16 of the Exchange Act. Accordingly, Section 13(d) Individuals of an FPI are not subject to the short-swing
profit limits set forth in Section 16(b), nor are they required to comply with the Section 16(a) reporting requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Sections 13(d) and 13(g) of the Exchange Act, and the U.S. Securities and Exchange Commission (&ldquo;<B>SEC</B>&rdquo;) related rules,
subject to certain exemptions, any person who after acquiring, directly or indirectly the beneficial ownership of a certain class of
equity securities, becomes, either directly or indirectly, the beneficial owner of more than 5% of such class must deliver a statement
to the issuer of the security and to each exchange where the security is traded. Delivery to each exchange can be satisfied by making
a filing on EDGAR (as defined below). In addition, Section 13(d) Individuals must file with the SEC a statement containing certain information,
as well as any additional information that the SEC may deem necessary or appropriate in the public interest or for the protection of
investors. Attached hereto as <U>Exhibit A</U> is a separate memorandum which discusses the relevant terms of Section 13.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.
<U>Other Persons Subject to Policy</U>.</B> In addition, certain employees, consultants, and advisors of the Company as described in
Section I above have, or are likely to have, from time to time access to Inside Information and together with the Insiders, are subject
to the Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>III.
<U>Appointment of Chief Compliance Officer</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has appointed Jamarson Kong as the Company&rsquo;s Chief Compliance Officer (the &ldquo;<B>Compliance Officer</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IV.
<U>Duties of the Compliance Officer</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compliance Officer has been designated by the Board to handle any and all matters relating to the Company&rsquo;s Insider Trading Compliance
Program. Certain duties may be delegated to outside counsel with special expertise in securities issues and relevant law. The duties
of the Compliance Officer shall include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
Pre-clearing all transactions involving the Company&rsquo;s securities by the Insiders and those individuals having regular access to
Inside Information, defined for these purposes to include all officers, directors, and employees of the Company and its subsidiaries
and members of the immediate family or household of any such person, in order to determine compliance with the Policy, insider trading
laws, Section 13 and Section 16 of the Exchange Act and Rule 144 promulgated under the Securities Act of 1933, as amended. Attached hereto
as <U>Exhibit C</U> is a Pre-Clearance Checklist to assist the Compliance Officer in the performance of his or her duties hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Assisting in the preparation and filing of Section 13(d) reports for all Section 13(d) Individuals although the filings are their individual
obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
Serving as the designated recipient at the Company of copies of reports filed with the SEC by Section 13(d) Individuals under Section
13(d) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
Performing periodic reviews of available materials, which may include Schedule 13D, Schedule 13G, Form 144, officers&rsquo; and directors&rsquo;
questionnaires, as applicable, and reports received from the Company&rsquo;s stock administrator and transfer agent, to determine trading
activity by officers, directors and others who have, or may have, access to Inside Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
Circulating the Policy (and/or a summary thereof) to all covered employees, including the Insiders, on an annual basis, and providing
the Policy and other appropriate materials to new officers, directors and others who have, or may have, access to Inside Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
Assisting the Board in implementing the Policy and Sections I and II of this memorandum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
Coordinating with Company counsel regarding all securities compliance matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
Retaining copies of all appropriate securities reports, and maintaining records of his or her activities as Compliance Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>APPLICABILITY
</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OF POLICY</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy applies to all transactions in the Company&rsquo;s securities, including ordinary shares, options and warrants to purchase ordinary
shares, and any other securities the Company may issue from time to time, such as preferred shares, and convertible debentures, as well
as derivative securities relating to the Company&rsquo;s shares, whether issued by the Company, such as exchange-traded options. It applies
to all officers and directors of the Company, all other employees of the Company and its subsidiaries, all secretaries and assistants
supporting such directors, officers, and employees, and consultants or advisors to the Company or its subsidiaries who have or may have
access to Material Non-public Information (as defined below) regarding the Company and members of the immediate family or household of
any such person. This group of people is sometimes referred to in this Policy as &ldquo;Insiders.&rdquo; This Policy also applies to
any person who receives Material Non-public Information from any Insider.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
person who possesses Material Non-public Information regarding the Company is an Insider for so long as such information is not publicly
known.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITION
OF MATERIAL NON-PUBLIC INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not possible to define all categories of material information. However, information should be regarded as &ldquo;material&rdquo; if
there is a reasonable likelihood that it would be considered important to an investor in making an investment decision regarding the
purchase or sale of the Company&rsquo;s securities. Material information may be positive or negative. &ldquo;Non-public Information&rdquo;
is information that has not been previously disclosed to the general public and is otherwise not available to the general public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
it may be difficult to determine whether any particular information is material, there are various categories of information that are
particularly sensitive and, as a general rule, should always be considered material. Examples of such information may include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    results;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entry
    into a material agreement or discussions regarding entry into a material agreement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Projections
    of future earnings or losses;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
    contract awards, cancellations or write-offs;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint
    ventures or commercial ventures with third parties;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">News
    of a pending or proposed merger or acquisition;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">News
    of the disposition of material assets;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impending
    bankruptcy or financial liquidity problems;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
    or loss of a significant line of credit;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
    breach of a material agreement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    business or services announcements of a significant nature;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    splits;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    equity or debt offerings;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
    litigation exposure due to actual or threatened litigation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in senior management or the Board;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    investment plans; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in dividend policy.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the foregoing categories of information and any similar information should be considered &ldquo;Material Non-public Information&rdquo;
for purposes of this Policy. <B>If there are any questions regarding whether a particular item of information is Material Non-public
Information, please consult the Compliance Officer or the Company&rsquo;s legal counsel before taking any action with respect to such
information.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
III</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTAIN
EXCEPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Policy, the Company considers that the exercise of stock options under the Company&rsquo;s stock option plan (but <U>not
</U>the sale of any such shares) is exempt from this Policy, since the other party to the transaction involving only the Company itself
and the price does not vary with the market but is fixed by the terms of the option agreement or the plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATEMENT
OF POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>General
Policy</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is the policy of the Company to prohibit the unauthorized disclosure of any non-public information acquired in the workplace and the
misuse of Material Non-public Information in securities trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Specific
Policies</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<U>Trading on Material Non-public Information</U>.</B> With certain exceptions, no officer or director of the Company, no employee of
the Company or its subsidiaries and no consultant or advisor to the Company or any of its subsidiaries and no members of the immediate
family or household of any such person, shall engage in any transaction involving a purchase or sale of the Company&rsquo;s securities,
including any offer to purchase or offer to sell, during any period commencing with the date that he or she possesses Material Non-public
Information concerning the Company, and ending at the close of business on the second Trading Day (as defined below) following the date
of public disclosure of that information, or at such time as such non-public information is no longer material. However, see &ldquo;Permitted
Trading Period&rdquo; below for a full discussion of trading pursuant to a pre-established plan or by delegation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used herein, the term &ldquo;Trading Day&rdquo; shall mean a day on which national stock exchanges are open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
<U>Tipping</U>.</B> No Insider shall disclose (&ldquo;<B>tip</B>&rdquo;) Material Non-public Information to any other person (including
family members) where such information may be used by such person to his or her profit by trading in the securities of companies to which
such information relates, nor shall such Insider or related person make recommendations or express opinions on the basis of Material
Non-public Information as to trading in the Company&rsquo;s securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation
FD (Fair Disclosure) (&ldquo;<B>Disclosure Regulation</B>&rdquo;) is an issuer disclosure rule implemented by the SEC that addresses
selective disclosure. The Disclosure Regulation provides that when the Company, or person acting on its behalf, discloses Material Non-public
Information to certain enumerated persons (in general, securities market professionals and holders of the Company&rsquo;s securities
who may well trade on the basis of the information), it must make public disclosure of that information. The timing of the required public
disclosure depends on whether the selective disclosure was intentional or unintentional; for an intentional selective disclosure, the
Company must make public disclosures simultaneously; for a non-intentional disclosure, the Company must make public disclosure promptly.
Under the Disclosure Regulation, the required public disclosure may be made by filing or furnishing a Form 6-K, or by another method
or combination of methods that is reasonably designed to effect broad, non-exclusionary distribution of the information to the public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is the Company&rsquo;s policy that all communications with the press be handled through our Chief Executive Officer (CEO) or investor/public
relations firm. Please refer all press, analyst or similar requests for information to the Company&rsquo;s CEO and do not respond to
any inquiries without prior authorization from the Company&rsquo;s CEO. If the Company&rsquo;s CEO is unavailable, the Company&rsquo;s
Chief Financial Officer will fill this role.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
<U>Confidentiality of Non-public Information</U>.</B> Non-public information relating to the Company is the property of the Company and
the unauthorized disclosure of such information (including, without limitation, via email or by posting on Internet message boards or
blogs, anonymously or otherwise) is strictly forbidden.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
<U>Duty to Report Inappropriate and Irregular Conduct</U>.</B> All employees, and particularly executives, managers and/or supervisors,
have a responsibility for maintaining financial integrity within the Company, and being consistent with generally accepted accounting
principles and both federal and state securities laws. Any employee who becomes aware of any incidents involving financial or accounting
manipulation or irregularities, whether by witnessing the incident or being told of it, must report it to their immediate supervisor
and to the chairman of the Company&rsquo;s Audit Committee of the Board (or to the Chairman of the Board, if an Audit Committee has not
been established). For a more complete understanding of this issue, employees should consult their employee manual and or seek the advice
of the Company&rsquo;s general counsel or outside counsel. Our outside securities counsel is The Crone Law Group, P.C., attention: Liang
Shih, Esq. at (646) 861-7891, email lshih@cronelawgroup.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
V</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>POTENTIAL
CRIMINAL AND CIVIL LIABILITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AND/OR
DISCIPLINARY ACTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<U>Liability for Insider Trading</U>.</B> Insiders may be subject to penalties of up to $5,000,000 and up to twenty (20) years in jail
for engaging in transactions in the Company&rsquo;s securities at a time when they possess Material Non-public Information regarding
the Company, regardless of whether such transactions were profitable. In addition, the SEC has the authority to seek a civil monetary
penalty of up to three times the amount of profit gained or loss avoided by illegal insider trading. &ldquo;Profit gained&rdquo; or &ldquo;loss
avoided&rdquo; generally means the difference between the purchase or sale price of the Company&rsquo;s shares and its value as measured
by the trading price of the shares a reasonable period after public dissemination of the non-public information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
<U>Liability for Tipping</U>.</B> Insiders may also be liable for improper transactions by any person (commonly referred to as a &ldquo;<B>tippee</B>&rdquo;)
to whom they have disclosed Material Non-public Information regarding the Company or to whom they have made recommendations or expressed
opinions on the basis of such information as to trading in the Company&rsquo;s securities. The SEC has imposed large penalties even when
the disclosing person did not profit from the trading. The SEC, the stock exchanges and the Financial Industry Regulatory Authority,
Inc. use sophisticated electronic surveillance techniques to monitor <I>all trades</I> and uncover insider trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
<U>Possible Disciplinary Actions</U>.</B> Individuals subject to the Policy who violate this Policy shall also be subject to disciplinary
action by the Company, which may include suspension, forfeiture of perquisites and ineligibility for future participation in the Company&rsquo;s
equity incentive plans and/or termination of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
VI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PERMITTED
TRADING PERIOD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<U>Black-Out Period and Trading Window</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
ensure compliance with this Policy and applicable federal and state securities laws, the Company requires that all officers, directors,
employees, and all members of the immediate family or household of any such person refrain from conducting any transactions involving
the purchase or sale of the Company&rsquo;s securities, other than during the period in any half year commencing at the close of business
on the second Trading Day following the date of public disclosure of the financial results for the prior interim period or fiscal year
and ending on the twenty-fifth day of the sixth month of the half year (the &ldquo;<B>Trading Window</B>&rdquo;). Notwithstanding the
foregoing, persons subject to this Policy may submit a request to the Company to purchase or sell the Company&rsquo;s securities outside
the Trading Window on the basis that they do not possess any Material Non-public Information. The Compliance Officer shall review all
such requests and may grant such requests on a case-by-case basis if he or she determines that the person making such request does not
possess any Material Non-public Information at that time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
such public disclosure occurs on a Trading Day before the markets close, then such date of disclosure shall be considered the first Trading
Day following such public disclosure. For example, if such public disclosure occurs at 1:00 p.m. EST on June 10, then June 10 shall be
considered the first Trading Day following such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
be advised that these guidelines are merely estimates. The actual trading window may be different because the Company&rsquo;s interim
report or annual report may be filed earlier or later.</B> The filing date of an interim report or annual report may fall on a weekend
or the Company may delay filing an annual report due to an extension. Please check with the Compliance Officer to confirm whether the
trading window is open.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
safest period for trading in the Company&rsquo;s securities, assuming the absence of Material Non-public Information, is generally the
first ten Trading Days of the Trading Window. It is the Company&rsquo;s policy that the period when the Trading Window is &ldquo;closed&rdquo;
is a particularly sensitive period of time for transactions in the Company&rsquo;s securities from the perspective of compliance with
applicable securities laws. This is because the officers, directors and certain other employees are, as any half-year period progresses,
increasingly likely to possess Material Non-public Information about the expected financial results for the period. The purpose of the
Trading Window is to avoid any unlawful or improper transactions or even the appearance of any such transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
should be noted that even during the Trading Window any person possessing Material Non-public Information concerning the Company shall
not engage in any transactions involving the Company&rsquo;s securities until such information has been known publicly for at least two
Trading Days. The Company has adopted the policy of delaying trading for &ldquo;at least two Trading Days&rdquo; because the securities
laws require that the public be informed <U>effectively</U> of previously undisclosed material information before Insiders trade in the
Company&rsquo;s shares. Public disclosure may occur through a widely disseminated press release or through filings, such as Form 6-K,
with the SEC. Furthermore, in order for the public to be effectively informed, the public must be given time to evaluate the information
disclosed by the Company. Although the amount of time necessary for the public to evaluate the information may vary depending on the
complexity of the information, generally two Trading Days is sufficient.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may also require that directors, officers, selected employees, and others suspend trading because of developments
known to the Company and not yet disclosed to the public. In such event, such persons may not engage in any transaction involving the
purchase or sale of the Company&rsquo;s securities during such period and may not disclose to others the fact of such suspension of trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the Company may from time to time require during a Trading Window that directors, officers, selected employees, and others suspend trading
because of developments known to the Company and not yet disclosed to the public, <B><I>each person is individually responsible at all
times for compliance with the prohibitions against insider trading. Trading in the Company&rsquo;s securities during the Trading Window
should <U>not</U> be considered a &ldquo;safe harbor,&rdquo; and all directors, officers and other persons should use good judgment at
all times.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
these general rules, Insiders may trade <U>outside</U> of the Trading Window provided that such trades are made pursuant to a pre-established
plan or by delegation. These alternatives are discussed in the next section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Trading According to a Pre-established Plan or by Delegation.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
which is not &ldquo;on the basis of&rdquo; Material Non-public Information may not give rise to insider trading liability. The SEC has
adopted Rule 10b5-1 under which insider trading liability can be avoided if Insiders follow very specific procedures. In general, such
procedures involve trading according to pre-established instructions (a &ldquo;<B>Pre-established Trade</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-established
Trades must:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)
Be documented by a contract, written plan, or formal instruction which provides that the trade take place in the future.</B> For example,
an Insider can contract to sell his or her shares on a specific date, or simply delegate such decisions to an investment manager, 401(k)
plan administrator or a similar third party. This documentation must be provided to the Compliance Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)
Include in its documentation the specific amount, price and timing of the trade, or the formula for determining the amount, price and
timing.</B> For example, the Insider can buy or sell shares in a specific amount and on a specific date each month, or according to a
pre-established percentage (of the Insider&rsquo;s salary, for example) each time that the share price falls or rises to pre-established
levels. In the case where trading decisions have been delegated, the specific amount, price and timing need <U>not</U> be provided;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)
Include additional representation in its documentation for Directors and Officers.</B> If the person who entered into the pre-established
contract, written plan, or formal instruction (discussed in Section VI.2(a) above) is a director or officer of the Company, such director
or officer shall include a representation certifying that, on the date of adoption of the pre-established contract, plan, or instruction,
(i) he or she is not aware of any material nonpublic information about the Company or its securities, and (ii) he or she is adopting
the pre-established contract, plan, or instruction in good faith and not as part of a plan or scheme to evade prohibitions on inside
trading;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)
Be implemented at a time when the Insider does not possess Material Non-public Information and Upon the Expiration of a Cooling-Off Period.
</B>As a practical matter, this means that the Insider may set up Pre-established Trades, or delegate trading discretion, <U>only</U>
during a &ldquo;Trading Window&rdquo; (discussed in Section VI.1 above); <I>provided that </I>(i) any director or officer of the Company
may not conduct a Pre-established Trade until the expiration of a cooling-off period, consisting of the later of (A) 90 days after the
adoption or modification of the pre-established contract, plan, or instruction, and (B) two business days following the disclosure of
the Company&rsquo;s financial results in a Form 20-F or Form 6-K (but, in any event, this required cooling period is subject to a maximum
of 120 days after adoption of the pre-established contract, plan, or instruction), and (ii) any other persons, who are covered by the
Policy (as discussed in Section I above) and are not directors or officers, may not conduct a Pre-established Trade until the expiration
of a cooling-off period that is 30 days after the adoption of the pre-established contract, plan, or instruction; and,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)
Remain beyond the scope of the Insider&rsquo;s influence after implementation.</B> In general, the Insider must allow the Pre-established
Trade to be executed without changes to the accompanying instructions, and the Insider cannot later execute a hedge transaction that
modifies the effect of the Pre-established Trade. An Insider wishing to change the amount, price or timing of a Pre-established Trade,
or terminate a Pre-established Trade, can do so <U>only</U> during a &ldquo;Trading Window&rdquo; (discussed in Section 1, above). If
the Insider has delegated decision-making authority to a third party, the Insider cannot subsequently influence the third party in any
way and such third party must not possess material non-public information at the time of any of the trades.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to implementing a pre-established plan for trading, all officers and directors must receive the approval for such plan from the Compliance
Officer. In addition, Insiders are generally prohibited from having more than one pre-established contract, plan, or instruction covering
the same time period for open market purchase of sales of the Company&rsquo;s securities, unless one of the exceptions under 17 C.F.R
240.10b5-1(c)(1)(ii)(D) is met. Furthermore, Issuers are prohibited from entering into more than one pre-established contract, plan,
or instruction, which is designed to effect open-market purchase or sale of the Company&rsquo;s securities as a single transaction, for
any given 12-month period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
<U>Pre-Clearance of Trades</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
during a Trading Window, all officers, directors, employees, as well as members of the immediate family or household of such individuals,
must comply with the Company&rsquo;s &ldquo;pre-clearance&rdquo; process prior to trading in the Company&rsquo;s securities, implementing
a pre-established plan for trading, or delegating decision-making authority over the Insider&rsquo;s trades. To do so, each officer and
director must contact the Compliance Officer prior to initiating any of these actions. Trades executed pursuant to a properly implemented
Pre-Established Trade approved by the Compliance Officer do not need to be pre-cleared. The Company may also find it necessary, from
time to time, to require compliance with the pre-clearance process from certain individuals other than those mentioned above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
<U>Individual Responsibility</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Insiders, every person subject to this Policy has the individual responsibility to comply with this Policy against insider trading, regardless
of whether the Company has established a Trading Window applicable to that Insider or any other Insiders of the Company. Each individual,
and not necessarily the Company, is responsible for his or her own actions and will be individually responsible for the consequences
of their actions. Therefore, appropriate judgment, diligence and caution should be exercised in connection with any trade in the Company&rsquo;s
securities. An Insider may, from time to time, have to forego a proposed transaction in the Company&rsquo;s securities even if he or
she planned to make the transaction before learning of the Material Non-public Information and even though the Insider believes he or
she may suffer an economic loss or forego anticipated profit by waiting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
<U>Exceptions to the Policy</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
exceptions to this Policy may only be made by advance written approval of each of: (i) the CEO, (ii) the Compliance Officer and (iii)
the Chairman of the Audit Committee of the Board (or the Chairman of the Board if an Audit Committee has not been established). Any such
exceptions shall be immediately reported to the remaining members of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
VII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPLICABILITY
OF POLICY TO INSIDE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGARDING
OTHER COMPANIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy and the guidelines described herein also apply to Material Non-public Information relating to other companies, including the Company&rsquo;s
customers, vendors or suppliers or potential acquisition targets (&ldquo;<B>business partners</B>&rdquo;), when that information is obtained
in the course of employment or performance of other services on behalf of the Company. Civil and criminal penalties, as well as the termination
of employment, may result from trading on inside information regarding the Company&rsquo;s business partners. All employees should treat
Material Non-public Information about the Company&rsquo;s business partners with the same care as is required with respect to the information
relating directly to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
VIII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROHIBITION
AGAINST BUYING AND SELLING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY
ORDINARY SHARES WITHIN A SIX-MONTH PERIOD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insiders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
purchases and sales (or sales and purchases) of Company ordinary shares occurring within any six-month period in which a mathematical
profit is realized result in illegal &ldquo;short-swing profits&rdquo;. The prohibition against short-swing profits is found in Section
16 of the Exchange Act. Section 16 was drafted as a rather arbitrary prohibition against profitable &ldquo;insider trading&rdquo; in
a company&rsquo;s securities within any six-month period regardless of the presence or absence of Material Non-public Information that
may affect the market price of those securities. Each executive officer, director and 10% or greater shareholder of the Company is subject
to the prohibition against short-swing profits under Section 16. The measure of damages is the profit computed from any purchase and
sale or any sale and purchase within the short-swing (i.e., six-month) period, without regard to any setoffs for losses, any first-in
or first-out rules, or the identity of the ordinary shares. This approach sometimes has been called the &ldquo;lowest price in, highest
price out&rdquo; rule and can result in a realization of &ldquo;profits&rdquo; for Section 16 purposes even when the Insider has suffered
a net loss on his or her trades. Rule 3a12-3 under the Exchange Act exempts securities registered by an FPI from Section 16 of the Exchange
Act. Accordingly, Section 13(d) Individuals of an FPI are not subject to the short-swing profit limits set forth in Section 16(b), nor
are they required to comply with the Section 16(a) reporting requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Section
IX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INQUIRIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
direct your questions as to any of the matters discussed in this Policy to the Compliance Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
13 Memorandum</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All
    Officers, Directors and 5% or greater Shareholders (&ldquo;Insider&rdquo;)</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview
    of Section 13 Under the Exchange Act of 1934, as amended</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.
<U>Introduction</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Memorandum provides an overview of Section 13 of the Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), and the
related rules promulgated by the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Each
executive officer, director and 5% or greater shareholder (commonly called an &ldquo;Insider&rdquo;) of Fitell Corporation (the &ldquo;Company&rdquo;)
is personally responsible for complying with the provisions of Section 13, and failure by an Insider to comply strictly with his or her
reporting requirements will result in an obligation by the Company to publicly disclose such failure. </I></B>Moreover, Congress has
granted the SEC authority to seek monetary court-imposed fines on Insiders who fail to timely comply with their reporting obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 13 of the Exchange Act, reports made to the SEC are filed on Schedule 13D, Schedule 13G, Form 13F, and Form 13H. A securities
firm (and, in some cases, its parent company or other control persons) generally will have a Section 13 reporting obligation if the firm
directly or indirectly:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">beneficially
    owns, in the aggregate, more than 5% of a class of the voting, equity securities (the &ldquo;<B>Section 13(d) Securities</B>&rdquo;):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">registered
    under Section 12 of the Exchange Act,</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued
    by any closed-end investment company registered under the Investment Company Act of 1940, as amended (the &ldquo;<B>Investment Company
    Act</B>&rdquo;), or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued
    by any insurance company that would have been required to register its securities under Section 12 of the Exchange Act but for the
    exemption under Section 12(g)(2)(G) thereof (see Schedules 13D and 13G: Reporting Significant Acquisition and Ownership Positions
    below);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manages
    discretionary accounts that, in the aggregate, hold equity securities trading on a national securities exchange with an aggregate
    fair market value of $100 million or more; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manages
    discretionary accounts that, in the aggregate, purchase or sell any NMS securities (generally exchange-listed equity securities and
    standardized options) in an aggregate amount equal to or greater than (i) 2 million shares or shares with a fair market value of
    over $20 million during a day, or (ii) 20 million shares or shares with a fair market value of over $200 million during a calendar
    month.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.
<U>Reporting Requirements Under Section 13(d) and 13(g)</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<I><U>General</U></I>.</B> Sections 13(d) and 13(g) of the Exchange Act require any person or group of persons<SUP>1</SUP> who directly
or indirectly acquires or has beneficial ownership<SUP>2</SUP> of more than 5% of a class of an issuer&rsquo;s Section 13(d) Securities
(the &ldquo;<B>5% threshold</B>&rdquo;) to report such beneficial ownership on Schedule 13D or Schedule 13G, as appropriate. Both Schedule
13D and Schedule 13G require background information about the reporting persons and the Section 13(d) Securities listed on the schedule,
including the name, address, and citizenship or place of organization of each reporting person, the amount of the securities beneficially
owned and aggregate beneficial ownership percentage, and whether voting and investment power is held solely by the reporting persons
or shared with others. Reporting persons that must report on Schedule 13D are also required to disclose a significant amount of additional
information, including certain disciplinary events, the source and amount of funds or other consideration used to purchase the Section
13(d) Securities, the purpose of the acquisition, any plans to change or influence the control of the issuer, and a list of any transactions
in the securities effected in the last 60 days. A reporting person may use the less burdensome Schedule 13G if it meets certain criteria
described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Schedule 13G is available to any reporting person that falls within one of the following three categories:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exempt
    Investors</I>. A reporting person is an &ldquo;Exempt Investor&rdquo; if the reporting person beneficially owns more than 5% of a
    class of an issuer&rsquo;s Section 13(d) Securities at the end of a calendar year, but its acquisition of the securities is exempt
    under Section 13(d)(6) of the Exchange Act. For example, a person that acquired all of its Section 13(d) Securities prior to the
    issuer&rsquo;s registration of such securities (or class of securities) under the Exchange Act, or acquired no more than 2% of the
    Section 13(d) Securities within a 12-month period, is considered to be an Exempt Investor and would be eligible to file reports on
    Schedule 13G.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    &ldquo;group&rdquo; is defined in Rule 13d-5 as &ldquo;two or more persons [that] agree to act together for the purpose of acquiring,
    holding, voting or disposing of equity securities of an issuer.&rdquo; See, for example, the persons described above in <I>Reporting
    Obligations of &ldquo;Control Persons</I>&rdquo;. An agreement to act together does not need to be in writing and may be inferred
    by the SEC or a court from the concerted actions or common objective of the group members.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    Rule 13d-3, &ldquo;<B>beneficial ownership</B>&rdquo; of a security exists if a person, directly or indirectly, through any contract,
    arrangement, understanding, or relationship or otherwise, has or shares voting power and/or investment power over a security. &ldquo;<B>Voting
    power</B>&rdquo; means the power to vote or direct the voting of a security. <B>&ldquo;Investment power&rdquo;</B> means the power
    to dispose of or direct the disposition of a security. Under current SEC rules, a person holding securities-based swaps or other
    derivative contracts may be deemed to beneficially own the underlying securities if the swap or derivative contract provides the
    holder with voting or investment power over the underlying securities. Please contact us if you would like guidance regarding the
    application of Section 13 to securities-based swaps or other derivative contracts.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Qualified
    Institutions</I>. Along with certain other institutions listed under the Exchange Act<SUP>3</SUP>, a reporting person that is a registered
    investment adviser or broker-dealer may file a Schedule 13G as a &ldquo;Qualified Institution&rdquo; if it (a) acquired its position
    in a class of an issuer&rsquo;s Section 13(d) Securities in the ordinary course of its business, (b) did not acquire such securities
    with the purpose or effect of changing or influencing control of the issuer, nor in connection with any transaction with such purpose
    or effect (such purpose or effect, an &ldquo;<B>activist intent</B>&rdquo;), and (c) promptly notifies any discretionary account
    owner on whose behalf the firm holds more than 5% of the Section 13(d) Securities of such account owner&rsquo;s potential reporting
    obligation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Passive
    Investors.</I> A reporting person is a &ldquo;Passive Investor&rdquo; if it beneficially owns more than 5% but less than 20% of a
    class of an issuer&rsquo;s Section 13(d) Securities and (a) the securities were not acquired or held with an activist intent, and
    (b) the securities were not acquired in connection with any transaction having an activist intent. There is no requirement that a
    Passive Investor limit its acquisition of Section 13(d) Securities to purchases made in the ordinary course of its business. In addition,
    a Passive Investor does not have an obligation to notify discretionary account owners on whose behalf the firm holds more than 5%
    of such Section 13(d) Securities of such account owner&rsquo;s potential reporting obligation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
<I><U>Method of Filing</U>.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
An Insider must file Section 13 schedules in electronic format via the Commission&rsquo;s Electronic Data Gathering Analysis and Retrieval
System (&ldquo;<B>EDGAR</B>&rdquo;) in accordance with EDGAR rules set forth in Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Filing Date</U>. Schedules are deemed filed with the SEC or the applicable exchange on the date recognized by EDGAR. For Section 13
purposes, filings may be made up to 10 p.m. EST. In the event that a due date falls on a weekend or SEC holiday, the filing will be deemed
timely filed if it is filed on EDGAR by the next business day after such weekend or holiday. An Insider must first obtain several different
identification codes from the SEC before the filings can be submitted. In order to receive such filing codes, the Insider first submits
a Form ID to the SEC. The Form ID must be signed, notarized, and submitted electronically through the SEC&rsquo;s Filer Management website,
which can be accessed at https://www.filermanagement.edgarfiling.sec.gov. The Insider is required to retain a manually signed hard copy
of all EDGAR filings (and related documents like powers of attorney) in its records available for SEC inspection for a period of five
years after the date of filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Under
    Rule 13d-1, a reporting person also qualifies as a Qualified Institution if it is a bank as defined in Section 3(a)(6) of the Exchange
    Act, an insurance company as defined in Section 3(a)(19) of the Exchange Act, an investment company registered under the Investment
    Company Act, or an employee benefit plan, savings association, or church plan. The term &ldquo;Qualified Institution&rdquo; also
    includes a non-U.S. institution that is the functional equivalent of any of the foregoing entities and the control persons and parent
    holding companies of an entity that qualifies as a Qualified Institution.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Company</U>. In addition, the rules under Section 13 require that a copy of the applicable filing be sent to the issuer of the security
at its principal executive office by registered or certified mail. A copy of Schedules filed pursuant to &sect;&sect; 240.13d-1(a) and
240.13d-2(a) shall also be sent to each national securities exchange where the security is traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Securities to be Reported</U>. A person who is subject to Section 13 must only report as beneficially owned those securities in which
he or she has a pecuniary interest. See the discussion of &ldquo;beneficial ownership&rdquo; below at Section D.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
<I><U>Initial Report of Ownership &ndash; Schedule 13D or 13G</U>.</I></B> Under Section 13, Insiders are required to make an initial
report on Schedule 13D or Schedule 13G to the SEC of their holdings of all equity securities of the corporation (whether or not such
equity securities are registered under the Exchange Act). This would include all traditional types of securities, such as ordinary shares,
preferred shares and junior shares, as well as all types of derivative securities, such as warrants to purchase shares, options to purchase
shares, puts and calls. Even Insiders who do not beneficially own any equity securities of the Company must file a report to that effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Initial Filing Deadline</U>. An Insider who is not eligible to use Schedule 13G must file a Schedule 13D within 10 days of such reporting
person&rsquo;s direct or indirect acquisition of beneficial ownership of more than 5% of a class of an issuer&rsquo;s Section 13(d) Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    reporting person that is an Exempt Investor is required to file its initial Schedule 13G within 45 days of the end of the calendar
    year in which the person exceeds the 5% threshold.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    reporting person that is a Qualified Institution also is required to file its initial Schedule 13G within 45 days of the end of the
    calendar year in which the person exceeds the 5% threshold. Since the 5% threshold for a Qualified Institution is calculated as of
    the end of a calendar year, a Qualified Institution that acquires directly or indirectly more than 5% of a class of an issuer&rsquo;s
    Section 13(d) Securities during a calendar year, but as of December 31 has reduced its interest below the 5% threshold, will not
    be required to file an initial Schedule 13G. However, a Qualified Institution that acquires direct or indirect beneficial ownership
    of more than 10% of a class of an issuer&rsquo;s Section 13(d) Securities prior to the end of a calendar year must file an initial
    Schedule 13G within 10 days after the first month in which the person exceeds the 10% threshold.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    reporting person that is a Passive Investor must file its initial Schedule 13G within 10 days of the date on which it exceeds the
    5% threshold.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Switching from Schedule 13G to Schedule 13D</U>. If an Insider that previously filed a Schedule 13G no longer satisfies the conditions
to be an Exempt Investor, Qualified Institution, or Passive Investor, the person must switch to reporting its beneficial ownership of
a class of an issuer&rsquo;s Section 13(d) Securities on a Schedule 13D (assuming that the person continues to exceed the 5% threshold).
This could occur in the case of (1) an Insider that changes from acquiring or holding Section 13(d) Securities for passive investment
to acquiring or holding such securities with an activist intent, (2) an Insider that is a Qualified Institution that deregisters as an
investment adviser pursuant to an exemption under the Investment Advisers Act of 1940, as amended, or applicable state law, or (3) an
Insider that is a Passive Investor that acquires 20% or more of a class of an issuer&rsquo;s Section 13(d) Securities. In each case,
the Insider must file a Schedule 13D within 10 days of the event that caused it to no longer satisfy the necessary conditions (except
that, if a former Qualified Institution is able to qualify as a Passive Investor, such person may simply amend its Schedule 13G within
10 days to switch its status).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Insider who is required to switch to reporting on a Schedule 13D will be subject to a &ldquo;cooling off&rdquo; period from the date
of the event giving rise to a Schedule 13D obligation (such as the change to an activist intent or acquiring 20% of a class of an issuer&rsquo;s
Section 13(d) Securities) until 10 calendar days after the filing of Schedule 13D. During the &ldquo;cooling off&rdquo; period, the reporting
person may not vote or direct the voting of the Section 13(d) Securities or acquire additional beneficial ownership of such securities.
Consequently, a person should file a Schedule 13D as soon as possible once he is obligated to switch from a Schedule 13G to reduce the
duration of the &ldquo;cooling off&rdquo; period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Insider will thereafter be subject to the Schedule 13D reporting requirements with respect to the Section 13(d) Securities until such
time as the former Schedule 13G reporting person once again qualifies as a Qualified Institution or Passive Investor with respect to
the Section 13(d) Securities or has reduced its beneficial ownership interest below the 5% threshold. However, only a reporting person
that was originally eligible to file a Schedule 13G and was later required to file a Schedule 13D may switch to reporting on Schedule
13G.<SUP>4</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
<I><U>Changes in Ownership &ndash; Amendments to Schedule 13D or 13G</U></I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendments
to Schedule 13D</I>. If there has been any material change to the information in a Schedule 13D previously filed by an Insider<SUP>5</SUP>,
the person must promptly file an amendment to such Schedule 13D. A material change includes, without limitation, a reporting person&rsquo;s
acquisition or disposition of 1% or more of a class of the issuer&rsquo;s Section 13(d) Securities, including as a result of an issuer&rsquo;s
repurchase of its securities. An acquisition or disposition of less than 1% may be considered a material change depending on the circumstances.
A disposition that reduces a reporting person&rsquo;s beneficial ownership interest below the 5% threshold, but is less than a 1% reduction,
is not necessarily a material change that triggers an amendment to Schedule 13D. However, an amendment in such a circumstance is recommended
to eliminate the reporting person&rsquo;s filing obligations if the reporting person does not in the near term again expect to increase
its ownership above 5%. &ldquo;Promptly&rdquo; is generally considered to be within 2 to 5 calendar days of the material change, depending
on the facts and circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Question 103.07 (September 14, 2009), Regulation 13D-G C&amp;DIs.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    includes a change in the previously reported ownership percentage of a reporting person even if such change results solely from an
    increase or decrease in the aggregate number of outstanding securities of the issuer.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendments
to Schedule 13G.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual</B>.
    If a reporting person previously filed a Schedule 13G and there has been any change to the information reported in such Schedule
    13G as of the end of a calendar year, then an amendment to such Schedule 13G must be filed within 45 days of the calendar year end.
    A reporting person is not required to make an annual amendment to Schedule 13G if there has been no change since the previously filed
    Schedule 13G or if the only change results from a change in the person&rsquo;s ownership percentage as a result of a change in the
    aggregate number of Section 13(d) Securities outstanding (e.g., due to an issuer&rsquo;s repurchase of its securities).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
    than Annual (Qualified Institutions)</B>. A reporting person that previously filed a Schedule 13G as a Qualified Institution reporting
    beneficial ownership of less than 10% of a class of an issuer&rsquo;s Section 13(d) Securities, must file an amendment to its Schedule
    13G within 10 days of the end of the first month such Qualified Institution is the direct or indirect beneficial owner of more than
    10% of a class of the issuer&rsquo;s Section 13(d) Securities. Thereafter, within 10 days after the end of any month in which the
    person&rsquo;s direct or indirect beneficial ownership of such securities increases or decreases by more than 5% of the class of
    securities (computed as of the end of the month), the person must file an amendment to Schedule 13G.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
    than Annual (Passive Investors)</B>. A reporting person that previously filed a Schedule 13G as a Passive Investor must promptly
    file an amendment any time it directly or indirectly acquires more than 10% of a class of an issuer&rsquo;s Section 13(d) Securities.
    Thereafter, the reporting person must file an amendment to Schedule 13G promptly after its direct or indirect beneficial ownership
    of such securities increases or decreases by more than 5%.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
<I>Reporting Identifying Information for Large Traders - Form 13H</I>.</B> Rule 13h-1 of the Exchange Act requires a Form 13H to be filed
with the SEC by any individual or entity (each, a &ldquo;<B>Large Trader</B>&rdquo;) that, directly or indirectly, exercises investment
discretion over one or more accounts and effects transactions in NMS Securities (as defined below) for those accounts through one or
more registered broker-dealers that, in the aggregate, equal or exceed (a) 2 million shares or $20 million in fair market value during
any calendar day, or (b) 20 million shares or $200 million in fair market value during any calendar month (each, an &ldquo;<B>identifying
activity level</B>&rdquo;). Under Regulation NMS, an &ldquo;NMS Security&rdquo; is defined to include any U.S. exchange-listed equity
securities and any standardized options, but does not include any exchange-listed debt securities, securities futures, or shares of open-end
mutual funds that are not currently reported pursuant to an effective transaction reporting plan under the Exchange Act. A Large Trader
must file an initial Form 13H promptly after effecting aggregate transactions equal to or greater than one of the identifying activity
levels. The SEC has indicated that filing within 10 days will be deemed a prompt filing. Amendments to Form 13H must be filed within
45 days after the end of each full calendar year and then promptly following the end of a calendar quarter if any of the information
on Form 13H becomes inaccurate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
13H requires that a Large Trader, reporting for itself and for any affiliate that exercises investment discretion over NMS securities,
list the broker-dealers at which the Large Trader and its affiliates have accounts and designate each broker-dealer as a &ldquo;prime
broker,&rdquo; an &ldquo;executing broker,&rdquo; and/or a &ldquo;clearing broker.&rdquo; Form 13H filings with the SEC are confidential
and exempt from disclosure under the United States Freedom of Information Act. The information is, however, subject to disclosure to
Congress and other federal agencies and when ordered by a court. If a securities firm has multiple affiliates in its organization that
qualify as Large Traders, Rule 13h-1 permits the Large Traders to delegate their reporting obligation to a control person that would
file a consolidated Form 13H for all of the Large Traders it controls. Otherwise, each Large Trader in the organization will be required
to file a separate Form 13H.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
<I><U>Reporting Obligations of Control Persons and Clients</U></I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
Firm&rsquo;s Obligations</I>. As discussed above, a securities firm is deemed to be the beneficial owner of Section 13(d) Securities
in all accounts over which it exercises voting and/or investment power. Therefore, a firm will be a reporting person if it directly or
indirectly acquires or has beneficial ownership of more than 5% of a class of an issuer&rsquo;s Section 13(d) Securities. Unless a securities
firm has an activist intent with respect to the issuer of the Section 13(d) Securities, the firm generally will be able to report on
Schedule 13G as either a Qualified Institution or as a Passive Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Obligations
of a Firm&rsquo;s Control Persons.</I> Any control person (as defined below) of a securities firm, by virtue of its ability to direct
the voting and/or investment power exercised by the firm, may be considered an indirect beneficial owner of the Section 13(d) Securities.
Consequently, the direct or indirect control persons of a securities firm may also be reporting persons with respect to a class of an
issuer&rsquo;s Section 13(d) Securities. The following persons are likely to be considered &ldquo;control persons&rdquo; of a firm:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    general partner, managing member, trustee, or controlling shareholder of the firm; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    direct or indirect parent company of the firm and any other person that indirectly controls the firm (e.g., a general partner, managing
    member, trustee, or controlling shareholder of the direct or indirect parent company).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a securities firm (or parent company) is directly or indirectly owned by two partners, members, trustees, or shareholders, generally
each such partner, member, trustee, or shareholder is deemed to be a control person. For example, if a private fund that beneficially
owns more than 5% of a class of an issuer&rsquo;s Section 13(d) Securities is managed by a securities firm that is a limited partnership,
the general partner of which is a limited liability company that in turn is owned in roughly equal proportions by two managing members,
then each of the private fund, the securities firm, the firm&rsquo;s general partner, and the two managing members of the general partner
likely will have an independent Section 13 reporting obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Availability
of Filing on Schedule 13G by Control Persons</I>. Any direct and indirect control person of a securities firm may file a Schedule 13G
as an Exempt Investor, a Qualified Institution or as a Passive Investor to the same extent as any other reporting person as described
above. In order for a control person to file a Schedule 13G as a Qualified Institution, however, no more than 1% of a class of an issuer&rsquo;s
Section 13(d) Securities may be held (i) directly by the control person or (ii) directly or indirectly by any of its subsidiaries or
affiliates that are not Qualified Institutions. For example, a direct or indirect control person of a securities firm will not qualify
as a Qualified Institution if more than 1% of a class of an issuer&rsquo;s Section 13(d) Securities is held by a private fund managed
by the firm or other affiliate because a private fund is not among the institutions listed as a Qualified Institution under the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
securities firm that has one of its control persons serving on an issuer&rsquo;s board of directors may not be eligible to qualify as
a Passive Investor with respect to such issuer. Even though the securities firm may not otherwise have an activist intent, the staff
of the SEC has stated &ldquo;the fact that officers and directors have the ability to directly or indirectly influence the management
and policies of an issuer will generally render officers and directors unable to certify to the requirements&rdquo; necessary to file
as a Passive Investor.<SUP>6</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Obligations
of a Firm&rsquo;s Clients.</I> If a client of a securities firm (including a private or registered fund or a separate account client)
by itself beneficially owns more than 5% of a class of an issuer&rsquo;s Section 13(d) Securities, the client has its own independent
Section 13 reporting obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Availability
of Joint Filings by Reporting Persons.</I> As discussed above, each reporting person has an independent reporting obligation under Section
13 of the Exchange Act. The direct and indirect beneficial owners of the same Section 13(d) Securities may satisfy their reporting obligations
by making a joint Schedule 13D or Schedule 13G filing, provided that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    reporting person is eligible to file on the Schedule used to make the Section 13 report (e.g., each person filing on a Schedule 13G
    is a Qualified Institution, Exempt Investor, or Passive Investor);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    reporting person is responsible for the timely filing of the Schedule 13D or Schedule 13G and for the completeness and accuracy of
    its information in such filing<SUP>7</SUP>; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Schedule 13D or Schedule 13G filed with the SEC (i) contains all of the required information with respect to each reporting person;
    (ii) is signed by each reporting person in his, her, or its individual capacity (including through a power of attorney); and (iii)
    has a joint filing agreement attached.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Question 103.04 (September 14, 2009), Exchange Act Sections 13(d) and 13(g) and Regulation 13D-G Beneficial Ownership Reporting Compliance
    and Disclosure Interpretations of the Division of Corporation Finance of the SEC (the &ldquo;Regulation 13D-G C&amp;DIs&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    the reporting persons are eligible to file jointly on Schedule 13G under separate categories (e.g., a private fund as a Passive Investor
    and its control persons as Qualified Institutions), then the reporting persons must comply with the earliest filing deadlines applicable
    to the group in filing any joint Schedule 13G. In the example above, the reporting persons would be required to file a Schedule 13G
    initially within 10 days of exceeding the 5% threshold and thereafter promptly upon any transaction triggering an amendment (i.e.,
    the filing deadlines applicable to a Passive Investor) and not the later deadlines applicable to a Qualified Institution.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.
<U>Determining Beneficial Ownership</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining whether a securities firm has crossed the 5% threshold with respect to a class of an issuer&rsquo;s Section 13(d) Securities<SUP>8</SUP>,
it must include the positions held in any proprietary accounts and the positions held in all discretionary client accounts that it manages
(including any private or registered funds, accounts managed by or for principals and employees, and accounts managed for no compensation),
and positions held in any accounts managed by the firm&rsquo;s control persons (which may include certain officers and directors) for
themselves, their spouses, and dependent children (including IRA and most trust accounts).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<I><U>Determining Who is a Five Percent Holder</U></I>.</B> Beneficial ownership in the Section 13 context is determined by reference
to Rule 13d-3, which provides that a person is the beneficial owner of securities if that person has or shares voting or disposition
power with respect to such securities, or can acquire such power within 60 days through the exercise or conversion of derivative securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
<I><U>Determining Beneficial Ownership for Reporting and Short-Swing Profit Liability</U></I>.</B> For all Section 13 purposes other
than determining who is a five percent holder, beneficial ownership means a direct or indirect pecuniary interest in the subject securities
through any contract, arrangement, understanding, relationship or otherwise. &ldquo;Pecuniary interest&rdquo; means the opportunity,
directly or indirectly, to profit or share in any profit derived from a transaction in the subject securities. Discussed below are several
of the situations that may give rise to an indirect pecuniary interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Family Holdings</U>. An Insider is deemed to have an indirect pecuniary interest in securities held by members of the Insider&rsquo;s
immediate family sharing the same household. Immediate family includes grandparents, parents (and step-parents), spouses, siblings, children
(and step-children) and grandchildren, as well as parents-in-laws, siblings-in-laws, children-in-law and all adoptive relationships.
An Insider may disclaim beneficial ownership of shares held by members of his or her immediate family, but the burden of proof will be
on the Insider to uphold the lack of a pecuniary interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    calculating the 5% test, a person is permitted to rely upon the issuer&rsquo;s most recent interim or annual report for purposes
    of determining the amount of outstanding voting securities of the issuer, unless the person knows or has reason to believe that such
    information is inaccurate.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Partnership Holdings</U>. Beneficial ownership of a partnership&rsquo;s securities is attributed to the general partner of a limited
partnership in proportion of such person&rsquo;s partnership interest. Such interest is measured by the greater of the general partner&rsquo;s
share of partnership profits or of the general partner&rsquo;s capital account (including any limited partnership interest held by the
general partner).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Corporate Holdings</U>. Beneficial ownership of securities held by a corporation will not be attributed to its shareholders who are
not controlling shareholders and who do not have or share investment control over the corporation&rsquo;s portfolio securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Derivative Securities</U>. Ownership of derivative securities (warrants, share appreciation rights, convertible securities, options
and the like) is treated as indirect ownership of the underlying equity securities. Acquisition of derivative securities must be reported.
If the derivative securities are acquired pursuant to an employee plan, the timing of such reporting depends upon the Rule 16b-3 status
of the employee plan under which the grant was made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.
<U>Delinquent Filings</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<I><U>Correcting Late Filings</U></I>.</B> In the case of an Insider that has failed to make required amendments to its Schedule 13D
or Schedule 13G in a timely manner (i.e., any material changes), the Insider must immediately amend its schedule to disclose the required
information. The SEC Staff has explained that, &ldquo;[r]egardless of the approach taken, the security holder must ensure that the filings
contain the information that it should have disclosed in each required amendment, including the dates and details of each event that
necessitated a required amendment.&rdquo; However, the SEC Staff has also affirmed that, irrespective of whether a security holder takes
any of these actions, a security holder may still face liability under the federal securities laws for failing to promptly file a required
amendment to a Schedule 13D or Schedule 13G.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
<I><U>Potential Liability</U></I>.</B> The SEC may bring an enforcement action, in the context of a Schedule 13D or Schedule 13G filing,
for violations of Section 13(d), Section 13(g), Rule 10b-5 and Section 10(b), provided that the SEC specifically shows: (1) a material
misrepresentation or omission made by the defendant; (2) scienter on the part of the defendant; and (3) a connection between a misrepresentation
or omission and purchase or sale of a security regarding the Rule 10b-5 claim it brings. The SEC may seek civil remedies in the form
of injunctive relief, a cease-and-desist order, monetary penalties, and other forms of equitable relief (e.g., disgorgement of profits).
Under Section 32 of the Exchange Act, criminal sanctions may also extend to the willful violation of Section 13(d) and Section 13(g).
The U.S. Department of Justice, which prosecutes criminal offenses under the Exchange Act, may seek numerous penalties against any person
that violates the Exchange Act and any rules thereunder, including a monetary fine of up to $5,000,000, imprisonment for up to 20 years
and/or disgorgement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fitell
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Insider
Trading Compliance Program - Pre-Clearance Checklist</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Individual
Proposing to Trade:_________________________</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
of Shares covered by Proposed Trade:_________________________</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date:_________________________</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Trading
    Window</U>. Confirm that the trade will be made during the Company&rsquo;s &ldquo;trading window.&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
    13 Compliance</U>. Confirm, if the individual is subject to Section 13, that the proposed trade will not give rise to any potential
    liability under Section 13 as a result of matched past (or intended future) transactions. Also, ensure that an amendment to Schedule
    13D or 13G has been or will be completed and will be timely filed.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Prohibited
    Trades</U>. Confirm, if the individual is subject to Section 13, that the proposed transaction is not a &ldquo;short sale,&rdquo;
    put, call or other prohibited or strongly discouraged transaction.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Rule
    144 Compliance</U>. Confirm that:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    public information requirement has been met;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    are not restricted or, if restricted, the six-month holding period has been met;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volume
    limitations are not exceeded (confirm that the individual is not part of an aggregated group);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    manner of sale requirements has been met; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Notice of Form 144 Sale has been completed and filed.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Rule
    10b-5 Concerns</U>. Confirm that (i) the individual has been reminded that trading is prohibited when in possession of any material
    information regarding the Company that has not been adequately disclosed to the public, and (ii) the Compliance Officer has discussed
    with the individual any information known to the individual or the Compliance Officer which might be considered material, so that
    the individual has made an informed judgment as to the presence of inside information.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    of Compliance Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transactions
Report</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officer
    or Director:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.
TRANSACTIONS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    transactions.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    transactions described below.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid">Owner of Record</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transaction<BR> Date <SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transaction<BR> Code <SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Security (Common,<BR> Preferred)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Securities<BR> Acquired</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of<BR> Securities<BR> Disposed of</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Purchase/<BR> Sale Unit<BR> Price</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokerage
    transactions - trade date</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    purchases and sales - date firm commitment is made</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisitions
    under stock bonus plan - date of grant</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
    and SAR exercises - date of exercise</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
    - date of surrender of convertible security</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gifts
    - date on which gift is made</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
    Codes:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Q)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    pursuant to marital settlement</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(P)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-established
    Purchase or Sale</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(U)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tender
    of shares</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(N)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    or Sale (not &ldquo;Pre-established&rdquo;)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(W)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition
    or disposition of will</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(G)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gift</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(J)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    acquisition or disposition (specify)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(M)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
    exercise (in-the-money option)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">II.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
    OWNERSHIP FOLLOWING TRANSACTION</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Company Securities Directly or Indirectly Owned (other than stock options noted below)</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title of Security (<I>e.g.</I>,<BR> Preferred, Common, etc.)</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of<BR> Shares/Units</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Record Holder&nbsp;(if&nbsp;not<BR> Reporting Person)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Relationship to Reporting<BR> Person</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Stock Option Ownership</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid">Date of Grant</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number&nbsp;of&nbsp;Shares</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Exercise</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Price</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Vesting</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Dates</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Expiration</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Date</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Exercises to Date (Date, No. of Shares)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fitell
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Transaction
Reminder</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
[Name of Officer or Director]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FROM:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RE:
<B>Amendment to Schedule 13D filing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is to remind you that if there is a change in your beneficial ownership of ordinary shares or other securities of Fitell Corporation
(the &ldquo;Company&rdquo;), you must file an amendment to Schedule 13D with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
within 2-5 business days following the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
records indicate that on __________ (specify date) you had the transactions in the Company&rsquo;s securities indicated on the attached
exhibit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT>1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Please advise us whether the information on the attached exhibit is correct:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information is complete and correct.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    information is <U>not</U> complete and correct. I have marked the correct information on the attached exhibit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    advise us if we should assist you by preparing the amendment to Schedule 13D for your signature and filing it for you with the SEC
    based upon the information you provided to us, or if you will prepare and file the amendment to Schedule 13D yourself. (Please note
    that we have prepared and attached for your convenience an amendment to Schedule 13D reflecting the information we have, which (if
    it is complete and correct), you may sign and return in the envelope enclosed.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company should prepare and file the amendment to Schedule 13D on my behalf after receiving my signature on the form.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    shall prepare and file the amendment to Schedule 13D myself.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have any questions, contact Jamarson Kong, the Company&rsquo;s Compliance Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
understand that my amendment to Schedule 13D must be filed as follows: (i) on EDGAR (the SEC Electronic Data-Gathering, Analysis and
Retrieval system) and (ii) one copy with the Company&rsquo;s Compliance Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>3
<FILENAME>ex12-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
12.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certification
of the Principal Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Yinying Lu, certify that</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this annual report on Form 20-F of Fitell Corporation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this
    report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    company&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
    Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the
    effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the company&rsquo;s internal control over financial reporting that occurred during the period covered
    by the annual report that has materially affected, or is reasonably likely to materially affect, the company&rsquo;s internal control
    over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    company&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the company&rsquo;s auditors and the audit committee of the company&rsquo;s board of directors (or persons performing
    the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the company&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the company&rsquo;s internal
    control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    November 15, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Yinying Lu</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Yinying
    Lu</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer<BR>
(Principal Executive Officer)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>4
<FILENAME>ex12-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
12.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certification
of the Principal Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Jamarson Kong, certify that</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this annual report on Form 20-F of Fitell Corporation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this
    report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    company&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
    Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the
    effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the company&rsquo;s internal control over financial reporting that occurred during the period covered
    by the annual report that has materially affected, or is reasonably likely to materially affect, the company&rsquo;s internal control
    over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 86.95pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    company&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the company&rsquo;s auditors and the audit committee of the company&rsquo;s board of directors (or persons performing
    the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the company&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the company&rsquo;s internal
    control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    November 15, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jamarson Kong</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Jamarson
    Kong</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer<BR>
(Principal Financial and Accounting Officer)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>5
<FILENAME>ex13-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
13.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certification
by the Principal Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the annual report of Fitell Corporation (the &ldquo;Company&rdquo;) on Form 20-F for the fiscal year ended June 30, 2024,
as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Yinying Lu, Chief Executive Officer
of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    November 15, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Yinying Lu</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Yinying
    Lu</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer<BR>
(Principal Executive Officer)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>6
<FILENAME>ex13-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
13.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certification
by the Principal Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the annual report of Fitell Corporation (the &ldquo;Company&rdquo;) on Form 20-F for the fiscal year ended June 30, 2024,
as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Jamarson Kong, Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    November 15, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jamarson Kong</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Jamarson
    Kong</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer<BR>
(Principal Financial and Accounting Officer)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>7
<FILENAME>ex97-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
97.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fitell
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incentive
Compensation Recovery Policy</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
Date: November 30, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Purpose</U>.
                                            </B>The purpose of the Fitell Corporation Incentive Compensation Recovery Policy (this &ldquo;<B>Policy</B>&rdquo;)
                                            is to provide for the recovery of certain Incentive-Based Compensation in the event of an
                                            Accounting Restatement. This Policy is intended to comply with, and to be administered and
                                            interpreted consistent with, Section 10D of the Securities Exchange Act of 1934, as amended
                                            (the &ldquo;<B>Exchange Act</B>&rdquo;), Rule 10D-1 promulgated under the Exchange Act (&ldquo;<B>Rule
                                            10D-1</B>&rdquo;), and Listing Rule 5608 adopted by the Nasdaq Stock Market LLC (&ldquo;<B>Nasdaq</B>&rdquo;)
                                            (the &ldquo;<B>Listing Standards</B>&rdquo;). Unless otherwise defined in this Policy, capitalized
                                            terms shall have the meanings set forth in the Appendix attached hereto.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Policy
                                            for Recovery of Erroneously Awarded Compensation</U>.</B> In the event of an Accounting Restatement,
                                            it is the Company&rsquo;s policy to recover reasonably promptly the amount of any Erroneously
                                            Awarded Compensation Received during the Recovery Period.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Application
                                            of Policy</U>.</B> This Policy applies to Incentive-Based Compensation Received by an Executive
                                            Officer (i) on or after October 2, 2023 and after such individual began service as an Executive
                                            Officer, (ii) if that person served as an Executive Officer at any time during the performance
                                            period for the Incentive-Based Compensation, and (iii) while the Company had a listed class
                                            of securities on a national securities exchange.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Administration</U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Policy shall be administered by the Compensation Committee, except that the Board may determine
                                            to act as the administrator or designate another committee of the Board to act as the administrator
                                            with respect to any portion of this Policy other than Section 4(c) (the &ldquo;<B>Administrator</B>&rdquo;).
                                            The Administrator is authorized to interpret and construe this Policy and to make all determinations
                                            necessary, appropriate, or advisable for the administration of this Policy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company is authorized to take appropriate steps to implement this Policy and may effect recovery
                                            hereunder by: (i) requiring payment to the Company, (ii) set-off, (iii) reducing compensation,
                                            or (iv) such other means or combination of means as the Administrator determines to be appropriate.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company need not recover Erroneously Awarded Compensation if and to the extent that the Compensation
                                            Committee or a majority of the independent members of the Board determines that such recovery
                                            is impracticable and not required under Rule 10D-1 and the Listing Standards, including if
                                            the Compensation Committee or a majority of the independent members of the Board determines
                                            that: (i) the direct expense paid to a third party to assist in enforcing this Policy would
                                            exceed the amount to be recovered after making a reasonable attempt to recover, (ii) recovery
                                            would violate home country law adopted prior to November 28, 2022, after obtaining the opinion
                                            of home country counsel, or (iii) recovery would likely cause an otherwise tax-qualified
                                            broad-based retirement plan to fail the requirements of Section 401(a)(13) or Section 411(a)
                                            of the Internal Revenue Code of 1986, as amended, and regulations thereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Administrator may require each Executive Officer to sign and return to the Company an Acknowledgment
                                            Form substantially in the form attached to this Policy as <U>Exhibit A</U> or in such other
                                            form determined by the Administrator, pursuant to which the Executive Officer agrees to be
                                            bound by, and comply with, the terms of this Policy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            determinations made by the Administrator under this Policy shall be final and binding on
                                            all affected individuals and need not be uniform among affected individuals.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Other Recovery Rights;
  Company Claims</U>.</B> Any right of recovery pursuant to this Policy is in addition to, and not in lieu of, any other remedies or
  rights of recovery that may be available to the Company under applicable law or pursuant to the terms of any compensation recovery
  policy in any employment agreement, plan or award agreement, or pursuant to the terms of any other compensation recovery policy of
  the Company. Nothing contained in this Policy and no recovery hereunder shall limit any claims, damages, or other legal remedies the
  Company may have against an individual arising out of or resulting from any actions or omissions by such individual.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Reporting and Disclosure</U>.
  </B>The Company shall file all disclosures with respect to this Policy in accordance with the requirements of federal securities laws.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Indemnification Prohibition</U>.
  </B>Notwithstanding the terms of any indemnification or insurance policy or any contractual arrangement that may be interpreted to
  the contrary, the Company shall not indemnify any Executive Officer with respect to amount(s) recovered under this Policy or claims
  relating to the enforcement of this Policy, including any payment or reimbursement for the cost of third-party insurance purchased
  by such Executive Officer to fund potential clawback obligations hereunder.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Amendment; Termination</U>.
  </B>The Board or the Compensation Committee may amend or terminate this Policy from time to time in its discretion as it deems appropriate
  and shall amend this policy as it deems necessary to comply with applicable law or any rules or standards adopted by a national securities
  exchange on which the Company&rsquo;s securities are listed; provided, however, that no amendment or termination of this Policy shall
  be effective to the extent it would cause the Company to violate any federal securities laws, Securities and Exchange Commission rule
  or the rules or standards of any national securities exchange on which the Company&rsquo;s securities are listed.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Successors</U>.</B>
  This Policy shall be binding and enforceable against all individuals who are or were Executive Officers and their beneficiaries, heirs,
  executors, administrators, or other legal representatives.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Effective Date</U>.
  </B>This Policy was approved on November 30, 2023 and is effective only for Incentive-Based Compensation Received on or after October
  2, 2023.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>APPENDIX</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Definitions</U>:
</B>For purposes of this Policy, the following terms shall have the meanings set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Accounting
Restatement</B>&rdquo; means an accounting restatement of the Company&rsquo;s financial statements due to the Company&rsquo;s material
noncompliance with any financial reporting requirement under the securities laws, including any accounting restatement required to correct
an error in previously issued financial statements that is material to the previously issued financial statements, or that would result
in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Administrator</B>&rdquo;
has the meaning set forth in Section 4(a) hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Board</B>&rdquo;
means the Company&rsquo;s Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;
means Fitell Corporation, an exempted company incorporated under the laws of Cayman Islands, and its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Compensation
Committee</B>&rdquo; means the Compensation Committee of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Erroneously
Awarded Compensation</B>&rdquo; means the amount, as determined by the Administrator, of Incentive-Based Compensation received by an
Executive Officer that exceeds the amount of Incentive-Based Compensation that would have been received by the Executive Officer had
it been determined based on the restated amounts. For Incentive-Based Compensation based on stock price or total shareholder return (&ldquo;<B>TSR</B>&rdquo;)
the Administrator will determine the amount based on a reasonable estimate of the effect of the Accounting Restatement on the stock price
or TSR upon which the Incentive-Based Compensation was received, and the Company will maintain documentation of the determination of
that reasonable estimate and provide the documentation to Nasdaq. In all cases, the amount to be recovered will be calculated without
regard to any taxes paid by the Executive Officer with respect of the Erroneously Awarded Compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Executive
Officers</B>&rdquo; means the Company&rsquo;s current and former executive officers as determined by the Administrator in accordance
with Rule 10D-1 and the Listing Standards. Generally, Executive Officers include any executive officer designated by the Board as an
&ldquo;officer&rdquo; under Rule 16a-1(f) under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Financial
Reporting Measure</B>&rdquo; means (i) any measure that is determined and presented in accordance with the accounting principles used
in preparing the Company&rsquo;s financial statements and any measure derived wholly or in part from such a measure, and (ii) any measure
based wholly or in part on the Company&rsquo;s stock price or total shareholder return. A Financial Reporting Measure need not be presented
within the Company&rsquo;s financial statements or included in a filing with the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Incentive-Based
Compensation</B>&rdquo; means any compensation granted, earned, or vested based in whole or in part on the Company&rsquo;s attainment
of a Financial Reporting Measure. Incentive-Based Compensation is deemed to be &ldquo;<B>Received</B>&rdquo; for purposes of this Policy
in the fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even
if the payment or grant of such Incentive-Based Compensation occurs after the end of that period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Recovery
Period</B>&rdquo; means the three completed fiscal years immediately preceding the date that the Company is required to prepare the applicable
Accounting Restatement and any &ldquo;transition period&rdquo; as described under Rule 10D-1 and the Listing Standards. For purposes
of this Policy, the &ldquo;<B>date that the Company is required to prepare the applicable Accounting Restatement</B>&rdquo; is the earlier
to occur of (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action
if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting
Restatement, or (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fitell
Corporation<BR>
Incentive Compensation Recovery Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGEMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
the undersigned, acknowledge and affirm that I have received and reviewed a copy of the Fitell Corporation Incentive Compensation Recovery
Policy, and agree that: (i) I am and will continue to be subject to the Fitell Corporation Incentive Compensation Recovery Policy, as
amended from time to time (the &ldquo;<B>Policy</B>&rdquo;), (ii) the Policy will apply to me both during and after my employment with
the Company, and (iii) I will abide by the terms of the Policy, including, without limitation, by promptly returning any Erroneously
Awarded Compensation to the Company to the extent required by, and in a manner determined by the Administrator and permitted by, the
Policy. In the event of any inconsistency between the Policy and the terms of any employment agreement or offer letter to which I am
a party, or the terms of any compensation plan, program, or agreement under which any compensation has been granted, awarded, earned
or paid, the terms of the Policy shall govern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used but not otherwise defined in this Acknowledgement Form shall have the meanings ascribed to such terms in the Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Signature</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Name</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>form20-f_001.jpg
<TEXT>
begin 644 form20-f_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $. 8D# 2(  A$! Q$!_\0
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M<8IX8'H:KT4 6:*A$A'O4BN&^M #J*** "BBB@ HHHH **** "BBB@ HHHH
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MVAO;:2VN(EEAD&UT8<$5S>IP:!I%Y;0S:=YDL\3A29.-J 9)+-R<$#/)Q[4
M"ZMX4! \N% L98DVS*$ Z@\<']UT_P!BF#4?"\%E(;>Q\V%P(Y$AM2<"1@FU
MN.,D#CT%)!=^$[H,K11(9I3&RR1MAGQSST(_>GGI\U/$OA&56(EA<!"CG>Y^
M6/Y\D^W!#'\#0!/<>,-'LK&5K9VG,!V"*-&[<9SC[H]>E=)6(F@Z)?6<;)9(
M\#MYR@E@,MR>,\ ^G2MN@ HHHH #P*Q[?Q!8:IYL>E7<5T\1Q)Y9SL/N*O7=
MQY2A%/SM^@KR_P 6P?\ "%^,K+Q)8*8[:_8QW<:_=+^N/<<_4&HJ3<(\UM#:
MA2]M/D3UZ'H#)(9,-RYYP3R?PKGI/&WA>*5XI->L5D1BK*9.01P17B-I;>)9
M_BO#+<S7#7DE\LBW1+!&C+<$'IMQQC\*Y_62\GB.]2&)"1>R\MG'WSUK95DU
M=&,J4HNSW/HP^.?"H)!\06(_[:?_ %JU;2[@U2Q2_L9EN+-\[)HSE3@X/ZU\
MOZN"]PLY@CB/$<B+SAP._P!>H_&OH?X6_-\*=-W=_,SC_KJU.-1O44J?*VC=
MHH[T5L9$D4[PG*GCN#T-7SY5];M&V[:W#@-@_3BLRGQ2M%(&7\1ZBHE&^PT[
M&LB+&@1%"HHP% P *=34=9$#+T--EGCB^^P!]!R:Q-22BJ#ZB?\ EF@^K57:
M\G;^/'T&*0%O4>ME_P!?2?R-7,5S=]+(?LN78_Z0G?ZU9$D@Z.WYU3V0NK-N
MBLA;J=>DA/UYJ>/47'^L0$>W%2,T*;)&)8V0D@,,'!P:9%=12\*V#Z'BI: *
M.EZ7%I,$D$$DC1,Y<"0Y*D]>?2K<D@C'/)]*)'"+N/X"J;,6)+')IMWU8DDE
M9"O(SG)/X4VBBD,4$J<BI001FH:56VGV[T 344 @]#GZ48H <DC1GY3QZ5=C
ME61<CKW%4*56*-N'44 :-%-C<.@84Z@ HHHH **** "BC-)D4 +12;AZTM !
M1110!6O[V'3;">\N"1#"A=]HR<"LF74=!U"2)[J2)9S;L!'*^&6-\9Z''.!W
MK7OK.'4+&:SN 3#,A1P#@X/O6+-X/L9KA)3+<8"%)%,A_>?(5!/HP&.1Z4 5
M3_PBEO,\;O%& 0N6F.TDD @<^L2YX_A^M")X25UM$O(5:W=W6/[01L(!SW[
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M]R^%?/PITO\ [:?^C37@NMZM,;R\03O-).1OD?\ @7 PB_A7O7PLX^%6E_\
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MGO7$#HQ4* QRX(Q\Q/ ^A-:=_HD^CZC9WDM_->1&\B";P,Q 9Y)'4GIG&36
M&UW1[:;3M.CN/(+'#-;,P)S]X>G_ -:MS1KW4=2TM]'UFVNS.$^2Y\E@7]#T
MX8''UK&K&<)*3U1K0E"K3Y5=/S/04U 23[8@ZD@[/-&W)_G64+F_M;JZ+SVD
M%ND/GS*L@9XV_BXZXQW]O>N$63QA]B%K#I]S+<0LR),4(##LV3W!_0^U<UXF
M/BBTF?2[VQN+LE8YYYH$8LYV@;0X'..I'K5\MY)HE-Q33'Z=<3>,_B#YCK)/
M+<N?)38& 51P&!(PH4?G7NG@^^LK_0A)8Q^6D<K0NNW;AU !&.V!BO._!.K6
M7AO2T273[P3F1F4QV#M,4)X#L% S^->C>%C!)97EQ;VK6J7%Y)/Y+IM(+!2<
M^Y//XUO4?,TT91=H\INU=@.85JE5VWXA6H&2T444 %%%% $%W9V]_:O;748D
MA?[RGCW'3H?>L/5/#-H\4)MAY,@E4,[$N6SM'))Y^ZOY5T=5[O\ U<?_ %U3
M_P!"% %&W\-:3;&)H[0 QR"5<NQ^8# /)[=AT%:U%% !1110 4444 4M1^]9
M_P#7RO\ (U<JCJCI$+1Y'5%%PN68X X-2_VA9?\ /Y;_ /?U?\:;6B%U+5%5
MO[1LO^?RW_[^K_C1_:-E_P _EO\ ]_5_QHL.Y9JO>)OMF]1S2?VC9?\ /Y;_
M /?U?\:0ZA8D$&[M\'_IJO\ C0KK43L9G>N-\3> UU_Q(VL+J'V<F-4:/R=V
M2HQG.1[5U\EQ:QRE1=6Y /'[U>GYTQ[RS()^U1<_]-%_QK6I3516D@I5IT9<
MT'9C[2;[+8P6V-WDQJF[.,X&,UC7'A/PM=W$EQ<>';"2:1BSNT?+$]2?>M'[
M59_\_47_ '\7_&C[59_\_47_ '\7_&FJ=E:Q#FV[MF)=>#/!JPO++X:L]J+N
M.Q2#C\#70:=!8Z7IL6FZ=9I;6D?W(T)PN3D]?<U2OKJS-A<#[2A_=GA74G^=
M7U* @_-Q3Y$EL+F;8P]32<TDI(AD(."%8Y_"O!M U77[FTDNKSQ!JB1Q DM]
MH)Y(SW[ ?J:BH^A44>\T5\T7WC+Q DC-'KVH@L/E43L H]2,]3Q[50_X3+Q1
M_P!##J?_ ($M619]38/I17RU_P )GXG_ .AAU/\ \"6I/^$R\49_Y&'4_P#P
M):@#ZFHKY@B\:^(_)='\0:GO/W3]H;_'BEE\9^)%_P!7KNIAE.&'VIF4_0T7
M ^E;SI;_ /7=/ZU9KP#1O%6NS6]S!>:K=2QI;O()/./F(PY!4D]?Y5D1>+?$
M#2NC>)]010<!GD?G\J.@CZ6Q17@^AS>(]<OA;V_BZ^VA"SLL[,?H!GO7=ZK+
M?:#;0B&]O;MD0*T\LS,6]3MS@FLIU%$UA3<]CO<45\SZEXRU\7D@MM?U)$)R
M%%PW'Z]*L:#XU\0#4#]HUJ_G5D*A'G8\^WO5N7NW)4?>Y3Z0HKYNU?Q7XB@U
M.9(M>U%8PWR@7#=*S)?&OB?<0OB#4@,Y_P"/AJ(RN@E'E=CZE&0015M6W*#Z
MU\FQ^,_$^_!\0ZF?^WEJ^K+1LVR9.3M'7Z51)8W-_>/YT;F]325%D_:P,\>6
M?YT 39)[T!F' 8@?6DHH G5V*CYF_.@DGJ:9'T-/H .]:"+M0#T%5($WR GH
MO)J[0 4444 %%%% !5>[_P!7'_UU3_T(58JO=_ZN/_KJG_H0H L4444 %%%%
M !1110 UT61=KJK#T89J/[+;_P#/O%_WP*FHH A^R6__ #[Q?]\"C[);_P#/
MO%_WP*FHH A^R6__ #[Q?]\"C[);_P#/O%_WP*FHH I7.GP2Q_+!$''3Y!65
M+!$!@PQ@YZ;!7152O;59EW*0K_SK2$[:,B4;F+Y,/_/&/_O@4>3#_P \8_\
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ML6?M'+_[+32N)NP""0]L?4U*ML/XCGV%3T4ACX%"@[1@5-4<0^4U)0 4444
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M[5Y[XV_X2R^MIHA<?:-)$(C#3.H*.Q"EF(&2!FO0;?4+:2::..=&<1.=H//
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8J[*E*R+$:!$"CH*=1172<H4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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%10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>form20-f_002.jpg
<TEXT>
begin 644 form20-f_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #L C8# 2(  A$! Q$!_\0
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M_<F_[Y'^-'_"1V?]R;_OD?XT?7</_.@]C4[&Q16/_P )'9_W)O\ OD?XT?\
M"1V?]R;_ +Y'^-'UW#_SH/8U.QL45C_\)'9_\\YO^^1_C0OB.S<@!)3DXZ#_
M !H^N4/YT+V4^QL451U2YFM+%I85RV0"Y&1$#U<CN!5J#_4I^]\WY1\_'S>_
M''-=9F24444 %%%(QPI(ZXH 6BN;A\1W;H%;2Y6E)Y89" ;@."1DX]:/^$GF
MB@:6?3)D4 9;.%4D9QDCH.>?TH Z2BHK>87%M%,%*B1 VT]1D9J6@ HHHH *
M*** "BBB@"EK/_(#U#_KVD_]!-?-2?<7Z5]*ZS_R ]0_Z]I/_037S4OW%^E
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MX^5PH0#+<&L/4[%9(]MI(T?RI*4ER$1-HR..>AZ=C64NJQ6$Z17;*H15^9I
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MI6=)((462ZA@>>.;RXS'$!M5@>?<=!5HSQ")"L<9#OSE?P/:DLVK=(QMZ/\
MS*6"A;=D.E:6=1E0M/%%#C>S,>=G/('X5Z1-KUM!H<=\N&+ *L>><]L_E7FN
MGW4EM)]G:T 0.RMMAY(SP1CH./TJS<WN2N @)&Y0R\'BLZ^8UZ]N=+3L72PT
M*:]WJ>F66JVE^D?ER@2."1&>IQU_"I9+F.+S3/\ N8T;:LCL,/QG(KS.RNS&
MKRJ^R0+A0HP5S].W-3MJ@=88WE,JLN0"W!SW'KS6"Q?=&W(B;QU<7M]JUKI5
MH=RDH55>0Y;J3Z@#^M:MEJ,T/A::?S'\W3'D97/6382"",\ CM]*X9=0>ZU^
M_NUN)HI-."A&SSCI],8!X]ZWK'3+232=5G%W>79N([B1!MVQ@Y/)QW^OO7-6
MFY2N>E1C%143T+2M136-+M[]  94#$ YJ:]&+4GT9/\ T(5Q?A"X.F:!<W%P
M2MM@10HK?>..2/<D_I5V/Q"@ABM[Q%,URZK&R$#/(YQ^G%=M*M>-I'!6A:?N
M['7D<TAP!DX KEK'Q?9S7;17)@6,L0CHI! SQN!_F*U=7U*WL;*.01B8SMY<
M83&">O6M8SC+9F7*T2:C_KD_W?ZUDWU^EB%14$D[#=M8_*H[9]3[4EEJTNKI
M+)-$D;QMMPAR.1GK5#4QLU9973?'($8+_>  !'YC%>#2ITZV-J.6MCT7*4*$
M4B2'7'\P"X@C,9ZF-=K#Z=C6N<<%6#*0"K#H0>AK U JJHOV%[9LELNNW</\
M_E6S;*T=K!$_#I& P]#DG'ZT9GAZ4(*<59W##5).7*R6BBFSSVUC9O>WKE(%
M.T*OWI&_NK_4]J\:A0J5ZBI4E>3.YNP[OB@@CJ"/K7--XFUG49VATQ8[*( L
M1'@%5'=Y&_\ K4Q=5\20AY(=7BO0@+/$LRS<#J=I&2/I7UBX3K*/[RK%2[:_
MF2W+^F=116=HFOV^NL+9XDMM1QE40_NY_P#=S]UO;O6C7SF.P%?!5?9UE9_@
M_0I.^@53O]26R<0QQK)/@%MWW4ST&.YJVWW3CK6-?QM!KS^= S[WWA"O+ CC
MC_/2M\LH0JS;FKV.;$S<4DNI-;ZWF55O(D\LGEX5PRCUQT->EV,-O#:HMMCR
MB P(_BSWKRB_VYC5;-K=N>"/O9Z?7_Z^*]/T.&2WT>U@ESOCB56]CCI7OPH4
MX2YHQ29P.<FK-EBYC2:/86VL,X.,_G[5FQZ:$.U([>W!&&DBW%B.X&>E:\DB
MQKN8GK@ =2:B-UM/[Q&0=220<?7'2MU<R=B13$B*@QM4  8Z8I=\?M^5/_$T
M?C2*(V\AV1F52R'*DC[IQCBF116L#2-%%'&TK;I"B8W'U/J:G_$T9'K0 S=%
MZ#\J421CH<?A3L^YH_&@!OFIZ_I1YJ>OZ4_'O1CWH 9YJ>OZ4>:GK^E/Q[T8
M]Z &>:GK^E(SJPP#DY':I,>]-8[1GWH =1110!2UG_D!ZA_U[2?^@FOFI/N+
M]*^E=9_Y >H?]>TG_H)KYUTJ*&:\BCG21XRI^6,$G...!SCUQ0!5Q2UOC1(Y
M9A"SHA#R9\KYN%"\9/U[U5DTJ!;669)Y2RK(ZJR 9"L%Y[@G.:8'G7BL?\32
M/_KB/YFKE[#)<>#8(H@"Q1.I [^IJYXCTNVGN;*1Y'C+6RERN"23*4'7IBJV
MJPA/" A)W; JY]<-BDP*6HV5Q<Z'86L$:R3PA3(@<948JU;V=U'XH%Z8B+?R
MPN[(QG:!4V@Z?!:VD4R;_-GC!<EOY5;D:1)\JI$6ZG&-Q.5F82Z?>-9:H$95
M\R0,")!A@"21D'C\:AM[*Y:?3Y%T^"W2-@"R2KF0@C)//-2Z9M&BZR"0/;\Z
MK2HKZ;HR$<-(X./=A2*-K1[>6+6]1F.SRW8X(<'^+/;I6AJE_P#8[">2"2(S
MQX^0G..<<BL46\>G>*)8[-2BBW8A<YYVD_SK/BM+:3P_<7CY-T),;BW/4=N^
M<F@1V&GSO=:?;SR8WR(&;'3-635+1_\ D"V?_7,5>IB'0RS03++;LBS)RA<9
M7/N*Q;SQ#>7=Y)]INQ%-@;HXUP/,7G&/R_*MN")9[F.(QF7<<[!U..?Z5/?W
MNGW5^/MUK#DQ9BW6WR[SG[Q[<9/>N2M+WK,N*+5UJ&H+*\,6GSSO+%$B&0C8
M6*@L,Y)''?VKC-?U*[BNEN[C0TC:WF\O[0^60\#"_P"UCUK1\0>)]2TZ]58<
M1VR, /+ 8L=HX.?3'2GV&MQ:E8 ZI(TT<J,CVSN&C'.=V!R&]ZRBE?G:-8QY
MGRW);+Q-_;UI#&R);7=M*#Y<;;%D7'7U_"MK5&+:?+8_:YH9Q'N\Z%2<@^_4
M=*AT/2M+UC44O[#>@2,1#?$&A8*W '<'\:Z?4K&_MH!+#=QB*-29 L//U]0!
M6<HOFYXK0TDN1V9YT-7BALXU>X<1@9^T,P9B<=,5I:'XO9=- $^RX0[6/0.N
M?:I%T+P[<ZF+F[\R8.>896"1*W4GCD^W:N=UOPW#9R3K:S,KHQ9,-N5X_8^H
M[ULI1EL:1G?H=W8^(9+@22#[JL!C/)'K]*Z+3]6!PRR -GL:\MCO&33/.MT*
MR6Z;01P&'I4N@ZC<W:^?E5V-AX\\K5)M:@XQ>A[)%>QQ[-ZXB'!XR0Q.!3IK
MZ&.Y8R2!%3!=GXVCU_I7&-XB \O;#O &) W1AZ5<?Q#</)MATMO."^6J,."<
M9PW<\8->K# XF45+EW]/\SRIXFC&37-L:#WBV\[.2)?.E(18^A&"023T[ T1
M22V_S%HYII"0JA=JKQDCWQWKG!JM[<*PEME$G;9NV@?0]^U:%N);E0Q4B3;L
M5R.$4_W1V--X'$+[/XK_ #,WBZ*WE^9:\13W=IX/\Y(5FG^V*2BY_N/_ )YK
MA#=):O=&?+Q2A7"H#A7;K@$X.&&/8FNW\1J+7PI"KG8#?+EE)Z;&Z^IKBTU#
M3X%>PE@$D;*=KQR'D'MCUKRZ]*49M-&\*D9Q4H[$MA?+(+E)QMB8(?(D/,>>
M#G\<4JWSQZ>';: ZEDQSM/;CU[U6B2PDU218K96550R(V02 >_-=!HBVTVIP
MVVHQ6TL.YTC$A(#M@E%;/8G -3R6-$S"LKFXEU(O;PS/.4!\L GD#[WZU=0W
M.HI<W<<ZB&U==@?@G<,$8]<YKJ9M0T>RU"VMUCM[2^FA!F-M@H).>.#M].!6
M9JUNUS9,^GJL\UROSG"J&(P02/7K4)VG9@UH<C+K;"?;"A61)C&0?N,#ZGH*
MWWN\2PG9&!Y'F!F 4 ;CGC\*QH;RU73Y84M4\X,""(1G.:Z32].U#6-8L+:%
M_+C2$N[,N57#L,XK5P5A+5F!>+;Z78R7\ERC7FH# LTY*[6X;C/RXQSZ\5U&
MD>)]1O\ 2#+/_9FE:<Y,<C7$@61@>"0H/OQ6+KW@&4^(K;1WNDEFO',BW$/R
MO&HY)8=N/PJ]XP\#6NBZ=LMY%FLTB+3B9!F  ?>SWST'?-/D@]]SHC*2Z:$T
MFK1:Y:PRZ?)''I=O&&2)B58J"5W-]3Z>M55N+FY\1V4SSQ[1.B[!G 7Y< "I
M?"%C.-%M([>..Y>*Q8VR% 8VER" V3C.,\'@D5L:AI.-:2:WM94V2QEU0$H&
MP"VT],!L^U:*DD82DV[LY^6S9;P"2Y569V52N<9SS]*TC+<PZ3/:+<^;&662
M+;$6VG.#S_",9JW::=.))5GL9&*RLT;>Q/K^5216.IM(SFWD4,A)C8Y!;/?F
MA0:=T@;NA/ D=Q'I%S]IE$K&<@,%QP />NDDBD:.1(F5'*-Y3L/]6Y& P/;Z
M_P"%9VA6#Z>MXK1^6DLWF(GH,#/ZU;O]0%CMCC19)V&X[_NH.W'<FO 4*JQS
M=):IW\NF_D>C&48T4Y%?2K.^MDE-W$D8(79&S!_W@/,@Y...,]\^U:2KM'4D
MGDD]ZR(=;E#_ .D11R1GKL4*P^A']:V/E(!1MR, RL.X/2M<YGB*U7VM5)+R
MO;\2Z52,V[;B'IQUKD_&%XTVM-9J?W-DHB4=MV,L?Q/\JZMFVX;T(-<3XIC:
M'Q/J(;H\ID4^JMR#^M>UP=3@\14D]TM/OU-E\:((CL\/WS$X\R>&,>^-S$?3
MI4&CRK%KE@[' %P@)]B<?UJ73/\ 2H[O3FZ31&9#C[DD8+9^A&X'ZU'I)2$7
M.I,H<V<8>-",@R,=JD^P//X"OT"3252+W?ZJR')VYDRE*9;2\?8Q2:&4X93]
MUE/;\17KFFV\VNVEK?Q*J)<PK(['H'Z,/S!_.O&I)"SL[MEF)9B3R3W->Z>"
M('M?".EQ2##F'?@]MQ)'Z&O!XAPM.O1A[3=/]##$3<$FMS6L=(M[,!L>9+_?
M;M]!VK/\2:3+=Z=*UI&&N5'R$<-MR-R@]LBNA%%>!1C&C;D6QYO/+FYGJ<'X
M2T&]CDDDOK4Q1K@Q+*N"'[L!VXX__57=1H$4 4[%%;5JKJS<VK!.;G+F96N&
M"20R.<1JQ!/IGH?\^M5#BU>>6X <,IQ+G[P/1,5H."<CY<'L1FJZ6,$<@D2*
M(,.AV]/IZ5GH96?0K7ME>W>D0PVUQY%RNTEB2!QU!QR?IQ5 :3XB11&FMH(T
MBVH3$"Q;G!8D5T W_P!Y?RI<OZK^5(HQKJQULA9+?4P&2(#R_+7$C@<D\=S]
M*IZAI6O7=Q&D5^84:!0\Z.1L< [@$&,@GG/48Q72Y?U7\J,OZK^5 &++INL>
M86@U%48K&-SY;&!AAMZ')^;/4].*DTC3]6M+F5[_ %%;F%\E8POW6)ZYQ^G:
MM;+^J_E1E_5?RH ?13,OZK^5&7]5_*@!]%,R_JOY49?U7\J 'TV3[GXC^=)E
M_5?RI"&/!9<?2@"2BBB@"EK/_(#U#_KVD_\ 037S4GW5QGI7TKK/_(#U#_KV
MD_\ 037S4GW%^E $]M=36CL\+ %AM(90P(Z]#5IKNSF8R7%K/),_+O\ :,;C
MW.,<50HIB$O=-T'4)EEN+"[W!=HVWF./^^:KW&G6DUE]B"2+:C 52^6 '3)[
MU9HH J"V6WBCBB+!8P%4YR::59G4N=P!R !@9]ZGF8<+WJ-",_-4WL44&\/Z
M=),\IA<%\DJ'XR>^*F_L2R,=O'MDVV[%H_G[DYY]:OC':G"A 5CI]N=2%^0W
MGXVYW<8QCI5-O#>FM*\AB<%_X0Y 'TK6HJB2.W@2VMXX(\A(QM7)R<5)WI<4
MG>@ 2+=,N#&#G'[TX7'?/^>N*Y'4FOTU_P"PS7'G.LJ[9<=58 #Z#!KJ+NX6
MUMGF?RMJ8),J%TZ]P.HKF8$%_KUB\,<N]+R-78[LR(SYR,\X'H>QK.2NRD6O
M$=D-/UJZL7EE;RKC9'&A!9HP#AO4MSBM233;Y/#MCIT-FKWE_P#,\8C"NJ>Y
M[>I)KK8/#%I;:M>:Q?RK/>RW3S1LS?) NX[<#UQWK%U3Q>+>\>VTCRKJ]N'V
M>8&)&0.A8\<>@K&35[(Z:=-VNSH(%?0](@L[81!((P'"MEO<_4G-0Z+XW%UK
M0LG4*I^[N'/TS7#ZEKLEM;"":4-,WSW+KQN8_P (]ATK&T^_F74%OW.URXQC
MT%96?Q&[<?A/0_%]@\=]')#'YUA*/,10<;'R,KGL/3TKE-;AN+33MH06\MI.
M^Q$DWA1QD9]/K73:Y=?;M#@-A($ECOH]PS\NT_>S[=,USWB'4FUN]U*)[<0O
M;7#)L3';@Y]S@\U23^(P2496*XT/4[VQ,MA/$\3$9B=BA!*[N.W8UDZ?=76A
MZPK7:F-'^612.@[&NPT*:YE\*06]LJS7$-ZJ;>A50A/?@G%7=0;47B-O>Z7Y
M<P W)*BN'SQNSTQ2DYIVM="4K:BV3B\7S861@ASST_\ KU2O_'"0ZA)%>-(L
M\$A+,8UY.,9]^,?I4-I(+.X\B*W^S1\EE"% 3W(!YQ7">)[G[3X@NGQ@94?D
MH%>M2S/$Z1=G9=D<E7 T+<Z3U\SO[?XJVD2!76[P"3D1+GGWS[5J+\8=%DV_
M:+?4'V\C$:?_ !5>*45;QM1N^GW'++!4I*SO]Y]1>'M1TOXC:!.NG6S3BVN$
M,L-R@!0E6P?0UOZ=X%TJ-+BXO]'MI)85_=Q;1S@9ZBN$_9K!&G^(P00?.@X/
M^Z]>WS0EF#HQ5QQD>E82JN5[G13IQIP4([(Y 6'AQ&W?\(L!,P'_ "PZMZ9]
M!CK5F2ST6.9HY?#C960A"L6[< <;AZ<C^5=#LNO^>Q_(?X4;+K_GN?R'^%9W
M\RSG4L]"$&]?#X0B105,6,;F(SQ],GZT\?V+Y:2#0[K8YP,0G.?IGBM_9=?\
M]S^0_P *-EW_ ,]S_P!\C_"B[[@8%QHMI=::MW86HM)B^ K<;ANQS_.JT7A_
M5H+A98Y(P"A1@,GKW&>,UU MY7=6ED+8Z ]!^56P,"FY-JS*3:.9T7PU$&-W
MJ8%Q?*S*'Y&T<9Z=SQ^E:%]H&DSV\AN+!)U +%&).[CTSSQQ5^6%]Y>)RC'K
MCO4>R[_Y['_OD?X5*26PFV<MIUEX<T^'R;+PY+ & 9DAB.WIGKGGK5[?I E\
MLZ3<9S@L$)4#.,YSSUK;V7?_ #V/_?(_PHV7?_/8_P#?(_PJKON(B&AZ;_SZ
MJ/\ @1_QK,U?15C$3V$9WLVTQ[^",=>36QLNO^>Q_P"^1_A2I;R&0/*Y8@8&
M>U-2:UN!GZ-IKQ6DJWMLFXOD X;C%<3XBMVM/$DC&+='(RO&F.&' P/Q&*]0
M[5DZSICWME,L&T7&QO)<_P #$8R#V],U*2<K[7*W=CSG4"0B!K%K8[B02N-W
MZ=:[G0]$@.D6HNXF\X1_,-Q&,DG'ZUC^%?#5[:W$[WUFL$6<I&TGF9?/#>V!
MD9]Z[F)!&F*K$T*:DX74E_7J7)>SE:+*+:-IZKQ;*?\ >)-<GXL\)?VT]O-:
M%8KF+$;C'WXL]O=><#O7>$9%5)X-PR*6&E]6GST59^@1JRB[W/!KS4C$)K*S
M@^QP9*.#_K9!_ML>?P&!5"WOKBQE,MM)L<C:<@%6'HP/!'L:]NU'0[#4VS?Z
M?!<,/XV7#_\ ?0P:H0^$-"MWWQ:/!O'(,K-)C\"<5]#'-J*A9P=_ON=BQ4+6
M:/)+VZOKS6=1L]+NETJ"RD6-Q;0X,S]&8G.<9!PO0"O2/A;XGOM<M]2T_4IA
M<W&FRK&MT%"F5#D#('&1M/X8JAXA^&_]K:I-J.GZI/I=Q<D&Y6--R2$#&[ (
M(./PKJ_!?A.T\*Z>]M;/)-+,_FW%Q* &E?Z#H!V'N:^?G-S=VSAE)O5G6"BB
MBH)"BBB@"O<2%0J*VTL3EO0#K55)T>1TA>42+]W>20W'?T[U9N8_,0;642*3
MC/0YZ@UGBWD+_NH!"Y&TRM(#@>V.O6J1#\RU>:O::?917=TYCAD94#8S@GUJ
MHGBS19(U<7R#<!P5;(R,X/'!YY]*T3;6SVZ6\B1R1*  K@,./K318V"YQ;6X
MSU^1:DLH0^*]'F5<7BARH)C*G<O?!&/Q^G-">*M(8L#=!=K%264\X[_3W]CF
MKT>GZ?$<QVUNAZ?*@'^>IJ.32=+D6)6M+?;$P9 $  (Z?SH OCD4M-#*/XA^
M=&]?[P_.@!U%-WK_ 'A^=&]?[P_.@!U%-WK_ 'A^=&]?[P_.@!U-D^Y^(_G1
MO7^\/SI'8%< C.1WH ?1110!2UG_ ) >H?\ 7M)_Z":^;K8.<!(V<E>BC)KZ
M1UG_ ) >H?\ 7M)_Z":^:4)VKU'% %T1W .?L3Y_W#49M;DDG[/+S_L&JS2-
MNP&/N<TF6[L3^-%QV+#6]PH/^CRD^@0U7:&]?@6TRCV0TV1CY1Y/YU"K'<.3
M^=%PL6/L=UG_ (]IO^^#3Q8W'7[-+_WP:9@^I_.G G'WC^=("06EQC_CWE_[
MX-+]DN?^?>7_ +X-1 GU/YT$D?Q'\Z '+!=#K;3'_@!J7[+<'_EWE_[X-9VX
M]B?SJPK':/F/YT[BL6?LMQ_S[R_]\&C[+<?\^\O_ 'P:@#'^\?SIP8YZG\Z8
M-$%SIG]K9TUIOLYG^0R,N0O?D?A6FUS9Z#B&RF2XU"-"T\S\+&@'.2/NK[=3
M55$6214>5H@3S(O5?>IH;"PMXKB.&_NUCN"6F6-% D)X.?EYJ7#F*C44-;:G
M(^*O%1O,);:AYLF<2*D15%'LQ//Y5E:;K F>.!XXTNF98H)%7"H&."<>OO7>
MV^B:)$@0PO<QK]U9XE?;[ XR![9K1@M-.AB:*VLEA#9PT5I&&7/HV,BA4E8'
M6E<XWQWX*ET5(KVRDGNK0*!.SK\R2=S_ +I[>E<8]_,RJ%PF.XZU["OAC3'B
M(<W>TC!$LAY'OSS6:_AWPFO+H%'^W"PJO9D>T,7X>:9+XA;48;JZN([59(IW
M9%SOD!. <]L=?H*Z+Q!X4ATEKS58KJ5VO+@LZNH 7.344<'ABP3; 'VDY*P^
M8.??#52O[_2WMF6"POPV=HZDGCJ0S$8_6E*F[6L:0E[UV=+X.T?R/#EC<(1'
M//YDTC,#U((3I[5IW-AJ3I$[:A;-.BLC2/&X&"V01@]0!BN6M'T".UMXVM=\
MJHJG(<;CCTS6I!IMG*&>338$AQG=*Q4C]>GUJ94E9<Q*E)O0S_&;1IK;2Q8R
M\6202>23R?>E7PU::II$<5]%8AB@*R0G$H)'5CZ_I[52UJS@LR;A8HHH"5"I
M$X(]SUJJ=3\-YYTB 'UQ_P#7K.%)2;L;5)-1BB%/AHT#/*EY#<'=\D<JG;M[
M[B#R?IBIKOX=6;NC6UQ-;-NRRD>8H'MFHCK.@Q']WIZK_NR%?ZU*/%6G(@"P
M38'_ $W)_G6_)U.>[/8/@YH5KH=OK*6TTLWFR1%GE'S$@-_B:]0KRKX*:O#J
MUKK1A5U$<L0.Y]W4-7JM*UM!A41G 8JJL[#J%'3ZTLSE(69>O;ZUG7>MZ7I$
MBVUU<B.3:&QM))!/7@=>"?P)H$7_ +0 0'1DSP"W3\ZFK+AU[2KZ\-C%<+),
M<C9M/..O.,=C^1]*N6S'#1DY*,5R>] $TDBQKN8X%1^><9\F3'T'\LU#<7$-
MJL]W<MMB@'7&<>IQZ\XJB?%FB!-YOEV[MN=C>G7IT[9]>*!FO'(L@RIS_2GF
MJ,5S#<)!>V[;HIQC.,9&../7BK$['R@H."Y"Y],T *9P6(16?'7:./SH$Z[P
MK*R,>@8=:@O=0L])M5ENI!##D(#@D _A[ G/M3K>YMM4LA/ V^%\X."#D''?
MIR*!%JBH;:0O$-W+#@_4<5-0,**** $Q2T44 %(0#2T4 <CJWCO1M'UFZTV^
M2>)[=/,:3:"C+L#';SR>0,=>14+_ !%\,1+*[37'EQKG?]F;#<X 7U)(/Y&M
MS6([@-$;;2K:^5V/G"3:"!P,C/4_X55M3>SRPQW7AFUA@EXD;S4;8,'J,<\T
M ;,'DW5O%<1Y,<J!URN#@C(X/2IU0+TI44*@50  , #M2T %%%% !1110!'(
MZ(I=R !ZBHOM$>1N1D!. 67 -,O>%7/W?F _WL'%8U@\D5Q/Y\;B HP8N"!M
M[>WMZ\T[$ZZG1A1Z#\J-H]!^59UU%?3Z3"+68PW(V-DG&1W!X/:J(3Q.8T)F
ML _\2[#CH/?US^E(I&_M'H/RHVCT'Y5BJNO&ZTZ20P>6N\7:*^ V3P1P>@QQ
MG\:A6/Q*H"+);'KO>4[N<]5  P,8P#[Y[4 =!M'H/RHVCT'Y5S2P>*3,SM-:
M@,?]6&^4<=N,XSSZ\U8MQXE^T1-.;(P[P'5?O!>YSZ]?R% &[M'H/RHVCT'Y
M4ZB@!NT>@_*C:/0?E3J* &[1Z#\J1@%&<#\J?39/N?B/YT .HHHH I:S_P @
M/4/^O:3_ -!-?-4;(J9<9 7@>]?2NL_\@/4/^O:3_P!!-?-*2-%'N7;G;CE0
M?YT *HML_>>GXM^.7Z]Z:MY+Z1?]^E_PISWDJH3B+_OTO^%(HJ3.I)"_=)R/
MI48/(-3?;9B?^67_ 'Y3_"G?;)O^F7_?E/\ "F2.![TN:$U"9>&$1'_7)?\
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MW\X6\*2\X*1@,2>N/K@4^T5MI=_O,2QJBLRPSE&L+K.[;N1 PZXSFM<  8%
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M<RC'F=A+/QC:76IK!L,<;N5$CN,8QP3]:ZM#N (KF)O VF+9O(I828.U2P_
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M;_V45T4D22KMD177T89%3>S-(F#I^H))*YB!GG\A40/\NYE'S#)^N:WU4*H
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M GO^= %I1E<E0#]*QM=TN/4/)6-DCN,_?VY^7N#CWQ5_[ G^34D5HD1R *:
MI:#I#Z1;S1O,LIDDWY5<8X K6HHI#"BBB@##.FZ,5R\X(*C&^?&!VQ3OL&C?
M9WC$J"-G&XK-T;!QSG@]:86\/J,L+<;E!PP.<=?\/TIWF:"UL^/LYAWA7PIQ
MG!QG\,T ,72M%2)?,N%<#C+S\$^O7&:GFL-*>9GFFYW'*M-@9P,_TJLG_".1
M(N#;' VY.2:GG.B+.S3B 2;L?.#UP/\ ZU "1:?HL4;B.6,CR]KD39.WWY^E
M1II.C*C%KG<N[)W3\>P/-/AET'8_D"W*K'EMBG[O^<5$@\-QJS VY ;=R2>O
MI[4 6'T_2GC13-B-44 "; (RV.?^^J2#3]&2Y1XI(S*'W(!-GGV&:24Z&T<;
M2"#R@@V;L[=I+8_4-1!)H1N4$/V?SR^5PISNH C32M&8LRW/RLHPHGQ@=^]:
M6G06<$+"R96C+9.U]PS64H\-NSM_H_S %@V0./Y5JZ<UD\+M8[/+W?-L&.:
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M:MG=&[B9S!+"0<;9!@GWH LT444 %%%% !1110 4444 %%%% !1110 4444
M%%%% %'6?^0'J'_7M)_Z":^7I#AA[@5]0ZU_R M1_P"O:3_T$U\NRMM"MU^4
M5,]BX;F5K 5KF!&Z[<YI;96#;BY/&*BU%/,DCNL_Q;,>U6 N( RG!%8LU11U
M25+<.I8EF7/%&F:7;-;*TT8=V&XENV:S-4E\R[8DYPM;L#L-.^7J(LC\J>R%
MNRKI4BI++;'G8Q*8/;/-7[Z!;FT=7&3C*_45S<$A&R1'(<<@CUK1.KW#+@K'
MNQC=C^E4UU,U+2S(KFS>ZM8[Y6#!>9(\>G7%07%ZMRZB,;8U& #WK4T>3B2!
MN5;G%9\-M;Q7+QL@RK$8:AM+<:3:T-#1R[J9, JIVK]*9)>?\3XJ1PN%J];B
M.UMG<'C);'3'M7/PR,VJ-(<9+<YJ5KJ6]%8ZBT25!)L(*EB5.>E/O"R26LKD
M;O,QCV(I-.SY3'T)I=2A::"/;]X.&IH9/N/VF(]MW]*HZR8S=1(Q4 C+-C[H
MSW]:O:!:W&OZO8Z?;,B37#E5,A(7(4GG'TKMKCX+>([F\64WFF*BJ!RSDDY_
MW:=KD2W*OA?Q6US(M_II$FH0PFWN;=N)#@;?,4=P0 >.AR#1+?:C_84MA=$V
M]FUQ]HN+JZRH! QU/YX')-9;_ +Q:;EG34M*5]Y=2)Y PY_W:?/\!/&UUC[1
MK&G3 =/,N)6Q^:U[=',W3A9P3DK6?IM]QM'$\JVN^YY_K?BFYN-?N+K2YI+>
M#RUMXC@!FC0<9],D9Q[XK-;Q/J\DT4DU]+((EV*IQ@*<97&.G _*O2V_9Y\6
M8^6^TC.>\LG_ ,14+?L[>+!EFU#1P!U)E?\ ^(KRY2<FY/=G*W=W8Z[\5:J-
M %U;W#JN4"$-P%P ..XQV/?FJL'CJ:(22"&<3S >:RS<,0",]/<_G771?!OQ
M0OAU=-:XTHN%"[_-? P<@_=JC_PHGQ1_S^Z5_P!_'_\ B:YIPNRXU''8Y2^\
M;ZW=L/)G\C@#</F;'X\?I5O2/%.HP6=Y:7UZ\T$T1.9,$C )(S[@D5T(^!7B
M@=;[2_PD?_XFK$?P3\2;2IN]*8=#^\<_^RT1A;83FWN>'C4;@7,URDK*TC[B
M!T)/M5Y-=U1AA;C Z<(!_2O1W_9V\5"=C%?:3Y6[@&63./\ OBEB_9Z\6QL<
MW^D$'_IK)_\ $5M9,E2:V/.9-3U"XBVRWDQ4C!&_ Q^%=GX4N!=6C3,Y,L:B
M)@<$8 X;ZD']*UA\ O%4:@-J&D#)P,ROR?3[M;F@?!;Q/I2S++J&G!7(.$=C
MG'U6DT@O?<[CX5MNMM3]=\?\C7H5<CX%\,ZAX;@ODOY+=S,ZE/)8G@ ]<@>M
M==5"&N@=&4]",572X\H;)\@C^/'!_P *M5FW U3SG\F.UDC)^4NQ!'U_6@">
M2]3&(1YCGIZ#ZFGVL11,L<D\D^IJIY>I)-\L=J\>[JQ96"Y_PK3H KR;H9?,
M4%E(PRCK]11]MMP/O\^F#G\JBNVOPV+2*!UQUD<C!Y]/PJM)'JWF/Y<=D4Q\
MA9F!''?\: + +7,ZN5*HOW0>OUJXRAD*D9!&,54M/MWFD7,,$<>WCRV+$G\?
M:GWBWQ"?8G@4Y^?S03D>V* !)_('ES9PO ?&01[^]$E[%C$69'/0#I^)JKY>
ML$X8V)!(Y ;('?\ K0\6JIN,0M& Z!LY//Z<4"+=I&RJ6<Y9CDGWJS5&T74Q
M*/M;6IBQ_P L@V?;K5Z@845EZI-JT+JUBEAY 7+M=2,I!_ 8Q543>*" 1;Z2
M0>_FR?X5HJ=U>Z^\I1OU-ZBL+S?%/_/MI/\ W]D_PJ/[9XC\WRO+T;S/[GGO
MN]>F/2G[+S7WAR^:+9U#4<<:6Q(&3F0+D]\4XWNHB)I/[-PRL,() =RX.?QZ
M?G503>)R2!;Z1D=0)9./TI?-\4?\^^D?]_9/_B:/9>:^\.7S1.FI:B\:E-)<
M9&?FD &/RZUK*25!(P2.1Z5A>;XH_P"??2/^_LG_ ,32^;XH_P"??2?^_LG_
M ,31[+S7WCY?,W:*PO-\4?\ /OI/_?V3_P")H\WQ1_S[Z3_W]D_^)H]EYK[P
MY?,W:;)]P^G>L3S?%'_/OI/_ ']D_P#B:/-\4?\ /OI/_?V3_"CV7FOO#E\S
M7\Y3N! "XX/K0LPS@].F<US&I:MK>C6IN[V/2(XLA0!)(2Q/8#')IND:UK&L
MAY+6/2SY3[)8V>17C/N"*OZM/DY]+=[_ / '[.5N;H=?12"EKG,PHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH HZU_P @'4?^O:3_ -!-?+S#,:9Z8KZ@
MUO\ Y .H_P#7K+_Z":^66ES!GN%%3+8J&YGW('V<QY PQ/)IGVI?LAR0#]:Q
MM>F,EZ$QPHS^=97:HY;E\UF6[ME:5CD<UTMC()+*)AR&3']*X^M/2M1DMV\A
MF B)SDC.TTY1T)4M32?1K=4#+,82!R"<BD&BR,NZ.YC8>N#5V"X,QP KK[,.
M?SJQ);+ -WD^6>Y5PM)-EM(J6>F2VY)>1"QZ$'I4&J6"/<^;YFQV49YX)J.^
MUB>WCQ$4;+%=QYK*FO9KV023D%@,# P*=F]1<R6AL%XK>'RX;EIF(((/0?C6
M7#(%O6#8^\.M21,-@]:SKE2MR^>YS32)YCMK">$6S995).>6IFI:E"MNNR:/
M<#T# UQL?)YJ5P=N .2:?*'.>G?#; \<Z !S^^/_ * U?3E?,OPSC(\=:+QP
MLA'_ (XU?3=$=A3W*'V67[1NVK]_._/.*OT451(56NX#,JX7< >G']>#5FC-
M $5O&8XMI 7))V@YQGM4M%% ","5(%4K2WF@E.0HC(YYY)J]1F@ HHHH \T^
M(_A?6M<U>WN;*P35+06CP);F[,'V:<MD39R,\<<<C'%=]H]M<V6B6-K>S_:+
MJ&W2.:8?QN% +?B:>]A!)(7(<$G)PY )J6"!+=-B;L9S\S$G]:;>@62)#GM0
M<@9)%+2,H92IZ$8I 0QW,<KE$?+?2IL'U%5H;5HY%9GW!00!C_/J:M4 )@^M
M5KB^@M6599,,W0!23CUX[>I[59-9ER;>>:.:.YA#J. Y]^",$?X&FE=C1H1R
M++&KQL&1AD$=Q3\'UJ"S,(A6**59/+4 X/-6*0AK':I9F  Y)ID4RSKNC?(Z
M=*=*GF1LF<;AC-0V]J8)';S"0W\/84 6.?6C!]:6B@#&U7Q3H>AWEO::GJMM
M:W%Q_JXY&P2,XR?09XR>,UK@EAD'BN#\5_#R[U_6;N\LM6CM(=1MDM;Z.6W\
MUMBDX,9R-K<]\] :[FWA6VMHH$SMC0(N3DX QS3TL+4KZIIT.JZ?+8W08P2@
M!PIP2 0>OX5SU]X%M9H@MC=SVA#+\NXLFT-NQMR..@Z] *O^+=8N-&TE9K7R
MUFEE$2R2_<CSGD_E5/PYK=]/J=]IM]/#=&W4.L\( X)QM8#C-;QP\W2=5;?U
M_F:JFW#F'/X&TYM^VZOTW*%.V<_W2O?USGZU-=^#=+O+M[R7[0+I]N9TEVN-
MJ!!@CIP,\=ZW?/3WH\]/>N<S.;_X073@C(+J^&[EB)L$G&,]/3'\NA-=+#&(
M8(X@S,$4+N8Y)P,9/O2>>GO1YZ>] $E(I##(]<4U) Y.,\>M)&=L1)[,W\Z
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B444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>form20-f_003.jpg
<TEXT>
begin 644 form20-f_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #9 /$# 2(  A$! Q$!_\0
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M\MQ_5J]CKPKQ:Q;Q9J9/_/<BN>N_=/5RJ-ZS?9&-1117&?1A1110 5U6E?\
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/HH Z:BN9HH **=10!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>form20-f_004.jpg
<TEXT>
begin 644 form20-f_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #] D # 2(  A$! Q$!_\0
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MK'_7HW_H2UY/7G8FE&E/EB?591C*F+P_M*EKW:T/I+_A=O@W_GM??^ C4?\
M"[?!O_/:^_\  1J^;:,^]<QZY])?\+M\&_\ /:^_\!&H_P"%V^#?^>U]_P"
MC5\VY]Z,T ?27_"[?!O_ #VOO_ 1J/\ A=O@W_GM??\ @(U?-N:,T ?27_"[
M?!O_ #VOO_ 1J/\ A=O@W_GM??\ @(U?-N?>C- 'TE_PNWP;_P ]K[_P$:C_
M (7;X-_Y[7W_ ("-7S;GWHS[T ?27_"[?!O_ #VOO_ 1J/\ A=O@W_GM??\
M@(U?-N:,^] 'TE_PNWP;_P ]K[_P$:C_ (7;X-_Y[7W_ ("-7S;GWH_&@#Z2
M_P"%V^#?^>U]_P" C5IZ'\2] \3Z@;#29+AKE8S*1+ 4&T$ \GZBOEJO0_@Q
M_P CS+_UXR?^A+0!ZWKFJZ_'J;+8^(] L(-HQ!>Q;I >YSYB\'Z5G?VQXJ_Z
M'/PG_P" Y_\ CM>*?'/_ )*3+_UZ0_R->:XH ^M?[8\5?]#GX3_\!S_\=H_M
MCQ5_T.?A/_P'/_QVODJB@#ZU_MCQ5_T.?A/_ ,!S_P#':/[8\5?]#GX3_P#
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MMH^I7,FJ02*Z327(R\JL2<-VXSQ]!7A5P\VC^#/&7@V>9Y/[)OH?L['^*)I
M0#].#^- 'GE>A_!C_D>9?^O&3_T):\\KT3X+_P#(\R_]>,O_ *$M '._'/\
MY*3+_P!>D/\ (UY]81P37T4=S(8X6;#,.WX]OKVKT+XZ?\E)E_Z]8?Y&O-:
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M^A;N/^_D?_Q5?8D*NL""5@T@4!V P"<<FI.!3 ^-_P#A4/C[_H7+C_OY'_\
M%4?\*A\??]"Y<?\ ?R/_ .*KZ4U3QDFD6FH/)/'-<^<8K6%<,,@=3CMR,Y[U
MU&F"Z&G6_P!N;==%,R'CKZ<<4 ?(?_"H?'__ $+EQ_W\C_\ BJ]V^!OAG6?"
M_AK4;76[![.>6\\Q$=E.5V*,\$]P:]2HQ0!Y_P#$<_O]/_W9/YK7#9KM_B2<
M3Z=_NR?S6N%W>]>[A/X*/SC.E_MT_E^2'YHS3-U&ZND\BP_-&:9NHW4!8?FC
M-,W4;J L/S1FF;J,^] 6'YHS3-U&Z@+#\T9IFZC=[T!8KZN<^&]8_P"O1O\
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MT Y/_ J7_P"*H_X4KX"_Z <G_@5+_P#%5W_VZU[7$?\ WT*=%=03MMCE1F]
M<D4 >??\*5\!?] .3_P*E_\ BJ/^%*^ O^@')_X%2_\ Q5>CT4 ><?\ "E?
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MZ]P?0\]*UYYXSKFK0/*8FDD.T\=UQ^8S^IIIBM%AMK>:8/+ 2Y+R$@#^[C)
MYQTYP"?2BPKF-/#J,4T,,]U(ID4,"TIP ?4]L=ZEN=&U6)XU>Y#+)@[A*V%!
MZ$Y ...N*UM1EL=0@+02(K1?, 6Y)Z'J!UX/U!]:?)<1&W8&: MO!(63@94
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MN^CD;<D3"4*A'4OM!/..*ZFX\*>$+'27NK_3UA@,, :96;,9<E=_7L<&H_\
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M'*L,BGTT2(/2CS%]: '44WS%]:/,7UH '^X:S)_^/E?]P_SK2:12A -9L_\
MQ\K_ +A_G0!YC\6X?.&D J&'[X$$9SG;7F\>GA5^X!BO:?&?A34O$XLO[/:
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MUP=>5C/XGR/L,E_W9^K_ $-6'GP;J8R?^/\ L_I_RTKZ0GTL;!A?X1_*OF^
M_P#%'ZEU_P"/^S^G62OK4P!HUX_A'\JXSW83<6>;ZUX>MM2M'MKN 2Q'G!ZJ
M?4'L:\A\0>$K[PY(TZ;KBPS_ *T#YH_9A_7I7N_BSQ)H?A<PIJEPRRS@LD4:
M;F*COCL*Q-.UK1/$XE33YR[J#NAE3:Q7UP>HJ*E-5%9GJ8;&3HM21XE#,KH
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M6P" ?[1GP2<8_>&OHW2W$OB2TE QONU;'IELUX?KGA.YU+Q!K%]%=VBH^HW
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M2638IS\VX+C\35>DI6\PTZ(V;\B:U+S7TMPR$A5>Z#X^@KWW]F[_ )$_5O\
ML(?^TUKYIYKZ6_9N_P"1/U;_ *__ /VFM"#T+_QE.+C1_P#<E_FE>7;J]/\
MC.<76C?[DO\ -:\MW5ZV'_AH^3S!?[3+^NA)NI-U,W4;JZ#@Y1^ZC=3-U&Z@
M.4?NHW4S=1NH#E'[J7=4>ZC=0'*/W4NZH]U&Z@.4?NHW4S=1NH#E+ ;.F:M_
MUY/_ #6N.KKU.=-U7_KR?^:UR%>9BOXA]/E2_<?-_H:6<>!]7Y_Y?+4X_"3F
MJR)]J0W$:H]PF-R,1AQ]/6IR?^*&U<9'_'Y:\?A)6380WEQ%)]E#,4&25(R,
M^E<%1V5SZ; 14Y.-K^@R[U">9F#MCGD ;<>U5/.;(^<\>]:X2P%KNO8CN5@"
MR$ASZ^QQ[UD3/'YO[I?E P/?WK.,U+9'97P\J=G.5_O-*2XAGA@EG(64@J[!
M2,XZ'W/:J8$]V2L88Q@_E4R:7>R+&\D+%&&Y5+ $K6U]A!6);:V(50<K(X.X
M>]83G&/J>A1P]6LK--+\7_P#'BBAB5D*"1B"-Q[>_M44#&.0PLR@]F/\JZ*Y
MTFY@L([^\LLVLTC)'.G\4@X*^AQ_C5&ZT*>1WMH+:=KN-/,:+: 5&,GCJ>*4
M97WZFE6CR>]"VG3RZE4(K-@G!(^[CO[4QXR78Q)(% R0W)%.L2UZ/*&YI5YV
M@#&!]34TD4L!/VB,Q/U4'^(>H]12=T[%Q<:BYEL01/(A+*0"/7O1%,RMRW?\
M*N1P6\T99'W8[9P?RI!;#9]P;?UJ7-/1G1"A.+4HL9-DH&X-6]!_Y!7B<[?^
M7>#\/WRU2O+:YB3,:[E'.T<G%6O#K>9HOB9BIS]G@Z=OWRUT8>-G<\?.ZETH
MM-.Y2KT/X,?\CQ+_ ->,O_H25YY7H?P9_P"1XE_Z\9?_ $)*[#YH],\:V<]_
M;M9VL32SS6%ZD<:]6;:N *\'?PQXJCCVIX9U0L>_V9\"OHG6+B2UUJPN(@&D
MBM[MU![D*M5(_$FKS1JZSJ 1D9B&<4Z51QYDN_Z&U=7C#T_5G@%OX2\833 2
M:!J2)GYB;5AQ[<5MCP?K0_Y@.I@_]<6_PKV<^(-83[\X'?\ U0J2/7]3DF:$
M3KYBD!AY8X)Z5T1Q+CT.>/NGB?\ PB6N9_Y &I>W[AJ8WA+7]O.@ZEN]H&KV
MF[\3ZE;;P]U&I0?.&" KSCGGCFI-+\0ZK=SLLDZD;EQB,#@U?UM]AMG(?"+1
M-7T[Q/=7-]I=U:6XM2@>:,H"Q93@9Z]#7D_B#P3XM_X2/4S'X=U-U:[E972W
M9E8%R001P1@U]4Z3<W-SN6YD#,%3D+@9(YKY_P!7^,OC6#Q#?6MO<V\=O'=2
M1Q@6RG"JQ &3UZ5A.HYRYA6.9U3X<>)["WM6BTB_N)70&5([=FVGKCC\JSHO
M!'C*>4(OAS4UW'&6MF 'Z5VC?&#QUYJJ+ZWP49O^/5.HJS/\5_&L%@UQ+J<*
M8CR-MFA^;MP>U1J!Q:> O%MOJ BD\/ZA/&.K);L ?Q(KN-&\"231A+S0=2C<
M]2R,H%+#\5_&4RH?MT!W)G/V9*NCXH^+/+0&\M]Q&2?(6LYTW+K8VA54-U<P
M8O!NJZ5XW\R+0+R2P5,B5XSLA &2Q8^F*]]T[_D%Z9CI]CC_ )"O'[7XD^*+
MZ\2RN[F"2VN T4B>0%R"I'4=*]@TW_D%:9_UYQ_R%2DXSMY&KES4;_WOT%U*
MXAL[+[3+I3:CMD5!&D8=E!ZL ?3%4+76=,GN_(;PU+&=LC[_ +*"H"[N^.IV
M\#W'K72V'_+3\*N$XK6[6S.1Q3W1PZ^(;9W15\'78#OM&ZV5<<=P1Q\WR_A3
MVUO27CED?PQ*'2/?&LMH!YG3(!QUP>GMCK74/K%BEA)>M,%MXR0SD$<^@'?/
M;US5N&9+B".9,[)%#+GT(S3YI=Q<D>Q4BTO3E4,EA;+D=H0/Z4Y]+T]P ]C;
M,!V,2G^E7**7,^X^2/8H?V-I?_0-L_\ OPO^%']C:7_T#;/_ +\+_A3-5UNT
MTB)3.V97_P!7$" 6]3DD  =R2 *BT?7$U626%HDBFC19"J3I*"I) .5..H-'
M,^XN2/9?<6ETG3E^[86H^D*C^E+_ &7I_P#SY6W_ 'Z6KE075Y!9JC3MM#,%
M'&>31S2[AR1[#/[-L<8^QV^/^N0IO]EV'_/C;?\ ?I:5M2M4U%+ R9N74L$'
M. /7TJW1S/N/DCV*J:?91NKI:0*P.01& 17S[X*^'&B>._$WC*;5I+Q6M=4=
M8_L\H7AG<G.0?05]&5Y%\%O^0_X]_P"PL?\ T*2E=O<:26Q+_P ,\^#/^>VJ
M_P#@0O\ \11_PSSX,_Y[:K_X$+_\17K%5-2$[:;<K:R+'.8VV.QP%..N>U S
MS+_AGKP9G/G:K_X$+_\ $T?\,\^"_P#GMJO_ ($+_P#$5OGQ+9^'_"Z-(TJ7
M-R\A@MV.YHQR1DG/"C&3R,U<\!I?SZ9)JM^S&2]PX+-DL-S8;'0<$ #T% '*
M?\,\^"_^>VJ_^!"__$4?\,\^"_\ GMJO_@0O_P 17K%% 'D__#//@O\ Y[:K
M_P"!"_\ Q%'_  SSX+_Y[:K_ .!"_P#Q%>L5E7GB71=/NFM;O4[:*Y0 M"9!
MO&>GRCGGM0!YY_PSSX+_ .>VJ_\ @0O_ ,161?\ PB^%^F79M;W6KR&X R8V
MNU+#TR G%>D^*+G5;K388M"%T'F!D>>)!Q$!R 6((<\8'7/I7 Z3?^,M+TZ.
M9]$TNSTA_P!Y$9(#+.[L2%4HA+-*2.I./4TK@68OV?O!$\22Q7.IO&X#*RW*
MD,#W'RT[X%V<6G6'BFQ@W&&VUJ6%-QR=J@ 9]\"N_P#"=A>Z=X9LK?463[9M
M+RK&,+&S$ML7V7./PKB/@U][QG_V,%Q_2F!3^-)Q=:-_N3?S2O*\UZE\;#BZ
MT7_<F_FE>4YKU</_  T?+8]?[1(DS1FH\T9K<XK$F:,U'FC- 6),T9J/-&:
ML29HS4>:,T!8DS1FH\T9H"Q)FC-1YHS0%BU&<Z=JO_7C)_-:Y.NJA.;#5?\
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M;1@'=J#2*[L%4@EN,GOSTJXV,Z;E..JU Z=!'HIU*>1BPC?8D?. I"G/U+#
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M0W%O)!.JM%*I1U;HP(P1^5 '&^+=.M?%!AFTC5+$ZA8,T;H9QAD<#<A(R5/
M(/M7$ZMX*\-QZ1<2>+M9L[.ZV8MG@D#R1,/XC@9<]L8_6NW_ .%4^!\$1Z,D
M63G$5Q(O/X-6%9_"Z/2/&UKJ>E:A:2Z<#F6WOE\Z5%'58R>,'CD\CWK)T8.:
MJ-:E<SM8\K\,:7XTU/4UU'1M.NQ<@@?;7&(9"HVA\/C!QSG->PZ;?_$/0K*V
ML[OPY;ZI@JAN(K\;O<MN'\J]##(!A67 XP#TH$B$ AUP1D<UHE8D<I)4$C![
MCTKR_P"#7WO&?_8P7']*]/5T<95E8>H.:\P^#7WO&?\ V,%Q_2F!F?'$XNM$
M_P!R;^:5Y+GWKUGXYG_2M#_W)OYI7D>:].A_#1\[C%^^D/S[T9]Z9FC-;')8
M?GWHS[TS-&: L/S[T9]Z9FC- 6'Y]Z,^],S1F@+#\^]&?>F9HS0%A^?>C/O3
M,T9H"Q=M#_H>J#_IQD_FM<Y70V9_T35/^O&3^:USU>?B?C/>R_\ @_,U[4$^
M%+\X&!J-ED]QS)7U#XJ;996SYQMFS_XXU?+<+;/!^I.<;5O[-F/M^\KZA\3+
M)=Z1:M;Q/+EMV$7/!0US([GL>57^M2VE[:K_ &=>W(812;H(BP."/EZ=>/U%
M=!%XV6>'4(AX>UO?<2$\6Q^3@#!]^*0:=J0@M,Z?>!E"X*1$E2-AY'YBMS0[
M._CT_9<P2F4,22T9#$GJ35D+<YJ?QK)<^,(5.DZA#YMD+40O&0S$OG>!Z#&,
MUM3:]+J<,$GV.?Y%"R2; RD;N>%.1^-9=Y8:F/B#I=U%87C1*CPRN(3L"DYR
M3^%9'@__ (2&!]02X\/7ULI5<&5&Q(0_S8X[@Y_"H?NZET*/,VF]6]#J=#U5
M-2D\]+2Y5$?:N4QN]:XWXD>+[-/#UY9VUO*=0^T%(9L JC#[Q!SP=N1^-:1T
M/QC9VDECHT&+)G>1))/E=58YV<\@@D]/TKSWQ/X(\06FJ0V\6AZA+;A3^]1#
M('.3EN/NYXX-1%MNQM.$4=QX#8V^GVMQ=0QM"/E@\K!+NZ9VE3V'/?KTJO)I
MWV/3M"6YNA;O#+/(Z_9GS(-_(  .,8QS5W3X;I]/T'3K;1]1BN8;N%Y'>T=4
M4 $,6)&.]=+-X,O=2._5KV2ZBMU*QPQ1E-W<9]/?%12<DMBZ\82?Q;&7I.YK
M/3Q9+*70)PBXWJ"-Q!ST(S^=9/B'Q!=VOCZT,?VN/:T8VKG]T!CY2!P=W]17
M5Z+IMS8ZC96R6-PL"1N@8QD 8'>KT7AJRU/Q-_:-W8W*36TR%221'+M'#$=\
M'^0K;R."M'G5HFIH6HK?>(+Y38W]JZQ@G[3'M4C/;FO$/'0)\;^/SS@0VG3_
M 'H^M>_6C/\ V_=HT#*HC!$A4X//3-?/_C=M_C7X@D$[1':J<=,AH^M)&R//
MZ]#^#'_(\3?]>,O_ *$E>>5Z'\&/^1XE_P"O&7_T)*8SU/Q4C&2W(=XEDANH
M!.(6D".RKMR ">U<"FG:XH DOM+F'^WITA_]I5Z9?^.O#'AV]DL=6UF"SNA\
M_ENK$[3T/ -5_P#A:_@;_H9[7_OF3_XFI2DF[,Z/:4Y12G';3?\ X!YUI^@S
MV^M-J-Q)82"1TWP):3J@4#!( 3KWK4UC1=,U#6;BZMV\NWE.0C6TN0<<\!,#
MZ5V/_"U_ O\ T,UM_P!\R?\ Q-'_  MCP-_T,UM_WS)_\30N=;/\!.5%V]U_
M?_P#S:T\(6L:S>?<HY>4LN+6;Y5[#[E78_#MI",17(7/_3O./_9:[S_A;'@;
M_H9K;_OB3_XFC_A;'@7_ *&:U_[XD_\ B:%SKK^ .5%[Q?W_ / ,CPC/:Z!>
M.]Q<LT BV1QQ6DW'(/=?:O*]6^&]]=:_>7EMJUL;>:XDE3?;3@X9B>1LZ\U[
M7_PMCP-_T,UK_P!\2?\ Q-'_  MCP-_T,UM_WS)_\31[_<5Z"^R_O_X!X9=_
M#"^N(EVZG:*Z]Q;W R/^^*23X6W36JJFJ6ZR;0&!MY\9]0=E>Y_\+8\"_P#0
MS6W_ 'Q)_P#$T?\ "V/ W_0S6O\ WQ)_\31[W?\  ?-1_E?W_P# /"+?X6ZC
M%=02'6+;:K*6VV\_8_[G-=7+X3<X\F\A'/)-M-S_ ..5Z9_PMCP-_P!#-;?]
M\R?_ !-+_P +8\#?]#-:_P#?$G_Q-"YUU!RHO[+^_P#X!YE;>&)K6[2Y>^1D
MBRWEQ6TY9C@X RF.37LMBCQ:;IT<B%'6T0,IZ@X'%8W_  MCP-_T,]M_WS)_
M\36AI7B;1?$S23:+J$5[' -LC1@C:3R!R!19WNV*52')R05M;[WZ6[(P_B+X
M>N]?T&!K;68-)CLIC-/<3RLB["N.2OOZUY:OA8JV3\3-#8>AU"3'\Z]@^(/_
M "3/Q'_UZ_U%?*U68GJ1\/0^2J?\)_X>W!<>9_:<^3R>3\V,_P"%4V\)L5(_
MX6=HF2.O]H2?XUYS1BBPCVOQC9V7B"YTR2P^(6C6JVMC';2AKYAO=>K?*?Y\
MUBV/AU+2X\V7X@^'+M=I'ESZA-M^ORL#D5Y=118#TQO#(:/:/B3H0(.=PU&7
M/TZU=\/:'#I/B/3=1NOB/HD]O:W"2R1"_<EU!Y')Q^=>3 9Z#/T%''M189ZY
MXDT6'6/$NI:E:?$?18+>YG,D<1OW!0'MP<?E5.W\.1PD&7XA>'[C_KIJ4P_D
MPKR^BBPCTN3PQO8E?B5H29[#49<?SK;\(:=::!K4EY??$/1;F%K66$(M\Q(9
MA@'YCCBO&:*+ >Q>#O!EW)XJTR2V\>:7J)M9X[B2VM[R1V=$8%N,_P _6N@^
M#L$-UKGCY)HUD3^UR=K#(^])7$? K_DHQ_Z\9?YK4NC>+=0\&Q^--0TU;=II
M?$'DD3J67:?./8CGBD,][ET<!Y#%'9JF<J'B)XQSGGUK-C-G?0F19K1E5/,^
M6W?/E\J3CZCKZ"O&C\=?%1!!@TO!Z_N6_P#BJAL/BCKDD)ACCT6!%!4^=O4N
MK$D@G=R,G]10![1!+I\MS%%:W>G.['"JT!W$XZ]1_GCK2VBVM[.T-O/ISR/E
MOE@<'KD]_3\_I7C?_"S=:>[\\0^&Q,6\T2;6'S8VYSNXXJK#\6M;TZ[9[>RT
MCS%RH=4D(/OR_IQ].* /H:WTB$I_I=O;.ZM\AC4C XQG/?BKUQ:P72!)XED4
M'(##H:^=O^%[>*_^>&E?]^6_^*KN?B9\1M:\(7VE0Z='9LMU:F:3SXR2&R!Q
M@CB@#T.YL]*T^%[N:"-(X5W%MI./PJE<-I8BW6TEG%NE$3M*I^8[=VWUZ8/T
MKPNZ^-OB:\MI+>:WTPQR+M8"-P<?7=0GQ.UJ[MTDDBT%4C.X12!P<J  <;N>
M !]* /:K";2C,TIGL76*/S'\N-@1SC.#WY''T]:TK&/1KYV:U$4K1D$D9XR,
M#K^(_.O!5^)&L*)56#PXGRE&*AQE2=W!#<\G/X>U067QDU_3]YM;'2HM^-V(
MG/3_ ('[D_4F@#Z.M],LK2426]O'&^-N5':O.?@U][QG_P!C!<?TKF/"_P 8
M_$FL^*]*TRYATX07=RL4ACB8, ?3YJZCX-_?\9_]C!<?TH R/CI_Q]:'_N3?
MS2O(LFO7/CL<7.A_[D_\TKR#->E0_AH\#%K]\Q^31DTS-*,L< $D]A6USEL.
MR:,FE,,P4,89 I)&2IQD=:1HY456:-U5N 2I /THN/E89-&32M#,C%6AD# X
M(*D$&@Q2AG4Q2;D&7&TY7Z^E%PY6)DT9-.:VN%SNMY1MP#E#QGI^=(8I@SJ8
MI R#+C:<J/?THN'*Q,FC)I1%*0Q$4A"C+':>!TYI)$DB?9(C(W7##!HN%F&3
M1DTS-&:!6+]D?]%U3_KPD_FM8%;M@<VVJ?\ 7A)_-:PJ\_$?&>W@?X7S.T\(
M^'Y/$O@OQ98P1AYPD$L1SSN4N0 />O;OACXMA\4^$K8.X74K)!;WL#<,CJ,;
MB/0XS^8[5Y'\*?$VC^&Y=5;5KU;0SB+RI-C,W&[.  ?4=:T/$%YX,N]8_M[P
M[XK;0M:.?,DMX9#')_O+MYSWKG.X^@*,5\[K\6/&-F?*77_#U^%X$KV\B$_D
M!3C\8O&0Q_IWAD_2.6@#Z&ILDB1+ND=47IEC@5\]?\+C\9?\_OAK_OW+534?
MBAXDU>U^S:B?"EW!N#>7-!*RY'0T ?1?VVT_Y^8?^_@H^VVO_/S#_P!_!7R_
M_P )3/\ ] GP1_X"24?\)3/_ - GP1_X"24"U/J..XAE)$<T;D=0K U+7S)I
MOQ UC1IGFTRW\'VDKKM9X;>521UQ6G_PN/QE_P _GAK_ +]RT#/HC%)7SQ_P
MN/QG_P _OAK_ +]RTC?%_P 92+M_M/PW#G^,0RMC\.: />=9UFPT#2+G5-2G
M6&UMT+.S'KZ >I/0"OGE[2[OOA_XJ\8WZ/#+K=[&\,9'_+(2#&?;ICZ58CO=
M%\0WL5]XZ\;C5/);?%I\,$D=N#[X7^E;GCSQIX7U3P-=:7I.I+),QB$<:PLF
M]58'!RH  '2@#QJO0_@S_P CQ+_UXR_^A)7GE>A_!G_D>)?^O&7_ -"2@#%^
M-O\ R4F?_KTA_D:X>STN^U!"]I;22J#C*],UW'QL_P"2DS_]>D/\C6;I?C.W
ML-+M;.2T9]B.LS*J@D_P%?3'>@#C<YYJ>SLKG4+@6]I$TLI5GV@@<*"Q//H
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M@O7?^OB+_P!!-8'Q4\2>!?$&C6IT"2YFU6.<9EE63B'!RNY^V<8 KH/V??\
MD%Z[_P!?$7_H)H Z#XP>+K;P_P"$Y=(FM9I9-8A>..1" L94KUS_ +W:OFX7
MRG.(V..M>R?M$C(\.<_\_'_M.O-T2]TW-IH5F]ZJ(DEY<I 9%G5ESM(QQ'@]
M#@DC)Z#$RERC2N87V]!_RS;\Q1_:"?\ /-OSJ_XL6U:\L[FTMH;1+FTBE-M%
M_P LR1],<]?IUYJ+PJH.M@D-A8)6W)&)'3"'YE4\,P[#CZTXRYDF#5G8J_;T
M_N-^8J]IVK:7 Y>\M)IV_A4$;1]?6MG7'CFTVZLE %R(8YQ$T*IA  6DSVD;
M.2O09/)(Q7$="*)+F5F73J.G)227S5SNT\;Z>@VII\JCIA=HJI>^)M&OD(ET
MV97[.A4,*]$\+:/X5UKPS9:I<Z' 9IAY=P44!0Z_*X QA<@*W'][/&:\Q\?6
M>D:?XKGM=%C:.V1$WH7W!9"N6 ],9QCUS6$<-"+NK_>>A/-<3./)*S7^%&2;
M^/<0J.1GC.*/MZ <QO4_A_3X;^[<2%-T*"8))D1N 1N#$<@8]*['Q/%8C0XD
MANGFLHW"I@+(T*E<A QQM4'&.<G/TKIN>6</_:$?]QJ/MZ?\\V_,5GD8->^?
M#2P\$#X;21:]IR-J5X7+":V8S3 DB/R,CGMC;WSFBX'&?"'Q1;Z/\1;#S;:6
M3[;BR3:1\K2.H#'V%7-/\=Z5X4\0^++'5O#L>LQ7.JR2JLCJ%0JSC."IY^:N
M1\$0O;_$[P_"\<D;1ZM I20892)1P1ZU)JMA#?\ C[Q%]HF"0P7=U,ZA@'D"
MNQ*IGO\ R&34R=E=@E?0[S_A;W@S_HFUE_WW'_\ $4?\+>\%_P#1-K+_ +[C
M_P#B*XK3KF/5)'L-2TJ&&*6"06,S(46VPI8?-QN7C))R>I[FN/88;&0<<9%3
M&?,VFBG&VI[+_P +>\%_]$VLO^^X_P#XBC_A;_@O_HFUE_WW'_\ $5QGA^WM
MFTJ)I(XVD,<K[&@5N <>:7(_A_N]\>]<_KRQ&]2:W9)(98E*R(FSS"/E8[?X
M3D'BK)/4_P#A;_@O_HFUE_WW'_\ $5<U'XZ^'-6>-]1\!Q731+L0S3(Q5?09
M3@5Y?X'&FW'B6#3M5M8Y[2^_<$L<,C'[A5NQW  ]>":]*\1>"_"5CX>U&Y;3
M9;1H(6='$QW*_P#"N".<M@8/9CZ"@"'_ (6_X+_Z)M9?]]Q__$4?\+?\%_\
M1-K+_ON/_P"(KQC'.*]!\+:+:V<<&H$"9I8Q)$S,JYX*O'M;(QDCY^Q% '3'
MXO>"Q_S3:R_[[C_^(H_X6_X+_P"B;67_ 'W'_P#$5YIXJM8[;6+CREA1?-<!
M(R.!G(R,Y'7KWQ2>#K.POO%^F6^K)*VG-.#<B-22(QR2<<X]3V&: /4;;XS^
M$K.ZBN;?X=VT,\3!DDCD0,I]0=E=M\!KX:II7B74!&8Q=:Q).$)SMW*&QGOU
MKSCXU:3X/LO[,G\*Q6ZLVY+DV1W0XP"F2. _WN,YQUKNOV;O^1/U;_K_ /\
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MO17U1_PJWP3_ -"];?\ ?3_XT?\ "K?!/_0O6W_?3_XT ?*]%?5'_"K?!/\
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M/]EIGB/3]P6[L)H2S*]O+<JXDR"2".N#C.>!G'.:X^]A>WO9X9%5'1RK*AR
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M"=*U.UU&STZ9+FUE6:)C=2$!E.0<$\\BJU]\#_!>HZA<WMQ;7AGN)6ED(N6
M+,23Q]32DKJPT[.YX7?/NLY9C;SD1)(5#WB,%S#Y>-N,]!GBO/37U?\ \*$\
M"_\ /M>_^!34?\*#\"_\^M[_ .!35G2I\B>I4Y<Q\ZV&@:ZVG6]U:W<<=O)B
M5%^U!<')&2O;D5-KMEJ\>A@:G'9/]FD 2:*12Z*W\&%X(R<^U?0G_"A/ O\
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8\%6,]GHT<J0SR^:XED+G=@#O[ 4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>form20-f_005.jpg
<TEXT>
begin 644 form20-f_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )1!"L# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=<_[\0__ !VC_AH[P?\ ] W7/^_$/_QVOF"B@#Z?_P"&CO!__0-US_OQ#_\
M':/^&CO!_P#T#=<_[\0__':^8** /I__ (:.\'_] W7/^_$/_P =H_X:.\'_
M /0-US_OQ#_\=KY@HH ^G_\ AH[P?_T#=<_[\0__ !VC_AH[P?\ ] W7/^_$
M/_QVOF"B@#Z?_P"&CO!__0-US_OQ#_\ ':/^&CO!_P#T#=<_[\0__':^8**
M/I__ (:.\'_] W7/^_$/_P =H_X:.\'_ /0-US_OQ#_\=KY@HH ^G_\ AH[P
M?_T#=<_[\0__ !VC_AH[P?\ ] W7/^_$/_QVOF"B@#Z?_P"&CO!__0-US_OQ
M#_\ ':/^&CO!_P#T#=<_[\0__':^8** /I__ (:.\'_] W7/^_$/_P =H_X:
M.\'_ /0-US_OQ#_\=KY@HH ^G_\ AH[P?_T#=<_[\0__ !VC_AH[P?\ ] W7
M/^_$/_QVOF"B@#Z?_P"&CO!__0-US_OQ#_\ ':/^&CO!_P#T#=<_[\0__':^
M8** /I__ (:.\'_] W7/^_$/_P =H_X:.\'_ /0-US_OQ#_\=KY@HH ^G_\
MAH[P?_T#=<_[\0__ !VC_AH[P?\ ] W7/^_$/_QVOF"B@#Z?_P"&CO!__0-U
MS_OQ#_\ ':/^&CO!_P#T#=<_[\0__':^8** /I__ (:.\'_] W7/^_$/_P =
MH_X:.\'_ /0-US_OQ#_\=KY@HH ^G_\ AH[P?_T#=<_[\0__ !VC_AH[P?\
M] W7/^_$/_QVOF"B@#Z?_P"&CO!__0-US_OQ#_\ ':/^&CO!_P#T#=<_[\0_
M_':^8** /I__ (:.\'_] W7/^_$/_P =H_X:.\'_ /0-US_OQ#_\=KY@HH ^
MG_\ AH[P?_T#=<_[\0__ !VC_AH[P?\ ] W7/^_$/_QVOF"B@#Z?_P"&CO!_
M_0-US_OQ#_\ ':/^&CO!_P#T#=<_[\0__':^8** /I__ (:.\'_] W7/^_$/
M_P =H_X:.\'_ /0-US_OQ#_\=KY@HH ^G_\ AH[P?_T#=<_[\0__ !VC_AH[
MP?\ ] W7/^_$/_QVOF"B@#Z?_P"&CO!__0-US_OQ#_\ ':/^&CO!_P#T#=<_
M[\0__':^8** /I__ (:.\'_] W7/^_$/_P =H_X:.\'_ /0-US_OQ#_\=KY@
MHH ^G_\ AH[P?_T#=<_[\0__ !VC_AH[P?\ ] W7/^_$/_QVOF"B@#Z?_P"&
MCO!__0-US_OQ#_\ ':/^&CO!_P#T#=<_[\0__':^8** /I__ (:.\'_] W7/
M^_$/_P =H_X:.\'_ /0-US_OQ#_\=KY@HH ^G_\ AH[P?_T#=<_[\0__ !VC
M_AH[P?\ ] W7/^_$/_QVOF"B@#Z?_P"&CO!__0-US_OQ#_\ ':/^&CO!_P#T
M#=<_[\0__':^8** /I__ (:.\'_] W7/^_$/_P =H_X:.\'_ /0-US_OQ#_\
M=KY@HH ^G_\ AH[P?_T#=<_[\0__ !VC_AH[P?\ ] W7/^_$/_QVOF"B@#Z?
M_P"&CO!__0-US_OQ#_\ ':/^&CO!_P#T#=<_[\0__':^8** /I__ (:.\'_]
M W7/^_$/_P =H_X:.\'_ /0-US_OQ#_\=KY@HH ^G_\ AH[P?_T#=<_[\0__
M !VC_AH[P?\ ] W7/^_$/_QVOF"B@#Z?_P"&CO!__0-US_OQ#_\ ':/^&CO!
M_P#T#=<_[\0__':^8** /I__ (:.\'_] W7/^_$/_P =H_X:.\'_ /0-US_O
MQ#_\=KY@HH ^G_\ AH[P?_T#=<_[\0__ !VC_AH[P?\ ] W7/^_$/_QVOF"B
M@#Z?_P"&CO!__0-US_OQ#_\ ':GM/VA/"U]>0VEOI6NO-,X1%\F'DGI_RUKY
M9K;\'?\ (YZ-_P!?D?\ Z$* /KT>+[AAD>%-?_[XM_\ X[2_\)=<9_Y%37_^
M^+?_ ./5T,/W!]*=_'0!SO\ PEMS_P!"IK__ 'Q;_P#QVC_A+;G_ *%37_\
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M_CM=+BC% '-?\);<_P#0J:__ -\6_P#\=H_X2VY_Z%37_P#OBW_^.UTN*,4
M<U_PEMS_ -"IK_\ WQ;_ /QVC_A+;G_H5-?_ .^+?_X[72XHQ0!S7_"6W/\
MT*FO_P#?%O\ _':/^$MN?^A4U_\ [XM__CM=+BC% '-?\);<_P#0J:__ -\6
M_P#\=H_X2VY_Z%37_P#OBW_^.UTN*,4 <U_PEMS_ -"IK_\ WQ;_ /QVC_A+
M;G_H5-?_ .^+?_X[72XHQ0!S7_"6W/\ T*FO_P#?%O\ _':/^$MN?^A4U_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5M^#O^1ST;_K\C_P#0A6)6WX._Y'/1O^OR/_T(
M4 ?;\/W%^E/_ (Z9#]Q?I3OXZ 'T444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !2'H:6D/0T (G0UX!\2?^2[^$?^OVT_]'+7OZ=#7@'Q)_Y+
MOX1_Z_;3_P!'+0!] T444 %%%% !1110 5\P?M'?\E#T_P#[!4?_ *-EKZ?K
MY@_:._Y*'I__ &"H_P#T;+0!X_1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K;\'?\CGHW_7Y'_Z$
M*Q*V_!W_ ".>C?\ 7Y'_ .A"@#[?A^XOTIW\=-A^XOTIX^_0 ZBBB@ HHHH
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M&SUTU<S%_P E,O?^P1;_ /HV>@#IJ*** "BBB@ HHHH **** "BBB@ HHHH
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M.QYAXIU^;Q!K4TTS?N8W*Q+VQ6/ACM\H%Y6.U%'4U A"ID_>'7WKM?AMH/\
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MS,7_ "4R]_[!%O\ ^C9Z .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>)?8+[_GRN/^_9IAT^^_Y\KG_OV:]PHH_LF/\[*6?U5]A'AO]GW_ /SXW/\
MW[-(=.O_ /GQN?\ OV:]SH!H_LF/\[+_ -8:O\B^]GA1TZ_[V-S_ -^S3/[.
MO^UA<_\ ?LU[S15+*HK[;'_K%5_D7WL\%:POE^]97 'O&:K2))'\K @]P5P:
M^@&17&&&:J2Z592Y+VT9)[D5,\J3VD5#B%_:@>#[1CBF8YKU?5/ -C>/));L
M896Z''RYKS_6_#E]HKD2KYD9Y\U0<5Y];!5*/H>]@\WP^)M%.S,?%-84[[H7
MG<&Z&D(Y92.17&>S%W(\4A%/Q32*HT3&&FE<Y-/--]J$5<A8@D%20PZ&O;?
MVL_VIHD22,#+"-I]3[UXH1QCM76_#N_%IXE6"0G;<(50#UKT<%4]G/E/#S_"
MJOA>9;QU/:%YQ3JB4<BI1TKZ,_-@HHHH **** "BBB@ HHHH **** "BBB@
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MRZ&_\-IO(\:VQ)P&##]*^BN_MBOE[P[>'3_$-A=<</MY]Z^F[:3SH(Y0059
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M:G.%%%% !1110 4444 %%%% !1110 5\]?%3_DL_AW_KI%_Z%7T+7SU\5/\
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M/!Q;N77FI6L5M;G%KI-S,>,)7F/AB'[1K,M\>D2EC74_$/5!;Z4MF"1)*P)
M]*YW2V&E>#YKAAMFN2RKZXZ5RXJ;<O0Z</%\I0\/0MJ?BT2'LQ<_G7LB@YQV
M[5YQ\-;$F[N;ME! 7:#[YKTD]0*ZL*O<;9S8A^];L/HH%%=9@%%%% !1110
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M(_\ 7[:?^CEH ^@:*** "BBB@ HHHH *YF+_ )*9>_\ 8(M__1L]=-7,Q?\
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M4 %%%% !1110 4444 %?/7Q4_P"2S^'?^ND7_H5?0M?/7Q4_Y+/X=_ZZ1?\
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MG:Z\#]:F'PX23FR\2V[#J S$5JJASNA!L]V%_:'_ )>8?^^Q44NKZ="I,E[
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MIL"I(1^\D;EW/J373AE9?E((KT85Z4_AE<R<)+<J:7I5CHUE'9:?;)! @X5
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MQ)_Y+OX1_P"OVT_]'+7OZ=#7@'Q)_P"2[^$?^OVT_P#1RT ?0-%%% !1110
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M0 ^BBB@ HHHH 2EHHH SM8O?[/TN>Z",[(O"KU)-?-U]!JNMZY)*]K.&NY0
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M%)5VBMD+46BBBJU 3B@8STI>M+BBRZ@%%%%, II )S3J3I0 @Z]***!Q0"V
M4M)1B@6PM%)BC% !12T"C4-!.*/PIU)1J.R# HP***6HK(3%)\V:=3<46#87
M%&!G- %+CWIK0:;"B@#%+2 2EHHI@%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7SU\5/^2S^'?^ND7_ *%7T+7SU\5/^2S^'?\
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M*** "BBB@ HHHH *YF+_ )*9>_\ 8(M__1L]=-7,Q?\ )3+W_L$6_P#Z-GH
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M10 4444 %%%% !7+I_R4Z[X_YA%O_P"CIZZBO/\ Q-K,/A_Q3K.HSLP6/0X
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M!6\^T>!(;<DDPL1D^]>D =Z\]^#5@;+P#;,\9224ECGN*]"' %2!\]?M!_\
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M%^.H!^&EQGI]IBZ?6OF<)\GF%>", 9H2 ^LA\3?!W_08A_(_X4O_  L[P?\
M]!J+\C7R;@#I2X_SFBP'U>?B7X.8Y_MJ+\C_ (4X?$WP<" -9A!)P.#R:^3L
M?YS0%!DC!&[YU[].13L!]O)(LB*ZG*L,@TISV-5[$?\ $OM?>%?Y"I_:I \>
M^,W@1]1@/B'3H"]S"O[]5_NC^+%>!#YL;3FOMJ>%)XI(I0&612I7U&*^5OB+
MX+D\'^(/)B#M9W1+6[X_,?RIB./' W"K&GW]UI5VEU93O#,IR&!JMT) [<&B
MF Z61KB:2:5LO*Q9VSU--/)X^Z!BC /!I&/R^8P^0<<52 FM8);R[ALX$9[F
M9PL2*,YS7U%\-/!*>#]"_>_/?W6'F?'3C@?A7G7P4\$?:IT\3W8_=1MBWC8=
M_P"]7OGH":A@ 4@DYY[4['.:6BD,\B^//_( LO\ ?;^E?/=?0GQY_P"0!9?[
M[?TKY[JD 4?@?RHKJOAYIEOK/C6VL;L9AG4J1^%,1RN2 &7!H  ;-='XS\(7
M7@[6&LYBSP,289",;AFN<I 7+#5K_2C*;"ZE@\T;7"'J*I $!N>6.6]Z6B@
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M@.M0?;K7./M$?_?5 $WEI_='Y4>6G]T?E34N(I 2CJP'H<TXR*%+$X ZD]J
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MW;1%UKVM?V@O#H 'V2[_ .^:3 ]@K&\2Z1_;NA7>FAWC>5/D=6QANW->=?\
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M +YH ]>HKR'_ (:#\._\^=W_ -\T?\-!^'?^?.[_ .^: /7J*\A_X:#\._\
M/G=_]\T?\-!^'?\ GSN_^^: /7J*\A_X:#\._P#/G=_]\T?\-!^'?^?.[_[Y
MH ]>HKR'_AH/P[_SYW?_ 'S1_P -!^'?^?.[_P"^: /7J*\A_P"&@_#O_/G=
M_P#?-'_#0?AW_GSN_P#OF@#UZD/0UY%_PT'X=_Y\[O\ [YI#^T'X=Q_QYW?_
M 'S0!ZZG0UX!\2?^2[^$?^OVT_\ 1RUT"_M!^'!G_1+O_OFO/-8\8V7C/XQ^
M%+ZQCDCC34+1"'&#_KEH ^I**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1_8'B#_H<K__ ,!+;_XU0!TM%<U_8'B#_H<K_P#\!+;_ .-4?V!X@_Z'*_\
M_ 2V_P#C5 '2T5S7]@>(/^ARO_\ P$MO_C5']@>(/^ARO_\ P$MO_C5 '2T5
MS7]@>(/^ARO_ /P$MO\ XU1_8'B#_H<K_P#\!+;_ .-4 =+17-?V!X@_Z'*_
M_P# 2V_^-4?V!X@_Z'*__P# 2V_^-4 =+17-?V!X@_Z'*_\ _ 2V_P#C5']@
M>(/^ARO_ /P$MO\ XU0!TM%<U_8'B#_H<K__ ,!+;_XU1_8'B#_H<K__ ,!+
M;_XU0!TM%<U_8'B#_H<K_P#\!+;_ .-4?V!X@_Z'*_\ _ 2V_P#C5 '2T5S7
M]@>(/^ARO_\ P$MO_C5)_8'B#_H<K_\ \!+;_P"-4 =-17,_V!XA_P"AROO_
M  $MO_C5']@>(?\ H<K[_P !+;_XU0!TU%<S_8'B'_H<K_\ \!+;_P"-4O\
M8'B#_H<K_P#\!+;_ .-4 =+17-?V!X@_Z'*__P# 2V_^-4?V!X@_Z'*__P#
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M_P#C5 '345S/]@^(/^AROO\ P$M?_C5']@^(/^AROO\ P$M?_C5 '345S/\
M8/B#_H<K[_P$M?\ XU1_8'B#_H<K[_P$MO\ XU0!TU%<S_8'B#_H<K__ ,!+
M;_XU1_8'B#_H<K__ ,!+;_XU0!TU%<S_ &!X@_Z'*_\ _ 2V_P#C5']@>(/^
MARO_ /P$MO\ XU0!TU%<S_8'B#_H<K__ ,!+;_XU1_8'B#_H<K__ ,!+;_XU
M0!TU%<S_ &!X@_Z'*_\ _ 2V_P#C5']@>(/^ARO_ /P$MO\ XU0!TU%<S_8'
MB#_H<K__ ,!+;_XU1_8'B#_H<K__ ,!+;_XU0!TU%<S_ &!X@_Z'*_\ _ 2V
M_P#C5']@>(/^ARO_ /P$MO\ XU0!TU%<S_8'B#_H<K__ ,!+;_XU1_8'B#_H
M<K__ ,!+;_XU0!TU%<S_ &!X@_Z'*_\ _ 2V_P#C5']@>(/^ARO_ /P$MO\
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M %%)10 M%)2T %%&:0T +12=Z#B@!:*2EH **3\:* %HI*!0 M%%% !1110
M5Y]\2_\ D(>$?^P[:?\ HU:]!KS[XE_\A#PC_P!AVT_]&K0!Z#1110 4444
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M4YQ7!7P[I2LGH:0FI(MY]J,^E1K(K.4#C<.JT_/>L+&@ZBBB@ HHHH *\?\
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M8Q7O$*<I/0K_ /"]_"I_Y97O_?N@?'?PKQ^ZO<>OE]*N_P#"F/!@_P"7.?\
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M,F0V. *[OXW GX;WGU'\Q67^SU_R($X/_/VW\A0!L?\ "EO!A&W[%)_WW_\
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MC56'W0!Q6KEL>MR=3Y]^&_C:[\':R_AK7CY=I&S*7DX\LC^E0?$+QEJ'C?Q
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M_P"0AX1_[#MI_P"C5KT&O/OB7_R$/"/_ &';3_T:M 'H-%%% !1110 4444
M%<!\5_\ D&>'?^P];?\ H+UW]<!\5_\ D&>'?^P];?\ H+T =\GW%^E+2)]Q
M?I2T %%%% !1110 4444 %>/_'G2=1U71;5-/LYKEE<$B)"Q'->P44 <3\*[
M.YT_X=Z;;7<+V\Z[MR.,$<UVU-*YZFG4 %%%% '.^-X)KGPE?PP1-+(\9"HH
MR2<5\N:%8_$+PU)(^D:?J-L9!ABD1YK[%Q1C% 'RK_PD/Q=_NZK_ -^31_PD
M/Q=_NZK_ -^C7U510!\J_P#"0_%W^[JO_?HUZE\)K_Q=?P7I\2BZ^4'8)T(S
M]*]8HH ^2?$F@>++;Q[>:KI>EWJNDV^*5(S^8JX?$7Q=XXU7_OT:^J<>O-+0
M!\JCQ%\7O35?^_1H_P"$B^+WIJO_ 'Z-?55% 'SQX&UKXE7/BNUBU<:A]C)^
M<RQD+4WQWT+5]6UFQ?3["XN0H.6B0D"OH''%)C XH ^3[35_BO86D=K;QZHD
M,8VJHB/ J<>(?BZ.@U7_ +]&OJJB@#Y5_P"$A^+WIJO_ 'Z-/@\0?%LW$8<:
MIL+C.8SC&:^IZ,4 9VAM</HUI)=@_:6B'F;ASFM&DQ2T <!\8;"[U'P!=VUG
M;R7$[$82-<GJ*R_@3IM_I?@F:WO[66VF^U,P25<'&!7J1'(YI<4 %-;ZXIU1
MS$A"0NX]AZT 4M3U6STBREO+V9(H44G+'K7SGXR\<7/BO4_E=XM.BSY<2G&?
M>NT\=^&O''B_4WC1%@TZ,81%S\WUKD#\(_%RG/DJW&!BO1POLH>](YJG.]#E
MH[IE.R+<TDAQA>2?:O6O ?PR$]K_ &CXAA/[Y"5@;L#TJ[X ^$JZ+=IJ>M2>
M=<J#MAQ\H)[UZL$4  #@< >E:8K&\SM3V"G1LM3C_!'A)O"EYJJ*^ZTN&5HO
M8<\5V0  I @[=/2G8KRI2<G=G0E86BBB@84444 %>/\ A?\ Y.,\0?\ 8*?_
M -&PU[!7C_A?_DXSQ!_V"G_]&PT >P4444 %%%% !1110 4444 %%%% !7,^
M+?\ C\\,_P#877_T1-735S/BW_C\\,_]A=?_ $1-0!TU%%% !1110 4444 )
M2XHHH 3%&*6B@ Q28I:* $Q1@8Z4M% #=H]*7 Q2T4 )BEQ110*P8%)@'M2T
M4#$Q2XHHH 3&:,4M&* $P!1@4M&* $ HQBEHH 0@'K1@>E+10 F!Z4M%% !B
MBBB@ I,4M% "8&<XYI<444 %%%% !BDP/2EHH 3%&*6B@!,#TI:** #%-90P
MPP!'O3J* $XI:,44 %)BEHH 3 QC%+BBBD F*,4M%,5A,"C%+10,**** "BB
MB@ HHHH *\^^)?\ R$/"/_8=M/\ T:M>@UY]\2_^0AX1_P"P[:?^C5H ]!HH
MHH 0G J+>YYX'X43'$;?0TM $M%%% !7 ?%?_D&>'?\ L/6W_H+UW]<!\5_^
M09X=_P"P];?^@O0!WR?<7Z4M(GW%^E+0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-
M;[P%.HH 9COD_2@# X'Y4^BC4!BKM]3GN:?110 4E+10 4444 %%%% !7C_A
M?_DXSQ!_V"G_ /1L->P5X_X7_P"3C/$'_8*?_P!&PT >P4444 %%%% !1110
M 4444 %%%% !7,^+?^/SPS_V%U_]$35TU<SXM_X_/#/_ &%U_P#1$U '3444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7GWQ+_Y"'A'_
M +#MI_Z-6O0:\^^)?_(0\(_]AVT_]&K0!Z#0:*0T 07!_=M]#3_QJ*Y_U3?0
MU)0!-1110 5P'Q7_ .09X=_[#UM_Z"]=_7+^.?"4_C#2K.TMM4_LZ6UO4NUF
M\CS<E58 8W+W;.<]J .G3[B_2EKS\>"_&@&/^%@?^4L?_':/^$+\:?\ 10/_
M "EC_P".T >@45Y__P (7XT_Z*!_Y2Q_\=H_X0OQI_T4#_REC_X[0!Z!17G_
M /PA?C3_ **!_P"4L?\ QVC_ (0OQI_T4#_REC_X[0!Z!17G_P#PA?C3_HH'
M_E+'_P =H_X0OQI_T4#_ ,I8_P#CM 'H%%>?_P#"%^-/^B@?^4L?_':/^$+\
M:?\ 10/_ "EC_P".T >@45Y__P (7XT_Z*!_Y2Q_\=H_X0OQI_T4#_REC_X[
M0!Z!17G_ /PA?C3_ **!_P"4L?\ QVC_ (0OQI_T4#_REC_X[0!Z!17G_P#P
MA?C3_HH'_E+'_P =H_X0OQI_T4#_ ,I8_P#CM 'H%%>?_P#"%^-/^B@?^4L?
M_':/^$+\:?\ 10/_ "EC_P".T >@45Y__P (7XT_Z*!_Y2Q_\=H_X0OQI_T4
M#_REC_X[0!Z!17G_ /PA?C3_ **!_P"4L?\ QVC_ (0OQI_T4#_REC_X[0!Z
M!17G_P#PA?C3_HH'_E+'_P =H_X0OQI_T4#_ ,I8_P#CM 'H%%>?_P#"%^-/
M^B@?^4L?_':/^$+\:?\ 10/_ "EC_P".T >@45Y__P (7XT_Z*!_Y2Q_\=H_
MX0OQI_T4#_REC_X[0!Z!17G_ /PA?C3_ **!_P"4L?\ QVC_ (0OQI_T4#_R
MEC_X[0!Z!17G_P#PA?C3_HH'_E+'_P =H_X0OQI_T4#_ ,I8_P#CM 'H%%>?
M_P#"%^-/^B@?^4L?_':/^$+\:?\ 10/_ "EC_P".T >@45Y__P (7XT_Z*!_
MY2Q_\=H_X0OQI_T4#_REC_X[0!Z!17G_ /PA?C3_ **!_P"4L?\ QVC_ (0O
MQI_T4#_REC_X[0!Z!17G_P#PA?C3_HH'_E+'_P =H_X0OQI_T4#_ ,I8_P#C
MM 'H%%>?_P#"%^-/^B@?^4L?_':/^$+\:?\ 10/_ "EC_P".T >@45Y__P (
M7XT_Z*!_Y2Q_\=H_X0OQI_T4#_REC_X[0!Z!17G_ /PA?C3_ **!_P"4L?\
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M_P -#>&O^?6Z_*C_ (:&\-?\^MU^5 'L%%>/_P##0WAK_GUNORH_X:&\-?\
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M I#2TAH K7/^K?Z&I>:BN?\ 5O\ 0U+0!+1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
A444 %%%% !1110 4444 %(:** *US_JW^AJ0T44 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>form20-f_006.jpg
<TEXT>
begin 644 form20-f_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %= 64# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBN6^('B.Z\(^!]2URSBAEN+41[$F!*$M(J<X(/\6>M '4T5Y__
M ,7?_P"I&_\ )NC_ (N__P!2-_Y-T >@45Y__P 7?_ZD;_R;H_XN_P#]2-_Y
M-T >@45Y_P#\7?\ ^I&_\FZ/^+O_ /4C?^3= 'H%%>?_ /%W_P#J1O\ R;H_
MXN__ -2-_P"3= 'H%%>?_P#%W_\ J1O_ ";H_P"+O_\ 4C?^3= 'H%%>?_\
M%W_^I&_\FZ/^+O\ _4C?^3= 'H%%>?\ _%W_ /J1O_)NC_B[_P#U(W_DW0!Z
M!17G_P#Q=_\ ZD;_ ,FZ/^+O_P#4C?\ DW0!Z!17G_\ Q=__ *D;_P FZ/\
MB[__ %(W_DW0!Z!17G__ !=__J1O_)NC_B[_ /U(W_DW0!Z!17G_ /Q=_P#Z
MD;_R;H_XN_\ ]2-_Y-T >@45Y_\ \7?_ .I&_P#)NC_B[_\ U(W_ )-T >@4
M5Y__ ,7?_P"I&_\ )NC_ (N__P!2-_Y-T >@45Y__P 7?_ZD;_R;H_XN_P#]
M2-_Y-T >@45YO:^(_'&F^.= T3Q+%X>:VU<7.QM-$^]#%'OYWG'.0.A[]*](
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/\ XV?\DBUW_MW_ /2B
M.O0*\_\ C9_R2+7?^W?_ -*(Z /0**** "BBB@ HHHH **R/$6NP>&]!N]7N
MH)YX+5-\B6X4OMS@D!F X^M9P\7M'>3V=SX=UFVN4L9KZ.-D@D,Z1E0R1^7*
MV7RZX4XZT =116?;ZK:W%XEF&=+QK9;HP.A#+&QP">P.01C/:KKE@C% "V.
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MRT:2TTV^MUN=#9+N0V<RJTP:(IYKE<;PJRCYCD=.X%>@/(D,;2.RHB@LS,<
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M_P#84 >@45Y__P *L_ZGSQQ_X./_ +"C_A5G_4^>./\ P<?_ &% 'H%%>?\
M_"K/^I\\<?\ @X_^PH_X59_U/GCC_P ''_V% 'H%%>?_ /"K/^I\\<?^#C_[
M"C_A5G_4^>./_!Q_]A0!Z!17G_\ PJS_ *GSQQ_X./\ ["L[7? )T7P_J6J_
M\)KXXF^Q6LMSY7]L[=^Q"VW.PXSC&<&@#U&BO+M"\ G6O#^FZK_PFOCB'[;:
MQ7/E?VSNV;T#;<[!G&<9P*T?^%6?]3YXX_\ !Q_]A0!Z!17G_P#PJS_J?/''
M_@X_^PH_X59_U/GCC_P<?_84 >@45Y__ ,*L_P"I\\<?^#C_ .PH_P"%6?\
M4^>./_!Q_P#84 >@45Y__P *L_ZGSQQ_X./_ +"C_A5G_4^>./\ P<?_ &%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N?\=_\D]\2_\ 8*NO_135T%<_X[_Y)[XE_P"P5=?^BFH / G_
M "3WPU_V"K7_ -%+705SG@A@GP[\-L<X72;4G )/^I7L.M3:+K_]L7>JPM93
M6AL)UA(G*[F#1K(&P,[1AQP3GU /% &[17&:?XWEO;C2IY=*\C2=7F:"PNQ<
M;G9MK,I>/:-H8(Q&&;MD"DN?'$L,DUTNE[]$@U :?+>_:,2"3>(RPCVX*!R%
M)W ]>* .THKEXO$\LNO161T_%C-=RV,5WYWS-/'&TC Q[>$Q&X#;B<KT'6M/
M1]5_M=;FXBBVV:3&*WF+9\\+PS@8X7=D Y.0,]"* -6BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KG_'?_)/?$O_ &"KK_T4U=!7/^._^2>^)?\
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M /!C#_\ %4?\)WX0_P"AKT/_ ,&,/_Q5 '045S__  G?A#_H:]#_ /!C#_\
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M/^AKT/\ \&,/_P 50!T%%<__ ,)WX0_Z&O0__!C#_P#%4?\ "=^$/^AKT/\
M\&,/_P 50!T%%<__ ,)WX0_Z&O0__!C#_P#%4?\ "=^$/^AKT/\ \&,/_P 5
M0!T%%<__ ,)WX0_Z&O0__!C#_P#%4?\ "=^$/^AKT/\ \&,/_P 50!T%%<__
M ,)WX0_Z&O0__!C#_P#%4?\ "=^$/^AKT/\ \&,/_P 50!T%%<__ ,)WX0_Z
M&O0__!C#_P#%4?\ "=^$/^AKT/\ \&,/_P 50!T%%<__ ,)WX0_Z&O0__!C#
M_P#%4?\ "=^$/^AKT/\ \&,/_P 50!T%%<__ ,)WX0_Z&O0__!C#_P#%4?\
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M_P %T/\ \37044 <_P#\()X0_P"A4T/_ ,%T/_Q-'_"">$/^A4T/_P %T/\
M\37044 <_P#\()X0_P"A4T/_ ,%T/_Q-'_"">$/^A4T/_P %T/\ \37044 <
M_P#\()X0_P"A4T/_ ,%T/_Q-'_"">$/^A4T/_P %T/\ \37044 <_P#\()X0
M_P"A4T/_ ,%T/_Q-'_"">$/^A4T/_P %T/\ \37044 <_P#\()X0_P"A4T/_
M ,%T/_Q-'_"">$/^A4T/_P %T/\ \37044 <_P#\()X0_P"A4T/_ ,%T/_Q-
M'_"">$/^A4T/_P %T/\ \37044 <_P#\()X0_P"A4T/_ ,%T/_Q-'_"">$/^
MA4T/_P %T/\ \37044 <_P#\()X0_P"A4T/_ ,%T/_Q-'_"">$/^A4T/_P %
MT/\ \37044 <_P#\()X0_P"A4T/_ ,%T/_Q-'_"">$/^A4T/_P %T/\ \370
M44 <_P#\()X0_P"A4T/_ ,%T/_Q-'_"">$/^A4T/_P %T/\ \37044 <_P#\
M()X0_P"A4T/_ ,%T/_Q-'_"">$/^A4T/_P %T/\ \37044 <_P#\()X0_P"A
M4T/_ ,%T/_Q-'_"">$/^A4T/_P %T/\ \37044 <_P#\()X0_P"A4T/_ ,%T
M/_Q-'_"">$/^A4T/_P %T/\ \37044 >3_%SPIX<TSX7ZQ>6/A_2K6YC\G9-
M!91QNN9HP<,!D9!(_&O6*\_^-G_)(M=_[=__ $HCKT"@ HHHH *\_P#%O_)7
MOAW_ -Q/_P!)UKT"O/\ Q;_R5[X=_P#<3_\ 2=: /0**** "BBB@#SSQSJE]
MHWC'0+FSMM2OE%G?2R65I=&-93&(RI9-P5L;F[$G/0X%1:EIHG\!"[T_Q%JC
MRZM>V3K?Q7\P\M9KE$(B!?Y%"R,-OTSD@8ZZ]\/Q7OB/3=::\NHYM/CE2.&/
M9Y;B3&[=E2W.U>A'3ZYRD\!VT.FW.GV^LZK#:S7JWZ1(8,02+*)0(\Q'"[PI
MQST]SD X[5/$NK:[X=L[07-S97NG7-M#K3VTC1,93=)!Y89<$!P7DX.0-G]Z
MM_XCZZ+*UCTNUUZ#2+PP27BRS72Q%_*'[N++$$[W*YZY56'>NCUSPS::U82V
M@FFL1-<QW4TEFL:O+)&5*EBR-GE$YQGY0,XXI]GH*V6LZCJG]I7TLU]&B,DO
ME;8@F=NS" C&YNI(Y- &!K.H7FM:+H.LZ='?W.CSJ)KVWTZ<Q7!1D^0J5*L0
MK'E5()]\8K7\,7%N/# GM]3N-2MU:5TEN=WFJH9OW;[OFW)]T[N>.:S['P#!
MIUM9Q6>NZQ%+8F;[/.&@+(DI5GCP8MA4LH(!4X[8&!70:-I$&B:>+.W>9U\Q
MY7>9MSO([%W9CZEF)XP* .2\,:9J'B'P]H_B.?7=034;IXKV01W#^0(RX8P"
M'<$V[,KN(+ \Y/2M!_&C0^*;#1KBSM4%Y<26Z;;]'N$**S;GA4$*A"\'>2-P
MR >*?;>!+*U%O;PZEJ:Z7;W2W<.FB2/R$=7$B@'9OVA@"%WX]J(/ MI;S6+I
MJFI;+&^:^MHB\16-GW[T^YEE;S&ZDL.S"@"G#X[OS92W\^A1I96NI/I]X\=[
MO9&$WE;T7RQO7)!.2I [&J&L>(-5L8?'$^GAQ>6$]NJ&XO-\4:M#&<QJ8_DX
M()4Y!8DYI_ASPC>7(U/^W#J5M:RZS-?IISRP-#*#-YD;$IN?@[<KN R.AK=G
M\%V5RWB#S[R^==<VF==R+Y150BF,A 00 O4GI]<@$6M>)=3T'3%N+S3M,CG"
M22N)-5$<.%YVJ[1AF<CG&P#U;UI:==VVK>/- UJ"W$1U#PY--D@;]C2VS*K$
M=<;C^9K3F\&PSW:74NL:HT_V5K2=S)'FXC8Y(;Y/EY_YY[*-*\'6^E7VD7,&
MJ:C(-+L#I\,4ABV/$=OWL1@D_(G((^X/4Y (O%_BV3PO;S3K:6LL<,!N':YO
MT@+@9RD2X9G?CH0H.0 V> V;Q7J#Z\NEZ;HT=T\NF+J,4DMYY0(+;=C#8V#Z
M$9]\=:LZMX0M-8O;VXEO;Z%;^S^PW<,#($EC&_&<J6!'F-]T@'N"*+?PE':Z
MI%J$>KZA]HBTX::I/DX"#D/CR_OYY]/;'% %2+QD^J6VC)I.F+<WFJV)OQ!<
MW'E)#"-@)=@KDG+@ !3GGI4/PN01>#WC%NEN%U"\7R4(VQXG?Y1CC Z58L_
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M% !1110 4444 %%%% !1110 4444 >?_ !L_Y)%KO_;O_P"E$=>@5Y_\;/\
MDD6N_P#;O_Z41UZ!0 4444 %>?\ BW_DKWP[_P"XG_Z3K7H%>;_$"2\T[QOX
M-UZ#1]4U.UT\WHG33K<S2+YD2HO''?/4]C0!Z117G_\ PM/_ *D/QQ_X)_\
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M_P#]G0!Z!364,I5@"I&"#T-<#_PM/_J0_''_ ()__LZ/^%I_]2'XX_\ !/\
M_9T =K96-IIUN+>RM8+> ,6$<$81<DY)P.,DG-6Z\_\ ^%I_]2'XX_\ !/\
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M *D/QQ_X)_\ [.C_ (6G_P!2'XX_\$__ -G0!Z!17G__  M/_J0_''_@G_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>?ZCX[\0#Q9J^A:!X/.KG2Q#Y\QU*.WP94WK\KKSW'![5Z!7G_ (2_
MY*]\1/\ N&?^D[4 '_"6_$/_ *)C_P"5^W_PH_X2WXA_]$Q_\K]O_A7H%% '
MG_\ PEOQ#_Z)C_Y7[?\ PH_X2WXA_P#1,?\ ROV_^%>@44 >?_\ "6_$/_HF
M/_E?M_\ "C_A+?B'_P!$Q_\ *_;_ .%>@44 >?\ _"6_$/\ Z)C_ .5^W_PH
M_P"$M^(?_1,?_*_;_P"%>@44 >?_ /"6_$/_ *)C_P"5^W_PH_X2WXA_]$Q_
M\K]O_A7H%% 'G_\ PEOQ#_Z)C_Y7[?\ PH_X2WXA_P#1,?\ ROV_^%>@44 >
M?_\ "6_$/_HF/_E?M_\ "C_A+?B'_P!$Q_\ *_;_ .%>@44 >?\ _"6_$/\
MZ)C_ .5^W_PK.UW6?B%K7A_4]*_X5QY/VVTEMO-_MRW;9O0KNQ@9QG.,BO4:
M* /+M"UGXA:+X?TS2O\ A7'G?8K2*V\W^W+==^Q N[&#C.,XR:T?^$M^(?\
MT3'_ ,K]O_A7H%% 'G__  EOQ#_Z)C_Y7[?_  H_X2WXA_\ 1,?_ "OV_P#A
M7H%% 'G_ /PEOQ#_ .B8_P#E?M_\*/\ A+?B'_T3'_ROV_\ A7H%% 'G_P#P
MEOQ#_P"B8_\ E?M_\*/^$M^(?_1,?_*_;_X5Z!10!Y__ ,);\0_^B8_^5^W_
M ,*/^$M^(?\ T3'_ ,K]O_A7H%% 'G__  EOQ#_Z)C_Y7[?_  H_X2WXA_\
M1,?_ "OV_P#A7H%% 'G_ /PEOQ#_ .B8_P#E?M_\*/\ A+?B'_T3'_ROV_\
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MB@ HHHH *\_\)?\ )7OB)_W#/_2=J] KS_PE_P E>^(G_<,_])VH ] HHHH
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MT<,LSQL]U+)M&\!"=JA5/7!);H,5U-%% !1110 4444 %%%% !1110 4444
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,4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>form20-f_007.jpg
<TEXT>
begin 644 form20-f_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %D > # 2(  A$! Q$!_\0
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ME^+6GC2VTY;:[%NS^81Y:YS]=U '3Y&?NC\JT=)M(KJ9_.LWFA09D9,_(/8
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MU/,[7PWJ5R ;71;IP>ZVQQ^HK8MOA]XFGP1IGE ]Y943^N:]HTN__M+38;H
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MSQY9(P>F>O2JEW;&.TT^5F!\V#</;GO79Q0:=I_A[4V>?[%+?6K);R^1$/-
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MTZCWJTFI1WYTPRZ?&+E]UJIB=\8$;9;#C.2>P].M<5-XKNI1&K1Y6)0B#>W
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M+-&&7/N,5*;BZ5F,1A&3P'>0X]L\_P J=]G8'D4")NN* )XKZZCN6?S(5C8
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M2E%:H)-6=R,7UFDA\M5('14WN?Z"KQ\9:G';"UBN)HX3QY1<*"/IR:Y5M4C
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MUDYR-%"(L6GQP 33E,CU'0_UJ"YE>Y.P?+&#Q[_6ED>=B"R.V.F5/%-$K+_
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M,=SZT'/K1FCB@H;^-&3ZTI%&!0 WGUHYIU&* &Y/K1DT['%)0 @8T<T[%)2
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(_N&BBF!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>form20-f_008.jpg
<TEXT>
begin 644 form20-f_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %I > # 2(  A$! Q$!_\0
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M_P#/K!_W['^%9R>,84 659&?OM(_PJPWC&U=4\NWF4X^8E@<_3BINBK2+/\
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MI?\ "MY-1TR1<I=0'_@8I5U'3'8J+N#([;\4607,'_A'[+_GQM_^_2_X4?\
M"/67_/C;_P#?E?\ "NE6:S;[LT)^CBG@P'HZ?]]"CE#F.7_X1ZR_Y\;?_ORO
M^%+_ ,(]9?\ /C;_ /?E?\*ZD"$]&0_C2A8CTVG\:7*',<M_PCUC_P ^-O\
M]^E_PH_X1VQ_Y\;?_ORO^%=7LC(S@4>7'Z"CE"YRG_".V/\ SXVW_?I?\*7_
M (1RQ_Y\;;_OTO\ A75^4GH*/+3'04<H7.4_X1RQ_P"?&W_[]+_A1_PCEC_S
MXV__ 'Z7_"NK\M,]*/+3^[1RA<Y3_A';'_GQM_\ OTO^%'_".6/_ #XV_P#W
MZ7_"NK\I?2CRT]!1RA<Y3_A'+'_GQM_^_2_X4G_".V/_ #XV_P#WZ7_"NJ80
MJVUF4-C."<4G[@E5#)EAD#/446"[.6_X1VQ_Y\;?_OTO^%'_  CME_SXV_\
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M+ZM$?MY%<^&8=I DE'XT@\+Q%<&:?\#5H-,.[?G4BRW '#-^=+ZM$/;R*O\
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M%\OC[U*(O]O]*09]:<"WK0,7R_\ ;_2G"/\ VJ09]:</K3 79_M?I2A,=6-
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MKM]+\-VL-GLOO,DE;YC\_3W8]S[=JT>-KJ*UW\B%AH2>B+H\;6?FLGV*Y/\
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MMA*X))(W[CGL".GZ4X(L,TL@CWJ<E8@<8/8"NKV"M9HYG4UNCO\ 29-*U"\
MM(V#8.V3;CJ.U=$=-C@2)FE.R0+D%?4XKC? MQHVCVQN;ZY!U*20%8MA(A7T
M)Z'.>O:O1;_6/#USI15;K8(\!C''NV#.XGKTK&I@IK5*Z".)C>U[&3?Z69Y+
MBRM+EK.2W7S6<1;RX';T KJ]-BL=/LSL1W?(260IRS>E6AI6CSG^U+:[+">
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MDXJ5$NY[ZGB#PQI]NODR)&&085%^8C'MS63)\0M/64I;6DC ?QL>*\QMX)C
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M%WBW6;O[/9WDKR@;MIF"Y^F>M8ZE<J/54TRX,QCRC$#G!X%6$@O;7&Q6PIR
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ML332UNAO+,0W:-I/R>OW:,I2&YN[XK'/'(KN%4$@\=!P:9<!Y[XAK(;'?:I
M(XZ#D>U/CMHK5DF-R44*6C\Z%XR21\O)&/UJO8HT5Y&XF3:IW$I(,''/K6BJ
MP>S1S3P=:/Q1:^3_ ."$SVMQJ+8\U-TF 00>,X'I4TDDC:BQ2]&/-XW@CO[T
MRUFGDOHO, ;+ALL@/N:;#-"]VC&U4DR C:Q'>M#!QDMRQ$US%K<<D=M;LZW
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MR*+T.QYO5FK58J7RL_P*9\:YCA\^1D<2_,MQ;%0J[2,Y4X/6M5/$^B7UM/\
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M&;5[$WC[4X;:2QT9'V11Q^9(.P &%S^M>=ZCKVFZ<["1F9 619 G#.!DK_\
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M#<CQQO$+9H8U0D$!>>E.+E97)LCSM(S*."-VX* 35^ST#4K^80V\ :0J7P6
MX'?FJMB_EWT#'H'!(KT?P[I^HM?I?+#Y,01EWR]6!]!U-14FXG32IJ;LSB[S
MPEK%A92W=S B0Q#+'S!G\!WK'B($@R< \9KW*\L5N--O(7^=Y877<_7D=O2O
M#XT*-CN.**4W*]PQ%)4VK$C/MDX;.&P*]KL?%'C&\\.6<FKZ7 889@T=W,0
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M%K;95<G)9CW/J>E9LUNT,BH,G/<^M.LV"&65F'F%<+D9Y]JM6"-<.#._R1]
M/Z413E*PGHC:\.:+]JE"$C;G<X'4CTKT0VJYMTV[8XN0JU7\/VD%GID)4@,Z
M[G8=2?\ "K DS=N<DC&T ]!7-B)*K-4ULBN6T+G>>!;=4>^U2;"06Z>6A[#C
M+'^5>1^--=DO=3N9V8_OY"_'4#^']*]<U^3_ (1?X<)9J<7-T-K'H<MRQ_+B
MOGO5I'GN#QGG&*ZZ<$E8YWND1Z99/(TOVMRL$N21GD&K3Z:T]QNC8B!5 +,.
M:;;Q8"L>N.E;MI%*ZHFT)N/4]<?2E*"B^8W4KQY;$?E3OJ<=L6CFCD*;A+"K
M/@*!C.*Z\6-I%:FWMK1(E)!(3CFL31(HEUUSDEA'QGDDDG^@KK54+SBN><4W
M<N+MH9=IHEM:1SH80R2OEA(2=W>KBV5G!%)!!;11*XQ@#&?KBK1 *J<]3FH7
M!=R0:RY$]RN9F5IWAV&SU07C') ;8%9L(2"#U//!I= T.RTP*D"9D;@RORQ_
MP_"M9=VX+V /\JCC7R]I4<CFKN[V%9#!<IYR11(99L@L%QA!ZD]OI5J; E8
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M&)/2KC21JB[G4,$!(] ,?X5SUE='=@Y)2=Q%['U _I7*?$?!T&W.<_Z2O/\
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M P<U(6.WM7*; < 4H;)IF[M1U/%("</ZBE#\X''UJ(' ]JL0Q$C)&21D9[4
M.P A<GIUQ_*HS(6QG_\ 544LH=PJC"CM5<3L;UX-I"I&&+>Y)X_2@JQ<+\4%
MZAW\9H\P$#.,4 2A^>E/5AM.*K%^.M*&X-2!*7K&\5-GPOJ0_P"F/]16D6YK
M(\4/GPQJ(/7ROZBA;@>?VC.EK$RL1\HZ'VK3@U.[BQB0D>]9MKQ:0_[@K0TW
M3KW5[Y+.PMWN+F3.R-.IP,FO9Y8N*YCBN[Z&I!K$4^4O6D$9&-BG(/UKH]/O
M[9XECMGA5!_#T-4?^%6^+@J,=.50RY.^55V^QYJQ!\*_$SLN19PYZ$SY_D*Y
MYT(37NLM5''<V)(H[J,+) 7QR"#G'T/:JIN;BS<":222V/'"9=?J.X]ZU-.^
M%OB0.BOX@L8QV3YSG]!6'XB?7]$FN].CM%FN4<QK/'SD#^( _6N&=)QT9O&:
MEL9'C'Q!?1VD%EIJ2@2$,TR(0" 00!_6J<%\9RAU2!I+621KJ_"@J&_NI^)Z
MXK7\'ZI]DBO9=1\4R13P?,+:YB++*N.BCL<UB>)O$EUK$T3S"."V4G%NJ#/J
M"S=?PJHTG;E70;FEJ3Z5J5CI8N_$]]")+D-LL8PN%5B.,#V Q["N"N[N;4;^
M>]NI#)/.Y=V/<FI]3U$WK1(HVPPKM4>IZEC[DU6M83+(..*U4=;(R;+VGVP+
M!B*[+2+NUT-&NI4$]XRX2,'_ %8]S[US]O&J  <8')KTKP9X%TKQ)X8EU*>6
MY%RLDD>Q& 08&5[5U2484_>,DVY:'-PS:AJ[R7MU,3 6V"W7A23TK7B;!)+H
M=GW8N@SCW_SQ5+5=5?3DBLK>U$L@4'(. GI4.BVEUJ5]#(?GNWD6-8P/E4GC
M'O7ST*;K3]I)61M4=HGL?A QZ/X3O_$,H \U2R?[J\ ?BV:\"U[4IKIYI9)"
M9)F);GU.:]R^)-_!H7ABRT6+"@IRJ\?*HP/S/\J^==1EWS[1SBO:I12B8M:V
M[$*$X &*Z+2M-" 7%RF#GY%)_I6%9@K(#L#-VR*Z"WC)&Z8NP Y4'C\36TKV
M&MS4$N_(AP>Q<]!_C5%W4ZB ))GD"@*L9^9S_05#).;A&6$)'".&D/\ (#O5
M^T6VT6W-Q-*&N)02D:\L%[$GM4)6]2V[FC:Z#)<*3J-W.%ZF)9#@>Q/<U<D-
MMHL;&-Y9)6Z+DL5'L*Y277;QL")_)C49 7[Q^IK1TN-YXO.O'_>$8C+GG!]:
MY\6IPIW;'!INR%N-1F>42>8RR+@*&;Y2?4U.VO3*O[_/+#E1@D#TJC?V+O>@
MJK/$0,[FP  ?04NJ31&T=<&+G:O!)&>IR*\F#V2ZEG1WGB.VA@40$2.4#$CH
MHK@M0U+4+F_Q)F4$9"YRJ$="?I5JV2%+9I!,$E&2QD7C;[>U+964=\6DAE'E
M/\K <_6NI3:;; I2.(K.V#.@>=B7D?'R\=1Z5+:WJRR6L4Z%&(&S)[@=<=JO
MZA!:;9D=&.P;$E;&-WH/2J_E6EGN.X%UPR"1<L./NG\NM3S1:M;41H7$\BSK
M;$;RX C('.1ZX[54U%XI!':VX#/$/WCC@$^@%)!KXA1F^S!K@Q^7O+Y 'K[U
M&EZD166.!-L9&T'CZD^IKT,-AY4TI-:F<I)Z%-XC$,D@G.,#UJ(L&.0O'I4\
MUR]S/Y\X4\Y.%P#4'W6^9?PKTXWMJ8L<BM*P48'OT KI/#5A'=O,@E2.1>=V
M<GVQ6/IJ!Y&8#A%Y#'K7<>&='%DIN)80)7QCZ5S5ZEDT:0CU.@TRQCTV$01O
MP,[0>V>]7)F6W@,@(<CG ZFJZ./-!>H-0N"(N-^WIE1G'UKS*LVHN1NET(VU
M;RI$$EOU8$MGOZ5AMJ4\US=1RGRWGE=E*G(7)XJMJ%S* 92&*1#[I/+_ $]*
MALKN&^@>>-E5TX4D[BC=\_C7EN=2:]YZ%Z%?41<RV^T,QW/AP.X4$Y('X5AZ
MN\=Q TJ1/&4?J!\YR.!CW_2NDS/;VDLK O*3SM/4= <5SLT8N9!=7.TR+<_*
M%7 8=P1W.*UHS=[OH3)#[/2I;>Q-RW^L9,A6/('J/>NS\,:C/H%];W\4L<BQ
MX$ZQG[RGJ#_.L^",20W&%AE@8%D56X7CD8]ZJQ6\EN8=BE$D.9<R'&2,XQZ>
M]:T<7-R]]D5*>ET>H^.=%M[Z*'Q#8#S(YT42E!G(/W6_I7F@T>#4-1G@EB4L
M(P$DZ$OU"G\*]*\ :VE]:2Z!J!0JRGR4Q@ =U_J*Y+6]#N-$U.XMI&8G>7CD
M'&Y>QKUZ<G)6.=NSYCB;VRO89UMH[IA!(X4P.Q!7!Y&/3BMF&\OC(89(RY(*
MK(IX7Z^@I)%?7/$+WJ*0+*)5E_VB>-W^-:-Q:&:R;RY@/,PK,/2G*5D:I7#2
MM*-O9OFX,CYW,/0>U6A&N!\QI(W,)4QG!48%2R@-'Y\8PO\ &O\ =/\ A7$V
M[ZFZ1&8UZ<U*EL&A,B-G;]X=Q[U"&SQFG12-#*KH>?YCT-#N!-'"A89;\*EF
M.Q#&,C/4^U-E567SH?N$_,O]T^E*&$B;3R<<9I7'8ILJQJ7P6]=HR13IYX97
M4Q0K'M14;:<[B!]X^YH)*/D'!!J*2(*AFB3*]9HE'(_VE'\Q^(I=2T[)H;N&
M.M)N Y!J&2:*.U:Y\P&$#=O'(QZUSMSK<@<R02HR,,;>ZGU%7&+EL9MI'3[P
M3G=Q3MZCOFL?3-42]<QD@%0.2>3^%:FWT-)JSU&G?8<2/45D^)R#X9U Y'^J
M_J*TB,&LGQ*0OAV^_P!J(T+<&<_%X<O#I-K<0!94DA5L!AD9'2K&@7T_ASQ-
MIVHR1R1_9[A68$8RN<-^F:ZK3+@WFFZ;(DD2.;*.,H!M)VJ #[G@5E:^MQ?Z
M:C)"/+5_G8+T[=/;FNF->5^5[&3@MSZ,N(H;HF:.>1#( =P&01VJI_9Q=OFO
M)N3QB(5XYI'BZ\\/:"&BU$:DVY0?/8DHO3:!U Z47_QCOIK9[>VT^! Z_,QF
M+$#U ]16+KUU44(0O'J[K3Y;DNE!J[>I[7!!#;.)"LLK@Y#2$#!]A7CGQ?N8
MHO%%G(L649!+<*C_ #X''4=,C^5<XWQJU:"-XC:PSR+C9)(S$9QC-5-2EG\8
M^*/[2FNYAI*VZ23NW'EKCF(>I+9 ^N:(RJ5)OVD?=Z.^OW="TE!>Z]3'U1K9
MKD7MI'*UNPW6ZRMN8+[G'(SFN:O+F60M$SYRV3]:Z/Q)KHN(5CLX_L\6SR40
M?W,\#Z#%<D3@D-U[FM[V5DK$"!"6VULV,'EQ@UGVD322@@?*.N:Z-K*6VECA
MF4(719%(((*L,@@BMJ-D]=R97L:6BK!YJ1-"))I&XR. /<]JZ74K^6S#6EF3
M''L(58GVK]:R]"M8=IG"Y;."S+G ]O2EUJ[3R_+\MD5^"1][;U/X5Y>.J\U1
M0A\S6$;1NS)D>:YNX8#N:1\;I!T//?Z>M>O^ -/2\UY9_+4):1[V('#-T']3
M^%>1:,;F:]AW!7@#Y#*I)QFO>M(6/PSX%NM29<37 W#U.?E7_&G3I\MDR).\
MO0\_\=ZE%KGB&^9U)BMR(HN>H'?\3FO+[A8H+@3&$L3)\I7[OU/^%=3XBCGM
M;J6!)F^63+2MT(///X&N9NKN.0F.,-QGY^V,=L]:J4I<_*GH*"TNR2T,!EEE
MDW/-O^50.3]*N^5)=$+*?E'_ "S4_*/J>]9ME*L$XMR@ QEY3U(]*WK"#[<2
MB,T:$8!4?,Q]O0>]=D)VB.VI38!9(HK>%9)%;)R. >@SZ#VIM^OV><I-*'F/
M,A7U]*NZE:0V,HL[1'>1,&28MD%L= /6LM>&8.0\F<>O/<__ %S6U)IZD25M
M!&4^4)"A6+'R97[WJ:V_#P%XOE>4QV_Q8^7(Z9/?K^E9\%M>:GMAB 9%X+8Z
M?B:Z72X5TNR^RPRK-<,Y,C$_+'6.+E&5/E>Y=-:W&WL)VY08G&,N%.#6#<@2
M.J7"[QO.P*>YQU]JZ2YN06>)#O=#RS#O[5@7JP22(\K@.&WLBG[N!_6O"IJT
MK&S(=0M[61<+/F1EQY9'&!V'ZU=M8$&6@S:Q08WB08SQGM51$M_MZ3SNJ2R9
MV;T(7CMCL3VJ.YGB,)<F0QR%MQ)QM&.*Z'\236B)'WLQNG+V[H0,%HPI)Z]Q
M]*6[FTZY0Q7##&.HXP:SM.O%@=[E(-\*#;E6RRCJ2*GD72[Y97B:/?@=]I)-
M:*FN9=D%S.E>U$C+;DF/JN>H]JE #EB(^@SMSPH]?K5)D:POD5BAQAACY@ ?
M7/>MV"^T^&=U&9E9<,Q;!8_7TKV(SM%6U,&M3.B)>=.F,X&X9 'TJZVG'[/)
M<RRX ?8J@9W'OCZ5>@O+"SN_MC-'*VX[$7!(..#[ 5:L+VUO=8A>2./R806=
ML_+N/0*/U/O2E5END"BC0\.:!;*RWKAFD0_<;[H.,UUZL1WK)76K*) @E) ]
M>32_V]9@#YF_[Y/^%<4G*3NS=)(U6!;D=:BE>$0 R,1[8[U1.O6F!A9#_P
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MK?V/.Y.64\8^Z>*EP9NJD3GY% B:-5(VIC-7+:9F15/(*8_2M9M$G9>.F#_
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MR^C 86%NHSCYF;.:/^%BZDR ^5:*2,XP3_6IA.%-\UQ-)]34\;Q-#I.FV41
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M6_\ K5SUSXMO))#Y"I"O;C<:VISJU-4M!6EW/>F^)NL-]R*S!/3Y2?ZTD'Q
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MEH>H#QAI48.V\+#T*&HI/%6DOEC>Y;_<->:45/(AW/1_^$KTS;@77_CAJ/\
MX2G35/%QG_@)KSVBIY$.YZ,OBC2GP9+L@C_8-6$\7:-$N%N?_'#7F-%/D0<S
M/3)/&&FD?+><^R&FGQAIN,?:?_'#7FM%+D07/1?^$KTPDLUT2?\ =-!\5Z9_
MS\?^.FO.:*?(A7/11XJT['_'P/\ ODT'Q3I@&!<_^.FO.Z*7(AW.[N=?TR8[
MA=#<0 08R>GX55MM9LO,<37BJI/WO++''H*XZBKMH3;4Z:ZO[ WD9MKEC$P.
M\NI&/? JPM[I'\5[^49KD:*+ON/E1VBZCH8ZW3'_ (!_]:I$U30U(/G<@Y^Z
M:X>EI.[ZCLNQZ#;^*;.U0QPWP"Y)!V$').>>.:@M-8T*T=Y%N,RR'<[E#DG^
ME<'11RBN>E+XKTE>ES_XZ:=_PEVE?\_7_CAKS.BCD07/2_\ A+M+_P"?K_QP
MT'Q9I1_Y>C_WR:\THHY4%STH>+-*_P"?K_QPTO\ PE>D_P#/V3_P UYI11RH
M+GIG_"7Z4.EQ^:FFMXNTPG_C[./]TUYK11RH+GI(\5Z3C_CYY_W#2'Q9I9_Y
M>?\ QPUYO11RH+GI'_"5Z7G_ (^O_'32CQ7I?_/U_P".&O-J*.5!<]+_ .$K
MTG_G[_\ '#1_PEFDC_EZ_P#'#7FE%'*@N>E_\);I6/\ CZ_\<-'_  ENE?\
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J->>T4<J'<]"/BK3?^?@_]\FJ>J^(;*ZTJX@CN-SNF -IKB**?(A7/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>aud_001.jpg
<TEXT>
begin 644 aud_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !F 14# 2(  A$! Q$!_\0
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M>IJE_P )9XA_Z#-Y_P!_*T_!_@M_$ZS7$MP;>TB;9N5<L[=<#VKK/^%3:?\
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M'_H,WG_?RO7O!.O'7O#L4LK[KJ']U/ZDCH?Q']:P_P#A4^E_\_\ =_\ CO\
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MM 'NU%%% !1110 445!>WD.GV,]W.VV*%"['V% 'G7Q3US_CWT2%^N)I\?\
MCH_K^5<#HNERZUK%MI\6<S/AB/X5ZL?RJ/4]0FU74[F_G/[R=RV/0=A^ XKT
MCX6Z'Y5I/K4R_/-^Z@SV0=3^)_E0!Z#;6\5I:Q6T*A8HD"(H[ #%>'>-]#_L
M/Q),D:XMKC]]#Z 'J/P/]*]VKD_B#H?]K^''FB3-S9YE3'4K_$/RY_"@#A?A
MOKG]FZ_]AE?%O>X7GH)!]T_CR/RKV:OF='9'62-BK*0RL.Q'0U] ^&-977M
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MH.TE9F5HOAO2] C*V%L$=N&E8[G;ZDUJT5GZUK5CH&F2:AJ$IC@0A>%+%F/
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B*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>aud_002.jpg
<TEXT>
begin 644 aud_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! /0# 2(  A$! Q$!_\0
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M/W_CC0-->-+J[DC>3D*T$@(7(!8Y7A02,FNB!!&1TH ;)(D4;22,%1 69B<
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MH?M%RT<1($:!5R[XZ*H'+>P%4M+M+N]U#^VM3C,,FPI:6A.3!&>I;_;; SZ
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M%U,VZ&\6+R5E/)5,YP.PY]*KZ7I"Z?>:C>/*9KB^G\QW(QM0#"(/90/U-:=
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M\J1I7OKV2\E=A@[G/3\  /PK7HH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>aud_003.jpg
<TEXT>
begin 644 aud_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !. -P# 2(  A$! Q$!_\0
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MP>.!>JN([^!9,C^\ORG^E9X.5IN/<TQ,;QN>>6O_ !^6_P#UU3_T(5]/^/\
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M4I):YG:3GT)X_3%7"4:M7F70B473I\KZGI7P)T877B*^U9U^2SA\M#_MO_\
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M>!O#OB.^6]U;3EN+A4$8<NP^4=N#[US^WC[;GMH;>QE[/D/&_@/_ ,CC??\
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MNC_UJ=SZCVK[#B_U*?[HKSL;O$[<*MQ]%%%>>=H4444 %%%% !1110 4444
3%%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>aud_004.jpg
<TEXT>
begin 644 aud_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  N /@# 2(  A$! Q$!_\0
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M6,=M;7U]9M:6L8C40QG?* , L3T_"MJ?3;*YO+:[GMHY+BV),,C#E,C!Q5G
MK6I6YXQC;9&4:/+)R[G+Z=X?U;2M0N4LM0MX]-GN6N64PEI06ZJ#G&/>LZ7X
M::?+XBN-0,[K:W',ELO4MW&_.0I[@5W6*,5"JS3;3*=*+5FCG%\$Z$NJ"_\
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828%.-:<7>XG2BU811A0/2BG8HK(TL?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>20
<FILENAME>ftel-20240630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaKIWbP9z5Z8uekhvWB0bTkK7y8uX5SE6ihL2IM2scwF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:FTEL="http://fitellcorp.com/20240630" elementFormDefault="qualified" targetNamespace="http://fitellcorp.com/20240630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://fitellcorp.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss" id="StatementsOfOperationsAndComprehensiveLoss">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/StatementsOfStockholdersEquity" id="StatementsOfStockholdersEquity">
          <link:definition>00000005 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/OrganizationAndPrincipalActivities" id="OrganizationAndPrincipalActivities">
          <link:definition>00000007 - Disclosure - Organization and principal activities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000008 - Disclosure - Summary of significant accounting policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecurities" id="InvestmentInMarketableSecurities">
          <link:definition>00000009 - Disclosure - Investment in marketable securities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ConvertibleNotes" id="ConvertibleNotes">
          <link:definition>00000010 - Disclosure - Convertible Notes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/Warrants" id="Warrants">
          <link:definition>00000011 - Disclosure - Warrants</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/NoteReceivables" id="NoteReceivables">
          <link:definition>00000012 - Disclosure - Note Receivables</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>00000013 - Disclosure - Property and Equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities" id="LeaseRight-of-useAssetsAndLeaseLiabilities">
          <link:definition>00000014 - Disclosure - Lease right-of-use assets and lease liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000015 - Disclosure - Commitments and contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000016 - Disclosure - Income taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/DueToRelatedPartyTransactions" id="DueToRelatedPartyTransactions">
          <link:definition>00000017 - Disclosure - Due to Related Party Transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000018 - Disclosure - Summary of significant accounting policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables" id="OrganizationAndPrincipalActivitiesTables">
          <link:definition>00000019 - Disclosure - Organization and principal activities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables" id="InvestmentInMarketableSecuritiesTables">
          <link:definition>00000020 - Disclosure - Investment in marketable securities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/WarrantsTables" id="WarrantsTables">
          <link:definition>00000021 - Disclosure - Warrants (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>00000022 - Disclosure - Property and Equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" id="LeaseRight-of-useAssetsAndLeaseLiabilitiesTables">
          <link:definition>00000023 - Disclosure - Lease right-of-use assets and lease liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000024 - Disclosure - Income taxes (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails" id="ScheduleOfCompanyAndItsSubsidiariesDetails">
          <link:definition>00000025 - Disclosure - Schedule of the Company and its Subsidiaries (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000026 - Disclosure - Summary of significant accounting policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" id="ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails">
          <link:definition>00000027 - Disclosure - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" id="InvestmentInMarketableSecuritiesDetailsNarrative">
          <link:definition>00000028 - Disclosure - Investment in marketable securities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative" id="ConvertibleNotesDetailsNarrative">
          <link:definition>00000029 - Disclosure - Convertible Notes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ScheduleOfWarrantsDetails" id="ScheduleOfWarrantsDetails">
          <link:definition>00000030 - Disclosure - Schedule of Warrants (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/WarrantsDetailsNarrative" id="WarrantsDetailsNarrative">
          <link:definition>00000031 - Disclosure - Warrants (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/NoteReceivablesDetailsNarrative" id="NoteReceivablesDetailsNarrative">
          <link:definition>00000032 - Disclosure - Note Receivables (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
          <link:definition>00000033 - Disclosure - Schedule of Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>00000034 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" id="ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails">
          <link:definition>00000035 - Disclosure - Schedule of Operating Right of use Assets and Operating Lease Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" id="ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails">
          <link:definition>00000036 - Disclosure - Schedule of Maturity of Operating Lease Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" id="LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative">
          <link:definition>00000037 - Disclosure - Lease right-of-use assets and lease liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" id="ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails">
          <link:definition>00000038 - Disclosure - Schedule of Reconciliation of Provision of Income Tax (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" id="ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical">
          <link:definition>00000039 - Disclosure - Schedule of reconciliation of provision of income tax (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" id="ScheduleOfComponentsOfDeferredTaxAssetsDetails">
          <link:definition>00000040 - Disclosure - Schedule of Components of Deferred Tax Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative" id="DueToRelatedPartyTransactionsDetailsNarrative">
          <link:definition>00000041 - Disclosure - Due to Related Party Transactions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ftel-20240630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ftel-20240630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ftel-20240630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ftel-20240630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="FTEL_MerchandiseRevenueMember" name="MerchandiseRevenueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_SalesOfConsumableProductsMember" name="SalesOfConsumableProductsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_RevenueFromLicensingCustomersMember" name="RevenueFromLicensingCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_SubscriptionReceivableMember" name="SubscriptionReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_FitellCorporationMember" name="FitellCorporationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_KMASCapitalAndInvestmentPtyLtdMember" name="KMASCapitalAndInvestmentPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_GDWellnessPtyLtdMember" name="GDWellnessPtyLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_OneVendorsMember" name="OneVendorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_TwoVendorsMember" name="TwoVendorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ThreeVendorsMember" name="ThreeVendorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_FourVendorsMember" name="FourVendorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_WarrantOneMember" name="WarrantOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_WarrantTwoMember" name="WarrantTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ConvertibleNotesMember" name="ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_CapitalReceivablesOfConvertibleNotes" name="CapitalReceivablesOfConvertibleNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_DepositsAndPrepaids" name="DepositsAndPrepaids" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ConsultingFees" name="ConsultingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_PersonnelExpenses" name="PersonnelExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_LicensingFees" name="LicensingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_PublicOfferingRelatedExpenses" name="PublicOfferingRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription" name="StockIssuedDuringPeriodValueSettlementOfStockSubscription" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncreaseDecreaseInPrepaidOfferingCosts" name="IncreaseDecreaseInPrepaidOfferingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncreaseDecreaseInDeferredTaxAsset" name="IncreaseDecreaseInDeferredTaxAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" name="IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ProceedsFromIssuanceOfConvertibleNotes" name="ProceedsFromIssuanceOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_CapitalReceivableOfConvertibleNotes" name="CapitalReceivableOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_OperatingLeaseLiabilityAndRightOfUseAsset" name="OperatingLeaseLiabilityAndRightOfUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ConversionOfDebtToEquity" name="ConversionOfDebtToEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity" name="ConversionOfWarrantsOfConvertibleNotesToEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ConversionOfUnderwritersWarrantToEquity" name="ConversionOfUnderwritersWarrantToEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_DisclosureWarrantsAbstract" name="DisclosureWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" name="DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ConcentrationsofVendorsPolicyTextBlock" name="ConcentrationsofVendorsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_PrepaidOfferingCostsPolicyTextBlock" name="PrepaidOfferingCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_GoingConcernPolicyTextBlock" name="GoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock" name="ScheduleOfSubsidiariesOfCompanyTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_EquityMethodInvestmentPlaceOfIncorporation" name="EquityMethodInvestmentPlaceOfIncorporation" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_BrandNames" name="BrandNames" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_OriginalIssueDiscountPercentage" name="OriginalIssueDiscountPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_WarrantSharePricePercentage" name="WarrantSharePricePercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ConvertibleNotes" name="ConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_DebtInstrumentIncreaseAccruedInterestPercentage" name="DebtInstrumentIncreaseAccruedInterestPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_RightOfUseAssetsForOfficeLease" name="RightOfUseAssetsForOfficeLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_AdjustmentForAmortizations" name="AdjustmentForAmortizations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_OperatingLeaseLiabilityForOfficeLease" name="OperatingLeaseLiabilityForOfficeLease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_AnnualEscalationRate" name="AnnualEscalationRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncrementalBorrowingRate" name="IncrementalBorrowingRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" name="IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" name="IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" name="IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" name="IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" name="IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount" name="IncomeTaxReconciliationNondeductibleExpenseDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" name="IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" name="IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" name="IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" name="IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain" name="DeferredTaxAssetsUnrealizedCurrencyGain" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_DeferredTaxAssetsDepreciation" name="DeferredTaxAssetsDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" name="DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_DeferredTaxAssetsAccumulatedTaxLoss" name="DeferredTaxAssetsAccumulatedTaxLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_ThreeAndFourVendorsMember" name="ThreeAndFourVendorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FTEL_TwoAndTwoThousandTwentyThreeVendorsMember" name="TwoAndTwoThousandTwentyThreeVendorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>21
<FILENAME>ftel-20240630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fitellcorp.com/role/Cover" xlink:href="ftel-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/BalanceSheets" xlink:href="ftel-20240630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/BalanceSheetsParenthetical" xlink:href="ftel-20240630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="ftel-20240630.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/StatementsOfStockholdersEquity" xlink:href="ftel-20240630.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/StatementsOfCashFlows" xlink:href="ftel-20240630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/OrganizationAndPrincipalActivities" xlink:href="ftel-20240630.xsd#OrganizationAndPrincipalActivities" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ftel-20240630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecurities" xlink:href="ftel-20240630.xsd#InvestmentInMarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ConvertibleNotes" xlink:href="ftel-20240630.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/Warrants" xlink:href="ftel-20240630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/NoteReceivables" xlink:href="ftel-20240630.xsd#NoteReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/PropertyAndEquipment" xlink:href="ftel-20240630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities" xlink:href="ftel-20240630.xsd#LeaseRight-of-useAssetsAndLeaseLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/CommitmentsAndContingencies" xlink:href="ftel-20240630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/IncomeTaxes" xlink:href="ftel-20240630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/DueToRelatedPartyTransactions" xlink:href="ftel-20240630.xsd#DueToRelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ftel-20240630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables" xlink:href="ftel-20240630.xsd#OrganizationAndPrincipalActivitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables" xlink:href="ftel-20240630.xsd#InvestmentInMarketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/WarrantsTables" xlink:href="ftel-20240630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/PropertyAndEquipmentTables" xlink:href="ftel-20240630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" xlink:href="ftel-20240630.xsd#LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/IncomeTaxesTables" xlink:href="ftel-20240630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails" xlink:href="ftel-20240630.xsd#ScheduleOfCompanyAndItsSubsidiariesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ftel-20240630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="ftel-20240630.xsd#ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:href="ftel-20240630.xsd#InvestmentInMarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative" xlink:href="ftel-20240630.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfWarrantsDetails" xlink:href="ftel-20240630.xsd#ScheduleOfWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/WarrantsDetailsNarrative" xlink:href="ftel-20240630.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/NoteReceivablesDetailsNarrative" xlink:href="ftel-20240630.xsd#NoteReceivablesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ftel-20240630.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ftel-20240630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" xlink:href="ftel-20240630.xsd#ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" xlink:href="ftel-20240630.xsd#ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" xlink:href="ftel-20240630.xsd#LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" xlink:href="ftel-20240630.xsd#ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" xlink:href="ftel-20240630.xsd#ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:href="ftel-20240630.xsd#ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative" xlink:href="ftel-20240630.xsd#DueToRelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_CapitalReceivablesOfConvertibleNotes" xlink:label="loc_FTELCapitalReceivablesOfConvertibleNotes" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FTELCapitalReceivablesOfConvertibleNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaapNotesAndLoansReceivableNetCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapNotesAndLoansReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DepositsAndPrepaids" xlink:label="loc_FTELDepositsAndPrepaids" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FTELDepositsAndPrepaids" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:label="loc_us-gaapWorkersCompensationLiabilityNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapWorkersCompensationLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConsultingFees" xlink:label="loc_FTELConsultingFees" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_FTELConsultingFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PersonnelExpenses" xlink:label="loc_FTELPersonnelExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_FTELPersonnelExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_LicensingFees" xlink:label="loc_FTELLicensingFees" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_FTELLicensingFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PublicOfferingRelatedExpenses" xlink:label="loc_FTELPublicOfferingRelatedExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_FTELPublicOfferingRelatedExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncreaseDecreaseInPrepaidOfferingCosts" xlink:label="loc_FTELIncreaseDecreaseInPrepaidOfferingCosts" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FTELIncreaseDecreaseInPrepaidOfferingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncreaseDecreaseInDeferredTaxAsset" xlink:label="loc_FTELIncreaseDecreaseInDeferredTaxAsset" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FTELIncreaseDecreaseInDeferredTaxAsset" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" xlink:label="loc_FTELIncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FTELIncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="loc_us-gaapPaymentsToAcquireNotesReceivable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireNotesReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ProceedsFromIssuanceOfConvertibleNotes" xlink:label="loc_FTELProceedsFromIssuanceOfConvertibleNotes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_FTELProceedsFromIssuanceOfConvertibleNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/OrganizationAndPrincipalActivities" xlink:title="00000007 - Disclosure - Organization and principal activities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of significant accounting policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/InvestmentInMarketableSecurities" xlink:title="00000009 - Disclosure - Investment in marketable securities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ConvertibleNotes" xlink:title="00000010 - Disclosure - Convertible Notes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/Warrants" xlink:title="00000011 - Disclosure - Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/NoteReceivables" xlink:title="00000012 - Disclosure - Note Receivables" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/PropertyAndEquipment" xlink:title="00000013 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities" xlink:title="00000014 - Disclosure - Lease right-of-use assets and lease liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - Commitments and contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - Income taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/DueToRelatedPartyTransactions" xlink:title="00000017 - Disclosure - Due to Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000018 - Disclosure - Summary of significant accounting policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables" xlink:title="00000019 - Disclosure - Organization and principal activities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables" xlink:title="00000020 - Disclosure - Investment in marketable securities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/WarrantsTables" xlink:title="00000021 - Disclosure - Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" xlink:title="00000023 - Disclosure - Lease right-of-use assets and lease liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/IncomeTaxesTables" xlink:title="00000024 - Disclosure - Income taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails" xlink:title="00000025 - Disclosure - Schedule of the Company and its Subsidiaries (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000026 - Disclosure - Summary of significant accounting policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="00000027 - Disclosure - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:title="00000028 - Disclosure - Investment in marketable securities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000029 - Disclosure - Convertible Notes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfWarrantsDetails" xlink:title="00000030 - Disclosure - Schedule of Warrants (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/WarrantsDetailsNarrative" xlink:title="00000031 - Disclosure - Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/NoteReceivablesDetailsNarrative" xlink:title="00000032 - Disclosure - Note Receivables (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000033 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000034 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" xlink:title="00000035 - Disclosure - Schedule of Operating Right of use Assets and Operating Lease Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" xlink:title="00000036 - Disclosure - Schedule of Maturity of Operating Lease Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" xlink:title="00000037 - Disclosure - Lease right-of-use assets and lease liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" xlink:title="00000038 - Disclosure - Schedule of Reconciliation of Provision of Income Tax (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" xlink:title="00000039 - Disclosure - Schedule of reconciliation of provision of income tax (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:title="00000040 - Disclosure - Schedule of Components of Deferred Tax Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative" xlink:title="00000041 - Disclosure - Due to Related Party Transactions (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>22
<FILENAME>ftel-20240630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fitellcorp.com/role/Cover" xlink:href="ftel-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/BalanceSheets" xlink:href="ftel-20240630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/BalanceSheetsParenthetical" xlink:href="ftel-20240630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="ftel-20240630.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/StatementsOfStockholdersEquity" xlink:href="ftel-20240630.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/StatementsOfCashFlows" xlink:href="ftel-20240630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/OrganizationAndPrincipalActivities" xlink:href="ftel-20240630.xsd#OrganizationAndPrincipalActivities" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ftel-20240630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecurities" xlink:href="ftel-20240630.xsd#InvestmentInMarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ConvertibleNotes" xlink:href="ftel-20240630.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/Warrants" xlink:href="ftel-20240630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/NoteReceivables" xlink:href="ftel-20240630.xsd#NoteReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/PropertyAndEquipment" xlink:href="ftel-20240630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities" xlink:href="ftel-20240630.xsd#LeaseRight-of-useAssetsAndLeaseLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/CommitmentsAndContingencies" xlink:href="ftel-20240630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/IncomeTaxes" xlink:href="ftel-20240630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/DueToRelatedPartyTransactions" xlink:href="ftel-20240630.xsd#DueToRelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ftel-20240630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables" xlink:href="ftel-20240630.xsd#OrganizationAndPrincipalActivitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables" xlink:href="ftel-20240630.xsd#InvestmentInMarketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/WarrantsTables" xlink:href="ftel-20240630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/PropertyAndEquipmentTables" xlink:href="ftel-20240630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" xlink:href="ftel-20240630.xsd#LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/IncomeTaxesTables" xlink:href="ftel-20240630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails" xlink:href="ftel-20240630.xsd#ScheduleOfCompanyAndItsSubsidiariesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ftel-20240630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="ftel-20240630.xsd#ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:href="ftel-20240630.xsd#InvestmentInMarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative" xlink:href="ftel-20240630.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfWarrantsDetails" xlink:href="ftel-20240630.xsd#ScheduleOfWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/WarrantsDetailsNarrative" xlink:href="ftel-20240630.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/NoteReceivablesDetailsNarrative" xlink:href="ftel-20240630.xsd#NoteReceivablesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ftel-20240630.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ftel-20240630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" xlink:href="ftel-20240630.xsd#ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" xlink:href="ftel-20240630.xsd#ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" xlink:href="ftel-20240630.xsd#LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" xlink:href="ftel-20240630.xsd#ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" xlink:href="ftel-20240630.xsd#ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:href="ftel-20240630.xsd#ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative" xlink:href="ftel-20240630.xsd#DueToRelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_40" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag_40" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag_40" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName_40" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId_40" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation_40" xlink:type="arc" order="63" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_50" xlink:to="loc_us-gaapAssetsCurrentAbstract_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapMarketableSecuritiesCurrent_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapInventoryNet_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_CapitalReceivablesOfConvertibleNotes" xlink:label="loc_FTELCapitalReceivablesOfConvertibleNotes_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_FTELCapitalReceivablesOfConvertibleNotes_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaapNotesAndLoansReceivableNetCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapNotesAndLoansReceivableNetCurrent_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DepositsAndPrepaids" xlink:label="loc_FTELDepositsAndPrepaids_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_FTELDepositsAndPrepaids_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapPrepaidExpenseCurrent_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapAssetsCurrent_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapGoodwill_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_50" xlink:to="loc_us-gaapAssets_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapDeferredRevenueCurrent_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapTaxesPayableCurrent_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapLiabilitiesCurrent_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:label="loc_us-gaapWorkersCompensationLiabilityNoncurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapWorkersCompensationLiabilityNoncurrent_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapLiabilities_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapCommitmentsAndContingencies_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapStockholdersEquityAbstract_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapCommonStockValue_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapAdditionalPaidInCapital_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_50" xlink:type="arc" order="35" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_MerchandiseRevenueMember" xlink:label="loc_FTELMerchandiseRevenueMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FTELMerchandiseRevenueMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_SalesOfConsumableProductsMember" xlink:label="loc_FTELSalesOfConsumableProductsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FTELSalesOfConsumableProductsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_RevenueFromLicensingCustomersMember" xlink:label="loc_FTELRevenueFromLicensingCustomersMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FTELRevenueFromLicensingCustomersMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_us-gaapCostOfRevenue_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_us-gaapGrossProfit_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConsultingFees" xlink:label="loc_FTELConsultingFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_FTELConsultingFees_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PersonnelExpenses" xlink:label="loc_FTELPersonnelExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_FTELPersonnelExpenses_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapSellingAndMarketingExpense_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapOperatingLeaseExpense_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_LicensingFees" xlink:label="loc_FTELLicensingFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_FTELLicensingFees_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapDepreciation_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapOperatingExpenses_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PublicOfferingRelatedExpenses" xlink:label="loc_FTELPublicOfferingRelatedExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:to="loc_FTELPublicOfferingRelatedExpenses_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:to="loc_us-gaapOtherNonoperatingIncome_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:to="loc_us-gaapInvestmentIncomeInterest_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:to="loc_us-gaapInterestExpenseNonoperating_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:to="loc_us-gaapNonoperatingIncomeExpense_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_SubscriptionReceivableMember" xlink:label="loc_FTELSubscriptionReceivableMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELSubscriptionReceivableMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription" xlink:label="loc_FTELStockIssuedDuringPeriodValueSettlementOfStockSubscription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELStockIssuedDuringPeriodValueSettlementOfStockSubscription_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_70" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/OrganizationAndPrincipalActivities" xlink:title="00000007 - Disclosure - Organization and principal activities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of significant accounting policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/InvestmentInMarketableSecurities" xlink:title="00000009 - Disclosure - Investment in marketable securities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ConvertibleNotes" xlink:title="00000010 - Disclosure - Convertible Notes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/Warrants" xlink:title="00000011 - Disclosure - Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/NoteReceivables" xlink:title="00000012 - Disclosure - Note Receivables" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/PropertyAndEquipment" xlink:title="00000013 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities" xlink:title="00000014 - Disclosure - Lease right-of-use assets and lease liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - Commitments and contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - Income taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/DueToRelatedPartyTransactions" xlink:title="00000017 - Disclosure - Due to Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000018 - Disclosure - Summary of significant accounting policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables" xlink:title="00000019 - Disclosure - Organization and principal activities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables" xlink:title="00000020 - Disclosure - Investment in marketable securities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/WarrantsTables" xlink:title="00000021 - Disclosure - Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" xlink:title="00000023 - Disclosure - Lease right-of-use assets and lease liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/IncomeTaxesTables" xlink:title="00000024 - Disclosure - Income taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails" xlink:title="00000025 - Disclosure - Schedule of the Company and its Subsidiaries (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_FitellCorporationMember" xlink:label="loc_FTELFitellCorporationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FTELFitellCorporationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_KMASCapitalAndInvestmentPtyLtdMember" xlink:label="loc_FTELKMASCapitalAndInvestmentPtyLtdMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FTELKMASCapitalAndInvestmentPtyLtdMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_GDWellnessPtyLtdMember" xlink:label="loc_FTELGDWellnessPtyLtdMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FTELGDWellnessPtyLtdMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="loc_deiEntityIncorporationDateOfIncorporation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationDateOfIncorporation_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAdditionalInformation" xlink:label="loc_us-gaapEquityMethodInvestmentAdditionalInformation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentAdditionalInformation_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_EquityMethodInvestmentPlaceOfIncorporation" xlink:label="loc_FTELEquityMethodInvestmentPlaceOfIncorporation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELEquityMethodInvestmentPlaceOfIncorporation_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities" xlink:label="loc_us-gaapEquityMethodInvestmentDescriptionOfPrincipalActivities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentDescriptionOfPrincipalActivities_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_90" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000026 - Disclosure - Summary of significant accounting policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsTotalMember" xlink:label="loc_us-gaapCostOfGoodsTotalMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapCostOfGoodsTotalMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaapSupplierConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSupplierConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OneVendorsMember" xlink:label="loc_FTELOneVendorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FTELOneVendorsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_TwoVendorsMember" xlink:label="loc_FTELTwoVendorsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FTELTwoVendorsMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ThreeVendorsMember" xlink:label="loc_FTELThreeVendorsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FTELThreeVendorsMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_FourVendorsMember" xlink:label="loc_FTELFourVendorsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FTELFourVendorsMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantOneMember" xlink:label="loc_FTELWarrantOneMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantOneMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantTwoMember" xlink:label="loc_FTELWarrantTwoMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantTwoMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDeferredRevenueCurrent_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapPrepaidExpenseCurrent_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDepreciation_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_BrandNames" xlink:label="loc_FTELBrandNames_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FTELBrandNames_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapGoodwill_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill_160" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_160" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_160" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaapShortTermLeaseCost_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShortTermLeaseCost_160" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_160" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_160" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetIncomeLoss_160" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_160" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_160" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_160" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="00000027 - Disclosure - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:label="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:label="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapEquitySecuritiesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent_170" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:title="00000028 - Disclosure - Investment in marketable securities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:label="loc_us-gaapFinancingReceivableRecordedInvestmentPastDueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:label="loc_us-gaapScheduleOfFinancingReceivablesPastDueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancingReceivableRecordedInvestmentPastDueLineItems" xlink:to="loc_us-gaapScheduleOfFinancingReceivablesPastDueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralAxis" xlink:label="loc_us-gaapCollateralAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFinancingReceivablesPastDueTable" xlink:to="loc_us-gaapCollateralAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralDomain" xlink:label="loc_us-gaapCollateralDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCollateralAxis" xlink:to="loc_us-gaapCollateralDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralDomain" xlink:label="loc_us-gaapCollateralDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollateralAxis" xlink:to="loc_us-gaapCollateralDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollateralDomain" xlink:to="loc_us-gaapEquitySecuritiesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFinancingReceivableRecordedInvestmentPastDueLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000029 - Disclosure - Convertible Notes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConvertibleNotesMember" xlink:label="loc_FTELConvertibleNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_FTELConvertibleNotesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantTwoMember" xlink:label="loc_FTELWarrantTwoMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantTwoMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OriginalIssueDiscountPercentage" xlink:label="loc_FTELOriginalIssueDiscountPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELOriginalIssueDiscountPercentage_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebt_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantSharePricePercentage" xlink:label="loc_FTELWarrantSharePricePercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELWarrantSharePricePercentage_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ProceedsFromIssuanceOfConvertibleNotes" xlink:label="loc_FTELProceedsFromIssuanceOfConvertibleNotes_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELProceedsFromIssuanceOfConvertibleNotes_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_CapitalReceivablesOfConvertibleNotes" xlink:label="loc_FTELCapitalReceivablesOfConvertibleNotes_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELCapitalReceivablesOfConvertibleNotes_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConvertibleNotes" xlink:label="loc_FTELConvertibleNotes_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELConvertibleNotes_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_70" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfWarrantsDetails" xlink:title="00000030 - Disclosure - Schedule of Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" xlink:label="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" xlink:label="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_FTELSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:label="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" xlink:label="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_40" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/WarrantsDetailsNarrative" xlink:title="00000031 - Disclosure - Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantOneMember" xlink:label="loc_FTELWarrantOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantTwoMember" xlink:label="loc_FTELWarrantTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/NoteReceivablesDetailsNarrative" xlink:title="00000032 - Disclosure - Note Receivables (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000033 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000034 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" xlink:title="00000035 - Disclosure - Schedule of Operating Right of use Assets and Operating Lease Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" xlink:title="00000036 - Disclosure - Schedule of Maturity of Operating Lease Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" xlink:title="00000037 - Disclosure - Lease right-of-use assets and lease liabilities (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" xlink:title="00000038 - Disclosure - Schedule of Reconciliation of Provision of Income Tax (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" xlink:title="00000039 - Disclosure - Schedule of reconciliation of provision of income tax (Details) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:title="00000040 - Disclosure - Schedule of Components of Deferred Tax Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative" xlink:title="00000041 - Disclosure - Due to Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_30" xlink:type="arc" order="0" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>23
<FILENAME>ftel-20240630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_MerchandiseRevenueMember" xlink:label="FTEL_MerchandiseRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_MerchandiseRevenueMember" xlink:to="FTEL_MerchandiseRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_MerchandiseRevenueMember_lbl" xml:lang="en-US">Merchandise Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_SalesOfConsumableProductsMember" xlink:label="FTEL_SalesOfConsumableProductsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_SalesOfConsumableProductsMember" xlink:to="FTEL_SalesOfConsumableProductsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_SalesOfConsumableProductsMember_lbl" xml:lang="en-US">Sales of Consumable Products [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_RevenueFromLicensingCustomersMember" xlink:label="FTEL_RevenueFromLicensingCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_RevenueFromLicensingCustomersMember" xlink:to="FTEL_RevenueFromLicensingCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_RevenueFromLicensingCustomersMember_lbl" xml:lang="en-US">Revenue from Licensing Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_SubscriptionReceivableMember" xlink:label="FTEL_SubscriptionReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_SubscriptionReceivableMember" xlink:to="FTEL_SubscriptionReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_SubscriptionReceivableMember_lbl" xml:lang="en-US">Subscription Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_FitellCorporationMember" xlink:label="FTEL_FitellCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_FitellCorporationMember" xlink:to="FTEL_FitellCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_FitellCorporationMember_lbl" xml:lang="en-US">Fitell Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_KMASCapitalAndInvestmentPtyLtdMember" xlink:label="FTEL_KMASCapitalAndInvestmentPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_KMASCapitalAndInvestmentPtyLtdMember" xlink:to="FTEL_KMASCapitalAndInvestmentPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_KMASCapitalAndInvestmentPtyLtdMember_lbl" xml:lang="en-US">KMAS Capital and Investment Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_GDWellnessPtyLtdMember" xlink:label="FTEL_GDWellnessPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_GDWellnessPtyLtdMember" xlink:to="FTEL_GDWellnessPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_GDWellnessPtyLtdMember_lbl" xml:lang="en-US">GD Wellness Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsTotalMember" xlink:label="us-gaap_CostOfGoodsTotalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsTotalMember" xlink:to="us-gaap_CostOfGoodsTotalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsTotalMember_lbl" xml:lang="en-US">Cost of Goods and Service Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="us-gaap_SupplierConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplierConcentrationRiskMember" xlink:to="us-gaap_SupplierConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OneVendorsMember" xlink:label="FTEL_OneVendorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_OneVendorsMember" xlink:to="FTEL_OneVendorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_OneVendorsMember_lbl" xml:lang="en-US">One Vendors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_TwoVendorsMember" xlink:label="FTEL_TwoVendorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_TwoVendorsMember" xlink:to="FTEL_TwoVendorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_TwoVendorsMember_lbl" xml:lang="en-US">Two Vendors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ThreeVendorsMember" xlink:label="FTEL_ThreeVendorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ThreeVendorsMember" xlink:to="FTEL_ThreeVendorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ThreeVendorsMember_lbl" xml:lang="en-US">Three Vendors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_FourVendorsMember" xlink:label="FTEL_FourVendorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_FourVendorsMember" xlink:to="FTEL_FourVendorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_FourVendorsMember_lbl" xml:lang="en-US">Four Vendors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantOneMember" xlink:label="FTEL_WarrantOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_WarrantOneMember" xlink:to="FTEL_WarrantOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_WarrantOneMember_lbl" xml:lang="en-US">Warrant One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantTwoMember" xlink:label="FTEL_WarrantTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_WarrantTwoMember" xlink:to="FTEL_WarrantTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_WarrantTwoMember_lbl" xml:lang="en-US">Warrant Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralAxis" xlink:label="us-gaap_CollateralAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollateralAxis" xlink:to="us-gaap_CollateralAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollateralAxis_lbl" xml:lang="en-US">Collateral Held [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesMember" xlink:to="us-gaap_EquitySecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesMember_lbl" xml:lang="en-US">Equity Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConvertibleNotesMember" xlink:label="FTEL_ConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConvertibleNotesMember" xlink:to="FTEL_ConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ConvertibleNotesMember_lbl" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Defined Benefit Plan [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xml:lang="en-US">Investment in marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, at cost</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_CapitalReceivablesOfConvertibleNotes" xlink:label="FTEL_CapitalReceivablesOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_CapitalReceivablesOfConvertibleNotes" xlink:to="FTEL_CapitalReceivablesOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_CapitalReceivablesOfConvertibleNotes_lbl" xml:lang="en-US">Capital receivables of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_lbl" xml:lang="en-US">Note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DepositsAndPrepaids" xlink:label="FTEL_DepositsAndPrepaids" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DepositsAndPrepaids" xlink:to="FTEL_DepositsAndPrepaids_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_DepositsAndPrepaids_lbl" xml:lang="en-US">Deposits and prepaids</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating right of use asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Brand names</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US">Income tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Due to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:label="us-gaap_WorkersCompensationLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:to="us-gaap_WorkersCompensationLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WorkersCompensationLiabilityNoncurrent_lbl" xml:lang="en-US">Accrued employee benefits, non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 9)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.0001 par value; 500,000,000 shares authorized, 20,123,386 and 8,120,000 shares issued and outstanding at June 30, 2024 and 2023, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenues:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Total revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of goods sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConsultingFees" xlink:label="FTEL_ConsultingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConsultingFees" xlink:to="FTEL_ConsultingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ConsultingFees_lbl" xml:lang="en-US">Consulting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PersonnelExpenses" xlink:label="FTEL_PersonnelExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_PersonnelExpenses" xlink:to="FTEL_PersonnelExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_PersonnelExpenses_lbl" xml:lang="en-US">Personnel expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_LicensingFees" xlink:label="FTEL_LicensingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_LicensingFees" xlink:to="FTEL_LicensingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_LicensingFees_lbl" xml:lang="en-US">Licensing fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expenses):</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PublicOfferingRelatedExpenses" xlink:label="FTEL_PublicOfferingRelatedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_PublicOfferingRelatedExpenses" xlink:to="FTEL_PublicOfferingRelatedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FTEL_PublicOfferingRelatedExpenses_lbl" xml:lang="en-US">IPO related expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Unrealized loss on investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic loss per share on net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted loss per share on net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares outstanding - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average shares outstanding - diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock issued for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription" xlink:label="FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription" xlink:to="FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription_lbl" xml:lang="en-US">Settlement of stock subscription</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Funds raised in IPO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Funds raised in IPO, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Share issued for conversion of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Share issued for conversion of debt, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Share issued pursuant to warrants of the convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Share issued pursuant to warrants of the convertible notes, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Share issued pursuant to underwriter&#8217;s warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Share issued pursuant to underwriter's warrants, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash from operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Depreciation_2_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of right of use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Bad debt provision</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xml:lang="en-US">Unrealized loss on investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory, at cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Deposits and prepaids</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncreaseDecreaseInPrepaidOfferingCosts" xlink:label="FTEL_IncreaseDecreaseInPrepaidOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncreaseDecreaseInPrepaidOfferingCosts" xlink:to="FTEL_IncreaseDecreaseInPrepaidOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FTEL_IncreaseDecreaseInPrepaidOfferingCosts_lbl" xml:lang="en-US">Prepaid offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncreaseDecreaseInDeferredTaxAsset" xlink:label="FTEL_IncreaseDecreaseInDeferredTaxAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncreaseDecreaseInDeferredTaxAsset" xlink:to="FTEL_IncreaseDecreaseInDeferredTaxAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FTEL_IncreaseDecreaseInDeferredTaxAsset_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" xlink:label="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" xlink:to="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent_lbl" xml:lang="en-US">Accrued employee benefits, non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash from activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_lbl" xml:lang="en-US">Investment in note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Net activity on due to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Funds raised in IPO, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ProceedsFromIssuanceOfConvertibleNotes" xlink:label="FTEL_ProceedsFromIssuanceOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ProceedsFromIssuanceOfConvertibleNotes" xlink:to="FTEL_ProceedsFromIssuanceOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ProceedsFromIssuanceOfConvertibleNotes_lbl" xml:lang="en-US">Funds raised in convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_lbl" xml:lang="en-US">Foreign currency translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Change in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-Cash Investing and Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Stock issued for prepaid IPO services</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_CapitalReceivableOfConvertibleNotes" xlink:label="FTEL_CapitalReceivableOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_CapitalReceivableOfConvertibleNotes" xlink:to="FTEL_CapitalReceivableOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_CapitalReceivableOfConvertibleNotes_lbl" xml:lang="en-US">Capital receivable of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OperatingLeaseLiabilityAndRightOfUseAsset" xlink:label="FTEL_OperatingLeaseLiabilityAndRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_OperatingLeaseLiabilityAndRightOfUseAsset" xlink:to="FTEL_OperatingLeaseLiabilityAndRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_OperatingLeaseLiabilityAndRightOfUseAsset_lbl" xml:lang="en-US">Operating lease liability and right of use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConversionOfDebtToEquity" xlink:label="FTEL_ConversionOfDebtToEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConversionOfDebtToEquity" xlink:to="FTEL_ConversionOfDebtToEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ConversionOfDebtToEquity_lbl" xml:lang="en-US">Conversion of debt to equity</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity" xlink:label="FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity" xlink:to="FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity_lbl" xml:lang="en-US">Conversion of warrants of convertible notes to equity</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConversionOfUnderwritersWarrantToEquity" xlink:label="FTEL_ConversionOfUnderwritersWarrantToEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConversionOfUnderwritersWarrantToEquity" xlink:to="FTEL_ConversionOfUnderwritersWarrantToEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ConversionOfUnderwritersWarrantToEquity_lbl" xml:lang="en-US">Conversion of underwriter&#8217;s warrant to equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization and principal activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of significant accounting policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Investment in marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureWarrantsAbstract" xlink:label="FTEL_DisclosureWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DisclosureWarrantsAbstract" xlink:to="FTEL_DisclosureWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_DisclosureWarrantsAbstract_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantsDisclosureTextBlock" xlink:label="FTEL_WarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_WarrantsDisclosureTextBlock" xlink:to="FTEL_WarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FTEL_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">Note Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:label="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract_lbl" xml:lang="en-US">Lease Right-of-use Assets And Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Lease right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Due to Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Basic of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConcentrationsofVendorsPolicyTextBlock" xlink:label="FTEL_ConcentrationsofVendorsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConcentrationsofVendorsPolicyTextBlock" xlink:to="FTEL_ConcentrationsofVendorsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ConcentrationsofVendorsPolicyTextBlock_lbl" xml:lang="en-US">Concentrations of vendors</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionDeferredRevenue" xlink:label="us-gaap_RevenueRecognitionDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionDeferredRevenue" xlink:to="us-gaap_RevenueRecognitionDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionDeferredRevenue_lbl" xml:lang="en-US">Deferred Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PrepaidOfferingCostsPolicyTextBlock" xlink:label="FTEL_PrepaidOfferingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_PrepaidOfferingCostsPolicyTextBlock" xlink:to="FTEL_PrepaidOfferingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_PrepaidOfferingCostsPolicyTextBlock_lbl" xml:lang="en-US">Prepaid Offering Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionLoyaltyPrograms" xlink:label="us-gaap_RevenueRecognitionLoyaltyPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionLoyaltyPrograms" xlink:to="us-gaap_RevenueRecognitionLoyaltyPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionLoyaltyPrograms_lbl" xml:lang="en-US">Customers Loyalty Program</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising and Promotion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Income (Loss) Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Comprehensive Income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US">Convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_GoingConcernPolicyTextBlock" xlink:label="FTEL_GoingConcernPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_GoingConcernPolicyTextBlock" xlink:to="FTEL_GoingConcernPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_GoingConcernPolicyTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock" xlink:label="FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock" xlink:to="FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock_lbl" xml:lang="en-US">Schedule of the Company and its Subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of Assets Measured at Fair Value on Recurring Basis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Operating Right of use Assets and Operating Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Provision of Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Deferred Tax Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xml:lang="en-US">Date of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAdditionalInformation" xlink:label="us-gaap_EquityMethodInvestmentAdditionalInformation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentAdditionalInformation" xlink:to="us-gaap_EquityMethodInvestmentAdditionalInformation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentAdditionalInformation_lbl" xml:lang="en-US">Percentage of effective ownership description</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_EquityMethodInvestmentPlaceOfIncorporation" xlink:label="FTEL_EquityMethodInvestmentPlaceOfIncorporation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_EquityMethodInvestmentPlaceOfIncorporation" xlink:to="FTEL_EquityMethodInvestmentPlaceOfIncorporation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_EquityMethodInvestmentPlaceOfIncorporation_lbl" xml:lang="en-US">Place of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities" xlink:label="us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities" xlink:to="us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities_lbl" xml:lang="en-US">Principal activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Percentage of effective ownership</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US">Deferred revenue, revenue recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares issued, price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_2_lbl" xml:lang="en-US">Prepaid offering cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized loss on investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful receivable accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_BrandNames" xlink:label="FTEL_BrandNames" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_BrandNames" xlink:to="FTEL_BrandNames_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_BrandNames_lbl" xml:lang="en-US">Brand names cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Impairment of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Potential dilutive common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Foreign currency translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US">Short-term leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Number of warrant issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Warrant converted into share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net income loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net cash outflow from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:label="us-gaap_ImpairmentEffectsOnEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:to="us-gaap_ImpairmentEffectsOnEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentEffectsOnEarningsPerShareTable_lbl" xml:lang="en-US">Impairment Effects on Earnings Per Share [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:label="us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_lbl" xml:lang="en-US">Impairment Effects on Earnings Per Share [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MarketableSecuritiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:label="us-gaap_ScheduleOfFinancingReceivablesPastDueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:to="us-gaap_ScheduleOfFinancingReceivablesPastDueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFinancingReceivablesPastDueTable_lbl" xml:lang="en-US">Financing Receivable, Past Due [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:label="us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:to="us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_lbl" xml:lang="en-US">Financing Receivable, Past Due [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OriginalIssueDiscountPercentage" xlink:label="FTEL_OriginalIssueDiscountPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_OriginalIssueDiscountPercentage" xlink:to="FTEL_OriginalIssueDiscountPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_OriginalIssueDiscountPercentage_lbl" xml:lang="en-US">Original issue discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xml:lang="en-US">Maturity date description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Warrant outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantSharePricePercentage" xlink:label="FTEL_WarrantSharePricePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_WarrantSharePricePercentage" xlink:to="FTEL_WarrantSharePricePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_WarrantSharePricePercentage_lbl" xml:lang="en-US">Warrant share price percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrants exercise term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ProceedsFromIssuanceOfConvertibleNotes" xlink:to="FTEL_ProceedsFromIssuanceOfConvertibleNotes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FTEL_ProceedsFromIssuanceOfConvertibleNotes_2_lbl" xml:lang="en-US">Proceeds from issuance of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConvertibleNotes" xlink:label="FTEL_ConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConvertibleNotes" xlink:to="FTEL_ConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ConvertibleNotes_lbl" xml:lang="en-US">Convertible note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Shares issued upon note conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Number of warrants, Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Number of warrants, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Contractual Term (in years), Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Number of warrants, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Number of warrants, Ouststanding, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Warrants issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_2_lbl" xml:lang="en-US">Warrants converted into shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected average volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Loan lended amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Loan period</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DebtInstrumentIncreaseAccruedInterestPercentage" xlink:label="FTEL_DebtInstrumentIncreaseAccruedInterestPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DebtInstrumentIncreaseAccruedInterestPercentage" xlink:to="FTEL_DebtInstrumentIncreaseAccruedInterestPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_DebtInstrumentIncreaseAccruedInterestPercentage_lbl" xml:lang="en-US">Annualized interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_2_lbl" xml:lang="en-US">Note receivable outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract_2_lbl" xml:lang="en-US">Schedule Of Operating Right Of Use Assets And Operating Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_RightOfUseAssetsForOfficeLease" xlink:label="FTEL_RightOfUseAssetsForOfficeLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_RightOfUseAssetsForOfficeLease" xlink:to="FTEL_RightOfUseAssetsForOfficeLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_RightOfUseAssetsForOfficeLease_lbl" xml:lang="en-US">Office lease</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_AdjustmentForAmortizations" xlink:label="FTEL_AdjustmentForAmortizations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_AdjustmentForAmortizations" xlink:to="FTEL_AdjustmentForAmortizations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_AdjustmentForAmortizations_lbl" xml:lang="en-US">Less accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Right-of-use, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OperatingLeaseLiabilityForOfficeLease" xlink:label="FTEL_OperatingLeaseLiabilityForOfficeLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_OperatingLeaseLiabilityForOfficeLease" xlink:to="FTEL_OperatingLeaseLiabilityForOfficeLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FTEL_OperatingLeaseLiabilityForOfficeLease_lbl" xml:lang="en-US">Office lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Less: current portion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Long term portion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract_3_lbl" xml:lang="en-US">Schedule Of Maturity Of Operating Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Year ending June 30, 2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Year ending June 30, 2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total future minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">PV of Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePaymentsUse" xlink:label="us-gaap_OperatingLeasePaymentsUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePaymentsUse" xlink:to="us-gaap_OperatingLeasePaymentsUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasePaymentsUse_lbl" xml:lang="en-US">Operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_AnnualEscalationRate" xlink:label="FTEL_AnnualEscalationRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_AnnualEscalationRate" xlink:to="FTEL_AnnualEscalationRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_AnnualEscalationRate_lbl" xml:lang="en-US">Annual escalation rate</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncrementalBorrowingRate" xlink:label="FTEL_IncrementalBorrowingRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncrementalBorrowingRate" xlink:to="FTEL_IncrementalBorrowingRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncrementalBorrowingRate_lbl" xml:lang="en-US">Incremental borrowing rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_lbl" xml:lang="en-US">Expected income tax credit at statutory rate of 25% (2023: 25%)</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_lbl" xml:lang="en-US">Stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses_lbl" xml:lang="en-US">IPO related expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt_lbl" xml:lang="en-US">Provision for bad debt</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_lbl" xml:lang="en-US">Unrealized loss on investments</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost_lbl" xml:lang="en-US">Government Subsidy Tech Boost</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount_lbl" xml:lang="en-US">Debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome_lbl" xml:lang="en-US">Non-taxable other income</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses_lbl" xml:lang="en-US">-Non-tax deductible personnel expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees_lbl" xml:lang="en-US">Non-tax deductible consulting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses_lbl" xml:lang="en-US">Non-tax deductible general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesOther" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingenciesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxContingenciesOther" xlink:to="us-gaap_IncomeTaxReconciliationTaxContingenciesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingenciesOther_lbl" xml:lang="en-US">Other items, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Expected income tax credit at statutory rate, percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl" xml:lang="en-US">Accrued employee benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:to="us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_lbl" xml:lang="en-US">Unrealized loss on investments</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DeferredTaxAssetsUnrealizedCurrencyGain" xlink:label="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain" xlink:to="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain_lbl" xml:lang="en-US">Unrealized foreign exchange gain</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DeferredTaxAssetsDepreciation" xlink:label="FTEL_DeferredTaxAssetsDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DeferredTaxAssetsDepreciation" xlink:to="FTEL_DeferredTaxAssetsDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_DeferredTaxAssetsDepreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:label="FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:to="FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities_lbl" xml:lang="en-US">Operating right of use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DeferredTaxAssetsAccumulatedTaxLoss" xlink:label="FTEL_DeferredTaxAssetsAccumulatedTaxLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DeferredTaxAssetsAccumulatedTaxLoss" xlink:to="FTEL_DeferredTaxAssetsAccumulatedTaxLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_DeferredTaxAssetsAccumulatedTaxLoss_lbl" xml:lang="en-US">Accumulated tax loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Provision for bad debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Related Party Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Amount due to related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DepositsAndPrepaids" xlink:to="FTEL_DepositsAndPrepaids_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_DepositsAndPrepaids_doc" xml:lang="en-US">Amount of deposits and prepaids.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_PersonnelExpenses" xlink:to="FTEL_PersonnelExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_PersonnelExpenses_doc" xml:lang="en-US">Amount of personnel expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConsultingFees" xlink:to="FTEL_ConsultingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ConsultingFees_doc" xml:lang="en-US">Consulting fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_LicensingFees" xlink:to="FTEL_LicensingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_LicensingFees_doc" xml:lang="en-US">Licensing fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_PublicOfferingRelatedExpenses" xlink:to="FTEL_PublicOfferingRelatedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_PublicOfferingRelatedExpenses_doc" xml:lang="en-US">Amount of IPO related expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_SubscriptionReceivableMember" xlink:to="FTEL_SubscriptionReceivableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_SubscriptionReceivableMember_doc" xml:lang="en-US">Subscription Receivable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription" xlink:to="FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription_doc" xml:lang="en-US">Settlement of stock subscription.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncreaseDecreaseInDeferredTaxAsset" xlink:to="FTEL_IncreaseDecreaseInDeferredTaxAsset_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncreaseDecreaseInDeferredTaxAsset_doc" xml:lang="en-US">Changes in deferred tax asset.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" xlink:to="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent_doc" xml:lang="en-US">Changes in accured employee benefits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConversionOfUnderwritersWarrantToEquity" xlink:to="FTEL_ConversionOfUnderwritersWarrantToEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ConversionOfUnderwritersWarrantToEquity_doc" xml:lang="en-US">Conversion of underwriter&#8217;s warrant to equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity" xlink:to="FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity_doc" xml:lang="en-US">Conversion of warrants of convertible notes to equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConversionOfDebtToEquity" xlink:to="FTEL_ConversionOfDebtToEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ConversionOfDebtToEquity_doc" xml:lang="en-US">Conversion of debt to equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncreaseDecreaseInPrepaidOfferingCosts" xlink:to="FTEL_IncreaseDecreaseInPrepaidOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncreaseDecreaseInPrepaidOfferingCosts_doc" xml:lang="en-US">Increase decrease in prepaid offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ProceedsFromIssuanceOfConvertibleNotes" xlink:to="FTEL_ProceedsFromIssuanceOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ProceedsFromIssuanceOfConvertibleNotes_doc" xml:lang="en-US">Issuance of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_CapitalReceivablesOfConvertibleNotes" xlink:to="FTEL_CapitalReceivablesOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_CapitalReceivablesOfConvertibleNotes_doc" xml:lang="en-US">Capital receivables of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock" xlink:to="FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock_doc" xml:lang="en-US">Schedule of Subsidiaries of Company [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_FitellCorporationMember" xlink:to="FTEL_FitellCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_FitellCorporationMember_doc" xml:lang="en-US">Fitell Corporation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_KMASCapitalAndInvestmentPtyLtdMember" xlink:to="FTEL_KMASCapitalAndInvestmentPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_KMASCapitalAndInvestmentPtyLtdMember_doc" xml:lang="en-US">KMAS Capital and Investment Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_GDWellnessPtyLtdMember" xlink:to="FTEL_GDWellnessPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_GDWellnessPtyLtdMember_doc" xml:lang="en-US">GD Wellness Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_EquityMethodInvestmentPlaceOfIncorporation" xlink:to="FTEL_EquityMethodInvestmentPlaceOfIncorporation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_EquityMethodInvestmentPlaceOfIncorporation_doc" xml:lang="en-US">Equity method investment place of incorporation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_BrandNames" xlink:to="FTEL_BrandNames_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_BrandNames_doc" xml:lang="en-US">Amount of brand names.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_GoingConcernPolicyTextBlock" xlink:to="FTEL_GoingConcernPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_GoingConcernPolicyTextBlock_doc" xml:lang="en-US">Going Concern [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConvertibleNotesMember" xlink:to="FTEL_ConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ConvertibleNotesMember_doc" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_OriginalIssueDiscountPercentage" xlink:to="FTEL_OriginalIssueDiscountPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_OriginalIssueDiscountPercentage_doc" xml:lang="en-US">Original issue discount percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConvertibleNotes" xlink:to="FTEL_ConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ConvertibleNotes_doc" xml:lang="en-US">Convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_WarrantSharePricePercentage" xlink:to="FTEL_WarrantSharePricePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_WarrantSharePricePercentage_doc" xml:lang="en-US">Warrant share price percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_AnnualEscalationRate" xlink:to="FTEL_AnnualEscalationRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_AnnualEscalationRate_doc" xml:lang="en-US">Annual escalation rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncrementalBorrowingRate" xlink:to="FTEL_IncrementalBorrowingRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncrementalBorrowingRate_doc" xml:lang="en-US">Incremental borrowing rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_RightOfUseAssetsForOfficeLease" xlink:to="FTEL_RightOfUseAssetsForOfficeLease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_RightOfUseAssetsForOfficeLease_doc" xml:lang="en-US">Right of use assets for office lease.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_AdjustmentForAmortizations" xlink:to="FTEL_AdjustmentForAmortizations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_AdjustmentForAmortizations_doc" xml:lang="en-US">Adjustment for amortizations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_OperatingLeaseLiabilityForOfficeLease" xlink:to="FTEL_OperatingLeaseLiabilityForOfficeLease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_OperatingLeaseLiabilityForOfficeLease_doc" xml:lang="en-US">Operating lease liability for office lease.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense stock issued for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense ipo related expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense provision for bad debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense unrealized loss on investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense government subsidy tech boost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount_doc" xml:lang="en-US">Income tax reconciliation non deductible expense debt discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome_doc" xml:lang="en-US">Income tax reconciliation non taxable other income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses_doc" xml:lang="en-US">Income tax reconciliation non tax deductible personnel expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees_doc" xml:lang="en-US">Income tax reconciliation non tax deductible consulting fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses_doc" xml:lang="en-US">Income tax reconciliation non tax deductible general and administrative expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain" xlink:to="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain_doc" xml:lang="en-US">Deferred tax assets unrealized currency gain.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DeferredTaxAssetsDepreciation" xlink:to="FTEL_DeferredTaxAssetsDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_DeferredTaxAssetsDepreciation_doc" xml:lang="en-US">Deferred tax assets depreciation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:to="FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities_doc" xml:lang="en-US">Deferred tax assets operating right of use assets and lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DeferredTaxAssetsAccumulatedTaxLoss" xlink:to="FTEL_DeferredTaxAssetsAccumulatedTaxLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_DeferredTaxAssetsAccumulatedTaxLoss_doc" xml:lang="en-US">Deferred tax assets accumulated tax loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non options equity instruments weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments eeighted average exercise price granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Share based compensation arrangement by sharebased payment award non options equity instruments outstanding weighted average remaining contractual term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_WarrantsDisclosureTextBlock" xlink:to="FTEL_WarrantsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_WarrantsDisclosureTextBlock_doc" xml:lang="en-US">Warrants Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DebtInstrumentIncreaseAccruedInterestPercentage" xlink:to="FTEL_DebtInstrumentIncreaseAccruedInterestPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_DebtInstrumentIncreaseAccruedInterestPercentage_doc" xml:lang="en-US">Debt instrument increase accrued interest percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_OperatingLeaseLiabilityAndRightOfUseAsset" xlink:to="FTEL_OperatingLeaseLiabilityAndRightOfUseAsset_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_OperatingLeaseLiabilityAndRightOfUseAsset_doc" xml:lang="en-US">Operating lease liability and right of use asset.</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ThreeAndFourVendorsMember" xlink:label="FTEL_ThreeAndFourVendorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ThreeAndFourVendorsMember" xlink:to="FTEL_ThreeAndFourVendorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ThreeAndFourVendorsMember_doc" xml:lang="en-US">Three and Four Vendors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_TwoAndTwoThousandTwentyThreeVendorsMember" xlink:label="FTEL_TwoAndTwoThousandTwentyThreeVendorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_TwoAndTwoThousandTwentyThreeVendorsMember" xlink:to="FTEL_TwoAndTwoThousandTwentyThreeVendorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_TwoAndTwoThousandTwentyThreeVendorsMember_doc" xml:lang="en-US">Two and 2023 Vendors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_CapitalReceivableOfConvertibleNotes" xlink:to="FTEL_CapitalReceivableOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_CapitalReceivableOfConvertibleNotes_doc" xml:lang="en-US">Capital receivable of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_WarrantOneMember" xlink:to="FTEL_WarrantOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_WarrantOneMember_doc" xml:lang="en-US">Warrant One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_WarrantTwoMember" xlink:to="FTEL_WarrantTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_WarrantTwoMember_doc" xml:lang="en-US">Warrant Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_MerchandiseRevenueMember" xlink:to="FTEL_MerchandiseRevenueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_MerchandiseRevenueMember_doc" xml:lang="en-US">Merchandise Revenue [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_SalesOfConsumableProductsMember" xlink:to="FTEL_SalesOfConsumableProductsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_SalesOfConsumableProductsMember_doc" xml:lang="en-US">Sales of Consumable Products [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_RevenueFromLicensingCustomersMember" xlink:to="FTEL_RevenueFromLicensingCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_RevenueFromLicensingCustomersMember_doc" xml:lang="en-US">Revenue from Licensing Customers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ThreeVendorsMember" xlink:to="FTEL_ThreeVendorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ThreeVendorsMember_doc" xml:lang="en-US">Three Vendors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_FourVendorsMember" xlink:to="FTEL_FourVendorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_FourVendorsMember_doc" xml:lang="en-US">Four Vendors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_OneVendorsMember" xlink:to="FTEL_OneVendorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_OneVendorsMember_doc" xml:lang="en-US">One Vendors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_TwoVendorsMember" xlink:to="FTEL_TwoVendorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_TwoVendorsMember_doc" xml:lang="en-US">Two Vendors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ConcentrationsofVendorsPolicyTextBlock" xlink:to="FTEL_ConcentrationsofVendorsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_ConcentrationsofVendorsPolicyTextBlock_doc" xml:lang="en-US">Concentrations of Vendors [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_PrepaidOfferingCostsPolicyTextBlock" xlink:to="FTEL_PrepaidOfferingCostsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FTEL_PrepaidOfferingCostsPolicyTextBlock_doc" xml:lang="en-US">Prepaid Offering Costs [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_2_lbl" xml:lang="en-US">Cost of Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_PublicOfferingRelatedExpenses" xlink:to="FTEL_PublicOfferingRelatedExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_PublicOfferingRelatedExpenses_3_lbl" xml:lang="en-US">PublicOfferingRelatedExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseNonoperating_2_lbl" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2_lbl" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncreaseDecreaseInPrepaidOfferingCosts" xlink:to="FTEL_IncreaseDecreaseInPrepaidOfferingCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncreaseDecreaseInPrepaidOfferingCosts_3_lbl" xml:lang="en-US">IncreaseDecreaseInPrepaidOfferingCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncreaseDecreaseInDeferredTaxAsset" xlink:to="FTEL_IncreaseDecreaseInDeferredTaxAsset_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncreaseDecreaseInDeferredTaxAsset_3_lbl" xml:lang="en-US">IncreaseDecreaseInDeferredTaxAsset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" xlink:to="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent_3_lbl" xml:lang="en-US">IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_2_lbl" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2_lbl" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_WarrantsDisclosureTextBlock" xlink:to="FTEL_WarrantsDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_WarrantsDisclosureTextBlock_3_lbl" xml:lang="en-US">WarrantsDisclosureTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_2_lbl" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xml:lang="en-US">Marketable Security, Unrealized Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" xlink:to="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_OperatingLeaseLiabilityForOfficeLease" xlink:to="FTEL_OperatingLeaseLiabilityForOfficeLease_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_OperatingLeaseLiabilityForOfficeLease_3_lbl" xml:lang="en-US">OperatingLeaseLiabilityForOfficeLease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Operating Lease, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePaymentsUse" xlink:to="us-gaap_OperatingLeasePaymentsUse_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePaymentsUse_2_lbl" xml:lang="en-US">Operating Lease, Payments, Use</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_3_lbl" xml:lang="en-US">IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" xlink:to="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_3_lbl" xml:lang="en-US">IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:to="us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_2_lbl" xml:lang="en-US">Deferred Tax Asset, Debt Securities, Trading, Unrealized Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain" xlink:to="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FTEL_DeferredTaxAssetsUnrealizedCurrencyGain_3_lbl" xml:lang="en-US">DeferredTaxAssetsUnrealizedCurrencyGain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_2_lbl" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>24
<FILENAME>ftel-20240630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fitellcorp.com/role/Cover" xlink:href="ftel-20240630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/BalanceSheets" xlink:href="ftel-20240630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/BalanceSheetsParenthetical" xlink:href="ftel-20240630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="ftel-20240630.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/StatementsOfStockholdersEquity" xlink:href="ftel-20240630.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/StatementsOfCashFlows" xlink:href="ftel-20240630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/OrganizationAndPrincipalActivities" xlink:href="ftel-20240630.xsd#OrganizationAndPrincipalActivities" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ftel-20240630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecurities" xlink:href="ftel-20240630.xsd#InvestmentInMarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ConvertibleNotes" xlink:href="ftel-20240630.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/Warrants" xlink:href="ftel-20240630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/NoteReceivables" xlink:href="ftel-20240630.xsd#NoteReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/PropertyAndEquipment" xlink:href="ftel-20240630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities" xlink:href="ftel-20240630.xsd#LeaseRight-of-useAssetsAndLeaseLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/CommitmentsAndContingencies" xlink:href="ftel-20240630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/IncomeTaxes" xlink:href="ftel-20240630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/DueToRelatedPartyTransactions" xlink:href="ftel-20240630.xsd#DueToRelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ftel-20240630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables" xlink:href="ftel-20240630.xsd#OrganizationAndPrincipalActivitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables" xlink:href="ftel-20240630.xsd#InvestmentInMarketableSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/WarrantsTables" xlink:href="ftel-20240630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/PropertyAndEquipmentTables" xlink:href="ftel-20240630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" xlink:href="ftel-20240630.xsd#LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/IncomeTaxesTables" xlink:href="ftel-20240630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails" xlink:href="ftel-20240630.xsd#ScheduleOfCompanyAndItsSubsidiariesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ftel-20240630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="ftel-20240630.xsd#ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:href="ftel-20240630.xsd#InvestmentInMarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative" xlink:href="ftel-20240630.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfWarrantsDetails" xlink:href="ftel-20240630.xsd#ScheduleOfWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/WarrantsDetailsNarrative" xlink:href="ftel-20240630.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/NoteReceivablesDetailsNarrative" xlink:href="ftel-20240630.xsd#NoteReceivablesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ftel-20240630.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ftel-20240630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" xlink:href="ftel-20240630.xsd#ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" xlink:href="ftel-20240630.xsd#ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" xlink:href="ftel-20240630.xsd#LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" xlink:href="ftel-20240630.xsd#ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" xlink:href="ftel-20240630.xsd#ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:href="ftel-20240630.xsd#ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative" xlink:href="ftel-20240630.xsd#DueToRelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_CapitalReceivablesOfConvertibleNotes" xlink:label="loc_FTELCapitalReceivablesOfConvertibleNotes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FTELCapitalReceivablesOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaapNotesAndLoansReceivableNetCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapNotesAndLoansReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DepositsAndPrepaids" xlink:label="loc_FTELDepositsAndPrepaids" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FTELDepositsAndPrepaids" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:label="loc_us-gaapWorkersCompensationLiabilityNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapWorkersCompensationLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_MerchandiseRevenueMember" xlink:label="loc_FTELMerchandiseRevenueMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FTELMerchandiseRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_SalesOfConsumableProductsMember" xlink:label="loc_FTELSalesOfConsumableProductsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FTELSalesOfConsumableProductsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_RevenueFromLicensingCustomersMember" xlink:label="loc_FTELRevenueFromLicensingCustomersMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FTELRevenueFromLicensingCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConsultingFees" xlink:label="loc_FTELConsultingFees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_FTELConsultingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PersonnelExpenses" xlink:label="loc_FTELPersonnelExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_FTELPersonnelExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_LicensingFees" xlink:label="loc_FTELLicensingFees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_FTELLicensingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PublicOfferingRelatedExpenses" xlink:label="loc_FTELPublicOfferingRelatedExpenses" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_FTELPublicOfferingRelatedExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_SubscriptionReceivableMember" xlink:label="loc_FTELSubscriptionReceivableMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FTELSubscriptionReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription" xlink:label="loc_FTELStockIssuedDuringPeriodValueSettlementOfStockSubscription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELStockIssuedDuringPeriodValueSettlementOfStockSubscription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncreaseDecreaseInPrepaidOfferingCosts" xlink:label="loc_FTELIncreaseDecreaseInPrepaidOfferingCosts" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_FTELIncreaseDecreaseInPrepaidOfferingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncreaseDecreaseInDeferredTaxAsset" xlink:label="loc_FTELIncreaseDecreaseInDeferredTaxAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_FTELIncreaseDecreaseInDeferredTaxAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" xlink:label="loc_FTELIncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_FTELIncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="loc_us-gaapPaymentsToAcquireNotesReceivable" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireNotesReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ProceedsFromIssuanceOfConvertibleNotes" xlink:label="loc_FTELProceedsFromIssuanceOfConvertibleNotes" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_FTELProceedsFromIssuanceOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_CapitalReceivableOfConvertibleNotes" xlink:label="loc_FTELCapitalReceivableOfConvertibleNotes" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_FTELCapitalReceivableOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OperatingLeaseLiabilityAndRightOfUseAsset" xlink:label="loc_FTELOperatingLeaseLiabilityAndRightOfUseAsset" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_FTELOperatingLeaseLiabilityAndRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConversionOfDebtToEquity" xlink:label="loc_FTELConversionOfDebtToEquity" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_FTELConversionOfDebtToEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity" xlink:label="loc_FTELConversionOfWarrantsOfConvertibleNotesToEquity" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_FTELConversionOfWarrantsOfConvertibleNotesToEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConversionOfUnderwritersWarrantToEquity" xlink:label="loc_FTELConversionOfUnderwritersWarrantToEquity" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_FTELConversionOfUnderwritersWarrantToEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/OrganizationAndPrincipalActivities" xlink:title="00000007 - Disclosure - Organization and principal activities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of significant accounting policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/InvestmentInMarketableSecurities" xlink:title="00000009 - Disclosure - Investment in marketable securities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ConvertibleNotes" xlink:title="00000010 - Disclosure - Convertible Notes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/Warrants" xlink:title="00000011 - Disclosure - Warrants">
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureWarrantsAbstract" xlink:label="loc_FTELDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantsDisclosureTextBlock" xlink:label="loc_FTELWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureWarrantsAbstract" xlink:to="loc_FTELWarrantsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/NoteReceivables" xlink:title="00000012 - Disclosure - Note Receivables">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/PropertyAndEquipment" xlink:title="00000013 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities" xlink:title="00000014 - Disclosure - Lease right-of-use assets and lease liabilities">
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:label="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - Commitments and contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - Income taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/DueToRelatedPartyTransactions" xlink:title="00000017 - Disclosure - Due to Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000018 - Disclosure - Summary of significant accounting policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConcentrationsofVendorsPolicyTextBlock" xlink:label="loc_FTELConcentrationsofVendorsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FTELConcentrationsofVendorsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionDeferredRevenue" xlink:label="loc_us-gaapRevenueRecognitionDeferredRevenue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionDeferredRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_PrepaidOfferingCostsPolicyTextBlock" xlink:label="loc_FTELPrepaidOfferingCostsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FTELPrepaidOfferingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionLoyaltyPrograms" xlink:label="loc_us-gaapRevenueRecognitionLoyaltyPrograms" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionLoyaltyPrograms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaapDebtPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_GoingConcernPolicyTextBlock" xlink:label="loc_FTELGoingConcernPolicyTextBlock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FTELGoingConcernPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="loc_us-gaapSubsequentEventsPolicyPolicyTextBlock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables" xlink:title="00000019 - Disclosure - Organization and principal activities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock" xlink:label="loc_FTELScheduleOfSubsidiariesOfCompanyTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_FTELScheduleOfSubsidiariesOfCompanyTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables" xlink:title="00000020 - Disclosure - Investment in marketable securities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/WarrantsTables" xlink:title="00000021 - Disclosure - Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureWarrantsAbstract" xlink:label="loc_FTELDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables" xlink:title="00000023 - Disclosure - Lease right-of-use assets and lease liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:label="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/IncomeTaxesTables" xlink:title="00000024 - Disclosure - Income taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails" xlink:title="00000025 - Disclosure - Schedule of the Company and its Subsidiaries (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_FitellCorporationMember" xlink:label="loc_FTELFitellCorporationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FTELFitellCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_KMASCapitalAndInvestmentPtyLtdMember" xlink:label="loc_FTELKMASCapitalAndInvestmentPtyLtdMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FTELKMASCapitalAndInvestmentPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_GDWellnessPtyLtdMember" xlink:label="loc_FTELGDWellnessPtyLtdMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FTELGDWellnessPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="loc_deiEntityIncorporationDateOfIncorporation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationDateOfIncorporation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAdditionalInformation" xlink:label="loc_us-gaapEquityMethodInvestmentAdditionalInformation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentAdditionalInformation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_EquityMethodInvestmentPlaceOfIncorporation" xlink:label="loc_FTELEquityMethodInvestmentPlaceOfIncorporation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELEquityMethodInvestmentPlaceOfIncorporation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities" xlink:label="loc_us-gaapEquityMethodInvestmentDescriptionOfPrincipalActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentDescriptionOfPrincipalActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000026 - Disclosure - Summary of significant accounting policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsTotalMember" xlink:label="loc_us-gaapCostOfGoodsTotalMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapCostOfGoodsTotalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaapSupplierConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSupplierConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OneVendorsMember" xlink:label="loc_FTELOneVendorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FTELOneVendorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_TwoVendorsMember" xlink:label="loc_FTELTwoVendorsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FTELTwoVendorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ThreeVendorsMember" xlink:label="loc_FTELThreeVendorsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FTELThreeVendorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_FourVendorsMember" xlink:label="loc_FTELFourVendorsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FTELFourVendorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantOneMember" xlink:label="loc_FTELWarrantOneMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantTwoMember" xlink:label="loc_FTELWarrantTwoMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_BrandNames" xlink:label="loc_FTELBrandNames" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FTELBrandNames" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaapShortTermLeaseCost" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShortTermLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="00000027 - Disclosure - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:label="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:label="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapEquitySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" xlink:title="00000028 - Disclosure - Investment in marketable securities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:label="loc_us-gaapScheduleOfFinancingReceivablesPastDueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapScheduleOfFinancingReceivablesPastDueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:label="loc_us-gaapFinancingReceivableRecordedInvestmentPastDueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFinancingReceivablesPastDueTable" xlink:to="loc_us-gaapFinancingReceivableRecordedInvestmentPastDueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralAxis" xlink:label="loc_us-gaapCollateralAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFinancingReceivablesPastDueTable" xlink:to="loc_us-gaapCollateralAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralDomain" xlink:label="loc_us-gaapCollateralDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollateralAxis" xlink:to="loc_us-gaapCollateralDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollateralDomain" xlink:to="loc_us-gaapEquitySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancingReceivableRecordedInvestmentPastDueLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000029 - Disclosure - Convertible Notes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConvertibleNotesMember" xlink:label="loc_FTELConvertibleNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_FTELConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantTwoMember" xlink:label="loc_FTELWarrantTwoMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OriginalIssueDiscountPercentage" xlink:label="loc_FTELOriginalIssueDiscountPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELOriginalIssueDiscountPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantSharePricePercentage" xlink:label="loc_FTELWarrantSharePricePercentage" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELWarrantSharePricePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ProceedsFromIssuanceOfConvertibleNotes" xlink:label="loc_FTELProceedsFromIssuanceOfConvertibleNotes" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELProceedsFromIssuanceOfConvertibleNotes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_CapitalReceivablesOfConvertibleNotes" xlink:label="loc_FTELCapitalReceivablesOfConvertibleNotes" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELCapitalReceivablesOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ConvertibleNotes" xlink:label="loc_FTELConvertibleNotes" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_FTELConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfWarrantsDetails" xlink:title="00000030 - Disclosure - Schedule of Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureWarrantsAbstract" xlink:label="loc_FTELDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureWarrantsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" xlink:label="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" xlink:label="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_FTELSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:label="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" xlink:label="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FTELShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/WarrantsDetailsNarrative" xlink:title="00000031 - Disclosure - Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureWarrantsAbstract" xlink:label="loc_FTELDisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureWarrantsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantOneMember" xlink:label="loc_FTELWarrantOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_WarrantTwoMember" xlink:label="loc_FTELWarrantTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FTELWarrantTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/NoteReceivablesDetailsNarrative" xlink:title="00000032 - Disclosure - Note Receivables (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DebtInstrumentIncreaseAccruedInterestPercentage" xlink:label="loc_FTELDebtInstrumentIncreaseAccruedInterestPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FTELDebtInstrumentIncreaseAccruedInterestPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaapNotesAndLoansReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapNotesAndLoansReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000033 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000034 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails" xlink:title="00000035 - Disclosure - Schedule of Operating Right of use Assets and Operating Lease Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:label="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_RightOfUseAssetsForOfficeLease" xlink:label="loc_FTELRightOfUseAssetsForOfficeLease" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_FTELRightOfUseAssetsForOfficeLease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_AdjustmentForAmortizations" xlink:label="loc_FTELAdjustmentForAmortizations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_FTELAdjustmentForAmortizations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="loc_us-gaapOperatingLeaseLiabilityAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_OperatingLeaseLiabilityForOfficeLease" xlink:label="loc_FTELOperatingLeaseLiabilityForOfficeLease" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeaseLiabilityAbstract" xlink:to="loc_FTELOperatingLeaseLiabilityForOfficeLease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeaseLiabilityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeaseLiabilityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails" xlink:title="00000036 - Disclosure - Schedule of Maturity of Operating Lease Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:label="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" xlink:title="00000037 - Disclosure - Lease right-of-use assets and lease liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:label="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePaymentsUse" xlink:label="loc_us-gaapOperatingLeasePaymentsUse" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeasePaymentsUse" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_AnnualEscalationRate" xlink:label="loc_FTELAnnualEscalationRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_FTELAnnualEscalationRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncrementalBorrowingRate" xlink:label="loc_FTELIncrementalBorrowingRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_FTELIncrementalBorrowingRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FTELDisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails" xlink:title="00000038 - Disclosure - Schedule of Reconciliation of Provision of Income Tax (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeReclassificationsTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseDebtDiscount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseDebtDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" xlink:label="loc_FTELIncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELIncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxContingenciesOther" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxContingenciesOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxContingenciesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical" xlink:title="00000039 - Disclosure - Schedule of reconciliation of provision of income tax (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:title="00000040 - Disclosure - Schedule of Components of Deferred Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:label="loc_us-gaapDeferredTaxAssetsUnrealizedLossesOnTradingSecurities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DeferredTaxAssetsUnrealizedCurrencyGain" xlink:label="loc_FTELDeferredTaxAssetsUnrealizedCurrencyGain" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELDeferredTaxAssetsUnrealizedCurrencyGain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DeferredTaxAssetsDepreciation" xlink:label="loc_FTELDeferredTaxAssetsDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELDeferredTaxAssetsDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:label="loc_FTELDeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELDeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ftel-20240630.xsd#FTEL_DeferredTaxAssetsAccumulatedTaxLoss" xlink:label="loc_FTELDeferredTaxAssetsAccumulatedTaxLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FTELDeferredTaxAssetsAccumulatedTaxLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative" xlink:title="00000041 - Disclosure - Due to Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020690676496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FITELL
CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001928581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">23-25
Mangrove Lane<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Taren
Point<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">NSW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">AU<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary
    Shares, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FTEL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">20,123,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Astra
Audit & Advisory LLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">6920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tampa, Florida<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">122
East 42nd Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">18th Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New
York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">221-0102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Cogency
Global Inc.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020693657072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 939,014<span></span>
</td>
<td class="nump">$ 236,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="nump">124,963<span></span>
</td>
<td class="nump">494,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">60,042<span></span>
</td>
<td class="nump">174,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, at cost</a></td>
<td class="nump">2,439,793<span></span>
</td>
<td class="nump">525,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_CapitalReceivablesOfConvertibleNotes', window );">Capital receivables of convertible notes</a></td>
<td class="nump">1,472,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Note receivable</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DepositsAndPrepaids', window );">Deposits and prepaids</a></td>
<td class="nump">316,869<span></span>
</td>
<td class="nump">13,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid offering costs</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">5,317,866<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">9,052,681<span></span>
</td>
<td class="nump">6,762,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">27,133<span></span>
</td>
<td class="nump">38,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right of use asset, net</a></td>
<td class="nump">557,798<span></span>
</td>
<td class="nump">605,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset, net</a></td>
<td class="nump">342,122<span></span>
</td>
<td class="nump">132,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Brand names</a></td>
<td class="nump">337,504<span></span>
</td>
<td class="nump">337,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,161,052<span></span>
</td>
<td class="nump">1,161,052<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,478,290<span></span>
</td>
<td class="nump">9,037,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,210,956<span></span>
</td>
<td class="nump">1,168,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">209,100<span></span>
</td>
<td class="nump">238,351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income tax payable</a></td>
<td class="nump">408,681<span></span>
</td>
<td class="nump">486,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">278,432<span></span>
</td>
<td class="nump">212,062<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,145,977<span></span>
</td>
<td class="nump">2,129,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityNoncurrent', window );">Accrued employee benefits, non-current</a></td>
<td class="nump">21,520<span></span>
</td>
<td class="nump">18,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, less current portion</a></td>
<td class="nump">301,921<span></span>
</td>
<td class="nump">473,015<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,469,418<span></span>
</td>
<td class="nump">2,621,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 500,000,000 shares authorized, 20,123,386 and 8,120,000 shares issued and outstanding at June 30, 2024 and 2023, respectively</a></td>
<td class="nump">2,012<span></span>
</td>
<td class="nump">812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">19,014,389<span></span>
</td>
<td class="nump">7,097,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(13,737)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(9,993,792)<span></span>
</td>
<td class="num">(681,647)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">9,008,872<span></span>
</td>
<td class="nump">6,416,923<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">11,478,290<span></span>
</td>
<td class="nump">9,037,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to related parties</a></td>
<td class="nump">$ 38,808<span></span>
</td>
<td class="nump">$ 24,386<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_CapitalReceivablesOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital receivables of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_CapitalReceivablesOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DepositsAndPrepaids">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deposits and prepaids.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DepositsAndPrepaids</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691319472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">20,123,386<span></span>
</td>
<td class="nump">8,120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">20,123,386<span></span>
</td>
<td class="nump">8,120,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020693592208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 4,466,775<span></span>
</td>
<td class="nump">$ 4,799,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of goods sold</a></td>
<td class="num">(2,881,060)<span></span>
</td>
<td class="num">(2,625,821)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,585,715<span></span>
</td>
<td class="nump">2,173,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ConsultingFees', window );">Consulting fees</a></td>
<td class="nump">5,468,126<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">2,452,954<span></span>
</td>
<td class="nump">888,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_PersonnelExpenses', window );">Personnel expenses</a></td>
<td class="nump">951,451<span></span>
</td>
<td class="nump">965,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expenses</a></td>
<td class="nump">351,298<span></span>
</td>
<td class="nump">454,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">284,169<span></span>
</td>
<td class="nump">198,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_LicensingFees', window );">Licensing fees</a></td>
<td class="nump">65,839<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">10,385<span></span>
</td>
<td class="nump">12,268<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">9,584,222<span></span>
</td>
<td class="nump">2,519,713<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(7,998,507)<span></span>
</td>
<td class="num">(346,312)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_PublicOfferingRelatedExpenses', window );">IPO related expenses</a></td>
<td class="num">(50,523)<span></span>
</td>
<td class="num">(662,418)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on investments</a></td>
<td class="num">(354,781)<span></span>
</td>
<td class="num">(529,488)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Other income</a></td>
<td class="nump">121,889<span></span>
</td>
<td class="nump">9,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">2,574<span></span>
</td>
<td class="nump">1,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(1,242,140)<span></span>
</td>
<td class="num">(92,800)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expenses</a></td>
<td class="num">(1,522,981)<span></span>
</td>
<td class="num">(1,272,843)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes</a></td>
<td class="num">(9,521,488)<span></span>
</td>
<td class="num">(1,619,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(209,343)<span></span>
</td>
<td class="num">(25,761)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(9,312,145)<span></span>
</td>
<td class="num">(1,593,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(13,673)<span></span>
</td>
<td class="num">(27,063)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (9,325,818)<span></span>
</td>
<td class="num">$ (1,620,457)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per share on net loss</a></td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per share on net loss</a></td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic</a></td>
<td class="nump">14,020,251<span></span>
</td>
<td class="nump">7,714,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted</a></td>
<td class="nump">14,020,251<span></span>
</td>
<td class="nump">7,714,959<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=FTEL_MerchandiseRevenueMember', window );">Merchandise Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 3,956,962<span></span>
</td>
<td class="nump">$ 4,036,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=FTEL_SalesOfConsumableProductsMember', window );">Sales of Consumable Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">358,536<span></span>
</td>
<td class="nump">223,343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=FTEL_RevenueFromLicensingCustomersMember', window );">Revenue from Licensing Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 151,277<span></span>
</td>
<td class="nump">$ 539,832<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ConsultingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consulting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ConsultingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_LicensingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensing fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_LicensingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_PersonnelExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of personnel expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_PersonnelExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_PublicOfferingRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of IPO related expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_PublicOfferingRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=FTEL_MerchandiseRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=FTEL_MerchandiseRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=FTEL_SalesOfConsumableProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=FTEL_SalesOfConsumableProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=FTEL_RevenueFromLicensingCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=FTEL_RevenueFromLicensingCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020693505904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Subscription Receivable [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="num">$ (56)<span></span>
</td>
<td class="nump">$ 1,497,990<span></span>
</td>
<td class="nump">$ 26,999<span></span>
</td>
<td class="nump">$ 911,747<span></span>
</td>
<td class="nump">$ 2,437,380<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2022</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock issued for services</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,599,888<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for services, shares</a></td>
<td class="nump">1,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription', window );">Settlement of stock subscription</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(27,063)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(27,063)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,593,394)<span></span>
</td>
<td class="num">(1,593,394)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 812<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,097,822<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(681,647)<span></span>
</td>
<td class="nump">6,416,923<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2023</a></td>
<td class="nump">8,120,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(13,673)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(13,673)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(9,312,145)<span></span>
</td>
<td class="num">(9,312,145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Funds raised in IPO</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,497,342<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,497,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Funds raised in IPO, shares</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Share issued for conversion of debt</a></td>
<td class="nump">$ 409<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,599,591<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Share issued for conversion of debt, shares</a></td>
<td class="nump">4,090,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Share issued pursuant to warrants of the convertible notes</a></td>
<td class="nump">$ 489<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">819,599<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">820,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Share issued pursuant to warrants of the convertible notes, shares</a></td>
<td class="nump">4,892,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Share issued pursuant to underwriter&#8217;s warrants</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Share issued pursuant to underwriter's warrants, shares</a></td>
<td class="nump">19,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2024</a></td>
<td class="nump">$ 2,012<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 19,014,389<span></span>
</td>
<td class="num">$ (13,737)<span></span>
</td>
<td class="num">$ (9,993,792)<span></span>
</td>
<td class="nump">$ 9,008,872<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2024</a></td>
<td class="nump">20,123,386<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement of stock subscription.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020690498320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (9,312,145)<span></span>
</td>
<td class="num">$ (1,593,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">10,385<span></span>
</td>
<td class="nump">12,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right of use assets</a></td>
<td class="nump">284,169<span></span>
</td>
<td class="nump">198,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt provision</a></td>
<td class="nump">579,265<span></span>
</td>
<td class="nump">426,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on investments</a></td>
<td class="nump">354,781<span></span>
</td>
<td class="nump">529,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">1,108,088<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock issued for services</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">560,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(449,210)<span></span>
</td>
<td class="num">(560,215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory, at cost</a></td>
<td class="num">(1,914,007)<span></span>
</td>
<td class="nump">393,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Deposits and prepaids</a></td>
<td class="num">(303,457)<span></span>
</td>
<td class="num">(61,177)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncreaseDecreaseInPrepaidOfferingCosts', window );">Prepaid offering costs</a></td>
<td class="num">(1,999,475)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(340,897)<span></span>
</td>
<td class="num">(202,437)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncreaseDecreaseInDeferredTaxAsset', window );">Deferred tax asset</a></td>
<td class="num">(209,768)<span></span>
</td>
<td class="num">(20,759)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">42,233<span></span>
</td>
<td class="nump">363,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(29,251)<span></span>
</td>
<td class="num">(263,625)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="num">(77,377)<span></span>
</td>
<td class="num">(169,615)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent', window );">Accrued employee benefits, non-current</a></td>
<td class="nump">3,090<span></span>
</td>
<td class="nump">13,147<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash from activities</a></td>
<td class="num">(12,253,539)<span></span>
</td>
<td class="num">(373,104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Investment in note receivable</a></td>
<td class="num">(2,500,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash from investing activities</a></td>
<td class="num">(2,500,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Net activity on due to related parties</a></td>
<td class="nump">14,422<span></span>
</td>
<td class="num">(79,064)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Funds raised in IPO, gross</a></td>
<td class="nump">13,614,983<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ProceedsFromIssuanceOfConvertibleNotes', window );">Funds raised in convertible notes</a></td>
<td class="nump">1,840,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash from financing activities</a></td>
<td class="nump">15,469,405<span></span>
</td>
<td class="num">(79,064)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(13,673)<span></span>
</td>
<td class="num">(27,063)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents</a></td>
<td class="nump">702,193<span></span>
</td>
<td class="num">(479,231)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">236,821<span></span>
</td>
<td class="nump">716,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">939,014<span></span>
</td>
<td class="nump">236,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">247,313<span></span>
</td>
<td class="nump">80,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-Cash Investing and Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Stock issued for prepaid IPO services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,040,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_CapitalReceivableOfConvertibleNotes', window );">Capital receivable of convertible notes</a></td>
<td class="nump">1,472,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_OperatingLeaseLiabilityAndRightOfUseAsset', window );">Operating lease liability and right of use asset</a></td>
<td class="nump">836,697<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ConversionOfDebtToEquity', window );">Conversion of debt to equity</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity', window );">Conversion of warrants of convertible notes to equity</a></td>
<td class="nump">820,088<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ConversionOfUnderwritersWarrantToEquity', window );">Conversion of underwriter&#8217;s warrant to equity</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_CapitalReceivableOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital receivable of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_CapitalReceivableOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ConversionOfDebtToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of debt to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ConversionOfDebtToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ConversionOfUnderwritersWarrantToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of underwriter&#8217;s warrant to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ConversionOfUnderwritersWarrantToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of warrants of convertible notes to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes in accured employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncreaseDecreaseInDeferredTaxAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes in deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncreaseDecreaseInDeferredTaxAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncreaseDecreaseInPrepaidOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in prepaid offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncreaseDecreaseInPrepaidOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_OperatingLeaseLiabilityAndRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease liability and right of use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_OperatingLeaseLiabilityAndRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ProceedsFromIssuanceOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ProceedsFromIssuanceOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020774427200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and principal activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and principal activities</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zlMOP2hcn6O2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zrn7j9Jj8Bm2">Organization and principal activities</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fitell
Corporation (the &#8220;Company&#8221;) was incorporated in the Cayman Islands on April 11, 2022 under the Companies Act as an exempted
company with limited liability. The Company conducts its primary operations of selling gym and fitness equipment in Australia through
its indirectly held wholly owned subsidiary that are incorporated and domiciled in Australia, namely GD Wellness Pty Ltd (&#8220;GD&#8221;).
The Company holds GD via a wholly owned subsidiary, namely KMAS Capital and Investment Pty Ltd (&#8220;KMAS&#8221;) which is incorporated
and domiciled in Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zAZhsVtOGGlk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the Company and its subsidiaries are set out in the table as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_ziwBcBbKXaa1" style="display: none">Schedule of the Company and its Subsidiaries</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Percentage of effective ownership</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Name</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Date of incorporation</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2023</td><td>&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Place of incorporation</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Principal activities</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Fitell Corporation</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span id="xdx_901_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_za9zREEZQKv8" title="Date of incorporation">April 11, 2022</span></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_908_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zyCOFRLqjQH3" title="Percentage of effective ownership description">Parent</span></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_903_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20220701__20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zrVcGpcODDYk" title="Percentage of effective ownership description">Parent</span></td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_902_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zQdlS8nwqKNf" title="Place of incorporation">Cayman Islands</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zjXjIOxhY61f" title="Principal activities">Investment holdings</span></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">KMAS Capital and Investment Pty Ltd</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_z3hRSq96jH93" title="Date of incorporation">July 26, 2016</span></span></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zVibSR1cOR5e" title="Percentage of effective ownership">100</span></td><td>%</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zyXDegyk8Wwb" title="Percentage of effective ownership">100</span></td><td>%</td><td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_903_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zcckMFrif5q7" title="Place of incorporation">Australia</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span id="xdx_90A_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zqUL7glRaf1e" title="Principal activities">Investment holdings</span></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 15%">GD Wellness Pty Ltd</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zPbUYFnBwdoe" title="Date of incorporation">July 22, 2005</span></span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 13%"><span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zSbrjc1a7YAd" title="Percentage of effective ownership">100</span></td><td style="text-align: left; width: 1%">%</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 13%"><span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zCBPwKZfwkdc" title="Percentage of effective ownership">100</span></td><td style="text-align: left; width: 1%">%</td><td style="width: 2%">&#160;</td>
    <td style="text-align: justify; width: 15%"><span id="xdx_90D_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zZaMwOMd1JMa" title="Place of incorporation">Australia</span></td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zFNDkEOL8maf" title="Principal activities">Sales of gym and fitness equipment</span></span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zbdNEkVpTIei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020774546000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of significant accounting policies</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_ztJK3fGnOud3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_zaWeaWL8XvC9">Summary of significant accounting policies</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zdLEDuzG8uVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities
and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements have been prepared using the accrual basis of accounting
in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and presented in
US dollars. The year end is June 30.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_zRZ6MgKLFQa3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basic
of Consolidation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements of the Company and its subsidiaries. All inter-company transactions
and balances between the Company and its subsidiaries have been eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_ecustom--ConcentrationsofVendorsPolicyTextBlock_zNZvAji6B1el" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentrations
of vendors</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended June 30, 2024, there are two vendors which accounts for more than 10% of the Company total purchases
individually, and they account for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_z1AzUGQtk8Ib" title="Concentration risk percentage">23.68</span>%
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zuQ7Jo75IwHk" title="Concentration risk percentage">16.83</span>%
of the total purchases respectively. During the fiscal year ended June 30, 2023, there are three vendors which accounts for more
than 10% of the Company total purchase individually, and they account for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_zRUtLTivHyC" title="Concentration risk percentage">28.63</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zXnrg1OFlgHf" title="Concentration risk percentage">16.55</span>%, and<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zroiiC2ik71h" title="Concentration risk percentage"> 10.66</span>% of the total purchases
respectively. As of June 30, 2024 and 2023, three and four vendors, respectively, account for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zchNOoVAMM19" title="Concentration risk percentage">60</span>%
and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourVendorsMember_zD7wHxr38YG5" title="Concentration risk percentage">58</span>%
of total accounts payable, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zxohUoZmgnie" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables
arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions.
The Company controls credit risk related to accounts receivable through credit approvals, credit limits and monitoring procedures. The
Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an
allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure
beyond such allowance is limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--UseOfEstimates_z4fZuz8a4Sr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use
of Estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zmUYDeKS1ZJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue
Recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates it main income source from the sales of merchandise, which includes the sales of various gym equipment and fitness
products. It recognizes this merchandise revenue in accordance with Accounting Standards Update&#160;&#160; (&#8220;ASU&#8221;) 2014-09,
&#8220;<i>Revenue from contracts with customers,&#8221;</i> (Topic 606). Revenue is recognized when a customer obtains control of promised
goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows
arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to
receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification
of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether
they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration;
(iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies
each performance obligation. The Company&#8217;s main revenue stream is from sales of products. The Company recognizes as revenues the
amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied
or as it is satisfied. Generally, the Company&#8217;s performance obligations are transferred to customers at a point in time, typically
upon shipment. The Company offers <span style="background-color: white">refunds, repairs and replacements in accordance with the Australian
Consumer Law. The Company recognized the sales discount and returns against its revenues in the same period as the original sales transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also occasionally sells various consumable products. These products include, but are not limited to, coffee and nutritional supplement
products. Similar to the aforesaid merchandise revenue, it also recognizes the revenue in accordance with Topic 606 upon shipment. If
the Company <span style="background-color: white">provided a sales discount or allowed sales returns, it is recognized against its revenues
in the same period as the original sales transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also provides licensing services and gym equipment to gym studios in overseas. These services include, but are not limited to,
providing the brand name, and offer initial design services to these gym studios. Similar to the aforesaid merchandise revenue, it also
recognizes the revenue in accordance with Topic 606 based on the straight-line basis over the contractual service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--RevenueRecognitionDeferredRevenue_zrq3A5crubDj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred
Revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized the deposits received from its customers as deferred revenue if the goods or service is not delivered. It would be
recognized as revenue after the goods or service is delivered. During the fiscal years ended June 30, 2024 and 2023, a total of $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230701__20240630_zEaFFrY3lIq4" title="Deferred revenue, revenue recognized">238,351</span>
and $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220701__20230630_zZrOo4GFcNQ8" title="Deferred revenue, revenue recognized">501,976</span>, respectively, of deferred revenue was recognized into merchandise revenue. At June 30, 2024 and 2023, a total of $<span id="xdx_902_eus-gaap--DeferredRevenueCurrent_iI_c20240630_zjB8NmzyPGtf" title="Deferred revenue">209,100</span>
and $<span id="xdx_903_eus-gaap--DeferredRevenueCurrent_iI_c20230630_zmmlyyWhXq87" title="Deferred revenue">238,351</span>, respectively, of revenue has been deferred to be recognized in future periods as merchandise revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zR90CHWqDoy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Stock-based
Compensation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records stock-based compensation in accordance with the provisions of the Accounting Standards Codification (&#8220;ASC&#8221;)
718, &#8220;<i>Accounting for Stock Compensation</i>,&#8221; which establishes accounting standards for the transaction in
which an entity exchanges its equity instruments for goods or services. In accordance with guidance provided under ASC 718, the Company
recognizes an expense for the fair value of its stock awards at the time of the grant and the fair value of its outstanding stock options
as they vest, whether held by employees or others. During the fiscal year ended June 30, 2024, there was no stock-based compensation.
During the fiscal year ended June 30, 2023, the Company has issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220701__20230630_zmQQdpfzXE7k" title="Stock issued for services, shares">1,120,000</span> shares for services, and the value of those shares were
determined at $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_c20230630_z1BJB6aCTqh7" title="Shares issued, price per share">5.00</span> which was same as the IPO price on August 8, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_84D_ecustom--PrepaidOfferingCostsPolicyTextBlock_zN0x9mqLI4w1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="text-decoration: underline"><span id="xdx_86C_zk4T2Weg48Hc">Prepaid Offering Costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">Prepaid offering costs are accounted for under ASC 340-10 and consist of
legal, accounting and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are
directly related to IPO or other fundraising and that will be charged upon the completion of the IPO or fundraising.&#160; As of June
30, 2024 and 2023, the Company had prepaid offering costs of $<span id="xdx_90C_eus-gaap--PrepaidExpenseCurrent_iI_c20240630_zBk8pt9CcPIc" title="Prepaid offering cost">1,200,000</span> and $<span id="xdx_90B_eus-gaap--PrepaidExpenseCurrent_iI_c20230630_zeqGwuOsk69h" title="Prepaid offering cost">5,317,866</span>, respectively.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--RevenueRecognitionLoyaltyPrograms_zqLYer8wBuo7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Customers
Loyalty Program</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
certain sales transactions, the Company offers loyalty points to its customer based on the dollar value of the transaction which gives
the customer the option to acquire additional goods or services at a price that is lower than its stand-alone selling price. In accordance
with Topic 606, the Company evaluates whether these loyalty points constitute separate performance obligations and the need to allocate
the transaction price between revenue and performance obligation. As of June 30, 2024 and 2023, the Company does not believe that any
separate performance obligation under the loyalty program is material<span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z5qvaaAFU671" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
Value Measurements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 820, <i>Fair Value Measurements</i>, clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes
a fair value hierarchy to classify the inputs used in measuring fair value as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets
and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated
by observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Inputs are unobservable inputs which reflect the reporting entity&#8217;s own assumptions on what assumptions the market participants
would use in pricing the asset or liability based on the best available information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair value of certain financial instruments, including all current liabilities are carried at historical cost basis, which
approximates their fair values because of the short-term nature of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zhE6Wm3veNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
Value of Financial Instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Subtopic 825-10, <i>Financial Instruments</i> requires disclosure of the fair value of certain financial instruments. The carrying value
of cash and cash equivalents, accounts payable and accrued liabilities as reflected in the consolidated balance sheets, are approximately
fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and
equity instruments of the Company are either recognized or disclosed in the consolidated financial statements together with other information
relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values
of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair
value has been disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zrXimYK3vRqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
and Cash Equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--MarketableSecuritiesPolicy_zeF4adZfEXTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Marketable
Securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for investments in marketable securities in accordance with ASC Topic 825, <i>Financial Instruments. </i>All of the
Company&#8217;s investments at June 30, 2024 and 2023 are treated as trading securities with the unrealized gains and losses reflected
in Other income/(expense) on the consolidated statements of operations and comprehensive loss. During the years ended June 30, 2024 and
2023, the Company recorded an unrealized loss on investments in marketable securities of $<span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20230701__20240630_zQTgrsKh9Ewk" title="Unrealized loss on investments">354,781</span> and $<span id="xdx_901_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220701__20230630_zY4dlGzvQBO5" title="Unrealized loss on investments">529,488</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zTCNjzmSEOp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Advertising
and Promotion</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the policy of charging the costs of advertising, marketing, and public relations to expense as incurred. The Company
has $<span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20230701__20240630_z9rzveonpwId" title="Sales and marketing expenses">351,298</span> and $<span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20220701__20230630_z0jX5FMWia67" title="Sales and marketing expenses">454,995</span> in sales and marketing expenses for the years ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zIQSJwWrJf2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income
Taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their
respective tax basis and operating loss, capital loss and tax credit carryforwards. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes
the enactment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized
income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or
measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to
unrecognized tax benefits as a component of general and administrative expenses. Our federal tax return and any state tax returns are
not currently under examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted ASC 740-10, <i>Accounting for Income Taxes</i>, which requires an asset and liability approach to financial accounting
and reporting for income taxes. Deferred income tax assets and liabilities are computed annually from differences between the consolidated
financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on
enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances
are established when necessary to reduce deferred tax assets to the amount expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z96cGrTCLI9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Inventory</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consists of only finished goods and are stated at the lower of cost and net realizable value on a &#8216;first in first out&#8217; basis.
Cost comprises of direct materials and delivery costs, direct labor, import duties and other taxes, and an appropriate proportion of
variable and fixed overhead expenditure based on normal operating capacity. Costs of purchased inventory are determined after deducting
rebates and discounts received or receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
in transit is stated at the lower of cost and net realizable value. Cost comprises purchase and delivery costs, net of rebates and discounts
received or receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated
costs necessary to make the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company records an allowance for potentially excess and obsolete inventory based upon recent sales history, the quantity of inventory
on-hand, and a forecast of potential use of the inventory. The Company periodically reviews inventory to identify excess quantities and
part numbers that are experiencing a reduction in demand. Any part numbers with quantities identified during this process are reserved
for at rates based upon management&#8217;s judgment, historical rates, and consideration of possible scrap and liquidation values which
may be as high as 100% of cost if no liquidation market exists for the part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zUdhu2Begd8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Receivable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Account balances deemed to be uncollectible are
charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. At June 30, 2024 and 2023, the Company has considered an allowance of $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240630_z9RoaSTTwa9f" title="Allowance for doubtful accounts receivable">585,672</span> and $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20230630_zi3SvUbDEE6d" title="Allowance for doubtful receivable accounts">426,971</span>, respectively, for
doubtful receivable accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zHyXa7tPTC3b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property
and Equipment</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment is stated at cost, net of depreciation. Depreciation is provided over the estimated useful lives of the related assets
using the straight-line method. Depreciation expense totaled $<span id="xdx_90B_eus-gaap--Depreciation_c20230701__20240630_z94WZe1bFtN1" title="Depreciation expense">10,385</span> and $<span id="xdx_90C_eus-gaap--Depreciation_c20220701__20230630_zCOmyPPoeVX3" title="Depreciation expense">12,268</span> for the years ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z7eUSUczlSPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment
of Long-Lived Assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
impairments of long lived assets are reviewed when events or changes in circumstances indicate a potential impairment may exist. In accordance
with ASC Subtopic 360-10, <i>&#8220;Property, Plant and Equipment &#8211; Overall&#8221;</i>, impairment is determined when estimated
future undiscounted cash flows associated with an asset are less than asset&#8217;s carrying value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zXuSjj2WQo4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intangible
Assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s intangible assets consist of brand names and goodwill. At June 30, 2024 and 2023, the Company had brand names and goodwill
with costs of approximately $<span id="xdx_906_ecustom--BrandNames_iI_c20240630_zQDuWHJcvyq8" title="Brand names cost"><span id="xdx_907_ecustom--BrandNames_iI_c20230630_zsW6SEMq3DCj" title="Brand names cost">337,504</span></span> and $<span id="xdx_900_eus-gaap--Goodwill_iI_c20240630_zvu9LfTRBLgb" title="Goodwill"><span id="xdx_909_eus-gaap--Goodwill_iI_c20230630_zTZLYCKQT3A3" title="Goodwill">1,161,052</span></span> respectively, which all have indefinite lives. The Company evaluates intangible assets
with indefinite lives for impairment at least annually or when events or changes in circumstances indicate that an impairment may exist.
The Company determined that <span id="xdx_909_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20230701__20240630_zx5XQfHmgU0d" title="Impairment of intangible assets"><span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20220701__20230630_zNR1ESCIpFCh" title="Impairment of intangible assets">none</span></span> of its intangible assets were impaired in the fiscal years ended June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zgdajUijfRM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Net
Income (Loss) Per Common Share</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes income (loss) per common share in accordance with ASC Topic 260, <i>Earnings Per Share, </i>which requires dual presentation
of basic and diluted earnings per share. Basic income or loss per common share is computed by dividing net income or loss by the weighted
average number of common shares outstanding during the period. Diluted income or loss per common share is computed by dividing net income
or loss by the weighted average number of common shares outstanding, plus the issuance of common shares, if dilutive, that could result
from the exercise of outstanding stock options and warrants. <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230701__20240630_zXOaFnm78TS" title="Potential dilutive common shares">No</span> potential dilutive common shares are included in the computation of any
diluted per share amount when a loss is reported.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z48yciGiVuoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comprehensive
Income (loss)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 220, <i>Comprehensive Income</i>, establishes standards for reporting comprehensive income (loss) and its components.
Comprehensive income or loss is defined as the change in equity during a period from transactions and other events from non-owner
sources. The component of comprehensive loss totaling $<span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20230701__20240630_zpfmdYobXYii" title="Foreign currency translation adjustment">13,673</span>
and $<span id="xdx_900_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20220701__20230630_zPWTqaR0gQb9" title="Foreign currency translation adjustment">27,063</span>
for the years ended June 30, 2024 and 2023, respectively, related to foreign currency translation adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zbFHXOWfguFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
Currencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determined that its functional currency is the Australian dollar since the Australian dollar is the currency of the environment
in which the Company primarily generates and expends cash; however, the Company&#8217;s reporting currency is the U.S. dollar. Foreign
currency transaction gains and losses represent gains and losses resulting from transactions entered into in a currency other than the
functional currency of the Company. These transaction gains and losses, if any, are included in results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_z1M4V5P1r2lh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for leases in accordance with ASC Topic 842, <i>Lease</i>. Operating lease right-of-use assets represents the right
to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum
lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental
borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense
for minimum lease payments is amortized on a straight-line basis over the lease term and is presented on the consolidated statements
of operations and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
permitted under ASC Topic 842, the Company has made an accounting policy election not to apply the lease recognition provision to short
term leases (leases with a lease term of 12 months or less that do not include an option to purchase the underlying asset that the lessee
is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis
over the lease term. The Company did <span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20230701__20240630_z2aGYYDPEWQj" title="Short-term leases"><span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20220701__20230630_znwvMIWi5Udb" title="Short-term leases">no</span></span>t have any short-term leases at June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--DebtPolicyTextBlock_zY9ye2PWHI03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Convertible
notes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for convertible notes deemed conventional and conversion options embedded in non-conventional convertible notes which
qualify as equity under Accounting Standards Update No. 2020-06, <i>Debt-Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts
in an Entity&#8217;s Own Equity </i>(&#8220;ASU 2020-06&#8221;), which simplifies the accounting for certain financial instruments with
characteristics of liabilities and equity, including certain convertible instruments and contracts on an entity&#8217;s own equity. ASU
2020-06 removes the separation models required for convertible debt with cash conversion features and convertible instruments with beneficial
conversion features. It also removes certain settlement conditions that were required for equity for equity contracts to qualify for
the derivative scope exception and simplifies the diluted earnings per share calculation for convertible instruments. Accordingly, the
underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt
discounts under these arrangements are amortized over the term of the related debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zJvY2BiWmNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Warrants</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the warrants under ASC 815, <i>Derivatives and Hedging </i>(&#8220;ASC 815&#8221;), and determined that they did not
require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair values,
by using the Black-Scholes model when the warrants are granted. During the fiscal year June 30, 2024, the Company has issued <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zsX6QLjzmDP7" title="Issued warrants, net basis">30,000</span>
warrants on a net basis, and <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zYjkHZxiOdla" title="Number of warrant issued">5,645,455</span> warrants, respectively, to the IPO underwriter and the Convertible Notes noteholder. All of the
warrants were fully converted into shares during the fiscal year June 30, 2024. They were all converted based on cashless basis and have
been converted into <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zoW9zluA01dd" title="Converted warrant">19,750</span> shares and <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zvlj1x6bVhI9" title=" Warrant converted into share">4,892,727</span> shares respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zR89hiLUuXQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent
Accounting Pronouncements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on
the consolidated financial statements, and the Company does not believe that there are any other new accounting pronouncements that have
been issued that might have a material impact on its financial position or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_ecustom--GoingConcernPolicyTextBlock_zhhzDz1h17we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Going
Concern</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will be able to continue
trading, realise its assets and discharge its liabilities in the ordinary course of business for a period of at least 12 months from
the date that these consolidated financial statements are approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Directors note that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group made a loss of $<span id="xdx_90D_eus-gaap--NetIncomeLoss_iN_di_c20230701__20240630_z7PwMAYZxsXc" title="Net income loss">9,312,145</span> from its continuing operations for the year ended June 30,
                                            2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group held cash and cash equivalents of $<span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240630_zkfAI461Ib04" title="Cash and cash equivalents">939,014</span> as at June 30, 2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group incurred a net cash outflow from operating activities of $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230701__20240630_zLb6uYGVooMi" title="Net cash outflow from operating activities">12,253,539</span> for the year ended
                                            June 30, 2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            successful capital raising (IPO) in August 2023 arose for $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230701__20240630_zlZzxonGwjXl" title="Issuance of common stock">13,614,983</span> before cost of capital.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the appropriateness of using the going concern assumption, the Directors have noted:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                            are reasonable grounds to believe that the Company will be able to continue as a going concern
                                            as the Directors are satisfied that the Company will be able to either secure additional
                                            working capital as required through raising additional capital or reducing the Company&#8217;s
                                            discretionary spending;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
                                            the directors consider it appropriate to prepare the consolidated financial statements on
                                            a going concern basis.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whilst
the Directors remain confident in the Company&#8217;s ability to access further working capital through debt, equity or asset sales if
required, there remains material uncertainty as to whether the Company will continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Had
the going concern basis not been used, adjustments would need to be made relating to the recoverability and classification of certain
assets, and the classification and measurement of certain liabilities to reflect the fact that the Company may be required to realize
its assets and settle its liabilities other than in the ordinary course of business, and at amounts different from those stated in the
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zbrWAtnQg7G6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Subsequent
Events</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC Topic 855, <i>Subsequent Events</i>, the Companies evaluated subsequent events through November 15, 2024; the date
the consolidated financial statements were available for issue.</span></p>

<p id="xdx_856_z3baOFxSydR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020774520016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in marketable securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investment in marketable securities</a></td>
<td class="text"><p id="xdx_804_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zCBTKM8mtRO8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zjvSkQHccGqd">Investment in marketable securities</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zqY8JaNkrKC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and 2023, the Company held some equity securities which are publicly traded on registered Stock Exchanges. The equity
securities being held as of June 30, 2024 and 2023 were valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zezLm7sdIfYg" title="Investment in marketable securities">124,963</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_906_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zKVFPp2jUcUb" title="Investment in marketable securities">494,275</span> respectively. The following tables classify the
Company&#8217;s assets measured at fair value on a recurring basis into the fair value hierarchy: &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zMdqkMGft4kb" style="display: none">Schedule of Assets Measured at Fair Value on Recurring Basis</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at June 30, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Description</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-bottom: 1pt">Equity securities</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvEZtKuJ1H27" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">124,963</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmI1RvqnzPB1" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0736">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zznqeo8Bp622" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0738">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zl2egzj8G3o6" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">124,963</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zX4kmtQFuCll" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">124,963</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z42YydfQ2lWj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zULrCbRv5hmf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zx8xID1OKiW8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">124,963</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at June 30, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Description</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-bottom: 1pt">Equity securities</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCJCRnZ51lJ7" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">494,275</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z6aMo0MjMy11" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpKBE11yQZ13" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUQNdFTbPEu9" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">494,275</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxo1oTN8VFhc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">494,275</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmWgqANFnVDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOCB5xLwsLk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0762">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGrwJk02w4Sk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">494,275</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zneESdwv62Ek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/940-320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph b<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691714976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Notes</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zm9ee2n0XjT1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_zkdW9q8AuNz2">Convertible Notes</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2024, the Company issued Convertible Notes with a principal amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_znKMHBt1Xpyb" title="Principal amount">3,600,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
with an <span id="xdx_90A_ecustom--OriginalIssueDiscountPercentage_iI_dp_uPure_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zQRUZduzdTnb" title="Original issue discount">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
original issue discount (&#8220;OID&#8221;) for a total funding amount of $<span id="xdx_901_eus-gaap--ConvertibleDebt_iI_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zXEkdbkrkDWh" title="Convertible debt">3,312,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
notes bear interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zFzM9x8DUYB" title="Interest rate">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per annum and a maturity date of <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20240115__20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zOLIETcCFTHa" title="Maturity date description">36
months</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The noteholder was given the right to
convert all or any amount of the principal face amount into the ordinary shares of the Company at a conversion price based on the lowest
closing price of the Company&#8217;s ordinary shares as reported on the Nasdaq Capital Market during the five (5) trading days immediately
preceding the date of conversion, provided, however that conversion price shall not be lower than $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240115_zdDMn6p2lj28" title="Conversion price">0.80
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. In addition to the Convertible Notes,
the note holder received an aggregate <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240115__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zIAwVzt5BTGf" title="Warrant outstanding">5,645,455
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants. The warrants have an exercise price
of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240115__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zLEfbJG5WBri" title="Exercise price">1.056</span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share which represents <span id="xdx_900_ecustom--WarrantSharePricePercentage_iI_pid_dp_c20240115__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z6AWQIzHVd21" title="Warrant share price percentage">120</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the share price on the Nasdaq Capital Market as of the issue date, and have a <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zVHahspFGcEi" title="Warrants exercise term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0786">five</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-year
exercise term. The noteholder has paid the Company $<span id="xdx_901_ecustom--ProceedsFromIssuanceOfConvertibleNotes_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zLMqq3Bgjqbk" title="Proceeds from issuance of convertible notes">1,840,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of June 30, 2024, thus there was a capital
receivable of $<span id="xdx_90C_ecustom--CapitalReceivablesOfConvertibleNotes_iI_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z9LxUNPe6Io6" title="Capital receivables of convertible notes">1,472,000</span> as of June 30, 2024.</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This capital receivable has been fully settled subsequent to
June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has used the Black Scholes model to evaluate the fair value of the aforesaid warrants attached to the Convertible Notes at $<span id="xdx_909_ecustom--ConvertibleNotes_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z2qcEdn5Ya96" title="Convertible note">820,088
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in total. These Convertible Notes were fully
converted into shares during the fiscal year ended June 30, 2024, on cashless basis and converted into <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z2TpbdcLcz06" title="Shares issued upon note conversion">4,090,909
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares, at which time the discount was fully amortized, which totaled $<span id="xdx_903_eus-gaap--AmortizationOfDebtDiscountPremium_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_ze0Q8wOzMNta" title="Amortization of debt discount">1,108,088</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020774285712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_WarrantsDisclosureTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_805_ecustom--WarrantsDisclosureTextBlock_zmVxCWWCRghf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_822_z3tRHah10IQ5">Warrants</span></span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year June 30, 2024, the Company has issued <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zFzMRREJ7DL4" title="Warrants issued">30,000</span> warrants on a net basis, and <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zS8Wyyhl13Hb" title="Warrants issued">5,645,455</span> warrants, respectively, to the IPO
underwriter and the Convertible Notes noteholder. All of the warrants were fully converted into shares during the fiscal year June 30,
2024. They were all converted based on cashless basis, and converted into <span id="xdx_90E_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zPWc1yCK3acc" title="Warrants converted into shares">19,750</span> shares and <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zGmDUZXbawL8" title="Warrants converted into shares">4,892,727</span> shares respectively. The warrants
are detailed as follows:</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z27Osr7LE71i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zVeEWUeTc6l9" style="display: none">Schedule
of Warrants</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Contractual Term (in years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Outstanding as June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl7LbqMSYDBl" style="text-align: right" title="Number of warrants, Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7iYr2Sl25F5" style="text-align: right" title="Weighted-Average Exercise Price, Outstanding, Beginning Balance">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%">Granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMFmN1Ae01D7" style="width: 12%; text-align: right" title="Number of warrants, Granted">5,675,455</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrGzWlSoHkLj" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Granted">1.08</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zy8FrtL4KYZ9" title="Weighted Average Contractual Term (in years), Granted">5.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuzWMVOUjIBa" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Exercised">(5,675,455</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zx317BbuXLOa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0822">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Outstanding as June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zY0JujF3k1D5" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Ouststanding, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl0824">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6tdc1iFjq66" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl0826">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zPWifVD66gG6" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each warrant on the date of grant is estimated using the Black-Scholes option valuation model. The following weighted-average
assumptions were used for warrants granted during the year ended June 30, 2024: exercise price of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zFNJOtl4CUZ1" title="Exercise price">1.0560</span>, expected term of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUSa7VKLlzz" title="Expected term">five years</span>,
expected average volatility of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zJrEWFFzH767" title="Expected average volatility">27.76</span>%, <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dpo_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zbjdeboQpQd8" title="Expected dividend yield">no</span> expected dividend yield, and risk-free interest rate of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPgigwPqsDHi" title="Risk-free interest rate">3.84</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691339120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Note Receivables</a></td>
<td class="text"><p id="xdx_807_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zHS2Hmq9Y6Fi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zIE8ajkraa5">Note Receivables</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 2, 2023, the Company has entered into a loan agreement with an independent third party (&#8220;Borrower&#8221;), in which,
the Company has lent $<span id="xdx_905_eus-gaap--OtherReceivablesNetCurrent_iI_c20230802_z2XCsHGQC3vd" title="Loan lended amount">2,500,000</span>
to the Borrower, with a loan period of <span id="xdx_90F_eus-gaap--DebtInstrumentTerm_dtM_c20230802__20230802_zB6ESpLjNT27" title="Loan period">36</span>
months, and at an annualized interest of <span id="xdx_909_ecustom--DebtInstrumentIncreaseAccruedInterestPercentage_dp_uPure_c20230802__20230802_zedRkryPdsr4" title="Annualized interest">6.8</span>%,
with the first eight months being interest-free. The Company has the option to convert this loan into equity of the Borrower. As of
June 30, 2024, the total balance outstanding was $<span id="xdx_905_eus-gaap--NotesAndLoansReceivableNetCurrent_iI_c20240630_zepvfZRjmC43" title="Note receivable outstanding">2,500,000</span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-10/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020774495120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zk27CUEGmah7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zjEgIF49u6Y6">Property and Equipment</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zkHrHygNCJSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s property and equipment at June 30, 2024 and 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zX0BPzo7oCg7" style="display: none">Schedule
of Property and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240630_zqPzPufjjqea" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20230630_zz8st7gQp3n" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zyKeB7OeBCee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; text-align: left; padding-bottom: 1pt">Motor Vehicle</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 14%; text-align: center; padding-bottom: 1pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zIl6FYmYshe5" title="Estimated Useful Life">5</span> years</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">51,741</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">51,741</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzbdW_zdSzExPJk0yl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property and equipment, gross</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,741</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,741</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzbdW_zyTLiZfNDHbd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,608</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(12,998</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzbdW_zI877cMqrynh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27,133</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,743</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A1_zyCQ6dy5ARHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended June 30, 2024 and 2023, the Company recorded $<span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20230701__20240630_z5zGcv8hzGb4" title="Depreciation expense">10,385</span> and $<span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20220701__20230630_zuI1tqfzbwOd" title="Depreciation">12,268</span>, respectively, of depreciation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020693179968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease right-of-use assets and lease liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract', window );"><strong>Lease Right-of-use Assets And Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lease right-of-use assets and lease liabilities</a></td>
<td class="text"><p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_zOkYJXgVjthf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_zoQ0pznev3M3">Lease right-of-use assets and lease liabilities</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
leases</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases office space in Taren Point, NSW, Australia. The lease commenced July 15, 2018 and ended on July 14, 2023, at which time
the Company extended the lease, which commenced on July 15, 2023 and ends on July 14, 2026. The initial monthly lease
payments are $<span id="xdx_900_eus-gaap--OperatingLeasePayments_uAUD_c20230701__20240630_zn94Q1PViOBa" title="Operating lease payments">25,000</span> AUD and the monthly payments of the lease extension are $<span id="xdx_90E_eus-gaap--OperatingLeasePaymentsUse_uAUD_c20230701__20240630_z2Us7J2ANlQ2" title="Operating lease payments">36,667</span> AUD and are subject to annual escalation
rate of <span id="xdx_907_ecustom--AnnualEscalationRate_pid_dp_uPure_c20230701__20240630_zygwthcABA0f" title="Annual escalation rate">3</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease right-of-use assets and liabilities are recognized at the present value of the future lease payments at the lease commencement
date. The interest rate used to determine the present value is the Company&#8217;s incremental borrowing rate, estimated to be <span id="xdx_90A_ecustom--IncrementalBorrowingRate_pid_dp_uPure_c20230701__20240630_zHqQq9xmdfLd" title="Incremental borrowing rate">3.70</span>%,
as the interest rate implicit in most of the Company leases is not readily determinable. Operating lease expense is recognized on a straight-line
basis over the lease term. During the years ended June 30, 2024 and 2023, the Company recorded $<span id="xdx_908_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zZTygI2sILZ3" title="Operating lease expense">284,169</span> and $<span id="xdx_90A_eus-gaap--OperatingLeaseExpense_c20220701__20230630_zIS3dwhNf36" title="Operating lease expense">198,914</span>, respectively, as
operating lease expense on the consolidated statements of operations and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--LeaseCostTableTextBlock_z7diGR7hWIqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
right-of- use assets are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zbSyHoMEwi66" style="display: none">Schedule
of Operating Right of use Assets and Operating Lease Liabilities</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240630_z8WknsJvSLz8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230630_zfuq8aTlSJce" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RightOfUseAssetsForOfficeLease_iI_zhiqXCzHStIc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Office lease</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">836,697</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,541,390</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AdjustmentForAmortizations_iI_zsJX6Wbr891f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(278,899</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(935,596</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zESJ0dHRni16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Right-of-use, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">557,798</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">605,794</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    lease liabilities are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zacSsWYNQJv9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230630_zNZO6lj9hDr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zC0qo7YHYdE6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--OperatingLeaseLiabilityForOfficeLease_i01I_zCsMAC5wtQCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Office lease</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">580,353</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">685,077</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_z5sJvuQBVZEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">278,432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">212,062</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_z973UiSt0dl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">301,921</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">473,015</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zec8Dg8mIGBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zO1BmhNRgKLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zcaODomHCCHh">Schedule of Maturity of Operating Lease Liabilities</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zoRlLsgTAAH4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzYvG_zlDHNGCMXp5k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Year ending June 30, 2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">301,127</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzYvG_z5SoOw7qQHQd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Year ending June 30, 2026</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">310,160</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzYvG_z044FjJ7QmHd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">611,287</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zV7QKS0QdEFb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,934</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseLiability_iTI_zwPZuivlSuua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">PV of Payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">580,353</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zKEgMofct5Pl" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020692131312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and contingencies</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z0RBL5Jms2u6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_825_zRpEOWSw6TSi">Commitments and contingencies</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates
the merits of the case in accordance with ASC 450-20-50, <i>Contingencies</i>. The Company evaluates its exposure to the matter, possible
legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is
probable and can be reasonably estimated, it establishes the necessary accruals. As of June 30, 2024 and 2023, the Company is not aware
of any contingent liabilities that should be reflected in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020774470320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text"><p id="xdx_805_eus-gaap--IncomeTaxDisclosureTextBlock_zwZTE5NCS7La" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_820_zDSmsY44uTFj">Income taxes</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zY8kUMKyxBC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the effective tax rate to the statutory rate is shown below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B9_zey4Pai7f8cb" style="display: none">Schedule of Reconciliation of Provision of Income Tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230701__20240630_zs18L6nifvxg" style="border-bottom: Black 1pt solid; text-align: right">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220701__20230630_z9A0mcQEcnh1" style="border-bottom: Black 1pt solid; text-align: right">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z8aJc3TVMtM5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 1pt">Loss before taxes</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(9,521,488</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(1,619,155</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsTax_znaiwqsugeAa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Expected income tax credit at statutory rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230701__20240630_zCHlPT3bxFlc" title="Expected income tax credit at statutory rate, percent">25</span>% <br/>(2023: <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20220701__20230630_zhpj2PjROZSe" title="Expected income tax credit at statutory rate, percent">25</span>%)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,380,372</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(404,789</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Increase (decrease) in income taxes resulting from:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_zEwqseE5qKti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">140,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses_zFiKXX8cI9Mj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">IPO related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,622</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,601</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt_z2b5pX2Pwvpc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Provision for bad debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144,816</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,742</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_zkN7g8795bXi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Unrealized loss on investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,695</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">131,613</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost_zqGc2MhZLRkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Government Subsidy Tech Boost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,721</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxReconciliationNondeductibleExpenseDebtDiscount_zoabnxNW9Vf7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">277,022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0951">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome_zUN0f0fzz93g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-taxable other income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(30,472</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses_zAUheZ3dBiwl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">-Non-tax deductible personnel expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,544</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0957">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees_zdlrPyauni4l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-tax deductible consulting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,367,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses_zeko93dyfLca" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Non-tax deductible general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">308,512</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0963">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxContingenciesOther_z1RkZtK6PVX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other items, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(26,742</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(20,207</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_zr01HQ1Q6xod" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(209,343</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,761</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A8_zUbbi7ykRf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zWQcrDJeQtec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax effects temporary differences that gave rise to the deferred tax assets and liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_zXR1LzmgNvx9" style="display: none">Schedule of Components of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20240630_zKpglvizraSe" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230630_z0HpqOiPyBca" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_zCC5nGc12gLj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Accrued employee benefits</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">37,199</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,877</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_iI_zxktZAdYfdY9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized loss on investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0976">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,082</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--DeferredTaxAssetsUnrealizedCurrencyGain_iNI_di_zNMV84rbgKPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Unrealized foreign exchange gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,294</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,394</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--DeferredTaxAssetsDepreciation_zO7prOH2xZ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,783</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,049</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities_iI_zryj0QXs4Yve" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating right of use assets and lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0986">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsAccumulatedTaxLoss_iI_zTPtHKunWhQ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated tax loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">238,989</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0989">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zUsJv7Ux7es6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Provision for bad debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">56,784</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">106,740</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iI_zwnXuUX1CPyj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">342,122</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">132,354</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zEHt4BY2O99a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and 2023, the Company had no material net operating loss or tax credit carryforwards. As of June 30, 2024 and 2023,
the Company had no provision for uncertain tax positions and no provisions for penalties or interest. In addition, the Company does not
believe that there are any uncertain tax benefits that could be recognized in the near future that would impact the Company&#8217;s effective
tax rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691302720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Due to Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Due to Related Party Transactions</a></td>
<td class="text"><p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zCgMXinV4fo5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zlEzodukS974">Due to Related Party Transactions</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount due to a related party called Ansa Group Limited (&#8220;Ansa&#8221;), an entity under common control of the majority shareholder
of the Company was $<span id="xdx_90D_eus-gaap--OtherLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zclZIcclJq73">38,808</span> and $<span id="xdx_903_eus-gaap--OtherLiabilitiesCurrent_iI_c20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zJBYRoZ8bM87" title="Amount due to related party">24,386</span> as at June 30, 2024 and 2023 respectively. The balance is interest-free and does not have a fixed
maturity. The terms are not necessarily indicative of what a third party would agree to.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020693587024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_847_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zdLEDuzG8uVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities
and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements have been prepared using the accrual basis of accounting
in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and presented in
US dollars. The year end is June 30.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basic of Consolidation</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_zRZ6MgKLFQa3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basic
of Consolidation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the financial statements of the Company and its subsidiaries. All inter-company transactions
and balances between the Company and its subsidiaries have been eliminated upon consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ConcentrationsofVendorsPolicyTextBlock', window );">Concentrations of vendors</a></td>
<td class="text"><p id="xdx_845_ecustom--ConcentrationsofVendorsPolicyTextBlock_zNZvAji6B1el" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentrations
of vendors</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended June 30, 2024, there are two vendors which accounts for more than 10% of the Company total purchases
individually, and they account for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_z1AzUGQtk8Ib" title="Concentration risk percentage">23.68</span>%
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zuQ7Jo75IwHk" title="Concentration risk percentage">16.83</span>%
of the total purchases respectively. During the fiscal year ended June 30, 2023, there are three vendors which accounts for more
than 10% of the Company total purchase individually, and they account for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_zRUtLTivHyC" title="Concentration risk percentage">28.63</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zXnrg1OFlgHf" title="Concentration risk percentage">16.55</span>%, and<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zroiiC2ik71h" title="Concentration risk percentage"> 10.66</span>% of the total purchases
respectively. As of June 30, 2024 and 2023, three and four vendors, respectively, account for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zchNOoVAMM19" title="Concentration risk percentage">60</span>%
and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourVendorsMember_zD7wHxr38YG5" title="Concentration risk percentage">58</span>%
of total accounts payable, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zxohUoZmgnie" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration
of Credit Risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables
arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions.
The Company controls credit risk related to accounts receivable through credit approvals, credit limits and monitoring procedures. The
Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an
allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure
beyond such allowance is limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_848_eus-gaap--UseOfEstimates_z4fZuz8a4Sr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use
of Estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zmUYDeKS1ZJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue
Recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates it main income source from the sales of merchandise, which includes the sales of various gym equipment and fitness
products. It recognizes this merchandise revenue in accordance with Accounting Standards Update&#160;&#160; (&#8220;ASU&#8221;) 2014-09,
&#8220;<i>Revenue from contracts with customers,&#8221;</i> (Topic 606). Revenue is recognized when a customer obtains control of promised
goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows
arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to
receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification
of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether
they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration;
(iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies
each performance obligation. The Company&#8217;s main revenue stream is from sales of products. The Company recognizes as revenues the
amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied
or as it is satisfied. Generally, the Company&#8217;s performance obligations are transferred to customers at a point in time, typically
upon shipment. The Company offers <span style="background-color: white">refunds, repairs and replacements in accordance with the Australian
Consumer Law. The Company recognized the sales discount and returns against its revenues in the same period as the original sales transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also occasionally sells various consumable products. These products include, but are not limited to, coffee and nutritional supplement
products. Similar to the aforesaid merchandise revenue, it also recognizes the revenue in accordance with Topic 606 upon shipment. If
the Company <span style="background-color: white">provided a sales discount or allowed sales returns, it is recognized against its revenues
in the same period as the original sales transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also provides licensing services and gym equipment to gym studios in overseas. These services include, but are not limited to,
providing the brand name, and offer initial design services to these gym studios. Similar to the aforesaid merchandise revenue, it also
recognizes the revenue in accordance with Topic 606 based on the straight-line basis over the contractual service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionDeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text"><p id="xdx_840_eus-gaap--RevenueRecognitionDeferredRevenue_zrq3A5crubDj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred
Revenue</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized the deposits received from its customers as deferred revenue if the goods or service is not delivered. It would be
recognized as revenue after the goods or service is delivered. During the fiscal years ended June 30, 2024 and 2023, a total of $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230701__20240630_zEaFFrY3lIq4" title="Deferred revenue, revenue recognized">238,351</span>
and $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220701__20230630_zZrOo4GFcNQ8" title="Deferred revenue, revenue recognized">501,976</span>, respectively, of deferred revenue was recognized into merchandise revenue. At June 30, 2024 and 2023, a total of $<span id="xdx_902_eus-gaap--DeferredRevenueCurrent_iI_c20240630_zjB8NmzyPGtf" title="Deferred revenue">209,100</span>
and $<span id="xdx_903_eus-gaap--DeferredRevenueCurrent_iI_c20230630_zmmlyyWhXq87" title="Deferred revenue">238,351</span>, respectively, of revenue has been deferred to be recognized in future periods as merchandise revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-based Compensation</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zR90CHWqDoy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Stock-based
Compensation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records stock-based compensation in accordance with the provisions of the Accounting Standards Codification (&#8220;ASC&#8221;)
718, &#8220;<i>Accounting for Stock Compensation</i>,&#8221; which establishes accounting standards for the transaction in
which an entity exchanges its equity instruments for goods or services. In accordance with guidance provided under ASC 718, the Company
recognizes an expense for the fair value of its stock awards at the time of the grant and the fair value of its outstanding stock options
as they vest, whether held by employees or others. During the fiscal year ended June 30, 2024, there was no stock-based compensation.
During the fiscal year ended June 30, 2023, the Company has issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220701__20230630_zmQQdpfzXE7k" title="Stock issued for services, shares">1,120,000</span> shares for services, and the value of those shares were
determined at $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_c20230630_z1BJB6aCTqh7" title="Shares issued, price per share">5.00</span> which was same as the IPO price on August 8, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_PrepaidOfferingCostsPolicyTextBlock', window );">Prepaid Offering Costs</a></td>
<td class="text"><p id="xdx_84D_ecustom--PrepaidOfferingCostsPolicyTextBlock_zN0x9mqLI4w1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="text-decoration: underline"><span id="xdx_86C_zk4T2Weg48Hc">Prepaid Offering Costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">Prepaid offering costs are accounted for under ASC 340-10 and consist of
legal, accounting and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are
directly related to IPO or other fundraising and that will be charged upon the completion of the IPO or fundraising.&#160; As of June
30, 2024 and 2023, the Company had prepaid offering costs of $<span id="xdx_90C_eus-gaap--PrepaidExpenseCurrent_iI_c20240630_zBk8pt9CcPIc" title="Prepaid offering cost">1,200,000</span> and $<span id="xdx_90B_eus-gaap--PrepaidExpenseCurrent_iI_c20230630_zeqGwuOsk69h" title="Prepaid offering cost">5,317,866</span>, respectively.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionLoyaltyPrograms', window );">Customers Loyalty Program</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--RevenueRecognitionLoyaltyPrograms_zqLYer8wBuo7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Customers
Loyalty Program</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
certain sales transactions, the Company offers loyalty points to its customer based on the dollar value of the transaction which gives
the customer the option to acquire additional goods or services at a price that is lower than its stand-alone selling price. In accordance
with Topic 606, the Company evaluates whether these loyalty points constitute separate performance obligations and the need to allocate
the transaction price between revenue and performance obligation. As of June 30, 2024 and 2023, the Company does not believe that any
separate performance obligation under the loyalty program is material<span style="background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z5qvaaAFU671" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
Value Measurements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 820, <i>Fair Value Measurements</i>, clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes
a fair value hierarchy to classify the inputs used in measuring fair value as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets
and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated
by observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Inputs are unobservable inputs which reflect the reporting entity&#8217;s own assumptions on what assumptions the market participants
would use in pricing the asset or liability based on the best available information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair value of certain financial instruments, including all current liabilities are carried at historical cost basis, which
approximates their fair values because of the short-term nature of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zhE6Wm3veNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
Value of Financial Instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Subtopic 825-10, <i>Financial Instruments</i> requires disclosure of the fair value of certain financial instruments. The carrying value
of cash and cash equivalents, accounts payable and accrued liabilities as reflected in the consolidated balance sheets, are approximately
fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and
equity instruments of the Company are either recognized or disclosed in the consolidated financial statements together with other information
relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values
of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair
value has been disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zrXimYK3vRqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
and Cash Equivalents</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--MarketableSecuritiesPolicy_zeF4adZfEXTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Marketable
Securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for investments in marketable securities in accordance with ASC Topic 825, <i>Financial Instruments. </i>All of the
Company&#8217;s investments at June 30, 2024 and 2023 are treated as trading securities with the unrealized gains and losses reflected
in Other income/(expense) on the consolidated statements of operations and comprehensive loss. During the years ended June 30, 2024 and
2023, the Company recorded an unrealized loss on investments in marketable securities of $<span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20230701__20240630_zQTgrsKh9Ewk" title="Unrealized loss on investments">354,781</span> and $<span id="xdx_901_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220701__20230630_zY4dlGzvQBO5" title="Unrealized loss on investments">529,488</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising and Promotion</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zTCNjzmSEOp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Advertising
and Promotion</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the policy of charging the costs of advertising, marketing, and public relations to expense as incurred. The Company
has $<span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20230701__20240630_z9rzveonpwId" title="Sales and marketing expenses">351,298</span> and $<span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20220701__20230630_z0jX5FMWia67" title="Sales and marketing expenses">454,995</span> in sales and marketing expenses for the years ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zIQSJwWrJf2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income
Taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their
respective tax basis and operating loss, capital loss and tax credit carryforwards. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes
the enactment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized
income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or
measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to
unrecognized tax benefits as a component of general and administrative expenses. Our federal tax return and any state tax returns are
not currently under examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted ASC 740-10, <i>Accounting for Income Taxes</i>, which requires an asset and liability approach to financial accounting
and reporting for income taxes. Deferred income tax assets and liabilities are computed annually from differences between the consolidated
financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on
enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances
are established when necessary to reduce deferred tax assets to the amount expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z96cGrTCLI9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Inventory</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consists of only finished goods and are stated at the lower of cost and net realizable value on a &#8216;first in first out&#8217; basis.
Cost comprises of direct materials and delivery costs, direct labor, import duties and other taxes, and an appropriate proportion of
variable and fixed overhead expenditure based on normal operating capacity. Costs of purchased inventory are determined after deducting
rebates and discounts received or receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
in transit is stated at the lower of cost and net realizable value. Cost comprises purchase and delivery costs, net of rebates and discounts
received or receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated
costs necessary to make the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company records an allowance for potentially excess and obsolete inventory based upon recent sales history, the quantity of inventory
on-hand, and a forecast of potential use of the inventory. The Company periodically reviews inventory to identify excess quantities and
part numbers that are experiencing a reduction in demand. Any part numbers with quantities identified during this process are reserved
for at rates based upon management&#8217;s judgment, historical rates, and consideration of possible scrap and liquidation values which
may be as high as 100% of cost if no liquidation market exists for the part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zUdhu2Begd8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Receivable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Account balances deemed to be uncollectible are
charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. At June 30, 2024 and 2023, the Company has considered an allowance of $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240630_z9RoaSTTwa9f" title="Allowance for doubtful accounts receivable">585,672</span> and $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20230630_zi3SvUbDEE6d" title="Allowance for doubtful receivable accounts">426,971</span>, respectively, for
doubtful receivable accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zHyXa7tPTC3b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property
and Equipment</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment is stated at cost, net of depreciation. Depreciation is provided over the estimated useful lives of the related assets
using the straight-line method. Depreciation expense totaled $<span id="xdx_90B_eus-gaap--Depreciation_c20230701__20240630_z94WZe1bFtN1" title="Depreciation expense">10,385</span> and $<span id="xdx_90C_eus-gaap--Depreciation_c20220701__20230630_zCOmyPPoeVX3" title="Depreciation expense">12,268</span> for the years ended June 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z7eUSUczlSPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment
of Long-Lived Assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
impairments of long lived assets are reviewed when events or changes in circumstances indicate a potential impairment may exist. In accordance
with ASC Subtopic 360-10, <i>&#8220;Property, Plant and Equipment &#8211; Overall&#8221;</i>, impairment is determined when estimated
future undiscounted cash flows associated with an asset are less than asset&#8217;s carrying value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zXuSjj2WQo4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intangible
Assets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s intangible assets consist of brand names and goodwill. At June 30, 2024 and 2023, the Company had brand names and goodwill
with costs of approximately $<span id="xdx_906_ecustom--BrandNames_iI_c20240630_zQDuWHJcvyq8" title="Brand names cost"><span id="xdx_907_ecustom--BrandNames_iI_c20230630_zsW6SEMq3DCj" title="Brand names cost">337,504</span></span> and $<span id="xdx_900_eus-gaap--Goodwill_iI_c20240630_zvu9LfTRBLgb" title="Goodwill"><span id="xdx_909_eus-gaap--Goodwill_iI_c20230630_zTZLYCKQT3A3" title="Goodwill">1,161,052</span></span> respectively, which all have indefinite lives. The Company evaluates intangible assets
with indefinite lives for impairment at least annually or when events or changes in circumstances indicate that an impairment may exist.
The Company determined that <span id="xdx_909_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20230701__20240630_zx5XQfHmgU0d" title="Impairment of intangible assets"><span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20220701__20230630_zNR1ESCIpFCh" title="Impairment of intangible assets">none</span></span> of its intangible assets were impaired in the fiscal years ended June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Common Share</a></td>
<td class="text"><p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zgdajUijfRM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Net
Income (Loss) Per Common Share</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes income (loss) per common share in accordance with ASC Topic 260, <i>Earnings Per Share, </i>which requires dual presentation
of basic and diluted earnings per share. Basic income or loss per common share is computed by dividing net income or loss by the weighted
average number of common shares outstanding during the period. Diluted income or loss per common share is computed by dividing net income
or loss by the weighted average number of common shares outstanding, plus the issuance of common shares, if dilutive, that could result
from the exercise of outstanding stock options and warrants. <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230701__20240630_zXOaFnm78TS" title="Potential dilutive common shares">No</span> potential dilutive common shares are included in the computation of any
diluted per share amount when a loss is reported.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (loss)</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z48yciGiVuoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comprehensive
Income (loss)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 220, <i>Comprehensive Income</i>, establishes standards for reporting comprehensive income (loss) and its components.
Comprehensive income or loss is defined as the change in equity during a period from transactions and other events from non-owner
sources. The component of comprehensive loss totaling $<span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20230701__20240630_zpfmdYobXYii" title="Foreign currency translation adjustment">13,673</span>
and $<span id="xdx_900_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20220701__20230630_zPWTqaR0gQb9" title="Foreign currency translation adjustment">27,063</span>
for the years ended June 30, 2024 and 2023, respectively, related to foreign currency translation adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currencies</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zbFHXOWfguFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
Currencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determined that its functional currency is the Australian dollar since the Australian dollar is the currency of the environment
in which the Company primarily generates and expends cash; however, the Company&#8217;s reporting currency is the U.S. dollar. Foreign
currency transaction gains and losses represent gains and losses resulting from transactions entered into in a currency other than the
functional currency of the Company. These transaction gains and losses, if any, are included in results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_z1M4V5P1r2lh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for leases in accordance with ASC Topic 842, <i>Lease</i>. Operating lease right-of-use assets represents the right
to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum
lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental
borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense
for minimum lease payments is amortized on a straight-line basis over the lease term and is presented on the consolidated statements
of operations and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
permitted under ASC Topic 842, the Company has made an accounting policy election not to apply the lease recognition provision to short
term leases (leases with a lease term of 12 months or less that do not include an option to purchase the underlying asset that the lessee
is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis
over the lease term. The Company did <span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20230701__20240630_z2aGYYDPEWQj" title="Short-term leases"><span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20220701__20230630_znwvMIWi5Udb" title="Short-term leases">no</span></span>t have any short-term leases at June 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Convertible notes</a></td>
<td class="text"><p id="xdx_841_eus-gaap--DebtPolicyTextBlock_zY9ye2PWHI03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Convertible
notes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for convertible notes deemed conventional and conversion options embedded in non-conventional convertible notes which
qualify as equity under Accounting Standards Update No. 2020-06, <i>Debt-Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts
in an Entity&#8217;s Own Equity </i>(&#8220;ASU 2020-06&#8221;), which simplifies the accounting for certain financial instruments with
characteristics of liabilities and equity, including certain convertible instruments and contracts on an entity&#8217;s own equity. ASU
2020-06 removes the separation models required for convertible debt with cash conversion features and convertible instruments with beneficial
conversion features. It also removes certain settlement conditions that were required for equity for equity contracts to qualify for
the derivative scope exception and simplifies the diluted earnings per share calculation for convertible instruments. Accordingly, the
underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt
discounts under these arrangements are amortized over the term of the related debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zJvY2BiWmNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Warrants</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the warrants under ASC 815, <i>Derivatives and Hedging </i>(&#8220;ASC 815&#8221;), and determined that they did not
require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair values,
by using the Black-Scholes model when the warrants are granted. During the fiscal year June 30, 2024, the Company has issued <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zsX6QLjzmDP7" title="Issued warrants, net basis">30,000</span>
warrants on a net basis, and <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zYjkHZxiOdla" title="Number of warrant issued">5,645,455</span> warrants, respectively, to the IPO underwriter and the Convertible Notes noteholder. All of the
warrants were fully converted into shares during the fiscal year June 30, 2024. They were all converted based on cashless basis and have
been converted into <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zoW9zluA01dd" title="Converted warrant">19,750</span> shares and <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zvlj1x6bVhI9" title=" Warrant converted into share">4,892,727</span> shares respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FITELL
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zR89hiLUuXQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent
Accounting Pronouncements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on
the consolidated financial statements, and the Company does not believe that there are any other new accounting pronouncements that have
been issued that might have a material impact on its financial position or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_GoingConcernPolicyTextBlock', window );">Going Concern</a></td>
<td class="text"><p id="xdx_849_ecustom--GoingConcernPolicyTextBlock_zhhzDz1h17we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Going
Concern</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will be able to continue
trading, realise its assets and discharge its liabilities in the ordinary course of business for a period of at least 12 months from
the date that these consolidated financial statements are approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Directors note that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group made a loss of $<span id="xdx_90D_eus-gaap--NetIncomeLoss_iN_di_c20230701__20240630_z7PwMAYZxsXc" title="Net income loss">9,312,145</span> from its continuing operations for the year ended June 30,
                                            2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group held cash and cash equivalents of $<span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240630_zkfAI461Ib04" title="Cash and cash equivalents">939,014</span> as at June 30, 2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Group incurred a net cash outflow from operating activities of $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230701__20240630_zLb6uYGVooMi" title="Net cash outflow from operating activities">12,253,539</span> for the year ended
                                            June 30, 2024;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            successful capital raising (IPO) in August 2023 arose for $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230701__20240630_zlZzxonGwjXl" title="Issuance of common stock">13,614,983</span> before cost of capital.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the appropriateness of using the going concern assumption, the Directors have noted:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
                                            are reasonable grounds to believe that the Company will be able to continue as a going concern
                                            as the Directors are satisfied that the Company will be able to either secure additional
                                            working capital as required through raising additional capital or reducing the Company&#8217;s
                                            discretionary spending;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
                                            the directors consider it appropriate to prepare the consolidated financial statements on
                                            a going concern basis.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whilst
the Directors remain confident in the Company&#8217;s ability to access further working capital through debt, equity or asset sales if
required, there remains material uncertainty as to whether the Company will continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Had
the going concern basis not been used, adjustments would need to be made relating to the recoverability and classification of certain
assets, and the classification and measurement of certain liabilities to reflect the fact that the Company may be required to realize
its assets and settle its liabilities other than in the ordinary course of business, and at amounts different from those stated in the
consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zbrWAtnQg7G6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Subsequent
Events</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC Topic 855, <i>Subsequent Events</i>, the Companies evaluated subsequent events through November 15, 2024; the date
the consolidated financial statements were available for issue.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ConcentrationsofVendorsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concentrations of Vendors [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ConcentrationsofVendorsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_GoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Going Concern [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_GoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_PrepaidOfferingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Offering Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_PrepaidOfferingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionLoyaltyPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for customer loyalty programs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionLoyaltyPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691733360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and principal activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock', window );">Schedule of the Company and its Subsidiaries</a></td>
<td class="text"><p id="xdx_898_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zAZhsVtOGGlk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the Company and its subsidiaries are set out in the table as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_ziwBcBbKXaa1" style="display: none">Schedule of the Company and its Subsidiaries</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Percentage of effective ownership</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Name</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Date of incorporation</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2023</td><td>&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Place of incorporation</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Principal activities</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Fitell Corporation</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span id="xdx_901_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_za9zREEZQKv8" title="Date of incorporation">April 11, 2022</span></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_908_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zyCOFRLqjQH3" title="Percentage of effective ownership description">Parent</span></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_903_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20220701__20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zrVcGpcODDYk" title="Percentage of effective ownership description">Parent</span></td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_902_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zQdlS8nwqKNf" title="Place of incorporation">Cayman Islands</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zjXjIOxhY61f" title="Principal activities">Investment holdings</span></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">KMAS Capital and Investment Pty Ltd</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_z3hRSq96jH93" title="Date of incorporation">July 26, 2016</span></span></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zVibSR1cOR5e" title="Percentage of effective ownership">100</span></td><td>%</td><td>&#160;</td>
    <td colspan="2" style="text-align: right"><span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zyXDegyk8Wwb" title="Percentage of effective ownership">100</span></td><td>%</td><td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_903_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zcckMFrif5q7" title="Place of incorporation">Australia</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span id="xdx_90A_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zqUL7glRaf1e" title="Principal activities">Investment holdings</span></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 15%">GD Wellness Pty Ltd</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zPbUYFnBwdoe" title="Date of incorporation">July 22, 2005</span></span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 13%"><span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zSbrjc1a7YAd" title="Percentage of effective ownership">100</span></td><td style="text-align: left; width: 1%">%</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 13%"><span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zCBPwKZfwkdc" title="Percentage of effective ownership">100</span></td><td style="text-align: left; width: 1%">%</td><td style="width: 2%">&#160;</td>
    <td style="text-align: justify; width: 15%"><span id="xdx_90D_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zZaMwOMd1JMa" title="Place of incorporation">Australia</span></td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zFNDkEOL8maf" title="Principal activities">Sales of gym and fitness equipment</span></span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Subsidiaries of Company [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020692122176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in marketable securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zqY8JaNkrKC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2024 and 2023, the Company held some equity securities which are publicly traded on registered Stock Exchanges. The equity
securities being held as of June 30, 2024 and 2023 were valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zezLm7sdIfYg" title="Investment in marketable securities">124,963</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_906_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zKVFPp2jUcUb" title="Investment in marketable securities">494,275</span> respectively. The following tables classify the
Company&#8217;s assets measured at fair value on a recurring basis into the fair value hierarchy: &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BF_zMdqkMGft4kb" style="display: none">Schedule of Assets Measured at Fair Value on Recurring Basis</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at June 30, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Description</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-bottom: 1pt">Equity securities</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvEZtKuJ1H27" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">124,963</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmI1RvqnzPB1" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0736">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zznqeo8Bp622" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0738">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zl2egzj8G3o6" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">124,963</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zX4kmtQFuCll" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">124,963</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z42YydfQ2lWj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zULrCbRv5hmf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zx8xID1OKiW8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">124,963</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at June 30, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Description</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-bottom: 1pt">Equity securities</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCJCRnZ51lJ7" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">494,275</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z6aMo0MjMy11" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpKBE11yQZ13" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUQNdFTbPEu9" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total">494,275</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxo1oTN8VFhc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">494,275</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmWgqANFnVDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOCB5xLwsLk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0762">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGrwJk02w4Sk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">494,275</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691714480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrants</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z27Osr7LE71i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zVeEWUeTc6l9" style="display: none">Schedule
of Warrants</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Contractual Term (in years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Outstanding as June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl7LbqMSYDBl" style="text-align: right" title="Number of warrants, Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7iYr2Sl25F5" style="text-align: right" title="Weighted-Average Exercise Price, Outstanding, Beginning Balance">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%">Granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMFmN1Ae01D7" style="width: 12%; text-align: right" title="Number of warrants, Granted">5,675,455</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrGzWlSoHkLj" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Granted">1.08</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zy8FrtL4KYZ9" title="Weighted Average Contractual Term (in years), Granted">5.0</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuzWMVOUjIBa" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Exercised">(5,675,455</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zx317BbuXLOa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0822">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Outstanding as June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zY0JujF3k1D5" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Ouststanding, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl0824">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6tdc1iFjq66" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl0826">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020690962528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zkHrHygNCJSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s property and equipment at June 30, 2024 and 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zX0BPzo7oCg7" style="display: none">Schedule
of Property and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240630_zqPzPufjjqea" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20230630_zz8st7gQp3n" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zyKeB7OeBCee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; text-align: left; padding-bottom: 1pt">Motor Vehicle</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 14%; text-align: center; padding-bottom: 1pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zIl6FYmYshe5" title="Estimated Useful Life">5</span> years</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">51,741</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">51,741</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzbdW_zdSzExPJk0yl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property and equipment, gross</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,741</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,741</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzbdW_zyTLiZfNDHbd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,608</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(12,998</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzbdW_zI877cMqrynh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27,133</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,743</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691328864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease right-of-use assets and lease liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract', window );"><strong>Lease Right-of-use Assets And Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Operating Right of use Assets and Operating Lease Liabilities</a></td>
<td class="text"><p id="xdx_899_eus-gaap--LeaseCostTableTextBlock_z7diGR7hWIqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
right-of- use assets are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zbSyHoMEwi66" style="display: none">Schedule
of Operating Right of use Assets and Operating Lease Liabilities</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240630_z8WknsJvSLz8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230630_zfuq8aTlSJce" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RightOfUseAssetsForOfficeLease_iI_zhiqXCzHStIc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Office lease</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">836,697</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,541,390</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AdjustmentForAmortizations_iI_zsJX6Wbr891f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(278,899</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(935,596</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zESJ0dHRni16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Right-of-use, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">557,798</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">605,794</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    lease liabilities are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zacSsWYNQJv9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230630_zNZO6lj9hDr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zC0qo7YHYdE6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--OperatingLeaseLiabilityForOfficeLease_i01I_zCsMAC5wtQCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Office lease</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">580,353</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">685,077</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_z5sJvuQBVZEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">278,432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">212,062</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_z973UiSt0dl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">301,921</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">473,015</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zO1BmhNRgKLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zcaODomHCCHh">Schedule of Maturity of Operating Lease Liabilities</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240630_zoRlLsgTAAH4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzYvG_zlDHNGCMXp5k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Year ending June 30, 2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">301,127</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzYvG_z5SoOw7qQHQd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Year ending June 30, 2026</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">310,160</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzYvG_z044FjJ7QmHd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">611,287</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zV7QKS0QdEFb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,934</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseLiability_iTI_zwPZuivlSuua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">PV of Payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">580,353</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020848769136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Provision of Income Tax</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zY8kUMKyxBC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the effective tax rate to the statutory rate is shown below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B9_zey4Pai7f8cb" style="display: none">Schedule of Reconciliation of Provision of Income Tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230701__20240630_zs18L6nifvxg" style="border-bottom: Black 1pt solid; text-align: right">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220701__20230630_z9A0mcQEcnh1" style="border-bottom: Black 1pt solid; text-align: right">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z8aJc3TVMtM5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 1pt">Loss before taxes</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(9,521,488</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(1,619,155</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsTax_znaiwqsugeAa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Expected income tax credit at statutory rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230701__20240630_zCHlPT3bxFlc" title="Expected income tax credit at statutory rate, percent">25</span>% <br/>(2023: <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20220701__20230630_zhpj2PjROZSe" title="Expected income tax credit at statutory rate, percent">25</span>%)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,380,372</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(404,789</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Increase (decrease) in income taxes resulting from:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_zEwqseE5qKti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">140,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses_zFiKXX8cI9Mj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">IPO related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,622</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,601</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt_z2b5pX2Pwvpc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Provision for bad debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144,816</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,742</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_zkN7g8795bXi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Unrealized loss on investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,695</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">131,613</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost_zqGc2MhZLRkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Government Subsidy Tech Boost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,721</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxReconciliationNondeductibleExpenseDebtDiscount_zoabnxNW9Vf7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">277,022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0951">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome_zUN0f0fzz93g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-taxable other income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(30,472</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses_zAUheZ3dBiwl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">-Non-tax deductible personnel expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,544</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0957">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees_zdlrPyauni4l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-tax deductible consulting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,367,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses_zeko93dyfLca" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Non-tax deductible general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">308,512</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0963">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxContingenciesOther_z1RkZtK6PVX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other items, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(26,742</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(20,207</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_zr01HQ1Q6xod" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(209,343</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,761</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Deferred Tax Assets</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zWQcrDJeQtec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax effects temporary differences that gave rise to the deferred tax assets and liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BF_zXR1LzmgNvx9" style="display: none">Schedule of Components of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20240630_zKpglvizraSe" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230630_z0HpqOiPyBca" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_zCC5nGc12gLj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Accrued employee benefits</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">37,199</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,877</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_iI_zxktZAdYfdY9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized loss on investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0976">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,082</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--DeferredTaxAssetsUnrealizedCurrencyGain_iNI_di_zNMV84rbgKPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Unrealized foreign exchange gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,294</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,394</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--DeferredTaxAssetsDepreciation_zO7prOH2xZ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,783</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,049</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities_iI_zryj0QXs4Yve" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating right of use assets and lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0986">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsAccumulatedTaxLoss_iI_zTPtHKunWhQ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated tax loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">238,989</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0989">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zUsJv7Ux7es6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Provision for bad debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">56,784</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">106,740</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iI_zwnXuUX1CPyj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">342,122</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">132,354</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020694548272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of the Company and its Subsidiaries (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FTEL_FitellCorporationMember', window );">Fitell Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">Apr. 11,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAdditionalInformation', window );">Percentage of effective ownership description</a></td>
<td class="text">Parent<span></span>
</td>
<td class="text">Parent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_EquityMethodInvestmentPlaceOfIncorporation', window );">Place of incorporation</a></td>
<td class="text">Cayman Islands<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities', window );">Principal activities</a></td>
<td class="text">Investment holdings<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FTEL_KMASCapitalAndInvestmentPtyLtdMember', window );">KMAS Capital and Investment Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">Jul. 26,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_EquityMethodInvestmentPlaceOfIncorporation', window );">Place of incorporation</a></td>
<td class="text">Australia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities', window );">Principal activities</a></td>
<td class="text">Investment holdings<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of effective ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FTEL_GDWellnessPtyLtdMember', window );">GD Wellness Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">Jul. 22,  2005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_EquityMethodInvestmentPlaceOfIncorporation', window );">Place of incorporation</a></td>
<td class="text">Australia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities', window );">Principal activities</a></td>
<td class="text">Sales of gym and fitness equipment<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of effective ownership</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_EquityMethodInvestmentPlaceOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity method investment place of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_EquityMethodInvestmentPlaceOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAdditionalInformation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This serves as a place to record data that is not required by accounting literature but is useful for readers of the financial statements as it relates to the details of an equity method investment in common stock. Such information may include the amount of change for a change in ownership (equity) percentage in a given period and the amount and type of the consideration given or received in relation to the change in ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAdditionalInformation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the principal activities of an investee accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FTEL_FitellCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FTEL_FitellCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FTEL_KMASCapitalAndInvestmentPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FTEL_KMASCapitalAndInvestmentPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FTEL_GDWellnessPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FTEL_GDWellnessPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691687040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Deferred revenue, revenue recognized</a></td>
<td class="nump">$ 238,351<span></span>
</td>
<td class="nump">$ 501,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">209,100<span></span>
</td>
<td class="nump">$ 238,351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid offering cost</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">$ 5,317,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized loss on investments</a></td>
<td class="nump">354,781<span></span>
</td>
<td class="nump">529,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expenses</a></td>
<td class="nump">351,298<span></span>
</td>
<td class="nump">454,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful receivable accounts</a></td>
<td class="nump">585,672<span></span>
</td>
<td class="nump">426,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">10,385<span></span>
</td>
<td class="nump">12,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_BrandNames', window );">Brand names cost</a></td>
<td class="nump">337,504<span></span>
</td>
<td class="nump">337,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,161,052<span></span>
</td>
<td class="nump">1,161,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive common shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">$ 13,673<span></span>
</td>
<td class="nump">27,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income loss</a></td>
<td class="nump">9,312,145<span></span>
</td>
<td class="nump">1,593,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">939,014<span></span>
</td>
<td class="nump">236,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash outflow from operating activities</a></td>
<td class="nump">12,253,539<span></span>
</td>
<td class="nump">$ 373,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of common stock</a></td>
<td class="nump">$ 13,614,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantOneMember', window );">Warrant One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrant issued</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Warrant converted into share</a></td>
<td class="nump">19,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantTwoMember', window );">Warrant Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrant issued</a></td>
<td class="nump">5,645,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Warrant converted into share</a></td>
<td class="nump">4,892,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember', window );">Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | One Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">23.68%<span></span>
</td>
<td class="nump">28.63%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember', window );">Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Two Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">16.83%<span></span>
</td>
<td class="nump">16.55%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember', window );">Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Three Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">10.66%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember', window );">Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Four Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_BrandNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of brand names.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_BrandNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FTEL_WarrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FTEL_WarrantTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FTEL_OneVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FTEL_OneVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FTEL_TwoVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FTEL_TwoVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FTEL_ThreeVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FTEL_ThreeVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FTEL_FourVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FTEL_FourVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691762496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Assets Measured at Fair Value on Recurring Basis (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total</a></td>
<td class="nump">$ 124,963<span></span>
</td>
<td class="nump">$ 494,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total</a></td>
<td class="nump">124,963<span></span>
</td>
<td class="nump">494,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total</a></td>
<td class="nump">124,963<span></span>
</td>
<td class="nump">494,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total</a></td>
<td class="nump">124,963<span></span>
</td>
<td class="nump">494,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total</a></td>
<td class="nump">124,963<span></span>
</td>
<td class="nump">494,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020692515696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investment in marketable securities (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems', window );"><strong>Financing Receivable, Past Due [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="nump">$ 124,963<span></span>
</td>
<td class="nump">$ 494,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollateralAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems', window );"><strong>Financing Receivable, Past Due [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="nump">$ 124,963<span></span>
</td>
<td class="nump">$ 494,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 80<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479294/326-20-55-80<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollateralAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollateralAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020694466528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 15, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ProceedsFromIssuanceOfConvertibleNotes', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,840,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_CapitalReceivablesOfConvertibleNotes', window );">Capital receivables of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,472,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,108,088<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantTwoMember', window );">Warrant Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,645,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=FTEL_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_OriginalIssueDiscountPercentage', window );">Original issue discount</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt</a></td>
<td class="nump">$ 3,312,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Maturity date description</a></td>
<td class="text">36
months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercise term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ProceedsFromIssuanceOfConvertibleNotes', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_CapitalReceivablesOfConvertibleNotes', window );">Capital receivables of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,472,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ConvertibleNotes', window );">Convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 820,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Shares issued upon note conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,090,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,108,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=FTEL_ConvertibleNotesMember', window );">Convertible Notes [Member] | Warrant Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="nump">5,645,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 1.056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_WarrantSharePricePercentage', window );">Warrant share price percentage</a></td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_CapitalReceivablesOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital receivables of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_CapitalReceivablesOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_OriginalIssueDiscountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Original issue discount percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_OriginalIssueDiscountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ProceedsFromIssuanceOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ProceedsFromIssuanceOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_WarrantSharePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant share price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_WarrantSharePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FTEL_WarrantTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=FTEL_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=FTEL_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020693067856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Warrants (Details) - Warrant [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of warrants, Outstanding, Beginning Balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding, Beginning Balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Number of warrants, Granted</a></td>
<td class="nump">5,675,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted', window );">Weighted-Average Exercise Price, Granted</a></td>
<td class="nump">1.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Contractual Term (in years), Granted</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Number of warrants, Exercised</a></td>
<td class="num">(5,675,455)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised', window );">Weighted-Average Exercise Price, Exercised</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of warrants, Ouststanding, Ending Balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable', window );">Weighted-Average Exercise Price, Outstanding, Ending Balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments eeighted average exercise price granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non options equity instruments weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by sharebased payment award non options equity instruments outstanding weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020693178528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 1.0560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected average volatility</a></td>
<td class="nump">27.76%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.84%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantOneMember', window );">Warrant One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued</a></td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Warrants converted into shares</a></td>
<td class="nump">19,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantTwoMember', window );">Warrant Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued</a></td>
<td class="nump">5,645,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Warrants converted into shares</a></td>
<td class="nump">4,892,727<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FTEL_WarrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FTEL_WarrantTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FTEL_WarrantTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020689758688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note Receivables (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 02, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Loan lended amount</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Loan period</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DebtInstrumentIncreaseAccruedInterestPercentage', window );">Annualized interest</a></td>
<td class="nump">6.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Note receivable outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DebtInstrumentIncreaseAccruedInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument increase accrued interest percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DebtInstrumentIncreaseAccruedInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020689599952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 51,741<span></span>
</td>
<td class="nump">$ 51,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(24,608)<span></span>
</td>
<td class="num">(12,998)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">27,133<span></span>
</td>
<td class="nump">38,743<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 51,741<span></span>
</td>
<td class="nump">$ 51,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020692182496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 10,385<span></span>
</td>
<td class="nump">$ 12,268<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020693011280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Operating Right of use Assets and Operating Lease Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract', window );"><strong>Lease Right-of-use Assets And Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_RightOfUseAssetsForOfficeLease', window );">Office lease</a></td>
<td class="nump">$ 836,697<span></span>
</td>
<td class="nump">$ 1,541,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_AdjustmentForAmortizations', window );">Less accumulated amortization</a></td>
<td class="num">(278,899)<span></span>
</td>
<td class="num">(935,596)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use, net</a></td>
<td class="nump">557,798<span></span>
</td>
<td class="nump">605,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_OperatingLeaseLiabilityForOfficeLease', window );">Office lease</a></td>
<td class="nump">580,353<span></span>
</td>
<td class="nump">685,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">278,432<span></span>
</td>
<td class="nump">212,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long term portion</a></td>
<td class="nump">$ 301,921<span></span>
</td>
<td class="nump">$ 473,015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_AdjustmentForAmortizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for amortizations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_AdjustmentForAmortizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_OperatingLeaseLiabilityForOfficeLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease liability for office lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_OperatingLeaseLiabilityForOfficeLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_RightOfUseAssetsForOfficeLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right of use assets for office lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_RightOfUseAssetsForOfficeLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020692139680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Maturity of Operating Lease Liabilities (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract', window );"><strong>Lease Right-of-use Assets And Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Year ending June 30, 2025</a></td>
<td class="nump">$ 301,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Year ending June 30, 2026</a></td>
<td class="nump">310,160<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">611,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(30,934)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">PV of Payments</a></td>
<td class="nump">$ 580,353<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020690520208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease right-of-use assets and lease liabilities (Details Narrative)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract', window );"><strong>Lease Right-of-use Assets And Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePaymentsUse', window );">Operating lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_AnnualEscalationRate', window );">Annual escalation rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncrementalBorrowingRate', window );">Incremental borrowing rate</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 284,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_AnnualEscalationRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual escalation rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_AnnualEscalationRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncrementalBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental borrowing rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncrementalBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePaymentsUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePaymentsUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020691151888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Reconciliation of Provision of Income Tax (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes</a></td>
<td class="num">$ (9,521,488)<span></span>
</td>
<td class="num">$ (1,619,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Expected income tax credit at statutory rate of 25% (2023: 25%)</a></td>
<td class="num">(2,380,372)<span></span>
</td>
<td class="num">(404,789)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices', window );">Stock issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">140,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses', window );">IPO related expenses</a></td>
<td class="nump">12,622<span></span>
</td>
<td class="nump">27,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt', window );">Provision for bad debt</a></td>
<td class="nump">144,816<span></span>
</td>
<td class="nump">106,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments', window );">Unrealized loss on investments</a></td>
<td class="nump">88,695<span></span>
</td>
<td class="nump">131,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost', window );">Government Subsidy Tech Boost</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(6,721)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount', window );">Debt discount</a></td>
<td class="nump">277,022<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome', window );">Non-taxable other income</a></td>
<td class="num">(30,472)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses', window );">-Non-tax deductible personnel expenses</a></td>
<td class="nump">29,544<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees', window );">Non-tax deductible consulting fees</a></td>
<td class="nump">1,367,032<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses', window );">Non-tax deductible general and administrative expenses</a></td>
<td class="nump">308,512<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingenciesOther', window );">Other items, net</a></td>
<td class="num">(26,742)<span></span>
</td>
<td class="num">(20,207)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax credit</a></td>
<td class="num">$ (209,343)<span></span>
</td>
<td class="num">$ (25,761)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation non deductible expense debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense government subsidy tech boost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense ipo related expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation non tax deductible consulting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation non tax deductible general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation non tax deductible personnel expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation non taxable other income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense provision for bad debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense stock issued for services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense unrealized loss on investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingenciesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in other income tax contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingenciesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020693578784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of reconciliation of provision of income tax (Details) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Expected income tax credit at statutory rate, percent</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020694469600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Components of Deferred Tax Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Accrued employee benefits</a></td>
<td class="nump">$ 37,199<span></span>
</td>
<td class="nump">$ 1,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities', window );">Unrealized loss on investments</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">22,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DeferredTaxAssetsUnrealizedCurrencyGain', window );">Unrealized foreign exchange gain</a></td>
<td class="nump">10,294<span></span>
</td>
<td class="num">(1,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DeferredTaxAssetsDepreciation', window );">Depreciation</a></td>
<td class="num">(6,783)<span></span>
</td>
<td class="nump">3,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities', window );">Operating right of use assets and lease liabilities</a></td>
<td class="nump">5,639<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FTEL_DeferredTaxAssetsAccumulatedTaxLoss', window );">Accumulated tax loss</a></td>
<td class="nump">238,989<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Provision for bad debt</a></td>
<td class="nump">56,784<span></span>
</td>
<td class="nump">106,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 342,122<span></span>
</td>
<td class="nump">$ 132,354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DeferredTaxAssetsAccumulatedTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets accumulated tax loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DeferredTaxAssetsAccumulatedTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DeferredTaxAssetsDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DeferredTaxAssetsDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets operating right of use assets and lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FTEL_DeferredTaxAssetsUnrealizedCurrencyGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets unrealized currency gain.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FTEL_DeferredTaxAssetsUnrealizedCurrencyGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FTEL_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45020774671568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Due to Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Amount due to related party</a></td>
<td class="nump">$ 38,808<span></span>
</td>
<td class="nump">$ 24,386<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>67
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0-D W%]+:1XFMF4.-V3^!U!+ P04    " #1@V]9847) PX'   !(0  &
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M+ZUOVM'*FJ)JEO%.UNK70HV3DRFO!"^+/)4L!W=2?:@UD@+P&7B_8G7:^%J
MM,K!E"]5H"R:%=PP\(X+ 8;@X]T5>/7MZ_%(*BR-QE&VG?>RFQ<YYH4(W/!*
M+@3XL<I9?JQ@I(S86X)VEEPBK\9?UM49P,'W  6(6 !-GS\<>^#@O6-QJP\[
M]'U@&U:MF3BW^:8;2NQ#FYU[+E9IQBX&RN."U1LVF'SW#0R#'VQVG4C9D95D
M;R7Q:9_\QF5:JNW<V6HSM1L?MN.;G+*9$!*&443'H\VA%1:Y*$D00GNY(X!T
M#Y!Z 4ZYD$TPSSG/!5"AGMM =CKHP>1#%,<P"(,>2IM@B&B,H!UFN(<9>F'^
M5#?[:57S62%M $-C7DAC&L&^%TTY!"-, @>\: \O\@;S-A54<\ >%8$(1UA'
MIPSK$RD[LC?>VQL_$3654#S0&#QC]KB.#4]3$L80A;T5\4YD-P-X+$CV%B3^
M@&*56K*RS=QIKHBC$+)90I6Z=TMHLRHQXX=0E%#2L\J4B]5^(8XP@X%FH\ +
M^Y;5@E<5*[THMTH.IT\H)!3V4-KD0HH3ZH!Y0)K0"_,N+5G'BJKV^<R.=H85
M,#2 8 I1$O<!FW*$DL0)&&G R M8;^"2J:)G!]:*%9DQ$!,8)GVLIAQ,X@02
M!U9-G-#+6)-W1=84&9Z]MU5P.'5(8VP@_ IF].T]J%D1^FGQBBF-6=%63UY?
M$].' 8[[6=TFAE 8.SRMN1'ZR;%C;VXD=RM4D_H2&I-#@MZ"-041A4D$L0.N
MYDCH)\FVYIS5?+F#K+*T%:K)@D-52\0TB/I8+9*8A!@ZJ@ZH"1,^P9ARP6I0
M5!E?,O!JY]C75MJ$)^7-4VD[-EPS)_13Y_7M>U4/EFT_X8TGDT"'-* (]Y?(
M(A>&B$!7]&N&A'Z*_%BIOK<L_E% RR:RU%8MJ@T3LNV K)A-VAMB2J+8(!Z+
MH*)1$CM (TV0R$^0AW%E@XA,RH,(QG$_-UKDDCAV\ S2Q(C\Q'A=2::B2OH0
MFAR':-0O,"Q2*H>XW*=Y$/EY<(_/DY2126Q#B B"I-\-V"03% >! Z:F0.2G
MP&UB;M?:MXF0281#2)$J+/H1:95$D6)V1UI&FNR0G^S:M'S/9KQF0*:/#J0F
MA0T3JGP:]VL@FR0,80*I*SHUWR$_WUUWZ5B!5'@KYNBUD*W)"Q),^JG)*DBC
MT%$%(TUTR$]TOS+9IB0K.@ME)8JP5/G;AV>1A#3!.'&4:$BS&_*2R.2M6NMB
M7H%L7=>LRKX U5M4HNSJG33_:]TE42O^R((*AY'A7(L<BH+0%:Z:H-!3O=WA
M.9;3S;%Q'J'<K#I]:,2K11*&*" T<D#5#(7\#'69BB+KR$D5/$ L4K7%E(<K
M7WQT*N-#.,%9V&]+[6*N8PRL^0G[^>FJ*-=RQZC/!KU5^A1HNY@3M&8M[&>M
M3^UAKT*=;E1=.6<=:%41K*60JLMK:N-A<UI<9%;T%JXB 0J0T9!:)*,(DH0F
M#A,TL6$_L3W/A+Q;':L1EG;.880IZ3?BX,C43WLWK,X6#5C5H6[/3\$?-VQY
MS^H_K9A/>X[Z?QRD8DVCF/R' V,O!;_8TA-I.[94TS!^3MOI.S3>*CC,J3BA
M81+VFTV+( EP&!!'[L6:@[&?@[LC'CX#[5G@,KTO&;BM>;[.I/ 'I5?OBY?J
M1-J.O:")'OO;6']0GK1O/96V8TMU68#]9<$S@M+L1#&-*398RI1#"&-7H8UU
M.8#]Y< N);9'(/J4;-K>$K+ZB;#TZG[Q8IU(V_&EDZXR2/#U84F\%<I++3V5
MMF-+=6E"_*7),R[8H)$"(56M7?^LRR)'<1+C_E'7Z. R6475O+UC%R#CZTIV
MM['[M_M[_#?M[77O_24\GW:W\5I-]\\!-VD]+RH!2C93*H.S2.V5NKMO[QXD
M7[57UO=<JM!NORY8FK.Z$5"_SSB7NX=F@OU_/4S^!5!+ P04    " #1@V]9
M)V&=0IT&  #:*P  &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;+5::Y/:
M-A3]*QK22=J9;+#\5L(RDRRVD\ZDV=EMV@^=?A!8N[@Q-I'$DOS[2L8!; GQ
MJ)J="1CN/5>^YUX]#AZM:_J%S0GAX-NBK-CU8,[Y\O5PR&9SLL#L5;TDE?CF
MH:8+S,4E?1RR)24X;YP6Y=!UG'"XP$4U&(^:SV[I>%2O>%E4Y)8"MEHL,/W^
MCI3U^GH !S\^N"L>YUQ^,!R/EOB1W!/^>7E+Q=5PBY(7"U*QHJX )0_7@[?P
M=>:ZTJ&Q^*,@:[;W'LA;F=;U%WGQ(;\>.')$I"0S+B&P>'DB-Z0L)9(8Q]<6
M=+"-*1WWW_] 3YN;%S<SQ8S<U.6?1<[GUX-X '+R@%<EOZO7[TE[0X'$F]4E
M:_X'ZXUM& W ;,5XO6B=Q0@61;5YQ=_:1.PYB!O5.[BM@]MS\+P##E[KX/4=
MP@,.?NO@]QT.W4/0.@3]>SCD$+8.8<\!'KJ'J'6(&K(VV6VHF6".QR-:KP&5
MU@)-OFGX;;P%(T4E2_&>4_%M(?SX^*:N6%T6.>8D!_=<O(@ZXPS4#^*JGGV9
MUV5.*'L!DJ^K@G\'5^#S_03\_-,OHR$7X27(<-:&>K<)Y1X,M5B(XFM@P5\?
MR6)*Z-\:F!LSS/UJRF:T6#:5?$=FI'C"TY*8$"=FQ+=Y7D@T7();7.17105N
M\++@XMH FAP!_73S ;SEG!;3%6\&R&L!3T5V3:BI&?6.<#&]"*H23*NB>F0F
MK,R,]7LM[K#K-A35LRTA=UM";H/C'\!YATM<S0C '/RZJEX!SWD)7,=U=16R
M00H;)#E+/HTCQQD-G_;I5VVN@K!K,U%MH(\BA'I8B6KGA@BAKE6J6B$((S_J
MFF4:,-^+O'@7M),_;YL_SYP_\EA4DDPQIS:9? G87!0*.RFC&^R@FU'YKY=5
MXQCD@O>:+?&,7 _$BL8(?2*#,="UT@4XSY_!T'FC:R&;8*E-L,P26*<@_&U!
M^,:"V,R0!6,KT>ABMP%D@&)&F(Y_7^T$Z/:X-X8[@WM?J;4@0"B.XU[768J7
M6L+)U!P%8;='.CP%6YZ"RWCZT< ZO@(EAX(O3;\:0Y]9S1.;8(E-L-0F6'8\
MMQV>PRW/H9EGPGG9[(ODMH@UK+.]78B.9B/BZ:5[$ZHMUU\+51-EO4PL#2>U
MA)/]=YP.D]&6R<C(I#B]B+-))3;65&S$9M\!I[AB)=Z<BO)_Q'Y;TJPCU A\
M!J&6<":6<))(K1XW<D*OMT6R%"X[&J[#:[SE-3;R^ILXLY<UTTZX1L\SB+.$
M,[&$DUC"26.5$1@@ST-^;_M[@F&'/+0E#UUR?O!T9")E)8^5W8XQVAE$(<W.
M&D6QVXN7J'9782]WJ<XFAJ%RQ%#M0A^&R#W0']#9'?,=8Y*3*C_AA*'->8L<
M=).NV;*8AW!&YB\!.KQ?L8J66D7+;*%UJV)/_('_UWIH1CYC7K4%-+$%E+1
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M=DZPF*NE@?C^H19;LO9"/AJY?9QW_"]02P,$%     @ T8-O6:EB"R4K"
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MD6KDI7SY EC,+\(O3-N:#7^D-IIN: ">+PW\L_M"&X3_,\++_P502P,$%
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MP\';LPALTZL;@TP5^N/*$'?;,"WX>4/K'7A_;0SM#1^@>S!G/P!02P,$%
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M_[K?<T UHMDX1I:U4#U)0[)7FQG]9U#9!%I/I31'QV[0_KG&OP%02P,$%
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M.S;'1_2OACMR61%)QSS]P=9J-VA%+5C3#2E2]< /?]"*3ZCQ$IY*\PN'TC9
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MNQ>VROYT_%!\;YX=*Z[P$6.&.WPU4J$-<'W#N3I^Z #U.W3X#U!+ P04
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M:N!:J[:!S[6H7?[UR7&6)-&%2_EI?/%F $P"2EM394LW1$.AA""'%G1K-#E
M+<%62+?\I](.9"JFL5*<H$>;W*42#9//L&8&7D&:#;(H@V0T2+.SEXXZW#&(
M0+WRSX"A#:FISBO]:O_23#N#_8%WS]0-TZN:3H7CDDJCX=O3 '1G_2ZPJO%V
M6RA+YO73BEY+U Y ^:52=ANX#?KW-_\-4$L#!!0    ( -&#;UF&-2H]W!D
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M%-HR9PA*!#?DJBS36O-Y=S*MA82[ %W0$@E:,A(#,C=S,C=[4N8RQ/#2$?2
MT W".2QT6;0/_)E2!V0NVUP2/7MO,%($TK)-JQV1L("?=;O015ZD-<C52%R4
M)4!J9'V<F?M ]RN=DOM@N5ND)7):@[ T#R@O3T$-1$N6!=AO.D2[A:-EX4$'
M&31W#)H/,@A(E\%Q:Z\Z]R &JM9]/!H$U<^C+OS(PQ?O0#E!'9C^.@/B6R&$
MTQH99$L=(\EJT"KXUSPH!^%A761.>;2 <$-L%-X#>BXFXW_ML[!1#>P"-@0,
M@0:K4%1Y<5_D+>I83*R NW<6(,%+IJ/YF9C,1V=3D9R-YE/\/)L!]-%\+N9C
M,3L;XL*IX\+I\[E Z@+VI&C$IT)_[6/$(+1G,"+J;B'>6P4 FH#W:ED#@(X-
MN/(&OA1DAT!*_X+(:(^H*)5[,I0Q[!IA(]>R5*]CSZE:9K*X3Q>E)*HK9&_P
M(^@-K$1KN*S5AO2CPF@*["F:6*DU!V9DV]E^66RV98JJADMP3S28#W@*0&8!
MRB3OX2)@O) &Q6.(_YKU+K  2("B:>DHHRB$#<=L:@B=.J>SC@N ]AVO6=>J
M7:WMDG2[K=5]6NK8_H(*;GS@1H%95S5[ 97)'+T@'2^R*  P\!(278(&"=9X
MFCW[5<MJ!2X%F$!$H&A0UK1#3+&H,25+("$J$?A:@ J:8%Q7<+A82+"'B[*
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MX@,0KHPF/X$\;5MCJ=LJS?\"N0;>_MTJ_$-L-*DB-I*!2/57:4K5$,6#A<:
MQ)1)X+=.E>0^A>B8BFE<+]EX!,C>C@P6R?.PP#VUB;@/%&8>(1KWP/!X/P(8
M]0"T1[;.@42/=X&8GO%61KU ?;O[N45J@7Q#:G"Z81:"//H 5*&+JVNU4#65
MD1:[8)G! PF76L)-]P@7W&W@L]FJY;+LEL;0H" 5FAT&*Y/3-W"&AZI34U.F
M\MRMLSD\0-. B 5H))"-8]U64Q:#1W=]1"1K*!B[KME=2'#[7E"*BD<N7.IH
MRU= (11D9YZM)^B6O4W=/Q8^1  +)<CY5TU7.*FH7]<%1N6-6$/XH6H2"O2C
MG%29LE%$1>]OIO0(6 ,B'AMLBV5IJYW7T&N@[S'8D@UDEXVI*;+E#7#\)Y,Q
MW]N<##<W ^, .+H>"@B5P[/77+V@U1F8JT-;D>FZ:Q>-L5XS" _C [<.'=]W
M#B=/M ZQP8+*2!^NP',#1P\>^B6]0X ;]6W0R5DH^LTIYP1A74-F#X%G6<#=
M:"8@X&CXS-QIKWRY98/BA2I% E9+B1T8'#=!?<,FDVD4X>;2;S[LWWS';S+<
M\ON#[ "IK1]4Z*7<"YI]'GCD@7>+26'7-"23,]F$FO:K^XJRD(=89SD[(&LC
M,9V=Q*=GD#XGY_')V6"_=.+[,Y/A!LU%#OE]XS,(B',WZF"^_()63;!!U-F@
M0\:EPIH@6W8:>B)IH@S&-=1L8I%ZB+&A,7VDL*Z%,"OC?(E=A;*-#*QZV RL
M4T:.UG#E>R OY"OG9^($R'Q^/ALDKV]43(8[%=?<'?B<?CL@E"_H43#,B& *
M\Z6A+X?R7.\"P\!B!Y%0L\:"G*N& 9B#S:9:A@4L!$ZUH)9\"RX,&I,0P31-
M72Q:EGY@ K>$Y*,!CJ>Z=.0==R2=OD\EOX&?I-\.-]/(049 M*WD4 Q1Y"(E
MI?);[.,@C%)I;".GVP(+5?B-U^.)N&]**,"!'[#X\GQJF3@SCWB>2580K9E5
MW$)"P<QLTWN[+6D( "Z;&(0DQY2[N=96V 00V 8"#12"( HG"$/JXM8AY 7S
MC<IX$>5_35-:%9#<K 1MS)]Q*E0^8::_$#%WDF[=WG?%#/:F3L]9IFE^4:Y&
M- D"\=YJ*5L%B^G2PL;=J8!JPD0@'Q5&D3+^=V($#K.4Q5?L]U-PC*$S %I(
M*OM#D \Q'%+DDSM#U+M)R%6;39189,'HD<339=*K6J:-#<9GXW_9_=VV<+W$
MG4;BD@A*W*V#MJ.JHS!38?VC -H/L!G"!G(A _[\U>8K6JLR,'OZ<>\,:XDT
M=44'H*P8'#JQVE><HK8*"]>H1;*22YHUX'D$D,**MEG:63ONC.>;HBHTS;/<
M2]=/'HF;%B)7F=.-)$/4 >(U@!GI?G"!Z!XASTP$#61DNR:_I336]:C%@Q8]
MS17-^J%S/:4B7[Q?"@VM\S\7"">^*Y$,=R6N(7ZH( '8];F*X;6'7(4!*-RG
MR%0Y29M):Y;(I350BDM$Q(9:,AN\F%-EB,82C*Q4LC%"3/;*Y$3 1BH\3^9O
MED6-S3O,CO"#:AN3Y+$9'D58LR7QJ0O-UH4+GJX&8L8BN FQXP@@MC=!JJ9J
MR+'0!H+]:)WE-UDP,C4V0L4#0[ /567@$^:>5 :-L%7K)JB6Q3=,"F&WM4S-
M" 1X /1P+E\T(U3>@8#K2#-PIR-3A(9SV-DXCIR9 TC37&)"AL;&-%YRB8U;
MC(UJN7 S);Z&[%I#*ASL&G$1GWJA6.WBSNE+&,8X!TRPF/=2'B'0F$@/JM$A
M5#_*)GHD)X4QZBZO[I07K7D# P7J3?N#_:*4S4VN<6;1@>$BQ*#0;4N%[JZ(
M[ZH 0ZT1MAWKL1,$C[U035H1#$FA[0CG^>2W3)JP02T@G $N!XP/AL60+F H
MN7#,R?Z.JXI_XSBV2:+<TDA5QVN>_$(QQGTAR:<.A=]?!$F_6[DWS4=N LL*
MU$NXQ\<K @2Q(DW%J*4[BD''J%2$5191M9L%IH>NF(3J41<0=5 H!H!)EKF[
ME<L-+!R)"]P^7$T)3P#>[(P%$#=H!-)!DWO:AIUDSO((Z0Y[<\P1D-4/:;DR
MDO5]<5A3H86Q[_7DTH^+@9?7-'*GLSK=FM 'DU^^PQ19N!*S27<85J6:TF3\
M.QGSF"PI&X0AE>JL-L4JBENUBYV1+H-9<.*[GLEPU_/"IJ&?G.;U^I 7-#PM
MZ,B#?NQK(7HM[!0.6.22&4I6-\6X1)FXB0)A&YS:T4V% YAV.*I%*Y0"]9:@
MP)L@E.7(W.H@"+B%R67_0U#!0.8R'(H-QL)7M6JW,O>V/4]W/,.0HVDT)_>3
MY[D$(;-!]=Z@)J!A&VYX/47KN6A\\DG%5@I]7?3F#0H[ ZR[P)',Z*\!#E@%
M<^S?UBG7I*U=\V9@R787L=]%A7823H,#D'+C@9IG=3:0H\'JCNFCQM[L;!;/
M3Q-QDLSC\]/!QGWB&\;)4PUC=*D-S_)?V=&;7BE^4<.8H4<=Z*+SLY_WZ7A3
MU&GG^W(),"%%Y9CS7?!-L-7BL2<W!^.]$PCVLH4$$WMWUE[;*-N4_?V#+]W9
M&I^G!]M9R:(!"X#Q/1BA>'HV$Y,D3N:#Y:'$=UJ3X4[K]0;']C8FNO^@JM7Q
M!W+R%X1Q+W=>T&_UVT1]VXA;*^51X>XD(I8*,WBZU>:LY##0Q<%O#VM4FGN^
MNS:I$0_^%G76;K#!R9TE]([@M=- H?Q6 @T^&>_>QB=F&*Y@/)USJF&F+ZR
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MV9&H^96*_ 62)WJ-X4(UC=K01QR0D37> ->7"BR]^8(;N!=;OOT_4$L#!!0
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M+ +;]]]^0:8-/6]EB#MHF-;\9*'U!OR_-(9V"Q]@> 3G/P!02P,$%     @
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MI3Q83;N<\NQTINE^M?T )E.X>:UX22=NX?B1S06:D[%OJ8@+]9,5X%4#&.T
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M0&D4Z#P70A\6)L#PB;+Z!U!+ P04    " #1@V]9E&ZRL-($  #5"@  &0
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M<O82O[CVB9E0C_B-LYTZN4;&E7LA/I@O-]GES#.(6,Y2;4PD\/' KEF>&TN
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M%PQ6^O&!77@M^6$W^]T4L&5)4_A&#?)2)^6:UPFJ%!M)SR'-]3<N/"3,$:[
M+0MB-PW>"@TH>9*CC.>54:*PZ$4!&3K.@GC(7 .H$S%EUZN6 K&; Z$M@::C
M!-4/&J1,_T$:DEKE3>DEV5]5LRM;G1L2&*;A@O8=7 S%R\(+Z<AZM&2'W6QW
MMQ%2?ZN9+%#.DK&=>$AU@P5P#>EB:PD.NQGN+;3"O(3T8#7#69$-R2JFF&!_
ML'L-!^(@IC0>V1I(2VO$36O7B=K4K)::"_9W!=R0CU$P&7)53&,/]S<RRSA"
MPXB,D )I.8VX.<W$M 8J*KT">D,K*0HD0*\E-2'7O3G7W)X(9,A5P $!#6C<
M=P /TIHN*![;B4G+:L3-:C>@,VM.AHWNL',8:6V%2VRUA?TXZI>7^Z&?N7^0
ME@.)FP-_-VTY;-Z_0(?YQQM6W#-I[3'=9LZ5SE-9ZSK=<BKQ)V^RB9.FSP[
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M;JNP#!L48>KG8A/Z.!@/Y"IL=G-_/2P8!WC8KX=I605U5H$QJT:9%SNZ_/P
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MD!R]/^[Y:-*P9'Y6+WE9+1F^L.3W4IR2*#@A81#&+?#!_O!H%^X;\8T#8>-
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M>O@=%Q?D*;V 1CS[#P[YN9YM@6#'!8V+8-F"F"3Y.WHH0-0"'/=, "P"X''
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MHW?S-XG 4E< AD3K8V 1_ZW>8M+9^Z;4FDPJX^[HG?LM$CM&Q",()1/97WC
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MPFS0[Y><JX>)(6C[ON0O4$L#!!0    ( -&#;UGHAL->I@(  '<)   9
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;*V6T6Z;,!2&7\5BT]1*6R! :-41
MI+1HVJ:MJEIUNYAVX<!)L&IL9INDV]//-A21BK)D2BZ"C?W_A_/Y8!-ON7B0
M!8!"CR5E<NX42E47KBNS DHL)[P"ID=67)18Z:Y8N[(2@',K*JGK>U[DEI@P
M)XGMO1N1Q+Q6E#"X$4C698G%[TN@?#MWIL[3C5NR+I2YX29QA==P!^J^NA&Z
MYW8N.2F!2<(9$K":.XOI11J9^7;"-P);V6LCD\F2\P?3^93/'<\\$%#(E''
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M\-]8*A"$YT,\QL5!A$K.5"&'*F=4>BBB(YGM()IUB&:C62X8JS$E?W3A$*9
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M G<G<!NC+5ECZQI+G,PXVR*NHU4V?='4IE$K-Z34N[B07-TE2B>3A6J+K*:
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M[9'>#B2KFE-QR:0Z8YO+M?H* JX#U/V<,?D\T =M]UV5_ %02P,$%     @
MT8-O6?Y[W:^+ @  2P8  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL
MG95O;YLP$,:_BL6FJ9/60B"0KB-(_:-IFUHM:M9.>^F$([%J,+./I/GV.YL$
M10W)B[T)-OB>YW=G^Y*NE7XQ2P!DKZ6LS-A;(M97OF_F2RBYN5 U5/2E4+KD
M2%.]\$VM@><NJ)1^& 2)7W)1>5GJWDUTEJH&I:A@HIEIRI+KS0U(M1Y[ V_W
MXE$LEFA?^%E:\P5, 9_JB::9WZGDHH3*"%4Q#<78NQY<W8SL>K?@6<#:[(V9
MS62FU(N=?,_'7F"!0,(<K0*GQPIN04HK1!A_MYI>9VD#]\<[]:\N=\IEQ@W<
M*OE;Y+@<>Y<>RZ'@C<1'M?X&VWQBJS=7TKA?MF[7)J''YHU!56Z#B: 45?OD
MK]LZ[ 6$QP+";4#HN%LC1WG'D6>I5FNF[6I2LP.7JHLF.%'939FBIJ^"XC";
MTB[GC02F"O; L=$"-W;\LP;-450+=@^4-+L7?":D0 &&G=T!<B'-Q]1'0K!"
M_GQK=]/:A4?L?C35!8N"3RP,PB%[FMZQL_=O9'S*H$LC[-((G6YT1+>%=$?J
M7!7G#4VNC0$T[+K*#U/H V\-AOT&]FY<F9K/8>S1X3>@5^!E']X-DN#+"?RH
MPX].J6=_@&L&56[K326"78GB/M!6*G%2]LZMLB@8#,)1ZJ]Z$(8=PO"_$)(^
MA%8JWD<8!%2+?H2X0XA/(OQ2R"4K&CJ%8,^Z*)N22;=W-=]0)\#>C8L/8!(J
MQ^61>B0=3'(2YAZ,8:*L&X2<B0J!=AW[[),#^_,H^!P-^^U'G?WHI/WDV=["
MR8FT1P?'(+X,HCAZX^OO]0;;9A^X7HC*4%T+"@PN1D2NV];53E#5KEW,%%+S
M<<,E=7O0=@%]+Y3"W<1VH.[_(_L'4$L#!!0    ( -&#;UDJ\>M0"0,   D+
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;*U6;6_:,!#^*U8V39VT
MDE<"=! )R*9U:K>J5;?/)CD@:F)GM@/MOY_MA!1HB*#B2^*7N^?N>2YV;KBF
M[(DO 01ZSE+"1\92B/S*-'FTA SS#LV!R)TY91D6<LH6)L\9X%@[9:GI6)9O
M9C@A1C#4:W<L&-)"I F!.X9XD668O4P@I>N181N;A?MDL11JP0R&.5[  XC'
M_([)F5FCQ$D&A">4( ;SD3&VK\*^LM<&?Q)8\ZTQ4DQFE#ZIR74\,BR5$*00
M"86 Y6L%4TA3!233^%=A&G5(Y;@]WJ!_U]PEEQGF,*7IWR06RY'1-U ,<URD
MXIZN?T#%IZOP(IIR_43KTM:7QE'!!<TJ9YE!EI#RC9\K';8<'.> @U,Y.,<Z
MN)6#>ZR#5SEX6IF2BM8AQ ('0T;7B"EKB:8&6DSM+>DG1)7]03"YFT@_$=R
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MRI9@04[(BBR'.4F#<+!FSMG?(&Q7K:&[7%N$+0DC I< LP+@0M^0J;E=F=[
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M]BQBMITGK8&F#BVY,$@-'K8EC6"P/H#.E\;@SO 7]$,]_PU02P,$%     @
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M(Y@#\( A<6S?@SOOHVCUGHK6_^4;_0902P,$%     @ T8-O69>*NQS
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M)VDA+]U&&G@<*H0TM>@<F HZJ8><0R!?,I OTT*N^[:5[B%&SL/& %XF34#
MRO9F OF*@7R5%O+<[)0/\20!1B#OG<*<KI7PJNH=A7S-0+Y._D[NHHTBUP6J
MCV;&?,[E[GE:L*_2.>S3"0_KDL0RB<$1UZI2L(N=..'B%)(G=@A.6# +AX=A
MK'[XMX<N7D#I.'?DB>7Q24FOA(/--KRPS8L>#Z3WT6\15U-,SAYY<GVT+80Q
M&T>P"F=M.(%2F/BF/<W9(T^LCW-3V5;AO/#;E(F319[8%JL>@2R."SU([4K&
M-_$&!ZZ/LK 4D]-%_IR^^*>@F)PP\L3&8-T[Q>24D2=V!BNV"6;!&:0XD$'$
MT<V0L?^@8)Q*BL0J>3IE/XG)+DX2FX7-W=-NYA13)%8,38M/QI 32Y%8+&ML
MH^YQ:&#F"5LE4#2=-&//PW09RJFE2*P6/C^6%).S39'8-C2:[\97\3.^I+U#
M]<@@*"9GFR*Q;?C\.(DF9YLBL6U^F?J+HQ6"@O;B E,GQ>1L4R2V#>WT'RG]
M.RD=Z"4GF_)@LJ$QE'&3;L+(>:<\\!+F)U:*R7FG3.P=VN%/J))BLMMBB;WS
M.XM_CRG%Y Q4'M! <;].QH6-N(Y6CT44DS-0F=I !/.S#+V#\$"0*29GH#*Q
M@?@Y$4WM)6>@,O5ZAT03![S%182&<5D1!Q7%Y Q4)C80Q70_8TYFF"5GH/*
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MT#M'O?-WZAWBM?+AV?-8X_W?276\7>N?M[\O'YN]AW#'V<$OC=4O4$L#!!0
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M";]=DUJ5S=&?=?])YI]02P$"% ,4    " #1@V]9!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -&#
M;UGA1JRV[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( -&#;UF97)PC$ 8  )PG   3              "
M <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ T8-O67/4#N,,
M!P  @2   !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( -&#;UD)^U;?'0<  %0>   8              "
M@4\/  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #1@V]9
M7-HP$(@"   M!P  &               @(&B%@  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ T8-O66%%R0,.!P   2$  !@
M     ("!8!D  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M -&#;UDG89U"G08  -HK   8              " @:0@  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " #1@V]9J6(+)2L(  !%)@  &
M            @(%W)P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ T8-O6?OIKY+L P  <0D  !@              ("!V"\  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( -&#;UE;W"8HC!<  "5!
M   8              " @?HS  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " #1@V]9?YP,S?0"   \!P  &               @(&\2P
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ T8-O6;^]A'X6
M!0  '@L  !D              ("!YDX  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " #1@V]958''+R<#  #P!@  &0
M@($S5   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( -&#
M;UF%5N(D;@(  &4%   9              " @9%7  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ T8-O61>9*4T0 P  Q08  !D
M         ("!-EH  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    " #1@V]9UQ8WLH<$  "3"@  &0              @(%]70  >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( -&#;UF3JL54B@(  ,X%
M   9              " @3MB  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ T8-O61-83^!A!0  NPL  !D              ("!_&0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #1@V]9%[^J
M$78"  "+!0  &0              @(&4:@  >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( -&#;UF&-2H]W!D  .12   9
M  " @4%M  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
MT8-O60WKUP(< P  $ <  !D              ("!5(<  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    " #1@V]93CIA2_H"   W!P  &0
M            @(&GB@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( -&#;UG>$G-7;@(  (<%   9              " @=B-  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ T8-O60_Y1MVY @
M,08  !D              ("!?9   'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    " #1@V]9I%!,_6L#  "N"   &0              @(%M
MDP  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( -&#;UF4
M;K*PT@0  -4*   9              " @0^7  !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ T8-O68@&ND/) P  =!$  !D
M     ("!&)P  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -&#;UF/I[9KU0(  )@)   9              "
M@3FT  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ T8-O
M653B'] 4 P   PH  !D              ("!1;<  'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    " #1@V]9Z(;#7J8"  !W"0  &0
M        @(&0N@  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( -&#;UG[Z^VAU0(  .T)   9              " @6V]  !X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ T8-O6<V*JT56 @  I@4
M !D              ("!><   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    " #1@V]94WW7E $#  !C"0  &0              @($&PP
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( -&#;UG^>]VO
MBP(  $L&   9              " @3[&  !X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ T8-O62KQZU ) P  "0L  !D
M ("! ,D  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " #1
M@V]9>C,TCW8$  "D#P  &0              @(% S   >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( -&#;UD"ZRC+=@(  . %   9
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M  !X;"]S='EL97,N>&UL4$L! A0#%     @ T8-O69>*NQS     $P(   L
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64$L%!@     Q #$ 3@T  *#E      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>91</ContextCount>
  <ElementCount>277</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>31</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/StatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Organization and principal activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/OrganizationAndPrincipalActivities</Role>
      <ShortName>Organization and principal activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Summary of significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Investment in marketable securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/InvestmentInMarketableSecurities</Role>
      <ShortName>Investment in marketable securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fitellcorp.com/role/ConvertibleNotes</Role>
      <ShortName>Convertible Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Note Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/NoteReceivables</Role>
      <ShortName>Note Receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Lease right-of-use assets and lease liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities</Role>
      <ShortName>Lease right-of-use assets and lease liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/IncomeTaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Due to Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/DueToRelatedPartyTransactions</Role>
      <ShortName>Due to Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Summary of significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Organization and principal activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables</Role>
      <ShortName>Organization and principal activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/OrganizationAndPrincipalActivities</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Investment in marketable securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables</Role>
      <ShortName>Investment in marketable securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/InvestmentInMarketableSecurities</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/Warrants</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/PropertyAndEquipment</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Lease right-of-use assets and lease liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables</Role>
      <ShortName>Lease right-of-use assets and lease liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/IncomeTaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/IncomeTaxes</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Schedule of the Company and its Subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails</Role>
      <ShortName>Schedule of the Company and its Subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Summary of significant accounting policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of significant accounting policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Schedule of Assets Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Investment in marketable securities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative</Role>
      <ShortName>Investment in marketable securities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Convertible Notes (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative</Role>
      <ShortName>Convertible Notes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/ConvertibleNotes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Schedule of Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/ScheduleOfWarrantsDetails</Role>
      <ShortName>Schedule of Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/WarrantsDetailsNarrative</Role>
      <ShortName>Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/WarrantsTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Note Receivables (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/NoteReceivablesDetailsNarrative</Role>
      <ShortName>Note Receivables (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/NoteReceivables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Schedule of Operating Right of use Assets and Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Schedule of Operating Right of use Assets and Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Schedule of Maturity of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Schedule of Maturity of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Lease right-of-use assets and lease liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative</Role>
      <ShortName>Lease right-of-use assets and lease liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Schedule of Reconciliation of Provision of Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails</Role>
      <ShortName>Schedule of Reconciliation of Provision of Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Schedule of reconciliation of provision of income tax (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical</Role>
      <ShortName>Schedule of reconciliation of provision of income tax (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Schedule of Components of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails</Role>
      <ShortName>Schedule of Components of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="form20-f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Due to Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Due to Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fitellcorp.com/role/DueToRelatedPartyTransactions</ParentRole>
      <Position>41</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="form20-f.htm">form20-f.htm</File>
    <File>ftel-20240630.xsd</File>
    <File>ftel-20240630_cal.xml</File>
    <File>ftel-20240630_def.xml</File>
    <File>ftel-20240630_lab.xml</File>
    <File>ftel-20240630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>aud_001.jpg</File>
    <File>aud_002.jpg</File>
    <File>aud_003.jpg</File>
    <File>aud_004.jpg</File>
    <File>form20-f_001.jpg</File>
    <File>form20-f_002.jpg</File>
    <File>form20-f_003.jpg</File>
    <File>form20-f_004.jpg</File>
    <File>form20-f_005.jpg</File>
    <File>form20-f_006.jpg</File>
    <File>form20-f_007.jpg</File>
    <File>form20-f_008.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="454">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="48">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>74
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form20-f.htm": {
   "nsprefix": "FTEL",
   "nsuri": "http://fitellcorp.com/20240630",
   "dts": {
    "inline": {
     "local": [
      "form20-f.htm"
     ]
    },
    "schema": {
     "local": [
      "ftel-20240630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ftel-20240630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ftel-20240630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ftel-20240630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ftel-20240630_pre.xml"
     ]
    }
   },
   "keyStandard": 226,
   "keyCustom": 51,
   "axisStandard": 15,
   "axisCustom": 0,
   "memberStandard": 15,
   "memberCustom": 14,
   "hidden": {
    "total": 91,
    "http://fasb.org/us-gaap/2024": 62,
    "http://fitellcorp.com/20240630": 26,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 91,
   "entityCount": 1,
   "segmentCount": 31,
   "elementCount": 409,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 454,
    "http://xbrl.sec.gov/dei/2024": 48
   },
   "report": {
    "R1": {
     "role": "http://fitellcorp.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://fitellcorp.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://fitellcorp.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
     "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://fitellcorp.com/role/StatementsOfStockholdersEquity",
     "longName": "00000005 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://fitellcorp.com/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://fitellcorp.com/role/OrganizationAndPrincipalActivities",
     "longName": "00000007 - Disclosure - Organization and principal activities",
     "shortName": "Organization and principal activities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000008 - Disclosure - Summary of significant accounting policies",
     "shortName": "Summary of significant accounting policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://fitellcorp.com/role/InvestmentInMarketableSecurities",
     "longName": "00000009 - Disclosure - Investment in marketable securities",
     "shortName": "Investment in marketable securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://fitellcorp.com/role/ConvertibleNotes",
     "longName": "00000010 - Disclosure - Convertible Notes",
     "shortName": "Convertible Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://fitellcorp.com/role/Warrants",
     "longName": "00000011 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FTEL:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FTEL:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://fitellcorp.com/role/NoteReceivables",
     "longName": "00000012 - Disclosure - Note Receivables",
     "shortName": "Note Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://fitellcorp.com/role/PropertyAndEquipment",
     "longName": "00000013 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities",
     "longName": "00000014 - Disclosure - Lease right-of-use assets and lease liabilities",
     "shortName": "Lease right-of-use assets and lease liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://fitellcorp.com/role/CommitmentsAndContingencies",
     "longName": "00000015 - Disclosure - Commitments and contingencies",
     "shortName": "Commitments and contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://fitellcorp.com/role/IncomeTaxes",
     "longName": "00000016 - Disclosure - Income taxes",
     "shortName": "Income taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://fitellcorp.com/role/DueToRelatedPartyTransactions",
     "longName": "00000017 - Disclosure - Due to Related Party Transactions",
     "shortName": "Due to Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000018 - Disclosure - Summary of significant accounting policies (Policies)",
     "shortName": "Summary of significant accounting policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables",
     "longName": "00000019 - Disclosure - Organization and principal activities (Tables)",
     "shortName": "Organization and principal activities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FTEL:ScheduleOfSubsidiariesOfCompanyTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "FTEL:ScheduleOfSubsidiariesOfCompanyTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables",
     "longName": "00000020 - Disclosure - Investment in marketable securities (Tables)",
     "shortName": "Investment in marketable securities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://fitellcorp.com/role/WarrantsTables",
     "longName": "00000021 - Disclosure - Warrants (Tables)",
     "shortName": "Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "FTEL:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "FTEL:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://fitellcorp.com/role/PropertyAndEquipmentTables",
     "longName": "00000022 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables",
     "longName": "00000023 - Disclosure - Lease right-of-use assets and lease liabilities (Tables)",
     "shortName": "Lease right-of-use assets and lease liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://fitellcorp.com/role/IncomeTaxesTables",
     "longName": "00000024 - Disclosure - Income taxes (Tables)",
     "shortName": "Income taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails",
     "longName": "00000025 - Disclosure - Schedule of the Company and its Subsidiaries (Details)",
     "shortName": "Schedule of the Company and its Subsidiaries (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_FitellCorporationMember",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FTEL:ScheduleOfSubsidiariesOfCompanyTableTextBlock",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_custom_FitellCorporationMember",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FTEL:ScheduleOfSubsidiariesOfCompanyTableTextBlock",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000026 - Disclosure - Summary of significant accounting policies (Details Narrative)",
     "shortName": "Summary of significant accounting policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RevenueRecognitionDeferredRevenue",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RevenueRecognitionDeferredRevenue",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails",
     "longName": "00000027 - Disclosure - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)",
     "shortName": "Schedule of Assets Measured at Fair Value on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_FairValueMeasurementsRecurringMember",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
     "longName": "00000028 - Disclosure - Investment in marketable securities (Details Narrative)",
     "shortName": "Investment in marketable securities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_EquitySecuritiesMember",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R29": {
     "role": "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative",
     "longName": "00000029 - Disclosure - Convertible Notes (Details Narrative)",
     "shortName": "Convertible Notes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "AsOf2024-01-15",
      "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-01-15",
      "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://fitellcorp.com/role/ScheduleOfWarrantsDetails",
     "longName": "00000030 - Disclosure - Schedule of Warrants (Details)",
     "shortName": "Schedule of Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30_us-gaap_WarrantMember175940953",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "FTEL:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30_us-gaap_WarrantMember175940953",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "FTEL:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://fitellcorp.com/role/WarrantsDetailsNarrative",
     "longName": "00000031 - Disclosure - Warrants (Details Narrative)",
     "shortName": "Warrants (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_WarrantMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "FTEL:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_WarrantMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "FTEL:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://fitellcorp.com/role/NoteReceivablesDetailsNarrative",
     "longName": "00000032 - Disclosure - Note Receivables (Details Narrative)",
     "shortName": "Note Receivables (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "AsOf2023-08-02",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-08-02",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "longName": "00000033 - Disclosure - Schedule of Property and Equipment (Details)",
     "shortName": "Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "00000034 - Disclosure - Property and Equipment (Details Narrative)",
     "shortName": "Property and Equipment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R35": {
     "role": "http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails",
     "longName": "00000035 - Disclosure - Schedule of Operating Right of use Assets and Operating Lease Liabilities (Details)",
     "shortName": "Schedule of Operating Right of use Assets and Operating Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "FTEL:RightOfUseAssetsForOfficeLease",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "FTEL:RightOfUseAssetsForOfficeLease",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails",
     "longName": "00000036 - Disclosure - Schedule of Maturity of Operating Lease Liabilities (Details)",
     "shortName": "Schedule of Maturity of Operating Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative",
     "longName": "00000037 - Disclosure - Lease right-of-use assets and lease liabilities (Details Narrative)",
     "shortName": "Lease right-of-use assets and lease liabilities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "AUD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "AUD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails",
     "longName": "00000038 - Disclosure - Schedule of Reconciliation of Provision of Income Tax (Details)",
     "shortName": "Schedule of Reconciliation of Provision of Income Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical",
     "longName": "00000039 - Disclosure - Schedule of reconciliation of provision of income tax (Details) (Parenthetical)",
     "shortName": "Schedule of reconciliation of provision of income tax (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2024-06-30",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails",
     "longName": "00000040 - Disclosure - Schedule of Components of Deferred Tax Assets (Details)",
     "shortName": "Schedule of Components of Deferred Tax Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative",
     "longName": "00000041 - Disclosure - Due to Related Party Transactions (Details Narrative)",
     "shortName": "Due to Related Party Transactions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_RelatedPartyMember",
      "name": "us-gaap:OtherLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form20-f.htm",
      "first": true
     },
     "uniqueAnchor": null
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued expenses",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r137",
      "r437"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive loss",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r73",
      "r140",
      "r432",
      "r457",
      "r458"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r13",
      "r20",
      "r361",
      "r364",
      "r408",
      "r453",
      "r454",
      "r617",
      "r618",
      "r619",
      "r626",
      "r627",
      "r628",
      "r629"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r565",
      "r712"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r470",
      "r626",
      "r627",
      "r628",
      "r629",
      "r663",
      "r713"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_AdjustmentForAmortizations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "AdjustmentForAmortizations",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less accumulated amortization",
        "documentation": "Adjustment for amortizations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash from operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising and Promotion",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful receivable accounts",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r211",
      "r220"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative",
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of debt discount",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r81",
      "r273",
      "r672"
     ]
    },
    "FTEL_AnnualEscalationRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "AnnualEscalationRate",
     "presentation": [
      "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual escalation rate",
        "documentation": "Annual escalation rate"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Potential dilutive common shares",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r112",
      "r139",
      "r166",
      "r196",
      "r198",
      "r205",
      "r206",
      "r217",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r356",
      "r358",
      "r387",
      "r428",
      "r492",
      "r542",
      "r543",
      "r565",
      "r587",
      "r653",
      "r654",
      "r678"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r145",
      "r166",
      "r217",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r356",
      "r358",
      "r387",
      "r565",
      "r653",
      "r654",
      "r678"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r599",
      "r601",
      "r602"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r599",
      "r601",
      "r602"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r599",
      "r601",
      "r602"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322"
     ]
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "FTEL_BrandNames": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "BrandNames",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand names cost",
        "documentation": "Amount of brand names."
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r601",
      "r602"
     ]
    },
    "FTEL_CapitalReceivableOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "CapitalReceivableOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital receivable of convertible notes",
        "documentation": "Capital receivable of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_CapitalReceivablesOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "CapitalReceivablesOfConvertibleNotes",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital receivables of convertible notes",
        "documentation": "Capital receivables of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r135",
      "r534"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r82",
      "r163"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Change in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r82"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of warrant issued",
        "verboseLabel": "Warrant outstanding",
        "terseLabel": "Warrants issued",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollateralAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollateralAxis",
     "presentation": [
      "http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collateral Held [Axis]",
        "documentation": "Information by category of collateral or no collateral, from lender's perspective."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_CollateralDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollateralDomain",
     "presentation": [
      "http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of collateral or no collateral, from lender's perspective."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies (Note 9)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r104",
      "r430",
      "r479"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r238",
      "r239",
      "r530",
      "r646",
      "r650"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r574",
      "r575",
      "r576",
      "r578",
      "r579",
      "r580",
      "r581",
      "r626",
      "r627",
      "r629",
      "r663",
      "r711",
      "r713"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r480"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r67",
      "r480",
      "r498",
      "r713",
      "r714"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, $0.0001 par value; 500,000,000 shares authorized, 20,123,386 and 8,120,000 shares issued and outstanding at June 30, 2024 and 2023, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r431",
      "r565"
     ]
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based Compensation",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r98"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r147",
      "r149",
      "r154",
      "r424",
      "r442",
      "r443"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (loss)",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r50",
      "r51",
      "r209",
      "r529"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r50",
      "r51",
      "r209",
      "r459",
      "r529"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r50",
      "r51",
      "r209",
      "r529",
      "r613"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r121"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration risk percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r50",
      "r51",
      "r209"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r50",
      "r51",
      "r209",
      "r529"
     ]
    },
    "FTEL_ConcentrationsofVendorsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ConcentrationsofVendorsPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentrations of vendors",
        "documentation": "Concentrations of Vendors [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r537"
     ]
    },
    "FTEL_ConsultingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ConsultingFees",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fees",
        "documentation": "Consulting fees."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue, revenue recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "FTEL_ConversionOfDebtToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ConversionOfDebtToEquity",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of debt to equity",
        "documentation": "Conversion of debt to equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant converted into share",
        "verboseLabel": "Warrants converted into shares",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28"
     ]
    },
    "FTEL_ConversionOfUnderwritersWarrantToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ConversionOfUnderwritersWarrantToEquity",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of underwriter\u2019s warrant to equity",
        "documentation": "Conversion of underwriter\u2019s warrant to equity."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_ConversionOfWarrantsOfConvertibleNotesToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ConversionOfWarrantsOfConvertibleNotesToEquity",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of warrants of convertible notes to equity",
        "documentation": "Conversion of warrants of convertible notes to equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible debt",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r103",
      "r681"
     ]
    },
    "FTEL_ConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ConvertibleNotes",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible note",
        "documentation": "Convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ConvertibleNotesMember",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes [Member]",
        "documentation": "Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsTotalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsTotalMember",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Goods and Service Benchmark [Member]",
        "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of goods sold",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r166",
      "r217",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r387",
      "r542",
      "r653"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued upon note conversion",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r165",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r240",
      "r241",
      "r251",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r267",
      "r274",
      "r275",
      "r276",
      "r395"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r57",
      "r58",
      "r102",
      "r103",
      "r171",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r563",
      "r624",
      "r647",
      "r648",
      "r649",
      "r671",
      "r673"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r254"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r395",
      "r396",
      "r549",
      "r550",
      "r563"
     ]
    },
    "FTEL_DebtInstrumentIncreaseAccruedInterestPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "DebtInstrumentIncreaseAccruedInterestPercentage",
     "presentation": [
      "http://fitellcorp.com/role/NoteReceivablesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annualized interest",
        "documentation": "Debt instrument increase accrued interest percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r253"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDateDescription",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity date description",
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r171",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r563",
      "r624",
      "r647",
      "r648",
      "r649",
      "r671",
      "r673"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://fitellcorp.com/role/NoteReceivablesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan period",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible notes",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax asset, net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r327"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "FTEL_DeferredTaxAssetsAccumulatedTaxLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "DeferredTaxAssetsAccumulatedTaxLoss",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated tax loss",
        "documentation": "Deferred tax assets accumulated tax loss."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_DeferredTaxAssetsDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "DeferredTaxAssetsDepreciation",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "Deferred tax assets depreciation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net deferred tax asset",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "FTEL_DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating right of use assets and lease liabilities",
        "documentation": "Deferred tax assets operating right of use assets and lease liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Provision for bad debt",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r658"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued employee benefits",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other."
       }
      }
     },
     "auth_ref": [
      "r658"
     ]
    },
    "FTEL_DeferredTaxAssetsUnrealizedCurrencyGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "DeferredTaxAssetsUnrealizedCurrencyGain",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized foreign exchange gain",
        "documentation": "Deferred tax assets unrealized currency gain.",
        "label": "DeferredTaxAssetsUnrealizedCurrencyGain"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsUnrealizedLossesOnTradingSecurities",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unrealized loss on investments",
        "label": "Deferred Tax Asset, Debt Securities, Trading, Unrealized Loss",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in net income (trading)."
       }
      }
     },
     "auth_ref": [
      "r658"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_DepositsAndPrepaids": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "DepositsAndPrepaids",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits and prepaids",
        "documentation": "Amount of deposits and prepaids."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fitellcorp.com/role/StatementsOfCashFlows",
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "verboseLabel": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r37"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r46",
      "r47",
      "r48",
      "r49",
      "r170",
      "r185"
     ]
    },
    "FTEL_DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "DisclosureLeaseRightofuseAssetsAndLeaseLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Right-of-use Assets And Lease Liabilities",
        "verboseLabel": "Schedule Of Operating Right Of Use Assets And Operating Lease Liabilities",
        "terseLabel": "Schedule Of Maturity Of Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_DisclosureWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "DisclosureWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r599",
      "r601",
      "r602"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r599",
      "r601",
      "r602",
      "r604"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic loss per share on net loss",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r186",
      "r188",
      "r190",
      "r191",
      "r192",
      "r195",
      "r352",
      "r355",
      "r367",
      "r368",
      "r425",
      "r444",
      "r539"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted loss per share on net loss",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r188",
      "r190",
      "r191",
      "r192",
      "r195",
      "r352",
      "r355",
      "r367",
      "r368",
      "r425",
      "r444",
      "r539"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Per Common Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r194"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected income tax credit at statutory rate, percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r558"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Date of incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative",
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails",
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r130",
      "r151",
      "r152",
      "r153",
      "r172",
      "r173",
      "r174",
      "r176",
      "r181",
      "r183",
      "r185",
      "r197",
      "r218",
      "r219",
      "r232",
      "r278",
      "r341",
      "r342",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r397",
      "r399",
      "r408",
      "r441",
      "r453",
      "r454",
      "r455",
      "r470",
      "r522"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r348",
      "r609",
      "r610",
      "r611",
      "r659",
      "r660",
      "r661",
      "r662"
     ]
    },
    "us-gaap_EquityMethodInvestmentAdditionalInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentAdditionalInformation",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of effective ownership description",
        "documentation": "This serves as a place to record data that is not required by accounting literature but is useful for readers of the financial statements as it relates to the details of an equity method investment in common stock. Such information may include the amount of change for a change in ownership (equity) percentage in a given period and the amount and type of the consideration given or received in relation to the change in ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentDescriptionOfPrincipalActivities",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal activities",
        "documentation": "A description of the principal activities of an investee accounted for under the equity method."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of effective ownership",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "FTEL_EquityMethodInvestmentPlaceOfIncorporation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "EquityMethodInvestmentPlaceOfIncorporation",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Place of incorporation",
        "documentation": "Equity method investment place of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesMember",
     "presentation": [
      "http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities [Member]",
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r566",
      "r582",
      "r583",
      "r584",
      "r715"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/InvestmentInMarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Assets Measured at Fair Value on Recurring Basis",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r665"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r383",
      "r561"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r383",
      "r561"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374",
      "r381",
      "r382",
      "r384",
      "r417",
      "r418",
      "r419",
      "r549",
      "r550",
      "r555",
      "r556",
      "r557",
      "r559",
      "r562"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r374",
      "r559",
      "r667",
      "r669"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r290",
      "r295",
      "r371",
      "r382",
      "r417",
      "r555",
      "r556",
      "r557",
      "r559"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r290",
      "r295",
      "r371",
      "r372",
      "r382",
      "r418",
      "r549",
      "r550",
      "r555",
      "r556",
      "r557",
      "r559"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r371",
      "r372",
      "r373",
      "r374",
      "r382",
      "r419",
      "r549",
      "r550",
      "r555",
      "r556",
      "r557",
      "r559",
      "r562"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r374",
      "r559",
      "r667",
      "r669"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374",
      "r381",
      "r382",
      "r384",
      "r417",
      "r418",
      "r419",
      "r549",
      "r550",
      "r555",
      "r556",
      "r557",
      "r559",
      "r562"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r559",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableRecordedInvestmentPastDueLineItems",
     "presentation": [
      "http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, Past Due [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r641"
     ]
    },
    "FTEL_FitellCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "FitellCorporationMember",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fitell Corporation [Member]",
        "documentation": "Fitell Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currencies",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "FTEL_FourVendorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "FourVendorsMember",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Four Vendors [Member]",
        "documentation": "Four Vendors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_GDWellnessPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "GDWellnessPtyLtdMember",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GD Wellness Pty Ltd [Member]",
        "documentation": "GD Wellness Pty Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative expenses",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r502"
     ]
    },
    "FTEL_GoingConcernPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "GoingConcernPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Going Concern",
        "documentation": "Going Concern [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r228",
      "r422",
      "r543",
      "r546",
      "r560",
      "r565",
      "r643",
      "r644"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r642",
      "r645"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r76",
      "r111",
      "r166",
      "r217",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r387",
      "r541",
      "r542",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r653"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r599",
      "r601",
      "r602"
     ]
    },
    "us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentEffectsOnEarningsPerShareLineItems",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment Effects on Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentEffectsOnEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentEffectsOnEarningsPerShareTable",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment Effects on Earnings Per Share [Table]",
        "documentation": "Disclosure of information about the effects of asset impairment charge on per share or per unit basis."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of intangible assets",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r229",
      "r231"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r90"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails",
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss before taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r106",
      "r111",
      "r426",
      "r439",
      "r541",
      "r542",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r323",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r337",
      "r343",
      "r345",
      "r346",
      "r347",
      "r466",
      "r558"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails",
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit",
        "verboseLabel": "Income tax credit",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r127",
      "r184",
      "r185",
      "r196",
      "r203",
      "r206",
      "r328",
      "r329",
      "r344",
      "r445",
      "r558"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r324",
      "r325",
      "r334",
      "r335",
      "r336",
      "r340",
      "r463"
     ]
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseDebtDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseDebtDiscount",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt discount",
        "documentation": "Income tax reconciliation non deductible expense debt discount."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Government Subsidy Tech Boost",
        "documentation": "Income tax reconciliation nondeductible expense government subsidy tech boost"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO related expenses",
        "documentation": "Income tax reconciliation nondeductible expense ipo related expenses"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-tax deductible consulting fees",
        "documentation": "Income tax reconciliation non tax deductible consulting fees."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-tax deductible general and administrative expenses",
        "documentation": "Income tax reconciliation non tax deductible general and administrative expenses."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "-Non-tax deductible personnel expenses",
        "documentation": "Income tax reconciliation non tax deductible personnel expenses."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-taxable other income",
        "documentation": "Income tax reconciliation non taxable other income."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for bad debt",
        "documentation": "Income tax reconciliation nondeductible expense provision for bad debt"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock issued for services",
        "documentation": "Income tax reconciliation nondeductible expense stock issued for services",
        "label": "IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unrealized loss on investments",
        "documentation": "Income tax reconciliation nondeductible expense unrealized loss on investments",
        "label": "IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationTaxContingenciesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxContingenciesOther",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other items, net",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in other income tax contingencies."
       }
      }
     },
     "auth_ref": [
      "r656"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for income taxes",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r162",
      "r338",
      "r339"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued expenses",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable, net",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "FTEL_IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued employee benefits, non-current",
        "documentation": "Changes in accured employee benefits.",
        "label": "IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income tax payable",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "FTEL_IncreaseDecreaseInDeferredTaxAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncreaseDecreaseInDeferredTaxAsset",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax asset",
        "documentation": "Changes in deferred tax asset.",
        "label": "IncreaseDecreaseInDeferredTaxAsset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory, at cost",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r614",
      "r622"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deposits and prepaids",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "FTEL_IncreaseDecreaseInPrepaidOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncreaseDecreaseInPrepaidOfferingCosts",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid offering costs",
        "documentation": "Increase decrease in prepaid offering costs.",
        "label": "IncreaseDecreaseInPrepaidOfferingCosts"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_IncrementalBorrowingRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "IncrementalBorrowingRate",
     "presentation": [
      "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental borrowing rate",
        "documentation": "Incremental borrowing rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand names",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r230",
      "r547"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r621"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r160",
      "r161"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, at cost",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r535",
      "r565"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r134",
      "r142",
      "r222",
      "r223",
      "r224",
      "r420",
      "r538"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r201",
      "r206",
      "r542",
      "r620"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/InvestmentInMarketableSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment in marketable securities",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r129",
      "r212",
      "r213",
      "r385",
      "r386",
      "r680"
     ]
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock issued for services",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "FTEL_KMASCapitalAndInvestmentPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "KMASCapitalAndInvestmentPtyLtdMember",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "KMAS Capital and Investment Pty Ltd [Member]",
        "documentation": "KMAS Capital and Investment Pty Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Operating Right of use Assets and Operating Lease Liabilities",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r675"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturity of Operating Lease Liabilities",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year ending June 30, 2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year ending June 30, 2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease right-of-use assets and lease liabilities",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r57",
      "r58",
      "r59",
      "r62",
      "r63",
      "r64",
      "r65",
      "r166",
      "r217",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r357",
      "r358",
      "r359",
      "r387",
      "r478",
      "r540",
      "r587",
      "r653",
      "r678",
      "r679"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r105",
      "r434",
      "r565",
      "r625",
      "r640",
      "r670"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r133",
      "r166",
      "r217",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r357",
      "r358",
      "r359",
      "r387",
      "r565",
      "r653",
      "r678",
      "r679"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_LicensingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "LicensingFees",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing fees",
        "documentation": "Licensing fees."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/NoteReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Receivables",
        "documentation": "The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r635"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r209",
      "r554",
      "r568",
      "r571",
      "r655",
      "r682",
      "r683",
      "r684",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710"
     ]
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative",
      "http://fitellcorp.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in marketable securities",
        "verboseLabel": "Total",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unrealized loss on investments",
        "label": "Marketable Security, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "FTEL_MerchandiseRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "MerchandiseRevenueMember",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merchandise Revenue [Member]",
        "documentation": "Merchandise Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r209",
      "r554",
      "r568",
      "r571",
      "r655",
      "r682",
      "r683",
      "r684",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash from financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash from investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash from activities",
        "negatedLabel": "Net cash outflow from operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r83",
      "r84"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows",
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "label": "Net loss",
        "negatedLabel": "Net income loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r84",
      "r107",
      "r131",
      "r146",
      "r148",
      "r153",
      "r166",
      "r175",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r189",
      "r217",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r352",
      "r355",
      "r368",
      "r387",
      "r440",
      "r500",
      "r520",
      "r521",
      "r585",
      "r653"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash Investing and Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other expenses",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expenses):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/NoteReceivablesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note receivable",
        "verboseLabel": "Note receivable outstanding",
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r636"
     ]
    },
    "FTEL_OneVendorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "OneVendorsMember",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Vendors [Member]",
        "documentation": "One Vendors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r541",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative",
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfMaturityOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "PV of Payments",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityAbstract",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_OperatingLeaseLiabilityAndRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "OperatingLeaseLiabilityAndRightOfUseAsset",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability and right of use asset",
        "documentation": "Operating lease liability and right of use asset."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of operating lease liability",
        "verboseLabel": "Less: current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "FTEL_OperatingLeaseLiabilityForOfficeLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "OperatingLeaseLiabilityForOfficeLease",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Office lease",
        "documentation": "Operating lease liability for office lease.",
        "label": "OperatingLeaseLiabilityForOfficeLease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability, less current portion",
        "verboseLabel": "Long term portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r405"
     ]
    },
    "us-gaap_OperatingLeasePaymentsUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePaymentsUse",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/LeaseRight-of-useAssetsAndLeaseLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease payments",
        "label": "Operating Lease, Payments, Use",
        "documentation": "Amount of cash outflow from operating lease to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r405"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating right of use asset, net",
        "verboseLabel": "Right-of-use, net",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of right of use assets",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/OrganizationAndPrincipalActivities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization and principal activities",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r99",
      "r460",
      "r461"
     ]
    },
    "FTEL_OriginalIssueDiscountPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "OriginalIssueDiscountPercentage",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original issue discount",
        "documentation": "Original issue discount percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r13",
      "r100"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r13",
      "r100"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfReconciliationOfProvisionOfIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected income tax credit at statutory rate of 25% (2023: 25%)",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r151",
      "r441"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency translation adjustment",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r441"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related parties",
        "verboseLabel": "Amount due to related party",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r565"
     ]
    },
    "us-gaap_OtherNonoperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncome",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income",
        "documentation": "Amount of income related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/NoteReceivablesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan lended amount",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireNotesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in note receivable",
        "label": "Payments to Acquire Notes Receivable",
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "FTEL_PersonnelExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "PersonnelExpenses",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Personnel expenses",
        "documentation": "Amount of personnel expenses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid offering costs",
        "verboseLabel": "Prepaid offering cost",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r225",
      "r226",
      "r536"
     ]
    },
    "FTEL_PrepaidOfferingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "PrepaidOfferingCostsPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Offering Costs",
        "documentation": "Prepaid Offering Costs [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Funds raised in IPO, gross",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "FTEL_ProceedsFromIssuanceOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ProceedsFromIssuanceOfConvertibleNotes",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative",
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Funds raised in convertible notes",
        "verboseLabel": "Proceeds from issuance of convertible notes",
        "documentation": "Issuance of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net activity on due to related parties",
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r207",
      "r421",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r533",
      "r553",
      "r567",
      "r569",
      "r570",
      "r572",
      "r573",
      "r651",
      "r652",
      "r655",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "auth_ref": [
      "r207",
      "r421",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r533",
      "r553",
      "r567",
      "r569",
      "r570",
      "r572",
      "r573",
      "r651",
      "r652",
      "r655",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r407"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r122",
      "r125",
      "r126"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r136",
      "r438"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r407",
      "r427",
      "r438",
      "r565"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r122",
      "r125",
      "r436"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r407"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bad debt provision",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r221"
     ]
    },
    "FTEL_PublicOfferingRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "PublicOfferingRelatedExpenses",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "IPO related expenses",
        "documentation": "Amount of IPO related expenses.",
        "label": "PublicOfferingRelatedExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r296",
      "r412",
      "r413",
      "r429",
      "r435",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r497",
      "r499",
      "r527"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r169",
      "r412",
      "r413",
      "r414",
      "r415",
      "r429",
      "r435",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r497",
      "r499",
      "r527"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r503",
      "r504",
      "r507"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r296",
      "r412",
      "r413",
      "r429",
      "r435",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r497",
      "r499",
      "r527",
      "r677"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/DueToRelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r410",
      "r411",
      "r413",
      "r416",
      "r467",
      "r468",
      "r469",
      "r505",
      "r506",
      "r507",
      "r525",
      "r526"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r94",
      "r433",
      "r456",
      "r458",
      "r465",
      "r481",
      "r565"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r172",
      "r173",
      "r174",
      "r176",
      "r181",
      "r183",
      "r185",
      "r218",
      "r219",
      "r232",
      "r341",
      "r342",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r360",
      "r362",
      "r363",
      "r365",
      "r366",
      "r397",
      "r399",
      "r453",
      "r455",
      "r470",
      "r713"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total revenues",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r110",
      "r196",
      "r199",
      "r200",
      "r204",
      "r206",
      "r207",
      "r208",
      "r209",
      "r287",
      "r288",
      "r421"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r532"
     ]
    },
    "FTEL_RevenueFromLicensingCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "RevenueFromLicensingCustomersMember",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Licensing Customers [Member]",
        "documentation": "Revenue from Licensing Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionDeferredRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionDeferredRevenue",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue",
        "documentation": "Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionLoyaltyPrograms": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionLoyaltyPrograms",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customers Loyalty Program",
        "documentation": "Disclosure of accounting policy for customer loyalty programs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues:"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_RightOfUseAssetsForOfficeLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "RightOfUseAssetsForOfficeLease",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office lease",
        "documentation": "Right of use assets for office lease."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_SalesOfConsumableProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "SalesOfConsumableProductsMember",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales of Consumable Products [Member]",
        "documentation": "Sales of Consumable Products [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Deferred Tax Assets",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r40",
      "r41",
      "r42",
      "r43"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Provision of Income Tax",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r558",
      "r656"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r348",
      "r609",
      "r610",
      "r611",
      "r659",
      "r660",
      "r661",
      "r662"
     ]
    },
    "us-gaap_ScheduleOfFinancingReceivablesPastDueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFinancingReceivablesPastDueTable",
     "presentation": [
      "http://fitellcorp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, Past Due [Table]",
        "documentation": "Disclosure of information about aging analysis for financing receivable."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r641"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "documentation": "Disclosure of information about concentration risk of product within nature of operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r407"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://fitellcorp.com/role/DueToRelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r503",
      "r504",
      "r507"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Warrants",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "FTEL_ScheduleOfSubsidiariesOfCompanyTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ScheduleOfSubsidiariesOfCompanyTableTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/OrganizationAndPrincipalActivitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of the Company and its Subsidiaries",
        "documentation": "Schedule of Subsidiaries of Company [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and marketing expenses",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected average volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of warrants, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of warrants, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of warrants, Outstanding, Beginning Balance",
        "periodEndLabel": "Number of warrants, Ouststanding, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97"
     ]
    },
    "FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted-Average Exercise Price, Outstanding, Ending Balance",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price exercisable.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-Average Exercise Price, Exercised",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price exercised."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-Average Exercise Price, Granted",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments eeighted average exercise price granted."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted-Average Exercise Price, Outstanding, Beginning Balance",
        "documentation": "Share based compensation arrangement by share based payment award non options equity instruments weighted average exercise price.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "FTEL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Contractual Term (in years), Granted",
        "documentation": "Share based compensation arrangement by sharebased payment award non options equity instruments outstanding weighted average remaining contractual term."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued, price per share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term leases",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r564"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of significant accounting policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r164"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative",
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails",
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r67",
      "r70",
      "r71",
      "r130",
      "r151",
      "r152",
      "r153",
      "r172",
      "r173",
      "r174",
      "r176",
      "r181",
      "r183",
      "r185",
      "r197",
      "r218",
      "r219",
      "r232",
      "r278",
      "r341",
      "r342",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r397",
      "r399",
      "r408",
      "r441",
      "r453",
      "r454",
      "r455",
      "r470",
      "r522"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails",
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails",
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity",
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r197",
      "r399",
      "r421",
      "r462",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r480",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r502",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r522",
      "r577"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfCompanyAndItsSubsidiariesDetails",
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails",
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity",
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r197",
      "r210",
      "r399",
      "r421",
      "r462",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r480",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r502",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r522",
      "r577"
     ]
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued for prepaid IPO services",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issued pursuant to warrants of the convertible notes, shares",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r39",
      "r67",
      "r70",
      "r94",
      "r268"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issued for conversion of debt, shares",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r39",
      "r66",
      "r67",
      "r94"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued for services, shares",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Funds raised in IPO, shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r66",
      "r67",
      "r94",
      "r464",
      "r522",
      "r528"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issued pursuant to underwriter's warrants, shares",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issued pursuant to warrants of the convertible notes",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r67",
      "r70",
      "r71",
      "r94"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issued for conversion of debt",
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r67",
      "r70",
      "r71",
      "r94"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued for services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Funds raised in IPO",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r66",
      "r67",
      "r94",
      "r470",
      "r522",
      "r528",
      "r586"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issued pursuant to underwriter\u2019s warrants",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_StockIssuedDuringPeriodValueSettlementOfStockSubscription": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "StockIssuedDuringPeriodValueSettlementOfStockSubscription",
     "crdr": "credit",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement of stock subscription",
        "documentation": "Settlement of stock subscription."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets",
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r70",
      "r71",
      "r87",
      "r482",
      "r498",
      "r523",
      "r524",
      "r565",
      "r587",
      "r625",
      "r640",
      "r670",
      "r713"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 equity:"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_SubscriptionReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "SubscriptionReceivableMember",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Receivable [Member]",
        "documentation": "Subscription Receivable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events",
        "documentation": "Disclosure of accounting policy for reporting subsequent events."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierConcentrationRiskMember",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplier Concentration Risk [Member]",
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58"
     ]
    },
    "FTEL_ThreeVendorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "ThreeVendorsMember",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Three Vendors [Member]",
        "documentation": "Three Vendors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r637",
      "r638",
      "r639"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_TwoVendorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "TwoVendorsMember",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Vendors [Member]",
        "documentation": "Two Vendors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://fitellcorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfCashFlows",
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized loss on investments",
        "negatedLabel": "Unrealized loss on investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r119",
      "r120",
      "r123",
      "r124"
     ]
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VehiclesMember",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://fitellcorp.com/role/ScheduleOfWarrantsDetails",
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r574",
      "r575",
      "r578",
      "r579",
      "r580",
      "r581"
     ]
    },
    "FTEL_WarrantOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "WarrantOneMember",
     "presentation": [
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant One [Member]",
        "documentation": "Warrant One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_WarrantSharePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "WarrantSharePricePercentage",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant share price percentage",
        "documentation": "Warrant share price percentage."
       }
      }
     },
     "auth_ref": []
    },
    "FTEL_WarrantTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "WarrantTwoMember",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative",
      "http://fitellcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://fitellcorp.com/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Two [Member]",
        "documentation": "Warrant Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://fitellcorp.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercise term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r667",
      "r668"
     ]
    },
    "FTEL_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fitellcorp.com/20240630",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://fitellcorp.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants",
        "documentation": "Warrants Disclosure [Text Block]",
        "label": "WarrantsDisclosureTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding - diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r192"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://fitellcorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding - basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r192"
     ]
    },
    "us-gaap_WorkersCompensationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WorkersCompensationLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fitellcorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fitellcorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued employee benefits, non-current",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://fitellcorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "80",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-80"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-10/tableOfContent"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>75
<FILENAME>0001493152-24-046303-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-046303-xbrl.zip
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MLTGS<?%)_Y^-V 8P4 *.(!8PB!\XQP ",X"(70 O (#(07\:\ \#G0.3D5-
M**FH:4@/5-,#YT!@\#DR,#DY&1EI-I0T#Y QD#/R26E0,-VU@_![,TM'/,^A
M%+A6V<YB.+0C*// )Y**FO4"&SN'D+"(Z"4Q63EY!44E9<WK6C>T;^KH&MTS
M-C$U,[>P?^C@Z.3LXNKKYQ^ 0 8&/8Z*CHF-BT](>?''R]2T5^D9N7GY!6\+
MBXK???A855U36U??T-'9U?VII_=SW_#(Z-CXQ.3WJ7G,PJ_%I>65U37L[M[^
MP>$1[OCD-Q<( (/^:?^6BX'$=8Z,#$P&^<T%.H?X_0 #&3F?% 6CQEV(G3<3
MOW0$)?.UYSF5[50",H8[+ ]\AJA9!67GA;"_T?XD^]^!1?Z_R/X%]C?7%$ +
M!I'$ S, <.#H1#0WG/H_-MYQ?"MD3<K[L<9D[RYZDW?6LQ.KF$WG9(I]9X9<
M&KA%I]:;]Z5>[2D10.PN[)6/M[C5UZ7NKEFF3U8-UR.\#/7=?H0PE*,\D3[L
M@NX_VD_3FW6XH1@I=6YN.R2ZFS6+O9+Q*VPZ7IHOG(M5K7 P>'P3J9#DSRXG
MR3JG4GF)YI4 3T(3"I8!I!*!GA;^UE=U+?*?LP1J0>KXH(P"(D#E%(=:D0DD
M BAQ@W8"#8JI=(+Q!V?PS=>.BU8?:ZV@KNOP>2,7(K#/U$ $6DS"%:&X6S!-
M(J#Q>N#TV%HAHLDN+.1::E#!?BV]-52"MBPS>7IO]=AD "_F 2=$(FR/^H8K
M.A*9_?W&KHR-1N:+_6)0YPG_4L_N<^.&-)2_"6XUAK^=NZY@$=+0O[V%7GQ
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M;]/U8%E6YFCD!J1G0UF=CG//-MCA'6$[>"@\"0A2U89AIRT_P[ZR*HXV2FU
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M""UI9KL--U*XCC8@5;"#UTB5%C<IQZWM;X;UW!N3DU">[/647;Z']OGI$"$
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M+0$I-B5N7!F'BWF-EF[33E2PY 0^,D'TW=7_U!\P./'[?P%02P,$%     @
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ML2D L(YYI_ZJB/\_'(S_&U!+ P04    " #1@V]9Y/BLOE@3  !*%   "P
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M*_:)[?7X6!P:VF0%J,14-BQ7[*+B-&\&SWKXSQO7QZ9)@\5UM:W--2^$I:]
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M9 1@'.[\ND6B6W''$I8**C6?!,(Y!=^J+I<'7"2Y-X=Q_]04+^-]7ZPUN9L
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MG</)PY]WTQI0(C/3](B%/)VSY0Z<9:SILTJ7"HB$\E%J#<]6RWR@)?@-=I%
M^5A#@F55'TD5Z)WIK@\-)P8WC_/%%D;;PYJ?PWBD!:[C@(,5E\#7V*Z"2GHH
MK.?;\=FGN$Q.*P&3%N4H+]W11 ID<-_D[&&/9W7< $<%6%?4TX*BLPNO\YE&
M\. JOHF"T"4V5."5$H3K.]W:H;3W3UK1JZ_'V6'1,3#9XO=GJG>SP_>6FZG
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MY=,[G(_O'/R:[,3WR7>T*#T\(1:P45R%J1>-<7MATMW%2[R&:#39:5[%IJ3
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MF&%@)CW1<6R53.7EQ'\!4$L#!!0    ( -&#;UFE;*G)@&@  &-Q P *
M97@Q,2TR+FAT;>V]>U/;V)8W_+^K_!WT],PY!57& 7+I[B1/ZB5 TCZ33A@@
MY\RIJ:FG9&D;[XXL^4@RQ//IWW7;%\DRD+0A-NC43 >,O+5OZ[[6;[W^[?SW
M#V^ZG=>_'1\<P;\!_N_U^>#\P_&;UT_X7_CK$_GSZ[>?COX9G)W_\\/Q__UI
ME*7ERV!O=UH&YWJBBN"CN@I.LTF8]OB#7G"F<CWZ";X(7SWYUN^]"B9A?J'3
MEP$^:O__IS>OWWWZ>.Z/MC,*)SJ9O[QI/'JVT/^K^/4_O?EK.BRFKUX_P0%A
MO2>KG>FKH%1?RYTPT1?PIUQ?C,M53O[UVS?'7\=ZJ,MN9V^OO__ZR=LW][.4
M2*6ERC?U(%8]>_G@,LQUB-,L)F&2[$3AM* S&J2%CE7>[9SG8:S3B^ PFTP3
M>#12P>]A.@N333XX6. [7:HDZ78.LWR:Y6&ILW235[3)5_&G-P=Q-BU5W.W\
M]U__[=<7/__ZZG]ZP?[N_K/[6<\?LZ+4H_FF'H=,7S[4::QP\-W^<YVN<DF#
MM-O)<N )09D%9?A%!5D:A/!_4:DO59!GB0IT&I1C%4QS=0F3 )(*LA%\2*PD
M*(637.HL(7HK@N$\T&4!#XUTI')X>:QS%949_JB WV1SA5.*X-E94@*?@E_"
M^%(7^$2W$Z9QD,$+\R!7,*2*X5VQOM0QL"=X$J?R-@OS&&=Q9$8.MO#SOR;Q
MOV;9*V $] 22_E]S^F@;GV;N$'C,H8=K55]A5OB>"+AAF,Z#++\(4]@DN+JS
ME!8)8R?A%:Z)?CX,Y["YP:!(8+(+[S[D8?RW]X)Q6, BB2!X-[-$1QK."I<[
MS;-(Q;,<?HU5$>5Z2*N&!W41W,RT^RU%_9CIHTCMPX0_,Z\3TI #"\QYG>!1
MPW7X_*9_?\+H81S67;._X]%($:<#MF.I.P:F$USENBP5,,)A=JF8ZPA=+Y!R
M\WG7N8*Y!3Y3N!KK:(S43ZIS89AIMS,,"Q@<KM,$Y@*Z7-(+TBS=F<Z&, AP
MAE&63XB! 8^\ $Z'K_6GB$P%!RQF0YB;!G40MF7+38:G##.W _D3ZP?G,!9/
MN-N)8 . P8(B:5DZC6^YNN6*U[R\Q]\GMFYEP.V_6*@H5R5]P (B+ I=D.R
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M$+J=)?L8<@^MZIJNZ4/1LMGUH;E3=3%CF+MNY]U1L/4NU'EP9*7_MD]?[N/
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MJ#^GEFU["E.]50^AW684#2+\$IM:9)J=<M>SINLX,&HK13]S)7D,1LMV5X\
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MP7"&G015FB;F0H5P.)&BA!\1*@'K-;GQ3;$MH3\[ =,)%L8)*<#FQ4[)UXG
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MU3!1"!!FMCV"MR)41+?CX,[(-?3 4I^NK\W\M:W-7&%MYJ]M;69;F[D9O&(
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M\>72G<C4TY. 7/3=79N08/Q4\AI^@SUJUZDIKUI]KJ"_M8]:B=9*M!\BT4Z
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M)DP[>#DN>;C>:[K(D;T<9W3O\JFEF4X1CL9EO4&@=.A4N/K5"!+,8R4R$O=
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MK%[;#?K;&?Z/:=#?W/@?4$L#!!0    ( -&#;UEV<*M1%0@  .%"   *
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M?.CV[X(Q3T;@BAKO,HG^M;[E]=;1/GA36D>A_^0_"BJ_))XM- DCJ5!"C@<
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MV77J"E5M=LF-9?5ZL8!Z%W\4-BUE-E2E7LEMWM*V3U_!T,LGI5V/$T;K(+7
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MUS2TM>%%&'Q-17\DHICP[$+F5Y> S7="1NA?\PYGE?F@&Y;X.&A&B03* QK
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M@:L#4XP0YA#FC\>P.8MA //1M;Y@/$ID*C5P?[@-+G=$!XJ-+!<%/!RJ5.-
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MX?OOCCDCV?*99;L]=5]7M+#/S@Y/#H[^.U6 _L+:H=ZF->B]= %]&#71$.,
M.ZJ11Y7T]P\HQO=W/YE((K9"G$PT"FQB5ARK$7D:;]E!K2_@@0\OM\7HP^S*
MAU EZBKIJHG6\I+71<NKEW85>"8P9!MNY?6M+HE^TOF &2YIB/[;ZE;-HG(R
M-E[=G\!-.=R^O)2JE/Q/LHY!D;.E&C"O@F%>7,IKDSCECFGZL6>LHRK:(?]7
MCK4KRTNP;)'G)F40#+\K:2J>I-8EW-FZ1G))R7I!;L&W>SPP#B'N?% F2KV\
MA(&Y>DAT(E6 2T,  R<9P19\%X:'"R5<2 O7<4?EI"4 RFZX<_T5',;GSF1O
M;EFPO#2T!;"6:3:[3M9=$/@JQ4748$&WQZ0;.?H;]#(\LXW-V:# @!U0=9S*
M]8)6CTDK2X\6:DTW<L9,,'0-)IGI(6S+^9%ITBV-WKPH:9"N'_D8(&)'.N8I
MEG62DP7$ A\,9(Q!F07!'T=SM31O5AI7D;=I#6=>%:U7'/L:J/=R]--&-]7V
M%K%M=#1Y$52Z>6.M!A!WKKLS;S2!7%YJ25E =<V4'/O3WSBRI^:16=07HCE=
M>]'(D$>@#Q;F=G]Y-(-*;<86*8B1A46O8PG-?'"JYS5U]\YR;#9)1<D%JJA#
MGHNABB-*BZ42'Z_I=^_BO-GQ>SH;?B2]OD?"QU,U<:,.&Q8@4>%UI\]V/['?
MVKO_NM5[*UA>@KD!/%9FC6#I7%2@[]P1(JB*]ET4F%:2<$FYKBQ289F8@)"+
M-XMFC0!ES!*QVY:'H[NF_?1H8SRL"*>&ZNO8 QDMZ!# U<&\VG:"#ZZ$/ ZQ
M4IDN%4-5@AV1BTO7N OCV?P:#B95YL_<;HV<([N\F[H_+)CDHS+)NA6L"WK.
M%F^^,NJ,/=R"6","U!85_545/[V1B3;31I>7:,O<INO%.OM=I)A"$8^#MM"M
M,=Q-LL449'6;N@HJHUU3_]KE)8L@>[?#AM^2XSU?VUH9K,YXP\)B$S_F)O[D
MG"'HB'+^G<_ +RG+>7(W8X\1ROHW-U1.%V^C&KY*L7KCWFA+;/9\02 M8/X,
MTW!*RE(T+I^,5XV.;^7BHB[.'F2PLTB<CT!VQF-;?8JYD2:QB[(@N;N[:G/<
M6-WRDI&0TT-8<3>5^',[ ;[.]EB%=C:%]485685)<[IE^\2M&"%XZ1P;,F!6
M.DY3$>'F;*G%47S,HSBA&C7?X];F&IXH5KK,.>Z4@ F>I_@).^!*4'-NLY%E
M2GM9W&(K8V6W3$W!.";$S=NPZS>\V$A3JJ-PKQ?RWI]C53U_;8/9\0UB#13B
MD!IT+.=5M2W1:Q5SWME"=8IZYSC'ZUS031F7=.@@W%X)D''6]^NE9A/RJ:,Y
M<I:YHZH0SIVV"1PF%SPR2^6OR0'\<@[>>57E9U[MT:[%%<-<").B2^4%=A>.
MX;1A0S(LCP/>2V\I@7U=53M$)K'8:\!FFU/Z@0\C\*QU5B7^@NG=;FXY86>7
M -I@JDUMI=D^#GA2(768RWZGIFC&:'6GD!C 5)BQQMYW+'"&.>GCW[XF!I <
M2\QS@K'H_."!J3J>&0BL'@K"?$;?Y,!E_3I-%I,,G<[;C*>UM0XU.D-H/%K
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M7CC9^MUFM;Z4CADY]KD*3GS!,BY37L[H"_586$[]GOG+F6^L[]K>*EB1%V$
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MBBE(?8XG-FJMV*Q1KC7K6UZ7N$-*<5@+@F3ONKI6B;&<D(%:V1G1GL#"TK1
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M@)0AL1P+GBRPP>CJ6QAF7WK_? NT<9'"#BH]5C;2RA!-@>HOZK:HXW*F5$'
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MG6:U:-:D_-+PW"XCZ(%$DY U."H Y# ">LS<#.>&AN 'RXLZ$:\D"A%)7)'
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M*'R]^J%Y^9G^JGWX1>KMF60^^BM!K73PR <]>O1!]?L8PNI,AC00EXD1& (
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MVE!X;UE/;('CIJ*\.@G&E00?%E$)W5E#-U;2[CS2_5LQY!W4E]#)0Y?0Y0]
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M GSSY]VV9@)J6QQ8S5XK8E%*27AZMW>:7H\YN7+Y^I(NC1F5B+>40!-=2X.
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M)HJ8V;A3K0(ZIFWOE+0Z]A1GBYTM]L:!SE0(+7TDW67?=>O9F&9CNG:L$7\
MALC[%<OZ<#LD$\&TI3;FR\XXQ'P%+X:ZG.ULMK-?E?>CTU*2R.>U$5Z$^I_\
M=K:QV<:NW\OVP]:M>7A+:7J19E?R[Q8K:=X9''EHK+"#D*.^*!?[V;1FT[IV
MK HVY/%%W2^^AZB(.X@*GX2+/GMBH&>-41-IAJUPT0!MBH"8L0.[.7\WF^8-
MQJJ2PQ:^<CN:2<A?N$A"'IU949=D;(*'&O>\-18B&[(.+:4*!Y>8F!?%MO9
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MI/2,ES(P>(V))I4?*B*)[IGI:LV<D5Q])6/))E)NRD*[9N$(7P@><T[?F+8
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MQH.?<SA"@XR2BI=IB5I+5,?)H&@9G:\$>\1UFD0IGD)7$3JP396-$85P^J7
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M2@3I_2X9E.S-'],FI[S=K<\<=QWBT.E2'HNHO<G. G^*5(XB;IQ1N)T<KID
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MR+)X(SO-7S2J0\)>GX% !'\%EB5,(AIXC8[E1>,XOAWOU7BCD.4F@U9?A76
M=?L51Y V+W+_]EF9+\FBDU2A^(?M(;C$6$##'JCCL[_IQQGI>P'GJ$BVV\3;
M*U0135\*>Z9G#DU^]-B7#6_O&(%H"^PG/,\8<WPZI3/ 0XSW>+4;;BU4&\F]
M2IVW@RRQ@]BMO)5#"QU0S WX'LZ.%)@6]$JF(='CYR5ZY_J^LU'?5I$K@/I&
M0#].TZ@9AV$$9LB)K])U45X1(K-D8<]NZCV;FF]341M:-&31VD3.(JGX\4*P
M_S2&.(8Q]<N$,SA VHR_C1.%2U=Q:J]NF>(,E3EF#A-F'H:J,L'#GW2CFQVN
M!S4ULJ]+HWG[3RR,=IL?OGWU4C@VF8BC_(7C(>[=KY>%*BDJ Z()7<5Z=TW7
MO3G9KGJ<Y!G3A!2YJY$E_'W^4?UQ_OGSWS(B!IF&+E;U4I/%G7F/E%OZ#*(-
M7S[F54X/N1/HX'(7@M,V@4.C-GAEG:P_JH+8RZ[B43S]\HO/A,EWS00%'PNY
MKJTB>DX?\\/YJ*89/'^2S." ?PY'%9W<'X54E3$0NBI3IX)[DIF$(O_7KNRW
M.-]S<CKZ\MQ];-P)R6. @E5]MMM:>*IWX;.;9@I=3<YJT*!6K@G,%O(W>TOZ
M%#.=&<^2KR23/,W_4,(KOSD)I.?<@0UU*M'HV3Q$V@V]S3S:F#CQO.LJ8+R+
MK#2_C[E!Q*&;:ITZ0R+*L5/"!@U+Y6D>V_GH; 6 (?3^:>]7:M5</<F.]5UY
MFA%..>,]</9NQZP-\E9E"8B:+73UV$.HG.:G.:EG:V;!&2CX]"6]VG@8[*AG
M$^N*&3\P4Z'<J8<X3$&6CI?=EDL^ X8JG$KJ4W]'4^IT_--FREZ7/2A5S>3[
MI=-C.'ZPZ#,7&34''V[I>G:9?+OZM;:3GFBAY2!QDM$N3E?&N^%)]-Q:@ &T
MG707:'.>$%B8V')D'E>]^5A@=[QA\@72+H?LI:EZOLVAJZWNIN99RK?D"%8I
M/ Q[VK@/=F'9'#)Y=+Q%Q)=#!#/<&1K,A]@T=?MSFI[-53263V<:RUNDL?QR
MIK%\0#26=W[/N=MMP4!XFM_QLMS3E_-70U.B/=WHFE1Z^Y#TFS.?7CDV+:>(
MV+57[:;?)%_E8HTP8+/'CK-4";&]9_^/EL5'7H-G:(Y1[^O4*$:%MP/"-];\
M91D7U8&)7SH;4Z.",X' 1U@J80['+552H1&C^G)9UF!>I_N>PQU&)$9.*[O!
M$O&IZC!S6%7YVE%T1[_928\&(ZD4DTH^8K>0SM\BE3\QD?F/?A0M^8^/+"-<
M4;]($U]W+=;<L8G\G6LFYRNI]"5+QDLX*TCF'*25VS$NUM+==,=)@G<+X+)E
M37%B#8<1X0-D;/B)UP&*&RCLA3=>7L5H=IA+V1LY4PE-;[(G^-[VY-/)YP>3
MSY+)1Y_2;6!T0U:<[!E"K*@W2:OK]J/U7C.DGRGZ7$@MQRU<I1B!P\LRA9FG
MN$^'^DU[WK"^B73ZB/0$/Z5+WN3(W^^W8FT(N1U(4CEW4>YH%^0W0(&\#U7.
M:F919+F44KZL8\JNMH:#_==B\? JJ]WT"SSZZFR/IR"$0_%FG\44E$)SML]]
MEDDNA&6SVTJ.^_ )<[*=81<_4^PRT)_C_MO1MHY\?0Q=/+0+YO]3X6Z5X891
M=16S>XVH:WW-W^+2T=W0<2P!%"]] ,D14M$=OJ8O7C+LA*M!G.YAPL$LW!0/
MW.:KC#*LY"[CT2<?]B$\8!:<GUKI29UB]&9"<='>#\:4>:I09MH$9RY]G3>\
MV"XB>DG;*Q#!^K!5+$Z7X/B,?8 'T ,^6\6-^X/CHF2F>85RVIJ4=%!04'$A
MD9E./44OF<H+H-9HT&7,59$'KHJS7C@]QR<1]VDP;JU#C<]VJ+ +27'+ 0^Z
M$"07+:9S3DE[BJ,SY%L*O[7Q4HT('W69Z9ALE_>=_>HU9,(LBBEIWMNS7G/Z
M3VJ.NHGS@#WC8_( 9J?SGDY-G<ZIJ&+".S-3&5G"IJ]IV+70_P:;R%\'B BR
MO6%%:8H5=VZZ!6Z:05*TKMSD=NN-W$OR29+O$C5O5DD+#HF(ZGE8+.<QP_C.
MM A XSPKVS=#GMXV.SQR4[*<=?FS^"D'C@,3T-IJ)D=1XL#C<QHQE]5;6ZJ^
M[@\42(W:P< RCLAY,EO,-?N*_VG+D%;X4!19[LIFVJ^P7XK" &>+<9<SU]3T
M*WK$(B)U47<">V!8J+A:5K\R@OSDLG:(=N($N0/_P[2Y+ND%%HH!P)U%?@M)
MYWH=S>PT^P9 7/V0\/8O0%!*K@>_3CR3]+'P8Z<]^TUM/ND5,;R\OV"](:A'
M,G^KCS[S>W+8D>/X0@W;A/CTIZML978E'@H[C$<R\)Y#.ZI4^I@=$%LGA, B
M6OF(/QE6.UCYHX%80#42?E!6^Y22V)B@E 2Z4G 5U"8C<!ZS/>-/+<V$J:7K
M4CB V2<6;G7>V\T;EWB4/[3IL986=S&K-!/2O9<G\((B_BL,$V=PL/<BBE!]
M?=<7'^FL;\^9==VP"PXJ@5ST[KO+K=<M*7R?4RAX9E$;:>/. 3(+B@"QZ /J
MXNU@0@]?=U5U\FU/9WW^$QR0U]O>N6W^(PH2DL-B.6<:!V0 MMI7]6*A0LR'
M2BTB8(AG<<"_3@OZ;^50E?^*AQ,1N$<GH-2L);46* /XM!<&O6XWC"[>ID^>
MKE)D 37@<Q%R))F(D6L-$1FHQR/AB@-,8A!%N'8[>$R+X#$>9W20&<1$(02"
M"7!RT*QJV$]8D_%B5&+@PB]4OQH\[PI<M@7^M5 4!:U^CK4=F7=8T;L^TT[Q
ML3""()K2U7?FY)LW.3RGQI1,4$_2,CE+@UJXGJJ7+$9C7(PLZQV.6!OHD [5
MNLV2X9NGP./DYW:P.NVZF?H2)O? &40LS O97#@CA_&=+'AO,V$1?*W9'S)2
MQJ^9'^ODYA1M9)SES@0\EYX&<?,+#R.@F'FX^)5LT(JX0\P")#5G,X*+[)'T
MD:=LOPLE#W*[!>529#%@YL@ PMT &0/J7:;(=_X7!4@JI>/69Q$"]*RC-YSJ
MU#+6F_9RWDWOGA__&'?$V_?Y7BUCL;<NHA"@/:398P$J$(^7P+!B9EH6=>],
M1F- %\]N.V) EU"7JP4L"15K30,^60^-D_Z>;D-;2H?F/32SFHP7]ZO\JLX@
M628!,7_'_-K93F],%3W!&1SJKD'_;XK.&)&CEP/WM4=OQ+(WBA7SR2"UH,DE
MD?DE86M![#[P$85>G-?A"DGKM[^$*&D/<$9K0)'#LD++<F'E*JV=JMRA (0C
M#0/W"WGH@0)$=)U*;EGAQ X H1,K%[?@=FV*5J 912_CBGF'0:,.RM@H/Q3+
M,ID+$K>+7]T [DN(!YR^$#YZ%:?KKAE6YNM>-BSNS.E:-\9I^XE<KCKY,%Y>
MU5VVYWU933?A=.$!3F]?]EBSJ5WPQLS;_#2:^HT+%-O\A@YG,43S6+ O9=,&
M38 8HPF^AE<O)LYO7OV='AUHETZW248F R_OG0XM)1_0S01NR^.[;D938#_/
MM\HAE1HURQW=RU4C0Z8?>W#'EZQ/9K:II623JZX(95+F"]OG?@UNN^)@::=:
M8;;07PH@X+5R4^SC!L,;$#?<'2]J/H1NYBS=&)K[;(;FWAXT]]F3&9K[@*"Y
M\P[T:\,U2;QR$VGE3I">G72$HV.02\: X[I?A (N[;IAQ$3H1_8)B2#3R6D&
M.E_;H4QP6]D5-TWT6<+X."F1J.*: [7M%10VAVGW=&I_G["(@U[!WD4:RN0_
MB3E[;U^ZK(H;Q7:LU*->[AJU#L%IBB=799.5"VDBU */]CCZ(5A5@Q86/C'9
M1*4 #+7;KATMK-C4Q0U>EHM4/,BKN%HL$7>*1?V1=T=RY/XKB\P"(G=DD/>'
MWK+DD1F<L+R@C292$-8([U^[SGB CP3#,^_O3*5Z0UN;Z":?U.%$-<HH$5Q+
M!PWGR0U)H(!!Y#WUY,O/^NX-MXOHJ76$^&;;\3#*BENL<:@BXP3'C(XV.KB4
MRN$(!PG]&PP$Y$\"&\^)*KV=%NQ\0FD .5>%&T\+P?$HYF4T+Z.W'2OL-=FU
M6W<ID8AF_^(T:>RJS9S7LX6]U49M6,<H2-8*9XAMTY*%UOTG)0)2AHD/0V$]
MD7>ZO<1%"BS\0,W3MYV*X8O5U?_YS=K]WR=/GOL,,1.=?WH:93#R6[UQ1)YN
M$:QN8P=)D_O:<6_6\D!S0)^^.,V2J_']:%?1WO??*]]CW;K?_/>?ZH';G'",
M?2UMAZ)MLTQ?O3ZG^\V&<L>R8_K+ND4/*P+B6XZ'K1&>.7L,4G?0!C_=I339
MO_M7M">W^8M-7S?YTZ=%_NS)LV=1PWQ;KIW%#M^2BT1!PLO N: AQ&GVDY/F
ME+8+F, +%S=""<Z .UEM[-KUQ*QI. LK!2-N?7_JH.7T9?Z7[UZ\MDA"^(H.
MOIT=_W;4E,4<:6=#7:'7N<C_^+6 H95=6*K+KG&;%8KH[0Z -[M"[\Z1!D0[
M@4#;$%D]^^3DV?/\N[(][\E5I.?9NB+[.]VXS7_HZG9;Y'][_5/^[-FS+XNX
M*?+_^>SIL_S+Y\\^??[LL\]\$Q>>=G&CL?SC=5YRC$5#>-G1OQ;[_(^B]O*J
M79P6^=-GS[)O2O)@/WW65HKMIM]^L5WEWS8=U"1A=?_L^C?TKW^2>3W][(LB
M_^B+)T\^IM$^/7GR],DSX42X=/2XMN$1T1U7V^UF^/WO?G=Y>7FZ9*N ]9V2
M,?[N--;JX.1JJ21VA?3^0)=9R+A*;E("I%2H_Z1L;K>K.GIW3.^F4@F,..5>
M?>M>$K8T+>P+9D:^DJR&F&DL0Z1:MZQ[S@:K:LU5<FL_TW;J/D/7 '"Q9%B)
MGRJ:UY4232SJ]3<O/?@5EU F08I:<8],!:KUSXI-*-#&]\M>X3_A,7*;&.>C
M8\1P_(F @^/%T$=-Z9><9::[+>O&Y0X<P7W7(MYH]D7F$<,8+WWHQL<,WCUY
MK*?GW85NOW<'H?"NM^%;.G5NB]7G74^7=H'LDG9=%& NVX3&.=U+"Z8&7P)>
M*\?0,_)S3_-_;+I6=]"N/R_;^M^EX'/HU]^5^_Q3.7;28H@>"<^^>%(\>?+$
MIW<RS3T)&V*7__5_E^O-5W^BU>6I2;\+4/:_2EQ?,$G&Q$DYS0SS!T1APRK_
MGQI/V<Y*67H__/C=U]'-,NZ1:22GZ\=^N[>ES0% )NX@X,=2&B^O,-.?R /O
MA],L03_AU/CHZ<>CS!B_(J[-TIZ(LPR0:%SL-9VQH5OX\+ ;7']1+SP?4Q^R
M<]O=9N1=_OJMX+ZLC<>V%;095NQS6['HD6C%3.BH W^/&-DW6N#,7YR3Y\%K
M\2-U(X]]0)W)CZ4WY-<Y?-B*\%?8]#57N=;II&,=2X[)4^5*\39%GVZ:K%Q(
MXCRZNEZ&%@DN(PN+EUC=^O+O&)7,0\(8/BL^_>3+XLLOOYS(N?NKH*^HKWP[
M#7??H2#@-Y1C3_IV5R<L[[WG4S[PLKO5X/X/IS?WNOY@H-+O+[ =N\NI./X1
M!_+W91_]5GRD3'TDWH16KJR4V5N\)USN-6U-*S3HXFI1 /G'KZ6NE_AEP1O#
M%B#Q.L<ZXK"YA(1$:>J J*;H#.8E'5^-1)GG^[6VV6W9X% :E$02/;:5NC "
MR^XV?4W?!+5.'Q@C.$;A7W!<JPQ[:]KBF$Y*H#6[&C3'+>1WACWY&VL)2&1>
MSM\<%[FDR<A(@M;&IKODAX46#;=8M5W3G>^]9T0S[=;PB_"T5BQ:TX/SC4'\
M3Y^(8^D_I>R!H)_+5,E/"/186IKW;_+$',(V_Q6^$K9:%1_TY"M&$B+PH9*I
MTDM+P^E38[X8[J[;2L@G#ZOI]F6S52TN^16&L^R:NK/0&<0PYUU/!J7G+H70
MSDV]BO">_D@O]&ONU).__3[_;C<LZ"%_UXF_^".+ =E/N.^WC7/;_Q?-U.AQ
MI-"T!A:)S.T9/SHN(Y^\<6Z#,VO7 MGTT>N__&/X>/;_'NAT1_)<3.S2-"<E
MMU1.[!7!<IEKS@AWM.EV38M(.GAM1;%'V92[=K&2Q)!SS,[AFRFL5CK(1H%&
M_O.^]*0V81/@G?79T]G7N3/SN'E#Q"=S0\0M-D0\G1LB[FI#Q =?DQ\&7?M5
M?O3MWSW@[7W W=[R&)^>W@MPS8VCYM>TB#A5VXH,X3?FG_P^UXF^W@I3D[$#
M>R(4:_SD@ RI+S@54JD:UDP<?>#S<%S6EML=2/ZX&7N(%(X6P)QY=T9NP36H
M0;B 2Z$B<K_ -1HHDJC?:'?,9=>_08/INN[[#E'-3YZ@)'*EQ'G":+]V"R;L
MP) _+4S.&!&>11^0..5*K("5&PX0_T9!C?_:-+CH@R_/N[D@[^:HWG>'QFPH
M[W54S^['7OWTV[HMFQ\1)OY>\-JT%]YX W_QZL12/?$FN6G*+6K@!IOS7%EQ
M(D1S6]O>LU"U6]O=%^4F0F0R[4>X.E]-*+#*AL?,U^ H5424/2.2DA)0%&*;
M-(W@'""">0.]]Z.:-] []TIN<U2?W(\-].8E(MI^:HKQ>2;?JG?ZLMF=#?E?
MZP6<T?9<9_S[_*\L_WAN!%J<QA8!>9]C]ZPN$ZEXSY8BX !<AJL#YM^*Y\HC
MB9)_1[)]3.]G(XRD!2"BLG62S<O7_WS]]V]^>)W_W;;SES3K>@&H!?*$M+DO
MW"9XY>19GT'UNVX+&87TZ"[K?MCJS9Q3:?.J7IA\^<HUG-/6RYP,Y<7%WHHT
MS7;%]($+IB)=*$FJU@]6]3GJ'E4];+I!76I(/-*#6*Q0$I"6J7S=;5E@0PD(
MY;+0G%DZ?L=R-51&VO/RW#Y6[5LRGT68'OG]R+MSNI.?O)YVR@[(_Q[<%O>A
M@.'#= I<!=B2',P=S):^=0^$GTF]/L^'?H&;]>MG3TZ6__?)DZ>G/V_.?Y/3
M._X_O_G-[SXD0N[V'_@'?-0/IX7@EB?S@\7W#((1X-;P$.;VX?#^M]S?I =S
MYE-1M]+J].'G=8M]6_<%#?R3R[0?F3ELT"-QF!04!CH1"K'LFZ"SZ>,*3?!J
M!UWK3LA%HF>VHO\ ).:](4%;,AK!0E,?VF;#=E?5G1%"6T;P?+]6\ 6TR'(6
M+NIW:Q::4Q2";W.M!Y%85,9?I;Z4:)<5PZ9Q!H+P4/Q#Y@&K@H_X_,EO0PO%
MA6MW;@A.Y4"!BHA4BZ;BGW?DL7SRA/&%GWX01I.YO#+SFLR\)BGZG\=6_W<"
M&,(>KZN?*Q[##C3H AY;@7?=$&315D2Q(L4S%#_Y;)S?(4]S<UI4YXA"G_5F
M50XU4Y!>.A%6XJ&<,=B*,X(YLF[TPYE#$*D@?=QYC7BK=7,";F[3?RL;CU%P
MD8DO'0IZ=-&AIEN4?7*()^N"A5H5Q3B@U0K"+LMNL6,[CA9#O77KV3QG\WPK
M\Q1(9FR8L"PGMH46P"YLJ1$W7#!7:POLQ:&S;;(859P+\BI=6=%X5?4&7"FG
M/(H7OLD!(GHP8H$1QT5DSD7Q*9"> "="FJVHUP]$77$'&.S>S]3&B9/W%!"]
M:C-)LAX@QT,4<RX&>NDD8(H@T8/JB31<DPM8:^T2M@QGU_L$IY4!*<KY40(,
M#I!$1O:2_(@3-4 76GQ%D\<))WD*;G[^Q>GGSWS(LNT@FJD@<&W7N29L*6(=
MGK7%9GP%DQTWN7'O&-%?<W;:!P67K+K+ONO$@Y(.</ES'#1N5W5?<4_T'DEN
M*/5$C;]_V+6X,QU/')W24UHX3@BY/Y2WT*%W!T.K^S>+FV-B/YTQL;>(B7TV
M8V+O*B9VWE=N)Q/KB[V9-0T^A!3SHW.F?H)@SA)RF3D%H.T;M\>.ON-($_[(
M018XMRSP*/>"I A7PI6@1*2_]Q::+H_6WP>F;I^JKMN=O,2F5,\]M[8J]^%R
MJ@!#MRF7K*Q$SA_X/TOF25C7585MLBD%5.!UN>.:.L<[67D)<AU#(FBS7)'O
MAAT(3<2QHOUGR)]]@;$\?RZI[^U^@UW1U_PE9E&5;AH-YZQ;MQ,1.YL@N85+
MQPV+96.$/.5:>X^263/XJP<BHQ*I(.[_EDYP<"A!)D= P-SS*+ET]#:1[9S3
MC4,/TWK7;.N3BJRB'8SX3ZO]O#D+\!<XLPQBI<YD'\/K<\X+:6M[8DC@*XO#
M,*?6Y]3ZG%K_P'F=UV""PN &IF7"!L#A'FU&I6P(,RIP3@]>.]:O'<M%D*?'
MV#)TDN.,.>EVV]E^9ONY07IY2R[&U@R('(8:<H + ./!1CP)JV=.NI-N>4(?
M/T$CU-58A]D09T.\=JR@0>K=2C2P>93TXTFW<1+7[#:@$Y@M:;:D&Y0@:']J
M1*"=!TF!5=UN=S5W]EC;SCHP!0K[C#5DGE04YJY\2#V;W&QR-S YI2+18W3H
MA-I$(/H+B>_+S6;X:AJ'/YO3;$ZQ.)Z!.B4^E*S-1,;/V@\770D U*Q,,MO7
M#;>K$S&DT-EJ7487=;_=Q1EEH34[IZ-SR,][!SW"?-FX7TSX6^ROO2 _C<MH
M("2CN^>;KH-:.MWF+@ ][FL9X@/I# R#BEX>],L5^9^'G'F7\S^[0])CJ(6I
MR_Z9[]<;Y;#Q(=#3N[[-7Z[JM@1@@7PT$2)XIORRI]D/$?EJE.#.2T\KZX/3
M\1B5#K6OMUU?"^1<[#A.E(ON&?WC#8T9T06ZZ?!IW(\F8>/.;-Q(ZK]JJXY^
M"1K&US3+DKY']_NN;,H]_Q*0#W WR\R*_$\=/8J_T'\$G?I=N2AWI_FW2--O
MRCWGK,_VZ;#H]CN%5>5G)4UX"=B]ZS-PT3-T_Q^O_^LI/2?P\&T:^BS]_*DP
M&N*,8'IL3,!5HT>/JS"C_?H]04#N+S_[79W>3V#[33%+V\L.*E,E:&2N;-^-
M.E586 %KJV[;#KVH%\XWA,0T.+ _UKXE&ZR8+1PE#V;2R5("3*F^)=R;#/&"
M'>L5^8S)UUWE&E$E*%&9&OSX^+1@T6=6AY"Q1T<-36Y\/&4>_R6;P<+S_!BX
M,6>M!CWO/&S,'V\T&B@5VJ/215A9>9/K;9[0$X(07%C#-R$VT;7T_.FYK;NM
M&[*SOBO!N)F6*3&9S9:IFI6;>:)/5Q[*Z'U9AW7!L.*R&3H6&X80,!@W_[4+
M'PTO?<C 9J$C0=WWO-.GJA79B%]HV0OX96_/%?7$%4M%M MZE=)\C"%5J9A0
M=#L(1_AN8ZT),R5U0M8!1HPR1CS?T\KC!^]RN^7)O HO*3.^@&^29.X/NL!^
M]UUW!LMX@4X/B6@?R#/XL"_T YTCK+_^_?^\^OKDZ9?DB=!MP"T HN2*%FJY
M%8V87.CCJWS573)? ]E)P?B# LA;\?[I(-D;B8' 2PXW,.P(H,9QOV S9))A
MW(NI*\[)H<J MF >69&G\.(VNB5N(&>D1,MTOY[)$SS2%EB(7>^4NGI(N*MM
M3Q(8A/0UGO?=)1/(ICQN6=20]),;R<]'9]A5!'"&5(88@FO_3?\KQ!4\D:-T
M&"MIH"6SIG?_;Q5W#'1'F0=%-_6;A)[H9-VU<&V'WPVTI=.!A:?95BO7@,N"
MLP5%C!6V0S+>QME7]WB4R TP6MW@/69I>6>*A0GH9A0B!02DDT,3C"O7C;!5
M\,',/3)N>TF#UN->)!@D5#Q9XE"I<*;J=8NX[I0I?5-Q,(SHQ=DN]ATSY17<
M2Q9:SL)U<8E_=N?EB7R0WW;=LM!FPY3= J<"G*A0XA-EW,N2%EL:K-+N25-$
M>"('?'J\-FCV)7(K@W&,C[_&'7!G>$"P_5Y:YQC5--1P(KXK>[H9ATAWAGK:
M;V)WW:V_/Q-&W\_/4)$;^UZQW4_WFH]\8B@#+/IZ(W)BNO] FZBOT3R48,1F
M:-@,#?MP^=@9&B;0,*:LQ>A"..L";>UQJMBX<:^8XHV5#0&G/G8NLJC=8J4N
MA/$8)D2)4H?W+59S;>&^CVKF,[QSK^2Q[G()*^P8888(;UE+JWP+*:/Z7*I+
M8T=>16Z2P"8$;;3'09B&=\P#OQY=$&CJI'AE=];4BTS\^+M!E3?[1._5)_K\
MT?I$S^_=;L%CY-H=R#49)E@+Y(O\)%\2O#),.LU?T;: ?BK/[:%,_&C6,9$B
M;NSA=3)F=O;,IO3#K@$1B"= 0 ^49$HYOS'[3!_R*+PGQOV2*V90=%/TF/3X
M#6+E9S&_!G/$D<FOZ]V:J[W@B^O:DXXE_%"'$C00[>"G^3\XP[9!GM9_AZ,"
M7+9W"X?%L? W]V4:@85T6#<Q=^\ JEZNEG&60:%(_,W6N6K*UOVQ&9V;<M"]
MAS/NJI;ZYW-+_2VVU'\RM]3?ZY;ZB0G=2HK5YO^^U>9NE=+W;DSH<"JS"S^[
M\/?)RWFU#9X[(W^.LM9[(!#HC>I%O5']8H;U>?9(Z=_O6FU: ]N3>2@ _5S4
M)=>KP3M)(P:0I?-1@8X$M^>K:(WD#, A;1"A3QL*QC%LJ4]JL$7*SA]Q^GL>
M_]NG.+L;6]'#VUNG>/N?C7G['\QT'Q3=_6MPJV6"K06\D15.[O_,'AW7S6,G
M#KP/O(',IK.V94:O'3"A\WW,0ZH U4A )P9'=2E & ,M/.IUAT1<,4+[:[*!
MC_@LEEPC-X#)A0+85I^]4*,&'!9C8>GC[3D#Q&S.C,89G/_9)P#_V'7G]&!?
M.\;9?-3UYV5;+^29EG7U<9'9)U;=AO%@+\LU_>6<;%S_\@(\0/3H"Q >U0TT
M1/F)<\.6)5D*ZQ)<NZHN_1OXEI[X6=>]X1MR*RL^3=[&R1KJG?[I%]GK[UY'
M/^;?Y(N2K*X[WSFI_7[+31$O@,"CI5P&9)0'<C+,;;>MD<.!B\/L0QO0%A]_
MRXP&+[=;=H/(1MDXF,Q)J6998R DENQ]^?=9Y!79<\0+Q8;?TD;!E_JEEA)-
M^NV(34H8DYH499WA0;,8$N?$S S$8I4HRIY\_L?].O^:MXO\K\#$_.CH4I4(
M98'RBF>9N'_LJ/9NX\IMOMF1790J;R4++,=&)N-P[8JAWF*%>N?[#WM^4$Y#
M_=_?\W'P$/#+C]5/T /=G -V"C:]JSJ*].1$]BY"1.@VX2IX"3?O*M!7[,2G
MG4(VBE,Z=T_+G:J<Y)?ED&G/F2G8T2GV[,F3ST_SEW[C6I2,)ZTD;IU63^%C
M*]J0: ,W9+-$IH>GJ.HXR]<S-+70B _=E5,CZT[<),!<&VWN:^.YVM2@YX!.
MDY++8WHZ^EW5=F7RA6@\]#W:/^_][O9@:#^_%]_V(>QKC[4O [!?"U%B&D[:
MI[" 7?!LV<$WOU \/A\ A,BCH4DY965B]\7[5>S\J3,E76R,V4]:83._[D/8
MT?4'E\H_"F(#H[Z+@CLR5)H%'8,M[V$HV-=;J7)^C'WXHJ9'E.Q4'IW#+A9<
M317GI)U]@6X/F9K?D234P:['8!^XH,V>SX5NN75MJ'-*RTBW/L-)H<2;_JX6
MHH3YAEER!T?F$XYGN^K<;:W)C]L2EPVZWBEJ:E5UR[^11=ES)W*IP[XH<0QP
M3Z,)XZ@J=:KC($[F]$GP.^MQS*+X3GHGN>WYE.*''*4 :;CA)P%64(M I GS
M_V?O6YO;-K(VO^-78/U:4W(MQ!#@/<ZDRO$E\4QL>2UG,K-?MIIDDT0, AQ<
M)#._?L^E&P IDJ(BBB2H3M5,(I) 7T[WN9_G:,+#?G-=RI1;F7#%( P#ROJ?
MDH]482CB)I'R_*M2KEF)MCXI'9N:#W)IB_WVS0=8%]M(/&:*>Y""(,;YX"K'
M<*9G) N+[48[ X[:.,.6*WUL!F0DS5&L8B7 =-G]5GWQ\^34:KBW,XD95);J
M^S>-D,4PWL JB 7FU648:905A=N R\!R9T#ASE%^%F2%4_\;,4#R@SC #L9^
MBO^1D._%L6()["$62KKIHN.4G"9Z(!)C.5];,=X*[.P\20S1I2]40YJ2CERX
M*_!75HI]:W# I-Q5IU#:G<4F4([-C7IXUN6>4EK''N2E\R.P'E)&>J84&ETB
MGN-XYXS=DB'%>U<5R2_VC%PT*# ,ILT9]EKJ\EU3/G;"]QG,Y)+DUZYE/TSY
MD"NUIY15R0HD5;4652>WC4\\3JP@Q3/L0%_RCN,[BM.E&X(2C@D=55^E1RYX
M=W.,")T\R= %;)H6W"1O4EH %91TG@*D=#)/".J=C.,2!&G-6L!QD,4+U85C
M?UWA4P3B2+3.^W(>*0L^?WD0\1*7D/.UKQJ15\AG2HGG$0;_I5X+1ZI4)(.>
M+]JY*T?$B2@Y]TW(:YN$O!TFY#5-0EZE$_*6;Z>>XL-8 KV\^-^C9_P4W>@M
MQBE702W&&D  D9U%$_:]M)TJ%-M,_M$!02(K=P$MQ&CS-BRZ<R.IH"4((!+A
M&E"*'.\4.45S (-VZ#]0.(%^3GD*KWV;":5W# G4"%9)^K8&HD)'U BX>X28
M'8$D@4UQP]QM$,L$'A@HP5N$=B_9D81N(@X\2S&U?=PY[&V>8)DL"G>2UM&,
M' RW5!VK7'>/(I^4#G1C!5&?_L#P 2$B@@)^0:]<4Y"OJFEO>=%Y!EPG0G/.
MG5DT8?3#6\KQA\T[XVLY3S#OWH^&"I\%U:E^*OP20!?!A*H=G,(/1SG^+%)@
MBD267 /S:H28<&I;YH1I!<=%[4WI+2G(FL2Q;J2NN@FQZ*5<:G,QB;)D-8*8
M&%[[2:26*D,@H*1Z/4(+T;!ANG^T:E]_H5[ WJ;;U3L6N=;R9VA6H*%1A]U9
M(%-6\>#49R-TS,4Z24\?\$3@SPJ#;T0886P[JHU2E8)ZDPCZ"T^4CC7AF$@;
M,(NGK!VJL+"*".>;4TQ3)X+ )A=X,H6.>CA(ODKSQ5VGDVERD:*>Q_*,I#H>
M2?6[M&3X1S3/<WO W,("O:589^GF$0\NXAX+7G&65A2Y@/M)(@Y$Q!#S/G48
M8>E-!5_!8X(P5H36HQQB4>QC3S(5)RZ,3F)2 >*D<I*7GWPE^P^=J,"+6([1
M!SC8/,<<(CB@@EF@*($G"+2/X@PX;8N? <&8Q!GAO'!TIRB$IK=XG6(ECNUZ
M.!K/$PWP/%$H7%JOVZ+OT6"&S4J*;PW'.LK[\:J<F&AU6V>WD@"H;I;Q.F\1
M5:?;S8MT"CI!I5,/_SV40+0+%G7ZM45PJ!0]4R&J$H38OS^_^X P1+[2VMY]
M 2NLI^KXEW$ 5([$@G_UEEN57_-O^]5/]08!H? 'Y(2%/;N1C.Y%(]Q"&F#'
M#_^X!B;T7"F,.7S2HA"_AF?,N3_*<_\3L,@;RR>/O^B34I]D4PI0J M C8F0
M.T[\60Z.E6N>&)BD5I )(6VAB[ZX.^IW^^J=> #:GW(YV5W.PWLOIT&>N=TA
M/JE32/-&9]YN"KH4X?)UNWBTU J\G2[@[F*YG9/ :^]T!=I192BP-06:N[T$
M7U#FGCY<QC_GH>Z\H=HFV.=>H];NGKTX/@R-8T3V8*6/9O(3HMZI7",_Y#^/
M;;K'N8E*T<WK8&'W.O90S)5#S@^O(TP'&X(1<?I7\CA)9&9U>K,ZS?OS481I
MI-J5?<%<5N$#0XX8I5V7G9V[[5JW883<=K/ZG/7[RA[X17ZSWV13^!M,LV.;
MYTYWKS(^];+TW/8?+!ZUQ5A@ZCO8O3/R2OSTW:\U&"4()'DGI-"(W/ %94-E
M<_1>40R* ;NHRI*'+_NA3H6[',5]-),X^DD<U5&O#-\J"^IM_WF3Q5$NQ%]'
M-<?^-1W6[/-.K=XK2?/9B<JD'88M_?&$10;V5#*&ZE\V5-UFR5(MI.(XBE9B
M4!X)DS@Q!FPF<523.(&CON+R_Q^XUT,1T53>3]$ *NS*G_&ZYP+)/N_66L:%
MNFV\296<LC32:0''-DMC6V[[C[$M*\V\S22.:A(G<-17ALT0R4R)4A2BB?TI
MG;/L;-4\XYG=-LTH^N8K$_IO8CI[:7_X\"K/@3NVR1[G%KH_)-GLQX1E'$P.
M_E!EF'DC0GL*#TUVCZ![-#G8FZLA.Z8:<H?5D"U3#7G<U9!'<!^KG?N*[;P1
M &*TF*V<I[-2V^HBHQ59[>MH"J//__8_7<_MO,PSP!DBCIM5^R'WKN;.Q>H!
M:MP=1JE-AX=^A6@4\,5-[*>I#"TQCJ7D G>-/)#(I:DY8'ZD-N'+)DNU4PM/
M,6Q>*3L](: ,.>0YY5BY^4\0+(N!FK"9MJYIX%\/MER!?7L%?I$B?_?4_71A
MQRP>S\:,?.KGK%%A&4-@95XRSD812O0CZF%5+D0Q*>A'>0W?AQ9A/=[(@+NT
M R6Y7G,5Y#,5$JHV3$/;[3@]KYTC-H=#VVL[7KM=5"Y1,W.%A$NE0FZW5C]C
MX(V%+RRW47//'"R/57@X6%!$IS]F:%O"F!'8/8UG1^B57H-JH[9?06-I!2W'
M[?9**[#@%U[#75B!/93% II>K:T6L/BY>W;OR7MXY^":WHA$ 1/Y6!*5(6/4
M]: @JJB\ R^DPC56A;0!E8G0F[';)$$9^WC!HWBQ=@8&X[(7JE2=R3)N-\I3
M6PZB,)KZ X+L\_F.^Z%5L")S=8_QZB+P8@E$%8A')>E1:#.4BZK#XS,ZQ(IT
MM];HG'$0JE[K-,[P:)1!WO&"X"FI$S+\[2^;-7NA5,MN-&O-,PL+3I0L >'$
M[U^#BDW20>'8Y()H%+-^.Z>;X-4\6PSB"&&R@S*8X<KYH- *,P19M_*2F26H
M1\UF%!Y]P^GT&NM6WG!ZC<[JD7X220%!.Q2@8L('3FD<^'<TM&!HM]=UW'8C
M[\L".R^I5\RMMRYR";?C.MU>)W].<.'EZF<;*RHV8SD*@ $E%@MAG[ /-%R0
M1KV#@9!1181N4-S]8703(NP8<P<@3!!0[3MH8?TD%8- &A%^G'S@[BHR!3V=
M8S7D-P^/\5.H#]O"MMU^N7=;P5VT2A?=L<MF+^_-_>N^EBWEV^Y;_>:_[%Z^
M2D6:+9:UK#;&>?R5!4,[G]0&MR!L/W[Z]V?>LJ/BD+OX/S2_:/1#/_Z.YUJ"
M9CCRK3W*21TYO5^Q5L.SS&E^A4#$P(4O<7Y'O\5'.:E*TOT+M5.ZFH'N1OC"
M1[['*^*'JT<%Z0=;C-C7X1 E8!1_;\?C_KE7;X+=W'6\5NO%;:&FJR_;9RM=
MO7]U'=PN*(7/2BTLWOT'%>LU._[P.M9M E3:.;W;U6Z\KGK(YM*8,69P/F!0
MUW.\MGO'H/M?IR'@7X]DUAKW2M3Y+?33=1J+.0#W&O?YGB^OUVK6W,:A:?<0
MT?+[Q$_E;7FRPPE_EN3TN$-^/.99V]?-V>7)(C?9EEK-KM=C:'$'AV_6VCOC
M\(:8&SGW3N]4O5GK'.92+:<IG907L-*^W=^EM2'<2BWM,'BP''==%<'8$(O=
M)OAJE>.7*\(1)CAPE >HU%5#=[)0W1A+(>ZU_<-TA^'!!!/UR\T?L$<:-^#(
MNZ85O=($HGWZ.*UD,(FB('&LB11!.AE@IH["--8 R]R)EQK*E'NLF?-TE.<I
M#S9A3'$<B]FD'&R*55_R_KP$#(Z9CH:8]R(FISGN&"CZ!W\ZMI-X@&^*IU[]
M8O3_ZO5&[8_9^!EB!__]V;/O?MQ?M^23H=6>+MZ[*+9NB_1E7HZ-B\" IDY(
M46QWZK7&^OS)E)S4ZLX:?GOP'%^XHS_'T4TZL:Y4!WL#XGX\%Q#3K<81:BF4
M0S,&2BTTZR[PHO-4&]4U"Q-U JF T#/5:E"&8Y'WN:5^&-27"WN3DBZ&_6SG
MB^U%1=&NPYH%(D4VKI.%N!M'/O)"/PON1"A"R@W32828**A[^H6P<79Z$[&J
MC^G+R&(XKUHDJL2EBD#"^VVCMWKF=S<2ZYK2F1V6SK1-Z<QQE\X8#>&O:P@^
M&/3LP;$TP-';7.XH6(1'Z6M\#.K#*>.]WWNZ]9KWN!UG'X0B_HB3[+4[O1W-
M\I'/\.^<%53TM(DQ9[ZH],!<<JQP]P<V*&6C$?Y[$D?9>*([TG'W,3N:I?[4
M_U-H+QYV*,%\[]S'0H[@A+Q\-?O7HN]<WC$Z%N%770,^B_B7Z"1>'">6U"8-
M!5Y"A3(^=H$;EEK?446<+D-!S&69I,1[X'6EWK<"#$W85?)#_U/.[<N9'^*(
MOTJ!CC^:QOD_+W]-7C@VIJ(G$74\2[C('PU2U=0ZRM)AA$V@AW2+$KF(]'%R
M-=;5F3R(HC>%D8'%%Y]B_QH.QL6OHB\#^[6(AWY42"<CBXPL,K+H8+((RZV)
M^<?1R$_51>*.IWQ1;[LQ_(1D!_D(1,C=AK#;FT+B4NW>,.I=:G2)3=P*J:&[
M8BZUL**9Z(;G:OQB7'BN"%/R@S Y7<[DAZHT$H7-J4@"8*;ZQ%>62]X6"#_/
MI_8;/Y9HDD1]=(&]PF)P#O=5>*5&'AAY4'EY$ O."L!:<H>Q:K$K=$#-LHGO
MEFJ+;V0?; 9R!@L[=ST#H\;2\\5J<^X>3?[K 3::SCL2+H>J2%2@ASF,;K2@
MT":*L$-!?4RGS#=$P3=PU%$6IQ/NZ*V+B@OC(Y]>N7\R").YHTJ#Z::J)M=@
M:?@H<Y))-,/12TW"V4HA"5ED2JB26^R,BKVN[3X6WX823#>?\A?0D!M\)1L(
M>TY3_+O4N9OK+JDC.,R#JY?[L"^VJMQ.5*@..U.K9? TJ):;FK;2&#A8DJ*9
MAMU8@4 ?R(Q#3(&\S#H:J5GIJO"\[VL@LG P ='+SW[$]MI]N9S&4VV)>HJQ
M^J:)U1_?00.UYZT.KJ'2\ZL/!X*N^$\J&&<T':/I&$WG8)I.X0[EBFQ013BZ
M#9>UD/;:KM1F,!NW04!_^.$0L7#FV 3ZVL<SCS4KDR+<+@A,8^B#KI&)A=1*
M4*IR<4L!?LT>V ;6+R M:?J?JR]O/UW9H)LQ0MCKP _)S6IC^P64SV[-?J65
MA(44W)5@3?J%*/FC&>@I0[N]L,+Q?$KS4$F<-?NU]E4[I=E*J?#'5/]VS".=
MR:(E/<Q!OY2%89+CL-GGG$**J_DE@O_[)_X?#OU!#$3V M&.X'U<'W_YK_=O
M+MR>/8M@7-ULFQ6[,C01D08U,)50(95_.HBPY_L,?<B8/($O@&F\#X<13,T7
M<$)@%@*^EHZ:02#F"2*M:6@7F@;NK'+9Z_5CH'WHE)%64/V4/ M0 0-8U 4V
MX(:IIXA=AXAIZ+U>F RJDEF"+NT$55)%Q%(3>^73H%G\'.&6P2,W(AXN^>*!
M(%^7WKWHH<\/F3T3,1 F1I@V>%F4SF(?/3M\UE_!XB\^ 0_'R$,LQ[2[K*_C
M^OADR(!3PO-7G8J&>)H^ERN82&J_CL(0R :'NH@.X^%XXX]]S/G3L>-/<32.
MQ;3".V T%*.A5%U#4;>2^6W63P:Q/T-1=\&8IE,,]\)U92= (-F\)[>"YN2_
MU:YJ2GPX\(K!!#TU'_PXCF+'_@3\(8UP&BBJT8>!L@L?&\HIY12"8$+I$@OB
M].SWT%I"X7E)2 N(_42&Y+M!9: D> B2E&!'E<@NHYERQV,0?1,IDI0D3VD>
M(,@'<I9JD3@!W8DF >I)CGQ*GHM1ALB'0PFR?BZ'IG/2D4_BD9,Y3X/JE<'
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MQ9$UG.L8>,3!CT'%.=='D69QWJMAB)C<.9]BE8A 8[&N!+E4X ^PR 1;-.A
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MR&^^0I@@@XU2.7AK\%&=U9$E:GX(>.%CDD J<S0SO6W2)Y"TB(CBPW_<P&%
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M1<RS+!Y,D,>-N%1H,$<WAE?SP"2G^F9,SLV?O;WR%;)P*&'[PES1U _KI6#
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MG@M96@Z>Y6D42SHN=A,N6IAO>CJ)HVP,,TGI(7P9 ^[B7WJJB3T0R826;Z?
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MU!_@;(<^YC[0SUYEF" 0^*)FX7C)AG4ZF"0@EK2M-$IA:Y7.Y7!N@9XT93N
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M2%P.]><9PXG@+C\5/7^5OCP_]'_\+02J!?#9T*(<CPAS0JYEDB*,D,D&,-D
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MG':SY31;+>S8&XLP3;@XHD]N%.4V8>WU:@!O@CE/HZ$,^/TCX<?LO5!&#Y&
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M0 ^C:&D4SR*:33XM@@5,TABH*&A/O-9=[[=NM16NV;]$-Q(4/IW[C$D'"7X
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MZ*=D<B<=*"F_'X+64JWHMXQ )8TXSCCT%T)#=%PG@D!C:H?O-(G:&W)R!LE
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M^_AX)1I*O&*S"^QSH&#/+8O_OQS?F]R[=_\*2L5]N!67#$'Q]-]D.FVBL)"
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M+DS!K" JG=55G-+_3YN*9$%514N3YH!!:.HJ3>S0[.E_OAM)>FLIR'FD%W;
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MD[1B1SZPVV7W#EH\>#:H2M]E8*X;?!A@?+51J!9N0OL.U(*F7@O)<"B+?E2
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M-NMY<VF-,O:!DJ_=U7R>1QT7K'/^AAJF<V]*BKB9P1* [BY9U7P-RT:<!FP
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M$CI"R=N$6$H8GY .IRY*:2I(VDR"GPY=?7):ZCYQF95F<+!55+F-O>[F3NN
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M+5[*8]WW*)A?X)$^F<Y\6#;9)E*2D.F0>9Z+1M0H<160YP_[T_E6#N)F]UR
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M[.@+,VBL% *5. F$7A%^$: *9KEX<!8'>#JG3:TA\E2&^1N]J& J42Q2!13
MH8 1/="6U1J4%. TPXLZ'4%$V-/( A%:DA#='D.@$CM X&8*-[&(S<[=8+9L
M;% /XSNS!2[XP.VZ @)"+<GB+T3O!//&,K_!T1#Y%ZB3@N-0R9<+.+^QGN,9
MV1'FAESOUA_>8@TT+W"5:U*@QYCJY96S#H-?.!K:+9P6CB)![(N (;ZW@)Y2
M2\Q%Y%;OZ M/?ND9C$&B7(]82P-O$*2C\Q"ONY2-1>/ O<7,J1N&$P&H0[!"
MG'BYA\%3J-I;#)U5"P)(8,YG!8MH^+R2Q76X;XU=)%B/1WR'W$4HRV,W'EA
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MBXKB,+$[O6LD8WL2Q%5\A<\<!,?62L"L\RC)R/=<,%QI2A]BYCD3V69BR"7
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M&FK'F^$I\62;(?P=9\MAB2Z?*"EC"?%JX!\4:> M;10ZD&(XES#;+&%: MK
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M,+.YT+>6B)!B92&&@P6Q$\T2B9M8V173B=D8ACZE:/YB/:E::/)B,AR<#,.
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MBKLHL<N"$5CYZ&T0^X11@#T(5'F!])_!.LI+0:Y%;P(=C]M$!86J1I?G N\
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M@ VP@>F6F>=^R$OZ,"(UI8@4BAGGU9)2;7<ERT)457TFJNI$?N_;P!]B%:?
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MRL9>O'C>]O0B1'-V?7K^TR)GNP3C55:6NE;UL&S!([:6\?3,P0$8] ?N_<'
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ME1)D+<J)I^ 6HOI<B&2Q!4HT";CF^<;<P5J6Q=(.A"R?%M.8S^U/*/HSGG?
M]82-N=ZR]B[E+H2K\?/D!ITRU\MM@>LMX<:XO/D^1G<B>LDE7&\=;7HMH_X
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M7*&$F?Z)BLJU$1EV^>(/ A?S?*D@[/KRW:DZPF_/D7PI*2H8*DVUKKX@9@O
M_6MT9*4S-EQW</:M>S&X?Y +U=Z^Q:4#+[5*-$BOL<$]*.V$H#+F/5RCCT"
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MLOK6&TKJ@)12C16#M+"R:C);U8I=!TI*7\.A]H%N:@#3A$]C'JI/\?-=($B
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M:1[/6,.<7=-I*HS60S*D I'MI2P0\&(F1@#DQ1A8N0;7WF+\64?JP!R2-'I
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MT-@- &UL,#3/P,:VJH5?F%YI:7S@06+@6XZE+='1RDX7NYZ-[G,C2$L&;!G
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M''!1-0+><#TX,)^78LJ[50%4ME;8NYDE1+@H"[IYZC<OH8*+U=C[8KEWA\:
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MBZXWAJD748;MF2 8XF# L!+U&58?-+$J53XARR=4&<?^*_YL^K5+_&DB6#D
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M1-5U!\2@&JSF!-]4@06!KW:LJ[JAP7 7X\KM_:5^2>V]+2WJ4A',%#,SH';
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M_!BI$MAPJ&\_3P*H3I^L3]O9A793BTQ[<F;8;J):CN#0RP,:)8.M=!;*C8"
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MSHJS;@38=R+ 7:UN(=Z9V1(1,DPW*?EL3)#3;L$= -NIIM' 8"? ?"$I:T'
M1F9P& WC<2B</#LL0'*$=3HS&T6%Q@DVOLGNF/FHBUJ)T),'G;D6E,"9@FBJ
MPTF3-\3A+]04M)Y\JW+03@?"&-*^@3@.N82/5_VYSC]-^*?/RZ%^=B%RPKPW
M73NXVL24-I) *5(81V8B")+$RTPAY?F>9KDMDS<)D,?K,TZ4'9*<J\M[IJJ.
MIK_Z>[^2\V@_;-L&?\&$C_&,DZ<".*")\J<H$;I\2RC$%'O;[KD<HHR3[,%6
M@&PK6MM%FJ$FR&2NW23P2B89QA#_1!I?2UBH8#3H,F%H].B%VCLG/Y[WM.7
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M:=S-;7*:'.*:;.O$%)R//QV0'ZML>VRF7:<<%NG'968GM;K*Q"=H+W6WFR:
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M=0U EQ25$ 6@H*  _;<?\+H(" ,(<'#P<+ (\/#PB(@(2,A8*,COWR/C87Y
MPR+")R$FPB<D)*5@H"0EIP,1$E)Q4--]86)E926AY.+C9.9E8&%E_D<)% (B
M(O)[9%P4%%QF,D(RYO_/X;4#P$  CMZQ0T.1 ^\PH* QH%Z[ 1( @(*%^H\
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ML&1,<)B""O &#A_(F7T1L(2BLZHZ$4$LBF?8AH[C2#@4K.N?SO^!]A_(_N^
M^?W_0O8_@/TGK@4 &1KJ;?"@,0 P</M 0YL24%N7O"$@^37LN*$<&"@G_:YQ
M=@\\9\COOOQB? 6P!8BVL?] _LR/@7=7Y5^!=JE7H$?A%7AO)O *9'@)OSS_
M2VCY_UIH[M^%E+0V5H,2RWYGO0+>B:] 2";J3<A:4$\[6H.4C=B_BLF^ H$U
MF9#1?Y,Y"5D'KUOOD5R>%D)6\UZ!C<+_2YFJ_RJSQ5KQ\X&]HEAK_^9LI72R
M?HH1/W $<7?GIORW#Q)5]K\B37H>S"U.)_VV>2YJ@6/]"M26MT9IO7^W#?/&
MP9(HUO>YK52G7J89'VXD6D;92+4/+)8L'0/^=8;:3AEZTJIY ):">G*8JUR9
M9JMJC7AT/"V--+92;.N742[<IT)HVQ#9Z='W1%^M=.U&(UE<4UJVY]/3O#@7
M[\;@143>A0!4V?\M%L]^O)DI#^;-PNND^2(K< !1$++$<:0R;O:-VX01Y[G*
M?,^JK* MS$1.K= /I)6BP>=)"<!BJ;BT!MMA3IVL=)$>WSO-XEWW@0,!]>R0
M(N(\._J^F)9J66B,3MZWK@&TL@MU#RK5):L&JW$,&FVPU5XPI7B?!VJN2#:U
M+WL4 E)-*))9E7>F)]C-2R%WXD>O0!/'\P6X-_+?TCF'C9!=X1LV'@(L5? 3
MA0MD*>7EGF13[-^2L_:OP(C_W-21M8+ZZEGT_"O@:/>X!0DG^?>T3M<KP(UF
MI%15(V+T"OP1,WL>:#^-?F&%_&?2RQ7M:8\O7+:W!SOR%4 DRKC]_ K\%KL;
M_Y^(ZR7P9>:_M>=RY#\J>+_!PT$*$[>UF?D*X/,W"=^/M<4]$F"I$"GN6$GA
M)& /&;_;,OZ*I@9JQ+9$NZ9^7.78)@&3<+03.NF8&L<IB+P-J7@?DOAA"*!)
MFQ+4[6KKJR45GT>9@(< M\9)8;PY$WDGL1,"E^#%;"P/I\6I0F&&!\K<S9CP
MX9:DH74/[*E5@J6A$%B44XA.3OC/>?86J:W %]!3X,,%N6>8V6&)VX_[>I*'
M_\Z2>F,)O!?!4@)RL&KER<I[Y-.OM=_UI3O)I0O>BGW.1E:V=V=-&K<0[13@
M*EZQ@@Z;JFH$:P()(53YI-DA5-!:79BM_)\K8]AI#LDZB7XKZ=S45!RLXQ#H
M**J;TL<(52SW-99#=QFY_CP2*PVZQS^J4P;;_?$1E].S+"R).1&TVP!CW ].
M6,:V2C6 $-Y[QU?9;81+FG<'N[P"S#$8]3'MVDA_+I"H%D+0JW?YD[8FCUWJ
M!K5*/P5D@*Q?T+7*+6MM.\MW_A)_;D\^TD215**EIB@N>N\CI^VI;-:M6=9*
M#3KXP&5F GJ_>%;J+&SR;9C R,B:3DQP\GRC7/C&\]%=^*M85)Z_69,U_@BS
M8O,1U^=@UE< \U!I_]:1OX#:9+$JI )OM*%.SF9#Q^2$](>.P%;\8^;W>; D
MW55W34 _>]JY;WA[Y'4A/;F!)[%\6/4U[JFF^0D1:N6!6A/HF+&O\A5 TI^R
M&YF\*>CE6H,$"L'_[=N7[,*[*@VA@YBO^ X/7;B]L87YB[Z'XWZTY6#G1H5(
M&CF$W12:*#3S@T-9H>P>91])SJ]>@:@W50;3C)<]DR_"3S0-K%W))9C?N-DS
MC[%&W1VB\(02.XZLY!Z%1E^\W^;X[Y)X/Y&0/T(=J8/M_=,6SN9D,/>*[%R<
M._6!B#(ZA-=,ROM#"7)*-8]>!4]/8J^ E\+-H]S]7>1E!7=*KPMZNLTN6*A.
M^^ZA4Q8E?D;LL7U3J_1WRP)=1KG2B8?=XC%X=P,\DGA\DW%Y3K*K:V>SF<;N
M&1"\EHZ^A<9T)O"P-BL7TEN._RTMO]0"Z3SCSXF5#D.\1V<Y,:5^(!3]&";B
MBU 1$4C@$R+&-JH@,WY9""W#5STNT_>1J'NN2+!7Z%(TI0;&&0F[$2A6S[\G
M7[Q!3X>];.'L>V[%@NZ.T65_TXT_,,?X0/G@O@*H\+C77(<Z)XDV=/C?,'C]
M;'(L^U%=&=R>'#0^-Z5JU&9/*2<J%?\+YOTTQR->NU9.8768_S8\@901=)W)
M9G+(EB$Z9%'N&4&U]>=0ZK[WJL4K ,9X<1;E_+97'O!G7QR>)B ,^L5#U7N!
M?;S?/]7LY^<(J_YD2K5WO(0D'G_JP[,OH<.JK.\S5A\>C/+,5\,D,TZF->^>
MG.K)K4:?(LW0RC@KLT-H Y;^,;MIGP.^%I[]Z%,]G7VB$72P"L]_I[90K*!)
M4ZWS>\,=O<RO#QJ:%TF2JG3PG^5+EJ;QRSYW*F&H+A8$TW@<<7509V!"?SQ8
M:H24BV,TAC23P;J5A5W$7"U34_.IO1DA5SL[4%D%T(=:R&QS4;\IZA5F @NF
MJG[ZD<6W_%>A]$M/O*'N%T$8M&T]RTC,7;&F5Z 9S,T!OA7;569T-JZ:S&R-
M81YO(:^"AX(Z\1*X*4Y8H9LL+VCX0=',R'.D_<>>"T1QU0=_D6DZL_NR][0W
M] I\\W:._AA<FM\L!:'9QY> ,1_%@?YPFB%K6=<>LMDX95"KQ=7N229ST.EG
M!/8D(HAL=B?T&(,7_%?-HDM=R"&"1U89$%Q-,<MJ7LS[2.*K<'$[;3CP'[<M
MXJ"(5M7>7T7"Q0M>^;#Q2@YR*Y\GQ&_>-B8NR$GD2/CH\_C]Y%XFG.W_AOK+
M7?BT?S7/O[M!!37U9E\59R!;\(60V=J,!\2*Y-@3QHG?\?\+RP<G(::&K:5D
MR$K]I3MW"'2\SD%H5/>%-6V"E1%$0W6@OJ:$OT%F;<O;<U%_LIK.=*B-D\F8
M8/)Q1QB$TB$^O[F_4'=MFNK&O3CT?AM+CS5V5)?I;@S.S[(>LRA.IZ_RBV+W
M9H;DV$4P,$NZ7<;Z7BU]<#I^"6OM@FEJ[;JLR5EKO82(?P)!^UZ_?$.4$_ZB
M"*]L*W: =:V%EE9NQK;<AN%6,Y@A4Y]=K,-V]0>3_.<Z3Z+K5H[HQ?C430QV
M#:X^WDEH6X(AS^#<']3Q>9&GA0=MQ1Z[K(SWN&QR1:_ 6$E.OG@M<5Q<+539
M.N0>K_85>-A_!:J3C^I<J9T<6!40\92J^@Q6&OEHP&#E^I_B(+H[5-DO#IK-
MX=<G_D4[MQP*X@X4/U?)LS@!U)V:U"6<+LGMGVR7K#LSG@1Y)O?^/Y#*\,#4
MMV7A_"<+\(^ZF]OV6<"0O16:4I4&:-$")':1F_>I_ZM,#BC"@S@MW(2A!#M@
M'WN1)D#E/EE@'J]7C(O0*&0]WK*H/CS.R(JELB49'F$0\=?68!:O[PD/DGAK
M'IT/Z;W6R6\I5R[LF.3IM_:W-GQ""N,M;ZOQGRD5<\<2E?A>JPJ"$T@RA5\I
MCW?9K5"0_*@JIK7S9YS"^[M!)1P'\NY$_H7*B9%1:H'DI=6QT%+USI=H8J*?
M>U8U9^79LS/BY<.@KRZGH)C&P=@[",W1CMI8HJR4ZC>Q[5P0Z%!8 G=D_V/$
M?'XPCLA?:P+B'X6^DML_+ F"U).9AWVT *.B/ Z$Z&"*>U$6/TNN3\S]A4DP
M)"E\JCX4/<RF&*+J1=;O[',H9DRFKP=U.K&;!/XZ'HBJ 1?\C3L%,1:YC3+E
M+>S;<22M8OJ>GF-)H>LR*PFO@"E-W[#20)^1^J3%0Z[M!F,-W#<NM3BT1#X(
MD^H)8\[X-YZ4P*'!"W)8>&@W5=[;<KA'[?0#-]MR*>8E:O$\DZ6JU.>E&YB-
M.O5=(=ZBSPY3G7_R9%V;"HJ6+!UP6P=8;SXPB:@38LHB\G&[/A57K^IADV7(
MA0LL]?03MY*,YIE)D ;B2!7JNV^F#(7UH1.H^.XN?<,V'T4/1NK#0WW:AD O
MQ R7? NSV7L%_N;Y!388<ZLF../)UYZ+H'+4,.V:\?K>J>7*5&@)9O5];S3L
MH'ES*Q;!\>[E&<Z?:C/,K 30>6AM@F)8.G'W.)]IAH=/)-=(*6SEASHW:BJ2
M9BMLO]4>Z="Q4E>X%NTG:);E/8AM#\)$(&*D%Q!!D!*DDC8NI=_\Q' "R_ZC
M+T]FY*TC@T>]%32_!]ZM"X5ACTXVL/%8^L[@KBC15&^]6R*\)6Z=>?]QF<"1
MW(Y(6W?5<J99)6LI-TM%5SCA0*X0^F&F+"&'E1\G&<+TM,RT9>(T(Q/@AS *
M1*Q*KB?*>Y9YOQS;?@Z1X:02'>7<O^J%VEQI*/TV),&:INK@ZNYB"VJ,AENN
M\H\=Z(-4M#FIIL25>R@;86-_&*LM$V$+9UAY!N"4D06XBBI$Z26NC-]68Z"#
M-WHCMZFODX.]Y**^"!*MUV:$^"W%2[P+&#WS!ZUGMQ+;4'%OO\ H*-4[5<V&
M9C8\UUXUL.#DR'G+2=P>3A8HU^SKN7'2J57[#!M6A;"7B\[2NP9)*M/14VRH
MJHX0Q$T:6=$V8/+SN"XSXAPR-1D<_YSST@1>?JF+]?).(%.0E^!!651_*N8Q
MFWI4U+"<.-BGB_T:W6K3@.#(A7>HS,94HZJAP]%'*OK^>0V \3;"7ILHD*UG
MSTFHY_M(+12@2!&D#?GR_B>(*3V?;:%K?VZFJ0]6G3D*J7)/<,\*6IZF./3F
M8[UUPE#Y<M?3BTJ-=1E1*088-=JG:VPKU;O6U,U#WB]5):T+15%6NS0AA+IF
MU,;(]+:A7!&61ZAB);J]N7WJI@(_$"G^@$8Y?FMDYXCG-Q5I1&9DF9/,AHV9
M0EK6) X/E0_=5S=895=W@E>@3%I'K3LJ*(9(EW;,IZ:[AFX)M< "#[2OI]XH
M6QUY2M,C5=_^BW[HP4Q!Q,P\^?EW\Y_YC;<3(9ZR\./;5K0\NFQG>YVCQQ71
MH=:I<N,<G['VC"3[ *O4/I4PT,W46RWGH^6Z+'V%>V*YZ#4941<.(1"L *=!
M\]^NH%?0(6Q&7DXT#%$)E2XFMT582R\I2A6Q_6[XI6)'+D>7KHO=177=)ZR;
M:(32REY8/W?Q$QGAA>ZV@JI],6G:>F&Y:2VR+3U#[^4W[>05IW'#^+%^(L]F
ML$I;!+=:.Q+6.H-YSV=[KH$2=O6F\,^1!C:E+/YA+][3*<3)Z,?BQ\>=N!;D
M2^H1:V9Y5@/DO2U)Z8V \^=L#BVY4XPH9XHHA^L^R67M@;EH:?$0?P)E ([;
M,/&[]VH\^)S5FS4$9$<VCQ<O1388P[_?RYDO@EV* A+!<J@M:Q8*#N^;>DC.
M.&<U]AB#YA#9 ],H4!AE]:W+CC;EG&?"W1<=/BCL%%3LR_6UX=YFPKG_;VA%
MEA)DZ-CHA=R^-K:(\0P/P!E+00"K+N,>ZH#D^ICRQ<]J)_<Q]*HBS_G?6+LZ
M-%2FK2%<$V)A1?=&,*F;$?"<USV 2@^]73@FEREZ33;ZA=G@?:-\J_&SY[0&
M:R'.C$:,NQ1-_T&ICS$M[&XC)5<^?)I;*:1[ ORP ?Y5DE@YX+ V1_[S7<^'
M(NCVHI)TT,1Q05-U]);;D!:U8R-%++7@;#Y-?0F"' *"Q'(ES>XL2H@TDF9X
M?,](D($5C!7%62 SJ4,\;HGJC:O"7:9NTL^&BS\G_;TNODKFW-]QZJ.E4Y[F
M-V$'[+95MRPPOQ='XQPXA'=OFQHP9+C-:&:*JEQ2("-$&?A01$>Y/5D2>-(F
M9,A%?[NCGV 'JB6;HOR8Y7BGFDW'LP])H_C:N<MH:/>;F3&ZQ-<VEP/)P\N(
M5]3KVD2-:H9<.,DZ7^AN]C7Q\UZ!N2/*&$1REK[(J-3-5$=:+*V^ K=L]:.I
M[% 7,J=TE]BG0WY:*0M>L(/;/8>0M"W]J,+B;T=SC#F+R[:9##O>I%5R..MO
MPQIL4F]^?Q1]QK,3MD=2D##=F'3U8C7=P.!'/.W'D)[6<Y3MY:T,BQ8,&=]F
MSEGHO[H.D4,798WD&B=&/WM-EIPJG3EW'Y1O;YN]IN\>G4NYF$SI9U89+C-:
M/1UB5YIHI59J&*CJG LMW]-VX63PGM(ID.,AS*D7TK'$B!$]EX3-7M,VEB><
M; J++ZS8,1ZC)0AW_'D%ZB(UQ\_A@Z_IN:]5"<6LPX"+#L,^\[7=22+J&_PE
MS7@?[MQP5L<<T"+/CS"GM#G"'[>EV?'W"VQA[AGT ]:M,L]M%LC6P3:N-E3\
MVC95QMK.UT^T5LJ&"]_KP5;)>-V>K7O*J?ZG4]\*O_'12LVP8;57KOB",%#.
MX0+]&@!7^//R#,6J]GH?*90E0ZJI7^^Z1F>GH#0&&5/2:84E&,1,W<>F-WZ,
ML'D&8?AFU++ &3I,8N=EW;4ER@!RU>NH,WS0Y5[%(F.M/$Y%H2GMS/J[22;Z
MT;3.E!%R#9:[SNTH7684AU8LM#DXTNS;;L^1A:=:U*):^**N>ZXN_&0Q:Q*D
MC\4=1KS1AU?EH7+3OEUT/NR>^!=SIWBLH]S+2 .V*8*$<,3Q#/Z%2\L5&?$Z
MX4&1O&6*-I:H3![$ ]A'#D<KC3_MW0:096&YK?:,FHPH?+&_Z&2$Y\P^J.&N
MD$,/+:*>P5&@C ?E:4/0EWA3#"861]YO%W]92S5#63KWURW]POE+1"H1(G?)
M6[1AWBOC9&W.M[$X,B*>.!(7H/Z X2=(<76$@B%!W_Y7DRL_*JKXHV4%'FB5
MZ# 5O^SX3V7"_->T>ML%^+';8TV<#:UX9.5@]B,U4(#2\_C<I!NAT",XY!5@
MX0C-;DC<T3S'NG5)1[N,P4Z&U%-3-;ULO@+I5@$<$I:WHM];%0/M"U&Q%\NA
M.#D-(@VM&L[Q0_60A,I=H+\WF5#F]QX>6(7*",OYZOY1AXFN3JL@#(KR-)II
M;;[*PZL=;Z41=5",Z*[_.$3:)-$[ET1V0<';EXX*(50LN^PK"++)Y$Z0=JJ]
MV9QM4PVFHYBF4"^+CU=!_CD/X^-YJ0/WLW[2TG[1DDE+"G57O#O Y]A/08LO
MN(.--X%5^D]U4V.B(J,=\BB7P/=*Q"VTMH?I*0[N$.WE/NZ?-CHN\&MI73!&
MLUSE^3;"8M53]&4S/)Y2^UEP1C9^?K)N:\=7:ZJF9;:S[-(/'J67VA4C]L6X
M8>CBUX?R:06F*.:.S(?6E(M(V-&?F:*\-Z$//)!6/5NE$.=QB<62\'SDX3;3
MP4B]/RZFO]T;2"E?^K]#"##C*H^5FJQ#,5*OK ]\:IS //G;I-)5.4*K!FM
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M%JA7@(Z[(=\+CGOZ%]V5^H[Y]MFFB3$94D^+/3Q!4 'H7DVX^O#%DZ0?$DC
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MQ6VXQ[]<(Q ,317B#?!VBN(I>,ENXI^'!^XOF]YQ=O_OU'][B? ?5%2"07B
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M#)]_GZ^:2KQH#2\7._/7_<<4KPZ6.YZK ?Z_\[,_Y'T]]7]02P,$%     @
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MG)%G-2U,AR8H@1R^L>__:C7^S5?37\$_ANS<SW@L[R:4\K_=4@KB]<&$D?\
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MCA :7I9'&+60.,;CS.WEY1S4+<TI#:?KU_%3231P#J&> _DBR2;:5L7&VMI
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M,$:!X86#:NS&R=UU&%Z=("@NFWE*4KEP9\+AVJ3+UYN.I"_)A? 7%O/OO:'
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MR,%12K.M^8RUQX@6)]XP'DG=V\2G\;0=]E:G,)8$:><9:$C*H#G2K[K%#S=
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M>#U*"5]$PUJ#3;P8T^@B,Y6\$_ <\G*N!;P"C>9%ZJ[>JJRA:$4+WIX.:#L
M'Y1FBEE(BC.NBEHN+[PPTV!J@IF&1$Q9^3#9@,;VJ(?Q_-KNS[O0"JF1E@#\
M'H$/9R.7KU!.%OZ-+9F\QXG'QHUHX$W.X(G<Z9%J3@!$T+91DZ/K]$@A>.=O
M;$V6/K-;RO\'W/XMX$W[E8ATI(7Z\N^C7VNUF_%_P'3D<@XB8?>?H/L9EF])
MMVW2=NO_I^3=$EI?![\/;I5'[9V"\PJP,)F:T_"-^T63-AK(YWC-].6M6(]L
MDB19:?RR4PWHFK\HUO;)I="J36O_-82P;0W9IFL"ZQ*?SG>@[\G^+#@ZF$A;
M],P])T2<H;H6106;Y!K=J>/0PU_XCJ7IL\4)E5R/#] 7A)U_%C7@E-+Y396H
M4N# #F![N.\,:6*HAMU[UB<YADU<"E1'-TM0&+S\1<E\R:%>-M^D@\?\5J7U
M/:)NRH=K2F_*LSD+3K%(3P8:>CTSR;*S1AQ3CV3A\C5E70LF%M__ZB7.VUPU
M'(U%I>CPDN^-?OENTC+W;=TQZLH0!P>GEF\N"_2A63:0KG*D=!&466CV\*8=
M#H&R0A:O(BK+#D@;4E=&@[2XM;KL_!+X2WE8YCZYIT!%MZ[7R^2\"Q'Q_:^:
MZVM:(K3NL_S:^ MO5%8,#3B Q0/V&%A_OOI!V?A.)ZB)>]C##\NM(  +4JA7
MWP(7SBTK5'4'N^5RU)0L0#=V4O9Z'>887K);?SF\XIY>;*M(M-J6YFB,7'XH
M,M[ET_#>M2\!JZGA;"NCS+O8+[J?>[/Q[<EC.^'CU(2M7W04%GX@E42DY1H5
MDQ?-YH8-HQ>H]IF4N,^WVB5A.'GMYNMIGJ "IKAA OS*K39ZQ_%P0T,Q.RXU
MQZ>#::88\L[[? ]AU\-_M>PP<<2B5,#YR'>Q)I1Z6#./;CHH@Z&,).;VVS3I
M;?8 XTA?[[@;J=FZI%<Q6RQ2P5QGV;R9BDX8N56L"_OQ];!9\;OCM+.K?XFY
M)M!^LM$[%O\)T'6//-QX7L[=JC_HRHD<(&#J@.+DD=^*U1DC/J*!"2K0F>.D
M*IT52?W1=.%$Z W;!Y^SDUPT,%9JLLH]O.]F=^A*P.""674"_SA_AXO\[[!8
M"9&_S2D=AP;,[ZE+36JUSA(X4*T^UC!N(SWAX)2FJ$(#4J1GI4\>GZJU,R7$
M%4:?0M1&L3M'PEI\-CVK,U,NAN3<2^2<>=.87&;?8/;E7N!4PN!DK3JQC0L5
MSCDYEGI-C'[OT3.R4:H1P:TI)C47$BRM]H,]@YA>)39J^NU%QMQ<0O7O\^QF
M'X1_'M[[L5X.*GPT[1S&_*8I[*:)Q/'B["(_(% +B[A$4O4Q72EQ=+"@4O@X
MA"_8'FM2-ZCG//^7I0G >$CS*P<E;7C;A=Q3+M!YAV.,\1HZ@ ;JP5F /Z2G
M/FBU #LOZB@,UTYLWL*5(9LB9(6JP@&>$R'$2Q;#NW\1&IS9B@:$!K9$>Y^1
MYI4[A%#ZO2>II48#Y<6,U_><*<EC7Q7,=O6\'%[3" Z<VG.2S)?S=F&K"W)1
MGZ>RR6??5PB 6>?<"Y(?WJID5"8!IZBTD4C*Y&/MHUHQ:96PW#YZW"3;O,1$
M\8MC1O &O[)(\M-/!"\[<!FRE*3;(ER,+>=V1>:MW_HJ\X>,[D1P3\)T,5HQ
M>LG:E(:ZIHM/Z119HL*O#.J03.(K,A\NA+1'">ZB,O58]<JO&>3]+SYS.Z)
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M@/G][;'""H'E/L?09Q(9R1IJ<W[YN"^M0M' AO[7BV-5FC0UQFT+#@Q)9;A
M ]=BG*4$\#:Y[C7Z9Y4&-Y;Y_$[_?:W&^@<?P!A\4$/H;DOPI;Q$S9:^-I30
M]XPOR"BQ:[=! ^KWC!,)K M2GGLH[09_Q>JO;/(\'P)9!^C::%$YFW'$$E:X
M6]E]ZJM[T*VROH'RPK*S#M"ND>*(<7#Y56"Q4&(AZFBYWP5!7'WV.9C_T+\3
MJW5G\<..:B6H2<]4=>'KO86-4A=B#4V-CSFSZF@ 5"<%@$1,@+;-XD+>U-84
MBK*&VO?%&2?$&Y2[' & 76KK1W^G'<TOH<Q^D^SMW^?C>0QO1_9,()?JKQ?^
M8 $8)H"AXR+=-$=(9FFJ2:&XZ,[Y019A][>KRNO96$/^GB&CGEDO"@+,*V8\
MYE_[W_7 UTR3M&U" ^]9*1!.:_C9+*E"=?<VVY[+80L@UII)YLRQG2475(OF
MH1Y-MG71$F9X[;CY=*=]9T=*I.I1ZXL?$U^O18KY6O7J0Q@:\,F7$?928O>;
M!R7KDZDT0C3$;A:#6TH'-Z=B6Q5GFR5P59@YX)^T7O\D\9"17E:9'SL?#"22
M.760YUFK8R>X&]M4E<(F=;J4FNL[QP@5%<KRF5"G\9/S]DCH7<B,M!+;)S6I
M67>-9>NT>-0V-CW OE7'1]7U"L] ICLY)PC+PF;5W&37DM(^8<&4/<G\.?T)
MIQ5.LQT.%44-7,59&A3MFZA:;#QPX$H,X?J1KB$#O.4'18U_>OB]E=^!_[OZ
M5S]?Y4AEGCO=A8^7:\W6_0]-Z;8J'"?#UUUBBA28JWY4QR\6+G3>C;5)/A7F
MYP^$92D'?]F!_9:2>!%_LB3/Q: $/.UV[KW+3&=781*E,6FK^LEB70'BV*L]
MJXVW'TL6ZXVJ_L20(G) ]$K@(EBT_]2]*;9B)0"FZ@PWX&S#LO#+XQY[6=ND
MZD-,F\=! +40,4S<LV#BI?](XYT>/_WTE*,O^ONK$7P.<2O2,J]:PQ+/8[;N
M-)&'VL]4.VK9"9C6!WO=W]K+:+15<QV$#-ZF.-:&/B@?_VMKU$:4FJ*8$5I*
M&6:<_^$U2V2,S0:IV1;%;U6>L MF#Z]YUYK>3J-'JNK?]F+W;9*SE>G%]?V]
M;<0@^ZWTD4^1"1'$RI=A-[/M8NODSZ3"%1"K+TN=Q'U2N=W=?7UJ,<20 T<8
M:SC@U(*T MPW6P&>40'?$L,*$90&U>J!RM'!?&L-#B\CJ"D(PYNMDF&BP^K^
M12UH@-FV#0V\Y(3<$D_)[A+GRY,;%-QQ]G.$.Q]9$) \M ) !R0I,?)V!H0%
M=(RZI00?4FF:G13S]EKIIJ%1WBF3:M(^?8O8+E 6JU=31^2[#,R3Q+I.?(-W
MJIN[[M+:()MR*H2VEJBFMIIA@D/2FR]*G_QR:A,5'0&;G#-^N)XW]G.9*HA5
M4N_3 ]81FJS-=@K?05[7![^#8X:>)5<0/X>H"E]:Y&S!^E:.#L=[!Y07SJBT
M=Q<CW*A9D@*RU4W;)EV$J.6&NW .OYR9E%BDTD15QC=5;9W&]MM\*]>,E/"_
M?"E/;FB\=B?P:!^3BA[7UF!"948#N=Q^%/]+EUHMC5 K5Z:9@^7A('*Z>5UH
MN^WA,(]@Q>5K3#WGG''^HZU3L<<VYK;<DK<O6= V?XBZ/'SH'_@S>7R1R-I2
M-K^SW8.3V;>.T/)09U>6-T\C=/'0CM\?&1$]4O!#>2_YI?6X^3T_EQ1;-<>F
M+9.'4R7VKKUB%H4:,GGXTSMX$U2<<P?*8[Z-=[(KP45R9,Z&F6%)=[>!E1,!
ML\KN)8/*7;V!*Z;"(=] ^\^H[VX2L)O.-*$=UW4GHF UA^NTB"]UP;M)I(G1
M=JW"I].5(<Q^(2,*D\XN7#;WY;W*&I_<?!N,5RSR-%&H\M!.JOGEN*+GT)B0
M(\)S+8@&R.*'J+^>*CAY#O\CH#_O6_N'8_X<V2:C@6U5LSN^R3F(Y-WE\PU,
M-G\ P[<P$$#D,._S6U[:_?D]D0%#$&U); X"#51=@P=5KI\'<[VALEQE'&AU
MQ4!"#V,)ANQ ;D#%QIQ[NH ]#()Y4C_B0^9N]WG/@J%VLHQA[A"+2S&3X5NP
M[+Y37Y#L*N<1B=)$T5X,,1HHP_D-F8TZW[$X6AMY8!]"^:RHQ&V0:^6G/(V+
M=7ZK!&'W1$T96?>:WL06SR[)]FOU[X8P_*]?2]3U#.Q*(GLU8G04/\CQ-P+B
M&<G+0C.(_-6-1(FE;8=8CXN0MD-PU*:9FD!0KQAY:4D7)_%?P??\]=W&8Z2W
M<-)UNUFR-^,:L"MY%VA3Z676&@75^^[B4X2#B\WDF =_5$OY:JOD<#8)#]F(
MR'N47OZE26?P@IRX&UFC7> _<R@E"OB48L^IS@K@XC+171.F=@Z(,1)[;'N&
MC4YG[^M?9XM4E5EHOT7X' 2&!*9:Q45\>5LC/8['H4MV]T>PPW"4PWJ9AT35
M3IY<DO#^>\J&]F*'_%NRGF#2:TEZ\-Y/W6BX^@3TFC?Z&@QM:;.\WDV9"D<L
MYYT&J96]@R#:%%X9YB&I, QFS?4_WIQJ_NN;TY*KJ[-[)5>,C*>C&54M+>KN
MK8]:,\:5R,T79=]4+IBI7Q@0'E4: @](Q&%$C-V"R4,S0DB%PGAO\EMI%;<(
ME;2-N'VG07717L^JU!+C-M[1B\6#/=7F:UATQ_JZX._'V8^T8]-)\A@ *5!D
M]7QW*7U%UI/?=;1WNSX&;J[GF&?Q#3O>QH$WD=K-S\:R$W-6T,"O\^"#/873
MVUUX$;Q;8DV_'F:D\KU/_L0S''(8X*G%VXU!).KSC;D;L\]GG;$X.0U'<OFF
M5V!RTP[CV<%C\.] V],]A8OS<IPN2LXU&]ZTDCTW7&LLIY0WZW2W2^)3G,$F
M#H]:FQH^6U3]>&L835W4K'Y)JTQ-4!7J#A6*O5HY>(IB]>SJ)$W5A8UEIS>C
M@8"XK>GF8.1K8D?S\IHI2)74"2]JT/@D2'7B2T)X<)F_S*O^B_/>8/S^_A+=
MX+;'P7&@+23U(>U(V2///0O*;T@U<SZKQ)=P.KC:Y_"RD] VRZ2J<FF^>=-A
M^*<@F0ZCV#@5:0S)!(H*V2;@E%6%2#00+AV^H*[;\,^S75C$3ALET]31VH^8
MFY EXY/* 5@_DT%'!^>/5W9E@?H%XV8S,YJ<+DFJ>KZBO<I AJ.ACWWZN(KD
M6,KTO* 54G$>4\X-6BQ?!M6?H@'PPU;O</T?M1E/:<2 .>.-.+G[L+#DL[76
M"$0.>7(0%QQ76^%$::PG0IXE9XGWI>6S'1K=PL$L3=4V/Y^@/.Z%K%F&3P>)
M>M9>J0'[)DE5*9R/;R^">-:OIMIJY.*-07S&/M<A48_S&D>]C?H]?]]=2X[H
MZ%VX2=G;43>7D'M0[TQJ8/_ASMU(>6^&J"32MIUH&5<_%[]E*,U=!<VKNW++
MMY4FE@]M:\+7?$JYVK,J7[B))V\2$QN2KJAS:L>LX4<5)&LVOC!_COUK] ?.
M%KU?>?BZ15:P)]Q0+Y6(,]V&'8_ZL2W^I>H"H95-\0=G*R/:_H3OZ8M4LF$C
M5%M[)B6^][54'ZW?=#9D":B$FD9,>K5HAEST1^,/$ZZZS[_U",PD]BVSW#\B
M3:$:/7>[\5LDCI #UX1G!DO8S87RC'@3R$7*(J)W]UFC4.0*#;]_'@2KDUMM
ML?'!+:2D(2$N+,\<TCH?0ZWL:1]Y]OI5*$Z<W4S=9GL[>=JYL8IWOU*P=NY^
M*=8KKH4OPE#VVIDWJ81MD-IZ-Q<YLP,K5FFQ*Y<O*4ES31V\'%QQL>D_&J^O
MV _6187!<BY7VSH;):1$5!_^151&IB?BUQW[.-D*),)&EXG,)+:AM\>I/B[L
M5NP5?[S)[YJ'@PL.,B0K[;QD$(!9JS=]UJWO_0T$GR[ Y%;VZ)\$.>1>F0@7
MXG"?W7F=RL8B#(]% R3\^*-D.]&=S9-OO([>!]3TYMFGI>Y\,Q-,'79[0OO)
M*GMA0LZ@M<!RQC?[!WCY' W0@'X<25FA@;9!E)")E*FJDNO8]\>\8GB+R%Z0
M+=9/&?RC5^[)0R^$N$5-[PY]M]7">[TT"XK@!5^E+:(!W)V+3ZY7F%K@F!<U
M.1[5=9DT0!9$2 I^)@S"&I+U+E@TX=D)^NXR?])',#*>7]>@.JNSK%9IX[/L
MV[<P[ X##.5=CT=Z*1T9Z.EJ%90$>FGA=ZI>^"=?9K!^_SI --M1'&Q^5+SP
M'L4X*S027_W#O9;- 0):U %G<]8@NG_-^23?94XO\!#8S@6;5*QHXB#"NUJY
M3(=L-&\$'R_)&_#G!T$!$H++\HKN5LI:N$)%<=DI:,8Y+^7S8 *[ X$9\;45
MF5F*;;ZY\GX<NVSC/>[9%0O=FQ O?\V#*UCI(O+1S\]:'^<<(<X./_SM5Y3F
M&X8UZ;PNRXDLCN,K5R>3 @=UIATWY7^]XD_,)L!)&6GQ?MXBMIT^)$X6N=US
MDC-_FC_@ZCI<2EL/VLI%EAH$NZJDW8@,5"G%->CR$9*FQS70BVUK#HV([IB:
M4Y/'OL'3 (E?MLU.H.2=G5"=BFA QN2X7RCP8?1M4*]M5@?DF4)]!SX;H]=%
M)]QB\T8L88E\6FG;^X'B[7$-O[W])*+173KY[VI[2,2P &DI6C\.7DR[*O//
M=IKJ A,P4J=77)0$M3VZ^;JHAB$Y,=G>48?E,1TT0ZT?UNQ=7.:=F_)?'-T.
M+1)<]%$,8<KN?G;YGHSQSX5"HH?QE]V,I//=&>]03.;/[^).(!.^#Z@IU^-P
MU(LNZ+G@Q'J5#P\:3O V&\7<.?.0+3;^A(0EO"SPP2FY@1+U7U:0CE"U0POI
M MS-<@Q:]\_;:KB/.^>6P;O0,G,_F^>0;@&GQN+WW$O,(CD;+EK\XM@>RC@X
M=4)0Q'SWSIJZN<7"L^HZG81#*N[L,@AXQRRW??L.CY.)5X/Y?$N\RDRKG^AS
MR9*F-KY_CRLXZC#?6T#0-B8BZI=G@>,_R0V1>7>4N$89!BHUD=/U 2>5X&[I
M.C;+?30@<DWS ]R751*;>=LZ NE5N5Z[_RB"7U$66;JAY]%*.*4D&;/W' ^T
M5^C5V!9=L_<>SEKC-<C457Z2&X(3:\B]'SBY<UHD O6]M\9(ZVAH2-SQZ&-[
M-,G*?5$@V!\4)]">\7IS)/9-V\]R&ZV"@57("\MF$ _GYRBM9Y+OGXW]:)=2
M$CILNRMXP.<U6)K(1>:H_NXCQVJ^;!_U41)85B=]3(36D\5K8B<W>82BQZ^X
M_>'<C,A?B<Y?L4Z&\Z,NW)?WIEOTOUM+82%WRZ:*^M*3N/?Q"26FX\='V=?H
M6#(MBH=XZ7]_"/ ZT)G]\LE#HA2B+]4C8-0<<T.?_^)1>E0(4.$^7?U4:)[9
MN<0!4H=08O:RF]*TL6!>MR38;670VH=(9S41>-;1!N/$0Y?SRE6J34P8C2.&
MZ4H:O7TK!Q0])57T63B*O]+OWH8[Z\A0GW^#.TS4Z] _ZV+&JW:N;JIX^A%X
MZR9MQ?GV2^-/*4ER3G;VZGTSIL]:&]Y0P?CZ@Q[+-,TF=6D6OE"H"YYC;%/*
M+ D!/IVNX_R%="2_^E_92#T#NGF_"H#Q+!#<=5FBX>$&K2]R:!,JCNZGN\TF
MN04%U!@IWD"W@XK)A<Z-*HY"8OLJ7B!X,050=]OY.B_J7<J6]W;.'32PX9>&
M:GZ%!D:36N1.NR:"K'VZ3<=[+]& K K<R#E#+V.+)*A^AKX%SVD6^6:FQA,-
M:%"V71,:9ME__XDP.+][];Y]O3# WZ/9%L,BY :&^7COB5,\:$V]V1C&1JU=
M_7[VXO,ZP#?G+TE2LSBS+'H\+PC/M5<*==G44+3LDI*2MW&8"UA87% 6A5B%
M'A#6N^#CYIA,_JQS6B90Q.5-_]6K:,NXR(3QQMQ!*+!JJETOLS+^85T3N,WZ
M2R-KCK- +2Q^X:/HH2DQ@'2BF5OY.92X;$?4+VEHZ> X0C+K]2Y%3H"SST.6
MC8UABJ5V ADK^)X \I$/^UW@S9A3CKHXB:=NFUPUPJ8WWRM=]*[H2(B &206
MJ>%2(U$FY()C6>+!;)'()(H&6DN_(5XZ>[J66_B/?8Q;)P[-7$^T8 <76/24
M.S:>F,_+V]W;W^'JE$^<BA$F+_),GJ_Q-ZHOUCOA&YZ*I?Z=Y+135L.:YI&3
M8:7\5,HG.7RN9$Y"_JLLI_19O"RL?@1AZ+XZ@LE$N^[+CAXQ$MI4\<ZEITW$
M81"-9YZF&$9+X)7HPS3!6T-M_%??[HLWQI[Q=WM)8>6<$=/OS#^+I3(4I(SS
M-YO\+/]<N&A2I3!JYL_5-S/P ]?NI)Q(*T,DTU^%R.I(=+?[=TN@WO'0!@-%
M_<V+2DWZQG#FYR'>]GU;#KV!9Q5L\;T" A("5\8#F(R28ZG2Z*RJ9Z?#PZNG
MN>HJ@GH0)Y:O@Y\I0D%?NE<F@9(UL;OU+SZA.!G^X$WC=!W$'I8>2MB,-=U:
M--&V05D$AF6"^W33H">WZKHMI#>!9QQ[TBS)7;W8J:6BGWU\Q<QL&);.737@
M]WKSBQ7]F&OBS'WO\/,AL: LOO2EZ7"8*BF"\2Q?[;@VQ?=E4?.)!4'YVNFS
M,!^>@(NUI@;V;]H?J]M^G5SMBH^_\Z[KV^7U'FPR%2O6K[*AH7RT^1H7*[N^
MW!SU=*"V4J7QC=K(%.X69+R:K". [OMCLJ6@O9ST9WP[EPXQQTT**-KYKK/7
M&.+8J$F8UE8QB")(T8]QO0P(0@,KU'MPC3\\G15T@P)W9DL_U0#_IL!4&;50
M),<]W8X _83:A[ T?HEE>:>GUM):6]F+]E6CDHQ@?V\'Y^^+DK6_#&3PJ>]5
MKQQT=*RLU7IT&$NX[J'L^".MYI4/=E#R$(3Q)>,9(02%!G*.2]80,;Z\H%GM
M;]?I$(1N<CN*D4O/4>15;("O*&.7"?=*,/]=U9;%OA=T28;%FSI;X3N,(\@A
M9F)?PRMPHIH?RO4:G^WV%K2JB&0[!8^*@8XPI3YA_E<'$^$T;\\GFQO]Q1VV
M==Q/.T "!SAA9\A=<V;5X\,ZJ[140]\#6KLCQ;=W6>Y/4./2I!['%/_6^?^Z
M>\^PJ)9M;70B((($15!R2Q*1)#G3 I(%%)#4!,E)<HY-4"0T64"1()*S2,Z2
M<TZ20Y-SIH&F^S9K[7/VV>N[SW=^W_NSZIESC%$U:XYZWZI1-2*Y,;Z?H1L1
M\!P-?'&"+HRBR#XM$[:BC+HQP%H5\7;\0")ABT)_]MU)]YMKUE@$F\)'N (7
MY]LL475F3W"\JL2#JC6)5_;0KLC.3K5Y:X&)[.9[RL\Z(/TLE$(G)4G%/JRY
M'@6=?LQ5HZFS2O;N8H5E"F5L:_=C$#$7DU56,7=\5*WN">-[Y..?^6@-2K!Z
M/NBHW4_8*73%[^QQ3)NGZGVD<B]V19_HYUL6H49W;Y[YO$5E+<4*J[6D$35*
M<I-@J7UZ-WH!F'-*T86S[CWDLT.BW\JQ.K?-\&QZ-& P?R?NU/G.H+"3:_#B
M^:<B,9+;6<O?ZJ[N_LG@T7^5**0] "]?#-H2%R[!MIFJA]=ZKH1[BK[*87HP
MN&P38^U.*U[2FN+E$6MI5JD_0C&X3T'>2MX-S^GQ2[:@S,M N!8U(,^@TYI*
M?.H4GBF-3HRDI$*;Y5$=I9P<F<%S64J;PP"S1LT*G2-B45-#396]*]!*\(&_
M.QUO@/(/C3@MN;>^B\K6S0Q6]N],F-LT>^[/(O?2/XDZPIZOE2[(U04/9R>=
M,D837A :^CG)<D>*6,3-:DP'<?^Z3;G7VAXXLV9.%.3O6WIM#;T]5=RP7.=-
M*Z6S$NC0H:<HZ</*R++U++:N-'E+E]-]F&3$A[)P&W?B[A<3MELJ+T=X5G5Z
M8(Y;^)>:(0B39=880G>W6!GF[@J<OM9UG*!H60>!N&2WHL'0>>(1)$O6M&J6
M@E,97SZLP\TH,.NG1-I$_?FK6*4ZI-X@7VCIRCLSHSH"59;1R>E0Z01-@K?Q
M\LZT5$B.2=VG*3F_I!G8R"S>9WL+]C9C_B7""9]4['%X59)>2P<E+269,)@]
MD,=O3R3UZ\!M1W7K ^;*;TS12GS.C 6D91(4IOX.VN>4>.)LC"^5BJ3?!G89
M#)*^6O=F_P2[AD\VLCK5_2FQ(<<3_"68A; HU)V6<W9U-\&Q&_C>S4A(KC:+
MK#=E+3&Y3B8K^>#Z#KJ.!M" 59$G5UC](_>E7<9=^P)5!P7">X'?L9L'5/5,
MLKP&=Q;;Z^D+3->OP3=//OCP?9?!<C+'0&QL;CCK\,,R7!X-N!FN5:P)ER@C
M.APE8OZ"F'V"6GG!*"H)+6[#79X+/^FROZ(*]?'2_O-8V_\M$K&MT#GK;W#6
M;Q-6/)2\Z55U[7%S&'V[MQT-W+LLS+E>N-F]D0<ATD\=TRY\R^$HE$;<_ 7Q
M3P7091N.8 6W*O*-R,]!9.,TC4G)94])@8%ODSJ,['F(R?WH^09EQX;![^D'
MY?7A,4ID@A3RDDQ8 0.0F=NU"Q]K#T:1VK3C@]-8,J':A'%_)LF*+SE6*]JT
MO3_2O>,8>C!:XE7",7W=J!3^[H#5=P/;*?,25&Q-!G<>3KF=E\-5C6%-%#[F
M]:6'V+H;#,.[18GOYRWG&E7@C-]IA<YSBU LB,M1U:@VJH10$X'0)M-> IYN
MBD'UN)C=#K8>EWYYJP<7A]K:<[RWW&;;F*:][Z>I5&201-1+/_PJD)Q(IU^^
M^Y4 PPWDQ;L886IGI75C%8%J42W%OH*9UM$>X?)5XWP7&;$C2^Z,)FE2=W8D
M%R?%X:ID"&BK  ]G@9AS+T/\0^ZEU%=G;'^\DRXF%0X32I=B'&^'^PQ+<_67
M(WLB8':O/6X7>A@J#U44O>Q>3G';&L[^*M?]\"Q.7">3A4#\P'I.8[CG8"*N
MLG)'DN/26F0&#9A8Q4K2]%_5R7_ID1N%P6<J;'3TRMM5SA08NMA@M//Q^[KR
M![+AV=W74:Z9S?;6C7IE<@P/:2S6_ J])V,P.-Z/9-P^LWHD]DA<D@3I*W/O
MOFK4_BU)\+X)6+?'07_0GJO?>M0GDJ.MPHQ=,"R*[;G?%[#B:C$%^\CBN]O@
M@4(KD3_WN$5?)<>D_OB%W.?N36"*==[7TPX>D;_<$7CRH/Y'AY[>G4FVL?,,
M>7M>U4.E7=#A/IY?6J-NV-Z+MUI,#]0L9S<;GPH-<"RNHV8X#(AT9B\BF7)7
M<4JRT("L^>2_5M4,+P_C_H_S"- -!8.80Y8,CPN8U_L^D0B)OQ%C :WUY<CP
M+ESF:)62*:<DRQO4!K[ U8/^$3F_8/8HBO\=.?^87Q!F2_GBZ\QNFN)V<W]G
M$H8N2].T?+#.MU:\]"LL3ZQ*&(Z/$ A]A+.SQ2:M>(@[D&)J2Q])]&&E3"X!
MN16X($,WAAHR?_W!&40W?HLC6ZCAHF$(@PMF1#:$6C SM_5$4\R8Y+)WG6F;
M,:B=5QU$L04 8I'@S12GQ1F! [NPCV+<AO5"&V"1S',<7F *./"UFBL;\LAI
M&+1#N!9VYV\5K3U6>\P$SW;',L#.FT(#;6A ,UY3JLB3IY269,"C1!O!ZW+D
MD;3\X!PWS^ATOF+U7.L'K846;(O(3OD$#7#V!1VG.D>5;.I11"W3:">%.:_)
MU.G;JU7X_PZYM6+JZ1,$(UG5=9/@&R]\\)X]C+>+-3G-:\ULC/0E@:OY8SJR
M]LMKUA*_MW?T7U<EW&Z_OT@J@G4Q29@KLVTD??]I@=Y&2;U-02.3N<STE&KT
M(@WT]%A/P]&SJ"+E0%7-:M1P=NZI3A8/H$"9TR(/3'S>S.4@S%=Y2SLC2D*
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MU+DXRP^C&7\5S_KC[^H16$TO^S,UCJR!=C='0-=9!E^A\!)"#[<S)5J(3N#
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M)?&2*QO3P_.?@H21&=0A)T*#:Z):,4C60X&HI1I7S?$2S:$!AJ/,/WVS=@,
MWIAK$<D] P^>?6W4_,%^V(S41*1/-\=2="?+56]5\GFQ<_7E+9C6P/:A28>
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M:]4)4NMNP/X.+@!%3_T_4$L#!!0    ( -&#;UFY1I!N-*0  "K8   0
M9F]R;3(P+69?,# U+FIP9^R\!514[?<_.@@"(B$Z=$F7B'0S( T" M(E@J2
M=)=(=\M(P] P(-U*(](Q--(M#)TS=WS?;[QYU__>^_NO]?W?]3VLO=8<9I\]
MSS[/LS\[GGT.<@KY'7!/459!%H"&A@9XB?H#(&<!4@!L3$PLS-O86%A8=^Y@
MX^ "\7#OWL4EN_^  $A%3D--14Y)^9#A,?-#ND?TE)0L JR/GG#Q\O+2, N)
M"7*+/N;AY?XI! W[SAW<N[BD>'BDW+24M-S_CP_D9P A]BTU#'9T-#K +4(T
M=$(T9"> !@! NXWVRP'XQX%V"QWC-B86]AV<NRB&FGN 6VCHZ+<PT&_?QL!
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MRG5%@]DXA4?/F2X8L-OV*'$BKE2&R*Z>&9]-047/(:6B7%*F%/<ZW[UU,/+
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MS#L1H6(H#U?N4@BW(BL^4WKVR[\_YYO'2,FX/D'!,>W&9&IDFI,RDV5S-^&
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M9HM!'8E6,SA3*O!)^U@V45\31_U*P("37DHX3+F5O^TU9QT-OPW$=9:,N6+
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MBNG;43QAN)ZJ5I/1C?VKIR:TAXR)0*M5YVZ(1ADD(%M[N.;WF_<OT(XQ?G4
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MK]U3OJ'7N).MD8@*@^?)):=3-YC!BK$!_JQY..<K1=S<K%RJ]& [%ADF&86
MN%C5BH*]/GHQ+*;8-?HCBE7)/M//Z)/5$6=04YTF#OF-B>7AXZO^B]E[7\A
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ME01U,7K:'Y%9_KKB/PK.'__O/D@-CV+;"GP2]8S=19Z-K(A/9E>. AH70@5
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M/@-#\KV=O@U4%H'GIK.NB2K=$ _Y<TT3R<5NJ,S]B"2JK[3289C/V#W/[MX
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M^K2EV%JJ,ROMF[GW\@JT?E3F%!:!ZKYI $3)T4^_Q[L'1Z^Y^[@;9*8>ZE6
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M^II8W<Z;_6D<\%@&JFT4"<QRVB+NJ AZ.T__)C'X'P1>GVTZ_I^&W%4*-AY
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MKI#5>UE#594:Y&,!GT!NG^\\BNP7H@"$.S)+;)-D#@H0_P1/O_<@@P)H-JI
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M&*U9/[R,4#E#/:4"?>L<]8?QI^.6.^M '^6S>@-\DY<:QI9O\= B$"].5H.
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MADE(3)!'E.,!+\^/AR#<04/#Q, DQ<(BY;E+>9?G/WW!6@"\.P@&"&8@!#H
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MN+<% ]XVPP!U :C2-]1T-4,_&$#B!\VTO_F4 >6  ;?R2Y<"DM0!,IXPX,8
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MZ*D!27B#]2))3$65YO#+$*X-O;4H*U")?B<QFK=%2J<PI;D__W<?^FM#4K#
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ME5<0$.H212*H*D_C+A'IROL'OX(*F_E?4$L#!!0    ( -&#;UD@2LG?%78
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MOS^@AQUNGM#1]*TNW:AU47 9S$%!G=K-<"OFM8@:P(%A<!<^5-RP7%\ '[:
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M) *K/9;)O5Q<#$TNY9IDP,OHD^HKP**LSP46H__W*X"V].:<\"H5C3_!MK]
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M(VAQ)SQC!-,!(069!U);'ZUO7$,D9'F1NF0<;E(S6=HB[M7L!ZW"?^A"N_\
MB"29[+)Z*_\ ,4UL+J><,OSGZU:A7;;M]:BQ\U2HW#IC@#-#T&M3-C3O5N->
M*@12, ]:WM'DTU+:=+R$R3,RB+"Y^O/:J2)/8-)\J&PMT>'S L:@#<5[>U;-
MK';WA>-+58F X<R,<<^E<O%*\5^CM=JMM(Q6.(R+CIPH'7-;4,LD;@QNR$\'
M!Q7/5C.4&HNTNAI&R?O;'SKXB&/$NJ#.?]+D_P#0C696CK?SZ_J)SR;F3_T(
MU0V^]6O,0RI88PX;.>*BP2<"IHG,:MD=Q0")O)7!_P *KL/05-YQ(/\ A_\
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MP]'T2?6;AUCDCC2/!=V(XSTP,C-:5L/"FE9MJR,Z6)E.[DDM6=%+XPTN1?\
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M/NEWP32H%=1R"& XR#BLYTN8W1Y][QKG:Q.5_.O6&^'GV'PC'97NK0"6W#R
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MW1[R(6Z7###R1,H!'/7\*N,4M4C!PC'4YHECT9:0,V,;E%:,G@_58F(2UCE
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M,#:C9W'OTK>EG<D0VV1&.,CJ?_K57>T)?);# ]#41G+ELRY0C?0SU3D>6"%
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M_P >KXSTZ4)Z@UH>:O-%!CS7"D]%ZL?PI!+<3?ZJ,0I_>DY;\NU,AACAR54
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MTL0=\<YN[?MZV@3^$\$CE/T'C6!6;D5*L$]F\G?2+S=O&EN"(>F"/Y4<8U\
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M:ZN+2&/?B"'!" $AF/I6)%X;U">[?REQL!V^8I4'C YZ4[Q!%J-UXMN+G;A
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MEC\Z@$C&/<5H:/HLNKW4ZVLL+F)%+ [@0"/<52UNZ6]>33':&V5+I;G[5/(
MH#Q+QCJ3QFMCPW<0>'1>WMI>IJP95B\NW49//4>^,\5,ZO*GW-8PNT;5SX&U
M"YM+1V$6U$V9+GGDFLR]\)R6)LHKAXE-U<"WB(R1O(R,^@XK;L/'5U>ZFUC;
M6\20(N^7SE^8\C[OH<4OB/4EUJ"SD@:)?[.O%O2JD$MMZKQ6/MVGJ:>S70SK
MKP'<6EA+-/-#LC!D;;DD@"O/-7UK2YM%N+&T,SR2LC!C'M48/UKU_P#X2DZW
MI]S$;-H5EB8)ND!+ J3G%>'VL$=NZ>7:_:KD_<\P$J#[*.OXUO2FY1NS*<4G
M9#_#^CW4VIV%PPCC@^T)M:5L;^1PH[U[;):N9&.">3Q@UP.@^$KF34[34M4D
M,;Q,KI"O4'KSV'/85Z2^H7$$A 92/:L:LE)G7AN9)V*'EE&&5;\17A^JVOV3
M6KV#&-D[@#VS7O3ZC/*I#LN#VQ7C_CFW\CQ9<L,;9D24?B,'^570?O6#%)N*
M;,*(\UJVP&,DUE0]:T(VVC'>NZVAYQZ/X<O1<Z2D9(+0GRSD]NU;T-M/+$6C
MC)0\<'K7FWA?43;ZKY#<I<#;]&'(_K7LD$?V>T 1"S,HX4<(<=:\^M>$CHA[
MR,F/7[O2(A(+Z>*/. IRP8^@'>J>@V=K(\MS90L2\V^5Y 5=WZ\Y&3UKL;B)
M[0V*F+D31H&QDC)R3QTI\GB71)O$,5O<7ZB.*(NH9P ) V#D^P/0THU7TW"4
M%UV.!\2"QM-4L9-1CN(U2?S<(A8,3[UN7FIZ0VG6\JV\KH%*[%)#,W7.".#4
MFJ6-CKOB*VUNRO=T-LPVHA$B,5/4_G3KK4[?Q#KOV.Y1+-E?RIF7DC/0UV4Z
MKFK3U.:=-0LX:&1X2M[[5O&-O=",R);RAY''W8UYP,UI?$FR.JZE-:6QS>A$
M\I01SP<YKK]37_A&]"6ST6&*#<IQ,_0'U)[D^M<1IUA+Y\M_>OYU\V#(2V[9
MZ4UJ[DOW=.I<\/Z5#H?AO[*XN(H(P1N6,N[,PR6P!QDGO7GOCP7?V*VLWLT@
M9F1F=1B5P<^6#CD]":LZUXJUAO$D0\,W]W#/)\K&-RRS8X^Z?E 'K6K=QRWN
MKPZOJ3)<:FMLL$DB#",PS\P'KSC-<[2AIU9U+WM272WFLM#M+)FE8I"%<LYW
M9[Y(ZX-0C3+-8@JJXP .3FIQ(".<YJ5 9G5%ZFN>QV4,35H.].31%:6L%JKY
M\N7< %60=/7GM1-!',KLUNT?!.Z,YP!4S,IDVJ3L7@>]-V@,2 ,]L<4CICF6
M(]IS\[O^'W;%N5K6V\&QVSRXD,S3W(!Y4*O&:Y;3++RM"COYI-CS,6\LCGDY
M'Z8I-5EGO;H:7;L4,YQ,^/\ 5Q=S]3TK;2 ?9XX"-T,8&P9]L4VKH[%CIT<1
M[TM+W>B>]F_\C'657[@_6IA(8@'5RI]5.*MR:?:N> 4/M4;:6I'RRG\:FS/I
M*>98.IUMZEBT\4ZQ:;1%J,P'96;</UK<M?B)J\)Q,L,X'7*[3^E<L=+GC(92
MK9[5 T<T98M$V?6C4TEA<%B->6+]+?I8]'M_B9;D 75@Z^K1L&'Y'%=!:>,=
M%NU7;=&,D9 D0BO$<X8 Y'UK8=9!:VK6LAR1AL'BKIKF>I\WG. PV%IQE25F
MWWT/;(;^SGV^3=0ON&0%<<U9ZUX+K-VUIJ>DZ?EFN) ,[%R3A<]OK34\0ZWI
MDGRW=Y$.NUR<#\#1./*>7@L!+%\W+)*W?J>^#D<TI( )/05Y)IGQ UN0[)'L
MY J%B9CY>['8$=ZWQXUO+K0VN'TUHXYPT<<RR@@-CTZTUKL/$997PZ;G:R\S
MGM7O#?:K=7&<AY#M^@X%<YXLNIU\'ZK$)I C0D%=QP>1VK4.#@=:Q?%W_(IZ
MG_UQ/\Q779)'E7U/+[HI"L4<5X+A&B4IM).S(&5/H<U'%+N49)SBJ4HEB1(F
MCP=H8'/8CBF1I-^%$%9W14I7T-@$CG\JEA DE5'D6,$\NP.!^54(O-X%7HU)
MX/%=L6VC!G>Z-X3TLQ+<37 U GD>6V(Q^ Y/XUU5K:10*L4$21)_=08%>3Z?
M]L2Y1=/><7!Z"'.3^%>I:)_:?V ?VM%&L_9E;DCW X!KS\1"<=7*YO3DGLC3
MD52H!QCT-4-6\:VGANQ/VMC*_6&W1MK,?Z#WJMX@O;ZRL2=-TZ6]NV'R*JY"
M?[3?X5X[J5EX@NKR:>_LKQYRV'9HSP3T'M]*Y8PYGJ]#9MI:(7Q%XDO_ !%?
MM>7\N>3LB4_)&/0#^M9]I;W$LN^,?(1M<]@I'>KD&E;2GVI98]WW]Z%=J]\9
M[U/*8+>.:"%6C&>%)RQ(Z$UV<J@D8:R9%&8;.W:.&5G60 OR1OZ]1Z"HM&TR
M?7M;M]/BR-Y)>3^X@Y9C] #5.:3YCC[Q.:U+>630].FE1RMQ>1F(GIA#U'XC
M^="!C?$<ML;N/3=.5A:VV57)R68]SZGI6;-;M#(J#)SW/K3K-@AEE9AYA7"Y
M&>?:K5@C7#@SO\D?0#^E$4Y2L)Z(VO#FB_:I0A(VYW.!U(]*]$-JN;=-NV.+
MD*M5_#]I!9Z9"5(#.NYV'4G_  JP),W;G)(QM /05S8B2JS5-;(KEM"YWG@6
MW5'OM4FPD%NGEH>PXRQ_E7D?C379+W4[F=F/[^0OQU _A_2O7-?D_P"$7^'"
M6:G%S=#:QZ'+<L?RXKY[U:1Y[@\9YQBNNG!)6.=[I$>F63R-+]K<K!+DD9Y!
MJT^FM/<;HV(@50"S#FFV\6 K'KCI6[:12NJ)M";CU/7'TI2@HOF-U*\>6Q'Y
M4[ZG';%HYHY"FX2PJSX"@8SBNO%C:16IM[:T2)202$XYK$T2*)==<Y)81\9Y
M)))_H*ZU5"\XKGG%-W+B[:&7::);6D<Z&$,DKY82$G=WJXME9P12006T42N,
M8 QGZXJT0"JG/4YJ%P7<D&LN1/<KF9E:=X=AL]4%XQR0&V!6;"$@@]3SP:70
M-#LM,"I F9&X,K\L?\/PK67=N"]@#_*HXU\O:5'(YJ[N]A60P7*><D42&6;(
M+!<80>I/;Z5:FP)6 (X/K4$,<=O&$CC"H.<"K7E*TTI<!CNX[8SC_&L9R4=6
M=N%3;:(LC(_K7!?$: &ZL+E1]Y&C8_0Y'\Z]"$:$_=/ '?Z?XUR7Q%B1-&MW
MVX9;@ ?BN:NA43FDC7%4W[)W/.8P%[U*)/6J^<]#3P"1]*]9'B$\=R\$J31G
MYT8,#]*]=T_79Y]/A:*=C"X$BCWKA="\*O,4NM10B/JD'=O=O0>U=E'&J !8
M]J@8"C@"N6NXR>AK"Z-H:[>3R$M.2S$$D@=NE95YX*M=3N9+YKN:)ICN9%0$
M9]>32ID,"%Q72KK,'DQ((7&U0#A1U[]ZK#*G%OG,L0ZC7N'"Z/X=M$\1ZMIJ
MEYS"L)5F?:,L"3P#Q_\ 6K:U#0(K+3YYK1DAN8T+F59,L0O.#ZU:T>R\OQ+J
M.H!FE>]F5Q&PY5 , ?A5S7#*="U,)9.A^S. Q"X)Q75",))R1SSE--19U'A3
M58_%OA5(KD W"(,YYSZ&N+\;V&H06,=W9[K:_MB5?R6P9$_ND=&%.\,W;>'K
MRVBB8%8E5)ASCH,BNI\=1W,=O;:OIX2>WP4E0],,.'S6$6D[]&:N]O-'B'@S
M52NJW$$\0,LR;8W[HJ]5_&NY#(WWLUPMWI,T&JR7T'RMG<BJ<98]<^@KI],U
M!;V$@_+-'Q(GH:PJQ5[HZ(2T-(HN< C\ZF"^1;$ _O)>I]%_^O5/WI0Y6L&C
M2XXJX.0>,=JE@CEEE6,'!)QD]JB\T]QFIXKD1(X .YQC=Z#O2:*N0&WAANYW
MCRV]A\YZX'2IQ)CITJ/(;H0:. , 8I6*G-SDY2>K+=N0(IIV'W1M3ZFJP '2
MK$[".*.#NHW-]35?C-(0\;L9!J22$1;6<?.Z@GCM385,LJIGJ0*DNI/-N'8'
MCH/H*#2-24=4RLT,$K M$#@^E)?:68V C>[6-EZQ/P#G-2*?F7ZUNV3B74X]
MP!1<L0>G JHNVH5:U2JDJDF[;7,GPMIR+XGL;^>X>XGBW1QM* &4$<G\L#\:
M]&U!-4FD8Q6=M/;]HY-I)_/UKD;6\MM-DN-6O4+P0,%"IU9F. !^ )_"N@M_
M'&@W139=&W_O"=2,?TK9:K4YKV>ASGC#1; :#'?V^FQ6=XLNV4(-HQW&.E<O
MIUQ<26YBEFF-O&?W<9R54GKBO0_%-]:W>CK):7<-Q$TFQO*8$#@GFN6D,-M8
M6UFD<;@@SR#T9NG3V KGG/DJ126YZ\,<W@Y49:MO2^MEU\S.4INR'%8OB[/_
M  BFI8.1Y)_F*Z"2WM9/X9(S_LG</UKGO%MDJ>%M2>.<,!"3@@@]176IIGC<
MK1Y,F##%D#. *M1(.N*I0AG"9&% 'XUJ6;+!/&[PI,BG)C<\-7133L1)W99L
MK&YO'"6\#R$_W1Q^==3IO@J5I@VHSB)/^><)W,?Q[5K^'];L+Z/R(D2TF4?Z
MD<9'L>]=+&BHH"KCN:YZF(J)\MK&D:<=]R#3=-L-+C(M+<1$\%SRS?4U<#9/
M?%(2>@YIW ')KD;;U9HDD(':.X1D/.,8S7,ZK"\>OW-S"'\NV6"ZF4^H8J3C
M_=)KI"55MR %QW]*I0BZCUJZN6>%X[J)$:,QG/R@CKG&#FL.IW4ZL5#E94\8
M69G\(W$[;6,;+)&Z]"N?\#7$>'_#D-RK7VJG"N!Y<; Y*CJWY=*[Q(KNUTN:
MPN3:_8(R?*,A)(3.0K#IQT%95_J4=O!O@D$[,.!&I//OZ"BES13B95YJ;N<7
MJ^F:?<^(5M--ACL[>/[\K9QM'+N<]@.GK7,ZQ>I?:C+-"&6$';$IZA1P,^_>
MMS5=09=*O))GS<W\@2/@\0H3N(] 6P/?;7+(.,XKTH_"CA>Y)&KNP4<D]<UT
M6G6Q0Q)\K.6'7I^-9EA;Y;S".:ZO0-/:\OD9D3R5.6:121^'O6K<:5-SF1N[
M([!X%0*V[8, 8'3Z5K>%=.34_$=K;!1Y2-YLHZC"\X_E600]Q<2.JE4 VIV'
MUKT#P#91:5I&H:Q-C;@J&/<+R?U_E7E85\SN74G=\ISGQ;U8RZ@MNK?N[5=N
M!_>/)_H*\=ABDN;IGZ <Y;WKH/%FLR7UW<22,29)68\]<\USEK</(^Q/W:DY
MPHR37LI61A'5W.AMK1+8!W*EO4]JOPEW<L/D&#@L.3]!4%M:I @D=F9\?>;M
M4^\A2P&% SN-8/4V6AH^&X,7%W.!R6VACUP.*Z/D@9K(\.6RQ:8LF3ND^8FM
M?CUK&>Y:V'DC:J@=!S3, =*7('?B@L!VJ=ABIL4Y(]:C&.F:5FZ\U'N^;DU(
MQ6(P>:L]92_J!_[+51B3TJXTD:HNYU#! 2/0#'^%<]971W8.24G<1>Q]0/Z5
MRGQ'P=!MSG/^DKS_ , KJED3"?.O0=_I6%XVL'UK3K2VTZ+DW(+9/"#;@DGT
MK.A=58W6AU8F<72DDSRJV@FN)TAAC:21SA54<FN]T/PLFGE;B]"R7754ZK'_
M (GWK6T7P]:Z)%\G[R=AAYB.3[#T%:4DL46?,=5P,Y)Q7J3JN6D3PXQMJQ@3
M'(-+LSCN*RM4\0PVF(X%+RYR<CC'K7/2^(=3,I F.]Q@+'T4>OUI1I28W-'=
M*ON,U5CUBTDOVM/,Q(IV\]SZ 5Q]]J5\VX+>F)#AMH;)./\ :J7PY<M_:1E"
M$,?O.,''/)8G^E:>R]V[(YM;'HEN[0RK(C8=>AQ5IKJ>2&2)G)6088'OWJC%
M*LWS(<CL<=:M;@H ;&:RNTK%-*]RK=0!8Q+&.0,,/0UT_@_4HKRUFT6] >*1
M3Y8;N#U7^HK!,B@?,/D/!JIF33[M)(GV.C!D8>HK2F[KE9C47*^=&;XFTF72
M-3FL#RP^:-R.J'H?\]ZY@*VGRK<0$Y7_ %@/\8[Y]Z]FU^S3Q7X9BU*U0?;+
M=2=HZG^\O]17C]_$9#S\L2\M_M>WTJFKH(NSL;-O?17-M'/$?DD^[GK4P8$\
MBN5L[W^S[CSI!MMWZ@_P>_XUT,=U#<*'256!Z$&L)1L="99)[T;L]Z:IR>:5
ML5F4*" <8Q3LL#P<"F;C3]WK^E #][$Y8Y/O3@PS4((/2G#&!S2:*+EM*L3L
MY."%.WZU$2<9Y/TJ+FG9I6 <CX8'! !YK;MKR'$C@@$(1T]:P@23@5.7,49
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M?0R'Y[MY%C6,#Y5)XQ[U\]"FZT_:25D;5':)['X0,>C^$[_Q#* /-4LG^ZO
M'XMFO M>U*:Z>:620F29B6Y]3FO<OB3?P:%X8LM%BPH*<JO'RJ,#\S_*OG74
M9=\^T<XKVJ44HF+6MNQ"A. !BNBTK30@%Q<I@Y^12?Z5A68*R [ S=LBN@MX
MR1NF+L .5!X_$UM*]AK<U!+OR(<'L7/0?XU1=U.H@"29Y H"K&?F<_T%0R3F
MX1EA"1PCAI#_ " [U?M%MM%MS<32AKB4$I&O+!>Q)[5"5O4MNYHVN@R7"DZC
M=SA>IB60X'L3W-7)#;:+&QC>625NBY+%1["N4EUV\; B?R8U&0%^\?J:T=+C
M>>+SKQ_WA&(RYYP?6N?%J<*=VQP:;LA;C49GE$GF,LBX"AF^4GU-3MKTRK^_
MSRPY48) ]*HW]B[WH*JSQ$#.YL  'T%+JDT1M'7!BYVKP21GJ<BO)@]DNI9T
M=YXCMH8%$!$CE Q(Z**X+4-2U"YO\29E!&0N<JA'0GZ5:MDA2V:03!)1DL9%
MXV^WM2V5E'?%I(91Y3_*P'/UKJ4VFVP*4CB*SM@SH'G8EY'Q\O'4>E2VMZLL
MEK%.A1B!LR>X'7':K^H06FV9'1CL&Q)6QC=Z#TJOY5I9[CN!=<,@D7+#C[I_
M+K4\T6K6U$:%Q/(LZVQ&\N (R!SD>N.U5-1>*01VMN SQ#]XXX!/H!20:^(4
M9OLP:X,?E[R^0!Z^]1I>I$5EC@3;&1M!X^I/J:]##8>5-*36IG*2>A3>(Q#)
M()SC ]:B+!CD+QZ5/-<O<S^?.%/.3A< U!]UOF7\*].-[:F+'(K2L%&![] *
MZ3PU81W;S()4CD7G=G)]L5CZ:@>1F X1>0QZUW'AG1Q9*;B6$"5\8^E<U>I9
M-&D(]3H-,L8]-A$$;\#.T'MGO5R9EMX#("'(YP.IJNCCS07J#4+@B+C?MZ94
M9Q]:\RK-J+D;I="-M6\J1!);]6!+9[^E8;:E/-<W4<I\MYY792IR%R>*K:A<
MR@&4ABD0^Z3R_P!/2H;*[AOH'GC95=.%).XHW?/XUY;G4FO>>A>A7U$7,MOM
M#,=SX<#N%!.2!^%8>KO'<0-*D3QE'Z@?.<C@8]_TKI,SV]I+*P+RD\[3U'0'
M%<[-&+F075SM,BW/RA5P&'<$=SBM:,W>[Z$R0^STJ6WL3<M_K&3(5CR!ZCWK
ML_#&HSZ!?6]_%+'(L>!.L9^\IZ@_SK/@C$D-QA898&!9%5N%XY&/>JL5O);F
M'8I1)#F7,AQDC.,>GO6M'%S<O?9%2GI='J/CG1;>^BA\0V \R.=%$I09R#]U
MOZ5YH-'@U#49X)8E+",!).A+]0I_"O2O &MI?6DN@:@4*LI\E,8 '=?ZBN2U
MO0[C1-3N+:1F)WEXY!QN7L:]>G)R5CG;L^8XF]LKV&=;:.Z802.%,#L05P>1
MCTXK9AO+XR&&2,N2"JR*>%^OH*217USQ"]ZBD"RB59?]HGC=_C6C<6AFLF\N
M8#S,*S#TIRE9&J5PTK2C;V;YN#(^=S#T'M5H1K@?,:2-S"5,9P5&!4LH#1^?
M&,+_ !K_ '3_ (5Q-N^IND1F->G-2I;!H3(C9V_>'<>]0AL\9IT4C0RJZ'G^
M8]#0[@31PH6&6_"I9CL0QC(SU/M3955E\Z'[A/S+_=/I2AA(FT\G'&:5QV*;
M*L:E\%O7:,D4Z>>&5U,4*Q[45&VG.X@?>/N:"2CY!P0:BDB"H9HDRO6:)1R/
M]I1_,?B*74M.R:&[ACK2;@.0:ADFBCM6N?,!A W;QR,>M<[<ZW(',D$J,C#&
MWNI]15QBY;&;:1T^\$YW<4[>H[YK'TS5$O7,9(!4#DGD_A6IM]#2:L]1IWV'
M$CU%9/B<@^&=0.1_JOZBM(C!K)\2D+X=OO\ :B-"W!G/Q>'+PZ3:W$ 65)(5
M; 89&1TJQH%]/X<\3:=J,D<D?V>X5F!&,KG#?IFNJTRX-YINFR))$CFRCC*
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MQGWUP;BY+XP.@ ["FV\7G2$GIWI@CW N6XK4TZW.P,!P.33BN>0-V1<@MO*
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MC0L"VTXW#T_45YNNBZFQC7]P)1!"K?=P-^,]#US]:MZC:JT1*2!8&X88!_\
MU5+>Z6K2F2)7V*OS!1DC\.U=5;^!()889Y[UCD+(=J8R .!C-=$(<Z4H]-S-
MNVYY]'I]Q;.T2LCI$-Q48Z-U/OVZUBO=VMK).BN6F!*JRCY:]/MO"EJ][<26
M]Q(75S&8W  ;(R:S+OX>:9:Z%/JJ222,J-((G4 =>G%=>'E=[CG!Q7,SSLR,
MTA+$Y_VNM6(@SC"J3]!FM,10MJ%R@B@),V%#[B>@XXK?MX5L]EK;I!]OE&00
MI(C'>N]3L<]KG.:=IT^H7?V>(;6'+LPX0>]=Q:V<UE;I!"UNJJ/[AY]^M6+2
MS2TA*H%WMR[@8+'UJ7:2?7ZFL:DW,TBK$16]8@":+\(C_C2;+K/-T@/_ %R_
M^O5I00.<#Z4H0@_*>:SL5<A\B[P?],P,?\\A_C44D5T1\M^0V.OE BKH5_XF
M_2HF)# !N3Q0@92WWH\,W+)J2RO+-&W^JV;4 8G/XXKDI)=4LT@,4;/*[[Y
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M0?!J'8/,\/04G*S2I$O4R0_HO][E?=Y@W!;SE<C_4&7&UA;'(!?UQ<G;X^.
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M1* S/E]X1!&H""0=HW=[AV_'J-NUX/L;82X77^X&,=^94@MYW.L]/C[N,?Z
M'[GX)O<</K=C>*^P\F7,;?]I/_QGU_R&2B=N_/']S4+^]'1'?Y\2]L$_Q^Q1
M?L6_#KZ.AQ__>O>?#S[Y-GOX>KH_'GW[]:?E!__W=_<7[^GL^G!P<RB=Q\M
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M0;TF5CCG\FUKMR3_W]_Y]1]]A-4=F2!S]-6Q/F_II".I/GRL$Y;-!)F<=":
M>S<Z"^D/4'OO:>Y%)%I"Q=%79I1D+14*CEA@X>2XY([F B8F!0!N6R_J?,1
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M-.'5J-$CA][!W]&,^Q+K2ZA?5KRN6*/!]U7P4R\XFP N_P=02P,$%     @
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M#9E,LSTZWLM3?)2F?$WCGRS^<DG0 XF-^GO[EOKK^;,9*49:N9P5TP(WQPU
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MW$I@!DQL%1X(!S+4D/9_<:']LR0RU7U5=%":KV-6.9AM*OZ<I"&*2WSG_'>
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M>9%DF/'?P$Q!-09(E5(4D"MGF_LEO$J^NN JNL!*@V1,+0U(FK/G<*"P'4S
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M7E]C=D#]^AK3GS2\ZW%47LG]C+,IC=;K6O.W&%^AF2)=[\M:]/3MYHOE KN
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M<5YBLV?1R/KT)D:X0P^B% Q.&1=TBE#63)9V4DM,V+%J-OH)3YS1>IC+FEG
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M8^)DUWM.$7!HNA5NQ6)(6PHJ>+ZI>%@.RHH]Y]S<ALBWN(I8C+:+B.0LQ<@
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M:CQ2HG8F@'(F :.?',247$[C\UV\Q%F=T"Z]C>&G(?[,,@+%#74W3Q,PU%Y
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MGI6/EC4=7&"T2O-T5:^:!8!UHPR;J9]IVRIC=OT )Q<O,14]X9<1MGE=^K+
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MX.)Y51#-VJ]1 72UJ7 ZUM= %4P]-3N-;9"C9JQ$_0Z/R*O?@=JN)- U.\L
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MPL.Y$G].QVS//,NF*9*!71I0'3J E.-!=RH ZZCW[KU7[_-RLGR<NLL^;IJ
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M33_1K]NOZ/\]T $@_>;_ U!+ P04    " #1@V]9\4C[U1 X  "@@0, %0
M &9T96PM,C R-# V,S!?<')E+GAM;.U]6W/CN)+F^T;L?]#61FR<>7#7K<^E
M>D[OA*\UCN.RO+:K>V=?.F@2DG&*(G1 TK;ZUR\ DA)%$D""(I60NR9FIETV
M "*_#[=,)#+__A\OBWCR1'A*6?+SF_<_O'LS(4G((IK,?W[S]>[H^.[T\O+-
M),V") IBEI"?WR3LS7_\[__^WR;B?_[^/XZ.)A>4Q-%/DS,6'ETF,_;OD^M@
M07Z:?"8)X4'&^+]/?@GB7/Z&7="8\,DI6RQCDA'QA^+#/TW^_,.''Q\F1T>
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M;R50\@>%F$)+_.,W]:'CAS3C J6JI3AX(+%J_S=1IE'D[1YZ=2Y4,[&Q1Y&
M/RTUYN[.=9=L]K%.XS'?[F_ PZII\>,6A^U[\[+$VZ6:WD?A(XW7],\X6^A
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M) OD1=-YP!,9HZTFA[R""JEA!X/4A3(YFLG$F4DX(NCDM65S.6[ R1G-;#+
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M9BL,!ZQ$;#2BZCJ?)KF0<^-$?D)FC)-UG':2GK\(L 19- GX2AW,9= >Z0C
ME$T4LFR/^%'TF(Q@Q64/V'NP6Y1]+Z=,^6C5-C8Z*J#'='3D52LS.B?7)(,8
M?1K%T",UP@T"7?(=\!IMBGYQ(=8'.D^*F&MA/;GV<1*I?\4%0]$_\^)8:8\M
M,M;WT$-*P@V&HR*.O@!T2&8?%<9*Z.$CP=0"9#_@I:**L%*]!C\)4AKJ.=44
M1X\F"6;3*"_Z/&OV[HS&>69Z4:VM@!Y1LC<C#9G1.?F5R'1@)#I^$H?L.;G.
MY0. Z:SU>M@R<QR;08\8">:O%SZ^LEH./H>7\LX-H<>5W)59&T;>/9\W!"W:
M>C+_9_B3^7J3_RM8LO3?)V7+V,%]^H5!!57__HQ^IU 5/0*M?7]4/RHGGCRJ
M[T- ,8"D;L(2N2AI7MHWA>FN=HBT=$LRSAM\EQ/\=K>T;_&KPV]W<<\(,0VV
MYFF^6Z#::P3T,$C:I\P;A;]9%/N=91\FM!*/]7@_?TA#3I<2DUL2$OHDI['Y
MY;ZQ"O8;2B?0[>)XHOAH E[;)H6E&O8CRCX3!(0$/E_VH-96[N!->/.2TH5'
M5X30.6V&M[81J"N/_4*S#UMFV=&IV5,X;WQ?@A$B.2\)IRP2/> 9ZIV&@_5N
M!_L</H,  ]R!$BC'9A%']2R7KN$WJF,J;''QZPM6!0DS:KU.S7ASA@%-75=X
M_%A9V[VN!\W=A55M.]X<:7K2:@%H+&W.,,;N2);%=:-F7?'1J7K]V_/FE*,E
M<$<!/9F@?S"O(7Q?A%?N-#2JUR"^WX+-:="K758M0]?D6?VEYY&I5AT[^,8@
M1Z46'+Z25YP ^K/7JH\=HF.8(]'!\*=&VRE+GH2J+1">SKXFU/3VT[$9],@@
M@\Q&+3Z^LEH,PMUIU;:#'GEDF&EZ<,2VAF/Q<T8?8G&2#T5)<V;O'9M%#W8R
M^'0VXN?K*&@/WF&& ;C=PXF6,@R"O@X$-9R5JM9ORI=5#R<\"A@'7QDK#>.]
M*-NJBQY599@IZ"%IO6_8?OO@0>B3'2[99/\'N:4Y3W"?^N]RR>9"(KZAI[/[
M(W&(ZRA_&J2/%S%[UJ24^PO</UZV-"F:PG:(7POEY ??40O-BBK[<L/9$Q6\
MGJR^IB2Z3-81ZH[#C#X5Z9GM4=QZM.5+EA #D6W#;$_$T/?&44WFH]D)=@#\
M$$SJFRL6%3M#2*IVBWMV2T+Q;QJ3K7[?L\'FZ_A?QG9V&6SH[(LD]-$X8@SC
MT2P)>R/'*1*RVXGMB? 'EA(_0O"J4.6W\G7F=";0D7F3LN,%XQG]74GK&+L=
MTA*V&PW2&.H+.?HZH4279K<+QL]8_I#-\O@X#%EN##MJKH7MB8,T!B!0HO.-
M'FEV-&L+$NON<6H/+UYC?0&;SL[(0W9&4S6P;SA9T'QA.)O:JV*[\B -'#"H
MZ&N&-!@'24A*K\3C)/HUX#P0>-4<3:?\- ZHZ:6W8S/8SD-(PZ(7V =]7!48
M<GEJ.B/%?VNHE6_M["JP2QO8;DU8 \L99OR%I]7EZCRU>3?K,B:Z:J.[1?7@
MQ4:L'J6#/H:T!94'K41\R.AA8:F&[C\UP@#HP.65,2_.2,N 1F>E)%7 [:1X
MVZO4;J<A 6L/W>EJA+'B@B3F(-*\0-(*5.6+D<FK=>ERH)71G:SZ\^XB)C[)
M8QXFE6GNB@8/-#9ZDS@T@>ZM-<)Z8,%KI(>$[7Y4"])]\*(6(? 4;E=$=] :
M>OKJL'EE4[<ZQ]X$*WF(E4FAPY#GHI_EJ'0\]\':0_<;&U$C@"#YRHP)U5RY
M)>),G#OIBZVJZ-YH(PP-#3ZO;!24P[V6\J2<"H[KAZX1]+Q@XRP:9LPPQPCX
M'%%*<;Y8QFQ%JJ0IRO2F7DW##Q: EM!3C@U]T@"C=]#K!=R_: BO21]2E@WH
MB^>(W %GP= (6USW#N-D:VS+GQ1D.[O9 C!#OWX0NYVZI;EGQ^&_<LK)-<L(
MZ.K!7A,]Z]@.O#!'65^!;@I':X@9[T%2M,&&ASMRKV^#N*!)D(3#;!#&MOS)
MA+;S!@' #'^#X"PD)%)I-F_)LEP(I[,R1?U-P+.5=.PQ.E("6T#/A+8#3RT_
M22?4O**Y<L^Y3(2H07R3/\0TK*Y18#Q;FD!/DC8*T2#<1KI;Z.K'5I0!=6+1
MF &@E=$SJ>U.FXNXGDQ-N-!#;+0>Y%L;;'*Z(W? YS)="$7W\(E%YNS[X.5&
M>N^*OV09IP]Y)C6=>W83: R*U3.1/??#GR1R\/,@#E<'K9U*:.7_R=@13T%,
ME.N? )F&HF?R#P*A[5_42A8A0-J6WS#.912#\Y?P,4CFY%9(>2[V:Y/*LN]^
M@!\L>C2\<;@ZX+5[)\#6T)S1=,G2(/[,6;X4-=1;BR2C24ZBTEC-$L,A8;^]
M@ YLGPR]&#P=? J#/][@=@CJ\W'\V(5^#N_7$_TI7RZ+B/9!7 %]F8A3V:+@
MVAYJ!]H =$B-'P81/J0<T4%7MB^3C A8,YD'[;K3(7/MA- H"&5G/+NT(]1-
MUYA.P3T@I.:98^6D719*RWB!"W>D12<^.C/5P[[U+5<2K2TKZK4?X/X'W@24
MQ_$C'3I<^[@BA,YI+7CF>\..M54*RLQX5F%GF+410]\/Q83&3%_ZIVT\!\ V
M>E!-*!7CF6[[4@$6<51Z-.]"Y+%W.]R-AB2'^E"J1C-;[D25,U!CS:=:2&UY
MGWK/M'%TU0C3%@?'=/*2#AL,>T"_BN#0GK,.G$ :@3(U7HS'H9B"0[8'_KXF
M K9G3H46D)8=<R#.6!O*V'A^@$,Q!@"I@ZK]1S*>\GF0E'%WA+ WG I9ET'<
M<>&Y%=;XKY.CB337Q"S-.1'_J#<T"9)HLJR:F@2;MG#N.VM=VX1?K@3>H#F=
ME5P'\28PLUTU&:AYI+O@73J_&0#W8N"=B!Y^&PFFSB\A1UD>=%@UKWU'HL6+
M-><N7RP"OIK.[N@\H3,:BL6Q?)(IDS (64/MNO.WYKI3-B;CIZ>;YL2:4[4W
M658-XD2+:PD&"&%LJ(.D[9N8 DQ^:'WD*6TGJVD0<,+%B]FW"<=XF7P)^#>B
M/$ Z4@MMS;M/S7FW:69"D\EBW= DW;2$9 9>AYN4"HY8,(MCUT9"2  U>!M8
MQNYU#^6C9=7'#9NMWB;1J= : IK<\T#>O!6!;)SV[_&^B#SIW0=,R_(^+A<#
M/R;=_Y*CM<W5EYCW[YI+3*W:I*B'%#R^"$9:],N^>.C*8X6^K_<&,,^U%9"G
MJ9F&5A1[H]1>;,254:=[-KQOSH9U\0'-.IL/5*T;AK>L8:HPI+VI:ATV<F45
M8PVLH6N#K&U# @A^\-N!7,LW5S>:\?^A.?YEK4F]&LIR6NN ?2?H+(RS#5RQ
M($D+B[$X=:P#&M9ZZ+1)]&P.>0LQD-?8/W:"RXO=Y8:SI3@\K<KC[')1=^_?
MFFD?FS.MJJK,N)O*6*\-55]N8JEBUV2QSSY 5;07E-T=<YJ";JT@SSPPC>U'
MD\Y0>3']-IEOCMCL*"_ON*7RMW4/KK.WO/^Q.2E5M0FOM3@)5)-JEL;JKW&M
MU5%.B1NIV,PD$_@4Z=X@TO9)1,_(MB\#Q.YIJ^?'P;0OK<U-$P22%]/SE"T6
MM##92'N,<CJ?DT1[[_#^SVWCQ+H%-0/#K39PGD_HA7*Q7S@V@_14!-))P 1U
M;0=Y'^U%<?/M1B_HO)BV-1_G[FGZE_8UA:PQR5057+=TESEHK(3L7N]X:V"J
MA6[YMU*C<[+W?::<Y42FT-G$D*F]$-?,G99+CVACDK%)V<I$-3/9:@?)!-,M
M%<0>8ZN),[5T_7*::4Z-H!MB8!0V9E\/G+R8C#"'%Z/CR_L='%\F?ZJ:_K?O
M/C#]I3@)4II.9W7W*W%^VM4S9K=6#\U?9@@,T9\^;3GDJ6ZN0)J&J18X\9HO
M3$) &,\9/102E<_#V>P7L1HSGMJ9*)VT097!0:G1"7&1RI\9M.GN+4V_G7(2
MT4S^9)Q ^DK@X#?H=$&D\82FKRF9SL[3C"Z"[N>&9<%F.?2T]ZYD= N*CG^9
MA$1&'Y1F&BG KS1[/,W33&BA'+SUN+:#GK+>E;]^0/G"K\QT.Y>10!D\/0^@
M*GH*^IXLVN% )TX&Y"-"_51K=Z&4JJ2!#H=!8 /HZ>#=]S4G:$8+<MO.Z @[
M'X)JHF=C=SH<.H"!/K/::\ 56P5QMKKA;,Z#A>$4 JB*GNQ\]R51 P<Z<1<!
MY;\$<4Z^D$!:J.3]4C'(P(NB0Q/H><J=F73&QQ]&:X\,+Q,A9*[N#HMN ]@T
M5T=/.-Z?20@NZ"R6P?B:H5/!!Q58=?14X.[G%!=<T%GL>JAGFX"F.N@IO)WY
MLB. 3M)QI)XKI? #9P6&K2)Z9FUGNH!8H'.VOM 'DZ6O@9Y8VYDEF_0>T"/.
MOZ)9^"%27P,]DW4/>LS2H].S]3BBRJJ]>21AVZ& U='S3#L3YX0+.HM:)WOP
MI(.W@)X9VIE+5W0&?IZWY_5VL13:C8I=RJOHW-/9%4OF5_2)1(5G.'PM[M4:
M>M9H]W5Z!]309_]GQJ)G&L=B:%\*E).Y?&_O2+1+&^C9GIWI=4<(G=3S@"="
M0)DBY>Y1@ )FTEH1/>NR,WU +- YZ\CRY&A A;> GG"YU[V2"SKH=.HS=*7;
M*;K@R^P.3:*G4'8WL^Z*'_H(*-[#%<_@P!P;*Z%G-'9F$8 !.D\R6 R8G\["
MZ.F(G7DQR.P!'USHR9E8Y^'3QE0'/8=P#W9L"!RTEGE-GFN0<):('T-2NST#
MT^[>$GIF8N?!T!>MD5QK/C-ETQ==X #G=UG%6 ,]A[";+PU >O3U\RY_2,F_
M<B'Z^5./.06LCIY-USU8JPLN7CP<LT=GOS>$T&K%; 7%:)_\J6@3Z:W8*P[6
MKEE0[\)'$N4RAXT<H#2B 1<TR%0/BV60K!0;MB76L8W7&#F]!PP>S71;5&;#
M//_0"IP*B,V,/,O_&$&:UYYBA;&X]/R+ILFM[*+TQ57O(5U<(\$MH8=6V#&H
M<E_LO)C-511/TZS5!GC=;6IZ&^EU]V/M9G&7:?@>62Q&<%H,*QFJ<9TDB:M0
M5J"T!/V;]"-RERVD[.YR>C2KND):FF98*X1L=V!+Y*WP#Q7A<A=?$@\F'QSW
MSFD(A\6+^0:/86F:A:WPLHZ1+$?>#O_ (2U%?Z1OKE7!7%_E:"KXL14.%L32
M" NZ<:\KR.8ZJ^J7().G:[O-8.MVSK$QM% E>PM:"L33BT6Z%A+1M JWX@G7
M R.B&P->1X3$S2G[?#8CTJ!*UKV\#53. Y:$8F IZJ%S=+=6T<T KA$6AP 1
M?9'>"%%%,!"]WZQ0C8.3TR!P;! [KM0N Z 7=EXLRAL92LNS=!W-TKI1^HQD
M 8TUJW4KVG35H(SVESV22=FL.C%3<7*NMSSY4]GV]QL<[]+MKGNB!J]AOC?*
MV:9Q:^P?SKV-1N+Z"WYDKL1Z0%3R;P!?M;)^<-8]XG3@U[I?]\,?D("49S7P
MQ;\VP(M_U,]0RCKYA62/+-K<)K1_2\AUL"#'+[2+'M'D;BT> HD["UD[!.R/
M:5V7SM@BH$DWE[8ZR&SM3$2+5YO F^/[D!X)%^I(<RJ.-*R(3_B%+!X([^!$
M%M>61CM[ H!K^PY8A![)F^X?7X[O3H,ES8+B>5$U3FZRU546&7&'544+C-F+
M!!<XQO)O//M5C(.$I"F  UUAM-A[O5 WBSRH-IV2\(<Y>WH;$5IL#N*'S;X@
M_O';>2)TH974&]<S\4SL?M/9UJ\Z^!"5H761K2+ZDV7%BH,LGI@\NK>[XRA2
M4<MDA*09XPL==]53/9=&L$T;=A;[2#7JVM;=DYLX" 'S2[;@T@!V!&T[/ZX2
M>3W5SD@:<KHL].\.3V'766=O#SOF]HX3$ J8IWQ/GQ/"TT>ZO"%<1A(/Y@9[
MDD,3V,&[=V35 (L?IF%0+IC2@GLM_;+D%4BWF;B5[<PE)TSYB<GZ&]^3PPQR
MXW/#692'66U3M]EZ[57]L$*Y/[BQ2X9OYFUW#6#O-5;R@RWPB&P[J>E%&\DH
M[$!7*V_&R>J$).&C?.6@,0*75>TU#YLXNWSCV'EW(J_JH-;JJQ6N6=,/\J##
MT\I=4[P=+;T#4)=FTYD,A93>LRR(M6:QM43=Y;&U=N@0;!%D$A]=1>@8=O?B
M<\X+XJ:2']-IP+5P(UK-\. )6[)OSBM@O9(?; %&H8VGNE#82]Y=OES&E/!6
M)VUKG[6B=XM@>P"VWLZ#L!AG(;3<)'\)_LEXE>LIU7L"=)7S8^(X+W,::6H6
MM_W!+^^6IK.M[ICN\ W%\:_O]4.IAKQ!@G'NXZ<)*1,Z&B\CV\4P;^"MPZ)N
MA==).-(]R/TS@P#:+H9VI^$*J$["L0 5?P6-T:Z":.D&G4'52CD2K!<LYQ!4
M.\JA)8YS!54K([I2M;Z)*&X:I,\U2Y0KJU&MLE0[T!,'3+C:Y1#F7=FZ6S:E
M2E/<$XX@XZ_S4JPET#CGDC)L@-B\C:M3NQAZNBCC,*FO3CH11UKPR\^)W1N"
M:*T8>D(G5T1;(J(O]RW5=G.#_-[!++-5"S]0@>UNRV:0Z0#!!Z9:.9[7;W:W
M4V;^OKF:[^3.J1ULLTTO.GL@A4YP(^]S$0/<X ^@*X_M@N9.F%ER=&)4^*#+
M-,U)=);+(%QB>: L4GD5TN+W%XS?$?Y$0Y/+F6L[V*YF[D3V0PJ?X%K_;KCH
M6I4UP\"EO@JV+UD/VFSRHS-49O,^?Y%IUNU+HZ8XFLVE-S-&N0\Z''I7O,^O
M"2=!+#?ES^(<?<52PV(*K8_V**4WYV[('/0@N".Q:&Y^G$2%T.+G<J@;5EY#
M'33[7_^EUXH ^MI[',?L.1 :DMBZSUC^D,WRN)W>T;HF.S8#I'*T"/GN5/;"
M"9W=,R*0#:GEC=)V*2 WHP7![Z-AM*4<R9IUPH,DDI<!79N7+%$O %:N/8"R
MV7=/!G"5J% _>#<EH'![9,QHBH>.=RWOYZR9&?+\)8SS2.QA=E(<FT$WGKLS
MUPLH='J/DXQ&-,[EXYC-^;/HK]#>!2S2W)U7,6^:>2:/%W*_,YP"AFD>W?+?
MXW@P)+#HPT0E^>Y(3ZE/8+B=O_ X^F=>O%V[)F)^W <O-XRK/V09IP^YTG_N
MV4U@/E3NN1O08>>1;0>%*'>E]%.AE"9D'F1E63QKH!#PGO#%.BJNR0S8+@L=
M)!Z9F?0BHR\TIW&0IM-9=25=Q.J?YEDJ-E2Y@1HNNJPUH4QY9!R"PH'/&TN>
M"$_57J:N!0HC<_%K,<7-M\NVJE#F/++T@ %!ITXL],4>8;; -HI!*?'(8M,I
MZ$'O7:=!^BCV;_D?Z9OR%,3*=2H[%>O%2BP/*KF08>;!JD.I]L@ Y 2,#S-0
M]E2(^42%<G"R^IJ2Z#)9!VR'!#AQ:0/L,N /H>X0'?3$%G*&A$2IU!/E1:VT
M,ZM RPN6J-W$=!EJK0KEWR.[&!@0/P*@K#V/MS.['6?KE&_-)&_&6-E_-<7*
M+CXQJ;XQ";*)_,I$?6;"DLGZ0Q/U)>S8V7^,O(@;<V 1XS^=)DT;CR5F"KP%
M/URY=TZ'"!<8/Z(*H*^M):T7Q5>^Q5QQ'=CN)%_Y%(MEO6"?K-1"JS1R\^,8
M0Y570:%!/O3H*\"4JE\3]I 2KJ[H+Y-EGFVG7*D+9GM>,]X7_1@LU@G0+ZEM
M#SRP8R4TMS-;B 1=>6P7^['G2.=S+1ULZ,IW;7RO?_Q/*M1*'CZNKL@3B<&K
MO;&^'[-YN*7?*"QZ^)EU[\K1K8ZE[2Z#%W=8,WYP[#:B=0S#),9>D]<]4RM4
MJJ1[;UN8C96\69U=1JZ.1#TJ_JR[M3Y^Z,/<!_3 %2,S]^$ F/O8A[F/CLR-
MYMXS%G,??67N9%63](*3?^72*P1\T-%7]F,''.Z4HY=TG#A4.QYQUGWL<[!I
M5?:#3(=!"SC+M(3TY@137WO6FAAX6376]O%,HQFJD..H!AWTY;7K*9?UH8RQ
M$G)LA3Y6;L#SMG$?-F+D)Z]N/BZ3+GEAF0[^UDY?7C4[H<EDL6YXDJY;]B?%
MP1_C5F]SL5MF?TWFF[=>Z4V09F>Y[5[/I0T_=N"=;_9<1,:_V^OHHS1]BG[5
MLR<5G6XM?QU;=+_F_*#>?< W-_!^TN-?_)VR. XRH?E9[+_-<J^$MZ98Z#=[
MFP[9HX@W2_K!2?>(TN+NBX+R6JZ]= /HL*ZK7IV.L=-NNY.R@:<PE*\ Y /1
M:Y9!%81/306AULQ$M>./.B#/B9N^VH_^NO+8Q_SU4RG90?#!OJN6'WN0F1?M
ML;U+(/R#^E:O "=Q77D_J($,.MU#OH9 ^*=GV:'+1(RN7.4!-IZ@N\H>+"5=
MPJ"?G;<[U4Z4;N.D7L,/9O3CR\A'79!QXD4WMW9CC&-=8>RCLFV\U&/$F 5&
M/R__,0+<PW<,4&Q[/+^M[['M]Q_;?K1([*/%Q3C\0.S;*^Q%$%I#Z>AK("OP
MYE.X<3MNRSU2E+8IIW.:!+$*>BOU'_E-8U)YE;')5@M[GX9!#Q+%DWE1.TU(
MF4Q&WD9!;.\_IVF@$1,=_NWI>9ED1*"8W8I]3&UFD7'*=$YQ<QO8CG\[K%T0
M<#SC\TN02:/HZDST]HRD(:=+6QQ04'7LX\ .+%H@\8S VK*QB2^C0K@;XNLX
M-($=,7T'(@'0H)/I07"KT6);N6U_[F&M#B_:>:>0YR]BDZ I42-S_<>T_&MJ
M"I/5KSGL&.F[CPLH9..F*U/.CE6V#+/:8*R!'>@<KC( !$=?4:O!<)Q$Q6BH
M+2)22/UTLM?$#GON-'.@0(PT273A>;9-PYKY JV,'CT=/G?<\,#<YG37&,&2
M9D%<\QD#TPFKBAZ;'4ZF"Q8CS2\H]+UA1C:+='?>DTU&]GRC4ZPC>&YTCWI"
M+8LBYM(.>M1S9W7,'25T<H\7,K[U[V48]LH]1EE'.5G0W'"$ %1%CR#N1"$8
M"R^<Z#:WG]7AQQ1#[^,[4PR]JH4=8^-I5N_-9]?'-+U#G*QAJH!\C6[S@6N4
M0[Z)M8'9.0V:,GC@Z%;UJ#6##0Q<>>?@UCF&=.!?^>3.]JJ]2)QH,?J-X'FX
M??<;&<-O9"C[C.W)2*,8]K4ZR+VDN^N>G&K56?LD2$DDI2!)6F(GNCI70^MD
MM2ER$ZR4$^5SP*-K<?)3-V %!IO3>]V@=)V;Z=S/U['=7K1[<E>ZY3UQT=N2
MM"PR=V<!ST:P)NT.0=K"X%<B[9PD.A9Z9C G6[<$FF/U_KN!O9+9!RD.+GZ,
M5A^7V<]R-]EHP7M97-??1/>A0EQ3&\"/9,@=H>.FF:8?3</,^WZ=0??ZVM.J
MN M58XZ_![M0#PY+?>TTTA#PELB3L_C]*4N4Q24/8LVU[!IQ#SJ'[L\&'Y\>
MH/5Z59YJ?NYW-ZY]%=T?#W$_;H'_.G9DTYA"V'7<!]MX'H0^[LJ#CT(?USG/
M3#N_??# ;=$GZXX$9!"-^3S9*:V=5RNHYAX2;XV 77B.[M_I\2JZ=;\T]$C>
MOP-"P^W '+WGX_NF_T'+YV#7H#W?O0^^>Q]\]S[X[GWPW?O@N_?!:_ ^,#_(
MF28$$K6B5@S[,LXU:D5+PG%?.(T6!F2TZZ+##P.BSM3WX@/FE;Q1S+.%PK1R
M-WJ.'E_(JOBD.LUG(TD2W<1! HFB-L[7_*"_<^BZ&D=ZR?^JG=I&?%L_WL@_
M")\X#U[?HULK1W]XGQ&._>Q^_09I.KO+6/BM>'>T?I!D>F)OKXI]AH0S#87A
MH&,L]+9CUG,@YXOR-MSB0KBKQ1_P3>P3]?C7'F#@#W]<]O'-Z(9G24(Q9:6[
MA6'U&O.;_GML[0$$3\XQ T^]0L1?6"R:B84Z+>.9[6WQZ_ZX__Y7^T3C-0^[
M,_I$(Y)$"(-N^]/HVAGJD.NBX74-N%N:?KO@A-2C-NYIP'5_VG]OJ_UAH1UP
M^[_3EY%':H%>8%?['YI7^[*52:T9?_+RU#IE3\K361AG,9AFCX37^G--,FO6
M*U,=9(.-@8;&]+,+CKY0;P?B-(==ZRJ+;5.!DZ&7=*2KN6;(X9 3L<P>AR'/
M96B=8A&U!B1T;@7;# %@I)=<GDP8%=[J.(FN6)"D&UDA:QJ@*K:N#I].8!P&
MM@5AQBJZX6Q)>+8JDR@OY<@UQBWZ:(I;5+4V"9)HLFYOQRA&.X_OJE?RLBBK
M"VH_<@"J8J<$U'81G![0UH(?%[Q@%K59 VURXKLV:GO8THH<ANJ5=ZZ/CF.W
M02A$4'PG26TO3U9V!QM0Y==-9EU2=(=*O6CBHS:O&U!E/\AT&+10'NM"8GO*
M_$(>:1C;4X8WRV%KA [#KT%+M\3H&H=6H,^<I7W6Q;(>LAD%OGU#9\\6'O[2
M]C4ELSR^HC/#>1-4V=N9UIO!-C3H-!Z'8;[(8YDCZHP(A$.J\!4_QT0!G43U
MT+M:T0P.PH-] =OTTWM # VRN\WA4Z'K)V0N.X'J?Z*5[IKT4;Y5+6R[TO!+
M10V,_@Z/+ MB=/N2P:IDN;OZL6E>LIB4T&^P7J-QJ;Y@F>Y.ZJ5\/7I9KU#:
MHKXB\^Y4@"(:3>:%9_5,G$:.TY2HQ#SKOUW):XHK&CQ(+Q^ZOF7NGJ!_-ME_
MUTU.U/?DK_*43(I/JAF\*:&^.JE]=NQ@]^J#JE]LEM=P:(H/?H[NWN"0=W%-
M1B\8G\YF-"RZI>F\K1+6+-X5V/9E' R>D>Y)CZ-_YFDFEQ_QV?HQ3Y<IQU0!
M32<:GA0[+NC*T?:JV!A%!N<.<S4T-698#F'"CK*+8HZ""IF5_4QGK8BFMNQA
M)&AQ&FF9U7P=M!,"ZV+[?D,!9LZ2O=Y9:O?$L]3#]KYV)!THU>LE_)HE84_.
MZU6Q?: 'I;V-R2M2:[\$6<Z%D#4%UTF)_8M)B:T:WU9HOZNK^YKD5T3TC&B&
M=>G1GY[EY%H,H/MG$C^1+RS)'@W7AOU;?!WZ\,XP>**;007X+Q+P^V>V^X!8
M-_1*=/"^XA\8_[L3_]HT=E?D!KU_\FB0?$VB,H4LB<Y?0E'T>"'_U7/$Z)M[
M76K^3I@>],VU1F9G/0/1DK!/P\\KN;_>@'3$9D<FF&"WVG]MZAN%-L%K7Y@$
MFTNR6/TU[M U1H_)_(?5.K8'=+4E0N?YIORKTAC,H*"?![N[][73YFN4Z*N#
MJ?= SOA6;# -@;IKTR3)@_@\#8-8H:Z)BJ!N$CN+OI)#NU[ 4:]3U(M5.4R"
M^(1QSIZEWXB> GWQ5W+X-0OIY1HH(Z@D\/5O7?PU'TX;F'@1UV-CRKXE(4M"
M(9=J6;VB>J)%G$0Q]MB"W <O1EOVWTRV[.W6RR>Z1?OR'\47)N(3V&]T-[*N
M1;%?MALKX4S'HDM7+$TOQ!B7R0EIDHN16 Y)EJ0G9,8X67>=I.<OHL=B@M$D
MX"OE."SO;F1:0Q:+KLVKR $V'$;Z*+)C)V!@-&;_'BC 7_5E&!89 (F31[&X
M"7UP(W4AG9CY,K@NG=&P$%H(:M@6>K:'_5['?73LAMQX)Z]"C.WU6@Q"L:GD
M848?XFH;4\%S+],T)]$%XW>$/]&0Z-P*!V@7^P&. \,#2>RM>N0@V^62W1+U
M^*C\Q0 CI*M-[$<XXXT./8+X:\#Z#"?&[4D0R;A#N]/;V2BV^]MX_!HPQ"?X
M:\))$-/?Q9(CMJ5I<ID\D<)O>H!Y;&P<V_5M/,(!F![VFO^9B6XD4J"[_"&E
MT>J>A(\GC'5J#H[@F=K&=IL;;\C8$<5?*N3"=5;>O^[.\W9KV%F/QV.V"S5\
M+L7OLN!%1LM16DI1<W=2-<UBIP8>CUTCCK[0?+;^]0WA*4L2$@]W5@=\ DC_
MIT.E'X"O?T/AE"5I'DO3]0498QPTVP?;;PY_%'1#Z]\0^$P2PH-8Q@>)%C2A
M$@SI\#'>XF#_(G28^&#G&QT,3TS &AG%+PJ3]YR(7Y)4[8" *Q10*]!QX(,U
ML)> OG%;CKH3,2AG%'(3UJP 9<P'"YU-EE&4] .Y^[U16#^2C(9!W'T1_,ET
M$<Q;%\'+^D4P+2Z"L_I%\.1/6Q_]?C&\6T[VV8R$V?JZ22Y(04:Z;B?U8KFT
M<7#7MNX >>;)L4E-/YV=E0N3D*)P8C&Y</SXSC1S-\W*?U4-*Y^-,J[.=]>-
M@:)>-3A3JV_QNW(KNA4CAS^I) $JK4,0V\Y7.S5Z<'-X  C1SUXM&;8O#L11
M,;GG@<Q.?$="^5"8=NID.D1 K1V>6\4NJ'EX[6(0IXBG$*X^=P?]+A+! &L?
MF'.%(RJ8#[^@O%I"'79*W2OPH0\*%D":4:UBK6^;PA,V?7ZA[+BU>6 .#H,@
MN"]V:R&0Q>^NNB.[=TK55?/ /!,<T/#OR.-ZJ'4[K_K@"6"1!/]@,CRIQEC;
MW:4/R ' *(=']H*SG-Q7GH4W <]6XEB<I$(@:=D O2;^\7W37"#:G&1L4K8Z
M4<U.ZNWZ$RY;)SDD^ZNM)G8F-ET/3U9;?X&F97-JSH_\05!VM2G:G&3&S]>F
MZ>Z5/5N;O:8?C.XTNALTVV7&3]L&D]*<O<VEC3\,RYW2HR=VJW?)EL>MJZP?
M]+D/6@-GOB1KJ_?)EK"MJRRV#54_M S@>Y:G36E#-0L"+,=]5P7T!/>PC;KK
ML:!>_KVY(I1_D?_O(4B)^,W_!U!+ 0(4 Q0    ( -&#;UD+H_HY,10  ,$5
M   +              "  0    !A=61?,# Q+FIP9U!+ 0(4 Q0    ( -&#
M;UF$GV<#F0P  )X-   +              "  5H4  !A=61?,# R+FIP9U!+
M 0(4 Q0    ( -&#;UGD^*R^6!,  $H4   +              "  1PA  !A
M=61?,# S+FIP9U!+ 0(4 Q0    ( -&#;UF2%6BKV@P  '0-   +
M      "  9TT  !A=61?,# T+FIP9U!+ 0(4 Q0    ( -&#;UFE;*G)@&@
M &-Q P *              "  :!!  !E>#$Q+3(N:'1M4$L! A0#%     @
MT8-O6?0J(^X*"   >D,   H              ( !2*H  &5X,3(M,2YH=&U0
M2P$"% ,4    " #1@V]9=G"K414(  #A0@  "@              @ %ZL@
M97@Q,BTR+FAT;5!+ 0(4 Q0    ( -&#;UEJS\?)!P0  " 7   *
M      "  ;>Z  !E>#$S+3$N:'1M4$L! A0#%     @ T8-O6?T)*9TF!
M4A8   H              ( !YKX  &5X,3,M,BYH=&U02P$"% ,4    " #1
M@V]9PC[KR%04   3F   "@              @ $TPP  97@Y-RTQ+FAT;5!+
M 0(4 Q0    ( -&#;UDVA,S(];\"  \V&P ,              "  ;#7  !F
M;W)M,C M9BYH=&U02P$"% ,4    " #1@V]969(B"E(G  #I*@  $
M        @ '/EP, 9F]R;3(P+69?,# Q+FIP9U!+ 0(4 Q0    ( -&#;UE*
M_9=-EUH   !>   0              "  4^_ P!F;W)M,C M9E\P,#(N:G!G
M4$L! A0#%     @ T8-O67?H5I,%$P  CQ8  !               ( !%!H$
M &9O<FTR,"UF7S P,RYJ<&=02P$"% ,4    " #1@V]9,Z44*7%^   *A@
M$               @ %'+00 9F]R;3(P+69?,# T+FIP9U!+ 0(4 Q0    (
M -&#;UFY1I!N-*0  "K8   0              "  >:K! !F;W)M,C M9E\P
M,#4N:G!G4$L! A0#%     @ T8-O68"935->*@  93T  !
M ( !2% % &9O<FTR,"UF7S P-BYJ<&=02P$"% ,4    " #1@V]9($K)WQ5V
M  "0=P  $               @ '4>@4 9F]R;3(P+69?,# W+FIP9U!+ 0(4
M Q0    ( -&#;UD#KEV,4IP  ->=   0              "  1?Q!0!F;W)M
M,C M9E\P,#@N:G!G4$L! A0#%     @ T8-O610QH\\5#@  F94  !$
M         ( !EXT& &9T96PM,C R-# V,S N>'-D4$L! A0#%     @ T8-O
M6?)9)< 0$0  P=   !4              ( !VYL& &9T96PM,C R-# V,S!?
M8V%L+GAM;%!+ 0(4 Q0    ( -&#;UEH=N\',2@  *9F @ 5
M  "  1ZM!@!F=&5L+3(P,C0P-C,P7V1E9BYX;6Q02P$"% ,4    " #1@V]9
MS0YU 3=6  ##X 0 %0              @ &"U08 9G1E;"TR,#(T,#8S,%]L
M86(N>&UL4$L! A0#%     @ T8-O6?%(^]40.   H($# !4
M ( !["L' &9T96PM,C R-# V,S!?<')E+GAM;%!+!08     &  8 *D%   O
%9 <    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>form20-f_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FTEL="http://fitellcorp.com/20240630"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ftel-20240630.xsd" xlink:type="simple"/>
    <context id="From2023-07-01to2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_MerchandiseRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:MerchandiseRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_MerchandiseRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:MerchandiseRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_SalesOfConsumableProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:SalesOfConsumableProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_SalesOfConsumableProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:SalesOfConsumableProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_RevenueFromLicensingCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:RevenueFromLicensingCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_RevenueFromLicensingCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FTEL:RevenueFromLicensingCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_FitellCorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:FitellCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_FitellCorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:FitellCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:KMASCapitalAndInvestmentPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:KMASCapitalAndInvestmentPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:KMASCapitalAndInvestmentPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_GDWellnessPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:GDWellnessPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_GDWellnessPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:GDWellnessPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_GDWellnessPtyLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FTEL:GDWellnessPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_OneVendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:OneVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:TwoVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_OneVendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:OneVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:TwoVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_ThreeVendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:ThreeVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_ThreeVendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:ThreeVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_FourVendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FTEL:FourVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-01-15_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-15</instant>
        </period>
    </context>
    <context id="From2024-01-152024-01-15_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-15</startDate>
            <endDate>2024-01-15</endDate>
        </period>
    </context>
    <context id="AsOf2024-01-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
        </entity>
        <period>
            <instant>2024-01-15</instant>
        </period>
    </context>
    <context id="AsOf2024-01-15_custom_WarrantTwoMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FTEL:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-15</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">FTEL:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_WarrantMember175940953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_WarrantMember175940953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-08-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
        </entity>
        <period>
            <instant>2023-08-02</instant>
        </period>
    </context>
    <context id="From2023-08-022023-08-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
        </entity>
        <period>
            <startDate>2023-08-02</startDate>
            <endDate>2023-08-02</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001928581</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="AUD">
        <measure>iso4217:AUD</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-07-01to2024-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-07-01to2024-06-30" id="Fact000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2023-07-01to2024-06-30" id="Fact000005">0001928581</dei:EntityCentralIndexKey>
    <FTEL:CapitalReceivablesOfConvertibleNotes
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0074"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0077"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0139"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0140"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:ConsultingFees
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0204"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:LicensingFees
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0291"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-07-012023-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0294"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0297"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0305"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0306"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0310"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0316"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0318"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0324"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0332"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0335"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0343"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0348"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0349"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0364"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0382"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0390"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0404"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0415"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0439"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:IncreaseDecreaseInPrepaidOfferingCosts
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0487"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:ProceedsFromIssuanceOfConvertibleNotes
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssued1
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0528"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:CapitalReceivableOfConvertibleNotes
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0532"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:OperatingLeaseLiabilityAndRightOfUseAsset
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:ConversionOfDebtToEquity
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0538"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:ConversionOfWarrantsOfConvertibleNotesToEquity
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0541"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:ConversionOfUnderwritersWarrantToEquity
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0544"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0736"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0738"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0744"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0746"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0752"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0754"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0760"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0762"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember"
      id="xdx2ixbrl0786">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2023-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl0810"
      unitRef="Shares"
      xsi:nil="true"/>
    <FTEL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice
      contextRef="AsOf2023-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl0812"
      unitRef="Shares"
      xsi:nil="true"/>
    <FTEL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953"
      id="xdx2ixbrl0822"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-06-30_us-gaap_WarrantMember175940953"
      id="xdx2ixbrl0824"
      unitRef="Shares"
      xsi:nil="true"/>
    <FTEL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable
      contextRef="AsOf2024-06-30_us-gaap_WarrantMember175940953"
      id="xdx2ixbrl0826"
      unitRef="Shares"
      xsi:nil="true"/>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0935"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost
      contextRef="From2023-07-01to2024-06-30"
      id="xdx2ixbrl0947"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseDebtDiscount
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0951"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0954"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0957"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0960"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses
      contextRef="From2022-07-012023-06-30"
      id="xdx2ixbrl0963"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0976"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0986"
      unitRef="USD"
      xsi:nil="true"/>
    <FTEL:DeferredTaxAssetsAccumulatedTaxLoss
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0989"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-07-01to2024-06-30" id="Fact000012">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="From2023-07-01to2024-06-30" id="Fact000013">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="From2023-07-01to2024-06-30" id="Fact000014">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2023-07-01to2024-06-30" id="Fact000015">2024-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-07-01to2024-06-30" id="Fact000016">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2023-07-01to2024-06-30" id="Fact000017">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2023-07-01to2024-06-30" id="Fact000018">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="From2023-07-01to2024-06-30" id="Fact000019">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="From2023-07-01to2024-06-30" id="Fact000020">001-41774</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-07-01to2024-06-30" id="Fact000021">FITELL CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-07-01to2024-06-30" id="Fact000022">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="From2023-07-01to2024-06-30" id="Fact000023">23-25 Mangrove Lane</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-07-01to2024-06-30" id="Fact000024">Taren Point</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-07-01to2024-06-30" id="Fact000025">NSW</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="From2023-07-01to2024-06-30" id="Fact000026">2229</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="From2023-07-01to2024-06-30" id="Fact000027">AU</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000028">Cogency Global Inc.</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000029">122 East 42nd Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000030">18th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000031">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000032">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000033">10168</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000034">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2023-07-012024-06-30_dei_BusinessContactMember"
      id="Fact000035">221-0102</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2023-07-01to2024-06-30" id="Fact000036">Ordinary     Shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-07-01to2024-06-30" id="Fact000037">FTEL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-07-01to2024-06-30" id="Fact000038">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000039"
      unitRef="Shares">20123386</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-07-01to2024-06-30" id="Fact000040">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2023-07-01to2024-06-30" id="Fact000041">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2023-07-01to2024-06-30" id="Fact000042">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-07-01to2024-06-30" id="Fact000043">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-07-01to2024-06-30" id="Fact000044">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-07-01to2024-06-30" id="Fact000045">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-07-01to2024-06-30" id="Fact000046">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="From2023-07-01to2024-06-30" id="Fact000047">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-07-01to2024-06-30" id="Fact000048">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard contextRef="From2023-07-01to2024-06-30" id="Fact000049">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="From2023-07-01to2024-06-30" id="Fact000050">false</dei:EntityShellCompany>
    <dei:AuditorName contextRef="From2023-07-01to2024-06-30" id="Fact000051">Astra Audit &amp; Advisory LLC</dei:AuditorName>
    <dei:AuditorFirmId contextRef="From2023-07-01to2024-06-30" id="Fact000052">6920</dei:AuditorFirmId>
    <dei:AuditorLocation contextRef="From2023-07-01to2024-06-30" id="Fact000053">Tampa, Florida</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000061"
      unitRef="USD">939014</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000062"
      unitRef="USD">236821</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000064"
      unitRef="USD">124963</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000065"
      unitRef="USD">494275</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000067"
      unitRef="USD">60042</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000068"
      unitRef="USD">174341</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000070"
      unitRef="USD">2439793</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000071"
      unitRef="USD">525786</us-gaap:InventoryNet>
    <FTEL:CapitalReceivablesOfConvertibleNotes
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000073"
      unitRef="USD">1472000</FTEL:CapitalReceivablesOfConvertibleNotes>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000076"
      unitRef="USD">2500000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <FTEL:DepositsAndPrepaids
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000079"
      unitRef="USD">316869</FTEL:DepositsAndPrepaids>
    <FTEL:DepositsAndPrepaids
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000080"
      unitRef="USD">13412</FTEL:DepositsAndPrepaids>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000082"
      unitRef="USD">1200000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000083"
      unitRef="USD">5317866</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000085"
      unitRef="USD">9052681</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000086"
      unitRef="USD">6762501</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000088"
      unitRef="USD">27133</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000089"
      unitRef="USD">38743</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000091"
      unitRef="USD">557798</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000092"
      unitRef="USD">605794</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000094"
      unitRef="USD">342122</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000095"
      unitRef="USD">132354</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000097"
      unitRef="USD">337504</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000098"
      unitRef="USD">337504</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000100"
      unitRef="USD">1161052</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000101"
      unitRef="USD">1161052</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000103"
      unitRef="USD">11478290</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000104"
      unitRef="USD">9037948</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000112"
      unitRef="USD">1210956</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000113"
      unitRef="USD">1168723</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000115"
      unitRef="USD">209100</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000116"
      unitRef="USD">238351</us-gaap:DeferredRevenueCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000118"
      unitRef="USD">408681</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000119"
      unitRef="USD">486058</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000121"
      unitRef="USD">38808</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000122"
      unitRef="USD">24386</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000124"
      unitRef="USD">278432</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000125"
      unitRef="USD">212062</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000127"
      unitRef="USD">2145977</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000128"
      unitRef="USD">2129580</us-gaap:LiabilitiesCurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000130"
      unitRef="USD">21520</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000131"
      unitRef="USD">18430</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000133"
      unitRef="USD">301921</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000134"
      unitRef="USD">473015</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000136"
      unitRef="USD">2469418</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000137"
      unitRef="USD">2621025</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000148"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact000150"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000152"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact000154"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000156"
      unitRef="Shares">20123386</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000158"
      unitRef="Shares">20123386</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact000160"
      unitRef="Shares">8120000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact000162"
      unitRef="Shares">8120000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000145"
      unitRef="USD">2012</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000146"
      unitRef="USD">812</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000164"
      unitRef="USD">19014389</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000165"
      unitRef="USD">7097822</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000167"
      unitRef="USD">-13737</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000168"
      unitRef="USD">-64</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000170"
      unitRef="USD">-9993792</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000171"
      unitRef="USD">-681647</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000173"
      unitRef="USD">9008872</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000174"
      unitRef="USD">6416923</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000176"
      unitRef="USD">11478290</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000177"
      unitRef="USD">9037948</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-07-012024-06-30_custom_MerchandiseRevenueMember"
      decimals="0"
      id="Fact000182"
      unitRef="USD">3956962</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-07-012023-06-30_custom_MerchandiseRevenueMember"
      decimals="0"
      id="Fact000183"
      unitRef="USD">4036047</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-07-012024-06-30_custom_SalesOfConsumableProductsMember"
      decimals="0"
      id="Fact000185"
      unitRef="USD">358536</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-07-012023-06-30_custom_SalesOfConsumableProductsMember"
      decimals="0"
      id="Fact000186"
      unitRef="USD">223343</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-07-012024-06-30_custom_RevenueFromLicensingCustomersMember"
      decimals="0"
      id="Fact000188"
      unitRef="USD">151277</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-07-012023-06-30_custom_RevenueFromLicensingCustomersMember"
      decimals="0"
      id="Fact000189"
      unitRef="USD">539832</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000191"
      unitRef="USD">4466775</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000192"
      unitRef="USD">4799222</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000194"
      unitRef="USD">2881060</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000195"
      unitRef="USD">2625821</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000197"
      unitRef="USD">1585715</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000198"
      unitRef="USD">2173401</us-gaap:GrossProfit>
    <FTEL:ConsultingFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000203"
      unitRef="USD">5468126</FTEL:ConsultingFees>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000206"
      unitRef="USD">2452954</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000207"
      unitRef="USD">888141</us-gaap:GeneralAndAdministrativeExpense>
    <FTEL:PersonnelExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000209"
      unitRef="USD">951451</FTEL:PersonnelExpenses>
    <FTEL:PersonnelExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000210"
      unitRef="USD">965395</FTEL:PersonnelExpenses>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000212"
      unitRef="USD">351298</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000213"
      unitRef="USD">454995</us-gaap:SellingAndMarketingExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000215"
      unitRef="USD">284169</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000216"
      unitRef="USD">198914</us-gaap:OperatingLeaseExpense>
    <FTEL:LicensingFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000218"
      unitRef="USD">65839</FTEL:LicensingFees>
    <us-gaap:Depreciation
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000221"
      unitRef="USD">10385</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000222"
      unitRef="USD">12268</us-gaap:Depreciation>
    <us-gaap:OperatingExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000224"
      unitRef="USD">9584222</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000225"
      unitRef="USD">2519713</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000227"
      unitRef="USD">-7998507</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000228"
      unitRef="USD">-346312</us-gaap:OperatingIncomeLoss>
    <FTEL:PublicOfferingRelatedExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000233"
      unitRef="USD">50523</FTEL:PublicOfferingRelatedExpenses>
    <FTEL:PublicOfferingRelatedExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000234"
      unitRef="USD">662418</FTEL:PublicOfferingRelatedExpenses>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000236"
      unitRef="USD">-354781</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000237"
      unitRef="USD">-529488</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000239"
      unitRef="USD">121889</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000240"
      unitRef="USD">9885</us-gaap:OtherNonoperatingIncome>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000242"
      unitRef="USD">2574</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000243"
      unitRef="USD">1978</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000245"
      unitRef="USD">1242140</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000246"
      unitRef="USD">92800</us-gaap:InterestExpenseNonoperating>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000248"
      unitRef="USD">-1522981</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000249"
      unitRef="USD">-1272843</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000251"
      unitRef="USD">-9521488</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000252"
      unitRef="USD">-1619155</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000254"
      unitRef="USD">-209343</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000255"
      unitRef="USD">-25761</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000257"
      unitRef="USD">-9312145</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000258"
      unitRef="USD">-1593394</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000260"
      unitRef="USD">-13673</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000261"
      unitRef="USD">-27063</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000263"
      unitRef="USD">-9325818</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000264"
      unitRef="USD">-1620457</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000266"
      unitRef="USDPShares">-0.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000268"
      unitRef="USDPShares">-0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000270"
      unitRef="USDPShares">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000272"
      unitRef="USDPShares">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000274"
      unitRef="Shares">14020251</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000276"
      unitRef="Shares">14020251</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000278"
      unitRef="Shares">7714959</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000280"
      unitRef="Shares">7714959</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000289"
      unitRef="Shares">7000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000282"
      unitRef="USD">700</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_custom_SubscriptionReceivableMember"
      decimals="0"
      id="Fact000283"
      unitRef="USD">-56</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000284"
      unitRef="USD">1497990</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000285"
      unitRef="USD">26999</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000286"
      unitRef="USD">911747</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000287"
      unitRef="USD">2437380</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000300"
      unitRef="Shares">1120000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000293"
      unitRef="USD">112</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000295"
      unitRef="USD">5599888</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000298"
      unitRef="USD">5600000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription
      contextRef="From2022-07-012023-06-30_custom_SubscriptionReceivableMember"
      decimals="0"
      id="Fact000303"
      unitRef="USD">56</FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription>
    <FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000304"
      unitRef="USD">-56</FTEL:StockIssuedDuringPeriodValueSettlementOfStockSubscription>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000312"
      unitRef="USD">-27063</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000314"
      unitRef="USD">-27063</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000320"
      unitRef="USD">-1593394</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000321"
      unitRef="USD">-1593394</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000330"
      unitRef="Shares">8120000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000323"
      unitRef="USD">812</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000325"
      unitRef="USD">7097822</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000326"
      unitRef="USD">-64</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000327"
      unitRef="USD">-681647</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000328"
      unitRef="USD">6416923</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000341"
      unitRef="Shares">8120000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000334"
      unitRef="USD">812</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000336"
      unitRef="USD">7097822</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000337"
      unitRef="USD">-64</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000338"
      unitRef="USD">-681647</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000339"
      unitRef="USD">6416923</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000352"
      unitRef="Shares">3000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000345"
      unitRef="USD">300</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000347"
      unitRef="USD">7497342</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000350"
      unitRef="USD">7497642</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000361"
      unitRef="Shares">4090909</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000354"
      unitRef="USD">409</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000356"
      unitRef="USD">3599591</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000359"
      unitRef="USD">3600000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000370"
      unitRef="Shares">4892727</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000363"
      unitRef="USD">489</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000365"
      unitRef="USD">819599</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000368"
      unitRef="USD">820088</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000379"
      unitRef="Shares">19750</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000372"
      unitRef="USD">2</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000374"
      unitRef="USD">35</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000377"
      unitRef="USD">37</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000384"
      unitRef="USD">-13673</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000386"
      unitRef="USD">-13673</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000392"
      unitRef="USD">-9312145</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000393"
      unitRef="USD">-9312145</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000402"
      unitRef="Shares">20123386</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000395"
      unitRef="USD">2012</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000397"
      unitRef="USD">19014389</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000398"
      unitRef="USD">-13737</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000399"
      unitRef="USD">-9993792</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000400"
      unitRef="USD">9008872</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000413"
      unitRef="Shares">20123386</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000406"
      unitRef="USD">2012</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000408"
      unitRef="USD">19014389</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000409"
      unitRef="USD">-13737</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000410"
      unitRef="USD">-9993792</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000411"
      unitRef="USD">9008872</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000420"
      unitRef="USD">-9312145</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000421"
      unitRef="USD">-1593394</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000426"
      unitRef="USD">10385</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000427"
      unitRef="USD">12268</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000429"
      unitRef="USD">284169</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000430"
      unitRef="USD">198914</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000432"
      unitRef="USD">579265</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000433"
      unitRef="USD">426971</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000435"
      unitRef="USD">-354781</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000436"
      unitRef="USD">-529488</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000438"
      unitRef="USD">1108088</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000441"
      unitRef="USD">37</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000442"
      unitRef="USD">560000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000447"
      unitRef="USD">449210</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000448"
      unitRef="USD">560215</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000450"
      unitRef="USD">1914007</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000451"
      unitRef="USD">-393636</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000453"
      unitRef="USD">303457</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000454"
      unitRef="USD">61177</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <FTEL:IncreaseDecreaseInPrepaidOfferingCosts
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000456"
      unitRef="USD">1999475</FTEL:IncreaseDecreaseInPrepaidOfferingCosts>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000459"
      unitRef="USD">-340897</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000460"
      unitRef="USD">-202437</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <FTEL:IncreaseDecreaseInDeferredTaxAsset
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000462"
      unitRef="USD">209768</FTEL:IncreaseDecreaseInDeferredTaxAsset>
    <FTEL:IncreaseDecreaseInDeferredTaxAsset
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000463"
      unitRef="USD">20759</FTEL:IncreaseDecreaseInDeferredTaxAsset>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000465"
      unitRef="USD">42233</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000466"
      unitRef="USD">363694</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000468"
      unitRef="USD">-29251</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000469"
      unitRef="USD">-263625</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000471"
      unitRef="USD">-77377</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000472"
      unitRef="USD">-169615</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <FTEL:IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000474"
      unitRef="USD">3090</FTEL:IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent>
    <FTEL:IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000475"
      unitRef="USD">13147</FTEL:IncreaseDecreaseInAccruedEmployeeBenefitsNoncurrent>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000477"
      unitRef="USD">-12253539</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000478"
      unitRef="USD">-373104</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000483"
      unitRef="USD">2500000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000486"
      unitRef="USD">-2500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000492"
      unitRef="USD">14422</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000493"
      unitRef="USD">-79064</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000495"
      unitRef="USD">13614983</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <FTEL:ProceedsFromIssuanceOfConvertibleNotes
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000498"
      unitRef="USD">1840000</FTEL:ProceedsFromIssuanceOfConvertibleNotes>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000501"
      unitRef="USD">15469405</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000502"
      unitRef="USD">-79064</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000504"
      unitRef="USD">13673</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000505"
      unitRef="USD">27063</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000507"
      unitRef="USD">702193</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000508"
      unitRef="USD">-479231</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000510"
      unitRef="USD">236821</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="Fact000511"
      unitRef="USD">716052</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000513"
      unitRef="USD">939014</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000514"
      unitRef="USD">236821</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000522"
      unitRef="USD">247313</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000523"
      unitRef="USD">80375</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:StockIssued1
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000529"
      unitRef="USD">5040000</us-gaap:StockIssued1>
    <FTEL:CapitalReceivableOfConvertibleNotes
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000531"
      unitRef="USD">1472000</FTEL:CapitalReceivableOfConvertibleNotes>
    <FTEL:OperatingLeaseLiabilityAndRightOfUseAsset
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000534"
      unitRef="USD">836697</FTEL:OperatingLeaseLiabilityAndRightOfUseAsset>
    <FTEL:ConversionOfDebtToEquity
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000537"
      unitRef="USD">3600000</FTEL:ConversionOfDebtToEquity>
    <FTEL:ConversionOfWarrantsOfConvertibleNotesToEquity
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000540"
      unitRef="USD">820088</FTEL:ConversionOfWarrantsOfConvertibleNotesToEquity>
    <FTEL:ConversionOfUnderwritersWarrantToEquity
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000543"
      unitRef="USD">37</FTEL:ConversionOfUnderwritersWarrantToEquity>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000546">&lt;p id="xdx_80A_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zlMOP2hcn6O2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_822_zrn7j9Jj8Bm2"&gt;Organization and principal activities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fitell
Corporation (the &#x201c;Company&#x201d;) was incorporated in the Cayman Islands on April 11, 2022 under the Companies Act as an exempted
company with limited liability. The Company conducts its primary operations of selling gym and fitness equipment in Australia through
its indirectly held wholly owned subsidiary that are incorporated and domiciled in Australia, namely GD Wellness Pty Ltd (&#x201c;GD&#x201d;).
The Company holds GD via a wholly owned subsidiary, namely KMAS Capital and Investment Pty Ltd (&#x201c;KMAS&#x201d;) which is incorporated
and domiciled in Australia.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zAZhsVtOGGlk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the Company and its subsidiaries are set out in the table as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_ziwBcBbKXaa1" style="display: none"&gt;Schedule of the Company and its Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Percentage of effective ownership&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Name&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Date of incorporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Place of incorporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Principal activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Fitell Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span id="xdx_901_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_za9zREEZQKv8" title="Date of incorporation"&gt;April 11, 2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zyCOFRLqjQH3" title="Percentage of effective ownership description"&gt;Parent&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20220701__20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zrVcGpcODDYk" title="Percentage of effective ownership description"&gt;Parent&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_902_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zQdlS8nwqKNf" title="Place of incorporation"&gt;Cayman Islands&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zjXjIOxhY61f" title="Principal activities"&gt;Investment holdings&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;KMAS Capital and Investment Pty Ltd&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_z3hRSq96jH93" title="Date of incorporation"&gt;July 26, 2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zVibSR1cOR5e" title="Percentage of effective ownership"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zyXDegyk8Wwb" title="Percentage of effective ownership"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_903_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zcckMFrif5q7" title="Place of incorporation"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zqUL7glRaf1e" title="Principal activities"&gt;Investment holdings&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 15%"&gt;GD Wellness Pty Ltd&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zPbUYFnBwdoe" title="Date of incorporation"&gt;July 22, 2005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 13%"&gt;&lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zSbrjc1a7YAd" title="Percentage of effective ownership"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 13%"&gt;&lt;span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zCBPwKZfwkdc" title="Percentage of effective ownership"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 15%"&gt;&lt;span id="xdx_90D_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zZaMwOMd1JMa" title="Place of incorporation"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zFNDkEOL8maf" title="Principal activities"&gt;Sales of gym and fitness equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zbdNEkVpTIei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <FTEL:ScheduleOfSubsidiariesOfCompanyTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000548">&lt;p id="xdx_898_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zAZhsVtOGGlk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Details
of the Company and its subsidiaries are set out in the table as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_ziwBcBbKXaa1" style="display: none"&gt;Schedule of the Company and its Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Percentage of effective ownership&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Name&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Date of incorporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Place of incorporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Principal activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Fitell Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span id="xdx_901_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_za9zREEZQKv8" title="Date of incorporation"&gt;April 11, 2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zyCOFRLqjQH3" title="Percentage of effective ownership description"&gt;Parent&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EquityMethodInvestmentAdditionalInformation_c20220701__20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zrVcGpcODDYk" title="Percentage of effective ownership description"&gt;Parent&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_902_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zQdlS8nwqKNf" title="Place of incorporation"&gt;Cayman Islands&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FitellCorporationMember_zjXjIOxhY61f" title="Principal activities"&gt;Investment holdings&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;KMAS Capital and Investment Pty Ltd&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_z3hRSq96jH93" title="Date of incorporation"&gt;July 26, 2016&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zVibSR1cOR5e" title="Percentage of effective ownership"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zyXDegyk8Wwb" title="Percentage of effective ownership"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_903_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zcckMFrif5q7" title="Place of incorporation"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KMASCapitalAndInvestmentPtyLtdMember_zqUL7glRaf1e" title="Principal activities"&gt;Investment holdings&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 15%"&gt;GD Wellness Pty Ltd&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zPbUYFnBwdoe" title="Date of incorporation"&gt;July 22, 2005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 13%"&gt;&lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zSbrjc1a7YAd" title="Percentage of effective ownership"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 13%"&gt;&lt;span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zCBPwKZfwkdc" title="Percentage of effective ownership"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; width: 15%"&gt;&lt;span id="xdx_90D_ecustom--EquityMethodInvestmentPlaceOfIncorporation_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zZaMwOMd1JMa" title="Place of incorporation"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; width: 13%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentDescriptionOfPrincipalActivities_c20230701__20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDWellnessPtyLtdMember_zFNDkEOL8maf" title="Principal activities"&gt;Sales of gym and fitness equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FTEL:ScheduleOfSubsidiariesOfCompanyTableTextBlock>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="From2023-07-012024-06-30_custom_FitellCorporationMember"
      id="Fact000550">2022-04-11</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:EquityMethodInvestmentAdditionalInformation
      contextRef="From2023-07-012024-06-30_custom_FitellCorporationMember"
      id="Fact000552">Parent</us-gaap:EquityMethodInvestmentAdditionalInformation>
    <us-gaap:EquityMethodInvestmentAdditionalInformation
      contextRef="From2022-07-012023-06-30_custom_FitellCorporationMember"
      id="Fact000554">Parent</us-gaap:EquityMethodInvestmentAdditionalInformation>
    <FTEL:EquityMethodInvestmentPlaceOfIncorporation
      contextRef="From2023-07-012024-06-30_custom_FitellCorporationMember"
      id="Fact000556">Cayman Islands</FTEL:EquityMethodInvestmentPlaceOfIncorporation>
    <us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities
      contextRef="From2023-07-012024-06-30_custom_FitellCorporationMember"
      id="Fact000558">Investment holdings</us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="From2023-07-012024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember"
      id="Fact000560">2016-07-26</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember"
      decimals="INF"
      id="Fact000562"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2023-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember"
      decimals="INF"
      id="Fact000564"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <FTEL:EquityMethodInvestmentPlaceOfIncorporation
      contextRef="From2023-07-012024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember"
      id="Fact000566">Australia</FTEL:EquityMethodInvestmentPlaceOfIncorporation>
    <us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities
      contextRef="From2023-07-012024-06-30_custom_KMASCapitalAndInvestmentPtyLtdMember"
      id="Fact000568">Investment holdings</us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="From2023-07-012024-06-30_custom_GDWellnessPtyLtdMember"
      id="Fact000570">2005-07-22</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-06-30_custom_GDWellnessPtyLtdMember"
      decimals="INF"
      id="Fact000572"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2023-06-30_custom_GDWellnessPtyLtdMember"
      decimals="INF"
      id="Fact000574"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <FTEL:EquityMethodInvestmentPlaceOfIncorporation
      contextRef="From2023-07-012024-06-30_custom_GDWellnessPtyLtdMember"
      id="Fact000576">Australia</FTEL:EquityMethodInvestmentPlaceOfIncorporation>
    <us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities
      contextRef="From2023-07-012024-06-30_custom_GDWellnessPtyLtdMember"
      id="Fact000578">Sales of gym and fitness equipment</us-gaap:EquityMethodInvestmentDescriptionOfPrincipalActivities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000580">&lt;p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_ztJK3fGnOud3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_821_zaWeaWL8XvC9"&gt;Summary of significant accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zdLEDuzG8uVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities
and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements have been prepared using the accrual basis of accounting
in accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;) and presented in
US dollars. The year end is June 30.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_zRZ6MgKLFQa3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Basic
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the financial statements of the Company and its subsidiaries. All inter-company transactions
and balances between the Company and its subsidiaries have been eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--ConcentrationsofVendorsPolicyTextBlock_zNZvAji6B1el" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Concentrations
of vendors&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal year ended June 30, 2024, there are two vendors which accounts for more than 10% of the Company total purchases
individually, and they account for &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_z1AzUGQtk8Ib" title="Concentration risk percentage"&gt;23.68&lt;/span&gt;%
and &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zuQ7Jo75IwHk" title="Concentration risk percentage"&gt;16.83&lt;/span&gt;%
of the total purchases respectively. During the fiscal year ended June 30, 2023, there are three vendors which accounts for more
than 10% of the Company total purchase individually, and they account for &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_zRUtLTivHyC" title="Concentration risk percentage"&gt;28.63&lt;/span&gt;%, &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zXnrg1OFlgHf" title="Concentration risk percentage"&gt;16.55&lt;/span&gt;%, and&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zroiiC2ik71h" title="Concentration risk percentage"&gt; 10.66&lt;/span&gt;% of the total purchases
respectively. As of June 30, 2024 and 2023, three and four vendors, respectively, account for &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zchNOoVAMM19" title="Concentration risk percentage"&gt;60&lt;/span&gt;%
and &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourVendorsMember_zD7wHxr38YG5" title="Concentration risk percentage"&gt;58&lt;/span&gt;%
of total accounts payable, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zxohUoZmgnie" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables
arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions.
The Company controls credit risk related to accounts receivable through credit approvals, credit limits and monitoring procedures. The
Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an
allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure
beyond such allowance is limited.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--UseOfEstimates_z4fZuz8a4Sr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
these estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zmUYDeKS1ZJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates it main income source from the sales of merchandise, which includes the sales of various gym equipment and fitness
products. It recognizes this merchandise revenue in accordance with Accounting Standards Update&#160;&#160; (&#x201c;ASU&#x201d;) 2014-09,
&#x201c;&lt;i&gt;Revenue from contracts with customers,&#x201d;&lt;/i&gt; (Topic 606). Revenue is recognized when a customer obtains control of promised
goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows
arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to
receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification
of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether
they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration;
(iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies
each performance obligation. The Company&#x2019;s main revenue stream is from sales of products. The Company recognizes as revenues the
amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied
or as it is satisfied. Generally, the Company&#x2019;s performance obligations are transferred to customers at a point in time, typically
upon shipment. The Company offers &lt;span style="background-color: white"&gt;refunds, repairs and replacements in accordance with the Australian
Consumer Law. The Company recognized the sales discount and returns against its revenues in the same period as the original sales transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also occasionally sells various consumable products. These products include, but are not limited to, coffee and nutritional supplement
products. Similar to the aforesaid merchandise revenue, it also recognizes the revenue in accordance with Topic 606 upon shipment. If
the Company &lt;span style="background-color: white"&gt;provided a sales discount or allowed sales returns, it is recognized against its revenues
in the same period as the original sales transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also provides licensing services and gym equipment to gym studios in overseas. These services include, but are not limited to,
providing the brand name, and offer initial design services to these gym studios. Similar to the aforesaid merchandise revenue, it also
recognizes the revenue in accordance with Topic 606 based on the straight-line basis over the contractual service period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--RevenueRecognitionDeferredRevenue_zrq3A5crubDj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Deferred
Revenue&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized the deposits received from its customers as deferred revenue if the goods or service is not delivered. It would be
recognized as revenue after the goods or service is delivered. During the fiscal years ended June 30, 2024 and 2023, a total of $&lt;span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230701__20240630_zEaFFrY3lIq4" title="Deferred revenue, revenue recognized"&gt;238,351&lt;/span&gt;
and $&lt;span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220701__20230630_zZrOo4GFcNQ8" title="Deferred revenue, revenue recognized"&gt;501,976&lt;/span&gt;, respectively, of deferred revenue was recognized into merchandise revenue. At June 30, 2024 and 2023, a total of $&lt;span id="xdx_902_eus-gaap--DeferredRevenueCurrent_iI_c20240630_zjB8NmzyPGtf" title="Deferred revenue"&gt;209,100&lt;/span&gt;
and $&lt;span id="xdx_903_eus-gaap--DeferredRevenueCurrent_iI_c20230630_zmmlyyWhXq87" title="Deferred revenue"&gt;238,351&lt;/span&gt;, respectively, of revenue has been deferred to be recognized in future periods as merchandise revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zR90CHWqDoy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Stock-based
Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records stock-based compensation in accordance with the provisions of the Accounting Standards Codification (&#x201c;ASC&#x201d;)
718, &#x201c;&lt;i&gt;Accounting for Stock Compensation&lt;/i&gt;,&#x201d; which establishes accounting standards for the transaction in
which an entity exchanges its equity instruments for goods or services. In accordance with guidance provided under ASC 718, the Company
recognizes an expense for the fair value of its stock awards at the time of the grant and the fair value of its outstanding stock options
as they vest, whether held by employees or others. During the fiscal year ended June 30, 2024, there was no stock-based compensation.
During the fiscal year ended June 30, 2023, the Company has issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220701__20230630_zmQQdpfzXE7k" title="Stock issued for services, shares"&gt;1,120,000&lt;/span&gt; shares for services, and the value of those shares were
determined at $&lt;span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_c20230630_z1BJB6aCTqh7" title="Shares issued, price per share"&gt;5.00&lt;/span&gt; which was same as the IPO price on August 8, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--PrepaidOfferingCostsPolicyTextBlock_zN0x9mqLI4w1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zk4T2Weg48Hc"&gt;Prepaid Offering Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;Prepaid offering costs are accounted for under ASC 340-10 and consist of
legal, accounting and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are
directly related to IPO or other fundraising and that will be charged upon the completion of the IPO or fundraising.&#160; As of June
30, 2024 and 2023, the Company had prepaid offering costs of $&lt;span id="xdx_90C_eus-gaap--PrepaidExpenseCurrent_iI_c20240630_zBk8pt9CcPIc" title="Prepaid offering cost"&gt;1,200,000&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--PrepaidExpenseCurrent_iI_c20230630_zeqGwuOsk69h" title="Prepaid offering cost"&gt;5,317,866&lt;/span&gt;, respectively.&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--RevenueRecognitionLoyaltyPrograms_zqLYer8wBuo7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Customers
Loyalty Program&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
certain sales transactions, the Company offers loyalty points to its customer based on the dollar value of the transaction which gives
the customer the option to acquire additional goods or services at a price that is lower than its stand-alone selling price. In accordance
with Topic 606, the Company evaluates whether these loyalty points constitute separate performance obligations and the need to allocate
the transaction price between revenue and performance obligation. As of June 30, 2024 and 2023, the Company does not believe that any
separate performance obligation under the loyalty program is material&lt;span style="background-color: white"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z5qvaaAFU671" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
Topic 820, &lt;i&gt;Fair Value Measurements&lt;/i&gt;, clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes
a fair value hierarchy to classify the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets
and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated
by observable market data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Inputs are unobservable inputs which reflect the reporting entity&#x2019;s own assumptions on what assumptions the market participants
would use in pricing the asset or liability based on the best available information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated fair value of certain financial instruments, including all current liabilities are carried at historical cost basis, which
approximates their fair values because of the short-term nature of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zhE6Wm3veNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
Subtopic 825-10, &lt;i&gt;Financial Instruments&lt;/i&gt; requires disclosure of the fair value of certain financial instruments. The carrying value
of cash and cash equivalents, accounts payable and accrued liabilities as reflected in the consolidated balance sheets, are approximately
fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and
equity instruments of the Company are either recognized or disclosed in the consolidated financial statements together with other information
relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values
of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair
value has been disclosed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zrXimYK3vRqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--MarketableSecuritiesPolicy_zeF4adZfEXTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Marketable
Securities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for investments in marketable securities in accordance with ASC Topic 825, &lt;i&gt;Financial Instruments. &lt;/i&gt;All of the
Company&#x2019;s investments at June 30, 2024 and 2023 are treated as trading securities with the unrealized gains and losses reflected
in Other income/(expense) on the consolidated statements of operations and comprehensive loss. During the years ended June 30, 2024 and
2023, the Company recorded an unrealized loss on investments in marketable securities of $&lt;span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20230701__20240630_zQTgrsKh9Ewk" title="Unrealized loss on investments"&gt;354,781&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220701__20230630_zY4dlGzvQBO5" title="Unrealized loss on investments"&gt;529,488&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zTCNjzmSEOp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Advertising
and Promotion&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the policy of charging the costs of advertising, marketing, and public relations to expense as incurred. The Company
has $&lt;span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20230701__20240630_z9rzveonpwId" title="Sales and marketing expenses"&gt;351,298&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20220701__20230630_z0jX5FMWia67" title="Sales and marketing expenses"&gt;454,995&lt;/span&gt; in sales and marketing expenses for the years ended June 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zIQSJwWrJf2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their
respective tax basis and operating loss, capital loss and tax credit carryforwards. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes
the enactment date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized
income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or
measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to
unrecognized tax benefits as a component of general and administrative expenses. Our federal tax return and any state tax returns are
not currently under examination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has adopted ASC 740-10, &lt;i&gt;Accounting for Income Taxes&lt;/i&gt;, which requires an asset and liability approach to financial accounting
and reporting for income taxes. Deferred income tax assets and liabilities are computed annually from differences between the consolidated
financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on
enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances
are established when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z96cGrTCLI9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
consists of only finished goods and are stated at the lower of cost and net realizable value on a &#x2018;first in first out&#x2019; basis.
Cost comprises of direct materials and delivery costs, direct labor, import duties and other taxes, and an appropriate proportion of
variable and fixed overhead expenditure based on normal operating capacity. Costs of purchased inventory are determined after deducting
rebates and discounts received or receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
in transit is stated at the lower of cost and net realizable value. Cost comprises purchase and delivery costs, net of rebates and discounts
received or receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated
costs necessary to make the sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company records an allowance for potentially excess and obsolete inventory based upon recent sales history, the quantity of inventory
on-hand, and a forecast of potential use of the inventory. The Company periodically reviews inventory to identify excess quantities and
part numbers that are experiencing a reduction in demand. Any part numbers with quantities identified during this process are reserved
for at rates based upon management&#x2019;s judgment, historical rates, and consideration of possible scrap and liquidation values which
may be as high as 100% of cost if no liquidation market exists for the part.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zUdhu2Begd8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Account balances deemed to be uncollectible are
charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. At June 30, 2024 and 2023, the Company has considered an allowance of $&lt;span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240630_z9RoaSTTwa9f" title="Allowance for doubtful accounts receivable"&gt;585,672&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20230630_zi3SvUbDEE6d" title="Allowance for doubtful receivable accounts"&gt;426,971&lt;/span&gt;, respectively, for
doubtful receivable accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zHyXa7tPTC3b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Property
and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment is stated at cost, net of depreciation. Depreciation is provided over the estimated useful lives of the related assets
using the straight-line method. Depreciation expense totaled $&lt;span id="xdx_90B_eus-gaap--Depreciation_c20230701__20240630_z94WZe1bFtN1" title="Depreciation expense"&gt;10,385&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--Depreciation_c20220701__20230630_zCOmyPPoeVX3" title="Depreciation expense"&gt;12,268&lt;/span&gt; for the years ended June 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z7eUSUczlSPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Potential
impairments of long lived assets are reviewed when events or changes in circumstances indicate a potential impairment may exist. In accordance
with ASC Subtopic 360-10, &lt;i&gt;&#x201c;Property, Plant and Equipment &#x2013; Overall&#x201d;&lt;/i&gt;, impairment is determined when estimated
future undiscounted cash flows associated with an asset are less than asset&#x2019;s carrying value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zXuSjj2WQo4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Intangible
Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s intangible assets consist of brand names and goodwill. At June 30, 2024 and 2023, the Company had brand names and goodwill
with costs of approximately $&lt;span id="xdx_906_ecustom--BrandNames_iI_c20240630_zQDuWHJcvyq8" title="Brand names cost"&gt;&lt;span id="xdx_907_ecustom--BrandNames_iI_c20230630_zsW6SEMq3DCj" title="Brand names cost"&gt;337,504&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--Goodwill_iI_c20240630_zvu9LfTRBLgb" title="Goodwill"&gt;&lt;span id="xdx_909_eus-gaap--Goodwill_iI_c20230630_zTZLYCKQT3A3" title="Goodwill"&gt;1,161,052&lt;/span&gt;&lt;/span&gt; respectively, which all have indefinite lives. The Company evaluates intangible assets
with indefinite lives for impairment at least annually or when events or changes in circumstances indicate that an impairment may exist.
The Company determined that &lt;span id="xdx_909_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20230701__20240630_zx5XQfHmgU0d" title="Impairment of intangible assets"&gt;&lt;span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20220701__20230630_zNR1ESCIpFCh" title="Impairment of intangible assets"&gt;none&lt;/span&gt;&lt;/span&gt; of its intangible assets were impaired in the fiscal years ended June 30, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zgdajUijfRM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Net
Income (Loss) Per Common Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company computes income (loss) per common share in accordance with ASC Topic 260, &lt;i&gt;Earnings Per Share, &lt;/i&gt;which requires dual presentation
of basic and diluted earnings per share. Basic income or loss per common share is computed by dividing net income or loss by the weighted
average number of common shares outstanding during the period. Diluted income or loss per common share is computed by dividing net income
or loss by the weighted average number of common shares outstanding, plus the issuance of common shares, if dilutive, that could result
from the exercise of outstanding stock options and warrants. &lt;span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230701__20240630_zXOaFnm78TS" title="Potential dilutive common shares"&gt;No&lt;/span&gt; potential dilutive common shares are included in the computation of any
diluted per share amount when a loss is reported.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z48yciGiVuoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Comprehensive
Income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
Topic 220, &lt;i&gt;Comprehensive Income&lt;/i&gt;, establishes standards for reporting comprehensive income (loss) and its components.
Comprehensive income or loss is defined as the change in equity during a period from transactions and other events from non-owner
sources. The component of comprehensive loss totaling $&lt;span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20230701__20240630_zpfmdYobXYii" title="Foreign currency translation adjustment"&gt;13,673&lt;/span&gt;
and $&lt;span id="xdx_900_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20220701__20230630_zPWTqaR0gQb9" title="Foreign currency translation adjustment"&gt;27,063&lt;/span&gt;
for the years ended June 30, 2024 and 2023, respectively, related to foreign currency translation adjustment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zbFHXOWfguFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Foreign
Currencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determined that its functional currency is the Australian dollar since the Australian dollar is the currency of the environment
in which the Company primarily generates and expends cash; however, the Company&#x2019;s reporting currency is the U.S. dollar. Foreign
currency transaction gains and losses represent gains and losses resulting from transactions entered into in a currency other than the
functional currency of the Company. These transaction gains and losses, if any, are included in results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_z1M4V5P1r2lh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for leases in accordance with ASC Topic 842, &lt;i&gt;Lease&lt;/i&gt;. Operating lease right-of-use assets represents the right
to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum
lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental
borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense
for minimum lease payments is amortized on a straight-line basis over the lease term and is presented on the consolidated statements
of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
permitted under ASC Topic 842, the Company has made an accounting policy election not to apply the lease recognition provision to short
term leases (leases with a lease term of 12 months or less that do not include an option to purchase the underlying asset that the lessee
is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis
over the lease term. The Company did &lt;span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20230701__20240630_z2aGYYDPEWQj" title="Short-term leases"&gt;&lt;span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20220701__20230630_znwvMIWi5Udb" title="Short-term leases"&gt;no&lt;/span&gt;&lt;/span&gt;t have any short-term leases at June 30, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--DebtPolicyTextBlock_zY9ye2PWHI03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Convertible
notes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for convertible notes deemed conventional and conversion options embedded in non-conventional convertible notes which
qualify as equity under Accounting Standards Update No. 2020-06, &lt;i&gt;Debt-Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts
in an Entity&#x2019;s Own Equity &lt;/i&gt;(&#x201c;ASU 2020-06&#x201d;), which simplifies the accounting for certain financial instruments with
characteristics of liabilities and equity, including certain convertible instruments and contracts on an entity&#x2019;s own equity. ASU
2020-06 removes the separation models required for convertible debt with cash conversion features and convertible instruments with beneficial
conversion features. It also removes certain settlement conditions that were required for equity for equity contracts to qualify for
the derivative scope exception and simplifies the diluted earnings per share calculation for convertible instruments. Accordingly, the
underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt
discounts under these arrangements are amortized over the term of the related debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zJvY2BiWmNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated the warrants under ASC 815, &lt;i&gt;Derivatives and Hedging &lt;/i&gt;(&#x201c;ASC 815&#x201d;), and determined that they did not
require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair values,
by using the Black-Scholes model when the warrants are granted. During the fiscal year June 30, 2024, the Company has issued &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zsX6QLjzmDP7" title="Issued warrants, net basis"&gt;30,000&lt;/span&gt;
warrants on a net basis, and &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zYjkHZxiOdla" title="Number of warrant issued"&gt;5,645,455&lt;/span&gt; warrants, respectively, to the IPO underwriter and the Convertible Notes noteholder. All of the
warrants were fully converted into shares during the fiscal year June 30, 2024. They were all converted based on cashless basis and have
been converted into &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zoW9zluA01dd" title="Converted warrant"&gt;19,750&lt;/span&gt; shares and &lt;span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zvlj1x6bVhI9" title=" Warrant converted into share"&gt;4,892,727&lt;/span&gt; shares respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zR89hiLUuXQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on
the consolidated financial statements, and the Company does not believe that there are any other new accounting pronouncements that have
been issued that might have a material impact on its financial position or results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--GoingConcernPolicyTextBlock_zhhzDz1h17we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Going
Concern&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will be able to continue
trading, realise its assets and discharge its liabilities in the ordinary course of business for a period of at least 12 months from
the date that these consolidated financial statements are approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Directors note that:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&#x25cf;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Group made a loss of $&lt;span id="xdx_90D_eus-gaap--NetIncomeLoss_iN_di_c20230701__20240630_z7PwMAYZxsXc" title="Net income loss"&gt;9,312,145&lt;/span&gt; from its continuing operations for the year ended June 30,
                                            2024;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Group held cash and cash equivalents of $&lt;span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240630_zkfAI461Ib04" title="Cash and cash equivalents"&gt;939,014&lt;/span&gt; as at June 30, 2024;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Group incurred a net cash outflow from operating activities of $&lt;span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230701__20240630_zLb6uYGVooMi" title="Net cash outflow from operating activities"&gt;12,253,539&lt;/span&gt; for the year ended
                                            June 30, 2024;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
                                            successful capital raising (IPO) in August 2023 arose for $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230701__20240630_zlZzxonGwjXl" title="Issuance of common stock"&gt;13,614,983&lt;/span&gt; before cost of capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
assessing the appropriateness of using the going concern assumption, the Directors have noted:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
                                            are reasonable grounds to believe that the Company will be able to continue as a going concern
                                            as the Directors are satisfied that the Company will be able to either secure additional
                                            working capital as required through raising additional capital or reducing the Company&#x2019;s
                                            discretionary spending;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
                                            the directors consider it appropriate to prepare the consolidated financial statements on
                                            a going concern basis.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Whilst
the Directors remain confident in the Company&#x2019;s ability to access further working capital through debt, equity or asset sales if
required, there remains material uncertainty as to whether the Company will continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Had
the going concern basis not been used, adjustments would need to be made relating to the recoverability and classification of certain
assets, and the classification and measurement of certain liabilities to reflect the fact that the Company may be required to realize
its assets and settle its liabilities other than in the ordinary course of business, and at amounts different from those stated in the
consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zbrWAtnQg7G6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Subsequent
Events&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC Topic 855, &lt;i&gt;Subsequent Events&lt;/i&gt;, the Companies evaluated subsequent events through November 15, 2024; the date
the consolidated financial statements were available for issue.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_z3baOFxSydR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000582">&lt;p id="xdx_847_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zdLEDuzG8uVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities
and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements have been prepared using the accrual basis of accounting
in accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;) and presented in
US dollars. The year end is June 30.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000584">&lt;p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_zRZ6MgKLFQa3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Basic
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the financial statements of the Company and its subsidiaries. All inter-company transactions
and balances between the Company and its subsidiaries have been eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <FTEL:ConcentrationsofVendorsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000586">&lt;p id="xdx_845_ecustom--ConcentrationsofVendorsPolicyTextBlock_zNZvAji6B1el" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Concentrations
of vendors&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal year ended June 30, 2024, there are two vendors which accounts for more than 10% of the Company total purchases
individually, and they account for &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_z1AzUGQtk8Ib" title="Concentration risk percentage"&gt;23.68&lt;/span&gt;%
and &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zuQ7Jo75IwHk" title="Concentration risk percentage"&gt;16.83&lt;/span&gt;%
of the total purchases respectively. During the fiscal year ended June 30, 2023, there are three vendors which accounts for more
than 10% of the Company total purchase individually, and they account for &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorsMember_zRUtLTivHyC" title="Concentration risk percentage"&gt;28.63&lt;/span&gt;%, &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zXnrg1OFlgHf" title="Concentration risk percentage"&gt;16.55&lt;/span&gt;%, and&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zroiiC2ik71h" title="Concentration risk percentage"&gt; 10.66&lt;/span&gt;% of the total purchases
respectively. As of June 30, 2024 and 2023, three and four vendors, respectively, account for &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zchNOoVAMM19" title="Concentration risk percentage"&gt;60&lt;/span&gt;%
and &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourVendorsMember_zD7wHxr38YG5" title="Concentration risk percentage"&gt;58&lt;/span&gt;%
of total accounts payable, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FTEL:ConcentrationsofVendorsPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_OneVendorsMember"
      decimals="INF"
      id="Fact000588"
      unitRef="Pure">0.2368</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember"
      decimals="INF"
      id="Fact000590"
      unitRef="Pure">0.1683</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_OneVendorsMember"
      decimals="INF"
      id="Fact000592"
      unitRef="Pure">0.2863</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_TwoVendorsMember"
      decimals="INF"
      id="Fact000594"
      unitRef="Pure">0.1655</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_ThreeVendorsMember"
      decimals="INF"
      id="Fact000596"
      unitRef="Pure">0.1066</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012024-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_ThreeVendorsMember"
      decimals="INF"
      id="Fact000598"
      unitRef="Pure">0.60</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-07-012023-06-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_FourVendorsMember"
      decimals="INF"
      id="Fact000600"
      unitRef="Pure">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-07-01to2024-06-30" id="Fact000602">&lt;p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zxohUoZmgnie" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables
arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions.
The Company controls credit risk related to accounts receivable through credit approvals, credit limits and monitoring procedures. The
Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an
allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure
beyond such allowance is limited.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:UseOfEstimates contextRef="From2023-07-01to2024-06-30" id="Fact000604">&lt;p id="xdx_848_eus-gaap--UseOfEstimates_z4fZuz8a4Sr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
these estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000606">&lt;p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zmUYDeKS1ZJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates it main income source from the sales of merchandise, which includes the sales of various gym equipment and fitness
products. It recognizes this merchandise revenue in accordance with Accounting Standards Update&#160;&#160; (&#x201c;ASU&#x201d;) 2014-09,
&#x201c;&lt;i&gt;Revenue from contracts with customers,&#x201d;&lt;/i&gt; (Topic 606). Revenue is recognized when a customer obtains control of promised
goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows
arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to
receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification
of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether
they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration;
(iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies
each performance obligation. The Company&#x2019;s main revenue stream is from sales of products. The Company recognizes as revenues the
amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied
or as it is satisfied. Generally, the Company&#x2019;s performance obligations are transferred to customers at a point in time, typically
upon shipment. The Company offers &lt;span style="background-color: white"&gt;refunds, repairs and replacements in accordance with the Australian
Consumer Law. The Company recognized the sales discount and returns against its revenues in the same period as the original sales transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also occasionally sells various consumable products. These products include, but are not limited to, coffee and nutritional supplement
products. Similar to the aforesaid merchandise revenue, it also recognizes the revenue in accordance with Topic 606 upon shipment. If
the Company &lt;span style="background-color: white"&gt;provided a sales discount or allowed sales returns, it is recognized against its revenues
in the same period as the original sales transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also provides licensing services and gym equipment to gym studios in overseas. These services include, but are not limited to,
providing the brand name, and offer initial design services to these gym studios. Similar to the aforesaid merchandise revenue, it also
recognizes the revenue in accordance with Topic 606 based on the straight-line basis over the contractual service period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueRecognitionDeferredRevenue contextRef="From2023-07-01to2024-06-30" id="Fact000608">&lt;p id="xdx_840_eus-gaap--RevenueRecognitionDeferredRevenue_zrq3A5crubDj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Deferred
Revenue&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized the deposits received from its customers as deferred revenue if the goods or service is not delivered. It would be
recognized as revenue after the goods or service is delivered. During the fiscal years ended June 30, 2024 and 2023, a total of $&lt;span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230701__20240630_zEaFFrY3lIq4" title="Deferred revenue, revenue recognized"&gt;238,351&lt;/span&gt;
and $&lt;span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220701__20230630_zZrOo4GFcNQ8" title="Deferred revenue, revenue recognized"&gt;501,976&lt;/span&gt;, respectively, of deferred revenue was recognized into merchandise revenue. At June 30, 2024 and 2023, a total of $&lt;span id="xdx_902_eus-gaap--DeferredRevenueCurrent_iI_c20240630_zjB8NmzyPGtf" title="Deferred revenue"&gt;209,100&lt;/span&gt;
and $&lt;span id="xdx_903_eus-gaap--DeferredRevenueCurrent_iI_c20230630_zmmlyyWhXq87" title="Deferred revenue"&gt;238,351&lt;/span&gt;, respectively, of revenue has been deferred to be recognized in future periods as merchandise revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionDeferredRevenue>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000610"
      unitRef="USD">238351</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000612"
      unitRef="USD">501976</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000614"
      unitRef="USD">209100</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000616"
      unitRef="USD">238351</us-gaap:DeferredRevenueCurrent>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000618">&lt;p id="xdx_84C_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zR90CHWqDoy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Stock-based
Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records stock-based compensation in accordance with the provisions of the Accounting Standards Codification (&#x201c;ASC&#x201d;)
718, &#x201c;&lt;i&gt;Accounting for Stock Compensation&lt;/i&gt;,&#x201d; which establishes accounting standards for the transaction in
which an entity exchanges its equity instruments for goods or services. In accordance with guidance provided under ASC 718, the Company
recognizes an expense for the fair value of its stock awards at the time of the grant and the fair value of its outstanding stock options
as they vest, whether held by employees or others. During the fiscal year ended June 30, 2024, there was no stock-based compensation.
During the fiscal year ended June 30, 2023, the Company has issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220701__20230630_zmQQdpfzXE7k" title="Stock issued for services, shares"&gt;1,120,000&lt;/span&gt; shares for services, and the value of those shares were
determined at $&lt;span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_c20230630_z1BJB6aCTqh7" title="Shares issued, price per share"&gt;5.00&lt;/span&gt; which was same as the IPO price on August 8, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000620"
      unitRef="Shares">1120000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact000622"
      unitRef="USDPShares">5.00</us-gaap:SharesIssuedPricePerShare>
    <FTEL:PrepaidOfferingCostsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000624">&lt;p id="xdx_84D_ecustom--PrepaidOfferingCostsPolicyTextBlock_zN0x9mqLI4w1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zk4T2Weg48Hc"&gt;Prepaid Offering Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;Prepaid offering costs are accounted for under ASC 340-10 and consist of
legal, accounting and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are
directly related to IPO or other fundraising and that will be charged upon the completion of the IPO or fundraising.&#160; As of June
30, 2024 and 2023, the Company had prepaid offering costs of $&lt;span id="xdx_90C_eus-gaap--PrepaidExpenseCurrent_iI_c20240630_zBk8pt9CcPIc" title="Prepaid offering cost"&gt;1,200,000&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--PrepaidExpenseCurrent_iI_c20230630_zeqGwuOsk69h" title="Prepaid offering cost"&gt;5,317,866&lt;/span&gt;, respectively.&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FTEL:PrepaidOfferingCostsPolicyTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000626"
      unitRef="USD">1200000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000628"
      unitRef="USD">5317866</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:RevenueRecognitionLoyaltyPrograms contextRef="From2023-07-01to2024-06-30" id="Fact000630">&lt;p id="xdx_84A_eus-gaap--RevenueRecognitionLoyaltyPrograms_zqLYer8wBuo7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Customers
Loyalty Program&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
certain sales transactions, the Company offers loyalty points to its customer based on the dollar value of the transaction which gives
the customer the option to acquire additional goods or services at a price that is lower than its stand-alone selling price. In accordance
with Topic 606, the Company evaluates whether these loyalty points constitute separate performance obligations and the need to allocate
the transaction price between revenue and performance obligation. As of June 30, 2024 and 2023, the Company does not believe that any
separate performance obligation under the loyalty program is material&lt;span style="background-color: white"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionLoyaltyPrograms>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000632">&lt;p id="xdx_845_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z5qvaaAFU671" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
Topic 820, &lt;i&gt;Fair Value Measurements&lt;/i&gt;, clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes
a fair value hierarchy to classify the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets
and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated
by observable market data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Inputs are unobservable inputs which reflect the reporting entity&#x2019;s own assumptions on what assumptions the market participants
would use in pricing the asset or liability based on the best available information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated fair value of certain financial instruments, including all current liabilities are carried at historical cost basis, which
approximates their fair values because of the short-term nature of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-07-01to2024-06-30" id="Fact000634">&lt;p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zhE6Wm3veNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
Subtopic 825-10, &lt;i&gt;Financial Instruments&lt;/i&gt; requires disclosure of the fair value of certain financial instruments. The carrying value
of cash and cash equivalents, accounts payable and accrued liabilities as reflected in the consolidated balance sheets, are approximately
fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and
equity instruments of the Company are either recognized or disclosed in the consolidated financial statements together with other information
relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values
of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair
value has been disclosed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000636">&lt;p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zrXimYK3vRqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2023-07-01to2024-06-30" id="Fact000638">&lt;p id="xdx_84B_eus-gaap--MarketableSecuritiesPolicy_zeF4adZfEXTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Marketable
Securities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for investments in marketable securities in accordance with ASC Topic 825, &lt;i&gt;Financial Instruments. &lt;/i&gt;All of the
Company&#x2019;s investments at June 30, 2024 and 2023 are treated as trading securities with the unrealized gains and losses reflected
in Other income/(expense) on the consolidated statements of operations and comprehensive loss. During the years ended June 30, 2024 and
2023, the Company recorded an unrealized loss on investments in marketable securities of $&lt;span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20230701__20240630_zQTgrsKh9Ewk" title="Unrealized loss on investments"&gt;354,781&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220701__20230630_zY4dlGzvQBO5" title="Unrealized loss on investments"&gt;529,488&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000640"
      unitRef="USD">354781</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000642"
      unitRef="USD">529488</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000644">&lt;p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zTCNjzmSEOp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Advertising
and Promotion&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the policy of charging the costs of advertising, marketing, and public relations to expense as incurred. The Company
has $&lt;span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20230701__20240630_z9rzveonpwId" title="Sales and marketing expenses"&gt;351,298&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--SellingAndMarketingExpense_c20220701__20230630_z0jX5FMWia67" title="Sales and marketing expenses"&gt;454,995&lt;/span&gt; in sales and marketing expenses for the years ended June 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000646"
      unitRef="USD">351298</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000648"
      unitRef="USD">454995</us-gaap:SellingAndMarketingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000650">&lt;p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zIQSJwWrJf2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their
respective tax basis and operating loss, capital loss and tax credit carryforwards. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes
the enactment date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized
income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or
measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to
unrecognized tax benefits as a component of general and administrative expenses. Our federal tax return and any state tax returns are
not currently under examination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has adopted ASC 740-10, &lt;i&gt;Accounting for Income Taxes&lt;/i&gt;, which requires an asset and liability approach to financial accounting
and reporting for income taxes. Deferred income tax assets and liabilities are computed annually from differences between the consolidated
financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on
enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances
are established when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000652">&lt;p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z96cGrTCLI9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
consists of only finished goods and are stated at the lower of cost and net realizable value on a &#x2018;first in first out&#x2019; basis.
Cost comprises of direct materials and delivery costs, direct labor, import duties and other taxes, and an appropriate proportion of
variable and fixed overhead expenditure based on normal operating capacity. Costs of purchased inventory are determined after deducting
rebates and discounts received or receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
in transit is stated at the lower of cost and net realizable value. Cost comprises purchase and delivery costs, net of rebates and discounts
received or receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated
costs necessary to make the sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company records an allowance for potentially excess and obsolete inventory based upon recent sales history, the quantity of inventory
on-hand, and a forecast of potential use of the inventory. The Company periodically reviews inventory to identify excess quantities and
part numbers that are experiencing a reduction in demand. Any part numbers with quantities identified during this process are reserved
for at rates based upon management&#x2019;s judgment, historical rates, and consideration of possible scrap and liquidation values which
may be as high as 100% of cost if no liquidation market exists for the part.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2023-07-01to2024-06-30" id="Fact000654">&lt;p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zUdhu2Begd8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has applied the simplified approach to measuring expected credit losses, which uses a lifetime expected loss allowance. To measure
the expected credit losses, trade receivables have been grouped based on days overdue. Account balances deemed to be uncollectible are
charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. At June 30, 2024 and 2023, the Company has considered an allowance of $&lt;span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240630_z9RoaSTTwa9f" title="Allowance for doubtful accounts receivable"&gt;585,672&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20230630_zi3SvUbDEE6d" title="Allowance for doubtful receivable accounts"&gt;426,971&lt;/span&gt;, respectively, for
doubtful receivable accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000656"
      unitRef="USD">585672</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000658"
      unitRef="USD">426971</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000660">&lt;p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zHyXa7tPTC3b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Property
and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment is stated at cost, net of depreciation. Depreciation is provided over the estimated useful lives of the related assets
using the straight-line method. Depreciation expense totaled $&lt;span id="xdx_90B_eus-gaap--Depreciation_c20230701__20240630_z94WZe1bFtN1" title="Depreciation expense"&gt;10,385&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--Depreciation_c20220701__20230630_zCOmyPPoeVX3" title="Depreciation expense"&gt;12,268&lt;/span&gt; for the years ended June 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:Depreciation
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000662"
      unitRef="USD">10385</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000664"
      unitRef="USD">12268</us-gaap:Depreciation>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000666">&lt;p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z7eUSUczlSPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Potential
impairments of long lived assets are reviewed when events or changes in circumstances indicate a potential impairment may exist. In accordance
with ASC Subtopic 360-10, &lt;i&gt;&#x201c;Property, Plant and Equipment &#x2013; Overall&#x201d;&lt;/i&gt;, impairment is determined when estimated
future undiscounted cash flows associated with an asset are less than asset&#x2019;s carrying value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000668">&lt;p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zXuSjj2WQo4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Intangible
Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s intangible assets consist of brand names and goodwill. At June 30, 2024 and 2023, the Company had brand names and goodwill
with costs of approximately $&lt;span id="xdx_906_ecustom--BrandNames_iI_c20240630_zQDuWHJcvyq8" title="Brand names cost"&gt;&lt;span id="xdx_907_ecustom--BrandNames_iI_c20230630_zsW6SEMq3DCj" title="Brand names cost"&gt;337,504&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--Goodwill_iI_c20240630_zvu9LfTRBLgb" title="Goodwill"&gt;&lt;span id="xdx_909_eus-gaap--Goodwill_iI_c20230630_zTZLYCKQT3A3" title="Goodwill"&gt;1,161,052&lt;/span&gt;&lt;/span&gt; respectively, which all have indefinite lives. The Company evaluates intangible assets
with indefinite lives for impairment at least annually or when events or changes in circumstances indicate that an impairment may exist.
The Company determined that &lt;span id="xdx_909_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20230701__20240630_zx5XQfHmgU0d" title="Impairment of intangible assets"&gt;&lt;span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_dn_c20220701__20230630_zNR1ESCIpFCh" title="Impairment of intangible assets"&gt;none&lt;/span&gt;&lt;/span&gt; of its intangible assets were impaired in the fiscal years ended June 30, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <FTEL:BrandNames
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000670"
      unitRef="USD">337504</FTEL:BrandNames>
    <FTEL:BrandNames
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000672"
      unitRef="USD">337504</FTEL:BrandNames>
    <us-gaap:Goodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000674"
      unitRef="USD">1161052</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000676"
      unitRef="USD">1161052</us-gaap:Goodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000678"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000680"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000682">&lt;p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zgdajUijfRM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Net
Income (Loss) Per Common Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company computes income (loss) per common share in accordance with ASC Topic 260, &lt;i&gt;Earnings Per Share, &lt;/i&gt;which requires dual presentation
of basic and diluted earnings per share. Basic income or loss per common share is computed by dividing net income or loss by the weighted
average number of common shares outstanding during the period. Diluted income or loss per common share is computed by dividing net income
or loss by the weighted average number of common shares outstanding, plus the issuance of common shares, if dilutive, that could result
from the exercise of outstanding stock options and warrants. &lt;span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230701__20240630_zXOaFnm78TS" title="Potential dilutive common shares"&gt;No&lt;/span&gt; potential dilutive common shares are included in the computation of any
diluted per share amount when a loss is reported.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000684"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000686">&lt;p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z48yciGiVuoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Comprehensive
Income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
Topic 220, &lt;i&gt;Comprehensive Income&lt;/i&gt;, establishes standards for reporting comprehensive income (loss) and its components.
Comprehensive income or loss is defined as the change in equity during a period from transactions and other events from non-owner
sources. The component of comprehensive loss totaling $&lt;span id="xdx_90B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20230701__20240630_zpfmdYobXYii" title="Foreign currency translation adjustment"&gt;13,673&lt;/span&gt;
and $&lt;span id="xdx_900_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_iN_di_c20220701__20230630_zPWTqaR0gQb9" title="Foreign currency translation adjustment"&gt;27,063&lt;/span&gt;
for the years ended June 30, 2024 and 2023, respectively, related to foreign currency translation adjustment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000688"
      unitRef="USD">-13673</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000690"
      unitRef="USD">-27063</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000692">&lt;p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zbFHXOWfguFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Foreign
Currencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determined that its functional currency is the Australian dollar since the Australian dollar is the currency of the environment
in which the Company primarily generates and expends cash; however, the Company&#x2019;s reporting currency is the U.S. dollar. Foreign
currency transaction gains and losses represent gains and losses resulting from transactions entered into in a currency other than the
functional currency of the Company. These transaction gains and losses, if any, are included in results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000694">&lt;p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_z1M4V5P1r2lh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for leases in accordance with ASC Topic 842, &lt;i&gt;Lease&lt;/i&gt;. Operating lease right-of-use assets represents the right
to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum
lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental
borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense
for minimum lease payments is amortized on a straight-line basis over the lease term and is presented on the consolidated statements
of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
permitted under ASC Topic 842, the Company has made an accounting policy election not to apply the lease recognition provision to short
term leases (leases with a lease term of 12 months or less that do not include an option to purchase the underlying asset that the lessee
is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis
over the lease term. The Company did &lt;span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20230701__20240630_z2aGYYDPEWQj" title="Short-term leases"&gt;&lt;span id="xdx_90D_eus-gaap--ShortTermLeaseCost_do_c20220701__20230630_znwvMIWi5Udb" title="Short-term leases"&gt;no&lt;/span&gt;&lt;/span&gt;t have any short-term leases at June 30, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000696"
      unitRef="USD">0</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000698"
      unitRef="USD">0</us-gaap:ShortTermLeaseCost>
    <us-gaap:DebtPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000700">&lt;p id="xdx_841_eus-gaap--DebtPolicyTextBlock_zY9ye2PWHI03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Convertible
notes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for convertible notes deemed conventional and conversion options embedded in non-conventional convertible notes which
qualify as equity under Accounting Standards Update No. 2020-06, &lt;i&gt;Debt-Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts
in an Entity&#x2019;s Own Equity &lt;/i&gt;(&#x201c;ASU 2020-06&#x201d;), which simplifies the accounting for certain financial instruments with
characteristics of liabilities and equity, including certain convertible instruments and contracts on an entity&#x2019;s own equity. ASU
2020-06 removes the separation models required for convertible debt with cash conversion features and convertible instruments with beneficial
conversion features. It also removes certain settlement conditions that were required for equity for equity contracts to qualify for
the derivative scope exception and simplifies the diluted earnings per share calculation for convertible instruments. Accordingly, the
underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt
discounts under these arrangements are amortized over the term of the related debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000702">&lt;p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zJvY2BiWmNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated the warrants under ASC 815, &lt;i&gt;Derivatives and Hedging &lt;/i&gt;(&#x201c;ASC 815&#x201d;), and determined that they did not
require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair values,
by using the Black-Scholes model when the warrants are granted. During the fiscal year June 30, 2024, the Company has issued &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zsX6QLjzmDP7" title="Issued warrants, net basis"&gt;30,000&lt;/span&gt;
warrants on a net basis, and &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zYjkHZxiOdla" title="Number of warrant issued"&gt;5,645,455&lt;/span&gt; warrants, respectively, to the IPO underwriter and the Convertible Notes noteholder. All of the
warrants were fully converted into shares during the fiscal year June 30, 2024. They were all converted based on cashless basis and have
been converted into &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zoW9zluA01dd" title="Converted warrant"&gt;19,750&lt;/span&gt; shares and &lt;span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zvlj1x6bVhI9" title=" Warrant converted into share"&gt;4,892,727&lt;/span&gt; shares respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_WarrantOneMember"
      decimals="INF"
      id="Fact000704"
      unitRef="Shares">30000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_WarrantTwoMember"
      decimals="INF"
      id="Fact000706"
      unitRef="Shares">5645455</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-07-012024-06-30_custom_WarrantOneMember"
      decimals="INF"
      id="Fact000708"
      unitRef="Shares">19750</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-07-012024-06-30_custom_WarrantTwoMember"
      decimals="INF"
      id="Fact000710"
      unitRef="Shares">4892727</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000712">&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zR89hiLUuXQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on
the consolidated financial statements, and the Company does not believe that there are any other new accounting pronouncements that have
been issued that might have a material impact on its financial position or results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <FTEL:GoingConcernPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000714">&lt;p id="xdx_849_ecustom--GoingConcernPolicyTextBlock_zhhzDz1h17we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Going
Concern&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will be able to continue
trading, realise its assets and discharge its liabilities in the ordinary course of business for a period of at least 12 months from
the date that these consolidated financial statements are approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Directors note that:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&#x25cf;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Group made a loss of $&lt;span id="xdx_90D_eus-gaap--NetIncomeLoss_iN_di_c20230701__20240630_z7PwMAYZxsXc" title="Net income loss"&gt;9,312,145&lt;/span&gt; from its continuing operations for the year ended June 30,
                                            2024;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Group held cash and cash equivalents of $&lt;span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240630_zkfAI461Ib04" title="Cash and cash equivalents"&gt;939,014&lt;/span&gt; as at June 30, 2024;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Group incurred a net cash outflow from operating activities of $&lt;span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230701__20240630_zLb6uYGVooMi" title="Net cash outflow from operating activities"&gt;12,253,539&lt;/span&gt; for the year ended
                                            June 30, 2024;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
                                            successful capital raising (IPO) in August 2023 arose for $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230701__20240630_zlZzxonGwjXl" title="Issuance of common stock"&gt;13,614,983&lt;/span&gt; before cost of capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
assessing the appropriateness of using the going concern assumption, the Directors have noted:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 17pt; text-align: justify; text-indent: -17pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
                                            are reasonable grounds to believe that the Company will be able to continue as a going concern
                                            as the Directors are satisfied that the Company will be able to either secure additional
                                            working capital as required through raising additional capital or reducing the Company&#x2019;s
                                            discretionary spending;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
                                            the directors consider it appropriate to prepare the consolidated financial statements on
                                            a going concern basis.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Whilst
the Directors remain confident in the Company&#x2019;s ability to access further working capital through debt, equity or asset sales if
required, there remains material uncertainty as to whether the Company will continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Had
the going concern basis not been used, adjustments would need to be made relating to the recoverability and classification of certain
assets, and the classification and measurement of certain liabilities to reflect the fact that the Company may be required to realize
its assets and settle its liabilities other than in the ordinary course of business, and at amounts different from those stated in the
consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FTEL:GoingConcernPolicyTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000716"
      unitRef="USD">-9312145</us-gaap:NetIncomeLoss>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000718"
      unitRef="USD">939014</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000720"
      unitRef="USD">-12253539</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000722"
      unitRef="USD">13614983</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000724">&lt;p id="xdx_84A_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zbrWAtnQg7G6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Subsequent
Events&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC Topic 855, &lt;i&gt;Subsequent Events&lt;/i&gt;, the Companies evaluated subsequent events through November 15, 2024; the date
the consolidated financial statements were available for issue.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000726">&lt;p id="xdx_804_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zCBTKM8mtRO8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_822_zjvSkQHccGqd"&gt;Investment in marketable securities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zqY8JaNkrKC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024 and 2023, the Company held some equity securities which are publicly traded on registered Stock Exchanges. The equity
securities being held as of June 30, 2024 and 2023 were valued at $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zezLm7sdIfYg" title="Investment in marketable securities"&gt;124,963&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_906_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zKVFPp2jUcUb" title="Investment in marketable securities"&gt;494,275&lt;/span&gt; respectively. The following tables classify the
Company&#x2019;s assets measured at fair value on a recurring basis into the fair value hierarchy: &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zMdqkMGft4kb" style="display: none"&gt;Schedule of Assets Measured at Fair Value on Recurring Basis&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at June 30, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Description&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-bottom: 1pt"&gt;Equity securities&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvEZtKuJ1H27" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;124,963&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmI1RvqnzPB1" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0736"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zznqeo8Bp622" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0738"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zl2egzj8G3o6" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;124,963&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zX4kmtQFuCll" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;124,963&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z42YydfQ2lWj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zULrCbRv5hmf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zx8xID1OKiW8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;124,963&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at June 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Description&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-bottom: 1pt"&gt;Equity securities&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCJCRnZ51lJ7" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;494,275&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z6aMo0MjMy11" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0752"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpKBE11yQZ13" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUQNdFTbPEu9" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;494,275&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxo1oTN8VFhc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;494,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmWgqANFnVDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0760"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOCB5xLwsLk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGrwJk02w4Sk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;494,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zneESdwv62Ek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000728">&lt;p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zqY8JaNkrKC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024 and 2023, the Company held some equity securities which are publicly traded on registered Stock Exchanges. The equity
securities being held as of June 30, 2024 and 2023 were valued at $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zezLm7sdIfYg" title="Investment in marketable securities"&gt;124,963&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEludmVzdG1lbnQgaW4gbWFya2V0YWJsZSBzZWN1cml0aWVzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_906_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--CollateralAxis__us-gaap--EquitySecuritiesMember_zKVFPp2jUcUb" title="Investment in marketable securities"&gt;494,275&lt;/span&gt; respectively. The following tables classify the
Company&#x2019;s assets measured at fair value on a recurring basis into the fair value hierarchy: &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zMdqkMGft4kb" style="display: none"&gt;Schedule of Assets Measured at Fair Value on Recurring Basis&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at June 30, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Description&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-bottom: 1pt"&gt;Equity securities&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvEZtKuJ1H27" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;124,963&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmI1RvqnzPB1" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0736"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zznqeo8Bp622" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0738"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zl2egzj8G3o6" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;124,963&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zX4kmtQFuCll" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;124,963&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z42YydfQ2lWj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zULrCbRv5hmf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20240630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zx8xID1OKiW8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;124,963&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at June 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Description&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-bottom: 1pt"&gt;Equity securities&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCJCRnZ51lJ7" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;494,275&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z6aMo0MjMy11" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0752"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpKBE11yQZ13" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--EquitySecuritiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUQNdFTbPEu9" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Total"&gt;494,275&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxo1oTN8VFhc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;494,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmWgqANFnVDb" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0760"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOCB5xLwsLk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGrwJk02w4Sk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;494,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember"
      decimals="0"
      id="Fact000730"
      unitRef="USD">124963</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember"
      decimals="0"
      id="Fact000732"
      unitRef="USD">494275</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000734"
      unitRef="USD">124963</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000740"
      unitRef="USD">124963</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000742"
      unitRef="USD">124963</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000748"
      unitRef="USD">124963</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000750"
      unitRef="USD">494275</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_EquitySecuritiesMember_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000756"
      unitRef="USD">494275</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000758"
      unitRef="USD">494275</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000764"
      unitRef="USD">494275</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000766">&lt;p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zm9ee2n0XjT1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_829_zkdW9q8AuNz2"&gt;Convertible Notes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 15, 2024, the Company issued Convertible Notes with a principal amount of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_znKMHBt1Xpyb" title="Principal amount"&gt;3,600,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
with an &lt;span id="xdx_90A_ecustom--OriginalIssueDiscountPercentage_iI_dp_uPure_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zQRUZduzdTnb" title="Original issue discount"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
original issue discount (&#x201c;OID&#x201d;) for a total funding amount of $&lt;span id="xdx_901_eus-gaap--ConvertibleDebt_iI_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zXEkdbkrkDWh" title="Convertible debt"&gt;3,312,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
notes bear interest at a rate of &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zFzM9x8DUYB" title="Interest rate"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
per annum and a maturity date of &lt;span id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20240115__20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zOLIETcCFTHa" title="Maturity date description"&gt;36
months&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;. The noteholder was given the right to
convert all or any amount of the principal face amount into the ordinary shares of the Company at a conversion price based on the lowest
closing price of the Company&#x2019;s ordinary shares as reported on the Nasdaq Capital Market during the five (5) trading days immediately
preceding the date of conversion, provided, however that conversion price shall not be lower than $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240115_zdDMn6p2lj28" title="Conversion price"&gt;0.80
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share. In addition to the Convertible Notes,
the note holder received an aggregate &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240115__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zIAwVzt5BTGf" title="Warrant outstanding"&gt;5,645,455
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants. The warrants have an exercise price
of $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240115__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zLEfbJG5WBri" title="Exercise price"&gt;1.056&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share which represents &lt;span id="xdx_900_ecustom--WarrantSharePricePercentage_iI_pid_dp_c20240115__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z6AWQIzHVd21" title="Warrant share price percentage"&gt;120&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the share price on the Nasdaq Capital Market as of the issue date, and have a &lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20240115__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zVHahspFGcEi" title="Warrants exercise term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0786"&gt;five&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-year
exercise term. The noteholder has paid the Company $&lt;span id="xdx_901_ecustom--ProceedsFromIssuanceOfConvertibleNotes_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zLMqq3Bgjqbk" title="Proceeds from issuance of convertible notes"&gt;1,840,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;as of June 30, 2024, thus there was a capital
receivable of $&lt;span id="xdx_90C_ecustom--CapitalReceivablesOfConvertibleNotes_iI_c20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z9LxUNPe6Io6" title="Capital receivables of convertible notes"&gt;1,472,000&lt;/span&gt; as of June 30, 2024.&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This capital receivable has been fully settled subsequent to
June 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has used the Black Scholes model to evaluate the fair value of the aforesaid warrants attached to the Convertible Notes at $&lt;span id="xdx_909_ecustom--ConvertibleNotes_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z2qcEdn5Ya96" title="Convertible note"&gt;820,088
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in total. These Convertible Notes were fully
converted into shares during the fiscal year ended June 30, 2024, on cashless basis and converted into &lt;span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z2TpbdcLcz06" title="Shares issued upon note conversion"&gt;4,090,909
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares, at which time the discount was fully amortized, which totaled $&lt;span id="xdx_903_eus-gaap--AmortizationOfDebtDiscountPremium_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_ze0Q8wOzMNta" title="Amortization of debt discount"&gt;1,108,088&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact000768"
      unitRef="USD">3600000</us-gaap:DebtInstrumentFaceAmount>
    <FTEL:OriginalIssueDiscountPercentage
      contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000770"
      unitRef="Pure">0.08</FTEL:OriginalIssueDiscountPercentage>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact000772"
      unitRef="USD">3312000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-01-15_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000774"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="From2024-01-152024-01-15_custom_ConvertibleNotesMember"
      id="Fact000776">36
months</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-01-15"
      decimals="INF"
      id="Fact000778"
      unitRef="USDPShares">0.80</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-01-15_custom_WarrantTwoMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000780"
      unitRef="Shares">5645455</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-01-15_custom_WarrantTwoMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000782"
      unitRef="USDPShares">1.056</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <FTEL:WarrantSharePricePercentage
      contextRef="AsOf2024-01-15_custom_WarrantTwoMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000784"
      unitRef="Pure">1.20</FTEL:WarrantSharePricePercentage>
    <FTEL:ProceedsFromIssuanceOfConvertibleNotes
      contextRef="From2023-07-012024-06-30_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact000788"
      unitRef="USD">1840000</FTEL:ProceedsFromIssuanceOfConvertibleNotes>
    <FTEL:CapitalReceivablesOfConvertibleNotes
      contextRef="AsOf2024-06-30_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact000790"
      unitRef="USD">1472000</FTEL:CapitalReceivablesOfConvertibleNotes>
    <FTEL:ConvertibleNotes
      contextRef="From2023-07-012024-06-30_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact000792"
      unitRef="USD">820088</FTEL:ConvertibleNotes>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-07-012024-06-30_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000794"
      unitRef="Shares">4090909</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-07-012024-06-30_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact000796"
      unitRef="USD">1108088</us-gaap:AmortizationOfDebtDiscountPremium>
    <FTEL:WarrantsDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000798">&lt;p id="xdx_805_ecustom--WarrantsDisclosureTextBlock_zmVxCWWCRghf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;&lt;span id="xdx_822_z3tRHah10IQ5"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal year June 30, 2024, the Company has issued &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zFzMRREJ7DL4" title="Warrants issued"&gt;30,000&lt;/span&gt; warrants on a net basis, and &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zS8Wyyhl13Hb" title="Warrants issued"&gt;5,645,455&lt;/span&gt; warrants, respectively, to the IPO
underwriter and the Convertible Notes noteholder. All of the warrants were fully converted into shares during the fiscal year June 30,
2024. They were all converted based on cashless basis, and converted into &lt;span id="xdx_90E_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zPWc1yCK3acc" title="Warrants converted into shares"&gt;19,750&lt;/span&gt; shares and &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zGmDUZXbawL8" title="Warrants converted into shares"&gt;4,892,727&lt;/span&gt; shares respectively. The warrants
are detailed as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z27Osr7LE71i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zVeEWUeTc6l9" style="display: none"&gt;Schedule
of Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Contractual Term (in years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Outstanding as June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl7LbqMSYDBl" style="text-align: right" title="Number of warrants, Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0810"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7iYr2Sl25F5" style="text-align: right" title="Weighted-Average Exercise Price, Outstanding, Beginning Balance"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0812"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMFmN1Ae01D7" style="width: 12%; text-align: right" title="Number of warrants, Granted"&gt;5,675,455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrGzWlSoHkLj" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Granted"&gt;1.08&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zy8FrtL4KYZ9" title="Weighted Average Contractual Term (in years), Granted"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercised&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuzWMVOUjIBa" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Exercised"&gt;(5,675,455&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zx317BbuXLOa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0822"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding as June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zY0JujF3k1D5" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Ouststanding, Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0824"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6tdc1iFjq66" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0826"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zPWifVD66gG6" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each warrant on the date of grant is estimated using the Black-Scholes option valuation model. The following weighted-average
assumptions were used for warrants granted during the year ended June 30, 2024: exercise price of $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zFNJOtl4CUZ1" title="Exercise price"&gt;1.0560&lt;/span&gt;, expected term of &lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUSa7VKLlzz" title="Expected term"&gt;five years&lt;/span&gt;,
expected average volatility of &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zJrEWFFzH767" title="Expected average volatility"&gt;27.76&lt;/span&gt;%, &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dpo_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zbjdeboQpQd8" title="Expected dividend yield"&gt;no&lt;/span&gt; expected dividend yield, and risk-free interest rate of &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPgigwPqsDHi" title="Risk-free interest rate"&gt;3.84&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FTEL:WarrantsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_WarrantOneMember"
      decimals="INF"
      id="Fact000800"
      unitRef="Shares">30000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_WarrantTwoMember"
      decimals="INF"
      id="Fact000802"
      unitRef="Shares">5645455</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-07-012024-06-30_custom_WarrantOneMember"
      decimals="INF"
      id="Fact000804"
      unitRef="Shares">19750</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-07-012024-06-30_custom_WarrantTwoMember"
      decimals="INF"
      id="Fact000806"
      unitRef="Shares">4892727</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000808">&lt;p id="xdx_89B_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z27Osr7LE71i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zVeEWUeTc6l9" style="display: none"&gt;Schedule
of Warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Contractual Term (in years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Outstanding as June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl7LbqMSYDBl" style="text-align: right" title="Number of warrants, Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0810"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsWeightedAverageExercisePrice_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7iYr2Sl25F5" style="text-align: right" title="Weighted-Average Exercise Price, Outstanding, Beginning Balance"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0812"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMFmN1Ae01D7" style="width: 12%; text-align: right" title="Number of warrants, Granted"&gt;5,675,455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrGzWlSoHkLj" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Granted"&gt;1.08&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zy8FrtL4KYZ9" title="Weighted Average Contractual Term (in years), Granted"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Exercised&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuzWMVOUjIBa" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Exercised"&gt;(5,675,455&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zx317BbuXLOa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0822"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding as June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zY0JujF3k1D5" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, Ouststanding, Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0824"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercisable_iE_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6tdc1iFjq66" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0826"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953"
      decimals="INF"
      id="Fact000814"
      unitRef="Shares">5675455</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <FTEL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953"
      decimals="INF"
      id="Fact000816"
      unitRef="Shares">1.08</FTEL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted>
    <FTEL:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953"
      id="Fact000818">P5Y</FTEL:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember175940953"
      decimals="INF"
      id="Fact000820"
      unitRef="Shares">-5675455</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000828"
      unitRef="USDPShares">1.0560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      id="Fact000830">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000832"
      unitRef="Pure">0.2776</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000834"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000836"
      unitRef="Pure">0.0384</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000838">&lt;p id="xdx_807_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zHS2Hmq9Y6Fi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_822_zIE8ajkraa5"&gt;Note Receivables&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 2, 2023, the Company has entered into a loan agreement with an independent third party (&#x201c;Borrower&#x201d;), in which,
the Company has lent $&lt;span id="xdx_905_eus-gaap--OtherReceivablesNetCurrent_iI_c20230802_z2XCsHGQC3vd" title="Loan lended amount"&gt;2,500,000&lt;/span&gt;
to the Borrower, with a loan period of &lt;span id="xdx_90F_eus-gaap--DebtInstrumentTerm_dtM_c20230802__20230802_zB6ESpLjNT27" title="Loan period"&gt;36&lt;/span&gt;
months, and at an annualized interest of &lt;span id="xdx_909_ecustom--DebtInstrumentIncreaseAccruedInterestPercentage_dp_uPure_c20230802__20230802_zedRkryPdsr4" title="Annualized interest"&gt;6.8&lt;/span&gt;%,
with the first eight months being interest-free. The Company has the option to convert this loan into equity of the Borrower. As of
June 30, 2024, the total balance outstanding was $&lt;span id="xdx_905_eus-gaap--NotesAndLoansReceivableNetCurrent_iI_c20240630_zepvfZRjmC43" title="Note receivable outstanding"&gt;2,500,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2023-08-02"
      decimals="0"
      id="Fact000840"
      unitRef="USD">2500000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:DebtInstrumentTerm contextRef="From2023-08-022023-08-02" id="Fact000842">P36M</us-gaap:DebtInstrumentTerm>
    <FTEL:DebtInstrumentIncreaseAccruedInterestPercentage
      contextRef="From2023-08-022023-08-02"
      decimals="INF"
      id="Fact000844"
      unitRef="Pure">0.068</FTEL:DebtInstrumentIncreaseAccruedInterestPercentage>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000846"
      unitRef="USD">2500000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000848">&lt;p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zk27CUEGmah7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_82A_zjEgIF49u6Y6"&gt;Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zkHrHygNCJSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s property and equipment at June 30, 2024 and 2023 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zX0BPzo7oCg7" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful Life&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240630_zqPzPufjjqea" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230630_zz8st7gQp3n" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zyKeB7OeBCee" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 48%; text-align: left; padding-bottom: 1pt"&gt;Motor Vehicle&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zIl6FYmYshe5" title="Estimated Useful Life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;51,741&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;51,741&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzbdW_zdSzExPJk0yl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Property and equipment, gross&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,741&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,741&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzbdW_zyTLiZfNDHbd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,608&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(12,998&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzbdW_zI877cMqrynh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;27,133&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;38,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A1_zyCQ6dy5ARHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended June 30, 2024 and 2023, the Company recorded $&lt;span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20230701__20240630_z5zGcv8hzGb4" title="Depreciation expense"&gt;10,385&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20220701__20230630_zuI1tqfzbwOd" title="Depreciation"&gt;12,268&lt;/span&gt;, respectively, of depreciation expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000850">&lt;p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zkHrHygNCJSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s property and equipment at June 30, 2024 and 2023 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zX0BPzo7oCg7" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful Life&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240630_zqPzPufjjqea" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230630_zz8st7gQp3n" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zyKeB7OeBCee" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 48%; text-align: left; padding-bottom: 1pt"&gt;Motor Vehicle&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zIl6FYmYshe5" title="Estimated Useful Life"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;51,741&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;51,741&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzbdW_zdSzExPJk0yl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Property and equipment, gross&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,741&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,741&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzbdW_zyTLiZfNDHbd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,608&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(12,998&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzbdW_zI877cMqrynh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;27,133&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;38,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-06-30_us-gaap_VehiclesMember"
      id="Fact000855">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_us-gaap_VehiclesMember"
      decimals="0"
      id="Fact000852"
      unitRef="USD">51741</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_VehiclesMember"
      decimals="0"
      id="Fact000853"
      unitRef="USD">51741</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000857"
      unitRef="USD">51741</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000858"
      unitRef="USD">51741</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000860"
      unitRef="USD">24608</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000861"
      unitRef="USD">12998</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000863"
      unitRef="USD">27133</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000864"
      unitRef="USD">38743</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000866"
      unitRef="USD">10385</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000868"
      unitRef="USD">12268</us-gaap:Depreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000870">&lt;p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_zOkYJXgVjthf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_829_zoQ0pznev3M3"&gt;Lease right-of-use assets and lease liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Operating
leases&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company leases office space in Taren Point, NSW, Australia. The lease commenced July 15, 2018 and ended on July 14, 2023, at which time
the Company extended the lease, which commenced on July 15, 2023 and ends on July 14, 2026. The initial monthly lease
payments are $&lt;span id="xdx_900_eus-gaap--OperatingLeasePayments_uAUD_c20230701__20240630_zn94Q1PViOBa" title="Operating lease payments"&gt;25,000&lt;/span&gt; AUD and the monthly payments of the lease extension are $&lt;span id="xdx_90E_eus-gaap--OperatingLeasePaymentsUse_uAUD_c20230701__20240630_z2Us7J2ANlQ2" title="Operating lease payments"&gt;36,667&lt;/span&gt; AUD and are subject to annual escalation
rate of &lt;span id="xdx_907_ecustom--AnnualEscalationRate_pid_dp_uPure_c20230701__20240630_zygwthcABA0f" title="Annual escalation rate"&gt;3&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
lease right-of-use assets and liabilities are recognized at the present value of the future lease payments at the lease commencement
date. The interest rate used to determine the present value is the Company&#x2019;s incremental borrowing rate, estimated to be &lt;span id="xdx_90A_ecustom--IncrementalBorrowingRate_pid_dp_uPure_c20230701__20240630_zHqQq9xmdfLd" title="Incremental borrowing rate"&gt;3.70&lt;/span&gt;%,
as the interest rate implicit in most of the Company leases is not readily determinable. Operating lease expense is recognized on a straight-line
basis over the lease term. During the years ended June 30, 2024 and 2023, the Company recorded $&lt;span id="xdx_908_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zZTygI2sILZ3" title="Operating lease expense"&gt;284,169&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--OperatingLeaseExpense_c20220701__20230630_zIS3dwhNf36" title="Operating lease expense"&gt;198,914&lt;/span&gt;, respectively, as
operating lease expense on the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--LeaseCostTableTextBlock_z7diGR7hWIqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
right-of- use assets are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_zbSyHoMEwi66" style="display: none"&gt;Schedule
of Operating Right of use Assets and Operating Lease Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240630_z8WknsJvSLz8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230630_zfuq8aTlSJce" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RightOfUseAssetsForOfficeLease_iI_zhiqXCzHStIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Office lease&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;836,697&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,541,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AdjustmentForAmortizations_iI_zsJX6Wbr891f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(278,899&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(935,596&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zESJ0dHRni16" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Right-of-use, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;557,798&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;605,794&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
    lease liabilities are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630_zacSsWYNQJv9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230630_zNZO6lj9hDr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zC0qo7YHYdE6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OperatingLeaseLiabilityForOfficeLease_i01I_zCsMAC5wtQCe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Office lease&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;580,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;685,077&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_z5sJvuQBVZEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;278,432&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;212,062&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_z973UiSt0dl4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long term portion&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;301,921&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;473,015&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zec8Dg8mIGBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zO1BmhNRgKLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zcaODomHCCHh"&gt;Schedule of Maturity of Operating Lease Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630_zoRlLsgTAAH4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzYvG_zlDHNGCMXp5k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Year ending June 30, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;301,127&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzYvG_z5SoOw7qQHQd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Year ending June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;310,160&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzYvG_z044FjJ7QmHd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total future minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;611,287&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zV7QKS0QdEFb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(30,934&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseLiability_iTI_zwPZuivlSuua" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;PV of Payments&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;580,353&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zKEgMofct5Pl" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FITELL
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000872"
      unitRef="AUD">25000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePaymentsUse
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000874"
      unitRef="AUD">36667</us-gaap:OperatingLeasePaymentsUse>
    <FTEL:AnnualEscalationRate
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000876"
      unitRef="Pure">0.03</FTEL:AnnualEscalationRate>
    <FTEL:IncrementalBorrowingRate
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000878"
      unitRef="Pure">0.0370</FTEL:IncrementalBorrowingRate>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000880"
      unitRef="USD">284169</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000882"
      unitRef="USD">198914</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000884">&lt;p id="xdx_899_eus-gaap--LeaseCostTableTextBlock_z7diGR7hWIqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
right-of- use assets are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_zbSyHoMEwi66" style="display: none"&gt;Schedule
of Operating Right of use Assets and Operating Lease Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240630_z8WknsJvSLz8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230630_zfuq8aTlSJce" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RightOfUseAssetsForOfficeLease_iI_zhiqXCzHStIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Office lease&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;836,697&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,541,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AdjustmentForAmortizations_iI_zsJX6Wbr891f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(278,899&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(935,596&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zESJ0dHRni16" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Right-of-use, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;557,798&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;605,794&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
    lease liabilities are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630_zacSsWYNQJv9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230630_zNZO6lj9hDr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityAbstract_iB_zC0qo7YHYdE6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OperatingLeaseLiabilityForOfficeLease_i01I_zCsMAC5wtQCe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Office lease&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;580,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;685,077&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_z5sJvuQBVZEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: current portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;278,432&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;212,062&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_z973UiSt0dl4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long term portion&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;301,921&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;473,015&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <FTEL:RightOfUseAssetsForOfficeLease
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000886"
      unitRef="USD">836697</FTEL:RightOfUseAssetsForOfficeLease>
    <FTEL:RightOfUseAssetsForOfficeLease
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000887"
      unitRef="USD">1541390</FTEL:RightOfUseAssetsForOfficeLease>
    <FTEL:AdjustmentForAmortizations
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000889"
      unitRef="USD">-278899</FTEL:AdjustmentForAmortizations>
    <FTEL:AdjustmentForAmortizations
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000890"
      unitRef="USD">-935596</FTEL:AdjustmentForAmortizations>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000892"
      unitRef="USD">557798</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000893"
      unitRef="USD">605794</us-gaap:OperatingLeaseRightOfUseAsset>
    <FTEL:OperatingLeaseLiabilityForOfficeLease
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000898"
      unitRef="USD">580353</FTEL:OperatingLeaseLiabilityForOfficeLease>
    <FTEL:OperatingLeaseLiabilityForOfficeLease
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000899"
      unitRef="USD">685077</FTEL:OperatingLeaseLiabilityForOfficeLease>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000901"
      unitRef="USD">278432</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000902"
      unitRef="USD">212062</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000904"
      unitRef="USD">301921</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000905"
      unitRef="USD">473015</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000907">&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zO1BmhNRgKLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zcaODomHCCHh"&gt;Schedule of Maturity of Operating Lease Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240630_zoRlLsgTAAH4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzYvG_zlDHNGCMXp5k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Year ending June 30, 2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;301,127&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzYvG_z5SoOw7qQHQd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Year ending June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;310,160&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzYvG_z044FjJ7QmHd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total future minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;611,287&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zV7QKS0QdEFb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(30,934&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseLiability_iTI_zwPZuivlSuua" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;PV of Payments&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;580,353&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000909"
      unitRef="USD">301127</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000911"
      unitRef="USD">310160</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000913"
      unitRef="USD">611287</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000915"
      unitRef="USD">30934</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000917"
      unitRef="USD">580353</us-gaap:OperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000919">&lt;p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z0RBL5Jms2u6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_825_zRpEOWSw6TSi"&gt;Commitments and contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates
the merits of the case in accordance with ASC 450-20-50, &lt;i&gt;Contingencies&lt;/i&gt;. The Company evaluates its exposure to the matter, possible
legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is
probable and can be reasonably estimated, it establishes the necessary accruals. As of June 30, 2024 and 2023, the Company is not aware
of any contingent liabilities that should be reflected in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000921">&lt;p id="xdx_805_eus-gaap--IncomeTaxDisclosureTextBlock_zwZTE5NCS7La" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_820_zDSmsY44uTFj"&gt;Income taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zY8kUMKyxBC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the effective tax rate to the statutory rate is shown below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span id="xdx_8B9_zey4Pai7f8cb" style="display: none"&gt;Schedule of Reconciliation of Provision of Income Tax&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230701__20240630_zs18L6nifvxg" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220701__20230630_z9A0mcQEcnh1" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z8aJc3TVMtM5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 1pt"&gt;Loss before taxes&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;(9,521,488&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;(1,619,155&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsTax_znaiwqsugeAa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Expected income tax credit at statutory rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230701__20240630_zCHlPT3bxFlc" title="Expected income tax credit at statutory rate, percent"&gt;25&lt;/span&gt;% &lt;br/&gt;(2023: &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20220701__20230630_zhpj2PjROZSe" title="Expected income tax credit at statutory rate, percent"&gt;25&lt;/span&gt;%)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,380,372&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(404,789&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Increase (decrease) in income taxes resulting from:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_zEwqseE5qKti" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock issued for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;140,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses_zFiKXX8cI9Mj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;IPO related expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,622&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt_z2b5pX2Pwvpc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Provision for bad debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_zkN7g8795bXi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unrealized loss on investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,695&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;131,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost_zqGc2MhZLRkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Government Subsidy Tech Boost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0947"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,721&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncomeTaxReconciliationNondeductibleExpenseDebtDiscount_zoabnxNW9Vf7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Debt discount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;277,022&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome_zUN0f0fzz93g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-taxable other income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(30,472&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0954"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses_zAUheZ3dBiwl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;-Non-tax deductible personnel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees_zdlrPyauni4l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-tax deductible consulting fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,367,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0960"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses_zeko93dyfLca" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-tax deductible general and administrative expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;308,512&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxContingenciesOther_z1RkZtK6PVX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other items, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(26,742&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(20,207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_zr01HQ1Q6xod" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(209,343&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(25,761&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zUbbi7ykRf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zWQcrDJeQtec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
tax effects temporary differences that gave rise to the deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BF_zXR1LzmgNvx9" style="display: none"&gt;Schedule of Components of Deferred Tax Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240630_zKpglvizraSe" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230630_z0HpqOiPyBca" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_zCC5nGc12gLj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Accrued employee benefits&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;37,199&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,877&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_iI_zxktZAdYfdY9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unrealized loss on investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0976"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredTaxAssetsUnrealizedCurrencyGain_iNI_di_zNMV84rbgKPa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unrealized foreign exchange gain&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,394&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredTaxAssetsDepreciation_zO7prOH2xZ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,783&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities_iI_zryj0QXs4Yve" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Operating right of use assets and lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0986"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeferredTaxAssetsAccumulatedTaxLoss_iI_zTPtHKunWhQ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accumulated tax loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;238,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0989"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zUsJv7Ux7es6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Provision for bad debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;56,784&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;106,740&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iI_zwnXuUX1CPyj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;342,122&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;132,354&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zEHt4BY2O99a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024 and 2023, the Company had no material net operating loss or tax credit carryforwards. As of June 30, 2024 and 2023,
the Company had no provision for uncertain tax positions and no provisions for penalties or interest. In addition, the Company does not
believe that there are any uncertain tax benefits that could be recognized in the near future that would impact the Company&#x2019;s effective
tax rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000923">&lt;p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zY8kUMKyxBC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the effective tax rate to the statutory rate is shown below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span id="xdx_8B9_zey4Pai7f8cb" style="display: none"&gt;Schedule of Reconciliation of Provision of Income Tax&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230701__20240630_zs18L6nifvxg" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220701__20230630_z9A0mcQEcnh1" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z8aJc3TVMtM5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 1pt"&gt;Loss before taxes&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;(9,521,488&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;(1,619,155&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossBeforeReclassificationsTax_znaiwqsugeAa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Expected income tax credit at statutory rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230701__20240630_zCHlPT3bxFlc" title="Expected income tax credit at statutory rate, percent"&gt;25&lt;/span&gt;% &lt;br/&gt;(2023: &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHJlY29uY2lsaWF0aW9uIG9mIHByb3Zpc2lvbiBvZiBpbmNvbWUgdGF4IChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20220701__20230630_zhpj2PjROZSe" title="Expected income tax credit at statutory rate, percent"&gt;25&lt;/span&gt;%)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,380,372&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(404,789&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Increase (decrease) in income taxes resulting from:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices_zEwqseE5qKti" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock issued for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;140,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses_zFiKXX8cI9Mj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;IPO related expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,622&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt_z2b5pX2Pwvpc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Provision for bad debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments_zkN7g8795bXi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unrealized loss on investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,695&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;131,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost_zqGc2MhZLRkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Government Subsidy Tech Boost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0947"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,721&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncomeTaxReconciliationNondeductibleExpenseDebtDiscount_zoabnxNW9Vf7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Debt discount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;277,022&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome_zUN0f0fzz93g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-taxable other income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(30,472&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0954"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses_zAUheZ3dBiwl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;-Non-tax deductible personnel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees_zdlrPyauni4l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-tax deductible consulting fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,367,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0960"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses_zeko93dyfLca" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-tax deductible general and administrative expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;308,512&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationTaxContingenciesOther_z1RkZtK6PVX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other items, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(26,742&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(20,207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_zr01HQ1Q6xod" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(209,343&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(25,761&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000925"
      unitRef="USD">-9521488</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000926"
      unitRef="USD">-1619155</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-07-01to2024-06-30"
      decimals="INF"
      id="Fact000931"
      unitRef="Pure">0.25</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact000933"
      unitRef="Pure">0.25</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000928"
      unitRef="USD">-2380372</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000929"
      unitRef="USD">-404789</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000936"
      unitRef="USD">140000</FTEL:IncomeTaxReconciliationNondeductibleExpenseStockIssuedForServices>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000938"
      unitRef="USD">12622</FTEL:IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000939"
      unitRef="USD">27601</FTEL:IncomeTaxReconciliationNondeductibleExpenseIpoRelatedExpenses>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000941"
      unitRef="USD">144816</FTEL:IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000942"
      unitRef="USD">106742</FTEL:IncomeTaxReconciliationNondeductibleExpenseProvisionForBadDebt>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000944"
      unitRef="USD">88695</FTEL:IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000945"
      unitRef="USD">131613</FTEL:IncomeTaxReconciliationNondeductibleExpenseUnrealizedLossOnInvestments>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000948"
      unitRef="USD">-6721</FTEL:IncomeTaxReconciliationNondeductibleExpenseGovernmentSubsidyTechBoost>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseDebtDiscount
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000950"
      unitRef="USD">277022</FTEL:IncomeTaxReconciliationNondeductibleExpenseDebtDiscount>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000953"
      unitRef="USD">-30472</FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxableOtherIncome>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000956"
      unitRef="USD">29544</FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductiblePersonnelExpenses>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000959"
      unitRef="USD">1367032</FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleConsultingFees>
    <FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000962"
      unitRef="USD">308512</FTEL:IncomeTaxReconciliationNondeductibleExpenseNontaxDeductibleGeneralAndAdministrativeExpenses>
    <us-gaap:IncomeTaxReconciliationTaxContingenciesOther
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000965"
      unitRef="USD">-26742</us-gaap:IncomeTaxReconciliationTaxContingenciesOther>
    <us-gaap:IncomeTaxReconciliationTaxContingenciesOther
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000966"
      unitRef="USD">-20207</us-gaap:IncomeTaxReconciliationTaxContingenciesOther>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2024-06-30"
      decimals="0"
      id="Fact000968"
      unitRef="USD">-209343</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000969"
      unitRef="USD">-25761</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000971">&lt;p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zWQcrDJeQtec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
tax effects temporary differences that gave rise to the deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BF_zXR1LzmgNvx9" style="display: none"&gt;Schedule of Components of Deferred Tax Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240630_zKpglvizraSe" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230630_z0HpqOiPyBca" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_zCC5nGc12gLj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Accrued employee benefits&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;37,199&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,877&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_iI_zxktZAdYfdY9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unrealized loss on investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0976"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredTaxAssetsUnrealizedCurrencyGain_iNI_di_zNMV84rbgKPa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unrealized foreign exchange gain&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,394&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredTaxAssetsDepreciation_zO7prOH2xZ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,783&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities_iI_zryj0QXs4Yve" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Operating right of use assets and lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0986"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeferredTaxAssetsAccumulatedTaxLoss_iI_zTPtHKunWhQ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accumulated tax loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;238,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0989"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_zUsJv7Ux7es6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Provision for bad debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;56,784&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;106,740&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iI_zwnXuUX1CPyj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;342,122&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;132,354&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000973"
      unitRef="USD">37199</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000974"
      unitRef="USD">1877</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000977"
      unitRef="USD">22082</us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities>
    <FTEL:DeferredTaxAssetsUnrealizedCurrencyGain
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000979"
      unitRef="USD">-10294</FTEL:DeferredTaxAssetsUnrealizedCurrencyGain>
    <FTEL:DeferredTaxAssetsUnrealizedCurrencyGain
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000980"
      unitRef="USD">1394</FTEL:DeferredTaxAssetsUnrealizedCurrencyGain>
    <FTEL:DeferredTaxAssetsDepreciation
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000982"
      unitRef="USD">-6783</FTEL:DeferredTaxAssetsDepreciation>
    <FTEL:DeferredTaxAssetsDepreciation
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000983"
      unitRef="USD">3049</FTEL:DeferredTaxAssetsDepreciation>
    <FTEL:DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000985"
      unitRef="USD">5639</FTEL:DeferredTaxAssetsOperatingRightOfUseAssetsAndLeaseLiabilities>
    <FTEL:DeferredTaxAssetsAccumulatedTaxLoss
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000988"
      unitRef="USD">238989</FTEL:DeferredTaxAssetsAccumulatedTaxLoss>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000991"
      unitRef="USD">56784</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000992"
      unitRef="USD">106740</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000994"
      unitRef="USD">342122</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000995"
      unitRef="USD">132354</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-07-01to2024-06-30" id="Fact000997">&lt;p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zCgMXinV4fo5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11. &lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_82A_zlEzodukS974"&gt;Due to Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amount due to a related party called Ansa Group Limited (&#x201c;Ansa&#x201d;), an entity under common control of the majority shareholder
of the Company was $&lt;span id="xdx_90D_eus-gaap--OtherLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zclZIcclJq73"&gt;38,808&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--OtherLiabilitiesCurrent_iI_c20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zJBYRoZ8bM87" title="Amount due to related party"&gt;24,386&lt;/span&gt; as at June 30, 2024 and 2023 respectively. The balance is interest-free and does not have a fixed
maturity. The terms are not necessarily indicative of what a third party would agree to.&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000998"
      unitRef="USD">38808</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001000"
      unitRef="USD">24386</us-gaap:OtherLiabilitiesCurrent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
